primaryid,caseid,drug_seq,role_cod,drugname,prod_ai,val_vbm,route,dose_vbm,cum_dose_chr,cum_dose_unit,dechal,rechal,lot_num,exp_dt,nda_num,dose_amt,dose_unit,dose_form,dose_freq,year_x,quarter_x,pt,drug_rec_act,year_y,quarter_y,caseversion,i_f_code,event_dt,mfr_dt,init_fda_dt,fda_dt,rept_cod,auth_num,mfr_num,mfr_sndr,lit_ref,age,age_cod,age_grp,sex,e_sub,wt,wt_cod,rept_dt,to_mfr,occp_cod,reporter_country,occr_country,year,quarter,age_group
100106813,10010681,8,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,35 UNITS QHS,,,,,,,,,,,,2016,Q1,Angioedema,,2016,Q1,3,F,,20160203.0,20140314,20160217,EXP,,US-RANBAXY-2014US-78398,RANBAXY,,67.0,YR,,M,Y,,,20160217.0,,OT,GB,US,2016,Q1,Elderly
103846514,10384651,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, QD",62.0,IU,,,,,,14.0,IU,,QD,2016,Q1,Blood urea increased,,2016,Q1,4,F,20140803.0,20160324.0,20140814,20160328,EXP,,KR-OTSUKA-JP-2014-16603,OTSUKA,,75.0,YR,,F,Y,,,20160328.0,,MD,KR,KR,2016,Q1,Elderly
103846514,10384651,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, QD",62.0,IU,,,,,,14.0,IU,,QD,2016,Q1,Hyperglycaemia,,2016,Q1,4,F,20140803.0,20160324.0,20140814,20160328,EXP,,KR-OTSUKA-JP-2014-16603,OTSUKA,,75.0,YR,,F,Y,,,20160328.0,,MD,KR,KR,2016,Q1,Elderly
103846514,10384651,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, QD",62.0,IU,,,,,,14.0,IU,,QD,2016,Q1,Pulmonary oedema,,2016,Q1,4,F,20140803.0,20160324.0,20140814,20160328,EXP,,KR-OTSUKA-JP-2014-16603,OTSUKA,,75.0,YR,,F,Y,,,20160328.0,,MD,KR,KR,2016,Q1,Elderly
103846514,10384651,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",62.0,IU,,,,,,20.0,IU,,QD,2016,Q1,Blood urea increased,,2016,Q1,4,F,20140803.0,20160324.0,20140814,20160328,EXP,,KR-OTSUKA-JP-2014-16603,OTSUKA,,75.0,YR,,F,Y,,,20160328.0,,MD,KR,KR,2016,Q1,Elderly
103846514,10384651,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",62.0,IU,,,,,,20.0,IU,,QD,2016,Q1,Hyperglycaemia,,2016,Q1,4,F,20140803.0,20160324.0,20140814,20160328,EXP,,KR-OTSUKA-JP-2014-16603,OTSUKA,,75.0,YR,,F,Y,,,20160328.0,,MD,KR,KR,2016,Q1,Elderly
103846514,10384651,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",62.0,IU,,,,,,20.0,IU,,QD,2016,Q1,Pulmonary oedema,,2016,Q1,4,F,20140803.0,20160324.0,20140814,20160328,EXP,,KR-OTSUKA-JP-2014-16603,OTSUKA,,75.0,YR,,F,Y,,,20160328.0,,MD,KR,KR,2016,Q1,Elderly
103846514,10384651,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU, QD",62.0,IU,,,,,,28.0,IU,,QD,2016,Q1,Blood urea increased,,2016,Q1,4,F,20140803.0,20160324.0,20140814,20160328,EXP,,KR-OTSUKA-JP-2014-16603,OTSUKA,,75.0,YR,,F,Y,,,20160328.0,,MD,KR,KR,2016,Q1,Elderly
103846514,10384651,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU, QD",62.0,IU,,,,,,28.0,IU,,QD,2016,Q1,Hyperglycaemia,,2016,Q1,4,F,20140803.0,20160324.0,20140814,20160328,EXP,,KR-OTSUKA-JP-2014-16603,OTSUKA,,75.0,YR,,F,Y,,,20160328.0,,MD,KR,KR,2016,Q1,Elderly
103846514,10384651,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU, QD",62.0,IU,,,,,,28.0,IU,,QD,2016,Q1,Pulmonary oedema,,2016,Q1,4,F,20140803.0,20160324.0,20140814,20160328,EXP,,KR-OTSUKA-JP-2014-16603,OTSUKA,,75.0,YR,,F,Y,,,20160328.0,,MD,KR,KR,2016,Q1,Elderly
104962836,10496283,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 MG, UNK",,,,,,,,15.0,MG,,,2016,Q1,Haemorrhage intracranial,,2016,Q1,6,F,20140829.0,20160302.0,20141003,20160317,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-21442439,BRISTOL MYERS SQUIBB,,62.0,YR,,M,Y,70.29,KG,20160317.0,,OT,US,US,2016,Q1,Adult
104962836,10496283,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 MG, UNK",,,,,,,,15.0,MG,,,2016,Q1,Post transplant lymphoproliferative disorder,,2016,Q1,6,F,20140829.0,20160302.0,20141003,20160317,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-21442439,BRISTOL MYERS SQUIBB,,62.0,YR,,M,Y,70.29,KG,20160317.0,,OT,US,US,2016,Q1,Adult
106538655,10653865,30,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q1,Bronchitis,,2016,Q1,5,F,20141007.0,20160120.0,20141216,20160126,EXP,,JP-ROCHE-1473529,ROCHE,,48.0,YR,,F,Y,61.1,KG,20160126.0,,MD,JP,JP,2016,Q1,Adult
106837427,10683742,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q1,Hyperglycaemia,,2016,Q1,7,F,20141213.0,20160309.0,20141230,20160316,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2014-001999,BRISTOL MYERS SQUIBB,,55.0,YR,,F,Y,45.0,KG,20160316.0,,OT,US,US,2016,Q1,Adult
106837427,10683742,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q1,Hypophysitis,,2016,Q1,7,F,20141213.0,20160309.0,20141230,20160316,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2014-001999,BRISTOL MYERS SQUIBB,,55.0,YR,,F,Y,45.0,KG,20160316.0,,OT,US,US,2016,Q1,Adult
106837427,10683742,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q1,Pulmonary embolism,,2016,Q1,7,F,20141213.0,20160309.0,20141230,20160316,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2014-001999,BRISTOL MYERS SQUIBB,,55.0,YR,,F,Y,45.0,KG,20160316.0,,OT,US,US,2016,Q1,Adult
107026833,10702683,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Anaemia,,2016,Q1,3,F,20140802.0,20150106.0,20150109,20160118,EXP,,US-ASTRAZENECA-2015SE02757,ASTRAZENECA,,24401.0,DY,,M,Y,,,20160118.0,,MD,US,US,2016,Q1,Elderly
107026833,10702683,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Gastrointestinal haemorrhage,,2016,Q1,3,F,20140802.0,20150106.0,20150109,20160118,EXP,,US-ASTRAZENECA-2015SE02757,ASTRAZENECA,,24401.0,DY,,M,Y,,,20160118.0,,MD,US,US,2016,Q1,Elderly
107795022,10779502,5,C,glargine insulin,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Acute kidney injury,,2016,Q1,2,F,,20160315.0,20150210,20160329,EXP,,US-DRREDDYS-USA/USA/15/0045941,DR REDDYS,"BAIRD P, LEUNG S, HOANG H, BABALOLA O, DEVOE C, WANCHOO R, ET AL. A CASE OF ACUTE KIDNEY INJURY FROM CRYSTAL NEPHROPATHY SECONDARY TO POMALIDOMIDE AND LEVOFLOXACIN USE. J ONCOL PHARM PRACT. 2016?22(2):357-60.",76.0,YR,,F,Y,,,20160329.0,,MD,COUNTRY NOT SPECIFIED,US,2016,Q1,Elderly
107795022,10779502,5,C,glargine insulin,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Crystal nephropathy,,2016,Q1,2,F,,20160315.0,20150210,20160329,EXP,,US-DRREDDYS-USA/USA/15/0045941,DR REDDYS,"BAIRD P, LEUNG S, HOANG H, BABALOLA O, DEVOE C, WANCHOO R, ET AL. A CASE OF ACUTE KIDNEY INJURY FROM CRYSTAL NEPHROPATHY SECONDARY TO POMALIDOMIDE AND LEVOFLOXACIN USE. J ONCOL PHARM PRACT. 2016?22(2):357-60.",76.0,YR,,F,Y,,,20160329.0,,MD,COUNTRY NOT SPECIFIED,US,2016,Q1,Elderly
107795022,10779502,5,C,glargine insulin,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Thrombocytopenia,,2016,Q1,2,F,,20160315.0,20150210,20160329,EXP,,US-DRREDDYS-USA/USA/15/0045941,DR REDDYS,"BAIRD P, LEUNG S, HOANG H, BABALOLA O, DEVOE C, WANCHOO R, ET AL. A CASE OF ACUTE KIDNEY INJURY FROM CRYSTAL NEPHROPATHY SECONDARY TO POMALIDOMIDE AND LEVOFLOXACIN USE. J ONCOL PHARM PRACT. 2016?22(2):357-60.",76.0,YR,,F,Y,,,20160329.0,,MD,COUNTRY NOT SPECIFIED,US,2016,Q1,Elderly
107828083,10782808,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (100UNIT/ML),,,,,,,,,,INJECTION,,2016,Q1,Diarrhoea,,2016,Q1,3,F,,20160122.0,20150210,20160127,PER,,US-PFIZER INC-2012242889,PFIZER,,62.0,YR,,F,Y,,,20160127.0,,OT,US,US,2016,Q1,Adult
107828083,10782808,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (100UNIT/ML),,,,,,,,,,INJECTION,,2016,Q1,Pain,,2016,Q1,3,F,,20160122.0,20150210,20160127,PER,,US-PFIZER INC-2012242889,PFIZER,,62.0,YR,,F,Y,,,20160127.0,,OT,US,US,2016,Q1,Adult
109655606,10965560,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,26.0,IU,UNSPECIFIED,,2016,Q1,Acute kidney injury,,2016,Q1,6,F,20150315.0,20150320.0,20150330,20160129,EXP,,US-JNJFOC-20150318577,JANSSEN,,34.0,YR,A,M,Y,103.16,KG,20160129.0,,OT,US,US,2016,Q1,Young Adult
109655606,10965560,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,26.0,IU,UNSPECIFIED,,2016,Q1,Diabetic ketoacidosis,,2016,Q1,6,F,20150315.0,20150320.0,20150330,20160129,EXP,,US-JNJFOC-20150318577,JANSSEN,,34.0,YR,A,M,Y,103.16,KG,20160129.0,,OT,US,US,2016,Q1,Young Adult
109655606,10965560,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,26.0,IU,UNSPECIFIED,,2016,Q1,Dyspepsia,,2016,Q1,6,F,20150315.0,20150320.0,20150330,20160129,EXP,,US-JNJFOC-20150318577,JANSSEN,,34.0,YR,A,M,Y,103.16,KG,20160129.0,,OT,US,US,2016,Q1,Young Adult
109655606,10965560,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,26.0,IU,UNSPECIFIED,,2016,Q1,Gastroenteritis viral,,2016,Q1,6,F,20150315.0,20150320.0,20150330,20160129,EXP,,US-JNJFOC-20150318577,JANSSEN,,34.0,YR,A,M,Y,103.16,KG,20160129.0,,OT,US,US,2016,Q1,Young Adult
109655606,10965560,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,26.0,IU,UNSPECIFIED,,2016,Q1,Oral candidiasis,,2016,Q1,6,F,20150315.0,20150320.0,20150330,20160129,EXP,,US-JNJFOC-20150318577,JANSSEN,,34.0,YR,A,M,Y,103.16,KG,20160129.0,,OT,US,US,2016,Q1,Young Adult
109655606,10965560,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,26.0,IU,UNSPECIFIED,,2016,Q1,Product use issue,,2016,Q1,6,F,20150315.0,20150320.0,20150330,20160129,EXP,,US-JNJFOC-20150318577,JANSSEN,,34.0,YR,A,M,Y,103.16,KG,20160129.0,,OT,US,US,2016,Q1,Young Adult
109655606,10965560,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,26.0,IU,UNSPECIFIED,,2016,Q1,Weight decreased,,2016,Q1,6,F,20150315.0,20150320.0,20150330,20160129,EXP,,US-JNJFOC-20150318577,JANSSEN,,34.0,YR,A,M,Y,103.16,KG,20160129.0,,OT,US,US,2016,Q1,Young Adult
110783023,11078302,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK, HS",,,,U,,,,,,,QD,2016,Q1,Angioedema,,2016,Q1,3,F,201202.0,20160303.0,20150430,20160310,EXP,,US-009507513-1504USA021756,MERCK,,67.0,YR,,M,Y,,,20160310.0,,CN,US,US,2016,Q1,Elderly
110783023,11078302,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK, HS",,,,U,,,,,,,QD,2016,Q1,Disease recurrence,,2016,Q1,3,F,201202.0,20160303.0,20150430,20160310,EXP,,US-009507513-1504USA021756,MERCK,,67.0,YR,,M,Y,,,20160310.0,,CN,US,US,2016,Q1,Elderly
110783023,11078302,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK, HS",,,,U,,,,,,,QD,2016,Q1,Hypersensitivity,,2016,Q1,3,F,201202.0,20160303.0,20150430,20160310,EXP,,US-009507513-1504USA021756,MERCK,,67.0,YR,,M,Y,,,20160310.0,,CN,US,US,2016,Q1,Elderly
110783023,11078302,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK, HS",,,,U,,,,,,,QD,2016,Q1,Swollen tongue,,2016,Q1,3,F,201202.0,20160303.0,20150430,20160310,EXP,,US-009507513-1504USA021756,MERCK,,67.0,YR,,M,Y,,,20160310.0,,CN,US,US,2016,Q1,Elderly
112027055,11202705,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,26.0,IU,,QD,2016,Q1,Crohn's disease,,2016,Q1,5,F,20150225.0,20160310.0,20150619,20160315,EXP,,US-ABBVIE-15P-163-1408227-00,ABBVIE,,63.0,YR,,F,Y,86.26,KG,20160315.0,,MD,COUNTRY NOT SPECIFIED,US,2016,Q1,Adult
112027055,11202705,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,26.0,IU,,QD,2016,Q1,Pulmonary embolism,,2016,Q1,5,F,20150225.0,20160310.0,20150619,20160315,EXP,,US-ABBVIE-15P-163-1408227-00,ABBVIE,,63.0,YR,,F,Y,86.26,KG,20160315.0,,MD,COUNTRY NOT SPECIFIED,US,2016,Q1,Adult
112031034,11203103,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2016,Q1,Supraventricular tachycardia,,2016,Q1,4,F,20140804.0,20150611.0,20150619,20160129,PER,,US-JNJFOC-20150609570,JANSSEN,,59.0,YR,A,M,Y,122.93,KG,20160129.0,,CN,US,US,2016,Q1,Adult
112360324,11236032,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q1,Arterial occlusive disease,,2016,Q1,4,F,20150530.0,20160204.0,20150702,20160216,EXP,,IT-SA-2015SA095691,AVENTIS,,79.0,YR,E,M,Y,77.0,KG,20160216.0,,OT,IT,IT,2016,Q1,Elderly
112684935,11268493,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2016,Q1,Ecchymosis,,2016,Q1,5,F,2014.0,20160105.0,20150714,20160112,EXP,,US-JNJFOC-20150616688,JANSSEN,,69.0,YR,E,M,Y,,,20160112.0,,CN,US,US,2016,Q1,Elderly
112684935,11268493,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2016,Q1,Extradural haematoma,,2016,Q1,5,F,2014.0,20160105.0,20150714,20160112,EXP,,US-JNJFOC-20150616688,JANSSEN,,69.0,YR,E,M,Y,,,20160112.0,,CN,US,US,2016,Q1,Elderly
112684935,11268493,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2016,Q1,Gastrointestinal haemorrhage,,2016,Q1,5,F,2014.0,20160105.0,20150714,20160112,EXP,,US-JNJFOC-20150616688,JANSSEN,,69.0,YR,E,M,Y,,,20160112.0,,CN,US,US,2016,Q1,Elderly
112684935,11268493,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2016,Q1,Internal haemorrhage,,2016,Q1,5,F,2014.0,20160105.0,20150714,20160112,EXP,,US-JNJFOC-20150616688,JANSSEN,,69.0,YR,E,M,Y,,,20160112.0,,CN,US,US,2016,Q1,Elderly
113440184,11344018,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 UNITS EVERY MORNING,,,,,,,,,,,,2016,Q1,Abdominal pain,,2016,Q1,4,F,2015.0,20151221.0,20150806,20160104,PER,,US-JNJFOC-20150802851,PHARMACYCLICS,,68.0,YR,E,M,Y,,,20160104.0,,CN,US,US,2016,Q1,Elderly
113440184,11344018,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 UNITS EVERY MORNING,,,,,,,,,,,,2016,Q1,Acute kidney injury,,2016,Q1,4,F,2015.0,20151221.0,20150806,20160104,PER,,US-JNJFOC-20150802851,PHARMACYCLICS,,68.0,YR,E,M,Y,,,20160104.0,,CN,US,US,2016,Q1,Elderly
113440184,11344018,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 UNITS EVERY MORNING,,,,,,,,,,,,2016,Q1,Alanine aminotransferase increased,,2016,Q1,4,F,2015.0,20151221.0,20150806,20160104,PER,,US-JNJFOC-20150802851,PHARMACYCLICS,,68.0,YR,E,M,Y,,,20160104.0,,CN,US,US,2016,Q1,Elderly
113440184,11344018,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 UNITS EVERY MORNING,,,,,,,,,,,,2016,Q1,Atrial fibrillation,,2016,Q1,4,F,2015.0,20151221.0,20150806,20160104,PER,,US-JNJFOC-20150802851,PHARMACYCLICS,,68.0,YR,E,M,Y,,,20160104.0,,CN,US,US,2016,Q1,Elderly
113440184,11344018,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 UNITS EVERY MORNING,,,,,,,,,,,,2016,Q1,Diarrhoea,,2016,Q1,4,F,2015.0,20151221.0,20150806,20160104,PER,,US-JNJFOC-20150802851,PHARMACYCLICS,,68.0,YR,E,M,Y,,,20160104.0,,CN,US,US,2016,Q1,Elderly
113440184,11344018,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 UNITS EVERY MORNING,,,,,,,,,,,,2016,Q1,Dysphagia,,2016,Q1,4,F,2015.0,20151221.0,20150806,20160104,PER,,US-JNJFOC-20150802851,PHARMACYCLICS,,68.0,YR,E,M,Y,,,20160104.0,,CN,US,US,2016,Q1,Elderly
113440184,11344018,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 UNITS EVERY MORNING,,,,,,,,,,,,2016,Q1,Dyspnoea,,2016,Q1,4,F,2015.0,20151221.0,20150806,20160104,PER,,US-JNJFOC-20150802851,PHARMACYCLICS,,68.0,YR,E,M,Y,,,20160104.0,,CN,US,US,2016,Q1,Elderly
113440184,11344018,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 UNITS EVERY MORNING,,,,,,,,,,,,2016,Q1,Enterococcal infection,,2016,Q1,4,F,2015.0,20151221.0,20150806,20160104,PER,,US-JNJFOC-20150802851,PHARMACYCLICS,,68.0,YR,E,M,Y,,,20160104.0,,CN,US,US,2016,Q1,Elderly
113440184,11344018,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 UNITS EVERY MORNING,,,,,,,,,,,,2016,Q1,Hypernatraemia,,2016,Q1,4,F,2015.0,20151221.0,20150806,20160104,PER,,US-JNJFOC-20150802851,PHARMACYCLICS,,68.0,YR,E,M,Y,,,20160104.0,,CN,US,US,2016,Q1,Elderly
113440184,11344018,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 UNITS EVERY MORNING,,,,,,,,,,,,2016,Q1,Malaise,,2016,Q1,4,F,2015.0,20151221.0,20150806,20160104,PER,,US-JNJFOC-20150802851,PHARMACYCLICS,,68.0,YR,E,M,Y,,,20160104.0,,CN,US,US,2016,Q1,Elderly
113440184,11344018,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 UNITS EVERY MORNING,,,,,,,,,,,,2016,Q1,Pericardial effusion,,2016,Q1,4,F,2015.0,20151221.0,20150806,20160104,PER,,US-JNJFOC-20150802851,PHARMACYCLICS,,68.0,YR,E,M,Y,,,20160104.0,,CN,US,US,2016,Q1,Elderly
113440184,11344018,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 UNITS EVERY MORNING,,,,,,,,,,,,2016,Q1,Pleural effusion,,2016,Q1,4,F,2015.0,20151221.0,20150806,20160104,PER,,US-JNJFOC-20150802851,PHARMACYCLICS,,68.0,YR,E,M,Y,,,20160104.0,,CN,US,US,2016,Q1,Elderly
113440184,11344018,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 UNITS EVERY MORNING,,,,,,,,,,,,2016,Q1,Pneumonia,,2016,Q1,4,F,2015.0,20151221.0,20150806,20160104,PER,,US-JNJFOC-20150802851,PHARMACYCLICS,,68.0,YR,E,M,Y,,,20160104.0,,CN,US,US,2016,Q1,Elderly
113440184,11344018,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 UNITS EVERY MORNING,,,,,,,,,,,,2016,Q1,Proteus infection,,2016,Q1,4,F,2015.0,20151221.0,20150806,20160104,PER,,US-JNJFOC-20150802851,PHARMACYCLICS,,68.0,YR,E,M,Y,,,20160104.0,,CN,US,US,2016,Q1,Elderly
113440184,11344018,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 UNITS EVERY MORNING,,,,,,,,,,,,2016,Q1,Pulmonary hypertension,,2016,Q1,4,F,2015.0,20151221.0,20150806,20160104,PER,,US-JNJFOC-20150802851,PHARMACYCLICS,,68.0,YR,E,M,Y,,,20160104.0,,CN,US,US,2016,Q1,Elderly
113440184,11344018,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 UNITS EVERY MORNING,,,,,,,,,,,,2016,Q1,Rash,,2016,Q1,4,F,2015.0,20151221.0,20150806,20160104,PER,,US-JNJFOC-20150802851,PHARMACYCLICS,,68.0,YR,E,M,Y,,,20160104.0,,CN,US,US,2016,Q1,Elderly
113440184,11344018,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 UNITS EVERY MORNING,,,,,,,,,,,,2016,Q1,Retroperitoneal lymphadenopathy,,2016,Q1,4,F,2015.0,20151221.0,20150806,20160104,PER,,US-JNJFOC-20150802851,PHARMACYCLICS,,68.0,YR,E,M,Y,,,20160104.0,,CN,US,US,2016,Q1,Elderly
113440184,11344018,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS EVERY EVENING,,,,,,,,,,,,2016,Q1,Abdominal pain,,2016,Q1,4,F,2015.0,20151221.0,20150806,20160104,PER,,US-JNJFOC-20150802851,PHARMACYCLICS,,68.0,YR,E,M,Y,,,20160104.0,,CN,US,US,2016,Q1,Elderly
113440184,11344018,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS EVERY EVENING,,,,,,,,,,,,2016,Q1,Acute kidney injury,,2016,Q1,4,F,2015.0,20151221.0,20150806,20160104,PER,,US-JNJFOC-20150802851,PHARMACYCLICS,,68.0,YR,E,M,Y,,,20160104.0,,CN,US,US,2016,Q1,Elderly
113440184,11344018,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS EVERY EVENING,,,,,,,,,,,,2016,Q1,Alanine aminotransferase increased,,2016,Q1,4,F,2015.0,20151221.0,20150806,20160104,PER,,US-JNJFOC-20150802851,PHARMACYCLICS,,68.0,YR,E,M,Y,,,20160104.0,,CN,US,US,2016,Q1,Elderly
113440184,11344018,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS EVERY EVENING,,,,,,,,,,,,2016,Q1,Atrial fibrillation,,2016,Q1,4,F,2015.0,20151221.0,20150806,20160104,PER,,US-JNJFOC-20150802851,PHARMACYCLICS,,68.0,YR,E,M,Y,,,20160104.0,,CN,US,US,2016,Q1,Elderly
113440184,11344018,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS EVERY EVENING,,,,,,,,,,,,2016,Q1,Diarrhoea,,2016,Q1,4,F,2015.0,20151221.0,20150806,20160104,PER,,US-JNJFOC-20150802851,PHARMACYCLICS,,68.0,YR,E,M,Y,,,20160104.0,,CN,US,US,2016,Q1,Elderly
113440184,11344018,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS EVERY EVENING,,,,,,,,,,,,2016,Q1,Dysphagia,,2016,Q1,4,F,2015.0,20151221.0,20150806,20160104,PER,,US-JNJFOC-20150802851,PHARMACYCLICS,,68.0,YR,E,M,Y,,,20160104.0,,CN,US,US,2016,Q1,Elderly
113440184,11344018,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS EVERY EVENING,,,,,,,,,,,,2016,Q1,Dyspnoea,,2016,Q1,4,F,2015.0,20151221.0,20150806,20160104,PER,,US-JNJFOC-20150802851,PHARMACYCLICS,,68.0,YR,E,M,Y,,,20160104.0,,CN,US,US,2016,Q1,Elderly
113440184,11344018,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS EVERY EVENING,,,,,,,,,,,,2016,Q1,Enterococcal infection,,2016,Q1,4,F,2015.0,20151221.0,20150806,20160104,PER,,US-JNJFOC-20150802851,PHARMACYCLICS,,68.0,YR,E,M,Y,,,20160104.0,,CN,US,US,2016,Q1,Elderly
113440184,11344018,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS EVERY EVENING,,,,,,,,,,,,2016,Q1,Hypernatraemia,,2016,Q1,4,F,2015.0,20151221.0,20150806,20160104,PER,,US-JNJFOC-20150802851,PHARMACYCLICS,,68.0,YR,E,M,Y,,,20160104.0,,CN,US,US,2016,Q1,Elderly
113440184,11344018,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS EVERY EVENING,,,,,,,,,,,,2016,Q1,Malaise,,2016,Q1,4,F,2015.0,20151221.0,20150806,20160104,PER,,US-JNJFOC-20150802851,PHARMACYCLICS,,68.0,YR,E,M,Y,,,20160104.0,,CN,US,US,2016,Q1,Elderly
113440184,11344018,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS EVERY EVENING,,,,,,,,,,,,2016,Q1,Pericardial effusion,,2016,Q1,4,F,2015.0,20151221.0,20150806,20160104,PER,,US-JNJFOC-20150802851,PHARMACYCLICS,,68.0,YR,E,M,Y,,,20160104.0,,CN,US,US,2016,Q1,Elderly
113440184,11344018,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS EVERY EVENING,,,,,,,,,,,,2016,Q1,Pleural effusion,,2016,Q1,4,F,2015.0,20151221.0,20150806,20160104,PER,,US-JNJFOC-20150802851,PHARMACYCLICS,,68.0,YR,E,M,Y,,,20160104.0,,CN,US,US,2016,Q1,Elderly
113440184,11344018,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS EVERY EVENING,,,,,,,,,,,,2016,Q1,Pneumonia,,2016,Q1,4,F,2015.0,20151221.0,20150806,20160104,PER,,US-JNJFOC-20150802851,PHARMACYCLICS,,68.0,YR,E,M,Y,,,20160104.0,,CN,US,US,2016,Q1,Elderly
113440184,11344018,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS EVERY EVENING,,,,,,,,,,,,2016,Q1,Proteus infection,,2016,Q1,4,F,2015.0,20151221.0,20150806,20160104,PER,,US-JNJFOC-20150802851,PHARMACYCLICS,,68.0,YR,E,M,Y,,,20160104.0,,CN,US,US,2016,Q1,Elderly
113440184,11344018,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS EVERY EVENING,,,,,,,,,,,,2016,Q1,Pulmonary hypertension,,2016,Q1,4,F,2015.0,20151221.0,20150806,20160104,PER,,US-JNJFOC-20150802851,PHARMACYCLICS,,68.0,YR,E,M,Y,,,20160104.0,,CN,US,US,2016,Q1,Elderly
113440184,11344018,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS EVERY EVENING,,,,,,,,,,,,2016,Q1,Rash,,2016,Q1,4,F,2015.0,20151221.0,20150806,20160104,PER,,US-JNJFOC-20150802851,PHARMACYCLICS,,68.0,YR,E,M,Y,,,20160104.0,,CN,US,US,2016,Q1,Elderly
113440184,11344018,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS EVERY EVENING,,,,,,,,,,,,2016,Q1,Retroperitoneal lymphadenopathy,,2016,Q1,4,F,2015.0,20151221.0,20150806,20160104,PER,,US-JNJFOC-20150802851,PHARMACYCLICS,,68.0,YR,E,M,Y,,,20160104.0,,CN,US,US,2016,Q1,Elderly
113746794,11374679,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,6444.0,IU,,,,,,36.0,IU,,QD,2016,Q1,Gastrointestinal carcinoma,,2016,Q1,4,F,20150416.0,20160220.0,20150813,20160226,EXP,,CN-ASTRAZENECA-2015SE40423,ASTRAZENECA,,22371.0,DY,,F,Y,,,20160227.0,,MD,CN,CN,2016,Q1,Elderly
113876263,11387626,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, QD",,,,, UNKNOWN,,,10.0,IU,,QD,2016,Q1,Multiple sclerosis,,2016,Q1,3,F,20100630.0,20160311.0,20150817,20160321,EXP,,JP-NOVOPROD-459303,NOVO NORDISK,MASANAO FUJII. A CASE OF A PATIENT WITH TYPE 1 DIABETES MELLITUS WHERE MULTIPLE SCLEROSIS DEVELOPED DURING THE CLINICAL COURSE. THE 42ND GENERAL MEETING OF THE KANTO SOCIETY OF RURAL MEDICINE. 2015?46,55.0,YR,A,F,Y,,,20160321.0,,MD,JP,JP,2016,Q1,Adult
114322106,11432210,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,5 UNITS Q AM,,,,,,,,,,,,2016,Q1,Blood blister,,2016,Q1,6,F,2015.0,20151228.0,20150828,20160105,PER,,US-JNJFOC-20150820645,PHARMACYCLICS,,57.0,YR,A,M,Y,118.0,KG,20160105.0,,CN,US,US,2016,Q1,Adult
114322106,11432210,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,5 UNITS Q AM,,,,,,,,,,,,2016,Q1,Drug interaction,,2016,Q1,6,F,2015.0,20151228.0,20150828,20160105,PER,,US-JNJFOC-20150820645,PHARMACYCLICS,,57.0,YR,A,M,Y,118.0,KG,20160105.0,,CN,US,US,2016,Q1,Adult
114322106,11432210,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,5 UNITS Q AM,,,,,,,,,,,,2016,Q1,Platelet count decreased,,2016,Q1,6,F,2015.0,20151228.0,20150828,20160105,PER,,US-JNJFOC-20150820645,PHARMACYCLICS,,57.0,YR,A,M,Y,118.0,KG,20160105.0,,CN,US,US,2016,Q1,Adult
114563584,11456358,6,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2016,Q1,Peripheral ischaemia,,2016,Q1,4,F,20141211.0,20160314.0,20150903,20160321,EXP,,"IT-ARIAD PHARMACEUTICALS, INC-2015IT005438",ARIAD,,79.0,YR,,M,Y,61.0,KG,20160321.0,,MD,IT,IT,2016,Q1,Elderly
115330493,11533049,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q1,Ecchymosis,,2016,Q1,3,F,2014.0,20160105.0,20150921,20160113,EXP,,US-BAYER-2015-366996,BAYER,,70.0,YR,E,M,Y,,,20160113.0,,OT,US,US,2016,Q1,Elderly
115330493,11533049,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q1,Extradural haematoma,,2016,Q1,3,F,2014.0,20160105.0,20150921,20160113,EXP,,US-BAYER-2015-366996,BAYER,,70.0,YR,E,M,Y,,,20160113.0,,OT,US,US,2016,Q1,Elderly
115330493,11533049,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q1,Gastrointestinal haemorrhage,,2016,Q1,3,F,2014.0,20160105.0,20150921,20160113,EXP,,US-BAYER-2015-366996,BAYER,,70.0,YR,E,M,Y,,,20160113.0,,OT,US,US,2016,Q1,Elderly
115330493,11533049,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q1,Internal haemorrhage,,2016,Q1,3,F,2014.0,20160105.0,20150921,20160113,EXP,,US-BAYER-2015-366996,BAYER,,70.0,YR,E,M,Y,,,20160113.0,,OT,US,US,2016,Q1,Elderly
115919056,11591905,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2016,Q1,Alanine aminotransferase increased,,2016,Q1,6,F,20150922.0,20160317.0,20151005,20160323,EXP,,US-ROCHE-1641435,ROCHE,,72.0,YR,,M,Y,81.37,KG,20160323.0,,MD,US,US,2016,Q1,Elderly
115919056,11591905,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2016,Q1,Aspartate aminotransferase increased,,2016,Q1,6,F,20150922.0,20160317.0,20151005,20160323,EXP,,US-ROCHE-1641435,ROCHE,,72.0,YR,,M,Y,81.37,KG,20160323.0,,MD,US,US,2016,Q1,Elderly
115919056,11591905,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2016,Q1,Autoimmune hepatitis,,2016,Q1,6,F,20150922.0,20160317.0,20151005,20160323,EXP,,US-ROCHE-1641435,ROCHE,,72.0,YR,,M,Y,81.37,KG,20160323.0,,MD,US,US,2016,Q1,Elderly
115919056,11591905,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2016,Q1,Gamma-glutamyltransferase increased,,2016,Q1,6,F,20150922.0,20160317.0,20151005,20160323,EXP,,US-ROCHE-1641435,ROCHE,,72.0,YR,,M,Y,81.37,KG,20160323.0,,MD,US,US,2016,Q1,Elderly
115919056,11591905,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2016,Q1,Hypercalcaemia,,2016,Q1,6,F,20150922.0,20160317.0,20151005,20160323,EXP,,US-ROCHE-1641435,ROCHE,,72.0,YR,,M,Y,81.37,KG,20160323.0,,MD,US,US,2016,Q1,Elderly
115919056,11591905,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2016,Q1,Hypophosphataemia,,2016,Q1,6,F,20150922.0,20160317.0,20151005,20160323,EXP,,US-ROCHE-1641435,ROCHE,,72.0,YR,,M,Y,81.37,KG,20160323.0,,MD,US,US,2016,Q1,Elderly
115919056,11591905,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE: 10 U,,,,,,,,,,,,2016,Q1,Alanine aminotransferase increased,,2016,Q1,6,F,20150922.0,20160317.0,20151005,20160323,EXP,,US-ROCHE-1641435,ROCHE,,72.0,YR,,M,Y,81.37,KG,20160323.0,,MD,US,US,2016,Q1,Elderly
115919056,11591905,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE: 10 U,,,,,,,,,,,,2016,Q1,Aspartate aminotransferase increased,,2016,Q1,6,F,20150922.0,20160317.0,20151005,20160323,EXP,,US-ROCHE-1641435,ROCHE,,72.0,YR,,M,Y,81.37,KG,20160323.0,,MD,US,US,2016,Q1,Elderly
115919056,11591905,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE: 10 U,,,,,,,,,,,,2016,Q1,Autoimmune hepatitis,,2016,Q1,6,F,20150922.0,20160317.0,20151005,20160323,EXP,,US-ROCHE-1641435,ROCHE,,72.0,YR,,M,Y,81.37,KG,20160323.0,,MD,US,US,2016,Q1,Elderly
115919056,11591905,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE: 10 U,,,,,,,,,,,,2016,Q1,Gamma-glutamyltransferase increased,,2016,Q1,6,F,20150922.0,20160317.0,20151005,20160323,EXP,,US-ROCHE-1641435,ROCHE,,72.0,YR,,M,Y,81.37,KG,20160323.0,,MD,US,US,2016,Q1,Elderly
115919056,11591905,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE: 10 U,,,,,,,,,,,,2016,Q1,Hypercalcaemia,,2016,Q1,6,F,20150922.0,20160317.0,20151005,20160323,EXP,,US-ROCHE-1641435,ROCHE,,72.0,YR,,M,Y,81.37,KG,20160323.0,,MD,US,US,2016,Q1,Elderly
115919056,11591905,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE: 10 U,,,,,,,,,,,,2016,Q1,Hypophosphataemia,,2016,Q1,6,F,20150922.0,20160317.0,20151005,20160323,EXP,,US-ROCHE-1641435,ROCHE,,72.0,YR,,M,Y,81.37,KG,20160323.0,,MD,US,US,2016,Q1,Elderly
115919056,11591905,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE: 15 U,,,,,,,,,,,,2016,Q1,Alanine aminotransferase increased,,2016,Q1,6,F,20150922.0,20160317.0,20151005,20160323,EXP,,US-ROCHE-1641435,ROCHE,,72.0,YR,,M,Y,81.37,KG,20160323.0,,MD,US,US,2016,Q1,Elderly
115919056,11591905,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE: 15 U,,,,,,,,,,,,2016,Q1,Aspartate aminotransferase increased,,2016,Q1,6,F,20150922.0,20160317.0,20151005,20160323,EXP,,US-ROCHE-1641435,ROCHE,,72.0,YR,,M,Y,81.37,KG,20160323.0,,MD,US,US,2016,Q1,Elderly
115919056,11591905,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE: 15 U,,,,,,,,,,,,2016,Q1,Autoimmune hepatitis,,2016,Q1,6,F,20150922.0,20160317.0,20151005,20160323,EXP,,US-ROCHE-1641435,ROCHE,,72.0,YR,,M,Y,81.37,KG,20160323.0,,MD,US,US,2016,Q1,Elderly
115919056,11591905,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE: 15 U,,,,,,,,,,,,2016,Q1,Gamma-glutamyltransferase increased,,2016,Q1,6,F,20150922.0,20160317.0,20151005,20160323,EXP,,US-ROCHE-1641435,ROCHE,,72.0,YR,,M,Y,81.37,KG,20160323.0,,MD,US,US,2016,Q1,Elderly
115919056,11591905,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE: 15 U,,,,,,,,,,,,2016,Q1,Hypercalcaemia,,2016,Q1,6,F,20150922.0,20160317.0,20151005,20160323,EXP,,US-ROCHE-1641435,ROCHE,,72.0,YR,,M,Y,81.37,KG,20160323.0,,MD,US,US,2016,Q1,Elderly
115919056,11591905,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE: 15 U,,,,,,,,,,,,2016,Q1,Hypophosphataemia,,2016,Q1,6,F,20150922.0,20160317.0,20151005,20160323,EXP,,US-ROCHE-1641435,ROCHE,,72.0,YR,,M,Y,81.37,KG,20160323.0,,MD,US,US,2016,Q1,Elderly
116124174,11612417,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2016,Q1,Gastrointestinal haemorrhage,,2016,Q1,4,F,20150101.0,20160119.0,20151008,20160125,EXP,,US-JNJFOC-20150907687,JANSSEN,,62.0,YR,A,F,Y,,,20160125.0,,CN,US,US,2016,Q1,Adult
117165915,11716591,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"44 UNIT, DAILY",,,,U,,,,44.0,DF,,,2016,Q1,Penile exfoliation,,2016,Q1,5,F,20151017.0,20160303.0,20151109,20160314,EXP,,CN-NAPPMUNDI-GBR-2015-0031944,PURDUE,,58.0,YR,,M,Y,,,20160314.0,,MD,CN,CN,2016,Q1,Adult
117841974,11784197,12,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q1,Cardiac arrest,,2016,Q1,4,F,20151117.0,20160106.0,20151128,20160111,EXP,,US-CELGENE-USA-2015116772,CELGENE,,61.0,YR,,M,Y,,,20160111.0,,MD,US,US,2016,Q1,Adult
117841974,11784197,12,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q1,Hyperkalaemia,,2016,Q1,4,F,20151117.0,20160106.0,20151128,20160111,EXP,,US-CELGENE-USA-2015116772,CELGENE,,61.0,YR,,M,Y,,,20160111.0,,MD,US,US,2016,Q1,Adult
117841974,11784197,12,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q1,Neutrophil count decreased,,2016,Q1,4,F,20151117.0,20160106.0,20151128,20160111,EXP,,US-CELGENE-USA-2015116772,CELGENE,,61.0,YR,,M,Y,,,20160111.0,,MD,US,US,2016,Q1,Adult
117841974,11784197,12,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q1,Renal failure,,2016,Q1,4,F,20151117.0,20160106.0,20151128,20160111,EXP,,US-CELGENE-USA-2015116772,CELGENE,,61.0,YR,,M,Y,,,20160111.0,,MD,US,US,2016,Q1,Adult
117841974,11784197,12,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q1,Respiratory distress,,2016,Q1,4,F,20151117.0,20160106.0,20151128,20160111,EXP,,US-CELGENE-USA-2015116772,CELGENE,,61.0,YR,,M,Y,,,20160111.0,,MD,US,US,2016,Q1,Adult
117841974,11784197,12,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q1,White blood cell count decreased,,2016,Q1,4,F,20151117.0,20160106.0,20151128,20160111,EXP,,US-CELGENE-USA-2015116772,CELGENE,,61.0,YR,,M,Y,,,20160111.0,,MD,US,US,2016,Q1,Adult
118034382,11803438,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, UNK",,,,,,,,14.0,IU,,,2016,Q1,Anaemia,,2016,Q1,2,F,20150501.0,20160219.0,20151204,20160225,EXP,,IT-PFIZER INC-2015414905,PFIZER,,50.0,YR,,M,Y,,,20160225.0,,MD,IT,IT,2016,Q1,Adult
118034382,11803438,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, UNK",,,,,,,,14.0,IU,,,2016,Q1,Gastric disorder,,2016,Q1,2,F,20150501.0,20160219.0,20151204,20160225,EXP,,IT-PFIZER INC-2015414905,PFIZER,,50.0,YR,,M,Y,,,20160225.0,,MD,IT,IT,2016,Q1,Adult
118034382,11803438,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, UNK",,,,,,,,14.0,IU,,,2016,Q1,Oesophagitis haemorrhagic,,2016,Q1,2,F,20150501.0,20160219.0,20151204,20160225,EXP,,IT-PFIZER INC-2015414905,PFIZER,,50.0,YR,,M,Y,,,20160225.0,,MD,IT,IT,2016,Q1,Adult
118166712,11816671,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,34 UNITS,,,,,,,,,,INJECTION,,2016,Q1,Asthenia,,2016,Q1,2,F,20151113.0,20151207.0,20151210,20160103,PER,,US-JNJFOC-20151115905,JANSSEN,,65.0,YR,A,F,Y,108.86,KG,20160103.0,,CN,US,US,2016,Q1,Elderly
118166712,11816671,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,34 UNITS,,,,,,,,,,INJECTION,,2016,Q1,Dizziness,,2016,Q1,2,F,20151113.0,20151207.0,20151210,20160103,PER,,US-JNJFOC-20151115905,JANSSEN,,65.0,YR,A,F,Y,108.86,KG,20160103.0,,CN,US,US,2016,Q1,Elderly
118166712,11816671,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,34 UNITS,,,,,,,,,,INJECTION,,2016,Q1,Dyspnoea,,2016,Q1,2,F,20151113.0,20151207.0,20151210,20160103,PER,,US-JNJFOC-20151115905,JANSSEN,,65.0,YR,A,F,Y,108.86,KG,20160103.0,,CN,US,US,2016,Q1,Elderly
118166712,11816671,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,34 UNITS,,,,,,,,,,INJECTION,,2016,Q1,Headache,,2016,Q1,2,F,20151113.0,20151207.0,20151210,20160103,PER,,US-JNJFOC-20151115905,JANSSEN,,65.0,YR,A,F,Y,108.86,KG,20160103.0,,CN,US,US,2016,Q1,Elderly
118166712,11816671,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,34 UNITS,,,,,,,,,,INJECTION,,2016,Q1,Nausea,,2016,Q1,2,F,20151113.0,20151207.0,20151210,20160103,PER,,US-JNJFOC-20151115905,JANSSEN,,65.0,YR,A,F,Y,108.86,KG,20160103.0,,CN,US,US,2016,Q1,Elderly
118166712,11816671,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,34 UNITS,,,,,,,,,,INJECTION,,2016,Q1,Urine output increased,,2016,Q1,2,F,20151113.0,20151207.0,20151210,20160103,PER,,US-JNJFOC-20151115905,JANSSEN,,65.0,YR,A,F,Y,108.86,KG,20160103.0,,CN,US,US,2016,Q1,Elderly
118166712,11816671,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,34 UNITS,,,,,,,,,,INJECTION,,2016,Q1,Vision blurred,,2016,Q1,2,F,20151113.0,20151207.0,20151210,20160103,PER,,US-JNJFOC-20151115905,JANSSEN,,65.0,YR,A,F,Y,108.86,KG,20160103.0,,CN,US,US,2016,Q1,Elderly
118229432,11822943,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q1,Gastrointestinal haemorrhage,,2016,Q1,2,F,20150101.0,20160119.0,20151210,20160126,EXP,,US-BAYER-2015-421345,BAYER,,62.0,YR,A,F,Y,,,20160126.0,,LW,US,US,2016,Q1,Adult
118348882,11834888,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2016,Q1,Epistaxis,,2016,Q1,2,F,20131023.0,20151231.0,20151215,20160301,PER,,US-JNJFOC-20151103955,JANSSEN,,55.0,YR,A,F,Y,,,20160301.0,,CN,US,US,2016,Q1,Adult
118348882,11834888,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2016,Q1,Gastrointestinal haemorrhage,,2016,Q1,2,F,20131023.0,20151231.0,20151215,20160301,PER,,US-JNJFOC-20151103955,JANSSEN,,55.0,YR,A,F,Y,,,20160301.0,,CN,US,US,2016,Q1,Adult
118499182,11849918,8,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q1,Acute myocardial infarction,,2016,Q1,2,F,20151211.0,20160108.0,20151218,20160115,EXP,,CO-BAXTER-2015BAX068847,BAXTER,,77.0,YR,,F,Y,67.3,KG,20160115.0,,OT,CO,CO,2016,Q1,Elderly
118499182,11849918,8,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q1,Cardiogenic shock,,2016,Q1,2,F,20151211.0,20160108.0,20151218,20160115,EXP,,CO-BAXTER-2015BAX068847,BAXTER,,77.0,YR,,F,Y,67.3,KG,20160115.0,,OT,CO,CO,2016,Q1,Elderly
118518684,11851868,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,,,,,,,,,,,,,2016,Q1,Acute kidney injury,Acute kidney injury,2016,Q1,4,F,20150729.0,20160308.0,20151218,20160316,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2015-BI-52879BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,96.0,KG,20160317.0,,MD,COUNTRY NOT SPECIFIED,US,2016,Q1,Elderly
118518684,11851868,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,,,,,,,,,,,,,2016,Q1,Respiratory failure,,2016,Q1,4,F,20150729.0,20160308.0,20151218,20160316,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2015-BI-52879BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,96.0,KG,20160317.0,,MD,COUNTRY NOT SPECIFIED,US,2016,Q1,Elderly
118518684,11851868,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,,,,,,,,,,,,,2016,Q1,Rhabdomyolysis,,2016,Q1,4,F,20150729.0,20160308.0,20151218,20160316,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2015-BI-52879BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,96.0,KG,20160317.0,,MD,COUNTRY NOT SPECIFIED,US,2016,Q1,Elderly
118518684,11851868,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,,,,,,,,,,,,,2016,Q1,Spinal column stenosis,,2016,Q1,4,F,20150729.0,20160308.0,20151218,20160316,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2015-BI-52879BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,96.0,KG,20160317.0,,MD,COUNTRY NOT SPECIFIED,US,2016,Q1,Elderly
118518684,11851868,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,,,,,,,,,,,,,2016,Q1,Spinal epidural haematoma,,2016,Q1,4,F,20150729.0,20160308.0,20151218,20160316,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2015-BI-52879BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,96.0,KG,20160317.0,,MD,COUNTRY NOT SPECIFIED,US,2016,Q1,Elderly
118615944,11861594,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 UNITS, IN THE MORNING",,,,,,,,,,INJECTION,,2016,Q1,Anaemia,,2016,Q1,4,F,20151112.0,20160219.0,20151222,20160229,EXP,,JP-GILEAD-2015-0187887AA,GILEAD,,55.0,YR,A,M,Y,45.0,KG,20160229.0,,MD,JP,JP,2016,Q1,Adult
118741693,11874169,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"TOTAL DAILY DOSE: 10 IU, (0-0-10)",,,,U,,,,10.0,IU,,QD,2016,Q1,Glaucoma,,2016,Q1,3,F,201211.0,20160227.0,20151229,20160304,EXP,,JP-009507513-1512JPN013177,MERCK,,61.0,YR,,M,Y,,,20160304.0,,CN,JP,JP,2016,Q1,Adult
118741693,11874169,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"TOTAL DAILY DOSE: 10 IU, (0-0-10)",,,,U,,,,10.0,IU,,QD,2016,Q1,Vogt-Koyanagi-Harada syndrome,,2016,Q1,3,F,201211.0,20160227.0,20151229,20160304,EXP,,JP-009507513-1512JPN013177,MERCK,,61.0,YR,,M,Y,,,20160304.0,,CN,JP,JP,2016,Q1,Adult
118741693,11874169,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"TOTAL DAILY DOSE: 16 IU, (16-0-0)",,,,U,,,,16.0,IU,,QD,2016,Q1,Glaucoma,,2016,Q1,3,F,201211.0,20160227.0,20151229,20160304,EXP,,JP-009507513-1512JPN013177,MERCK,,61.0,YR,,M,Y,,,20160304.0,,CN,JP,JP,2016,Q1,Adult
118741693,11874169,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"TOTAL DAILY DOSE: 16 IU, (16-0-0)",,,,U,,,,16.0,IU,,QD,2016,Q1,Vogt-Koyanagi-Harada syndrome,,2016,Q1,3,F,201211.0,20160227.0,20151229,20160304,EXP,,JP-009507513-1512JPN013177,MERCK,,61.0,YR,,M,Y,,,20160304.0,,CN,JP,JP,2016,Q1,Adult
118824454,11882445,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"BID, LATENCY: 1212 DAYS. DOSE (22-0-34)",,,,,,,,,,,,2016,Q1,Diabetic ketoacidosis,,2016,Q1,4,F,20151215.0,20160303.0,20151231,20160311,EXP,,ES-ASTRAZENECA-2015SF30318,ASTRAZENECA,,8442.0,DY,,F,Y,52.8,KG,20160311.0,,MD,ES,ES,2016,Q1,Elderly
118824454,11882445,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"BID, LATENCY: 1212 DAYS. DOSE (22-0-34)",,,,,,,,,,,,2016,Q1,Exposure during pregnancy,,2016,Q1,4,F,20151215.0,20160303.0,20151231,20160311,EXP,,ES-ASTRAZENECA-2015SF30318,ASTRAZENECA,,8442.0,DY,,F,Y,52.8,KG,20160311.0,,MD,ES,ES,2016,Q1,Elderly
118824454,11882445,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"BID, LATENCY: 1212 DAYS. DOSE (22-0-34)",,,,,,,,,,,,2016,Q1,Off label use,,2016,Q1,4,F,20151215.0,20160303.0,20151231,20160311,EXP,,ES-ASTRAZENECA-2015SF30318,ASTRAZENECA,,8442.0,DY,,F,Y,52.8,KG,20160311.0,,MD,ES,ES,2016,Q1,Elderly
118824454,11882445,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"BID, LATENCY: 1212 DAYS. DOSE (22-0-34)",,,,,,,,,,,,2016,Q1,Product use issue,,2016,Q1,4,F,20151215.0,20160303.0,20151231,20160311,EXP,,ES-ASTRAZENECA-2015SF30318,ASTRAZENECA,,8442.0,DY,,F,Y,52.8,KG,20160311.0,,MD,ES,ES,2016,Q1,Elderly
118824454,11882445,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"BID, LATENCY: 1212 DAYS. DOSE (22-0-34)",,,,,,,,,,,,2016,Q1,Stress,,2016,Q1,4,F,20151215.0,20160303.0,20151231,20160311,EXP,,ES-ASTRAZENECA-2015SF30318,ASTRAZENECA,,8442.0,DY,,F,Y,52.8,KG,20160311.0,,MD,ES,ES,2016,Q1,Elderly
118824454,11882445,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,56 IU DAILY,,,,,,,,,,,,2016,Q1,Diabetic ketoacidosis,,2016,Q1,4,F,20151215.0,20160303.0,20151231,20160311,EXP,,ES-ASTRAZENECA-2015SF30318,ASTRAZENECA,,8442.0,DY,,F,Y,52.8,KG,20160311.0,,MD,ES,ES,2016,Q1,Elderly
118824454,11882445,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,56 IU DAILY,,,,,,,,,,,,2016,Q1,Exposure during pregnancy,,2016,Q1,4,F,20151215.0,20160303.0,20151231,20160311,EXP,,ES-ASTRAZENECA-2015SF30318,ASTRAZENECA,,8442.0,DY,,F,Y,52.8,KG,20160311.0,,MD,ES,ES,2016,Q1,Elderly
118824454,11882445,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,56 IU DAILY,,,,,,,,,,,,2016,Q1,Off label use,,2016,Q1,4,F,20151215.0,20160303.0,20151231,20160311,EXP,,ES-ASTRAZENECA-2015SF30318,ASTRAZENECA,,8442.0,DY,,F,Y,52.8,KG,20160311.0,,MD,ES,ES,2016,Q1,Elderly
118824454,11882445,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,56 IU DAILY,,,,,,,,,,,,2016,Q1,Product use issue,,2016,Q1,4,F,20151215.0,20160303.0,20151231,20160311,EXP,,ES-ASTRAZENECA-2015SF30318,ASTRAZENECA,,8442.0,DY,,F,Y,52.8,KG,20160311.0,,MD,ES,ES,2016,Q1,Elderly
118824454,11882445,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,56 IU DAILY,,,,,,,,,,,,2016,Q1,Stress,,2016,Q1,4,F,20151215.0,20160303.0,20151231,20160311,EXP,,ES-ASTRAZENECA-2015SF30318,ASTRAZENECA,,8442.0,DY,,F,Y,52.8,KG,20160311.0,,MD,ES,ES,2016,Q1,Elderly
118835773,11883577,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 UNIT/ML (3ML), INJECT 28 UNITS",,,,,,,,,,,BID,2016,Q1,Abdominal discomfort,,2016,Q1,3,F,201503.0,20160201.0,20151231,20160205,EXP,,US-ROCHE-ITM201504IM015002,ROCHE,,70.0,YR,,M,Y,113.5,KG,20160205.0,,MD,US,US,2016,Q1,Elderly
118835773,11883577,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 UNIT/ML (3ML), INJECT 28 UNITS",,,,,,,,,,,BID,2016,Q1,Atrial fibrillation,,2016,Q1,3,F,201503.0,20160201.0,20151231,20160205,EXP,,US-ROCHE-ITM201504IM015002,ROCHE,,70.0,YR,,M,Y,113.5,KG,20160205.0,,MD,US,US,2016,Q1,Elderly
118835773,11883577,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 UNIT/ML (3ML), INJECT 28 UNITS",,,,,,,,,,,BID,2016,Q1,Decreased appetite,,2016,Q1,3,F,201503.0,20160201.0,20151231,20160205,EXP,,US-ROCHE-ITM201504IM015002,ROCHE,,70.0,YR,,M,Y,113.5,KG,20160205.0,,MD,US,US,2016,Q1,Elderly
118835773,11883577,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 UNIT/ML (3ML), INJECT 28 UNITS",,,,,,,,,,,BID,2016,Q1,Diarrhoea,,2016,Q1,3,F,201503.0,20160201.0,20151231,20160205,EXP,,US-ROCHE-ITM201504IM015002,ROCHE,,70.0,YR,,M,Y,113.5,KG,20160205.0,,MD,US,US,2016,Q1,Elderly
118835773,11883577,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 UNIT/ML (3ML), INJECT 28 UNITS",,,,,,,,,,,BID,2016,Q1,Dizziness,,2016,Q1,3,F,201503.0,20160201.0,20151231,20160205,EXP,,US-ROCHE-ITM201504IM015002,ROCHE,,70.0,YR,,M,Y,113.5,KG,20160205.0,,MD,US,US,2016,Q1,Elderly
118835773,11883577,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 UNIT/ML (3ML), INJECT 28 UNITS",,,,,,,,,,,BID,2016,Q1,Drug hypersensitivity,,2016,Q1,3,F,201503.0,20160201.0,20151231,20160205,EXP,,US-ROCHE-ITM201504IM015002,ROCHE,,70.0,YR,,M,Y,113.5,KG,20160205.0,,MD,US,US,2016,Q1,Elderly
118835773,11883577,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 UNIT/ML (3ML), INJECT 28 UNITS",,,,,,,,,,,BID,2016,Q1,Dyspnoea,,2016,Q1,3,F,201503.0,20160201.0,20151231,20160205,EXP,,US-ROCHE-ITM201504IM015002,ROCHE,,70.0,YR,,M,Y,113.5,KG,20160205.0,,MD,US,US,2016,Q1,Elderly
118835773,11883577,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 UNIT/ML (3ML), INJECT 28 UNITS",,,,,,,,,,,BID,2016,Q1,Fatigue,,2016,Q1,3,F,201503.0,20160201.0,20151231,20160205,EXP,,US-ROCHE-ITM201504IM015002,ROCHE,,70.0,YR,,M,Y,113.5,KG,20160205.0,,MD,US,US,2016,Q1,Elderly
118835773,11883577,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 UNIT/ML (3ML), INJECT 28 UNITS",,,,,,,,,,,BID,2016,Q1,Nausea,,2016,Q1,3,F,201503.0,20160201.0,20151231,20160205,EXP,,US-ROCHE-ITM201504IM015002,ROCHE,,70.0,YR,,M,Y,113.5,KG,20160205.0,,MD,US,US,2016,Q1,Elderly
118835773,11883577,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 UNIT/ML (3ML), INJECT 28 UNITS",,,,,,,,,,,BID,2016,Q1,Oxygen consumption increased,,2016,Q1,3,F,201503.0,20160201.0,20151231,20160205,EXP,,US-ROCHE-ITM201504IM015002,ROCHE,,70.0,YR,,M,Y,113.5,KG,20160205.0,,MD,US,US,2016,Q1,Elderly
118838402,11883840,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,15.0,IU,,QD,2016,Q1,Diabetes mellitus inadequate control,,2016,Q1,2,F,20151114.0,20160215.0,20160101,20160223,EXP,,IT-ASTRAZENECA-2015SF31283,ASTRAZENECA,,19799.0,DY,,F,Y,,,20160223.0,,MD,IT,IT,2016,Q1,Elderly
118838402,11883840,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,15.0,IU,,QD,2016,Q1,Fluid intake reduced,,2016,Q1,2,F,20151114.0,20160215.0,20160101,20160223,EXP,,IT-ASTRAZENECA-2015SF31283,ASTRAZENECA,,19799.0,DY,,F,Y,,,20160223.0,,MD,IT,IT,2016,Q1,Elderly
118838402,11883840,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,15.0,IU,,QD,2016,Q1,Gastrointestinal motility disorder,,2016,Q1,2,F,20151114.0,20160215.0,20160101,20160223,EXP,,IT-ASTRAZENECA-2015SF31283,ASTRAZENECA,,19799.0,DY,,F,Y,,,20160223.0,,MD,IT,IT,2016,Q1,Elderly
118838402,11883840,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,15.0,IU,,QD,2016,Q1,Hypokalaemia,,2016,Q1,2,F,20151114.0,20160215.0,20160101,20160223,EXP,,IT-ASTRAZENECA-2015SF31283,ASTRAZENECA,,19799.0,DY,,F,Y,,,20160223.0,,MD,IT,IT,2016,Q1,Elderly
118838402,11883840,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,15.0,IU,,QD,2016,Q1,Klebsiella bacteraemia,,2016,Q1,2,F,20151114.0,20160215.0,20160101,20160223,EXP,,IT-ASTRAZENECA-2015SF31283,ASTRAZENECA,,19799.0,DY,,F,Y,,,20160223.0,,MD,IT,IT,2016,Q1,Elderly
118838402,11883840,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,15.0,IU,,QD,2016,Q1,Lung infection,,2016,Q1,2,F,20151114.0,20160215.0,20160101,20160223,EXP,,IT-ASTRAZENECA-2015SF31283,ASTRAZENECA,,19799.0,DY,,F,Y,,,20160223.0,,MD,IT,IT,2016,Q1,Elderly
118838402,11883840,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,15.0,IU,,QD,2016,Q1,Metabolic acidosis,,2016,Q1,2,F,20151114.0,20160215.0,20160101,20160223,EXP,,IT-ASTRAZENECA-2015SF31283,ASTRAZENECA,,19799.0,DY,,F,Y,,,20160223.0,,MD,IT,IT,2016,Q1,Elderly
118838402,11883840,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,15.0,IU,,QD,2016,Q1,Pyelonephritis acute,,2016,Q1,2,F,20151114.0,20160215.0,20160101,20160223,EXP,,IT-ASTRAZENECA-2015SF31283,ASTRAZENECA,,19799.0,DY,,F,Y,,,20160223.0,,MD,IT,IT,2016,Q1,Elderly
118838402,11883840,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,15.0,IU,,QD,2016,Q1,Renal tubular disorder,,2016,Q1,2,F,20151114.0,20160215.0,20160101,20160223,EXP,,IT-ASTRAZENECA-2015SF31283,ASTRAZENECA,,19799.0,DY,,F,Y,,,20160223.0,,MD,IT,IT,2016,Q1,Elderly
118843241,11884324,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,40 UNITS,,,,,,,,,,UNSPECIFIED,,2016,Q1,Oral candidiasis,,2016,Q1,1,I,20151105.0,20151216.0,20160103,20160103,PER,,US-JNJFOC-20151214970,JANSSEN,,53.0,YR,A,M,Y,82.56,KG,20160103.0,,OT,US,US,2016,Q1,Adult
118931002,11893100,5,C,TOUJEO INSULIN GLARGINE,,2,Subcutaneous,50 UNITS DAILY,,,,,,,,,,INJECTION,,2016,Q1,Ankle fracture,,2016,Q1,2,F,20151219.0,20160101.0,20160106,20160108,EXP,,US-ASTRAZENECA-2015SF31964,ASTRAZENECA,,64.0,YR,,F,Y,93.0,KG,20160108.0,,MD,US,US,2016,Q1,Adult
118958913,11895891,6,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2016,Q1,Airway burns,,2016,Q1,3,F,20160101.0,20160126.0,20160107,20160203,EXP,,CO-BAXTER-2016BAX000139,BAXTER,,76.0,YR,,F,Y,69.0,KG,20160203.0,,CN,CO,CO,2016,Q1,Elderly
118958913,11895891,6,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2016,Q1,Cardio-respiratory arrest,,2016,Q1,3,F,20160101.0,20160126.0,20160107,20160203,EXP,,CO-BAXTER-2016BAX000139,BAXTER,,76.0,YR,,F,Y,69.0,KG,20160203.0,,CN,CO,CO,2016,Q1,Elderly
118958913,11895891,6,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2016,Q1,Fungal peritonitis,,2016,Q1,3,F,20160101.0,20160126.0,20160107,20160203,EXP,,CO-BAXTER-2016BAX000139,BAXTER,,76.0,YR,,F,Y,69.0,KG,20160203.0,,CN,CO,CO,2016,Q1,Elderly
118958913,11895891,6,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2016,Q1,General physical health deterioration,,2016,Q1,3,F,20160101.0,20160126.0,20160107,20160203,EXP,,CO-BAXTER-2016BAX000139,BAXTER,,76.0,YR,,F,Y,69.0,KG,20160203.0,,CN,CO,CO,2016,Q1,Elderly
118958913,11895891,6,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2016,Q1,Respiratory failure,,2016,Q1,3,F,20160101.0,20160126.0,20160107,20160203,EXP,,CO-BAXTER-2016BAX000139,BAXTER,,76.0,YR,,F,Y,69.0,KG,20160203.0,,CN,CO,CO,2016,Q1,Elderly
118958913,11895891,6,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2016,Q1,Thermal burn,,2016,Q1,3,F,20160101.0,20160126.0,20160107,20160203,EXP,,CO-BAXTER-2016BAX000139,BAXTER,,76.0,YR,,F,Y,69.0,KG,20160203.0,,CN,CO,CO,2016,Q1,Elderly
118990421,11899042,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"35 IU, 1X/DAY (AT BEDTIME)",,,,,,,,35.0,IU,,QD,2016,Q1,Urinary tract infection,,2016,Q1,1,I,,20151230.0,20160108,20160108,PER,,US-PFIZER INC-2015478101,PFIZER,,65.0,YR,,F,Y,,,20160108.0,,CN,US,US,2016,Q1,Elderly
119047971,11904797,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,10 UNITS,,,,,,,,,,,,2016,Q1,Angioedema,,2016,Q1,1,I,20150625.0,20150625.0,20160108,20160108,PER,,US-ROCHE-1600168,ROCHE,,66.0,YR,,F,Y,104.0,KG,20160109.0,,OT,US,US,2016,Q1,Elderly
119047971,11904797,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,10 UNITS,,,,,,,,,,,,2016,Q1,Cerebrovascular accident,,2016,Q1,1,I,20150625.0,20150625.0,20160108,20160108,PER,,US-ROCHE-1600168,ROCHE,,66.0,YR,,F,Y,104.0,KG,20160109.0,,OT,US,US,2016,Q1,Elderly
119047971,11904797,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,10 UNITS,,,,,,,,,,,,2016,Q1,Endotracheal intubation,,2016,Q1,1,I,20150625.0,20150625.0,20160108,20160108,PER,,US-ROCHE-1600168,ROCHE,,66.0,YR,,F,Y,104.0,KG,20160109.0,,OT,US,US,2016,Q1,Elderly
119047971,11904797,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,10 UNITS,,,,,,,,,,,,2016,Q1,Eye movement disorder,,2016,Q1,1,I,20150625.0,20150625.0,20160108,20160108,PER,,US-ROCHE-1600168,ROCHE,,66.0,YR,,F,Y,104.0,KG,20160109.0,,OT,US,US,2016,Q1,Elderly
119070841,11907084,6,C,Lantus - insulin glargine,,2,,DF,,,,,,,,,,,,2016,Q1,Non-cardiac chest pain,,2016,Q1,1,I,20151221.0,20151230.0,20160111,20160111,EXP,,GB-DEP_13364_2016,DEPOMED,,31.0,YR,,M,Y,106.0,KG,20160111.0,,MD,GB,GB,2016,Q1,Young Adult
119084441,11908444,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q1,Epistaxis,,2016,Q1,1,I,20131023.0,20151102.0,20160111,20160111,EXP,,US-BAYER-2015-464457,BAYER,,55.0,YR,A,F,Y,,,20160111.0,,OT,US,US,2016,Q1,Adult
119084441,11908444,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q1,Gastrointestinal haemorrhage,,2016,Q1,1,I,20131023.0,20151102.0,20160111,20160111,EXP,,US-BAYER-2015-464457,BAYER,,55.0,YR,A,F,Y,,,20160111.0,,OT,US,US,2016,Q1,Adult
119103161,11910316,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,"Hallucination, visual",,2016,Q1,1,I,20160108.0,,20160111,20160111,DIR,,,,,81.0,YR,,F,N,67.5,KG,20160108.0,N,PH,US,,2016,Q1,Elderly
119109311,11910931,3,C,LUNTUS INSULIN GLARGINE,,2,,,,,,,,,,,,,,2016,Q1,Abdominal pain upper,,2016,Q1,1,I,20160103.0,,20160111,20160111,DIR,,,,,64.0,YR,,F,N,152.0,LBS,20160108.0,N,,US,,2016,Q1,Adult
119109311,11910931,3,C,LUNTUS INSULIN GLARGINE,,2,,,,,,,,,,,,,,2016,Q1,Asthenia,,2016,Q1,1,I,20160103.0,,20160111,20160111,DIR,,,,,64.0,YR,,F,N,152.0,LBS,20160108.0,N,,US,,2016,Q1,Adult
119109311,11910931,3,C,LUNTUS INSULIN GLARGINE,,2,,,,,,,,,,,,,,2016,Q1,Balance disorder,,2016,Q1,1,I,20160103.0,,20160111,20160111,DIR,,,,,64.0,YR,,F,N,152.0,LBS,20160108.0,N,,US,,2016,Q1,Adult
119109311,11910931,3,C,LUNTUS INSULIN GLARGINE,,2,,,,,,,,,,,,,,2016,Q1,Dyspnoea,,2016,Q1,1,I,20160103.0,,20160111,20160111,DIR,,,,,64.0,YR,,F,N,152.0,LBS,20160108.0,N,,US,,2016,Q1,Adult
119109311,11910931,3,C,LUNTUS INSULIN GLARGINE,,2,,,,,,,,,,,,,,2016,Q1,Fatigue,,2016,Q1,1,I,20160103.0,,20160111,20160111,DIR,,,,,64.0,YR,,F,N,152.0,LBS,20160108.0,N,,US,,2016,Q1,Adult
119109311,11910931,3,C,LUNTUS INSULIN GLARGINE,,2,,,,,,,,,,,,,,2016,Q1,Haematochezia,,2016,Q1,1,I,20160103.0,,20160111,20160111,DIR,,,,,64.0,YR,,F,N,152.0,LBS,20160108.0,N,,US,,2016,Q1,Adult
119109311,11910931,3,C,LUNTUS INSULIN GLARGINE,,2,,,,,,,,,,,,,,2016,Q1,Nightmare,,2016,Q1,1,I,20160103.0,,20160111,20160111,DIR,,,,,64.0,YR,,F,N,152.0,LBS,20160108.0,N,,US,,2016,Q1,Adult
119109311,11910931,3,C,LUNTUS INSULIN GLARGINE,,2,,,,,,,,,,,,,,2016,Q1,Panic attack,,2016,Q1,1,I,20160103.0,,20160111,20160111,DIR,,,,,64.0,YR,,F,N,152.0,LBS,20160108.0,N,,US,,2016,Q1,Adult
119176521,11917652,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE:3600 UNIT(S),,,,, UNKNOWN,,21081.0,,,,,2016,Q1,Blood insulin increased,,2016,Q1,1,I,,20160106.0,20160114,20160114,EXP,,TR-SA-2016SA003812,AVENTIS,"KARATAS F, SAHIN S, KARATAS HG, KARSLI PB, EMRE C, KIVRAKOGLU F. THE HIGHEST (3600 IU) REPORTED OVERDOSE OF INSULIN GLARGINE EVER AND MANAGEMENT. INDIAN J CRIT CARE MED. 2015 DEC?19(12):750-1. DOI: 10.4103/0972-5229.171418",45.0,YR,A,M,Y,,,20160114.0,,OT,TR,TR,2016,Q1,Adult
119176521,11917652,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE:3600 UNIT(S),,,,, UNKNOWN,,21081.0,,,,,2016,Q1,Blood potassium decreased,,2016,Q1,1,I,,20160106.0,20160114,20160114,EXP,,TR-SA-2016SA003812,AVENTIS,"KARATAS F, SAHIN S, KARATAS HG, KARSLI PB, EMRE C, KIVRAKOGLU F. THE HIGHEST (3600 IU) REPORTED OVERDOSE OF INSULIN GLARGINE EVER AND MANAGEMENT. INDIAN J CRIT CARE MED. 2015 DEC?19(12):750-1. DOI: 10.4103/0972-5229.171418",45.0,YR,A,M,Y,,,20160114.0,,OT,TR,TR,2016,Q1,Adult
119176521,11917652,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE:3600 UNIT(S),,,,, UNKNOWN,,21081.0,,,,,2016,Q1,Hypoglycaemia,,2016,Q1,1,I,,20160106.0,20160114,20160114,EXP,,TR-SA-2016SA003812,AVENTIS,"KARATAS F, SAHIN S, KARATAS HG, KARSLI PB, EMRE C, KIVRAKOGLU F. THE HIGHEST (3600 IU) REPORTED OVERDOSE OF INSULIN GLARGINE EVER AND MANAGEMENT. INDIAN J CRIT CARE MED. 2015 DEC?19(12):750-1. DOI: 10.4103/0972-5229.171418",45.0,YR,A,M,Y,,,20160114.0,,OT,TR,TR,2016,Q1,Adult
119176521,11917652,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE:3600 UNIT(S),,,,, UNKNOWN,,21081.0,,,,,2016,Q1,Intentional overdose,,2016,Q1,1,I,,20160106.0,20160114,20160114,EXP,,TR-SA-2016SA003812,AVENTIS,"KARATAS F, SAHIN S, KARATAS HG, KARSLI PB, EMRE C, KIVRAKOGLU F. THE HIGHEST (3600 IU) REPORTED OVERDOSE OF INSULIN GLARGINE EVER AND MANAGEMENT. INDIAN J CRIT CARE MED. 2015 DEC?19(12):750-1. DOI: 10.4103/0972-5229.171418",45.0,YR,A,M,Y,,,20160114.0,,OT,TR,TR,2016,Q1,Adult
119176521,11917652,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE:3600 UNIT(S),,,,, UNKNOWN,,21081.0,,,,,2016,Q1,Loss of consciousness,,2016,Q1,1,I,,20160106.0,20160114,20160114,EXP,,TR-SA-2016SA003812,AVENTIS,"KARATAS F, SAHIN S, KARATAS HG, KARSLI PB, EMRE C, KIVRAKOGLU F. THE HIGHEST (3600 IU) REPORTED OVERDOSE OF INSULIN GLARGINE EVER AND MANAGEMENT. INDIAN J CRIT CARE MED. 2015 DEC?19(12):750-1. DOI: 10.4103/0972-5229.171418",45.0,YR,A,M,Y,,,20160114.0,,OT,TR,TR,2016,Q1,Adult
119254521,11925452,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Abdominal pain,,2016,Q1,1,I,20150820.0,20160113.0,20160118,20160118,EXP,,US-ABBVIE-16P-163-1540268-00,ABBVIE,,50.0,YR,,F,Y,88.45,KG,20160118.0,,CN,US,US,2016,Q1,Adult
119254521,11925452,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Acute kidney injury,,2016,Q1,1,I,20150820.0,20160113.0,20160118,20160118,EXP,,US-ABBVIE-16P-163-1540268-00,ABBVIE,,50.0,YR,,F,Y,88.45,KG,20160118.0,,CN,US,US,2016,Q1,Adult
119254521,11925452,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Anaemia,,2016,Q1,1,I,20150820.0,20160113.0,20160118,20160118,EXP,,US-ABBVIE-16P-163-1540268-00,ABBVIE,,50.0,YR,,F,Y,88.45,KG,20160118.0,,CN,US,US,2016,Q1,Adult
119254521,11925452,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Chest pain,,2016,Q1,1,I,20150820.0,20160113.0,20160118,20160118,EXP,,US-ABBVIE-16P-163-1540268-00,ABBVIE,,50.0,YR,,F,Y,88.45,KG,20160118.0,,CN,US,US,2016,Q1,Adult
119254521,11925452,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Diarrhoea,,2016,Q1,1,I,20150820.0,20160113.0,20160118,20160118,EXP,,US-ABBVIE-16P-163-1540268-00,ABBVIE,,50.0,YR,,F,Y,88.45,KG,20160118.0,,CN,US,US,2016,Q1,Adult
119254521,11925452,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Dizziness,,2016,Q1,1,I,20150820.0,20160113.0,20160118,20160118,EXP,,US-ABBVIE-16P-163-1540268-00,ABBVIE,,50.0,YR,,F,Y,88.45,KG,20160118.0,,CN,US,US,2016,Q1,Adult
119254521,11925452,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Dysuria,,2016,Q1,1,I,20150820.0,20160113.0,20160118,20160118,EXP,,US-ABBVIE-16P-163-1540268-00,ABBVIE,,50.0,YR,,F,Y,88.45,KG,20160118.0,,CN,US,US,2016,Q1,Adult
119254521,11925452,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Haematemesis,,2016,Q1,1,I,20150820.0,20160113.0,20160118,20160118,EXP,,US-ABBVIE-16P-163-1540268-00,ABBVIE,,50.0,YR,,F,Y,88.45,KG,20160118.0,,CN,US,US,2016,Q1,Adult
119254521,11925452,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Headache,,2016,Q1,1,I,20150820.0,20160113.0,20160118,20160118,EXP,,US-ABBVIE-16P-163-1540268-00,ABBVIE,,50.0,YR,,F,Y,88.45,KG,20160118.0,,CN,US,US,2016,Q1,Adult
119254521,11925452,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Hypophagia,,2016,Q1,1,I,20150820.0,20160113.0,20160118,20160118,EXP,,US-ABBVIE-16P-163-1540268-00,ABBVIE,,50.0,YR,,F,Y,88.45,KG,20160118.0,,CN,US,US,2016,Q1,Adult
119254521,11925452,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Leukopenia,,2016,Q1,1,I,20150820.0,20160113.0,20160118,20160118,EXP,,US-ABBVIE-16P-163-1540268-00,ABBVIE,,50.0,YR,,F,Y,88.45,KG,20160118.0,,CN,US,US,2016,Q1,Adult
119254521,11925452,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Thrombocytopenia,,2016,Q1,1,I,20150820.0,20160113.0,20160118,20160118,EXP,,US-ABBVIE-16P-163-1540268-00,ABBVIE,,50.0,YR,,F,Y,88.45,KG,20160118.0,,CN,US,US,2016,Q1,Adult
119254521,11925452,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Urinary tract infection,,2016,Q1,1,I,20150820.0,20160113.0,20160118,20160118,EXP,,US-ABBVIE-16P-163-1540268-00,ABBVIE,,50.0,YR,,F,Y,88.45,KG,20160118.0,,CN,US,US,2016,Q1,Adult
119254521,11925452,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Vomiting,,2016,Q1,1,I,20150820.0,20160113.0,20160118,20160118,EXP,,US-ABBVIE-16P-163-1540268-00,ABBVIE,,50.0,YR,,F,Y,88.45,KG,20160118.0,,CN,US,US,2016,Q1,Adult
119254521,11925452,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Vulvovaginal mycotic infection,,2016,Q1,1,I,20150820.0,20160113.0,20160118,20160118,EXP,,US-ABBVIE-16P-163-1540268-00,ABBVIE,,50.0,YR,,F,Y,88.45,KG,20160118.0,,CN,US,US,2016,Q1,Adult
119266751,11926675,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Blood glucose decreased,,2016,Q1,1,I,201508.0,20160112.0,20160119,20160119,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201601005512,ELI LILLY AND CO,,52.0,YR,,M,Y,75.0,KG,20160118.0,,CN,CN,CN,2016,Q1,Adult
119266751,11926675,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Blood glucose increased,,2016,Q1,1,I,201508.0,20160112.0,20160119,20160119,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201601005512,ELI LILLY AND CO,,52.0,YR,,M,Y,75.0,KG,20160118.0,,CN,CN,CN,2016,Q1,Adult
119266751,11926675,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Eye haemorrhage,,2016,Q1,1,I,201508.0,20160112.0,20160119,20160119,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201601005512,ELI LILLY AND CO,,52.0,YR,,M,Y,75.0,KG,20160118.0,,CN,CN,CN,2016,Q1,Adult
119266751,11926675,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Hyperglycaemia,,2016,Q1,1,I,201508.0,20160112.0,20160119,20160119,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201601005512,ELI LILLY AND CO,,52.0,YR,,M,Y,75.0,KG,20160118.0,,CN,CN,CN,2016,Q1,Adult
119266751,11926675,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Pruritus generalised,,2016,Q1,1,I,201508.0,20160112.0,20160119,20160119,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201601005512,ELI LILLY AND CO,,52.0,YR,,M,Y,75.0,KG,20160118.0,,CN,CN,CN,2016,Q1,Adult
119273081,11927308,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q1,Somnolence,,2016,Q1,1,I,20150929.0,20160113.0,20160119,20160119,EXP,,US-ABBVIE-16P-163-1540558-00,ABBVIE,,50.0,YR,,F,Y,88.45,KG,20160119.0,,MD,COUNTRY NOT SPECIFIED,US,2016,Q1,Adult
119273081,11927308,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q1,Vertigo positional,,2016,Q1,1,I,20150929.0,20160113.0,20160119,20160119,EXP,,US-ABBVIE-16P-163-1540558-00,ABBVIE,,50.0,YR,,F,Y,88.45,KG,20160119.0,,MD,COUNTRY NOT SPECIFIED,US,2016,Q1,Adult
119291311,11929131,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Abnormal behaviour,,2016,Q1,1,I,20151222.0,20160112.0,20160120,20160120,EXP,GB-MHRA-EYC 00133250,GB-DRREDDYS-GER/UKI/16/0055837,DR REDDYS,,29.0,YR,,F,Y,43.0,KG,20160120.0,,PH,GB,GB,2016,Q1,Young Adult
119291311,11929131,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Confusional state,,2016,Q1,1,I,20151222.0,20160112.0,20160120,20160120,EXP,GB-MHRA-EYC 00133250,GB-DRREDDYS-GER/UKI/16/0055837,DR REDDYS,,29.0,YR,,F,Y,43.0,KG,20160120.0,,PH,GB,GB,2016,Q1,Young Adult
119291311,11929131,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Decreased appetite,,2016,Q1,1,I,20151222.0,20160112.0,20160120,20160120,EXP,GB-MHRA-EYC 00133250,GB-DRREDDYS-GER/UKI/16/0055837,DR REDDYS,,29.0,YR,,F,Y,43.0,KG,20160120.0,,PH,GB,GB,2016,Q1,Young Adult
119291311,11929131,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Disorientation,,2016,Q1,1,I,20151222.0,20160112.0,20160120,20160120,EXP,GB-MHRA-EYC 00133250,GB-DRREDDYS-GER/UKI/16/0055837,DR REDDYS,,29.0,YR,,F,Y,43.0,KG,20160120.0,,PH,GB,GB,2016,Q1,Young Adult
119291311,11929131,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Fall,,2016,Q1,1,I,20151222.0,20160112.0,20160120,20160120,EXP,GB-MHRA-EYC 00133250,GB-DRREDDYS-GER/UKI/16/0055837,DR REDDYS,,29.0,YR,,F,Y,43.0,KG,20160120.0,,PH,GB,GB,2016,Q1,Young Adult
119291311,11929131,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Feeling of body temperature change,,2016,Q1,1,I,20151222.0,20160112.0,20160120,20160120,EXP,GB-MHRA-EYC 00133250,GB-DRREDDYS-GER/UKI/16/0055837,DR REDDYS,,29.0,YR,,F,Y,43.0,KG,20160120.0,,PH,GB,GB,2016,Q1,Young Adult
119291311,11929131,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Nausea,,2016,Q1,1,I,20151222.0,20160112.0,20160120,20160120,EXP,GB-MHRA-EYC 00133250,GB-DRREDDYS-GER/UKI/16/0055837,DR REDDYS,,29.0,YR,,F,Y,43.0,KG,20160120.0,,PH,GB,GB,2016,Q1,Young Adult
119291311,11929131,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Pain,,2016,Q1,1,I,20151222.0,20160112.0,20160120,20160120,EXP,GB-MHRA-EYC 00133250,GB-DRREDDYS-GER/UKI/16/0055837,DR REDDYS,,29.0,YR,,F,Y,43.0,KG,20160120.0,,PH,GB,GB,2016,Q1,Young Adult
119291311,11929131,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Palpitations,,2016,Q1,1,I,20151222.0,20160112.0,20160120,20160120,EXP,GB-MHRA-EYC 00133250,GB-DRREDDYS-GER/UKI/16/0055837,DR REDDYS,,29.0,YR,,F,Y,43.0,KG,20160120.0,,PH,GB,GB,2016,Q1,Young Adult
119291311,11929131,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Serotonin syndrome,,2016,Q1,1,I,20151222.0,20160112.0,20160120,20160120,EXP,GB-MHRA-EYC 00133250,GB-DRREDDYS-GER/UKI/16/0055837,DR REDDYS,,29.0,YR,,F,Y,43.0,KG,20160120.0,,PH,GB,GB,2016,Q1,Young Adult
119291311,11929131,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Somnolence,,2016,Q1,1,I,20151222.0,20160112.0,20160120,20160120,EXP,GB-MHRA-EYC 00133250,GB-DRREDDYS-GER/UKI/16/0055837,DR REDDYS,,29.0,YR,,F,Y,43.0,KG,20160120.0,,PH,GB,GB,2016,Q1,Young Adult
119291311,11929131,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Tremor,,2016,Q1,1,I,20151222.0,20160112.0,20160120,20160120,EXP,GB-MHRA-EYC 00133250,GB-DRREDDYS-GER/UKI/16/0055837,DR REDDYS,,29.0,YR,,F,Y,43.0,KG,20160120.0,,PH,GB,GB,2016,Q1,Young Adult
119329712,11932971,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 UNITS, QHS",,,,U,,,,40.0,DF,,QD,2016,Q1,Maternal exposure during pregnancy,,2016,Q1,2,F,20151204.0,20160308.0,20160120,20160316,PER,,US-009507513-1601USA004780,MERCK,,25.0,YR,,F,Y,92.63,KG,20160316.0,,PH,US,US,2016,Q1,Young Adult
119386462,11938646,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,18.0,IU,,QD,2016,Q1,Myelodysplastic syndrome,,2016,Q1,2,F,20150622.0,20160126.0,20160122,20160203,EXP,,NL-ASTRAZENECA-2016SE05140,ASTRAZENECA,,784.0,MON,,F,Y,,,20160203.0,,MD,NL,NL,2016,Q1,Elderly
119394541,11939454,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN",,,,U,,,,,,,,2016,Q1,Diabetic neuropathy,,2016,Q1,1,I,20151222.0,20160112.0,20160122,20160122,EXP,GB-MHRA-EYC 00133250,GB-ELI_LILLY_AND_COMPANY-GB201601004131,ELI LILLY AND CO,,29.0,YR,,F,Y,43.0,KG,20160122.0,,CN,GB,GB,2016,Q1,Young Adult
119394541,11939454,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN",,,,U,,,,,,,,2016,Q1,Fall,,2016,Q1,1,I,20151222.0,20160112.0,20160122,20160122,EXP,GB-MHRA-EYC 00133250,GB-ELI_LILLY_AND_COMPANY-GB201601004131,ELI LILLY AND CO,,29.0,YR,,F,Y,43.0,KG,20160122.0,,CN,GB,GB,2016,Q1,Young Adult
119394541,11939454,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN",,,,U,,,,,,,,2016,Q1,Pain,,2016,Q1,1,I,20151222.0,20160112.0,20160122,20160122,EXP,GB-MHRA-EYC 00133250,GB-ELI_LILLY_AND_COMPANY-GB201601004131,ELI LILLY AND CO,,29.0,YR,,F,Y,43.0,KG,20160122.0,,CN,GB,GB,2016,Q1,Young Adult
119394541,11939454,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN",,,,U,,,,,,,,2016,Q1,Serotonin syndrome,,2016,Q1,1,I,20151222.0,20160112.0,20160122,20160122,EXP,GB-MHRA-EYC 00133250,GB-ELI_LILLY_AND_COMPANY-GB201601004131,ELI LILLY AND CO,,29.0,YR,,F,Y,43.0,KG,20160122.0,,CN,GB,GB,2016,Q1,Young Adult
119397851,11939785,11,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Abdominal pain,,2016,Q1,1,I,20150820.0,20160113.0,20160122,20160122,EXP,,"US-KADMON PHARMACEUTICALS, LLC-KAD201601-000213",KADMON,,50.0,YR,,F,Y,88.45,KG,20160122.0,,CN,US,US,2016,Q1,Adult
119397851,11939785,11,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Acute kidney injury,,2016,Q1,1,I,20150820.0,20160113.0,20160122,20160122,EXP,,"US-KADMON PHARMACEUTICALS, LLC-KAD201601-000213",KADMON,,50.0,YR,,F,Y,88.45,KG,20160122.0,,CN,US,US,2016,Q1,Adult
119397851,11939785,11,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Anaemia,,2016,Q1,1,I,20150820.0,20160113.0,20160122,20160122,EXP,,"US-KADMON PHARMACEUTICALS, LLC-KAD201601-000213",KADMON,,50.0,YR,,F,Y,88.45,KG,20160122.0,,CN,US,US,2016,Q1,Adult
119397851,11939785,11,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Chest pain,,2016,Q1,1,I,20150820.0,20160113.0,20160122,20160122,EXP,,"US-KADMON PHARMACEUTICALS, LLC-KAD201601-000213",KADMON,,50.0,YR,,F,Y,88.45,KG,20160122.0,,CN,US,US,2016,Q1,Adult
119397851,11939785,11,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Diarrhoea,,2016,Q1,1,I,20150820.0,20160113.0,20160122,20160122,EXP,,"US-KADMON PHARMACEUTICALS, LLC-KAD201601-000213",KADMON,,50.0,YR,,F,Y,88.45,KG,20160122.0,,CN,US,US,2016,Q1,Adult
119397851,11939785,11,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Dizziness,,2016,Q1,1,I,20150820.0,20160113.0,20160122,20160122,EXP,,"US-KADMON PHARMACEUTICALS, LLC-KAD201601-000213",KADMON,,50.0,YR,,F,Y,88.45,KG,20160122.0,,CN,US,US,2016,Q1,Adult
119397851,11939785,11,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Dysuria,,2016,Q1,1,I,20150820.0,20160113.0,20160122,20160122,EXP,,"US-KADMON PHARMACEUTICALS, LLC-KAD201601-000213",KADMON,,50.0,YR,,F,Y,88.45,KG,20160122.0,,CN,US,US,2016,Q1,Adult
119397851,11939785,11,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Haematemesis,,2016,Q1,1,I,20150820.0,20160113.0,20160122,20160122,EXP,,"US-KADMON PHARMACEUTICALS, LLC-KAD201601-000213",KADMON,,50.0,YR,,F,Y,88.45,KG,20160122.0,,CN,US,US,2016,Q1,Adult
119397851,11939785,11,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Headache,,2016,Q1,1,I,20150820.0,20160113.0,20160122,20160122,EXP,,"US-KADMON PHARMACEUTICALS, LLC-KAD201601-000213",KADMON,,50.0,YR,,F,Y,88.45,KG,20160122.0,,CN,US,US,2016,Q1,Adult
119397851,11939785,11,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Hypophagia,,2016,Q1,1,I,20150820.0,20160113.0,20160122,20160122,EXP,,"US-KADMON PHARMACEUTICALS, LLC-KAD201601-000213",KADMON,,50.0,YR,,F,Y,88.45,KG,20160122.0,,CN,US,US,2016,Q1,Adult
119397851,11939785,11,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Leukopenia,,2016,Q1,1,I,20150820.0,20160113.0,20160122,20160122,EXP,,"US-KADMON PHARMACEUTICALS, LLC-KAD201601-000213",KADMON,,50.0,YR,,F,Y,88.45,KG,20160122.0,,CN,US,US,2016,Q1,Adult
119397851,11939785,11,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Thrombocytopenia,,2016,Q1,1,I,20150820.0,20160113.0,20160122,20160122,EXP,,"US-KADMON PHARMACEUTICALS, LLC-KAD201601-000213",KADMON,,50.0,YR,,F,Y,88.45,KG,20160122.0,,CN,US,US,2016,Q1,Adult
119397851,11939785,11,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Urinary tract infection,,2016,Q1,1,I,20150820.0,20160113.0,20160122,20160122,EXP,,"US-KADMON PHARMACEUTICALS, LLC-KAD201601-000213",KADMON,,50.0,YR,,F,Y,88.45,KG,20160122.0,,CN,US,US,2016,Q1,Adult
119397851,11939785,11,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Vomiting,,2016,Q1,1,I,20150820.0,20160113.0,20160122,20160122,EXP,,"US-KADMON PHARMACEUTICALS, LLC-KAD201601-000213",KADMON,,50.0,YR,,F,Y,88.45,KG,20160122.0,,CN,US,US,2016,Q1,Adult
119397851,11939785,11,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Vulvovaginal mycotic infection,,2016,Q1,1,I,20150820.0,20160113.0,20160122,20160122,EXP,,"US-KADMON PHARMACEUTICALS, LLC-KAD201601-000213",KADMON,,50.0,YR,,F,Y,88.45,KG,20160122.0,,CN,US,US,2016,Q1,Adult
119398151,11939815,11,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Condition aggravated,,2016,Q1,1,I,20150929.0,20160113.0,20160122,20160122,EXP,,"US-KADMON PHARMACEUTICALS, LLC-KAD201601-000219",KADMON,,50.0,YR,,F,Y,88.45,KG,20160122.0,,MD,US,US,2016,Q1,Adult
119398151,11939815,11,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Somnolence,,2016,Q1,1,I,20150929.0,20160113.0,20160122,20160122,EXP,,"US-KADMON PHARMACEUTICALS, LLC-KAD201601-000219",KADMON,,50.0,YR,,F,Y,88.45,KG,20160122.0,,MD,US,US,2016,Q1,Adult
119398151,11939815,11,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Vertigo positional,,2016,Q1,1,I,20150929.0,20160113.0,20160122,20160122,EXP,,"US-KADMON PHARMACEUTICALS, LLC-KAD201601-000219",KADMON,,50.0,YR,,F,Y,88.45,KG,20160122.0,,MD,US,US,2016,Q1,Adult
119406982,11940698,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q1,Hypokalaemia,,2016,Q1,2,F,20151114.0,20160224.0,20160122,20160309,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-093492,BRISTOL MYERS SQUIBB,,54.0,YR,,F,Y,,,20160309.0,,CN,IT,IT,2016,Q1,Adult
119406982,11940698,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q1,Klebsiella infection,,2016,Q1,2,F,20151114.0,20160224.0,20160122,20160309,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-093492,BRISTOL MYERS SQUIBB,,54.0,YR,,F,Y,,,20160309.0,,CN,IT,IT,2016,Q1,Adult
119406982,11940698,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q1,Lung consolidation,,2016,Q1,2,F,20151114.0,20160224.0,20160122,20160309,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-093492,BRISTOL MYERS SQUIBB,,54.0,YR,,F,Y,,,20160309.0,,CN,IT,IT,2016,Q1,Adult
119406982,11940698,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q1,Metabolic acidosis,,2016,Q1,2,F,20151114.0,20160224.0,20160122,20160309,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-093492,BRISTOL MYERS SQUIBB,,54.0,YR,,F,Y,,,20160309.0,,CN,IT,IT,2016,Q1,Adult
119406982,11940698,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q1,Pyelonephritis acute,,2016,Q1,2,F,20151114.0,20160224.0,20160122,20160309,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-093492,BRISTOL MYERS SQUIBB,,54.0,YR,,F,Y,,,20160309.0,,CN,IT,IT,2016,Q1,Adult
119414411,11941441,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,30.0,IU,,,2016,Q1,Dysuria,,2016,Q1,1,I,20140126.0,20140127.0,20160122,20160122,PER,,US-ASTRAZENECA-2014SE09673,ASTRAZENECA,,71.0,YR,,F,Y,,,20160123.0,,CN,US,CA,2016,Q1,Elderly
119426801,11942680,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"35 UNITS, BID",,,,,,,,,,,BID,2016,Q1,Asthenia,,2016,Q1,1,I,201506.0,20150612.0,20160125,20160125,PER,,US-UNITED THERAPEUTICS-UNT-2015-007258,UNITED THERAPEUTICS,,47.0,YR,,F,Y,117.91,KG,20160125.0,,CN,US,US,2016,Q1,Adult
119426801,11942680,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"35 UNITS, BID",,,,,,,,,,,BID,2016,Q1,Drug dose omission,,2016,Q1,1,I,201506.0,20150612.0,20160125,20160125,PER,,US-UNITED THERAPEUTICS-UNT-2015-007258,UNITED THERAPEUTICS,,47.0,YR,,F,Y,117.91,KG,20160125.0,,CN,US,US,2016,Q1,Adult
119426801,11942680,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"35 UNITS, BID",,,,,,,,,,,BID,2016,Q1,Dyspnoea,,2016,Q1,1,I,201506.0,20150612.0,20160125,20160125,PER,,US-UNITED THERAPEUTICS-UNT-2015-007258,UNITED THERAPEUTICS,,47.0,YR,,F,Y,117.91,KG,20160125.0,,CN,US,US,2016,Q1,Adult
119426801,11942680,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"35 UNITS, BID",,,,,,,,,,,BID,2016,Q1,Feeling hot,,2016,Q1,1,I,201506.0,20150612.0,20160125,20160125,PER,,US-UNITED THERAPEUTICS-UNT-2015-007258,UNITED THERAPEUTICS,,47.0,YR,,F,Y,117.91,KG,20160125.0,,CN,US,US,2016,Q1,Adult
119450191,11945019,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE: 15 UNITS,,,,,,,,,,UNKNOWN,,2016,Q1,Blood pressure decreased,,2016,Q1,1,I,,20160113.0,20160125,20160125,EXP,,BR-JNJFOC-20160118391,JANSSEN,,55.0,YR,A,F,Y,85.0,KG,20160125.0,,MD,BR,BR,2016,Q1,Adult
119450191,11945019,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE: 15 UNITS,,,,,,,,,,UNKNOWN,,2016,Q1,Weight decreased,,2016,Q1,1,I,,20160113.0,20160125,20160125,EXP,,BR-JNJFOC-20160118391,JANSSEN,,55.0,YR,A,F,Y,85.0,KG,20160125.0,,MD,BR,BR,2016,Q1,Adult
119450191,11945019,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE: 40 UNITS,,,,,,,,,,UNKNOWN,,2016,Q1,Blood pressure decreased,,2016,Q1,1,I,,20160113.0,20160125,20160125,EXP,,BR-JNJFOC-20160118391,JANSSEN,,55.0,YR,A,F,Y,85.0,KG,20160125.0,,MD,BR,BR,2016,Q1,Adult
119450191,11945019,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE: 40 UNITS,,,,,,,,,,UNKNOWN,,2016,Q1,Weight decreased,,2016,Q1,1,I,,20160113.0,20160125,20160125,EXP,,BR-JNJFOC-20160118391,JANSSEN,,55.0,YR,A,F,Y,85.0,KG,20160125.0,,MD,BR,BR,2016,Q1,Adult
119512631,11951263,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,20 BEDTIME,,,,,,,,,,UNSPECIFIED,,2016,Q1,Diabetic ketoacidosis,,2016,Q1,1,I,20140528.0,20160121.0,20160126,20160126,EXP,,CA-JNJFOC-20160117827,JANSSEN,,33.0,YR,A,F,Y,57.0,KG,20160126.0,,MD,CA,CA,2016,Q1,Young Adult
119512631,11951263,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,20 BEDTIME,,,,,,,,,,UNSPECIFIED,,2016,Q1,Infusion related reaction,,2016,Q1,1,I,20140528.0,20160121.0,20160126,20160126,EXP,,CA-JNJFOC-20160117827,JANSSEN,,33.0,YR,A,F,Y,57.0,KG,20160126.0,,MD,CA,CA,2016,Q1,Young Adult
119512631,11951263,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,20 BEDTIME,,,,,,,,,,UNSPECIFIED,,2016,Q1,Off label use,,2016,Q1,1,I,20140528.0,20160121.0,20160126,20160126,EXP,,CA-JNJFOC-20160117827,JANSSEN,,33.0,YR,A,F,Y,57.0,KG,20160126.0,,MD,CA,CA,2016,Q1,Young Adult
119512631,11951263,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,20 BEDTIME,,,,,,,,,,UNSPECIFIED,,2016,Q1,Product use issue,,2016,Q1,1,I,20140528.0,20160121.0,20160126,20160126,EXP,,CA-JNJFOC-20160117827,JANSSEN,,33.0,YR,A,F,Y,57.0,KG,20160126.0,,MD,CA,CA,2016,Q1,Young Adult
119525351,11952535,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"QD, (AT BEDTIME)",,,,,,,,,,,QD,2016,Q1,Anaphylactic reaction,,2016,Q1,1,I,,20160115.0,20160125,20160125,EXP,,PHHY2016CA006690,SANDOZ,"YANG A, BROWN J, MAK E. PERSISTENT DIARRHEA AFTER CELIAC PLEXUS BLOCK IN A PANCREATIC CANCER PATIENT: CASE REPORT AND LITERATURE REVIEW.. JOURNAL OF PALLIATIVE MEDICINE. 2016?19 (1):83-6",70.0,YR,,F,Y,,,20160125.0,,OT,CA,CA,2016,Q1,Elderly
119525351,11952535,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"QD, (AT BEDTIME)",,,,,,,,,,,QD,2016,Q1,Drug intolerance,,2016,Q1,1,I,,20160115.0,20160125,20160125,EXP,,PHHY2016CA006690,SANDOZ,"YANG A, BROWN J, MAK E. PERSISTENT DIARRHEA AFTER CELIAC PLEXUS BLOCK IN A PANCREATIC CANCER PATIENT: CASE REPORT AND LITERATURE REVIEW.. JOURNAL OF PALLIATIVE MEDICINE. 2016?19 (1):83-6",70.0,YR,,F,Y,,,20160125.0,,OT,CA,CA,2016,Q1,Elderly
119526072,11952607,7,C,RECOMBINANT INSULIN GLARGINE,,2,Unknown,20 U,,,,,,,,20.0,IU,,QD,2016,Q1,Decreased appetite,,2016,Q1,2,F,,20160203.0,20160125,20160209,EXP,,"CN-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-03749CS",BOEHRINGER INGELHEIM,,51.0,YR,,M,Y,,,20160210.0,,MD,CN,CN,2016,Q1,Adult
119526072,11952607,7,C,RECOMBINANT INSULIN GLARGINE,,2,Unknown,20 U,,,,,,,,20.0,IU,,QD,2016,Q1,Musculoskeletal pain,Musculoskeletal pain,2016,Q1,2,F,,20160203.0,20160125,20160209,EXP,,"CN-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-03749CS",BOEHRINGER INGELHEIM,,51.0,YR,,M,Y,,,20160210.0,,MD,CN,CN,2016,Q1,Adult
119526072,11952607,7,C,RECOMBINANT INSULIN GLARGINE,,2,Unknown,20 U,,,,,,,,20.0,IU,,QD,2016,Q1,Nasopharyngitis,,2016,Q1,2,F,,20160203.0,20160125,20160209,EXP,,"CN-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-03749CS",BOEHRINGER INGELHEIM,,51.0,YR,,M,Y,,,20160210.0,,MD,CN,CN,2016,Q1,Adult
119526072,11952607,7,C,RECOMBINANT INSULIN GLARGINE,,2,Unknown,20 U,,,,,,,,20.0,IU,,QD,2016,Q1,Urticaria,Urticaria,2016,Q1,2,F,,20160203.0,20160125,20160209,EXP,,"CN-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-03749CS",BOEHRINGER INGELHEIM,,51.0,YR,,M,Y,,,20160210.0,,MD,CN,CN,2016,Q1,Adult
119526072,11952607,7,C,RECOMBINANT INSULIN GLARGINE,,2,Unknown,20 U,,,,,,,,20.0,IU,,QD,2016,Q1,Weight decreased,,2016,Q1,2,F,,20160203.0,20160125,20160209,EXP,,"CN-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-03749CS",BOEHRINGER INGELHEIM,,51.0,YR,,M,Y,,,20160210.0,,MD,CN,CN,2016,Q1,Adult
119670901,11967090,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q1,Abnormal behaviour,,2016,Q1,1,I,20151222.0,20160112.0,20160127,20160127,EXP,GB-MHRA-EYC 00133250,GB-ACTAVIS-2016-00444,ACTAVIS,,29.0,YR,,F,Y,43.0,KG,20160127.0,,CN,GB,GB,2016,Q1,Young Adult
119670901,11967090,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q1,Confusional state,,2016,Q1,1,I,20151222.0,20160112.0,20160127,20160127,EXP,GB-MHRA-EYC 00133250,GB-ACTAVIS-2016-00444,ACTAVIS,,29.0,YR,,F,Y,43.0,KG,20160127.0,,CN,GB,GB,2016,Q1,Young Adult
119670901,11967090,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q1,Decreased appetite,,2016,Q1,1,I,20151222.0,20160112.0,20160127,20160127,EXP,GB-MHRA-EYC 00133250,GB-ACTAVIS-2016-00444,ACTAVIS,,29.0,YR,,F,Y,43.0,KG,20160127.0,,CN,GB,GB,2016,Q1,Young Adult
119670901,11967090,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q1,Disorientation,,2016,Q1,1,I,20151222.0,20160112.0,20160127,20160127,EXP,GB-MHRA-EYC 00133250,GB-ACTAVIS-2016-00444,ACTAVIS,,29.0,YR,,F,Y,43.0,KG,20160127.0,,CN,GB,GB,2016,Q1,Young Adult
119670901,11967090,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q1,Fall,,2016,Q1,1,I,20151222.0,20160112.0,20160127,20160127,EXP,GB-MHRA-EYC 00133250,GB-ACTAVIS-2016-00444,ACTAVIS,,29.0,YR,,F,Y,43.0,KG,20160127.0,,CN,GB,GB,2016,Q1,Young Adult
119670901,11967090,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q1,Feeling of body temperature change,,2016,Q1,1,I,20151222.0,20160112.0,20160127,20160127,EXP,GB-MHRA-EYC 00133250,GB-ACTAVIS-2016-00444,ACTAVIS,,29.0,YR,,F,Y,43.0,KG,20160127.0,,CN,GB,GB,2016,Q1,Young Adult
119670901,11967090,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q1,Nausea,,2016,Q1,1,I,20151222.0,20160112.0,20160127,20160127,EXP,GB-MHRA-EYC 00133250,GB-ACTAVIS-2016-00444,ACTAVIS,,29.0,YR,,F,Y,43.0,KG,20160127.0,,CN,GB,GB,2016,Q1,Young Adult
119670901,11967090,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q1,Pain,,2016,Q1,1,I,20151222.0,20160112.0,20160127,20160127,EXP,GB-MHRA-EYC 00133250,GB-ACTAVIS-2016-00444,ACTAVIS,,29.0,YR,,F,Y,43.0,KG,20160127.0,,CN,GB,GB,2016,Q1,Young Adult
119670901,11967090,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q1,Palpitations,,2016,Q1,1,I,20151222.0,20160112.0,20160127,20160127,EXP,GB-MHRA-EYC 00133250,GB-ACTAVIS-2016-00444,ACTAVIS,,29.0,YR,,F,Y,43.0,KG,20160127.0,,CN,GB,GB,2016,Q1,Young Adult
119670901,11967090,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q1,Serotonin syndrome,,2016,Q1,1,I,20151222.0,20160112.0,20160127,20160127,EXP,GB-MHRA-EYC 00133250,GB-ACTAVIS-2016-00444,ACTAVIS,,29.0,YR,,F,Y,43.0,KG,20160127.0,,CN,GB,GB,2016,Q1,Young Adult
119670901,11967090,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q1,Somnolence,,2016,Q1,1,I,20151222.0,20160112.0,20160127,20160127,EXP,GB-MHRA-EYC 00133250,GB-ACTAVIS-2016-00444,ACTAVIS,,29.0,YR,,F,Y,43.0,KG,20160127.0,,CN,GB,GB,2016,Q1,Young Adult
119670901,11967090,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q1,Tremor,,2016,Q1,1,I,20151222.0,20160112.0,20160127,20160127,EXP,GB-MHRA-EYC 00133250,GB-ACTAVIS-2016-00444,ACTAVIS,,29.0,YR,,F,Y,43.0,KG,20160127.0,,CN,GB,GB,2016,Q1,Young Adult
119674991,11967499,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,8 UNITS AT NIGHT,,,,U,,,,,,,,2016,Q1,Haemoptysis,,2016,Q1,1,I,20151226.0,20160122.0,20160127,20160127,EXP,,AU-VERTEX PHARMACEUTICALS-2016-000350,VERTEX,,41.0,YR,,M,Y,70.0,KG,20160127.0,,PH,AU,AU,2016,Q1,Adult
119674991,11967499,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,8 UNITS AT NIGHT,,,,U,,,,,,,,2016,Q1,Infective pulmonary exacerbation of cystic fibrosis,,2016,Q1,1,I,20151226.0,20160122.0,20160127,20160127,EXP,,AU-VERTEX PHARMACEUTICALS-2016-000350,VERTEX,,41.0,YR,,M,Y,70.0,KG,20160127.0,,PH,AU,AU,2016,Q1,Adult
119750261,11975026,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2016,Q1,Ascites,,2016,Q1,1,I,20151030.0,20151029.0,20160128,20160128,EXP,,AU-GILEAD-2015-0180292,GILEAD,,55.0,YR,A,M,Y,112.0,KG,20160128.0,,OT,AU,AU,2016,Q1,Adult
119750261,11975026,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2016,Q1,Dyspnoea,,2016,Q1,1,I,20151030.0,20151029.0,20160128,20160128,EXP,,AU-GILEAD-2015-0180292,GILEAD,,55.0,YR,A,M,Y,112.0,KG,20160128.0,,OT,AU,AU,2016,Q1,Adult
119755281,11975528,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q1,Dyspnoea,,2016,Q1,1,I,20160121.0,20160126.0,20160129,20160129,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-005669,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,,,20160129.0,,OT,US,US,2016,Q1,Elderly
119755281,11975528,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q1,Hyperhidrosis,,2016,Q1,1,I,20160121.0,20160126.0,20160129,20160129,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-005669,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,,,20160129.0,,OT,US,US,2016,Q1,Elderly
119802861,11980286,4,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2016,Q1,Eye disorder,,2016,Q1,1,I,201211.0,20160125.0,20160129,20160129,EXP,NL-LRB-212463,NL-PFIZER INC-2016043942,PFIZER,,58.0,YR,,M,Y,78.0,KG,20160129.0,,PH,NL,NL,2016,Q1,Adult
119802861,11980286,4,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2016,Q1,Papilloedema,,2016,Q1,1,I,201211.0,20160125.0,20160129,20160129,EXP,NL-LRB-212463,NL-PFIZER INC-2016043942,PFIZER,,58.0,YR,,M,Y,78.0,KG,20160129.0,,PH,NL,NL,2016,Q1,Adult
119804171,11980417,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 U, UNK",,,,,,,,1.0,DF,,,2016,Q1,Cerebral haemorrhage,,2016,Q1,1,I,20151215.0,20160121.0,20160129,20160129,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-004218,BRISTOL MYERS SQUIBB,,76.0,YR,,F,Y,,,20160129.0,,CN,IT,IT,2016,Q1,Elderly
119804171,11980417,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 U, UNK",,,,,,,,1.0,DF,,,2016,Q1,Confusional state,,2016,Q1,1,I,20151215.0,20160121.0,20160129,20160129,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-004218,BRISTOL MYERS SQUIBB,,76.0,YR,,F,Y,,,20160129.0,,CN,IT,IT,2016,Q1,Elderly
119804171,11980417,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 U, UNK",,,,,,,,1.0,DF,,,2016,Q1,Disorientation,,2016,Q1,1,I,20151215.0,20160121.0,20160129,20160129,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-004218,BRISTOL MYERS SQUIBB,,76.0,YR,,F,Y,,,20160129.0,,CN,IT,IT,2016,Q1,Elderly
119804171,11980417,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 U, UNK",,,,,,,,1.0,DF,,,2016,Q1,Femur fracture,,2016,Q1,1,I,20151215.0,20160121.0,20160129,20160129,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-004218,BRISTOL MYERS SQUIBB,,76.0,YR,,F,Y,,,20160129.0,,CN,IT,IT,2016,Q1,Elderly
119804171,11980417,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 U, UNK",,,,,,,,1.0,DF,,,2016,Q1,Injury,,2016,Q1,1,I,20151215.0,20160121.0,20160129,20160129,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-004218,BRISTOL MYERS SQUIBB,,76.0,YR,,F,Y,,,20160129.0,,CN,IT,IT,2016,Q1,Elderly
119811953,11981195,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,30.0,IU,INJECTION,,2016,Q1,Drug hypersensitivity,,2016,Q1,3,F,20160119.0,20160202.0,20160129,20160210,EXP,,CN-ASTRAZENECA-2016SE08524,ASTRAZENECA,,51.0,YR,,M,Y,,,20160210.0,,MD,CN,CN,2016,Q1,Adult
119811953,11981195,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,30.0,IU,INJECTION,,2016,Q1,Erythema of eyelid,,2016,Q1,3,F,20160119.0,20160202.0,20160129,20160210,EXP,,CN-ASTRAZENECA-2016SE08524,ASTRAZENECA,,51.0,YR,,M,Y,,,20160210.0,,MD,CN,CN,2016,Q1,Adult
119811953,11981195,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,30.0,IU,INJECTION,,2016,Q1,Eyelid oedema,,2016,Q1,3,F,20160119.0,20160202.0,20160129,20160210,EXP,,CN-ASTRAZENECA-2016SE08524,ASTRAZENECA,,51.0,YR,,M,Y,,,20160210.0,,MD,CN,CN,2016,Q1,Adult
119811953,11981195,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,30.0,IU,INJECTION,,2016,Q1,Rash generalised,,2016,Q1,3,F,20160119.0,20160202.0,20160129,20160210,EXP,,CN-ASTRAZENECA-2016SE08524,ASTRAZENECA,,51.0,YR,,M,Y,,,20160210.0,,MD,CN,CN,2016,Q1,Adult
119811953,11981195,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,20.0,IU,INJECTION,QD,2016,Q1,Drug hypersensitivity,,2016,Q1,3,F,20160119.0,20160202.0,20160129,20160210,EXP,,CN-ASTRAZENECA-2016SE08524,ASTRAZENECA,,51.0,YR,,M,Y,,,20160210.0,,MD,CN,CN,2016,Q1,Adult
119811953,11981195,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,20.0,IU,INJECTION,QD,2016,Q1,Erythema of eyelid,,2016,Q1,3,F,20160119.0,20160202.0,20160129,20160210,EXP,,CN-ASTRAZENECA-2016SE08524,ASTRAZENECA,,51.0,YR,,M,Y,,,20160210.0,,MD,CN,CN,2016,Q1,Adult
119811953,11981195,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,20.0,IU,INJECTION,QD,2016,Q1,Eyelid oedema,,2016,Q1,3,F,20160119.0,20160202.0,20160129,20160210,EXP,,CN-ASTRAZENECA-2016SE08524,ASTRAZENECA,,51.0,YR,,M,Y,,,20160210.0,,MD,CN,CN,2016,Q1,Adult
119811953,11981195,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,20.0,IU,INJECTION,QD,2016,Q1,Rash generalised,,2016,Q1,3,F,20160119.0,20160202.0,20160129,20160210,EXP,,CN-ASTRAZENECA-2016SE08524,ASTRAZENECA,,51.0,YR,,M,Y,,,20160210.0,,MD,CN,CN,2016,Q1,Adult
119826642,11982664,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"35 IU, QHS",,,,,,,,35.0,IU,,QD,2016,Q1,Angioedema,,2016,Q1,2,F,,20160203.0,20160201,20160218,EXP,,US-ACTAVIS-2016-01812,WATSON,"PHAM A, HARIRI S, YUSIN J. TIMING ISN^T EVERYTHING: A CASE OF RECURRENT ANGIO-OEDEMA. ALLERGOL IMMUNOPATHOL (MADR). 2015?43(2):230-1.",67.0,YR,,M,Y,,,20160218.0,,OT,US,US,2016,Q1,Elderly
119866431,11986643,2,C,GLARGINE INSULIN,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Ketoacidosis,,2016,Q1,1,I,20151130.0,,20160201,20160201,DIR,,,,,56.0,YR,,M,N,87.3,KG,20160129.0,N,MD,US,,2016,Q1,Adult
119877121,11987712,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,100.0,IU,,TID,2016,Q1,Bacterial infection,,2016,Q1,1,I,20151228.0,20160125.0,20160202,20160202,EXP,,US-ASTRAZENECA-2016SE08937,ASTRAZENECA,,59.0,YR,,F,Y,56.7,KG,20160202.0,,,US,US,2016,Q1,Adult
119877121,11987712,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,100.0,IU,,TID,2016,Q1,Blood cholesterol increased,,2016,Q1,1,I,20151228.0,20160125.0,20160202,20160202,EXP,,US-ASTRAZENECA-2016SE08937,ASTRAZENECA,,59.0,YR,,F,Y,56.7,KG,20160202.0,,,US,US,2016,Q1,Adult
119877121,11987712,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,100.0,IU,,TID,2016,Q1,Drug dose omission,,2016,Q1,1,I,20151228.0,20160125.0,20160202,20160202,EXP,,US-ASTRAZENECA-2016SE08937,ASTRAZENECA,,59.0,YR,,F,Y,56.7,KG,20160202.0,,,US,US,2016,Q1,Adult
119877121,11987712,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,100.0,IU,,TID,2016,Q1,Fall,,2016,Q1,1,I,20151228.0,20160125.0,20160202,20160202,EXP,,US-ASTRAZENECA-2016SE08937,ASTRAZENECA,,59.0,YR,,F,Y,56.7,KG,20160202.0,,,US,US,2016,Q1,Adult
119877121,11987712,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,100.0,IU,,TID,2016,Q1,Pyrexia,,2016,Q1,1,I,20151228.0,20160125.0,20160202,20160202,EXP,,US-ASTRAZENECA-2016SE08937,ASTRAZENECA,,59.0,YR,,F,Y,56.7,KG,20160202.0,,,US,US,2016,Q1,Adult
119958933,11995893,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,DAILY AT BEDTIME,,,,,,,,,,,,2016,Q1,Anaphylactic reaction,,2016,Q1,3,F,,20160205.0,20160203,20160216,EXP,,CA-BAYER-2016-012248,BAYER,,70.0,YR,E,F,Y,,,20160216.0,,CN,GB,CA,2016,Q1,Elderly
119958933,11995893,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,DAILY AT BEDTIME,,,,,,,,,,,,2016,Q1,Diarrhoea,,2016,Q1,3,F,,20160205.0,20160203,20160216,EXP,,CA-BAYER-2016-012248,BAYER,,70.0,YR,E,F,Y,,,20160216.0,,CN,GB,CA,2016,Q1,Elderly
119958933,11995893,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,DAILY AT BEDTIME,,,,,,,,,,,,2016,Q1,Nerve block,,2016,Q1,3,F,,20160205.0,20160203,20160216,EXP,,CA-BAYER-2016-012248,BAYER,,70.0,YR,E,F,Y,,,20160216.0,,CN,GB,CA,2016,Q1,Elderly
119960661,11996066,5,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2016,Q1,Cardio-respiratory arrest,,2016,Q1,1,I,20160126.0,20160128.0,20160203,20160203,EXP,,CO-BAXTER-2016BAX004947,BAXTER,,51.0,YR,,M,Y,70.0,KG,20160203.0,,OT,CO,CO,2016,Q1,Adult
119960661,11996066,5,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2016,Q1,Chest pain,,2016,Q1,1,I,20160126.0,20160128.0,20160203,20160203,EXP,,CO-BAXTER-2016BAX004947,BAXTER,,51.0,YR,,M,Y,70.0,KG,20160203.0,,OT,CO,CO,2016,Q1,Adult
119997481,11999748,10,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q1,Gastrointestinal tract mucosal discolouration,,2016,Q1,1,I,,20160120.0,20160204,20160204,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2016US-110867,RANBAXY,"SOHAIL U, ALMASHHRAWI A, RAHMAN R, ASHRAF I, COBERLY J, NGUYEN D ET AL. MYSTERIOUS BLACK CRYSTALLINE PIGMENT IN THE DUODENUM. AM-J-GASTROENTEROL. 2015?110:S437",72.0,YR,,F,Y,,,20160204.0,,OT,US,US,2016,Q1,Elderly
120038191,12003819,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,UNSPECIFIED,,2016,Q1,Drug dose omission,,2016,Q1,1,I,,20160119.0,20160204,20160204,PER,,US-JNJFOC-20160115817,JANSSEN,"SMITH K, GOMES D, NIXON D, PECORA PF. THE USE OF UNBOOSTED DARUNAVIR IN THE SETTING OF RITONAVIR INTOLERANCE: THREE CASE REPORTS. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, JAN-2016?54:52-57.",58.0,YR,A,F,Y,,,20160204.0,,OT,US,US,2016,Q1,Adult
120073951,12007395,9,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,25.0,IU,,QD,2016,Q1,Atrioventricular block complete,,2016,Q1,1,I,20160124.0,20160127.0,20160204,20160204,EXP,,CO-BAXTER-2016BAX004741,BAXTER,,58.0,YR,,F,Y,86.6,KG,20160204.0,,OT,CO,CO,2016,Q1,Adult
120073951,12007395,9,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,25.0,IU,,QD,2016,Q1,Cardiac arrest,,2016,Q1,1,I,20160124.0,20160127.0,20160204,20160204,EXP,,CO-BAXTER-2016BAX004741,BAXTER,,58.0,YR,,F,Y,86.6,KG,20160204.0,,OT,CO,CO,2016,Q1,Adult
120073951,12007395,9,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,25.0,IU,,QD,2016,Q1,Cardiac failure,,2016,Q1,1,I,20160124.0,20160127.0,20160204,20160204,EXP,,CO-BAXTER-2016BAX004741,BAXTER,,58.0,YR,,F,Y,86.6,KG,20160204.0,,OT,CO,CO,2016,Q1,Adult
120073951,12007395,9,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,25.0,IU,,QD,2016,Q1,Diarrhoea,,2016,Q1,1,I,20160124.0,20160127.0,20160204,20160204,EXP,,CO-BAXTER-2016BAX004741,BAXTER,,58.0,YR,,F,Y,86.6,KG,20160204.0,,OT,CO,CO,2016,Q1,Adult
120121951,12012195,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Anxiety,,2016,Q1,1,I,2014.0,20150821.0,20160205,20160205,PER,,US-ABBVIE-15K-163-1450966-00,ABBVIE,,54.0,YR,,F,Y,,,20160205.0,,CN,COUNTRY NOT SPECIFIED,US,2016,Q1,Adult
120121951,12012195,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Dry eye,,2016,Q1,1,I,2014.0,20150821.0,20160205,20160205,PER,,US-ABBVIE-15K-163-1450966-00,ABBVIE,,54.0,YR,,F,Y,,,20160205.0,,CN,COUNTRY NOT SPECIFIED,US,2016,Q1,Adult
120121951,12012195,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Influenza,,2016,Q1,1,I,2014.0,20150821.0,20160205,20160205,PER,,US-ABBVIE-15K-163-1450966-00,ABBVIE,,54.0,YR,,F,Y,,,20160205.0,,CN,COUNTRY NOT SPECIFIED,US,2016,Q1,Adult
120121951,12012195,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Injection site haemorrhage,,2016,Q1,1,I,2014.0,20150821.0,20160205,20160205,PER,,US-ABBVIE-15K-163-1450966-00,ABBVIE,,54.0,YR,,F,Y,,,20160205.0,,CN,COUNTRY NOT SPECIFIED,US,2016,Q1,Adult
120121951,12012195,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Injection site pain,,2016,Q1,1,I,2014.0,20150821.0,20160205,20160205,PER,,US-ABBVIE-15K-163-1450966-00,ABBVIE,,54.0,YR,,F,Y,,,20160205.0,,CN,COUNTRY NOT SPECIFIED,US,2016,Q1,Adult
120121951,12012195,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Insomnia,,2016,Q1,1,I,2014.0,20150821.0,20160205,20160205,PER,,US-ABBVIE-15K-163-1450966-00,ABBVIE,,54.0,YR,,F,Y,,,20160205.0,,CN,COUNTRY NOT SPECIFIED,US,2016,Q1,Adult
120121951,12012195,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Mouth swelling,,2016,Q1,1,I,2014.0,20150821.0,20160205,20160205,PER,,US-ABBVIE-15K-163-1450966-00,ABBVIE,,54.0,YR,,F,Y,,,20160205.0,,CN,COUNTRY NOT SPECIFIED,US,2016,Q1,Adult
120121951,12012195,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Panic attack,,2016,Q1,1,I,2014.0,20150821.0,20160205,20160205,PER,,US-ABBVIE-15K-163-1450966-00,ABBVIE,,54.0,YR,,F,Y,,,20160205.0,,CN,COUNTRY NOT SPECIFIED,US,2016,Q1,Adult
120121951,12012195,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Toothache,,2016,Q1,1,I,2014.0,20150821.0,20160205,20160205,PER,,US-ABBVIE-15K-163-1450966-00,ABBVIE,,54.0,YR,,F,Y,,,20160205.0,,CN,COUNTRY NOT SPECIFIED,US,2016,Q1,Adult
120121951,12012195,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Weight decreased,,2016,Q1,1,I,2014.0,20150821.0,20160205,20160205,PER,,US-ABBVIE-15K-163-1450966-00,ABBVIE,,54.0,YR,,F,Y,,,20160205.0,,CN,COUNTRY NOT SPECIFIED,US,2016,Q1,Adult
120529531,12052953,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2016,Q1,Acute myocardial infarction,,2016,Q1,1,I,20160122.0,20160201.0,20160209,20160209,EXP,,CO-BAXTER-2016BAX005662,BAXTER,,53.0,YR,,F,Y,99.0,KG,20160209.0,,OT,CO,CO,2016,Q1,Adult
120529531,12052953,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2016,Q1,Cardio-respiratory arrest,,2016,Q1,1,I,20160122.0,20160201.0,20160209,20160209,EXP,,CO-BAXTER-2016BAX005662,BAXTER,,53.0,YR,,F,Y,99.0,KG,20160209.0,,OT,CO,CO,2016,Q1,Adult
120594286,12059428,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DAILY AT BED TIME,,,,,,,,,,,,2016,Q1,Anaphylactic reaction,,2016,Q1,6,F,,20160218.0,20160210,20160304,EXP,,CA-ACTAVIS-2016-02793,WATSON,"YANG A, BROWN J, MAK E. PERSISTENT DIARRHEA AFTER CELIAC PLEXUS BLOCK IN A PANCREATIC CANCER PATIENT: CASE REPORT AND LITERATURE REVIEW. J PALLIATIVE MED. 2016?19(1):83-86.",70.0,YR,,F,Y,,,20160304.0,,MD,CA,CA,2016,Q1,Elderly
120594286,12059428,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DAILY AT BED TIME,,,,,,,,,,,,2016,Q1,Drug intolerance,,2016,Q1,6,F,,20160218.0,20160210,20160304,EXP,,CA-ACTAVIS-2016-02793,WATSON,"YANG A, BROWN J, MAK E. PERSISTENT DIARRHEA AFTER CELIAC PLEXUS BLOCK IN A PANCREATIC CANCER PATIENT: CASE REPORT AND LITERATURE REVIEW. J PALLIATIVE MED. 2016?19(1):83-86.",70.0,YR,,F,Y,,,20160304.0,,MD,CA,CA,2016,Q1,Elderly
120626191,12062619,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,DAILY AT BED TIME,,,,,,,,,,,,2016,Q1,Anaphylactic reaction,,2016,Q1,1,I,,20160129.0,20160210,20160210,EXP,,CA-BAUSCH-BL-2016-003304,BAUSCH AND LOMB,"YANG A, MAK E. PERSISTENT DIARRHEA AFTER CELIAC PLEXUS BLOCK IN A PANCREATIC CANCER PATIENT. JOURNAL OF PALLIATIVE MEDICINE. 2016?19(1):83-86.",70.0,YR,,F,Y,,,20160210.0,,MD,CA,CA,2016,Q1,Elderly
120626191,12062619,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,DAILY AT BED TIME,,,,,,,,,,,,2016,Q1,Drug intolerance,,2016,Q1,1,I,,20160129.0,20160210,20160210,EXP,,CA-BAUSCH-BL-2016-003304,BAUSCH AND LOMB,"YANG A, MAK E. PERSISTENT DIARRHEA AFTER CELIAC PLEXUS BLOCK IN A PANCREATIC CANCER PATIENT. JOURNAL OF PALLIATIVE MEDICINE. 2016?19(1):83-86.",70.0,YR,,F,Y,,,20160210.0,,MD,CA,CA,2016,Q1,Elderly
120689861,12068986,7,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,18.0,IU,,,2016,Q1,Hypoglycaemia,,2016,Q1,1,I,20151204.0,20160203.0,20160211,20160211,EXP,,CO-BAXTER-2016BAX006157,BAXTER,,73.0,YR,,F,Y,49.5,KG,20160211.0,,OT,CO,CO,2016,Q1,Elderly
120689861,12068986,7,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,18.0,IU,,,2016,Q1,Hypotension,,2016,Q1,1,I,20151204.0,20160203.0,20160211,20160211,EXP,,CO-BAXTER-2016BAX006157,BAXTER,,73.0,YR,,F,Y,49.5,KG,20160211.0,,OT,CO,CO,2016,Q1,Elderly
120689861,12068986,7,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,18.0,IU,,,2016,Q1,Sepsis,,2016,Q1,1,I,20151204.0,20160203.0,20160211,20160211,EXP,,CO-BAXTER-2016BAX006157,BAXTER,,73.0,YR,,F,Y,49.5,KG,20160211.0,,OT,CO,CO,2016,Q1,Elderly
120689861,12068986,7,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,18.0,IU,,,2016,Q1,Soft tissue infection,,2016,Q1,1,I,20151204.0,20160203.0,20160211,20160211,EXP,,CO-BAXTER-2016BAX006157,BAXTER,,73.0,YR,,F,Y,49.5,KG,20160211.0,,OT,CO,CO,2016,Q1,Elderly
120710542,12071054,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,,2016,Q1,Blood glucose increased,,2016,Q1,2,F,20151023.0,20160229.0,20160211,20160309,EXP,,JP-ASTRAZENECA-2015SF30978,ASTRAZENECA,,987.0,MON,,M,Y,73.2,KG,20160309.0,,MD,JP,JP,2016,Q1,Elderly
120723651,12072365,12,C,insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q1,Anaemia,,2016,Q1,1,I,,20160201.0,20160212,20160212,EXP,,US-DRREDDYS-USA/USA/16/0076461,DR REDDYS,"SOHAIL U, ALMASHHRAWI A, RAHMAN R, ASHRAF I, COBERLY J, NGUYEN D, ET AL. MYSTERIOUS BLACK CRYSTALLINE PIGMENT IN THE DUODENUM. AM J GASTROENTEROL. 2015?110:S437.",72.0,YR,,F,Y,,,20160212.0,,MD,COUNTRY NOT SPECIFIED,US,2016,Q1,Elderly
120723651,12072365,12,C,insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q1,Blood iron decreased,,2016,Q1,1,I,,20160201.0,20160212,20160212,EXP,,US-DRREDDYS-USA/USA/16/0076461,DR REDDYS,"SOHAIL U, ALMASHHRAWI A, RAHMAN R, ASHRAF I, COBERLY J, NGUYEN D, ET AL. MYSTERIOUS BLACK CRYSTALLINE PIGMENT IN THE DUODENUM. AM J GASTROENTEROL. 2015?110:S437.",72.0,YR,,F,Y,,,20160212.0,,MD,COUNTRY NOT SPECIFIED,US,2016,Q1,Elderly
120723651,12072365,12,C,insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q1,Gastrointestinal tract mucosal pigmentation,,2016,Q1,1,I,,20160201.0,20160212,20160212,EXP,,US-DRREDDYS-USA/USA/16/0076461,DR REDDYS,"SOHAIL U, ALMASHHRAWI A, RAHMAN R, ASHRAF I, COBERLY J, NGUYEN D, ET AL. MYSTERIOUS BLACK CRYSTALLINE PIGMENT IN THE DUODENUM. AM J GASTROENTEROL. 2015?110:S437.",72.0,YR,,F,Y,,,20160212.0,,MD,COUNTRY NOT SPECIFIED,US,2016,Q1,Elderly
120723651,12072365,12,C,insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q1,International normalised ratio increased,,2016,Q1,1,I,,20160201.0,20160212,20160212,EXP,,US-DRREDDYS-USA/USA/16/0076461,DR REDDYS,"SOHAIL U, ALMASHHRAWI A, RAHMAN R, ASHRAF I, COBERLY J, NGUYEN D, ET AL. MYSTERIOUS BLACK CRYSTALLINE PIGMENT IN THE DUODENUM. AM J GASTROENTEROL. 2015?110:S437.",72.0,YR,,F,Y,,,20160212.0,,MD,COUNTRY NOT SPECIFIED,US,2016,Q1,Elderly
120723651,12072365,12,C,insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q1,Transferrin decreased,,2016,Q1,1,I,,20160201.0,20160212,20160212,EXP,,US-DRREDDYS-USA/USA/16/0076461,DR REDDYS,"SOHAIL U, ALMASHHRAWI A, RAHMAN R, ASHRAF I, COBERLY J, NGUYEN D, ET AL. MYSTERIOUS BLACK CRYSTALLINE PIGMENT IN THE DUODENUM. AM J GASTROENTEROL. 2015?110:S437.",72.0,YR,,F,Y,,,20160212.0,,MD,COUNTRY NOT SPECIFIED,US,2016,Q1,Elderly
120731762,12073176,26,C,Insuline glargine,INSULIN GLARGINE,1,Unknown,DAILY AT BED TIME,,,,,,,,,,,,2016,Q1,Anaphylactic reaction,,2016,Q1,2,F,,20160218.0,20160212,20160303,EXP,,CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2016US-111481,RANBAXY,,70.0,YR,,F,Y,,,20160303.0,,OT,GB,CA,2016,Q1,Elderly
120731762,12073176,26,C,Insuline glargine,INSULIN GLARGINE,1,Unknown,DAILY AT BED TIME,,,,,,,,,,,,2016,Q1,Drug intolerance,,2016,Q1,2,F,,20160218.0,20160212,20160303,EXP,,CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2016US-111481,RANBAXY,,70.0,YR,,F,Y,,,20160303.0,,OT,GB,CA,2016,Q1,Elderly
120732782,12073278,19,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,28.0,IU,FORMULATION UNKNOWN,QD,2016,Q1,Asthenia,,2016,Q1,2,F,20150116.0,20160209.0,20160212,20160217,EXP,,FR-ASTELLAS-2016US003802,ASTELLAS,,73.0,YR,,F,Y,65.0,KG,20160217.0,,MD,FR,FR,2016,Q1,Elderly
120732782,12073278,19,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,28.0,IU,FORMULATION UNKNOWN,QD,2016,Q1,Bacterial pyelonephritis,,2016,Q1,2,F,20150116.0,20160209.0,20160212,20160217,EXP,,FR-ASTELLAS-2016US003802,ASTELLAS,,73.0,YR,,F,Y,65.0,KG,20160217.0,,MD,FR,FR,2016,Q1,Elderly
120732782,12073278,19,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,28.0,IU,FORMULATION UNKNOWN,QD,2016,Q1,Diarrhoea,,2016,Q1,2,F,20150116.0,20160209.0,20160212,20160217,EXP,,FR-ASTELLAS-2016US003802,ASTELLAS,,73.0,YR,,F,Y,65.0,KG,20160217.0,,MD,FR,FR,2016,Q1,Elderly
120732782,12073278,19,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,28.0,IU,FORMULATION UNKNOWN,QD,2016,Q1,Dyspnoea,,2016,Q1,2,F,20150116.0,20160209.0,20160212,20160217,EXP,,FR-ASTELLAS-2016US003802,ASTELLAS,,73.0,YR,,F,Y,65.0,KG,20160217.0,,MD,FR,FR,2016,Q1,Elderly
120732782,12073278,19,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,28.0,IU,FORMULATION UNKNOWN,QD,2016,Q1,Incisional hernia,,2016,Q1,2,F,20150116.0,20160209.0,20160212,20160217,EXP,,FR-ASTELLAS-2016US003802,ASTELLAS,,73.0,YR,,F,Y,65.0,KG,20160217.0,,MD,FR,FR,2016,Q1,Elderly
120732782,12073278,19,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,28.0,IU,FORMULATION UNKNOWN,QD,2016,Q1,Urinary retention,,2016,Q1,2,F,20150116.0,20160209.0,20160212,20160217,EXP,,FR-ASTELLAS-2016US003802,ASTELLAS,,73.0,YR,,F,Y,65.0,KG,20160217.0,,MD,FR,FR,2016,Q1,Elderly
120732782,12073278,19,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,28.0,IU,FORMULATION UNKNOWN,QD,2016,Q1,Urinary tract infection,,2016,Q1,2,F,20150116.0,20160209.0,20160212,20160217,EXP,,FR-ASTELLAS-2016US003802,ASTELLAS,,73.0,YR,,F,Y,65.0,KG,20160217.0,,MD,FR,FR,2016,Q1,Elderly
120732782,12073278,20,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,22.0,IU,FORMULATION UNKNOWN,QD,2016,Q1,Asthenia,,2016,Q1,2,F,20150116.0,20160209.0,20160212,20160217,EXP,,FR-ASTELLAS-2016US003802,ASTELLAS,,73.0,YR,,F,Y,65.0,KG,20160217.0,,MD,FR,FR,2016,Q1,Elderly
120732782,12073278,20,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,22.0,IU,FORMULATION UNKNOWN,QD,2016,Q1,Bacterial pyelonephritis,,2016,Q1,2,F,20150116.0,20160209.0,20160212,20160217,EXP,,FR-ASTELLAS-2016US003802,ASTELLAS,,73.0,YR,,F,Y,65.0,KG,20160217.0,,MD,FR,FR,2016,Q1,Elderly
120732782,12073278,20,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,22.0,IU,FORMULATION UNKNOWN,QD,2016,Q1,Diarrhoea,,2016,Q1,2,F,20150116.0,20160209.0,20160212,20160217,EXP,,FR-ASTELLAS-2016US003802,ASTELLAS,,73.0,YR,,F,Y,65.0,KG,20160217.0,,MD,FR,FR,2016,Q1,Elderly
120732782,12073278,20,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,22.0,IU,FORMULATION UNKNOWN,QD,2016,Q1,Dyspnoea,,2016,Q1,2,F,20150116.0,20160209.0,20160212,20160217,EXP,,FR-ASTELLAS-2016US003802,ASTELLAS,,73.0,YR,,F,Y,65.0,KG,20160217.0,,MD,FR,FR,2016,Q1,Elderly
120732782,12073278,20,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,22.0,IU,FORMULATION UNKNOWN,QD,2016,Q1,Incisional hernia,,2016,Q1,2,F,20150116.0,20160209.0,20160212,20160217,EXP,,FR-ASTELLAS-2016US003802,ASTELLAS,,73.0,YR,,F,Y,65.0,KG,20160217.0,,MD,FR,FR,2016,Q1,Elderly
120732782,12073278,20,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,22.0,IU,FORMULATION UNKNOWN,QD,2016,Q1,Urinary retention,,2016,Q1,2,F,20150116.0,20160209.0,20160212,20160217,EXP,,FR-ASTELLAS-2016US003802,ASTELLAS,,73.0,YR,,F,Y,65.0,KG,20160217.0,,MD,FR,FR,2016,Q1,Elderly
120732782,12073278,20,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,22.0,IU,FORMULATION UNKNOWN,QD,2016,Q1,Urinary tract infection,,2016,Q1,2,F,20150116.0,20160209.0,20160212,20160217,EXP,,FR-ASTELLAS-2016US003802,ASTELLAS,,73.0,YR,,F,Y,65.0,KG,20160217.0,,MD,FR,FR,2016,Q1,Elderly
120740234,12074023,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q1,Crystal deposit intestine,,2016,Q1,4,F,,20160211.0,20160212,20160219,PER,,PHHY2016US018409,SANDOZ,"SOHAIL U, ALMASHHRAWI A, RAHMAN R, ASHRAF I, COBERLY J, NGUYEN D ET AL.. MYSTERIOUS BLACK CRYSTALLINE PIGMENT IN THE DUODENUM. THE AMERICAN JOURNAL OF GASTROENTEROLOGY. 2015?110 (SUPPL. 1):S437",72.0,YR,,F,Y,,,20160219.0,,OT,US,US,2016,Q1,Elderly
120751182,12075118,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, QD",,,,,,,,,,,QD,2016,Q1,Diarrhoea,,2016,Q1,2,F,201503.0,20160216.0,20160212,20160229,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201602000794,ELI LILLY AND CO,,46.0,YR,,M,Y,48.0,KG,20160226.0,,CN,CN,CN,2016,Q1,Adult
120751182,12075118,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, QD",,,,,,,,,,,QD,2016,Q1,Fall,,2016,Q1,2,F,201503.0,20160216.0,20160212,20160229,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201602000794,ELI LILLY AND CO,,46.0,YR,,M,Y,48.0,KG,20160226.0,,CN,CN,CN,2016,Q1,Adult
120751182,12075118,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, QD",,,,,,,,,,,QD,2016,Q1,Hypoglycaemia,,2016,Q1,2,F,201503.0,20160216.0,20160212,20160229,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201602000794,ELI LILLY AND CO,,46.0,YR,,M,Y,48.0,KG,20160226.0,,CN,CN,CN,2016,Q1,Adult
120751182,12075118,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, QD",,,,,,,,,,,QD,2016,Q1,Peripheral swelling,,2016,Q1,2,F,201503.0,20160216.0,20160212,20160229,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201602000794,ELI LILLY AND CO,,46.0,YR,,M,Y,48.0,KG,20160226.0,,CN,CN,CN,2016,Q1,Adult
120751182,12075118,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, QD",,,,,,,,,,,QD,2016,Q1,Skin ulcer,,2016,Q1,2,F,201503.0,20160216.0,20160212,20160229,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201602000794,ELI LILLY AND CO,,46.0,YR,,M,Y,48.0,KG,20160226.0,,CN,CN,CN,2016,Q1,Adult
120751182,12075118,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, QD",,,,,,,,,,,QD,2016,Q1,Thermal burn,,2016,Q1,2,F,201503.0,20160216.0,20160212,20160229,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201602000794,ELI LILLY AND CO,,46.0,YR,,M,Y,48.0,KG,20160226.0,,CN,CN,CN,2016,Q1,Adult
120751182,12075118,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, QD",,,,,,,,5.0,IU,,QD,2016,Q1,Diarrhoea,,2016,Q1,2,F,201503.0,20160216.0,20160212,20160229,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201602000794,ELI LILLY AND CO,,46.0,YR,,M,Y,48.0,KG,20160226.0,,CN,CN,CN,2016,Q1,Adult
120751182,12075118,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, QD",,,,,,,,5.0,IU,,QD,2016,Q1,Fall,,2016,Q1,2,F,201503.0,20160216.0,20160212,20160229,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201602000794,ELI LILLY AND CO,,46.0,YR,,M,Y,48.0,KG,20160226.0,,CN,CN,CN,2016,Q1,Adult
120751182,12075118,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, QD",,,,,,,,5.0,IU,,QD,2016,Q1,Hypoglycaemia,,2016,Q1,2,F,201503.0,20160216.0,20160212,20160229,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201602000794,ELI LILLY AND CO,,46.0,YR,,M,Y,48.0,KG,20160226.0,,CN,CN,CN,2016,Q1,Adult
120751182,12075118,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, QD",,,,,,,,5.0,IU,,QD,2016,Q1,Peripheral swelling,,2016,Q1,2,F,201503.0,20160216.0,20160212,20160229,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201602000794,ELI LILLY AND CO,,46.0,YR,,M,Y,48.0,KG,20160226.0,,CN,CN,CN,2016,Q1,Adult
120751182,12075118,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, QD",,,,,,,,5.0,IU,,QD,2016,Q1,Skin ulcer,,2016,Q1,2,F,201503.0,20160216.0,20160212,20160229,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201602000794,ELI LILLY AND CO,,46.0,YR,,M,Y,48.0,KG,20160226.0,,CN,CN,CN,2016,Q1,Adult
120751182,12075118,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, QD",,,,,,,,5.0,IU,,QD,2016,Q1,Thermal burn,,2016,Q1,2,F,201503.0,20160216.0,20160212,20160229,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201602000794,ELI LILLY AND CO,,46.0,YR,,M,Y,48.0,KG,20160226.0,,CN,CN,CN,2016,Q1,Adult
120810742,12081074,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,DAILY AT BED TIME,,,,,,,,,,,,2016,Q1,Anaphylactic reaction,,2016,Q1,2,F,,20160218.0,20160216,20160224,EXP,,CA-TEVA-634645USA,TEVA,"YANG A,BROWN J,MAK E.",70.0,YR,,F,Y,,,20160225.0,,MD,CA,CA,2016,Q1,Elderly
120810742,12081074,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,DAILY AT BED TIME,,,,,,,,,,,,2016,Q1,Drug intolerance,,2016,Q1,2,F,,20160218.0,20160216,20160224,EXP,,CA-TEVA-634645USA,TEVA,"YANG A,BROWN J,MAK E.",70.0,YR,,F,Y,,,20160225.0,,MD,CA,CA,2016,Q1,Elderly
120833071,12083307,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Dizziness,,2016,Q1,1,I,20151016.0,,20160216,20160216,DIR,,,,,50.0,YR,,F,N,94.3,KG,20160212.0,N,CN,US,,2016,Q1,Adult
120833071,12083307,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Dysuria,,2016,Q1,1,I,20151016.0,,20160216,20160216,DIR,,,,,50.0,YR,,F,N,94.3,KG,20160212.0,N,CN,US,,2016,Q1,Adult
120833071,12083307,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Headache,,2016,Q1,1,I,20151016.0,,20160216,20160216,DIR,,,,,50.0,YR,,F,N,94.3,KG,20160212.0,N,CN,US,,2016,Q1,Adult
120833071,12083307,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Hyperglycaemia,,2016,Q1,1,I,20151016.0,,20160216,20160216,DIR,,,,,50.0,YR,,F,N,94.3,KG,20160212.0,N,CN,US,,2016,Q1,Adult
120833071,12083307,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Nausea,,2016,Q1,1,I,20151016.0,,20160216,20160216,DIR,,,,,50.0,YR,,F,N,94.3,KG,20160212.0,N,CN,US,,2016,Q1,Adult
120833071,12083307,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Pancytopenia,,2016,Q1,1,I,20151016.0,,20160216,20160216,DIR,,,,,50.0,YR,,F,N,94.3,KG,20160212.0,N,CN,US,,2016,Q1,Adult
120833071,12083307,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Uterine leiomyoma,,2016,Q1,1,I,20151016.0,,20160216,20160216,DIR,,,,,50.0,YR,,F,N,94.3,KG,20160212.0,N,CN,US,,2016,Q1,Adult
120833071,12083307,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Vaginal haemorrhage,,2016,Q1,1,I,20151016.0,,20160216,20160216,DIR,,,,,50.0,YR,,F,N,94.3,KG,20160212.0,N,CN,US,,2016,Q1,Adult
120833071,12083307,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Vulvovaginal pruritus,,2016,Q1,1,I,20151016.0,,20160216,20160216,DIR,,,,,50.0,YR,,F,N,94.3,KG,20160212.0,N,CN,US,,2016,Q1,Adult
120843931,12084393,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Chills,,2016,Q1,1,I,20160210.0,,20160216,20160216,DIR,,,,,34.0,YR,,F,N,111.0,KG,20160212.0,Y,PH,US,,2016,Q1,Young Adult
120843931,12084393,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Myalgia,,2016,Q1,1,I,20160210.0,,20160216,20160216,DIR,,,,,34.0,YR,,F,N,111.0,KG,20160212.0,Y,PH,US,,2016,Q1,Young Adult
120843931,12084393,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Nausea,,2016,Q1,1,I,20160210.0,,20160216,20160216,DIR,,,,,34.0,YR,,F,N,111.0,KG,20160212.0,Y,PH,US,,2016,Q1,Young Adult
120843931,12084393,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Pyrexia,,2016,Q1,1,I,20160210.0,,20160216,20160216,DIR,,,,,34.0,YR,,F,N,111.0,KG,20160212.0,Y,PH,US,,2016,Q1,Young Adult
120843931,12084393,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Rhabdomyolysis,,2016,Q1,1,I,20160210.0,,20160216,20160216,DIR,,,,,34.0,YR,,F,N,111.0,KG,20160212.0,Y,PH,US,,2016,Q1,Young Adult
120843931,12084393,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Vomiting,,2016,Q1,1,I,20160210.0,,20160216,20160216,DIR,,,,,34.0,YR,,F,N,111.0,KG,20160212.0,Y,PH,US,,2016,Q1,Young Adult
120893581,12089358,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Anaemia,,2016,Q1,1,I,20151016.0,20160212.0,20160218,20160218,EXP,,US-ABBVIE-16P-163-1560829-00,ABBVIE,,50.0,YR,,F,Y,94.43,KG,20160218.0,,CN,US,US,2016,Q1,Adult
120893581,12089358,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Dizziness,,2016,Q1,1,I,20151016.0,20160212.0,20160218,20160218,EXP,,US-ABBVIE-16P-163-1560829-00,ABBVIE,,50.0,YR,,F,Y,94.43,KG,20160218.0,,CN,US,US,2016,Q1,Adult
120893581,12089358,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Dysfunctional uterine bleeding,,2016,Q1,1,I,20151016.0,20160212.0,20160218,20160218,EXP,,US-ABBVIE-16P-163-1560829-00,ABBVIE,,50.0,YR,,F,Y,94.43,KG,20160218.0,,CN,US,US,2016,Q1,Adult
120893581,12089358,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Dysuria,,2016,Q1,1,I,20151016.0,20160212.0,20160218,20160218,EXP,,US-ABBVIE-16P-163-1560829-00,ABBVIE,,50.0,YR,,F,Y,94.43,KG,20160218.0,,CN,US,US,2016,Q1,Adult
120893581,12089358,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Haematocrit decreased,,2016,Q1,1,I,20151016.0,20160212.0,20160218,20160218,EXP,,US-ABBVIE-16P-163-1560829-00,ABBVIE,,50.0,YR,,F,Y,94.43,KG,20160218.0,,CN,US,US,2016,Q1,Adult
120893581,12089358,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Haemoglobin decreased,,2016,Q1,1,I,20151016.0,20160212.0,20160218,20160218,EXP,,US-ABBVIE-16P-163-1560829-00,ABBVIE,,50.0,YR,,F,Y,94.43,KG,20160218.0,,CN,US,US,2016,Q1,Adult
120893581,12089358,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Headache,,2016,Q1,1,I,20151016.0,20160212.0,20160218,20160218,EXP,,US-ABBVIE-16P-163-1560829-00,ABBVIE,,50.0,YR,,F,Y,94.43,KG,20160218.0,,CN,US,US,2016,Q1,Adult
120893581,12089358,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Hyperglycaemia,,2016,Q1,1,I,20151016.0,20160212.0,20160218,20160218,EXP,,US-ABBVIE-16P-163-1560829-00,ABBVIE,,50.0,YR,,F,Y,94.43,KG,20160218.0,,CN,US,US,2016,Q1,Adult
120893581,12089358,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Nausea,,2016,Q1,1,I,20151016.0,20160212.0,20160218,20160218,EXP,,US-ABBVIE-16P-163-1560829-00,ABBVIE,,50.0,YR,,F,Y,94.43,KG,20160218.0,,CN,US,US,2016,Q1,Adult
120893581,12089358,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Pancytopenia,,2016,Q1,1,I,20151016.0,20160212.0,20160218,20160218,EXP,,US-ABBVIE-16P-163-1560829-00,ABBVIE,,50.0,YR,,F,Y,94.43,KG,20160218.0,,CN,US,US,2016,Q1,Adult
120893581,12089358,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Uterine leiomyoma,,2016,Q1,1,I,20151016.0,20160212.0,20160218,20160218,EXP,,US-ABBVIE-16P-163-1560829-00,ABBVIE,,50.0,YR,,F,Y,94.43,KG,20160218.0,,CN,US,US,2016,Q1,Adult
120893581,12089358,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Vaginal haemorrhage,,2016,Q1,1,I,20151016.0,20160212.0,20160218,20160218,EXP,,US-ABBVIE-16P-163-1560829-00,ABBVIE,,50.0,YR,,F,Y,94.43,KG,20160218.0,,CN,US,US,2016,Q1,Adult
120893581,12089358,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Vulvovaginal pruritus,,2016,Q1,1,I,20151016.0,20160212.0,20160218,20160218,EXP,,US-ABBVIE-16P-163-1560829-00,ABBVIE,,50.0,YR,,F,Y,94.43,KG,20160218.0,,CN,US,US,2016,Q1,Adult
120900282,12090028,13,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,FORMULATION: SUBCUTANEOUS,,,,,,,,,,,QD,2016,Q1,Death,,2016,Q1,2,F,201501.0,20160307.0,20160218,20160310,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-08648BP",BOEHRINGER INGELHEIM,,66.0,YR,,M,Y,,,20160310.0,,MD,US,US,2016,Q1,Elderly
120900282,12090028,13,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,FORMULATION: SUBCUTANEOUS,,,,,,,,,,,QD,2016,Q1,Pancreatic carcinoma,,2016,Q1,2,F,201501.0,20160307.0,20160218,20160310,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-08648BP",BOEHRINGER INGELHEIM,,66.0,YR,,M,Y,,,20160310.0,,MD,US,US,2016,Q1,Elderly
120900282,12090028,13,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,FORMULATION: SUBCUTANEOUS,,,,,,,,,,,QD,2016,Q1,Unevaluable event,,2016,Q1,2,F,201501.0,20160307.0,20160218,20160310,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-08648BP",BOEHRINGER INGELHEIM,,66.0,YR,,M,Y,,,20160310.0,,MD,US,US,2016,Q1,Elderly
120901192,12090119,4,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,10.0,IU,,,2016,Q1,Cardiac disorder,,2016,Q1,2,F,20160203.0,20160212.0,20160218,20160219,EXP,,AR-BAXTER-2016BAX007170,BAXTER,,79.0,YR,,M,Y,83.0,KG,20160219.0,,CN,AR,AR,2016,Q1,Elderly
120901192,12090119,4,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,10.0,IU,,,2016,Q1,Hyperglycaemia,,2016,Q1,2,F,20160203.0,20160212.0,20160218,20160219,EXP,,AR-BAXTER-2016BAX007170,BAXTER,,79.0,YR,,M,Y,83.0,KG,20160219.0,,CN,AR,AR,2016,Q1,Elderly
120901192,12090119,4,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,10.0,IU,,,2016,Q1,Oedema peripheral,,2016,Q1,2,F,20160203.0,20160212.0,20160218,20160219,EXP,,AR-BAXTER-2016BAX007170,BAXTER,,79.0,YR,,M,Y,83.0,KG,20160219.0,,CN,AR,AR,2016,Q1,Elderly
120921691,12092169,6,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,40 UNITS,,,,,,,,,,,,2016,Q1,Tubulointerstitial nephritis,,2016,Q1,1,I,,20151216.0,20160219,20160219,PER,,US-LUPIN PHARMACEUTICALS INC.-2015-04387,LUPIN,"WOODRUFF A, MEANEY C, HANSEN E, PRESCOTT G. AZITHROMYCIN-INDUCED, BIOPSY-PROVEN ACUTE INTERSTITIAL NEPHRITIS IN AN ADULT SUCCESSFULLY TREATED WITH LOW-DOSE CORTICOSTEROIDS. PHARMACOTHERAPY. 2015?35(11):E169-E174.",59.0,YR,,M,Y,100.0,KG,20160219.0,,OT,US,US,2016,Q1,Adult
120926851,12092685,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,DAILY AT BED TIME,,,,,,,,,,,,2016,Q1,Anaphylactic reaction,,2016,Q1,1,I,,20160205.0,20160219,20160219,EXP,CA-MLMSERVICE-20160201-0137883-1,CA-ACCORD-038000,ACCORD,"YANG A, BROWN J, MAK E. PERSISTENT DIARRHEA AFTER CELIAC PLEXUS BLOCK IN A PANCREATIC CANCER PATIENT: CASE REPORT AND LITERATURE REVIEW.JOURNAL OF PALLIATIVE MEDICINE. 2016? 19(1):83-86",70.0,YR,,F,Y,,,20160219.0,,MD,CA,CA,2016,Q1,Elderly
120926851,12092685,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,DAILY AT BED TIME,,,,,,,,,,,,2016,Q1,Drug intolerance,,2016,Q1,1,I,,20160205.0,20160219,20160219,EXP,CA-MLMSERVICE-20160201-0137883-1,CA-ACCORD-038000,ACCORD,"YANG A, BROWN J, MAK E. PERSISTENT DIARRHEA AFTER CELIAC PLEXUS BLOCK IN A PANCREATIC CANCER PATIENT: CASE REPORT AND LITERATURE REVIEW.JOURNAL OF PALLIATIVE MEDICINE. 2016? 19(1):83-86",70.0,YR,,F,Y,,,20160219.0,,MD,CA,CA,2016,Q1,Elderly
120946071,12094607,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,35.0,IU,UNSPECIFIED,,2016,Q1,Aggression,,2016,Q1,1,I,20160204.0,20160209.0,20160219,20160219,EXP,,CO-JNJFOC-20160212378,JANSSEN,,58.0,YR,A,F,Y,92.0,KG,20160219.0,,OT,CO,CO,2016,Q1,Adult
120946071,12094607,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,35.0,IU,UNSPECIFIED,,2016,Q1,Irritability,,2016,Q1,1,I,20160204.0,20160209.0,20160219,20160219,EXP,,CO-JNJFOC-20160212378,JANSSEN,,58.0,YR,A,F,Y,92.0,KG,20160219.0,,OT,CO,CO,2016,Q1,Adult
120949071,12094907,9,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Anaemia,,2016,Q1,1,I,20151016.0,20160212.0,20160219,20160219,EXP,,"US-KADMON PHARMACEUTICALS, LLC-KAD201602-000607",KADMON,,50.0,YR,,F,Y,94.35,KG,20160219.0,,CN,US,US,2016,Q1,Adult
120949071,12094907,9,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Dizziness,,2016,Q1,1,I,20151016.0,20160212.0,20160219,20160219,EXP,,"US-KADMON PHARMACEUTICALS, LLC-KAD201602-000607",KADMON,,50.0,YR,,F,Y,94.35,KG,20160219.0,,CN,US,US,2016,Q1,Adult
120949071,12094907,9,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Dysfunctional uterine bleeding,,2016,Q1,1,I,20151016.0,20160212.0,20160219,20160219,EXP,,"US-KADMON PHARMACEUTICALS, LLC-KAD201602-000607",KADMON,,50.0,YR,,F,Y,94.35,KG,20160219.0,,CN,US,US,2016,Q1,Adult
120949071,12094907,9,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Dysuria,,2016,Q1,1,I,20151016.0,20160212.0,20160219,20160219,EXP,,"US-KADMON PHARMACEUTICALS, LLC-KAD201602-000607",KADMON,,50.0,YR,,F,Y,94.35,KG,20160219.0,,CN,US,US,2016,Q1,Adult
120949071,12094907,9,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Haematocrit decreased,,2016,Q1,1,I,20151016.0,20160212.0,20160219,20160219,EXP,,"US-KADMON PHARMACEUTICALS, LLC-KAD201602-000607",KADMON,,50.0,YR,,F,Y,94.35,KG,20160219.0,,CN,US,US,2016,Q1,Adult
120949071,12094907,9,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Haemoglobin decreased,,2016,Q1,1,I,20151016.0,20160212.0,20160219,20160219,EXP,,"US-KADMON PHARMACEUTICALS, LLC-KAD201602-000607",KADMON,,50.0,YR,,F,Y,94.35,KG,20160219.0,,CN,US,US,2016,Q1,Adult
120949071,12094907,9,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Headache,,2016,Q1,1,I,20151016.0,20160212.0,20160219,20160219,EXP,,"US-KADMON PHARMACEUTICALS, LLC-KAD201602-000607",KADMON,,50.0,YR,,F,Y,94.35,KG,20160219.0,,CN,US,US,2016,Q1,Adult
120949071,12094907,9,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Hyperglycaemia,,2016,Q1,1,I,20151016.0,20160212.0,20160219,20160219,EXP,,"US-KADMON PHARMACEUTICALS, LLC-KAD201602-000607",KADMON,,50.0,YR,,F,Y,94.35,KG,20160219.0,,CN,US,US,2016,Q1,Adult
120949071,12094907,9,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Nausea,,2016,Q1,1,I,20151016.0,20160212.0,20160219,20160219,EXP,,"US-KADMON PHARMACEUTICALS, LLC-KAD201602-000607",KADMON,,50.0,YR,,F,Y,94.35,KG,20160219.0,,CN,US,US,2016,Q1,Adult
120949071,12094907,9,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Pancytopenia,,2016,Q1,1,I,20151016.0,20160212.0,20160219,20160219,EXP,,"US-KADMON PHARMACEUTICALS, LLC-KAD201602-000607",KADMON,,50.0,YR,,F,Y,94.35,KG,20160219.0,,CN,US,US,2016,Q1,Adult
120949071,12094907,9,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Uterine leiomyoma,,2016,Q1,1,I,20151016.0,20160212.0,20160219,20160219,EXP,,"US-KADMON PHARMACEUTICALS, LLC-KAD201602-000607",KADMON,,50.0,YR,,F,Y,94.35,KG,20160219.0,,CN,US,US,2016,Q1,Adult
120949071,12094907,9,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Vaginal haemorrhage,,2016,Q1,1,I,20151016.0,20160212.0,20160219,20160219,EXP,,"US-KADMON PHARMACEUTICALS, LLC-KAD201602-000607",KADMON,,50.0,YR,,F,Y,94.35,KG,20160219.0,,CN,US,US,2016,Q1,Adult
120949071,12094907,9,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Vulvovaginal pruritus,,2016,Q1,1,I,20151016.0,20160212.0,20160219,20160219,EXP,,"US-KADMON PHARMACEUTICALS, LLC-KAD201602-000607",KADMON,,50.0,YR,,F,Y,94.35,KG,20160219.0,,CN,US,US,2016,Q1,Adult
120963802,12096380,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2016,Q1,Anaemia,,2016,Q1,2,F,,20160224.0,20160220,20160309,EXP,,US-AUROBINDO-AUR-APL-2016-01608,AUROBINDO,"SOHAIL U, ET AL.. ANTIHYPERTENSIVES : BLACK CRYSTALLINE PIGMENTATION DEPOSIT IN THE DUODENAL BULB AND THE SECOND PART OF DUODENUM: CASE REPORT. REACTIONS WEEKLY. 2016?1586:41",72.0,YR,,F,Y,,,20160309.0,,OT,US,US,2016,Q1,Elderly
120963802,12096380,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2016,Q1,Gastrointestinal tract mucosal pigmentation,,2016,Q1,2,F,,20160224.0,20160220,20160309,EXP,,US-AUROBINDO-AUR-APL-2016-01608,AUROBINDO,"SOHAIL U, ET AL.. ANTIHYPERTENSIVES : BLACK CRYSTALLINE PIGMENTATION DEPOSIT IN THE DUODENAL BULB AND THE SECOND PART OF DUODENUM: CASE REPORT. REACTIONS WEEKLY. 2016?1586:41",72.0,YR,,F,Y,,,20160309.0,,OT,US,US,2016,Q1,Elderly
120965011,12096501,3,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q1,Renal impairment,,2016,Q1,1,I,,20160203.0,20160220,20160220,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-010417,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,,,20160220.0,,CN,JP,JP,2016,Q1,Elderly
121054441,12105444,27,C,Insilin glargine,,2,,DAILY AT BED TIME,,,,,,,,,,,,2016,Q1,Anaphylactic reaction,,2016,Q1,1,I,,20160129.0,20160223,20160223,EXP,,CA-IPCA LABORATORIES LIMITED-E2B_00000016,IPCA,"YANG A,BROWN J,MAK E. PERSISTENT DIARRHEA AFTER CELIAC PLEXUS BLOCK IN A PANCREATIC CANCER PATIENT: CASE REPORT AND LITERATURE REVIEW. J PALLIAT MED 2015?19(1):83-6.",70.0,YR,,F,Y,,,20160223.0,,PH,CA,CA,2016,Q1,Elderly
121086251,12108625,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Osteomyelitis,,2016,Q1,1,I,20150924.0,,20160222,20160222,DIR,,,,,62.0,YR,,M,N,,,20151214.0,N,PH,US,,2016,Q1,Adult
121086251,12108625,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Osteonecrosis of jaw,,2016,Q1,1,I,20150924.0,,20160222,20160222,DIR,,,,,62.0,YR,,M,N,,,20151214.0,N,PH,US,,2016,Q1,Adult
121092091,12109209,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Hyperglycaemia,,2016,Q1,1,I,20160125.0,,20160222,20160222,DIR,,,,,50.0,YR,,M,N,,,20160130.0,N,PH,US,,2016,Q1,Adult
121092091,12109209,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Increased insulin requirement,,2016,Q1,1,I,20160125.0,,20160222,20160222,DIR,,,,,50.0,YR,,M,N,,,20160130.0,N,PH,US,,2016,Q1,Adult
121092091,12109209,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Weight decreased,,2016,Q1,1,I,20160125.0,,20160222,20160222,DIR,,,,,50.0,YR,,M,N,,,20160130.0,N,PH,US,,2016,Q1,Adult
121093471,12109347,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,N,Y,,,,12.0,IU,,HS,2016,Q1,Anion gap increased,,2016,Q1,1,I,20151122.0,,20160222,20160222,DIR,,,,,27.0,YR,,F,N,,,20151203.0,N,PH,US,,2016,Q1,Young Adult
121093471,12109347,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,N,Y,,,,12.0,IU,,HS,2016,Q1,Blood glucose decreased,,2016,Q1,1,I,20151122.0,,20160222,20160222,DIR,,,,,27.0,YR,,F,N,,,20151203.0,N,PH,US,,2016,Q1,Young Adult
121093471,12109347,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,N,Y,,,,12.0,IU,,HS,2016,Q1,Blood glucose increased,,2016,Q1,1,I,20151122.0,,20160222,20160222,DIR,,,,,27.0,YR,,F,N,,,20151203.0,N,PH,US,,2016,Q1,Young Adult
121093471,12109347,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Anion gap increased,,2016,Q1,1,I,20151122.0,,20160222,20160222,DIR,,,,,27.0,YR,,F,N,,,20151203.0,N,PH,US,,2016,Q1,Young Adult
121093471,12109347,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Blood glucose decreased,,2016,Q1,1,I,20151122.0,,20160222,20160222,DIR,,,,,27.0,YR,,F,N,,,20151203.0,N,PH,US,,2016,Q1,Young Adult
121093471,12109347,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Blood glucose increased,,2016,Q1,1,I,20151122.0,,20160222,20160222,DIR,,,,,27.0,YR,,F,N,,,20151203.0,N,PH,US,,2016,Q1,Young Adult
121094171,12109417,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Electrocardiogram QT prolonged,,2016,Q1,1,I,20151119.0,,20160222,20160222,DIR,,,,,55.0,YR,,F,N,,,20151218.0,N,PH,US,,2016,Q1,Adult
121095522,12109552,2,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,,,,,,16.0,IU,INJECTION,QD,2016,Q1,Hypoglycaemia,,2016,Q1,2,F,20151117.0,20160309.0,20160224,20160317,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201601009646,ELI LILLY AND CO,,83.0,YR,,M,Y,37.8,KG,20160317.0,,MD,JP,JP,2016,Q1,Elderly
121095522,12109552,2,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,,,,,,16.0,IU,INJECTION,QD,2016,Q1,Hypoglycaemic encephalopathy,,2016,Q1,2,F,20151117.0,20160309.0,20160224,20160317,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201601009646,ELI LILLY AND CO,,83.0,YR,,M,Y,37.8,KG,20160317.0,,MD,JP,JP,2016,Q1,Elderly
121095522,12109552,3,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"14 IU, QD",,,,,,,,14.0,IU,INJECTION,QD,2016,Q1,Hypoglycaemia,,2016,Q1,2,F,20151117.0,20160309.0,20160224,20160317,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201601009646,ELI LILLY AND CO,,83.0,YR,,M,Y,37.8,KG,20160317.0,,MD,JP,JP,2016,Q1,Elderly
121095522,12109552,3,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"14 IU, QD",,,,,,,,14.0,IU,INJECTION,QD,2016,Q1,Hypoglycaemic encephalopathy,,2016,Q1,2,F,20151117.0,20160309.0,20160224,20160317,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201601009646,ELI LILLY AND CO,,83.0,YR,,M,Y,37.8,KG,20160317.0,,MD,JP,JP,2016,Q1,Elderly
121098151,12109815,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Dyspnoea,,2016,Q1,1,I,20151010.0,,20160222,20160222,DIR,,,,,57.0,YR,,M,N,,,20151230.0,N,PH,US,,2016,Q1,Adult
121098151,12109815,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Paraesthesia oral,,2016,Q1,1,I,20151010.0,,20160222,20160222,DIR,,,,,57.0,YR,,M,N,,,20151230.0,N,PH,US,,2016,Q1,Adult
121098151,12109815,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Pharyngeal oedema,,2016,Q1,1,I,20151010.0,,20160222,20160222,DIR,,,,,57.0,YR,,M,N,,,20151230.0,N,PH,US,,2016,Q1,Adult
121098151,12109815,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Throat irritation,,2016,Q1,1,I,20151010.0,,20160222,20160222,DIR,,,,,57.0,YR,,M,N,,,20151230.0,N,PH,US,,2016,Q1,Adult
121107601,12110760,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, QD",,,,,,,,10.0,IU,,QD,2016,Q1,Acute myocardial infarction,,2016,Q1,1,I,2015.0,20160212.0,20160224,20160224,EXP,,US-BAYER-2016-029742,BAYER,,67.0,YR,E,M,Y,101.0,KG,20160224.0,,OT,US,US,2016,Q1,Elderly
121107601,12110760,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, QD",,,,,,,,10.0,IU,,QD,2016,Q1,Adenoma benign,,2016,Q1,1,I,2015.0,20160212.0,20160224,20160224,EXP,,US-BAYER-2016-029742,BAYER,,67.0,YR,E,M,Y,101.0,KG,20160224.0,,OT,US,US,2016,Q1,Elderly
121107601,12110760,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, QD",,,,,,,,10.0,IU,,QD,2016,Q1,Diarrhoea,,2016,Q1,1,I,2015.0,20160212.0,20160224,20160224,EXP,,US-BAYER-2016-029742,BAYER,,67.0,YR,E,M,Y,101.0,KG,20160224.0,,OT,US,US,2016,Q1,Elderly
121107601,12110760,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, QD",,,,,,,,10.0,IU,,QD,2016,Q1,Dysplasia,,2016,Q1,1,I,2015.0,20160212.0,20160224,20160224,EXP,,US-BAYER-2016-029742,BAYER,,67.0,YR,E,M,Y,101.0,KG,20160224.0,,OT,US,US,2016,Q1,Elderly
121107601,12110760,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, QD",,,,,,,,10.0,IU,,QD,2016,Q1,Endoscopy upper gastrointestinal tract,,2016,Q1,1,I,2015.0,20160212.0,20160224,20160224,EXP,,US-BAYER-2016-029742,BAYER,,67.0,YR,E,M,Y,101.0,KG,20160224.0,,OT,US,US,2016,Q1,Elderly
121107601,12110760,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, QD",,,,,,,,10.0,IU,,QD,2016,Q1,Faeces discoloured,,2016,Q1,1,I,2015.0,20160212.0,20160224,20160224,EXP,,US-BAYER-2016-029742,BAYER,,67.0,YR,E,M,Y,101.0,KG,20160224.0,,OT,US,US,2016,Q1,Elderly
121107601,12110760,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, QD",,,,,,,,10.0,IU,,QD,2016,Q1,Melaena,,2016,Q1,1,I,2015.0,20160212.0,20160224,20160224,EXP,,US-BAYER-2016-029742,BAYER,,67.0,YR,E,M,Y,101.0,KG,20160224.0,,OT,US,US,2016,Q1,Elderly
121107601,12110760,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, QD",,,,,,,,10.0,IU,,QD,2016,Q1,Occult blood positive,,2016,Q1,1,I,2015.0,20160212.0,20160224,20160224,EXP,,US-BAYER-2016-029742,BAYER,,67.0,YR,E,M,Y,101.0,KG,20160224.0,,OT,US,US,2016,Q1,Elderly
121107601,12110760,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, TID",,,,,,,,12.0,IU,,TID,2016,Q1,Acute myocardial infarction,,2016,Q1,1,I,2015.0,20160212.0,20160224,20160224,EXP,,US-BAYER-2016-029742,BAYER,,67.0,YR,E,M,Y,101.0,KG,20160224.0,,OT,US,US,2016,Q1,Elderly
121107601,12110760,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, TID",,,,,,,,12.0,IU,,TID,2016,Q1,Adenoma benign,,2016,Q1,1,I,2015.0,20160212.0,20160224,20160224,EXP,,US-BAYER-2016-029742,BAYER,,67.0,YR,E,M,Y,101.0,KG,20160224.0,,OT,US,US,2016,Q1,Elderly
121107601,12110760,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, TID",,,,,,,,12.0,IU,,TID,2016,Q1,Diarrhoea,,2016,Q1,1,I,2015.0,20160212.0,20160224,20160224,EXP,,US-BAYER-2016-029742,BAYER,,67.0,YR,E,M,Y,101.0,KG,20160224.0,,OT,US,US,2016,Q1,Elderly
121107601,12110760,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, TID",,,,,,,,12.0,IU,,TID,2016,Q1,Dysplasia,,2016,Q1,1,I,2015.0,20160212.0,20160224,20160224,EXP,,US-BAYER-2016-029742,BAYER,,67.0,YR,E,M,Y,101.0,KG,20160224.0,,OT,US,US,2016,Q1,Elderly
121107601,12110760,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, TID",,,,,,,,12.0,IU,,TID,2016,Q1,Endoscopy upper gastrointestinal tract,,2016,Q1,1,I,2015.0,20160212.0,20160224,20160224,EXP,,US-BAYER-2016-029742,BAYER,,67.0,YR,E,M,Y,101.0,KG,20160224.0,,OT,US,US,2016,Q1,Elderly
121107601,12110760,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, TID",,,,,,,,12.0,IU,,TID,2016,Q1,Faeces discoloured,,2016,Q1,1,I,2015.0,20160212.0,20160224,20160224,EXP,,US-BAYER-2016-029742,BAYER,,67.0,YR,E,M,Y,101.0,KG,20160224.0,,OT,US,US,2016,Q1,Elderly
121107601,12110760,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, TID",,,,,,,,12.0,IU,,TID,2016,Q1,Melaena,,2016,Q1,1,I,2015.0,20160212.0,20160224,20160224,EXP,,US-BAYER-2016-029742,BAYER,,67.0,YR,E,M,Y,101.0,KG,20160224.0,,OT,US,US,2016,Q1,Elderly
121107601,12110760,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, TID",,,,,,,,12.0,IU,,TID,2016,Q1,Occult blood positive,,2016,Q1,1,I,2015.0,20160212.0,20160224,20160224,EXP,,US-BAYER-2016-029742,BAYER,,67.0,YR,E,M,Y,101.0,KG,20160224.0,,OT,US,US,2016,Q1,Elderly
121130381,12113038,13,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,100UNIT/ML(3ML) 50 UNITS IN EVENING?40-60 U IN MORNING.,,,,,,,,,,UNKNOWN,,2016,Q1,Upper respiratory tract infection,,2016,Q1,1,I,20160217.0,20160217.0,20160225,20160225,PER,,US-CELGENEUS-USA-2016024317,CELGENE,,56.0,YR,,M,Y,140.5,KG,20160224.0,,MD,US,US,2016,Q1,Adult
121150561,12115056,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 U, QHS",,,,,,,,15.0,DF,,,2016,Q1,Alanine aminotransferase increased,,2016,Q1,1,I,20160203.0,20160212.0,20160225,20160225,EXP,,PHEH2016US003606,NOVARTIS,,34.0,YR,,F,Y,111.0,KG,20160225.0,,PH,US,US,2016,Q1,Young Adult
121150561,12115056,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 U, QHS",,,,,,,,15.0,DF,,,2016,Q1,Aspartate aminotransferase increased,,2016,Q1,1,I,20160203.0,20160212.0,20160225,20160225,EXP,,PHEH2016US003606,NOVARTIS,,34.0,YR,,F,Y,111.0,KG,20160225.0,,PH,US,US,2016,Q1,Young Adult
121150561,12115056,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 U, QHS",,,,,,,,15.0,DF,,,2016,Q1,Blood creatine phosphokinase increased,,2016,Q1,1,I,20160203.0,20160212.0,20160225,20160225,EXP,,PHEH2016US003606,NOVARTIS,,34.0,YR,,F,Y,111.0,KG,20160225.0,,PH,US,US,2016,Q1,Young Adult
121150561,12115056,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 U, QHS",,,,,,,,15.0,DF,,,2016,Q1,Chills,,2016,Q1,1,I,20160203.0,20160212.0,20160225,20160225,EXP,,PHEH2016US003606,NOVARTIS,,34.0,YR,,F,Y,111.0,KG,20160225.0,,PH,US,US,2016,Q1,Young Adult
121150561,12115056,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 U, QHS",,,,,,,,15.0,DF,,,2016,Q1,Hyponatraemia,,2016,Q1,1,I,20160203.0,20160212.0,20160225,20160225,EXP,,PHEH2016US003606,NOVARTIS,,34.0,YR,,F,Y,111.0,KG,20160225.0,,PH,US,US,2016,Q1,Young Adult
121150561,12115056,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 U, QHS",,,,,,,,15.0,DF,,,2016,Q1,Leukocytosis,,2016,Q1,1,I,20160203.0,20160212.0,20160225,20160225,EXP,,PHEH2016US003606,NOVARTIS,,34.0,YR,,F,Y,111.0,KG,20160225.0,,PH,US,US,2016,Q1,Young Adult
121150561,12115056,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 U, QHS",,,,,,,,15.0,DF,,,2016,Q1,Metabolic acidosis,,2016,Q1,1,I,20160203.0,20160212.0,20160225,20160225,EXP,,PHEH2016US003606,NOVARTIS,,34.0,YR,,F,Y,111.0,KG,20160225.0,,PH,US,US,2016,Q1,Young Adult
121150561,12115056,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 U, QHS",,,,,,,,15.0,DF,,,2016,Q1,Myalgia,,2016,Q1,1,I,20160203.0,20160212.0,20160225,20160225,EXP,,PHEH2016US003606,NOVARTIS,,34.0,YR,,F,Y,111.0,KG,20160225.0,,PH,US,US,2016,Q1,Young Adult
121150561,12115056,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 U, QHS",,,,,,,,15.0,DF,,,2016,Q1,Nausea,,2016,Q1,1,I,20160203.0,20160212.0,20160225,20160225,EXP,,PHEH2016US003606,NOVARTIS,,34.0,YR,,F,Y,111.0,KG,20160225.0,,PH,US,US,2016,Q1,Young Adult
121150561,12115056,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 U, QHS",,,,,,,,15.0,DF,,,2016,Q1,Pyrexia,,2016,Q1,1,I,20160203.0,20160212.0,20160225,20160225,EXP,,PHEH2016US003606,NOVARTIS,,34.0,YR,,F,Y,111.0,KG,20160225.0,,PH,US,US,2016,Q1,Young Adult
121150561,12115056,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 U, QHS",,,,,,,,15.0,DF,,,2016,Q1,Rash,,2016,Q1,1,I,20160203.0,20160212.0,20160225,20160225,EXP,,PHEH2016US003606,NOVARTIS,,34.0,YR,,F,Y,111.0,KG,20160225.0,,PH,US,US,2016,Q1,Young Adult
121150561,12115056,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 U, QHS",,,,,,,,15.0,DF,,,2016,Q1,Rhabdomyolysis,,2016,Q1,1,I,20160203.0,20160212.0,20160225,20160225,EXP,,PHEH2016US003606,NOVARTIS,,34.0,YR,,F,Y,111.0,KG,20160225.0,,PH,US,US,2016,Q1,Young Adult
121150561,12115056,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 U, QHS",,,,,,,,15.0,DF,,,2016,Q1,Sepsis,,2016,Q1,1,I,20160203.0,20160212.0,20160225,20160225,EXP,,PHEH2016US003606,NOVARTIS,,34.0,YR,,F,Y,111.0,KG,20160225.0,,PH,US,US,2016,Q1,Young Adult
121150561,12115056,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 U, QHS",,,,,,,,15.0,DF,,,2016,Q1,Tachycardia,,2016,Q1,1,I,20160203.0,20160212.0,20160225,20160225,EXP,,PHEH2016US003606,NOVARTIS,,34.0,YR,,F,Y,111.0,KG,20160225.0,,PH,US,US,2016,Q1,Young Adult
121150561,12115056,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 U, QHS",,,,,,,,15.0,DF,,,2016,Q1,Thrombocytopenia,,2016,Q1,1,I,20160203.0,20160212.0,20160225,20160225,EXP,,PHEH2016US003606,NOVARTIS,,34.0,YR,,F,Y,111.0,KG,20160225.0,,PH,US,US,2016,Q1,Young Adult
121150561,12115056,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 U, QHS",,,,,,,,15.0,DF,,,2016,Q1,Vomiting,,2016,Q1,1,I,20160203.0,20160212.0,20160225,20160225,EXP,,PHEH2016US003606,NOVARTIS,,34.0,YR,,F,Y,111.0,KG,20160225.0,,PH,US,US,2016,Q1,Young Adult
121151531,12115153,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Musculoskeletal pain,,2016,Q1,1,I,20151223.0,20151223.0,20160225,20160225,PER,,US-LANTHEUS-LMI-2015-00726,LANTHEUS MEDICAL IMAGING,,30.0,YR,,M,Y,96.0,KG,20160225.0,,OT,US,US,2016,Q1,Young Adult
121151531,12115153,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Paraesthesia,,2016,Q1,1,I,20151223.0,20151223.0,20160225,20160225,PER,,US-LANTHEUS-LMI-2015-00726,LANTHEUS MEDICAL IMAGING,,30.0,YR,,M,Y,96.0,KG,20160225.0,,OT,US,US,2016,Q1,Young Adult
121151531,12115153,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Pelvic pain,,2016,Q1,1,I,20151223.0,20151223.0,20160225,20160225,PER,,US-LANTHEUS-LMI-2015-00726,LANTHEUS MEDICAL IMAGING,,30.0,YR,,M,Y,96.0,KG,20160225.0,,OT,US,US,2016,Q1,Young Adult
121159331,12115933,15,C,GLARGINE,,2,,,,,,,,,,80.0,IU,,QD,2016,Q1,Back pain,,2016,Q1,1,I,20150810.0,20150810.0,20160225,20160225,PER,,US-LANTHEUS-LMI-2015-00434,LANTHEUS MEDICAL IMAGING,,68.0,YR,,M,Y,81.0,KG,20160225.0,,OT,US,US,2016,Q1,Elderly
121159331,12115933,15,C,GLARGINE,,2,,,,,,,,,,80.0,IU,,QD,2016,Q1,Muscle spasms,,2016,Q1,1,I,20150810.0,20150810.0,20160225,20160225,PER,,US-LANTHEUS-LMI-2015-00434,LANTHEUS MEDICAL IMAGING,,68.0,YR,,M,Y,81.0,KG,20160225.0,,OT,US,US,2016,Q1,Elderly
121159331,12115933,15,C,GLARGINE,,2,,,,,,,,,,80.0,IU,,QD,2016,Q1,Musculoskeletal pain,,2016,Q1,1,I,20150810.0,20150810.0,20160225,20160225,PER,,US-LANTHEUS-LMI-2015-00434,LANTHEUS MEDICAL IMAGING,,68.0,YR,,M,Y,81.0,KG,20160225.0,,OT,US,US,2016,Q1,Elderly
121159331,12115933,15,C,GLARGINE,,2,,,,,,,,,,80.0,IU,,QD,2016,Q1,Neck pain,,2016,Q1,1,I,20150810.0,20150810.0,20160225,20160225,PER,,US-LANTHEUS-LMI-2015-00434,LANTHEUS MEDICAL IMAGING,,68.0,YR,,M,Y,81.0,KG,20160225.0,,OT,US,US,2016,Q1,Elderly
121159331,12115933,15,C,GLARGINE,,2,,,,,,,,,,80.0,IU,,QD,2016,Q1,Renal pain,,2016,Q1,1,I,20150810.0,20150810.0,20160225,20160225,PER,,US-LANTHEUS-LMI-2015-00434,LANTHEUS MEDICAL IMAGING,,68.0,YR,,M,Y,81.0,KG,20160225.0,,OT,US,US,2016,Q1,Elderly
121163022,12116302,9,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,100 UNIT/ML,,,,,,,,3.0,ML,UNKNOWN,,2016,Q1,Acute kidney injury,,2016,Q1,2,F,20160131.0,20160223.0,20160225,20160302,EXP,,US-CELGENE-USA-2016023999,CELGENE,,65.0,YR,,M,Y,133.4,KG,20160302.0,,OT,US,US,2016,Q1,Elderly
121163022,12116302,9,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,100 UNIT/ML,,,,,,,,3.0,ML,UNKNOWN,,2016,Q1,Anaemia,,2016,Q1,2,F,20160131.0,20160223.0,20160225,20160302,EXP,,US-CELGENE-USA-2016023999,CELGENE,,65.0,YR,,M,Y,133.4,KG,20160302.0,,OT,US,US,2016,Q1,Elderly
121163022,12116302,9,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,100 UNIT/ML,,,,,,,,3.0,ML,UNKNOWN,,2016,Q1,Death,,2016,Q1,2,F,20160131.0,20160223.0,20160225,20160302,EXP,,US-CELGENE-USA-2016023999,CELGENE,,65.0,YR,,M,Y,133.4,KG,20160302.0,,OT,US,US,2016,Q1,Elderly
121163022,12116302,9,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,100 UNIT/ML,,,,,,,,3.0,ML,UNKNOWN,,2016,Q1,Fall,,2016,Q1,2,F,20160131.0,20160223.0,20160225,20160302,EXP,,US-CELGENE-USA-2016023999,CELGENE,,65.0,YR,,M,Y,133.4,KG,20160302.0,,OT,US,US,2016,Q1,Elderly
121163022,12116302,9,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,100 UNIT/ML,,,,,,,,3.0,ML,UNKNOWN,,2016,Q1,Haemorrhage intracranial,,2016,Q1,2,F,20160131.0,20160223.0,20160225,20160302,EXP,,US-CELGENE-USA-2016023999,CELGENE,,65.0,YR,,M,Y,133.4,KG,20160302.0,,OT,US,US,2016,Q1,Elderly
121163022,12116302,9,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,100 UNIT/ML,,,,,,,,3.0,ML,UNKNOWN,,2016,Q1,Pyrexia,,2016,Q1,2,F,20160131.0,20160223.0,20160225,20160302,EXP,,US-CELGENE-USA-2016023999,CELGENE,,65.0,YR,,M,Y,133.4,KG,20160302.0,,OT,US,US,2016,Q1,Elderly
121163022,12116302,9,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,100 UNIT/ML,,,,,,,,3.0,ML,UNKNOWN,,2016,Q1,Thrombocytopenia,,2016,Q1,2,F,20160131.0,20160223.0,20160225,20160302,EXP,,US-CELGENE-USA-2016023999,CELGENE,,65.0,YR,,M,Y,133.4,KG,20160302.0,,OT,US,US,2016,Q1,Elderly
121185101,12118510,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,B-cell lymphoma,,2016,Q1,1,I,20160129.0,,20160224,20160224,DIR,,,,,69.0,YR,,M,N,,,,N,CN,US,,2016,Q1,Elderly
121185101,12118510,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Diplopia,,2016,Q1,1,I,20160129.0,,20160224,20160224,DIR,,,,,69.0,YR,,M,N,,,,N,CN,US,,2016,Q1,Elderly
121185101,12118510,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Headache,,2016,Q1,1,I,20160129.0,,20160224,20160224,DIR,,,,,69.0,YR,,M,N,,,,N,CN,US,,2016,Q1,Elderly
121185101,12118510,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Malaise,,2016,Q1,1,I,20160129.0,,20160224,20160224,DIR,,,,,69.0,YR,,M,N,,,,N,CN,US,,2016,Q1,Elderly
121199892,12119989,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"8 IU, QD",,,,,,,205692.0,8.0,IU,,QD,2016,Q1,Haemoglobin decreased,,2016,Q1,2,F,20151224.0,20160302.0,20160226,20160307,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201601006713,ELI LILLY AND CO,,70.0,YR,,M,Y,93.4,KG,20160304.0,,CN,JP,JP,2016,Q1,Elderly
121199892,12119989,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"8 IU, QD",,,,,,,205692.0,8.0,IU,,QD,2016,Q1,Immune thrombocytopenic purpura,,2016,Q1,2,F,20151224.0,20160302.0,20160226,20160307,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201601006713,ELI LILLY AND CO,,70.0,YR,,M,Y,93.4,KG,20160304.0,,CN,JP,JP,2016,Q1,Elderly
121199892,12119989,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"8 IU, QD",,,,,,,205692.0,8.0,IU,,QD,2016,Q1,Platelet count decreased,,2016,Q1,2,F,20151224.0,20160302.0,20160226,20160307,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201601006713,ELI LILLY AND CO,,70.0,YR,,M,Y,93.4,KG,20160304.0,,CN,JP,JP,2016,Q1,Elderly
121199892,12119989,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"8 IU, QD",,,,,,,205692.0,8.0,IU,,QD,2016,Q1,White blood cell count decreased,,2016,Q1,2,F,20151224.0,20160302.0,20160226,20160307,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201601006713,ELI LILLY AND CO,,70.0,YR,,M,Y,93.4,KG,20160304.0,,CN,JP,JP,2016,Q1,Elderly
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Abdominal pain upper,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Anaemia,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Arthralgia,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Arthropathy,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Atrioventricular block first degree,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Back pain,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Blood cholesterol increased,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Blood creatinine increased,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Blood potassium increased,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Blood pressure increased,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Blood testosterone decreased,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Bone lesion,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Brachial plexus injury,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Cerumen impaction,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Chest pain,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Conjunctival filtering bleb leak,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Deep vein thrombosis,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Diabetes mellitus,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Diverticulum,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Drug ineffective,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Drug level decreased,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Electrocardiogram abnormal,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Exostosis,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Eye inflammation,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Fatigue,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Feeling hot,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Formication,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Gait disturbance,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Gingival bleeding,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Glaucoma,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Glomerular filtration rate decreased,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Haemorrhoids,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Herpes zoster,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Hypergammaglobulinaemia benign monoclonal,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Hypertension,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Hypoaesthesia,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Hypoglycaemia,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Hyporeflexia,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Intervertebral disc space narrowing,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Intraocular pressure test abnormal,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Iridectomy,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Iris atrophy,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Joint dislocation,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Joint effusion,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Joint injury,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Joint range of motion decreased,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Joint swelling,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Large intestine polyp,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Musculoskeletal pain,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Myocardial infarction,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Nephrogenic anaemia,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Obesity,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Osteoarthritis,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Osteoporosis,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Otitis externa,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Pain in extremity,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Peripheral swelling,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Post herpetic neuralgia,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Proteinuria,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Pulmonary embolism,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Renal function test abnormal,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Renal impairment,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Retinal vascular thrombosis,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Sinus bradycardia,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Spinal fusion acquired,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Tinnitus,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Vascular calcification,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Venous thrombosis,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Vertebral foraminal stenosis,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121220962,12122096,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML SOLN,,,,,,,,,,,,2016,Q1,Vitreous haemorrhage,,2016,Q1,2,F,200503.0,20160211.0,20160226,20160226,EXP,,US-ABBVIE-15P-163-1487592-00,ABBVIE,,59.0,YR,,M,Y,99.88,KG,20160226.0,,LW,US,US,2016,Q1,Adult
121223684,12122368,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 U,,,,,,,,15.0,IU,,QD,2016,Q1,Cardiac failure congestive,,2016,Q1,4,F,20120831.0,20160216.0,20160226,20160226,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-09910BP",BOEHRINGER INGELHEIM,,56.0,YR,,F,Y,,,20160227.0,,PH,US,US,2016,Q1,Adult
121223684,12122368,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 U,,,,,,,,15.0,IU,,QD,2016,Q1,Coronary artery disease,,2016,Q1,4,F,20120831.0,20160216.0,20160226,20160226,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-09910BP",BOEHRINGER INGELHEIM,,56.0,YR,,F,Y,,,20160227.0,,PH,US,US,2016,Q1,Adult
121223684,12122368,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 U,,,,,,,,15.0,IU,,QD,2016,Q1,Hyperlipidaemia,,2016,Q1,4,F,20120831.0,20160216.0,20160226,20160226,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-09910BP",BOEHRINGER INGELHEIM,,56.0,YR,,F,Y,,,20160227.0,,PH,US,US,2016,Q1,Adult
121223684,12122368,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 U,,,,,,,,15.0,IU,,QD,2016,Q1,Hypertension,,2016,Q1,4,F,20120831.0,20160216.0,20160226,20160226,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-09910BP",BOEHRINGER INGELHEIM,,56.0,YR,,F,Y,,,20160227.0,,PH,US,US,2016,Q1,Adult
121223684,12122368,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 U,,,,,,,,15.0,IU,,QD,2016,Q1,Implantable defibrillator insertion,,2016,Q1,4,F,20120831.0,20160216.0,20160226,20160226,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-09910BP",BOEHRINGER INGELHEIM,,56.0,YR,,F,Y,,,20160227.0,,PH,US,US,2016,Q1,Adult
121223684,12122368,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 U,,,,,,,,15.0,IU,,QD,2016,Q1,Incisional drainage,,2016,Q1,4,F,20120831.0,20160216.0,20160226,20160226,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-09910BP",BOEHRINGER INGELHEIM,,56.0,YR,,F,Y,,,20160227.0,,PH,US,US,2016,Q1,Adult
121223684,12122368,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 U,,,,,,,,15.0,IU,,QD,2016,Q1,Ischaemic cardiomyopathy,,2016,Q1,4,F,20120831.0,20160216.0,20160226,20160226,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-09910BP",BOEHRINGER INGELHEIM,,56.0,YR,,F,Y,,,20160227.0,,PH,US,US,2016,Q1,Adult
121223684,12122368,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 U,,,,,,,,15.0,IU,,QD,2016,Q1,Myocardial infarction,,2016,Q1,4,F,20120831.0,20160216.0,20160226,20160226,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-09910BP",BOEHRINGER INGELHEIM,,56.0,YR,,F,Y,,,20160227.0,,PH,US,US,2016,Q1,Adult
121223684,12122368,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 U,,,,,,,,15.0,IU,,QD,2016,Q1,Obesity,,2016,Q1,4,F,20120831.0,20160216.0,20160226,20160226,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-09910BP",BOEHRINGER INGELHEIM,,56.0,YR,,F,Y,,,20160227.0,,PH,US,US,2016,Q1,Adult
121223684,12122368,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 U,,,,,,,,15.0,IU,,QD,2016,Q1,Pericarditis,,2016,Q1,4,F,20120831.0,20160216.0,20160226,20160226,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-09910BP",BOEHRINGER INGELHEIM,,56.0,YR,,F,Y,,,20160227.0,,PH,US,US,2016,Q1,Adult
121223684,12122368,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 U,,,,,,,,15.0,IU,,QD,2016,Q1,Toe amputation,,2016,Q1,4,F,20120831.0,20160216.0,20160226,20160226,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-09910BP",BOEHRINGER INGELHEIM,,56.0,YR,,F,Y,,,20160227.0,,PH,US,US,2016,Q1,Adult
121223732,12122373,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,150.0,IU,,,2016,Q1,C-reactive protein increased,,2016,Q1,2,F,201601.0,20160324.0,20160226,20160331,EXP,,FI-ASTRAZENECA-2016SE18586,ASTRAZENECA,,67.0,YR,,M,Y,106.0,KG,20160331.0,,OT,FI,FI,2016,Q1,Elderly
121223732,12122373,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,150.0,IU,,,2016,Q1,Diarrhoea,,2016,Q1,2,F,201601.0,20160324.0,20160226,20160331,EXP,,FI-ASTRAZENECA-2016SE18586,ASTRAZENECA,,67.0,YR,,M,Y,106.0,KG,20160331.0,,OT,FI,FI,2016,Q1,Elderly
121223732,12122373,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,150.0,IU,,,2016,Q1,Hypotension,,2016,Q1,2,F,201601.0,20160324.0,20160226,20160331,EXP,,FI-ASTRAZENECA-2016SE18586,ASTRAZENECA,,67.0,YR,,M,Y,106.0,KG,20160331.0,,OT,FI,FI,2016,Q1,Elderly
121223732,12122373,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,150.0,IU,,,2016,Q1,Intestinal obstruction,,2016,Q1,2,F,201601.0,20160324.0,20160226,20160331,EXP,,FI-ASTRAZENECA-2016SE18586,ASTRAZENECA,,67.0,YR,,M,Y,106.0,KG,20160331.0,,OT,FI,FI,2016,Q1,Elderly
121223732,12122373,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,150.0,IU,,,2016,Q1,Obstruction gastric,,2016,Q1,2,F,201601.0,20160324.0,20160226,20160331,EXP,,FI-ASTRAZENECA-2016SE18586,ASTRAZENECA,,67.0,YR,,M,Y,106.0,KG,20160331.0,,OT,FI,FI,2016,Q1,Elderly
121223732,12122373,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,150.0,IU,,,2016,Q1,Weight decreased,,2016,Q1,2,F,201601.0,20160324.0,20160226,20160331,EXP,,FI-ASTRAZENECA-2016SE18586,ASTRAZENECA,,67.0,YR,,M,Y,106.0,KG,20160331.0,,OT,FI,FI,2016,Q1,Elderly
121254542,12125454,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,10.0,IU,,,2016,Q1,Death,,2016,Q1,2,F,201509.0,20160224.0,20160229,20160301,EXP,,IN-ROCHE-1644975,ROCHE,,44.0,YR,,M,Y,,,20160301.0,,CN,IN,IN,2016,Q1,Adult
121254542,12125454,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,10.0,IU,,,2016,Q1,Peripheral swelling,,2016,Q1,2,F,201509.0,20160224.0,20160229,20160301,EXP,,IN-ROCHE-1644975,ROCHE,,44.0,YR,,M,Y,,,20160301.0,,CN,IN,IN,2016,Q1,Adult
121254542,12125454,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,10.0,IU,,,2016,Q1,Pyrexia,,2016,Q1,2,F,201509.0,20160224.0,20160229,20160301,EXP,,IN-ROCHE-1644975,ROCHE,,44.0,YR,,M,Y,,,20160301.0,,CN,IN,IN,2016,Q1,Adult
121254542,12125454,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,10.0,IU,,,2016,Q1,Tuberculosis,,2016,Q1,2,F,201509.0,20160224.0,20160229,20160301,EXP,,IN-ROCHE-1644975,ROCHE,,44.0,YR,,M,Y,,,20160301.0,,CN,IN,IN,2016,Q1,Adult
121282461,12128246,7,C,Insulin glargine,INSULIN GLARGINE,1,Intravenous (not otherwise specified),,,,,,,,,50.0,IU,INFUSION,QD,2016,Q1,Dehydration,,2016,Q1,1,I,,20160215.0,20160229,20160229,EXP,,DK-IPCA LABORATORIES LIMITED-IPC201602-000284,IPCA,"STORGAARD H,BAGGER J,KNOP F,VILSBOLL T,RUNGBY J. DIABETIC KETOACIDOSIS IN A PATIENT WITH TYPE 2 DIABETES AFTER INITIATION OF SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITOR TREATMENT. BASIC CLIN PHARMACOL TOXICOL 2016 FEB?118(2):168-70.",44.0,YR,,M,Y,,,20160229.0,,OT,DK,DK,2016,Q1,Adult
121282461,12128246,7,C,Insulin glargine,INSULIN GLARGINE,1,Intravenous (not otherwise specified),,,,,,,,,50.0,IU,INFUSION,QD,2016,Q1,Ketoacidosis,,2016,Q1,1,I,,20160215.0,20160229,20160229,EXP,,DK-IPCA LABORATORIES LIMITED-IPC201602-000284,IPCA,"STORGAARD H,BAGGER J,KNOP F,VILSBOLL T,RUNGBY J. DIABETIC KETOACIDOSIS IN A PATIENT WITH TYPE 2 DIABETES AFTER INITIATION OF SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITOR TREATMENT. BASIC CLIN PHARMACOL TOXICOL 2016 FEB?118(2):168-70.",44.0,YR,,M,Y,,,20160229.0,,OT,DK,DK,2016,Q1,Adult
121282461,12128246,7,C,Insulin glargine,INSULIN GLARGINE,1,Intravenous (not otherwise specified),,,,,,,,,50.0,IU,INFUSION,QD,2016,Q1,Lactic acidosis,,2016,Q1,1,I,,20160215.0,20160229,20160229,EXP,,DK-IPCA LABORATORIES LIMITED-IPC201602-000284,IPCA,"STORGAARD H,BAGGER J,KNOP F,VILSBOLL T,RUNGBY J. DIABETIC KETOACIDOSIS IN A PATIENT WITH TYPE 2 DIABETES AFTER INITIATION OF SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITOR TREATMENT. BASIC CLIN PHARMACOL TOXICOL 2016 FEB?118(2):168-70.",44.0,YR,,M,Y,,,20160229.0,,OT,DK,DK,2016,Q1,Adult
121282461,12128246,8,C,Insulin glargine,INSULIN GLARGINE,1,Intravenous (not otherwise specified),,,,,,,,,6.0,IU,,/hr,2016,Q1,Dehydration,,2016,Q1,1,I,,20160215.0,20160229,20160229,EXP,,DK-IPCA LABORATORIES LIMITED-IPC201602-000284,IPCA,"STORGAARD H,BAGGER J,KNOP F,VILSBOLL T,RUNGBY J. DIABETIC KETOACIDOSIS IN A PATIENT WITH TYPE 2 DIABETES AFTER INITIATION OF SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITOR TREATMENT. BASIC CLIN PHARMACOL TOXICOL 2016 FEB?118(2):168-70.",44.0,YR,,M,Y,,,20160229.0,,OT,DK,DK,2016,Q1,Adult
121282461,12128246,8,C,Insulin glargine,INSULIN GLARGINE,1,Intravenous (not otherwise specified),,,,,,,,,6.0,IU,,/hr,2016,Q1,Ketoacidosis,,2016,Q1,1,I,,20160215.0,20160229,20160229,EXP,,DK-IPCA LABORATORIES LIMITED-IPC201602-000284,IPCA,"STORGAARD H,BAGGER J,KNOP F,VILSBOLL T,RUNGBY J. DIABETIC KETOACIDOSIS IN A PATIENT WITH TYPE 2 DIABETES AFTER INITIATION OF SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITOR TREATMENT. BASIC CLIN PHARMACOL TOXICOL 2016 FEB?118(2):168-70.",44.0,YR,,M,Y,,,20160229.0,,OT,DK,DK,2016,Q1,Adult
121282461,12128246,8,C,Insulin glargine,INSULIN GLARGINE,1,Intravenous (not otherwise specified),,,,,,,,,6.0,IU,,/hr,2016,Q1,Lactic acidosis,,2016,Q1,1,I,,20160215.0,20160229,20160229,EXP,,DK-IPCA LABORATORIES LIMITED-IPC201602-000284,IPCA,"STORGAARD H,BAGGER J,KNOP F,VILSBOLL T,RUNGBY J. DIABETIC KETOACIDOSIS IN A PATIENT WITH TYPE 2 DIABETES AFTER INITIATION OF SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITOR TREATMENT. BASIC CLIN PHARMACOL TOXICOL 2016 FEB?118(2):168-70.",44.0,YR,,M,Y,,,20160229.0,,OT,DK,DK,2016,Q1,Adult
121282461,12128246,9,C,Insulin glargine,INSULIN GLARGINE,1,Intravenous (not otherwise specified),,,,,,,,,60.0,IU,,QD,2016,Q1,Dehydration,,2016,Q1,1,I,,20160215.0,20160229,20160229,EXP,,DK-IPCA LABORATORIES LIMITED-IPC201602-000284,IPCA,"STORGAARD H,BAGGER J,KNOP F,VILSBOLL T,RUNGBY J. DIABETIC KETOACIDOSIS IN A PATIENT WITH TYPE 2 DIABETES AFTER INITIATION OF SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITOR TREATMENT. BASIC CLIN PHARMACOL TOXICOL 2016 FEB?118(2):168-70.",44.0,YR,,M,Y,,,20160229.0,,OT,DK,DK,2016,Q1,Adult
121282461,12128246,9,C,Insulin glargine,INSULIN GLARGINE,1,Intravenous (not otherwise specified),,,,,,,,,60.0,IU,,QD,2016,Q1,Ketoacidosis,,2016,Q1,1,I,,20160215.0,20160229,20160229,EXP,,DK-IPCA LABORATORIES LIMITED-IPC201602-000284,IPCA,"STORGAARD H,BAGGER J,KNOP F,VILSBOLL T,RUNGBY J. DIABETIC KETOACIDOSIS IN A PATIENT WITH TYPE 2 DIABETES AFTER INITIATION OF SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITOR TREATMENT. BASIC CLIN PHARMACOL TOXICOL 2016 FEB?118(2):168-70.",44.0,YR,,M,Y,,,20160229.0,,OT,DK,DK,2016,Q1,Adult
121282461,12128246,9,C,Insulin glargine,INSULIN GLARGINE,1,Intravenous (not otherwise specified),,,,,,,,,60.0,IU,,QD,2016,Q1,Lactic acidosis,,2016,Q1,1,I,,20160215.0,20160229,20160229,EXP,,DK-IPCA LABORATORIES LIMITED-IPC201602-000284,IPCA,"STORGAARD H,BAGGER J,KNOP F,VILSBOLL T,RUNGBY J. DIABETIC KETOACIDOSIS IN A PATIENT WITH TYPE 2 DIABETES AFTER INITIATION OF SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITOR TREATMENT. BASIC CLIN PHARMACOL TOXICOL 2016 FEB?118(2):168-70.",44.0,YR,,M,Y,,,20160229.0,,OT,DK,DK,2016,Q1,Adult
121432501,12143250,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, QD",,,,U,,,,10.0,IU,INJECTION,QD,2016,Q1,Abnormal behaviour,,2016,Q1,1,I,20151122.0,20151125.0,20160304,20160304,EXP,,JP-TAKEDA-2015TJP022453,TAKEDA,,88.0,YR,,F,Y,40.1,KG,20160304.0,,MD,JP,JP,2016,Q1,Elderly
121432501,12143250,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, QD",,,,U,,,,10.0,IU,INJECTION,QD,2016,Q1,Anal incontinence,,2016,Q1,1,I,20151122.0,20151125.0,20160304,20160304,EXP,,JP-TAKEDA-2015TJP022453,TAKEDA,,88.0,YR,,F,Y,40.1,KG,20160304.0,,MD,JP,JP,2016,Q1,Elderly
121432501,12143250,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, QD",,,,U,,,,10.0,IU,INJECTION,QD,2016,Q1,"Hallucination, visual",,2016,Q1,1,I,20151122.0,20151125.0,20160304,20160304,EXP,,JP-TAKEDA-2015TJP022453,TAKEDA,,88.0,YR,,F,Y,40.1,KG,20160304.0,,MD,JP,JP,2016,Q1,Elderly
121487852,12148785,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,20.0,IU,INJECTION,QD,2016,Q1,Decreased appetite,,2016,Q1,2,F,20160129.0,20160304.0,20160304,20160311,EXP,,JP-ASTRAZENECA-2016SE12665,ASTRAZENECA,,19050.0,DY,,M,Y,78.0,KG,20160311.0,,MD,JP,JP,2016,Q1,Elderly
121487852,12148785,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,20.0,IU,INJECTION,QD,2016,Q1,Interstitial lung disease,,2016,Q1,2,F,20160129.0,20160304.0,20160304,20160311,EXP,,JP-ASTRAZENECA-2016SE12665,ASTRAZENECA,,19050.0,DY,,M,Y,78.0,KG,20160311.0,,MD,JP,JP,2016,Q1,Elderly
121487852,12148785,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,20.0,IU,INJECTION,QD,2016,Q1,Pharyngitis,,2016,Q1,2,F,20160129.0,20160304.0,20160304,20160311,EXP,,JP-ASTRAZENECA-2016SE12665,ASTRAZENECA,,19050.0,DY,,M,Y,78.0,KG,20160311.0,,MD,JP,JP,2016,Q1,Elderly
121487852,12148785,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,10.0,IU,INJECTION,QD,2016,Q1,Decreased appetite,,2016,Q1,2,F,20160129.0,20160304.0,20160304,20160311,EXP,,JP-ASTRAZENECA-2016SE12665,ASTRAZENECA,,19050.0,DY,,M,Y,78.0,KG,20160311.0,,MD,JP,JP,2016,Q1,Elderly
121487852,12148785,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,10.0,IU,INJECTION,QD,2016,Q1,Interstitial lung disease,,2016,Q1,2,F,20160129.0,20160304.0,20160304,20160311,EXP,,JP-ASTRAZENECA-2016SE12665,ASTRAZENECA,,19050.0,DY,,M,Y,78.0,KG,20160311.0,,MD,JP,JP,2016,Q1,Elderly
121487852,12148785,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,10.0,IU,INJECTION,QD,2016,Q1,Pharyngitis,,2016,Q1,2,F,20160129.0,20160304.0,20160304,20160311,EXP,,JP-ASTRAZENECA-2016SE12665,ASTRAZENECA,,19050.0,DY,,M,Y,78.0,KG,20160311.0,,MD,JP,JP,2016,Q1,Elderly
121539481,12153948,18,C,Glargine,,2,,,,,,,,,,,,,,2016,Q1,Blood glucose abnormal,,2016,Q1,1,I,20160219.0,20160222.0,20160307,20160307,EXP,,US-BEH-2016059316,CSL BEHRING,,29.0,YR,,F,Y,84.0,KG,20160307.0,,OT,US,US,2016,Q1,Young Adult
121575501,12157550,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,DAILY AT BED TIME,,,,,,,,,,,,2016,Q1,Anaphylactic reaction,,2016,Q1,1,I,,20160223.0,20160308,20160308,EXP,CA-MLMSERVICE-20160201-0137883-1,CA-ALKEM-001500,ALKEM,"YANG A, BROWN J, MAK E. PERSISTENT DIARRHEA AFTER CELIAC PLEXUS BLOCK IN A PANCREATIC CANCER PATIENT: CASE REPORT AND LITERATURE REVIEW.JOURNAL OF PALLIATIVE MEDICINE. 2016? 19(1):83-86",70.0,YR,,F,Y,,,20160308.0,,MD,CA,CA,2016,Q1,Elderly
121575501,12157550,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,DAILY AT BED TIME,,,,,,,,,,,,2016,Q1,Drug intolerance,,2016,Q1,1,I,,20160223.0,20160308,20160308,EXP,CA-MLMSERVICE-20160201-0137883-1,CA-ALKEM-001500,ALKEM,"YANG A, BROWN J, MAK E. PERSISTENT DIARRHEA AFTER CELIAC PLEXUS BLOCK IN A PANCREATIC CANCER PATIENT: CASE REPORT AND LITERATURE REVIEW.JOURNAL OF PALLIATIVE MEDICINE. 2016? 19(1):83-86",70.0,YR,,F,Y,,,20160308.0,,MD,CA,CA,2016,Q1,Elderly
121575541,12157554,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,DAILY AT BED TIME,,,,,,,,,,,,2016,Q1,Anaphylactic reaction,,2016,Q1,1,I,,20160223.0,20160308,20160308,EXP,CA-MLMSERVICE-20160201-0137883-1,CA-INDICUS PHARMA-000396,INDICUS,"YANG A, BROWN J, MAK E. PERSISTENT DIARRHEA AFTER CELIAC PLEXUS BLOCK IN A PANCREATIC CANCER PATIENT: CASE REPORT AND LITERATURE REVIEW.JOURNAL OF PALLIATIVE MEDICINE. 2016? 19(1):83-86",70.0,YR,,F,Y,,,20160308.0,,MD,CA,CA,2016,Q1,Elderly
121575541,12157554,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,DAILY AT BED TIME,,,,,,,,,,,,2016,Q1,Drug intolerance,,2016,Q1,1,I,,20160223.0,20160308,20160308,EXP,CA-MLMSERVICE-20160201-0137883-1,CA-INDICUS PHARMA-000396,INDICUS,"YANG A, BROWN J, MAK E. PERSISTENT DIARRHEA AFTER CELIAC PLEXUS BLOCK IN A PANCREATIC CANCER PATIENT: CASE REPORT AND LITERATURE REVIEW.JOURNAL OF PALLIATIVE MEDICINE. 2016? 19(1):83-86",70.0,YR,,F,Y,,,20160308.0,,MD,CA,CA,2016,Q1,Elderly
121575601,12157560,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,DAILY AT BED TIME,,,,,,,,,,,,2016,Q1,Anaphylactic reaction,,2016,Q1,1,I,,20160223.0,20160308,20160308,EXP,CA-MLMSERVICE-20160201-0137883-1,CA-INVENTIA-000101,INVENTIA HEALTHCARE,"YANG A, BROWN J, MAK E. PERSISTENT DIARRHEA AFTER CELIAC PLEXUS BLOCK IN A PANCREATIC CANCER PATIENT: CASE REPORT AND LITERATURE REVIEW.JOURNAL OF PALLIATIVE MEDICINE. 2016? 19(1):83-86.",70.0,YR,,F,Y,,,20160308.0,,MD,CA,CA,2016,Q1,Elderly
121575601,12157560,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,DAILY AT BED TIME,,,,,,,,,,,,2016,Q1,Drug intolerance,,2016,Q1,1,I,,20160223.0,20160308,20160308,EXP,CA-MLMSERVICE-20160201-0137883-1,CA-INVENTIA-000101,INVENTIA HEALTHCARE,"YANG A, BROWN J, MAK E. PERSISTENT DIARRHEA AFTER CELIAC PLEXUS BLOCK IN A PANCREATIC CANCER PATIENT: CASE REPORT AND LITERATURE REVIEW.JOURNAL OF PALLIATIVE MEDICINE. 2016? 19(1):83-86.",70.0,YR,,F,Y,,,20160308.0,,MD,CA,CA,2016,Q1,Elderly
121611261,12161126,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,20 UNITS/DAY,,,,,,,,,,,,2016,Q1,Blood cholesterol increased,,2016,Q1,1,I,20150707.0,20151030.0,20160308,20160308,EXP,,BR-ASTRAZENECA-2016SE25863,ASTRAZENECA,,84.0,YR,,M,Y,74.5,KG,20160308.0,,MD,BR,BR,2016,Q1,Elderly
121611261,12161126,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,20 UNITS/DAY,,,,,,,,,,,,2016,Q1,Blood creatinine increased,,2016,Q1,1,I,20150707.0,20151030.0,20160308,20160308,EXP,,BR-ASTRAZENECA-2016SE25863,ASTRAZENECA,,84.0,YR,,M,Y,74.5,KG,20160308.0,,MD,BR,BR,2016,Q1,Elderly
121611261,12161126,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,20 UNITS/DAY,,,,,,,,,,,,2016,Q1,Blood glucose increased,,2016,Q1,1,I,20150707.0,20151030.0,20160308,20160308,EXP,,BR-ASTRAZENECA-2016SE25863,ASTRAZENECA,,84.0,YR,,M,Y,74.5,KG,20160308.0,,MD,BR,BR,2016,Q1,Elderly
121611261,12161126,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,20 UNITS/DAY,,,,,,,,,,,,2016,Q1,Blood triglycerides increased,,2016,Q1,1,I,20150707.0,20151030.0,20160308,20160308,EXP,,BR-ASTRAZENECA-2016SE25863,ASTRAZENECA,,84.0,YR,,M,Y,74.5,KG,20160308.0,,MD,BR,BR,2016,Q1,Elderly
121611261,12161126,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,20 UNITS/DAY,,,,,,,,,,,,2016,Q1,Blood urea increased,,2016,Q1,1,I,20150707.0,20151030.0,20160308,20160308,EXP,,BR-ASTRAZENECA-2016SE25863,ASTRAZENECA,,84.0,YR,,M,Y,74.5,KG,20160308.0,,MD,BR,BR,2016,Q1,Elderly
121611261,12161126,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,20 UNITS/DAY,,,,,,,,,,,,2016,Q1,Blood uric acid increased,,2016,Q1,1,I,20150707.0,20151030.0,20160308,20160308,EXP,,BR-ASTRAZENECA-2016SE25863,ASTRAZENECA,,84.0,YR,,M,Y,74.5,KG,20160308.0,,MD,BR,BR,2016,Q1,Elderly
121611261,12161126,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,20 UNITS/DAY,,,,,,,,,,,,2016,Q1,Fatigue,,2016,Q1,1,I,20150707.0,20151030.0,20160308,20160308,EXP,,BR-ASTRAZENECA-2016SE25863,ASTRAZENECA,,84.0,YR,,M,Y,74.5,KG,20160308.0,,MD,BR,BR,2016,Q1,Elderly
121611261,12161126,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,20 UNITS/DAY,,,,,,,,,,,,2016,Q1,High density lipoprotein decreased,,2016,Q1,1,I,20150707.0,20151030.0,20160308,20160308,EXP,,BR-ASTRAZENECA-2016SE25863,ASTRAZENECA,,84.0,YR,,M,Y,74.5,KG,20160308.0,,MD,BR,BR,2016,Q1,Elderly
121611261,12161126,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,20 UNITS/DAY,,,,,,,,,,,,2016,Q1,Low density lipoprotein increased,,2016,Q1,1,I,20150707.0,20151030.0,20160308,20160308,EXP,,BR-ASTRAZENECA-2016SE25863,ASTRAZENECA,,84.0,YR,,M,Y,74.5,KG,20160308.0,,MD,BR,BR,2016,Q1,Elderly
121611261,12161126,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,20 UNITS/DAY,,,,,,,,,,,,2016,Q1,Prostate cancer,,2016,Q1,1,I,20150707.0,20151030.0,20160308,20160308,EXP,,BR-ASTRAZENECA-2016SE25863,ASTRAZENECA,,84.0,YR,,M,Y,74.5,KG,20160308.0,,MD,BR,BR,2016,Q1,Elderly
121611261,12161126,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,20 UNITS/DAY,,,,,,,,,,,,2016,Q1,Weight fluctuation,,2016,Q1,1,I,20150707.0,20151030.0,20160308,20160308,EXP,,BR-ASTRAZENECA-2016SE25863,ASTRAZENECA,,84.0,YR,,M,Y,74.5,KG,20160308.0,,MD,BR,BR,2016,Q1,Elderly
121611261,12161126,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,18.0,IU,,QD,2016,Q1,Blood cholesterol increased,,2016,Q1,1,I,20150707.0,20151030.0,20160308,20160308,EXP,,BR-ASTRAZENECA-2016SE25863,ASTRAZENECA,,84.0,YR,,M,Y,74.5,KG,20160308.0,,MD,BR,BR,2016,Q1,Elderly
121611261,12161126,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,18.0,IU,,QD,2016,Q1,Blood creatinine increased,,2016,Q1,1,I,20150707.0,20151030.0,20160308,20160308,EXP,,BR-ASTRAZENECA-2016SE25863,ASTRAZENECA,,84.0,YR,,M,Y,74.5,KG,20160308.0,,MD,BR,BR,2016,Q1,Elderly
121611261,12161126,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,18.0,IU,,QD,2016,Q1,Blood glucose increased,,2016,Q1,1,I,20150707.0,20151030.0,20160308,20160308,EXP,,BR-ASTRAZENECA-2016SE25863,ASTRAZENECA,,84.0,YR,,M,Y,74.5,KG,20160308.0,,MD,BR,BR,2016,Q1,Elderly
121611261,12161126,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,18.0,IU,,QD,2016,Q1,Blood triglycerides increased,,2016,Q1,1,I,20150707.0,20151030.0,20160308,20160308,EXP,,BR-ASTRAZENECA-2016SE25863,ASTRAZENECA,,84.0,YR,,M,Y,74.5,KG,20160308.0,,MD,BR,BR,2016,Q1,Elderly
121611261,12161126,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,18.0,IU,,QD,2016,Q1,Blood urea increased,,2016,Q1,1,I,20150707.0,20151030.0,20160308,20160308,EXP,,BR-ASTRAZENECA-2016SE25863,ASTRAZENECA,,84.0,YR,,M,Y,74.5,KG,20160308.0,,MD,BR,BR,2016,Q1,Elderly
121611261,12161126,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,18.0,IU,,QD,2016,Q1,Blood uric acid increased,,2016,Q1,1,I,20150707.0,20151030.0,20160308,20160308,EXP,,BR-ASTRAZENECA-2016SE25863,ASTRAZENECA,,84.0,YR,,M,Y,74.5,KG,20160308.0,,MD,BR,BR,2016,Q1,Elderly
121611261,12161126,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,18.0,IU,,QD,2016,Q1,Fatigue,,2016,Q1,1,I,20150707.0,20151030.0,20160308,20160308,EXP,,BR-ASTRAZENECA-2016SE25863,ASTRAZENECA,,84.0,YR,,M,Y,74.5,KG,20160308.0,,MD,BR,BR,2016,Q1,Elderly
121611261,12161126,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,18.0,IU,,QD,2016,Q1,High density lipoprotein decreased,,2016,Q1,1,I,20150707.0,20151030.0,20160308,20160308,EXP,,BR-ASTRAZENECA-2016SE25863,ASTRAZENECA,,84.0,YR,,M,Y,74.5,KG,20160308.0,,MD,BR,BR,2016,Q1,Elderly
121611261,12161126,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,18.0,IU,,QD,2016,Q1,Low density lipoprotein increased,,2016,Q1,1,I,20150707.0,20151030.0,20160308,20160308,EXP,,BR-ASTRAZENECA-2016SE25863,ASTRAZENECA,,84.0,YR,,M,Y,74.5,KG,20160308.0,,MD,BR,BR,2016,Q1,Elderly
121611261,12161126,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,18.0,IU,,QD,2016,Q1,Prostate cancer,,2016,Q1,1,I,20150707.0,20151030.0,20160308,20160308,EXP,,BR-ASTRAZENECA-2016SE25863,ASTRAZENECA,,84.0,YR,,M,Y,74.5,KG,20160308.0,,MD,BR,BR,2016,Q1,Elderly
121611261,12161126,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,18.0,IU,,QD,2016,Q1,Weight fluctuation,,2016,Q1,1,I,20150707.0,20151030.0,20160308,20160308,EXP,,BR-ASTRAZENECA-2016SE25863,ASTRAZENECA,,84.0,YR,,M,Y,74.5,KG,20160308.0,,MD,BR,BR,2016,Q1,Elderly
121611261,12161126,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,40.0,IU,,QD,2016,Q1,Blood cholesterol increased,,2016,Q1,1,I,20150707.0,20151030.0,20160308,20160308,EXP,,BR-ASTRAZENECA-2016SE25863,ASTRAZENECA,,84.0,YR,,M,Y,74.5,KG,20160308.0,,MD,BR,BR,2016,Q1,Elderly
121611261,12161126,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,40.0,IU,,QD,2016,Q1,Blood creatinine increased,,2016,Q1,1,I,20150707.0,20151030.0,20160308,20160308,EXP,,BR-ASTRAZENECA-2016SE25863,ASTRAZENECA,,84.0,YR,,M,Y,74.5,KG,20160308.0,,MD,BR,BR,2016,Q1,Elderly
121611261,12161126,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,40.0,IU,,QD,2016,Q1,Blood glucose increased,,2016,Q1,1,I,20150707.0,20151030.0,20160308,20160308,EXP,,BR-ASTRAZENECA-2016SE25863,ASTRAZENECA,,84.0,YR,,M,Y,74.5,KG,20160308.0,,MD,BR,BR,2016,Q1,Elderly
121611261,12161126,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,40.0,IU,,QD,2016,Q1,Blood triglycerides increased,,2016,Q1,1,I,20150707.0,20151030.0,20160308,20160308,EXP,,BR-ASTRAZENECA-2016SE25863,ASTRAZENECA,,84.0,YR,,M,Y,74.5,KG,20160308.0,,MD,BR,BR,2016,Q1,Elderly
121611261,12161126,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,40.0,IU,,QD,2016,Q1,Blood urea increased,,2016,Q1,1,I,20150707.0,20151030.0,20160308,20160308,EXP,,BR-ASTRAZENECA-2016SE25863,ASTRAZENECA,,84.0,YR,,M,Y,74.5,KG,20160308.0,,MD,BR,BR,2016,Q1,Elderly
121611261,12161126,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,40.0,IU,,QD,2016,Q1,Blood uric acid increased,,2016,Q1,1,I,20150707.0,20151030.0,20160308,20160308,EXP,,BR-ASTRAZENECA-2016SE25863,ASTRAZENECA,,84.0,YR,,M,Y,74.5,KG,20160308.0,,MD,BR,BR,2016,Q1,Elderly
121611261,12161126,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,40.0,IU,,QD,2016,Q1,Fatigue,,2016,Q1,1,I,20150707.0,20151030.0,20160308,20160308,EXP,,BR-ASTRAZENECA-2016SE25863,ASTRAZENECA,,84.0,YR,,M,Y,74.5,KG,20160308.0,,MD,BR,BR,2016,Q1,Elderly
121611261,12161126,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,40.0,IU,,QD,2016,Q1,High density lipoprotein decreased,,2016,Q1,1,I,20150707.0,20151030.0,20160308,20160308,EXP,,BR-ASTRAZENECA-2016SE25863,ASTRAZENECA,,84.0,YR,,M,Y,74.5,KG,20160308.0,,MD,BR,BR,2016,Q1,Elderly
121611261,12161126,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,40.0,IU,,QD,2016,Q1,Low density lipoprotein increased,,2016,Q1,1,I,20150707.0,20151030.0,20160308,20160308,EXP,,BR-ASTRAZENECA-2016SE25863,ASTRAZENECA,,84.0,YR,,M,Y,74.5,KG,20160308.0,,MD,BR,BR,2016,Q1,Elderly
121611261,12161126,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,40.0,IU,,QD,2016,Q1,Prostate cancer,,2016,Q1,1,I,20150707.0,20151030.0,20160308,20160308,EXP,,BR-ASTRAZENECA-2016SE25863,ASTRAZENECA,,84.0,YR,,M,Y,74.5,KG,20160308.0,,MD,BR,BR,2016,Q1,Elderly
121611261,12161126,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,40.0,IU,,QD,2016,Q1,Weight fluctuation,,2016,Q1,1,I,20150707.0,20151030.0,20160308,20160308,EXP,,BR-ASTRAZENECA-2016SE25863,ASTRAZENECA,,84.0,YR,,M,Y,74.5,KG,20160308.0,,MD,BR,BR,2016,Q1,Elderly
121689351,12168935,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 U, BID",,,,U, UNKNOWN,,,50.0,DF,,BID,2016,Q1,Cutaneous amyloidosis,,2016,Q1,1,I,,20160301.0,20160310,20160310,EXP,,US-NOVOPROD-483053,NOVO NORDISK,"MAHENDRA GANDHI AND ET.ALL.,. LOCALIZED AMYLOIDOSIS: A CAUSE OF IMPAIRED GLYCEMIC CONTROL. 98TH ANNUAL MEETING OF THE ENDOCRINE SOCIETY (ENDO). 2016",64.0,YR,A,M,Y,,,20160310.0,,MD,US,US,2016,Q1,Adult
121689351,12168935,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 U, BID",,,,U, UNKNOWN,,,50.0,DF,,BID,2016,Q1,Hyperglycaemia,,2016,Q1,1,I,,20160301.0,20160310,20160310,EXP,,US-NOVOPROD-483053,NOVO NORDISK,"MAHENDRA GANDHI AND ET.ALL.,. LOCALIZED AMYLOIDOSIS: A CAUSE OF IMPAIRED GLYCEMIC CONTROL. 98TH ANNUAL MEETING OF THE ENDOCRINE SOCIETY (ENDO). 2016",64.0,YR,A,M,Y,,,20160310.0,,MD,US,US,2016,Q1,Adult
121689961,12168996,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,20.0,IU,,QD,2016,Q1,Renal failure,,2016,Q1,1,I,20151218.0,20160302.0,20160310,20160310,EXP,,FR-ASTRAZENECA-2016SE23307,ASTRAZENECA,,28513.0,DY,,M,Y,,,20160310.0,,MD,FR,FR,2016,Q1,Elderly
121690661,12169066,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,21081.0,,,,,2016,Q1,Abdominal distension,,2016,Q1,1,I,,20160302.0,20160310,20160310,EXP,,US-SA-2016SA044715,AVENTIS,"MYERS WT, WINTERGERST KA, KINGERY SE, FOSTER MB. GENERALIZED ANASARCA IN 15-YEAR-OLD GIRL WITH TYPE 1 DIABETES MELLITUS. PEDIATRICS IN REVIEW 2016?37(2):81-2. DOI: 10.1542/PIR.2015-0088",15.0,YR,T,F,Y,51.0,KG,20160310.0,,MD,US,US,2016,Q1,Youth
121690661,12169066,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,21081.0,,,,,2016,Q1,Abdominal tenderness,,2016,Q1,1,I,,20160302.0,20160310,20160310,EXP,,US-SA-2016SA044715,AVENTIS,"MYERS WT, WINTERGERST KA, KINGERY SE, FOSTER MB. GENERALIZED ANASARCA IN 15-YEAR-OLD GIRL WITH TYPE 1 DIABETES MELLITUS. PEDIATRICS IN REVIEW 2016?37(2):81-2. DOI: 10.1542/PIR.2015-0088",15.0,YR,T,F,Y,51.0,KG,20160310.0,,MD,US,US,2016,Q1,Youth
121690661,12169066,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,21081.0,,,,,2016,Q1,Blood albumin decreased,,2016,Q1,1,I,,20160302.0,20160310,20160310,EXP,,US-SA-2016SA044715,AVENTIS,"MYERS WT, WINTERGERST KA, KINGERY SE, FOSTER MB. GENERALIZED ANASARCA IN 15-YEAR-OLD GIRL WITH TYPE 1 DIABETES MELLITUS. PEDIATRICS IN REVIEW 2016?37(2):81-2. DOI: 10.1542/PIR.2015-0088",15.0,YR,T,F,Y,51.0,KG,20160310.0,,MD,US,US,2016,Q1,Youth
121690661,12169066,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,21081.0,,,,,2016,Q1,Face oedema,,2016,Q1,1,I,,20160302.0,20160310,20160310,EXP,,US-SA-2016SA044715,AVENTIS,"MYERS WT, WINTERGERST KA, KINGERY SE, FOSTER MB. GENERALIZED ANASARCA IN 15-YEAR-OLD GIRL WITH TYPE 1 DIABETES MELLITUS. PEDIATRICS IN REVIEW 2016?37(2):81-2. DOI: 10.1542/PIR.2015-0088",15.0,YR,T,F,Y,51.0,KG,20160310.0,,MD,US,US,2016,Q1,Youth
121690661,12169066,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,21081.0,,,,,2016,Q1,Generalised oedema,,2016,Q1,1,I,,20160302.0,20160310,20160310,EXP,,US-SA-2016SA044715,AVENTIS,"MYERS WT, WINTERGERST KA, KINGERY SE, FOSTER MB. GENERALIZED ANASARCA IN 15-YEAR-OLD GIRL WITH TYPE 1 DIABETES MELLITUS. PEDIATRICS IN REVIEW 2016?37(2):81-2. DOI: 10.1542/PIR.2015-0088",15.0,YR,T,F,Y,51.0,KG,20160310.0,,MD,US,US,2016,Q1,Youth
121690661,12169066,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,21081.0,,,,,2016,Q1,Inappropriate schedule of drug administration,,2016,Q1,1,I,,20160302.0,20160310,20160310,EXP,,US-SA-2016SA044715,AVENTIS,"MYERS WT, WINTERGERST KA, KINGERY SE, FOSTER MB. GENERALIZED ANASARCA IN 15-YEAR-OLD GIRL WITH TYPE 1 DIABETES MELLITUS. PEDIATRICS IN REVIEW 2016?37(2):81-2. DOI: 10.1542/PIR.2015-0088",15.0,YR,T,F,Y,51.0,KG,20160310.0,,MD,US,US,2016,Q1,Youth
121690661,12169066,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,21081.0,,,,,2016,Q1,Localised oedema,,2016,Q1,1,I,,20160302.0,20160310,20160310,EXP,,US-SA-2016SA044715,AVENTIS,"MYERS WT, WINTERGERST KA, KINGERY SE, FOSTER MB. GENERALIZED ANASARCA IN 15-YEAR-OLD GIRL WITH TYPE 1 DIABETES MELLITUS. PEDIATRICS IN REVIEW 2016?37(2):81-2. DOI: 10.1542/PIR.2015-0088",15.0,YR,T,F,Y,51.0,KG,20160310.0,,MD,US,US,2016,Q1,Youth
121690661,12169066,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,21081.0,,,,,2016,Q1,Oedema,,2016,Q1,1,I,,20160302.0,20160310,20160310,EXP,,US-SA-2016SA044715,AVENTIS,"MYERS WT, WINTERGERST KA, KINGERY SE, FOSTER MB. GENERALIZED ANASARCA IN 15-YEAR-OLD GIRL WITH TYPE 1 DIABETES MELLITUS. PEDIATRICS IN REVIEW 2016?37(2):81-2. DOI: 10.1542/PIR.2015-0088",15.0,YR,T,F,Y,51.0,KG,20160310.0,,MD,US,US,2016,Q1,Youth
121690661,12169066,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,21081.0,,,,,2016,Q1,Oedema genital,,2016,Q1,1,I,,20160302.0,20160310,20160310,EXP,,US-SA-2016SA044715,AVENTIS,"MYERS WT, WINTERGERST KA, KINGERY SE, FOSTER MB. GENERALIZED ANASARCA IN 15-YEAR-OLD GIRL WITH TYPE 1 DIABETES MELLITUS. PEDIATRICS IN REVIEW 2016?37(2):81-2. DOI: 10.1542/PIR.2015-0088",15.0,YR,T,F,Y,51.0,KG,20160310.0,,MD,US,US,2016,Q1,Youth
121690661,12169066,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,21081.0,,,,,2016,Q1,Oedema peripheral,,2016,Q1,1,I,,20160302.0,20160310,20160310,EXP,,US-SA-2016SA044715,AVENTIS,"MYERS WT, WINTERGERST KA, KINGERY SE, FOSTER MB. GENERALIZED ANASARCA IN 15-YEAR-OLD GIRL WITH TYPE 1 DIABETES MELLITUS. PEDIATRICS IN REVIEW 2016?37(2):81-2. DOI: 10.1542/PIR.2015-0088",15.0,YR,T,F,Y,51.0,KG,20160310.0,,MD,US,US,2016,Q1,Youth
121690661,12169066,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,21081.0,,,,,2016,Q1,Weight increased,,2016,Q1,1,I,,20160302.0,20160310,20160310,EXP,,US-SA-2016SA044715,AVENTIS,"MYERS WT, WINTERGERST KA, KINGERY SE, FOSTER MB. GENERALIZED ANASARCA IN 15-YEAR-OLD GIRL WITH TYPE 1 DIABETES MELLITUS. PEDIATRICS IN REVIEW 2016?37(2):81-2. DOI: 10.1542/PIR.2015-0088",15.0,YR,T,F,Y,51.0,KG,20160310.0,,MD,US,US,2016,Q1,Youth
121690661,12169066,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,21081.0,,,,,2016,Q1,Abdominal distension,,2016,Q1,1,I,,20160302.0,20160310,20160310,EXP,,US-SA-2016SA044715,AVENTIS,"MYERS WT, WINTERGERST KA, KINGERY SE, FOSTER MB. GENERALIZED ANASARCA IN 15-YEAR-OLD GIRL WITH TYPE 1 DIABETES MELLITUS. PEDIATRICS IN REVIEW 2016?37(2):81-2. DOI: 10.1542/PIR.2015-0088",15.0,YR,T,F,Y,51.0,KG,20160310.0,,MD,US,US,2016,Q1,Youth
121690661,12169066,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,21081.0,,,,,2016,Q1,Abdominal tenderness,,2016,Q1,1,I,,20160302.0,20160310,20160310,EXP,,US-SA-2016SA044715,AVENTIS,"MYERS WT, WINTERGERST KA, KINGERY SE, FOSTER MB. GENERALIZED ANASARCA IN 15-YEAR-OLD GIRL WITH TYPE 1 DIABETES MELLITUS. PEDIATRICS IN REVIEW 2016?37(2):81-2. DOI: 10.1542/PIR.2015-0088",15.0,YR,T,F,Y,51.0,KG,20160310.0,,MD,US,US,2016,Q1,Youth
121690661,12169066,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,21081.0,,,,,2016,Q1,Blood albumin decreased,,2016,Q1,1,I,,20160302.0,20160310,20160310,EXP,,US-SA-2016SA044715,AVENTIS,"MYERS WT, WINTERGERST KA, KINGERY SE, FOSTER MB. GENERALIZED ANASARCA IN 15-YEAR-OLD GIRL WITH TYPE 1 DIABETES MELLITUS. PEDIATRICS IN REVIEW 2016?37(2):81-2. DOI: 10.1542/PIR.2015-0088",15.0,YR,T,F,Y,51.0,KG,20160310.0,,MD,US,US,2016,Q1,Youth
121690661,12169066,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,21081.0,,,,,2016,Q1,Face oedema,,2016,Q1,1,I,,20160302.0,20160310,20160310,EXP,,US-SA-2016SA044715,AVENTIS,"MYERS WT, WINTERGERST KA, KINGERY SE, FOSTER MB. GENERALIZED ANASARCA IN 15-YEAR-OLD GIRL WITH TYPE 1 DIABETES MELLITUS. PEDIATRICS IN REVIEW 2016?37(2):81-2. DOI: 10.1542/PIR.2015-0088",15.0,YR,T,F,Y,51.0,KG,20160310.0,,MD,US,US,2016,Q1,Youth
121690661,12169066,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,21081.0,,,,,2016,Q1,Generalised oedema,,2016,Q1,1,I,,20160302.0,20160310,20160310,EXP,,US-SA-2016SA044715,AVENTIS,"MYERS WT, WINTERGERST KA, KINGERY SE, FOSTER MB. GENERALIZED ANASARCA IN 15-YEAR-OLD GIRL WITH TYPE 1 DIABETES MELLITUS. PEDIATRICS IN REVIEW 2016?37(2):81-2. DOI: 10.1542/PIR.2015-0088",15.0,YR,T,F,Y,51.0,KG,20160310.0,,MD,US,US,2016,Q1,Youth
121690661,12169066,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,21081.0,,,,,2016,Q1,Inappropriate schedule of drug administration,,2016,Q1,1,I,,20160302.0,20160310,20160310,EXP,,US-SA-2016SA044715,AVENTIS,"MYERS WT, WINTERGERST KA, KINGERY SE, FOSTER MB. GENERALIZED ANASARCA IN 15-YEAR-OLD GIRL WITH TYPE 1 DIABETES MELLITUS. PEDIATRICS IN REVIEW 2016?37(2):81-2. DOI: 10.1542/PIR.2015-0088",15.0,YR,T,F,Y,51.0,KG,20160310.0,,MD,US,US,2016,Q1,Youth
121690661,12169066,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,21081.0,,,,,2016,Q1,Localised oedema,,2016,Q1,1,I,,20160302.0,20160310,20160310,EXP,,US-SA-2016SA044715,AVENTIS,"MYERS WT, WINTERGERST KA, KINGERY SE, FOSTER MB. GENERALIZED ANASARCA IN 15-YEAR-OLD GIRL WITH TYPE 1 DIABETES MELLITUS. PEDIATRICS IN REVIEW 2016?37(2):81-2. DOI: 10.1542/PIR.2015-0088",15.0,YR,T,F,Y,51.0,KG,20160310.0,,MD,US,US,2016,Q1,Youth
121690661,12169066,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,21081.0,,,,,2016,Q1,Oedema,,2016,Q1,1,I,,20160302.0,20160310,20160310,EXP,,US-SA-2016SA044715,AVENTIS,"MYERS WT, WINTERGERST KA, KINGERY SE, FOSTER MB. GENERALIZED ANASARCA IN 15-YEAR-OLD GIRL WITH TYPE 1 DIABETES MELLITUS. PEDIATRICS IN REVIEW 2016?37(2):81-2. DOI: 10.1542/PIR.2015-0088",15.0,YR,T,F,Y,51.0,KG,20160310.0,,MD,US,US,2016,Q1,Youth
121690661,12169066,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,21081.0,,,,,2016,Q1,Oedema genital,,2016,Q1,1,I,,20160302.0,20160310,20160310,EXP,,US-SA-2016SA044715,AVENTIS,"MYERS WT, WINTERGERST KA, KINGERY SE, FOSTER MB. GENERALIZED ANASARCA IN 15-YEAR-OLD GIRL WITH TYPE 1 DIABETES MELLITUS. PEDIATRICS IN REVIEW 2016?37(2):81-2. DOI: 10.1542/PIR.2015-0088",15.0,YR,T,F,Y,51.0,KG,20160310.0,,MD,US,US,2016,Q1,Youth
121690661,12169066,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,21081.0,,,,,2016,Q1,Oedema peripheral,,2016,Q1,1,I,,20160302.0,20160310,20160310,EXP,,US-SA-2016SA044715,AVENTIS,"MYERS WT, WINTERGERST KA, KINGERY SE, FOSTER MB. GENERALIZED ANASARCA IN 15-YEAR-OLD GIRL WITH TYPE 1 DIABETES MELLITUS. PEDIATRICS IN REVIEW 2016?37(2):81-2. DOI: 10.1542/PIR.2015-0088",15.0,YR,T,F,Y,51.0,KG,20160310.0,,MD,US,US,2016,Q1,Youth
121690661,12169066,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,21081.0,,,,,2016,Q1,Weight increased,,2016,Q1,1,I,,20160302.0,20160310,20160310,EXP,,US-SA-2016SA044715,AVENTIS,"MYERS WT, WINTERGERST KA, KINGERY SE, FOSTER MB. GENERALIZED ANASARCA IN 15-YEAR-OLD GIRL WITH TYPE 1 DIABETES MELLITUS. PEDIATRICS IN REVIEW 2016?37(2):81-2. DOI: 10.1542/PIR.2015-0088",15.0,YR,T,F,Y,51.0,KG,20160310.0,,MD,US,US,2016,Q1,Youth
121748401,12174840,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 UT, HS",,,,,,,,,,,,2016,Q1,Blood chloride increased,,2016,Q1,1,I,,20160301.0,20160314,20160314,EXP,,"US-GLENMARK PHARMACEUTICALS INC, USA.-2016GMK022273",GLENMARK,"HUNTSBERRY AM, LINNEBUR SA, VEJAR M.. HYPONATREMIA AFTER INITIATION AND RECHALLENGE WITH TRIMETHOPRIM-SULFAMETHOXAZOLE IN AN OLDER ADULT. CLINICAL INTERVENTIONS IN AGING. 2015?10:1091-6",82.0,YR,,F,Y,46.6,KG,20160314.0,,OT,US,US,2016,Q1,Elderly
121748401,12174840,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 UT, HS",,,,,,,,,,,,2016,Q1,Blood urea increased,,2016,Q1,1,I,,20160301.0,20160314,20160314,EXP,,"US-GLENMARK PHARMACEUTICALS INC, USA.-2016GMK022273",GLENMARK,"HUNTSBERRY AM, LINNEBUR SA, VEJAR M.. HYPONATREMIA AFTER INITIATION AND RECHALLENGE WITH TRIMETHOPRIM-SULFAMETHOXAZOLE IN AN OLDER ADULT. CLINICAL INTERVENTIONS IN AGING. 2015?10:1091-6",82.0,YR,,F,Y,46.6,KG,20160314.0,,OT,US,US,2016,Q1,Elderly
121748401,12174840,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 UT, HS",,,,,,,,,,,,2016,Q1,Depression,,2016,Q1,1,I,,20160301.0,20160314,20160314,EXP,,"US-GLENMARK PHARMACEUTICALS INC, USA.-2016GMK022273",GLENMARK,"HUNTSBERRY AM, LINNEBUR SA, VEJAR M.. HYPONATREMIA AFTER INITIATION AND RECHALLENGE WITH TRIMETHOPRIM-SULFAMETHOXAZOLE IN AN OLDER ADULT. CLINICAL INTERVENTIONS IN AGING. 2015?10:1091-6",82.0,YR,,F,Y,46.6,KG,20160314.0,,OT,US,US,2016,Q1,Elderly
121748401,12174840,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 UT, HS",,,,,,,,,,,,2016,Q1,Hyperkalaemia,,2016,Q1,1,I,,20160301.0,20160314,20160314,EXP,,"US-GLENMARK PHARMACEUTICALS INC, USA.-2016GMK022273",GLENMARK,"HUNTSBERRY AM, LINNEBUR SA, VEJAR M.. HYPONATREMIA AFTER INITIATION AND RECHALLENGE WITH TRIMETHOPRIM-SULFAMETHOXAZOLE IN AN OLDER ADULT. CLINICAL INTERVENTIONS IN AGING. 2015?10:1091-6",82.0,YR,,F,Y,46.6,KG,20160314.0,,OT,US,US,2016,Q1,Elderly
121748401,12174840,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 UT, HS",,,,,,,,,,,,2016,Q1,Hyponatraemia,,2016,Q1,1,I,,20160301.0,20160314,20160314,EXP,,"US-GLENMARK PHARMACEUTICALS INC, USA.-2016GMK022273",GLENMARK,"HUNTSBERRY AM, LINNEBUR SA, VEJAR M.. HYPONATREMIA AFTER INITIATION AND RECHALLENGE WITH TRIMETHOPRIM-SULFAMETHOXAZOLE IN AN OLDER ADULT. CLINICAL INTERVENTIONS IN AGING. 2015?10:1091-6",82.0,YR,,F,Y,46.6,KG,20160314.0,,OT,US,US,2016,Q1,Elderly
121748401,12174840,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 UT, HS",,,,,,,,,,,,2016,Q1,Insomnia,,2016,Q1,1,I,,20160301.0,20160314,20160314,EXP,,"US-GLENMARK PHARMACEUTICALS INC, USA.-2016GMK022273",GLENMARK,"HUNTSBERRY AM, LINNEBUR SA, VEJAR M.. HYPONATREMIA AFTER INITIATION AND RECHALLENGE WITH TRIMETHOPRIM-SULFAMETHOXAZOLE IN AN OLDER ADULT. CLINICAL INTERVENTIONS IN AGING. 2015?10:1091-6",82.0,YR,,F,Y,46.6,KG,20160314.0,,OT,US,US,2016,Q1,Elderly
121748401,12174840,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 UT, HS",,,,,,,,,,,,2016,Q1,Nausea,,2016,Q1,1,I,,20160301.0,20160314,20160314,EXP,,"US-GLENMARK PHARMACEUTICALS INC, USA.-2016GMK022273",GLENMARK,"HUNTSBERRY AM, LINNEBUR SA, VEJAR M.. HYPONATREMIA AFTER INITIATION AND RECHALLENGE WITH TRIMETHOPRIM-SULFAMETHOXAZOLE IN AN OLDER ADULT. CLINICAL INTERVENTIONS IN AGING. 2015?10:1091-6",82.0,YR,,F,Y,46.6,KG,20160314.0,,OT,US,US,2016,Q1,Elderly
121748401,12174840,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 UT, HS",,,,,,,,,,,,2016,Q1,Off label use,,2016,Q1,1,I,,20160301.0,20160314,20160314,EXP,,"US-GLENMARK PHARMACEUTICALS INC, USA.-2016GMK022273",GLENMARK,"HUNTSBERRY AM, LINNEBUR SA, VEJAR M.. HYPONATREMIA AFTER INITIATION AND RECHALLENGE WITH TRIMETHOPRIM-SULFAMETHOXAZOLE IN AN OLDER ADULT. CLINICAL INTERVENTIONS IN AGING. 2015?10:1091-6",82.0,YR,,F,Y,46.6,KG,20160314.0,,OT,US,US,2016,Q1,Elderly
121748401,12174840,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 UT, HS",,,,,,,,,,,,2016,Q1,Transient ischaemic attack,,2016,Q1,1,I,,20160301.0,20160314,20160314,EXP,,"US-GLENMARK PHARMACEUTICALS INC, USA.-2016GMK022273",GLENMARK,"HUNTSBERRY AM, LINNEBUR SA, VEJAR M.. HYPONATREMIA AFTER INITIATION AND RECHALLENGE WITH TRIMETHOPRIM-SULFAMETHOXAZOLE IN AN OLDER ADULT. CLINICAL INTERVENTIONS IN AGING. 2015?10:1091-6",82.0,YR,,F,Y,46.6,KG,20160314.0,,OT,US,US,2016,Q1,Elderly
121751891,12175189,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,600 UNITS,,,,U, UNKNOWN,,,,,,,2016,Q1,Hypoglycaemia,,2016,Q1,1,I,,20160301.0,20160314,20160314,EXP,,TR-NOVOPROD-483224,NOVO NORDISK,"ABDUSSAMED VURAL AND ET.AL.,. A CASE OF SUICIDE ATTEMPT WITH HIGH DOSE INSULIN GLARGINE AND INSULIN ASPART. 10TH NATIONAL EMERGENCY MEDICINE CONGRESS + 1ST INTERCONTINENTAL EMERGENCY MEDIC. 2014",25.0,YR,A,F,Y,,,20160314.0,,OT,TR,TR,2016,Q1,Young Adult
121751891,12175189,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,600 UNITS,,,,U, UNKNOWN,,,,,,,2016,Q1,Intentional overdose,,2016,Q1,1,I,,20160301.0,20160314,20160314,EXP,,TR-NOVOPROD-483224,NOVO NORDISK,"ABDUSSAMED VURAL AND ET.AL.,. A CASE OF SUICIDE ATTEMPT WITH HIGH DOSE INSULIN GLARGINE AND INSULIN ASPART. 10TH NATIONAL EMERGENCY MEDICINE CONGRESS + 1ST INTERCONTINENTAL EMERGENCY MEDIC. 2014",25.0,YR,A,F,Y,,,20160314.0,,OT,TR,TR,2016,Q1,Young Adult
121751891,12175189,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,600 UNITS,,,,U, UNKNOWN,,,,,,,2016,Q1,Suicide attempt,,2016,Q1,1,I,,20160301.0,20160314,20160314,EXP,,TR-NOVOPROD-483224,NOVO NORDISK,"ABDUSSAMED VURAL AND ET.AL.,. A CASE OF SUICIDE ATTEMPT WITH HIGH DOSE INSULIN GLARGINE AND INSULIN ASPART. 10TH NATIONAL EMERGENCY MEDICINE CONGRESS + 1ST INTERCONTINENTAL EMERGENCY MEDIC. 2014",25.0,YR,A,F,Y,,,20160314.0,,OT,TR,TR,2016,Q1,Young Adult
121769981,12176998,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"12 U, QD",,,,,,,,12.0,DF,,QD,2016,Q1,Neuropathy peripheral,,2016,Q1,1,I,20160206.0,20160209.0,20160314,20160314,EXP,,PHHO2016ES002058,NOVARTIS,,84.0,YR,,F,Y,74.0,KG,20160314.0,,MD,ES,ES,2016,Q1,Elderly
121855621,12185562,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,32 UNITS-PRECONCEPTION  34-0 WEEK  38-14 WEEK  113-22 WEEK  220-29 WEEK  247-35 WEEK  257-38 WEEK,,,,U,,,,,,,,2016,Q1,Exposure during pregnancy,,2016,Q1,1,I,,20090922.0,20160316,20160316,PER,,US-ASTRAZENECA-2009BM00465,ASTRAZENECA,,35.0,YR,,F,Y,160.5,KG,20160316.0,,MD,US,US,2016,Q1,Adult
121908301,12190830,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2016,Q1,Blood glucose abnormal,,2016,Q1,1,I,,20160308.0,20160318,20160318,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201603004254,ELI LILLY AND CO,,65.0,YR,,F,Y,65.0,KG,20160318.0,,CN,CN,CN,2016,Q1,Elderly
121908301,12190830,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2016,Q1,Insomnia,,2016,Q1,1,I,,20160308.0,20160318,20160318,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201603004254,ELI LILLY AND CO,,65.0,YR,,F,Y,65.0,KG,20160318.0,,CN,CN,CN,2016,Q1,Elderly
122027101,12202710,19,C,Insulin glargine,INSULIN GLARGINE,1,,FREQUENCY TEXT: 14 UNITS,,,,U,,,,,,,,2016,Q1,Breast cancer,,2016,Q1,1,I,2012.0,20130125.0,20160322,20160322,EXP,,US-JAZZ-JPI-P-029535,JAZZ,,61.0,YR,,F,Y,90.91,KG,20160322.0,,MD,US,US,2016,Q1,Adult
122027101,12202710,19,C,Insulin glargine,INSULIN GLARGINE,1,,FREQUENCY TEXT: 14 UNITS,,,,U,,,,,,,,2016,Q1,Hyperhidrosis,,2016,Q1,1,I,2012.0,20130125.0,20160322,20160322,EXP,,US-JAZZ-JPI-P-029535,JAZZ,,61.0,YR,,F,Y,90.91,KG,20160322.0,,MD,US,US,2016,Q1,Adult
122027101,12202710,19,C,Insulin glargine,INSULIN GLARGINE,1,,FREQUENCY TEXT: 14 UNITS,,,,U,,,,,,,,2016,Q1,Hysterectomy,,2016,Q1,1,I,2012.0,20130125.0,20160322,20160322,EXP,,US-JAZZ-JPI-P-029535,JAZZ,,61.0,YR,,F,Y,90.91,KG,20160322.0,,MD,US,US,2016,Q1,Adult
122027101,12202710,19,C,Insulin glargine,INSULIN GLARGINE,1,,FREQUENCY TEXT: 14 UNITS,,,,U,,,,,,,,2016,Q1,Mastectomy,,2016,Q1,1,I,2012.0,20130125.0,20160322,20160322,EXP,,US-JAZZ-JPI-P-029535,JAZZ,,61.0,YR,,F,Y,90.91,KG,20160322.0,,MD,US,US,2016,Q1,Adult
122027101,12202710,19,C,Insulin glargine,INSULIN GLARGINE,1,,FREQUENCY TEXT: 14 UNITS,,,,U,,,,,,,,2016,Q1,Ovarian cyst,,2016,Q1,1,I,2012.0,20130125.0,20160322,20160322,EXP,,US-JAZZ-JPI-P-029535,JAZZ,,61.0,YR,,F,Y,90.91,KG,20160322.0,,MD,US,US,2016,Q1,Adult
122027101,12202710,19,C,Insulin glargine,INSULIN GLARGINE,1,,FREQUENCY TEXT: 14 UNITS,,,,U,,,,,,,,2016,Q1,Procedural pain,,2016,Q1,1,I,2012.0,20130125.0,20160322,20160322,EXP,,US-JAZZ-JPI-P-029535,JAZZ,,61.0,YR,,F,Y,90.91,KG,20160322.0,,MD,US,US,2016,Q1,Adult
122027101,12202710,19,C,Insulin glargine,INSULIN GLARGINE,1,,FREQUENCY TEXT: 14 UNITS,,,,U,,,,,,,,2016,Q1,Surgery,,2016,Q1,1,I,2012.0,20130125.0,20160322,20160322,EXP,,US-JAZZ-JPI-P-029535,JAZZ,,61.0,YR,,F,Y,90.91,KG,20160322.0,,MD,US,US,2016,Q1,Adult
122054461,12205446,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,6.0,IU,,,2016,Q1,Asthenia,,2016,Q1,1,I,20160227.0,20160315.0,20160323,20160323,EXP,,CO-BAXTER-2016BAX013241,BAXTER,,81.0,YR,,M,Y,84.0,KG,20160323.0,,OT,CO,CO,2016,Q1,Elderly
122054461,12205446,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,6.0,IU,,,2016,Q1,Cerebrovascular accident,,2016,Q1,1,I,20160227.0,20160315.0,20160323,20160323,EXP,,CO-BAXTER-2016BAX013241,BAXTER,,81.0,YR,,M,Y,84.0,KG,20160323.0,,OT,CO,CO,2016,Q1,Elderly
122072321,12207232,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Abdominal wall abscess,,2016,Q1,1,I,20160204.0,,20160323,20160323,DIR,,,,,67.0,YR,,F,N,,,20160222.0,N,PH,US,,2016,Q1,Elderly
122072321,12207232,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Faeces discoloured,,2016,Q1,1,I,20160204.0,,20160323,20160323,DIR,,,,,67.0,YR,,F,N,,,20160222.0,N,PH,US,,2016,Q1,Elderly
122072321,12207232,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Haemoglobin decreased,,2016,Q1,1,I,20160204.0,,20160323,20160323,DIR,,,,,67.0,YR,,F,N,,,20160222.0,N,PH,US,,2016,Q1,Elderly
122072321,12207232,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,International normalised ratio increased,,2016,Q1,1,I,20160204.0,,20160323,20160323,DIR,,,,,67.0,YR,,F,N,,,20160222.0,N,PH,US,,2016,Q1,Elderly
122072391,12207239,27,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Gingival bleeding,,2016,Q1,1,I,20160205.0,,20160323,20160323,DIR,,,,,66.0,YR,,M,N,,,20160219.0,N,PH,US,,2016,Q1,Elderly
122072391,12207239,27,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Haemoglobin decreased,,2016,Q1,1,I,20160205.0,,20160323,20160323,DIR,,,,,66.0,YR,,M,N,,,20160219.0,N,PH,US,,2016,Q1,Elderly
122072391,12207239,27,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Haemoptysis,,2016,Q1,1,I,20160205.0,,20160323,20160323,DIR,,,,,66.0,YR,,M,N,,,20160219.0,N,PH,US,,2016,Q1,Elderly
122072391,12207239,27,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Hypotension,,2016,Q1,1,I,20160205.0,,20160323,20160323,DIR,,,,,66.0,YR,,M,N,,,20160219.0,N,PH,US,,2016,Q1,Elderly
122072391,12207239,27,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,International normalised ratio increased,,2016,Q1,1,I,20160205.0,,20160323,20160323,DIR,,,,,66.0,YR,,M,N,,,20160219.0,N,PH,US,,2016,Q1,Elderly
122072391,12207239,27,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Mouth haemorrhage,,2016,Q1,1,I,20160205.0,,20160323,20160323,DIR,,,,,66.0,YR,,M,N,,,20160219.0,N,PH,US,,2016,Q1,Elderly
122072451,12207245,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,46 UNITS AT BEDTIME SC,,,,,,,,46.0,DF,,HS,2016,Q1,Hypoglycaemia,,2016,Q1,1,I,20160203.0,,20160323,20160323,DIR,,,,,73.0,YR,,M,N,,,20160222.0,N,PH,US,,2016,Q1,Elderly
122072661,12207266,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,Y,,,,10.0,DF,,HS,2016,Q1,Blood glucose decreased,,2016,Q1,1,I,20160221.0,,20160323,20160323,DIR,,,,,59.0,YR,,F,N,,,20160224.0,N,PH,US,,2016,Q1,Adult
122072661,12207266,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,Y,,,,10.0,DF,,HS,2016,Q1,Unresponsive to stimuli,,2016,Q1,1,I,20160221.0,,20160323,20160323,DIR,,,,,59.0,YR,,F,N,,,20160224.0,N,PH,US,,2016,Q1,Adult
122081161,12208116,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,12.0,IU,UNKNOWN,,2016,Q1,Asthenia,,2016,Q1,1,I,20160220.0,20160226.0,20160324,20160324,EXP,,CO-JNJFOC-20160322095,JANSSEN,,74.0,YR,E,F,Y,63.0,KG,20160324.0,,OT,CO,CO,2016,Q1,Elderly
122081161,12208116,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,12.0,IU,UNKNOWN,,2016,Q1,Fatigue,,2016,Q1,1,I,20160220.0,20160226.0,20160324,20160324,EXP,,CO-JNJFOC-20160322095,JANSSEN,,74.0,YR,E,F,Y,63.0,KG,20160324.0,,OT,CO,CO,2016,Q1,Elderly
122081161,12208116,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,12.0,IU,UNKNOWN,,2016,Q1,Metabolic disorder,,2016,Q1,1,I,20160220.0,20160226.0,20160324,20160324,EXP,,CO-JNJFOC-20160322095,JANSSEN,,74.0,YR,E,F,Y,63.0,KG,20160324.0,,OT,CO,CO,2016,Q1,Elderly
122081161,12208116,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,12.0,IU,UNKNOWN,,2016,Q1,Pollakiuria,,2016,Q1,1,I,20160220.0,20160226.0,20160324,20160324,EXP,,CO-JNJFOC-20160322095,JANSSEN,,74.0,YR,E,F,Y,63.0,KG,20160324.0,,OT,CO,CO,2016,Q1,Elderly
122081161,12208116,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,12.0,IU,UNKNOWN,,2016,Q1,Thirst,,2016,Q1,1,I,20160220.0,20160226.0,20160324,20160324,EXP,,CO-JNJFOC-20160322095,JANSSEN,,74.0,YR,E,F,Y,63.0,KG,20160324.0,,OT,CO,CO,2016,Q1,Elderly
122081161,12208116,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,12.0,IU,UNKNOWN,,2016,Q1,Urinary tract infection,,2016,Q1,1,I,20160220.0,20160226.0,20160324,20160324,EXP,,CO-JNJFOC-20160322095,JANSSEN,,74.0,YR,E,F,Y,63.0,KG,20160324.0,,OT,CO,CO,2016,Q1,Elderly
122098091,12209809,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q1,Acute kidney injury,,2016,Q1,1,I,,20160315.0,20160325,20160325,EXP,,US-WEST-WARD PHARMACEUTICALS CORP.-US-H14001-16-00478,WESTWARD,"BAIRD P,LEUNG S,HOANG H,BABALOLA O,DEVOE C,DEVOE C,WANCHOO R. A CASE OF ACUTE KIDNEY INJURY FROM CRYSTAL NEPHROPATHY SECONDARY TO POMALIDOMIDE AND LEVOFLOXACIN USE. JOURNAL OF ONCOLOGY PHARMACY PRACTICE 2016?22(2):357-360.",76.0,YR,,F,Y,,,20160324.0,,MD,US,US,2016,Q1,Elderly
122098091,12209809,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q1,Crystal nephropathy,,2016,Q1,1,I,,20160315.0,20160325,20160325,EXP,,US-WEST-WARD PHARMACEUTICALS CORP.-US-H14001-16-00478,WESTWARD,"BAIRD P,LEUNG S,HOANG H,BABALOLA O,DEVOE C,DEVOE C,WANCHOO R. A CASE OF ACUTE KIDNEY INJURY FROM CRYSTAL NEPHROPATHY SECONDARY TO POMALIDOMIDE AND LEVOFLOXACIN USE. JOURNAL OF ONCOLOGY PHARMACY PRACTICE 2016?22(2):357-360.",76.0,YR,,F,Y,,,20160324.0,,MD,US,US,2016,Q1,Elderly
122098091,12209809,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q1,Thrombocytopenia,,2016,Q1,1,I,,20160315.0,20160325,20160325,EXP,,US-WEST-WARD PHARMACEUTICALS CORP.-US-H14001-16-00478,WESTWARD,"BAIRD P,LEUNG S,HOANG H,BABALOLA O,DEVOE C,DEVOE C,WANCHOO R. A CASE OF ACUTE KIDNEY INJURY FROM CRYSTAL NEPHROPATHY SECONDARY TO POMALIDOMIDE AND LEVOFLOXACIN USE. JOURNAL OF ONCOLOGY PHARMACY PRACTICE 2016?22(2):357-360.",76.0,YR,,F,Y,,,20160324.0,,MD,US,US,2016,Q1,Elderly
122104441,12210444,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q1,Acute kidney injury,,2016,Q1,1,I,,20160315.0,20160325,20160325,EXP,,US-ACTAVIS-2016-06393,WATSON,"BAIRD P, LEUNG S, HOANG H, BABALOLA O, DEVOE CE, WANCHOO R ET AL. A CASE OF ACUTE KIDNEY INJURY FROM CRYSTAL NEPHROPATHY SECONDARY TO POMALIDOMIDE AND LEVOFLOXACIN USE. J ONCOL PHARM PRACT. 2016?22(2):357-360.",76.0,YR,,F,Y,,,20160325.0,,MD,US,US,2016,Q1,Elderly
122104441,12210444,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q1,Crystal nephropathy,,2016,Q1,1,I,,20160315.0,20160325,20160325,EXP,,US-ACTAVIS-2016-06393,WATSON,"BAIRD P, LEUNG S, HOANG H, BABALOLA O, DEVOE CE, WANCHOO R ET AL. A CASE OF ACUTE KIDNEY INJURY FROM CRYSTAL NEPHROPATHY SECONDARY TO POMALIDOMIDE AND LEVOFLOXACIN USE. J ONCOL PHARM PRACT. 2016?22(2):357-360.",76.0,YR,,F,Y,,,20160325.0,,MD,US,US,2016,Q1,Elderly
122104441,12210444,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q1,Thrombocytopenia,,2016,Q1,1,I,,20160315.0,20160325,20160325,EXP,,US-ACTAVIS-2016-06393,WATSON,"BAIRD P, LEUNG S, HOANG H, BABALOLA O, DEVOE CE, WANCHOO R ET AL. A CASE OF ACUTE KIDNEY INJURY FROM CRYSTAL NEPHROPATHY SECONDARY TO POMALIDOMIDE AND LEVOFLOXACIN USE. J ONCOL PHARM PRACT. 2016?22(2):357-360.",76.0,YR,,F,Y,,,20160325.0,,MD,US,US,2016,Q1,Elderly
122130481,12213048,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Crystal nephropathy,,2016,Q1,1,I,,20160315.0,20160328,20160328,EXP,US-MLMSERVICE-20160317-0203803-1,US-HOSPIRA-3226280,HOSPIRA,"BAIRD P, JHAVERI KD, LEUNG S, HOANG H, BABALOLA O, DEVOE CE, ET.AL. A CASE OF ACUTE KIDNEY INJURY FROM CRYSTAL NEPHROPATHY SECONDARY TO POMALIDOMIDE AND LEVOFLOXACIN USE J ONCOL PHARM PRACT. 2016 APR 01? 22(2): 357-360",76.0,YR,E,F,Y,,,20160328.0,,OT,GB,US,2016,Q1,Elderly
122130481,12213048,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Renal tubular necrosis,,2016,Q1,1,I,,20160315.0,20160328,20160328,EXP,US-MLMSERVICE-20160317-0203803-1,US-HOSPIRA-3226280,HOSPIRA,"BAIRD P, JHAVERI KD, LEUNG S, HOANG H, BABALOLA O, DEVOE CE, ET.AL. A CASE OF ACUTE KIDNEY INJURY FROM CRYSTAL NEPHROPATHY SECONDARY TO POMALIDOMIDE AND LEVOFLOXACIN USE J ONCOL PHARM PRACT. 2016 APR 01? 22(2): 357-360",76.0,YR,E,F,Y,,,20160328.0,,OT,GB,US,2016,Q1,Elderly
122135301,12213530,18,C,Insulin glargine,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q1,Diarrhoea,,2016,Q1,1,I,20160217.0,20160315.0,20160328,20160328,EXP,,"US-SUCAMPO PHARMACEUTICALS, INC.-SPI201600249",SUCAMPO,,59.0,YR,,F,Y,124.26,KG,20160328.0,,OT,US,US,2016,Q1,Adult
122135301,12213530,18,C,Insulin glargine,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q1,Diverticulitis,,2016,Q1,1,I,20160217.0,20160315.0,20160328,20160328,EXP,,"US-SUCAMPO PHARMACEUTICALS, INC.-SPI201600249",SUCAMPO,,59.0,YR,,F,Y,124.26,KG,20160328.0,,OT,US,US,2016,Q1,Adult
122186131,12218613,10,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q1,Gastrointestinal haemorrhage,,2016,Q1,1,I,20151103.0,20160324.0,20160329,20160329,PER,,US-CELGENEUS-USA-2016036497,CELGENE,,62.0,YR,,F,Y,94.7,KG,20160329.0,,OT,US,US,2016,Q1,Adult
122186131,12218613,10,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q1,Klebsiella sepsis,,2016,Q1,1,I,20151103.0,20160324.0,20160329,20160329,PER,,US-CELGENEUS-USA-2016036497,CELGENE,,62.0,YR,,F,Y,94.7,KG,20160329.0,,OT,US,US,2016,Q1,Adult
122252511,12225251,2,SS,Insulin Glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,U,,,,,,INJECTION,,2016,Q1,Blood glucose increased,,2016,Q1,1,I,,20160319.0,20160331,20160331,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201603009195,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20160330.0,,CN,JP,JP,2016,Q1,Elderly
122257181,12225718,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q1,Condition aggravated,,2016,Q1,1,I,,20160330.0,20160331,20160331,PER,,US-BAYER-2016-061310,BAYER,,67.0,YR,E,M,Y,,,20160331.0,,CN,US,US,2016,Q1,Elderly
71349492,7134949,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q1,Amniotic cavity infection,,2016,Q1,2,F,,20160126.0,20090930,20160128,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-14790364,BRISTOL MYERS SQUIBB,,35.0,YR,,F,Y,160.54,KG,20160128.0,,OT,US,US,2016,Q1,Adult
71349492,7134949,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q1,Caesarean section,,2016,Q1,2,F,,20160126.0,20090930,20160128,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-14790364,BRISTOL MYERS SQUIBB,,35.0,YR,,F,Y,160.54,KG,20160128.0,,OT,US,US,2016,Q1,Adult
71349492,7134949,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q1,Live birth,,2016,Q1,2,F,,20160126.0,20090930,20160128,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-14790364,BRISTOL MYERS SQUIBB,,35.0,YR,,F,Y,160.54,KG,20160128.0,,OT,US,US,2016,Q1,Adult
71349492,7134949,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q1,Maternal exposure during pregnancy,,2016,Q1,2,F,,20160126.0,20090930,20160128,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-14790364,BRISTOL MYERS SQUIBB,,35.0,YR,,F,Y,160.54,KG,20160128.0,,OT,US,US,2016,Q1,Adult
71349492,7134949,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q1,Pre-eclampsia,,2016,Q1,2,F,,20160126.0,20090930,20160128,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-14790364,BRISTOL MYERS SQUIBB,,35.0,YR,,F,Y,160.54,KG,20160128.0,,OT,US,US,2016,Q1,Adult
71349492,7134949,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q1,Urinary tract infection,,2016,Q1,2,F,,20160126.0,20090930,20160128,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-14790364,BRISTOL MYERS SQUIBB,,35.0,YR,,F,Y,160.54,KG,20160128.0,,OT,US,US,2016,Q1,Adult
87099614,8709961,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 UNITS UNDER THE SKIN AT BEDTIME,,,,,,,,,,,,2016,Q1,Angina pectoris,,2016,Q1,4,F,200703.0,20160223.0,20120806,20160302,EXP,,US-ASTRAZENECA-2012SE54040,ASTRAZENECA,,661.0,MON,,M,Y,74.8,KG,20160302.0,,,US,US,2016,Q1,Elderly
87099614,8709961,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 UNITS UNDER THE SKIN AT BEDTIME,,,,,,,,,,,,2016,Q1,Cardiac failure congestive,,2016,Q1,4,F,200703.0,20160223.0,20120806,20160302,EXP,,US-ASTRAZENECA-2012SE54040,ASTRAZENECA,,661.0,MON,,M,Y,74.8,KG,20160302.0,,,US,US,2016,Q1,Elderly
87099614,8709961,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 UNITS UNDER THE SKIN AT BEDTIME,,,,,,,,,,,,2016,Q1,Cardiovascular disorder,,2016,Q1,4,F,200703.0,20160223.0,20120806,20160302,EXP,,US-ASTRAZENECA-2012SE54040,ASTRAZENECA,,661.0,MON,,M,Y,74.8,KG,20160302.0,,,US,US,2016,Q1,Elderly
87099614,8709961,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 UNITS UNDER THE SKIN AT BEDTIME,,,,,,,,,,,,2016,Q1,Coronary artery disease,,2016,Q1,4,F,200703.0,20160223.0,20120806,20160302,EXP,,US-ASTRAZENECA-2012SE54040,ASTRAZENECA,,661.0,MON,,M,Y,74.8,KG,20160302.0,,,US,US,2016,Q1,Elderly
87099614,8709961,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 UNITS UNDER THE SKIN AT BEDTIME,,,,,,,,,,,,2016,Q1,Emotional distress,,2016,Q1,4,F,200703.0,20160223.0,20120806,20160302,EXP,,US-ASTRAZENECA-2012SE54040,ASTRAZENECA,,661.0,MON,,M,Y,74.8,KG,20160302.0,,,US,US,2016,Q1,Elderly
87099614,8709961,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 UNITS UNDER THE SKIN AT BEDTIME,,,,,,,,,,,,2016,Q1,Hypertension,,2016,Q1,4,F,200703.0,20160223.0,20120806,20160302,EXP,,US-ASTRAZENECA-2012SE54040,ASTRAZENECA,,661.0,MON,,M,Y,74.8,KG,20160302.0,,,US,US,2016,Q1,Elderly
87099614,8709961,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 UNITS UNDER THE SKIN AT BEDTIME,,,,,,,,,,,,2016,Q1,Myocardial infarction,,2016,Q1,4,F,200703.0,20160223.0,20120806,20160302,EXP,,US-ASTRAZENECA-2012SE54040,ASTRAZENECA,,661.0,MON,,M,Y,74.8,KG,20160302.0,,,US,US,2016,Q1,Elderly
90589612,9058961,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q1,Drug ineffective,,2016,Q1,2,F,,20160125.0,20130211,20160125,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-16449100,BRISTOL MYERS SQUIBB,,18.0,YR,,F,Y,,,20160125.0,,CN,US,US,2016,Q1,Youth
90589612,9058961,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q1,Maternal exposure during pregnancy,,2016,Q1,2,F,,20160125.0,20130211,20160125,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-16449100,BRISTOL MYERS SQUIBB,,18.0,YR,,F,Y,,,20160125.0,,CN,US,US,2016,Q1,Youth
90589612,9058961,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q1,Weight increased,,2016,Q1,2,F,,20160125.0,20130211,20160125,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-16449100,BRISTOL MYERS SQUIBB,,18.0,YR,,F,Y,,,20160125.0,,CN,US,US,2016,Q1,Youth
98175452,9817545,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,INJEC 70U INTO SKIN AT BEDTIME,,,,,,,,,,,,2016,Q1,Anion gap decreased,,2016,Q1,2,F,20120106.0,20140107.0,20140115,20160204,EXP,,US-ROCHE-1330949,ROCHE,,52.0,YR,,F,Y,125.0,KG,20160204.0,,MD,US,US,2016,Q1,Adult
98175452,9817545,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,INJEC 70U INTO SKIN AT BEDTIME,,,,,,,,,,,,2016,Q1,Asthma,,2016,Q1,2,F,20120106.0,20140107.0,20140115,20160204,EXP,,US-ROCHE-1330949,ROCHE,,52.0,YR,,F,Y,125.0,KG,20160204.0,,MD,US,US,2016,Q1,Adult
98175452,9817545,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,INJEC 70U INTO SKIN AT BEDTIME,,,,,,,,,,,,2016,Q1,Blood glucose increased,,2016,Q1,2,F,20120106.0,20140107.0,20140115,20160204,EXP,,US-ROCHE-1330949,ROCHE,,52.0,YR,,F,Y,125.0,KG,20160204.0,,MD,US,US,2016,Q1,Adult
98175452,9817545,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,INJEC 70U INTO SKIN AT BEDTIME,,,,,,,,,,,,2016,Q1,Forced expiratory volume decreased,,2016,Q1,2,F,20120106.0,20140107.0,20140115,20160204,EXP,,US-ROCHE-1330949,ROCHE,,52.0,YR,,F,Y,125.0,KG,20160204.0,,MD,US,US,2016,Q1,Adult
98175452,9817545,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,INJEC 70U INTO SKIN AT BEDTIME,,,,,,,,,,,,2016,Q1,Glycosylated haemoglobin increased,,2016,Q1,2,F,20120106.0,20140107.0,20140115,20160204,EXP,,US-ROCHE-1330949,ROCHE,,52.0,YR,,F,Y,125.0,KG,20160204.0,,MD,US,US,2016,Q1,Adult
98175452,9817545,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,INJEC 70U INTO SKIN AT BEDTIME,,,,,,,,,,,,2016,Q1,Haematocrit decreased,,2016,Q1,2,F,20120106.0,20140107.0,20140115,20160204,EXP,,US-ROCHE-1330949,ROCHE,,52.0,YR,,F,Y,125.0,KG,20160204.0,,MD,US,US,2016,Q1,Adult
98175452,9817545,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,INJEC 70U INTO SKIN AT BEDTIME,,,,,,,,,,,,2016,Q1,Haemoglobin increased,,2016,Q1,2,F,20120106.0,20140107.0,20140115,20160204,EXP,,US-ROCHE-1330949,ROCHE,,52.0,YR,,F,Y,125.0,KG,20160204.0,,MD,US,US,2016,Q1,Adult
98175452,9817545,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,INJEC 70U INTO SKIN AT BEDTIME,,,,,,,,,,,,2016,Q1,High density lipoprotein decreased,,2016,Q1,2,F,20120106.0,20140107.0,20140115,20160204,EXP,,US-ROCHE-1330949,ROCHE,,52.0,YR,,F,Y,125.0,KG,20160204.0,,MD,US,US,2016,Q1,Adult
98175452,9817545,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,INJEC 70U INTO SKIN AT BEDTIME,,,,,,,,,,,,2016,Q1,Lymphocyte count decreased,,2016,Q1,2,F,20120106.0,20140107.0,20140115,20160204,EXP,,US-ROCHE-1330949,ROCHE,,52.0,YR,,F,Y,125.0,KG,20160204.0,,MD,US,US,2016,Q1,Adult
98175452,9817545,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,INJEC 70U INTO SKIN AT BEDTIME,,,,,,,,,,,,2016,Q1,Mean cell haemoglobin concentration decreased,,2016,Q1,2,F,20120106.0,20140107.0,20140115,20160204,EXP,,US-ROCHE-1330949,ROCHE,,52.0,YR,,F,Y,125.0,KG,20160204.0,,MD,US,US,2016,Q1,Adult
98175452,9817545,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,INJEC 70U INTO SKIN AT BEDTIME,,,,,,,,,,,,2016,Q1,Mean cell volume decreased,,2016,Q1,2,F,20120106.0,20140107.0,20140115,20160204,EXP,,US-ROCHE-1330949,ROCHE,,52.0,YR,,F,Y,125.0,KG,20160204.0,,MD,US,US,2016,Q1,Adult
98175452,9817545,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,INJEC 70U INTO SKIN AT BEDTIME,,,,,,,,,,,,2016,Q1,Mucosal discolouration,,2016,Q1,2,F,20120106.0,20140107.0,20140115,20160204,EXP,,US-ROCHE-1330949,ROCHE,,52.0,YR,,F,Y,125.0,KG,20160204.0,,MD,US,US,2016,Q1,Adult
98175452,9817545,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,INJEC 70U INTO SKIN AT BEDTIME,,,,,,,,,,,,2016,Q1,Neutrophil count increased,,2016,Q1,2,F,20120106.0,20140107.0,20140115,20160204,EXP,,US-ROCHE-1330949,ROCHE,,52.0,YR,,F,Y,125.0,KG,20160204.0,,MD,US,US,2016,Q1,Adult
98175452,9817545,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,INJEC 70U INTO SKIN AT BEDTIME,,,,,,,,,,,,2016,Q1,Nodule,,2016,Q1,2,F,20120106.0,20140107.0,20140115,20160204,EXP,,US-ROCHE-1330949,ROCHE,,52.0,YR,,F,Y,125.0,KG,20160204.0,,MD,US,US,2016,Q1,Adult
98175452,9817545,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,INJEC 70U INTO SKIN AT BEDTIME,,,,,,,,,,,,2016,Q1,Red blood cell count increased,,2016,Q1,2,F,20120106.0,20140107.0,20140115,20160204,EXP,,US-ROCHE-1330949,ROCHE,,52.0,YR,,F,Y,125.0,KG,20160204.0,,MD,US,US,2016,Q1,Adult
98175452,9817545,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,INJEC 70U INTO SKIN AT BEDTIME,,,,,,,,,,,,2016,Q1,Red cell distribution width increased,,2016,Q1,2,F,20120106.0,20140107.0,20140115,20160204,EXP,,US-ROCHE-1330949,ROCHE,,52.0,YR,,F,Y,125.0,KG,20160204.0,,MD,US,US,2016,Q1,Adult
98175452,9817545,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,INJEC 70U INTO SKIN AT BEDTIME,,,,,,,,,,,,2016,Q1,White blood cell count increased,,2016,Q1,2,F,20120106.0,20140107.0,20140115,20160204,EXP,,US-ROCHE-1330949,ROCHE,,52.0,YR,,F,Y,125.0,KG,20160204.0,,MD,US,US,2016,Q1,Adult
99891525,9989152,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q1,Syncope,,2016,Q1,5,F,20140305.0,20160310.0,20140310,20160314,EXP,,JP-ROCHE-1360598,ROCHE,,83.0,YR,,F,Y,50.9,KG,20160314.0,,MD,JP,JP,2016,Q1,Elderly
99891525,9989152,27,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q1,Syncope,,2016,Q1,5,F,20140305.0,20160310.0,20140310,20160314,EXP,,JP-ROCHE-1360598,ROCHE,,83.0,YR,,F,Y,50.9,KG,20160314.0,,MD,JP,JP,2016,Q1,Elderly
101418374,10141837,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Pancreatitis acute,,2016,Q2,4,F,20140418.0,20160510.0,20140429,20160517,EXP,,US-JNJFOC-20140417349,JANSSEN,VERMA R. CANAGLIFLOZIN-ASSOCIATED ACUTE PANCREATITIS. AMERICAN JOURNAL OF THERAPEUTICS 2014. VERMA R. CANAGLIFLOZIN-ASSOCIATED ACUTE PANCREATITIS. AMERICAN JOURNAL OF THERAPEUTICS 2016;23/3:E972-3.,46.0,YR,A,F,Y,,,20160517.0,,OT,US,US,2016,Q2,Adult
101418374,10141837,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Septic shock,,2016,Q2,4,F,20140418.0,20160510.0,20140429,20160517,EXP,,US-JNJFOC-20140417349,JANSSEN,VERMA R. CANAGLIFLOZIN-ASSOCIATED ACUTE PANCREATITIS. AMERICAN JOURNAL OF THERAPEUTICS 2014. VERMA R. CANAGLIFLOZIN-ASSOCIATED ACUTE PANCREATITIS. AMERICAN JOURNAL OF THERAPEUTICS 2016;23/3:E972-3.,46.0,YR,A,F,Y,,,20160517.0,,OT,US,US,2016,Q2,Adult
102524737,10252473,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"100 UNIT/ML (3 ML), 10 UNITS AS DIRECTED NIGHTLY SOLO STAR",,,,,,,,10.0,IU,INJECTION,,2016,Q2,Malaise,,2016,Q2,7,F,20140420.0,20160608.0,20140623,20160615,EXP,,US-PFIZER INC-2014171159,PFIZER,,87.0,YR,,F,Y,104.0,KG,20160615.0,,MD,US,US,2016,Q2,Elderly
102524737,10252473,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"100 UNIT/ML (3 ML), 10 UNITS AS DIRECTED NIGHTLY SOLO STAR",,,,,,,,10.0,IU,INJECTION,,2016,Q2,Pneumonia,,2016,Q2,7,F,20140420.0,20160608.0,20140623,20160615,EXP,,US-PFIZER INC-2014171159,PFIZER,,87.0,YR,,F,Y,104.0,KG,20160615.0,,MD,US,US,2016,Q2,Elderly
1045086110,10450861,17,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,DOSE PER APPLICATION AND DAILY DOSE:18U/S,,,,,,,,,,,QD,2016,Q2,Activities of daily living impaired,,2016,Q2,10,F,20140707.0,20160505.0,20140912,20160512,EXP,,"AU-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2014-BI-32991BI",BOEHRINGER INGELHEIM,,64.0,YR,,M,Y,122.0,KG,20160512.0,,MD,COUNTRY NOT SPECIFIED,AU,2016,Q2,Adult
1045086110,10450861,17,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,DOSE PER APPLICATION AND DAILY DOSE:18U/S,,,,,,,,,,,QD,2016,Q2,Acute kidney injury,,2016,Q2,10,F,20140707.0,20160505.0,20140912,20160512,EXP,,"AU-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2014-BI-32991BI",BOEHRINGER INGELHEIM,,64.0,YR,,M,Y,122.0,KG,20160512.0,,MD,COUNTRY NOT SPECIFIED,AU,2016,Q2,Adult
1045086110,10450861,17,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,DOSE PER APPLICATION AND DAILY DOSE:18U/S,,,,,,,,,,,QD,2016,Q2,Anaemia,Anaemia,2016,Q2,10,F,20140707.0,20160505.0,20140912,20160512,EXP,,"AU-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2014-BI-32991BI",BOEHRINGER INGELHEIM,,64.0,YR,,M,Y,122.0,KG,20160512.0,,MD,COUNTRY NOT SPECIFIED,AU,2016,Q2,Adult
1045086110,10450861,17,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,DOSE PER APPLICATION AND DAILY DOSE:18U/S,,,,,,,,,,,QD,2016,Q2,Chest pain,,2016,Q2,10,F,20140707.0,20160505.0,20140912,20160512,EXP,,"AU-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2014-BI-32991BI",BOEHRINGER INGELHEIM,,64.0,YR,,M,Y,122.0,KG,20160512.0,,MD,COUNTRY NOT SPECIFIED,AU,2016,Q2,Adult
1045086110,10450861,17,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,DOSE PER APPLICATION AND DAILY DOSE:18U/S,,,,,,,,,,,QD,2016,Q2,Chronic kidney disease,,2016,Q2,10,F,20140707.0,20160505.0,20140912,20160512,EXP,,"AU-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2014-BI-32991BI",BOEHRINGER INGELHEIM,,64.0,YR,,M,Y,122.0,KG,20160512.0,,MD,COUNTRY NOT SPECIFIED,AU,2016,Q2,Adult
1045086110,10450861,17,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,DOSE PER APPLICATION AND DAILY DOSE:18U/S,,,,,,,,,,,QD,2016,Q2,Cough,,2016,Q2,10,F,20140707.0,20160505.0,20140912,20160512,EXP,,"AU-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2014-BI-32991BI",BOEHRINGER INGELHEIM,,64.0,YR,,M,Y,122.0,KG,20160512.0,,MD,COUNTRY NOT SPECIFIED,AU,2016,Q2,Adult
1045086110,10450861,17,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,DOSE PER APPLICATION AND DAILY DOSE:18U/S,,,,,,,,,,,QD,2016,Q2,Diarrhoea,,2016,Q2,10,F,20140707.0,20160505.0,20140912,20160512,EXP,,"AU-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2014-BI-32991BI",BOEHRINGER INGELHEIM,,64.0,YR,,M,Y,122.0,KG,20160512.0,,MD,COUNTRY NOT SPECIFIED,AU,2016,Q2,Adult
1045086110,10450861,17,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,DOSE PER APPLICATION AND DAILY DOSE:18U/S,,,,,,,,,,,QD,2016,Q2,Gastroenteritis,,2016,Q2,10,F,20140707.0,20160505.0,20140912,20160512,EXP,,"AU-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2014-BI-32991BI",BOEHRINGER INGELHEIM,,64.0,YR,,M,Y,122.0,KG,20160512.0,,MD,COUNTRY NOT SPECIFIED,AU,2016,Q2,Adult
111895153,11189515,19,C,Insulin glargine biomep,,2,Subcutaneous,"10 IU, UNK",,,,U,,,,10.0,IU,,QD,2016,Q2,Coagulation time abnormal,,2016,Q2,3,F,20150312.0,20160419.0,20150615,20160502,EXP,,US-ACORDA-ACO_110417_2015,ACORDA,,47.0,YR,,F,Y,102.49,KG,20160502.0,,CN,US,US,2016,Q2,Adult
111895153,11189515,19,C,Insulin glargine biomep,,2,Subcutaneous,"10 IU, UNK",,,,U,,,,10.0,IU,,QD,2016,Q2,Contusion,,2016,Q2,3,F,20150312.0,20160419.0,20150615,20160502,EXP,,US-ACORDA-ACO_110417_2015,ACORDA,,47.0,YR,,F,Y,102.49,KG,20160502.0,,CN,US,US,2016,Q2,Adult
111895153,11189515,19,C,Insulin glargine biomep,,2,Subcutaneous,"10 IU, UNK",,,,U,,,,10.0,IU,,QD,2016,Q2,Dizziness,,2016,Q2,3,F,20150312.0,20160419.0,20150615,20160502,EXP,,US-ACORDA-ACO_110417_2015,ACORDA,,47.0,YR,,F,Y,102.49,KG,20160502.0,,CN,US,US,2016,Q2,Adult
111895153,11189515,19,C,Insulin glargine biomep,,2,Subcutaneous,"10 IU, UNK",,,,U,,,,10.0,IU,,QD,2016,Q2,Dry skin,,2016,Q2,3,F,20150312.0,20160419.0,20150615,20160502,EXP,,US-ACORDA-ACO_110417_2015,ACORDA,,47.0,YR,,F,Y,102.49,KG,20160502.0,,CN,US,US,2016,Q2,Adult
111895153,11189515,19,C,Insulin glargine biomep,,2,Subcutaneous,"10 IU, UNK",,,,U,,,,10.0,IU,,QD,2016,Q2,Dysphagia,,2016,Q2,3,F,20150312.0,20160419.0,20150615,20160502,EXP,,US-ACORDA-ACO_110417_2015,ACORDA,,47.0,YR,,F,Y,102.49,KG,20160502.0,,CN,US,US,2016,Q2,Adult
111895153,11189515,19,C,Insulin glargine biomep,,2,Subcutaneous,"10 IU, UNK",,,,U,,,,10.0,IU,,QD,2016,Q2,Emotional disorder,,2016,Q2,3,F,20150312.0,20160419.0,20150615,20160502,EXP,,US-ACORDA-ACO_110417_2015,ACORDA,,47.0,YR,,F,Y,102.49,KG,20160502.0,,CN,US,US,2016,Q2,Adult
111895153,11189515,19,C,Insulin glargine biomep,,2,Subcutaneous,"10 IU, UNK",,,,U,,,,10.0,IU,,QD,2016,Q2,Fatigue,,2016,Q2,3,F,20150312.0,20160419.0,20150615,20160502,EXP,,US-ACORDA-ACO_110417_2015,ACORDA,,47.0,YR,,F,Y,102.49,KG,20160502.0,,CN,US,US,2016,Q2,Adult
111895153,11189515,19,C,Insulin glargine biomep,,2,Subcutaneous,"10 IU, UNK",,,,U,,,,10.0,IU,,QD,2016,Q2,Injection site bruising,,2016,Q2,3,F,20150312.0,20160419.0,20150615,20160502,EXP,,US-ACORDA-ACO_110417_2015,ACORDA,,47.0,YR,,F,Y,102.49,KG,20160502.0,,CN,US,US,2016,Q2,Adult
111895153,11189515,19,C,Insulin glargine biomep,,2,Subcutaneous,"10 IU, UNK",,,,U,,,,10.0,IU,,QD,2016,Q2,Injection site dryness,,2016,Q2,3,F,20150312.0,20160419.0,20150615,20160502,EXP,,US-ACORDA-ACO_110417_2015,ACORDA,,47.0,YR,,F,Y,102.49,KG,20160502.0,,CN,US,US,2016,Q2,Adult
111895153,11189515,19,C,Insulin glargine biomep,,2,Subcutaneous,"10 IU, UNK",,,,U,,,,10.0,IU,,QD,2016,Q2,Injection site pain,,2016,Q2,3,F,20150312.0,20160419.0,20150615,20160502,EXP,,US-ACORDA-ACO_110417_2015,ACORDA,,47.0,YR,,F,Y,102.49,KG,20160502.0,,CN,US,US,2016,Q2,Adult
111895153,11189515,19,C,Insulin glargine biomep,,2,Subcutaneous,"10 IU, UNK",,,,U,,,,10.0,IU,,QD,2016,Q2,Nerve compression,,2016,Q2,3,F,20150312.0,20160419.0,20150615,20160502,EXP,,US-ACORDA-ACO_110417_2015,ACORDA,,47.0,YR,,F,Y,102.49,KG,20160502.0,,CN,US,US,2016,Q2,Adult
111895153,11189515,19,C,Insulin glargine biomep,,2,Subcutaneous,"10 IU, UNK",,,,U,,,,10.0,IU,,QD,2016,Q2,Seizure,,2016,Q2,3,F,20150312.0,20160419.0,20150615,20160502,EXP,,US-ACORDA-ACO_110417_2015,ACORDA,,47.0,YR,,F,Y,102.49,KG,20160502.0,,CN,US,US,2016,Q2,Adult
111895153,11189515,19,C,Insulin glargine biomep,,2,Subcutaneous,"10 IU, UNK",,,,U,,,,10.0,IU,,QD,2016,Q2,Tremor,,2016,Q2,3,F,20150312.0,20160419.0,20150615,20160502,EXP,,US-ACORDA-ACO_110417_2015,ACORDA,,47.0,YR,,F,Y,102.49,KG,20160502.0,,CN,US,US,2016,Q2,Adult
112174232,11217423,4,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Agranulocytosis,,2016,Q2,2,F,,20160527.0,20150625,20160608,EXP,,US-DRREDDYS-USA/USA/15/0048894,DR REDDYS,"ISKANDAR J, VANCE J, KABLINGER A, KAVURU B. TRANSIENT AGRANULOCYTOSIS ASSOCIATED WITH ZIPRASIDONE IN A 45-YEAR-OLD MAN ON HEMODIALYSIS. J CLIN PSYCHOPHARMACOL. 2015;35(3):347-8.",45.0,YR,,M,Y,,,20160608.0,,OT,COUNTRY NOT SPECIFIED,US,2016,Q2,Adult
112174232,11217423,4,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Dyspnoea,,2016,Q2,2,F,,20160527.0,20150625,20160608,EXP,,US-DRREDDYS-USA/USA/15/0048894,DR REDDYS,"ISKANDAR J, VANCE J, KABLINGER A, KAVURU B. TRANSIENT AGRANULOCYTOSIS ASSOCIATED WITH ZIPRASIDONE IN A 45-YEAR-OLD MAN ON HEMODIALYSIS. J CLIN PSYCHOPHARMACOL. 2015;35(3):347-8.",45.0,YR,,M,Y,,,20160608.0,,OT,COUNTRY NOT SPECIFIED,US,2016,Q2,Adult
112174232,11217423,4,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Hypertension,,2016,Q2,2,F,,20160527.0,20150625,20160608,EXP,,US-DRREDDYS-USA/USA/15/0048894,DR REDDYS,"ISKANDAR J, VANCE J, KABLINGER A, KAVURU B. TRANSIENT AGRANULOCYTOSIS ASSOCIATED WITH ZIPRASIDONE IN A 45-YEAR-OLD MAN ON HEMODIALYSIS. J CLIN PSYCHOPHARMACOL. 2015;35(3):347-8.",45.0,YR,,M,Y,,,20160608.0,,OT,COUNTRY NOT SPECIFIED,US,2016,Q2,Adult
112174232,11217423,4,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Oedema peripheral,,2016,Q2,2,F,,20160527.0,20150625,20160608,EXP,,US-DRREDDYS-USA/USA/15/0048894,DR REDDYS,"ISKANDAR J, VANCE J, KABLINGER A, KAVURU B. TRANSIENT AGRANULOCYTOSIS ASSOCIATED WITH ZIPRASIDONE IN A 45-YEAR-OLD MAN ON HEMODIALYSIS. J CLIN PSYCHOPHARMACOL. 2015;35(3):347-8.",45.0,YR,,M,Y,,,20160608.0,,OT,COUNTRY NOT SPECIFIED,US,2016,Q2,Adult
112174232,11217423,4,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,White blood cell count decreased,,2016,Q2,2,F,,20160527.0,20150625,20160608,EXP,,US-DRREDDYS-USA/USA/15/0048894,DR REDDYS,"ISKANDAR J, VANCE J, KABLINGER A, KAVURU B. TRANSIENT AGRANULOCYTOSIS ASSOCIATED WITH ZIPRASIDONE IN A 45-YEAR-OLD MAN ON HEMODIALYSIS. J CLIN PSYCHOPHARMACOL. 2015;35(3):347-8.",45.0,YR,,M,Y,,,20160608.0,,OT,COUNTRY NOT SPECIFIED,US,2016,Q2,Adult
116204792,11620479,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Cardiac failure congestive,,2016,Q2,2,F,20150122.0,20150206.0,20151012,20160604,EXP,,US-ASTRAZENECA-2015SE09817,ASTRAZENECA,,27409.0,DY,,F,Y,,,20160604.0,,MD,US,US,2016,Q2,Elderly
116401446,11640144,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q2,Aspergillus infection,,2016,Q2,6,F,201509.0,20160616.0,20151019,20160629,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-064509,BRISTOL MYERS SQUIBB,,43.0,YR,,M,Y,115.9,KG,20160629.0,,OT,US,US,2016,Q2,Adult
116401446,11640144,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q2,Bone erosion,,2016,Q2,6,F,201509.0,20160616.0,20151019,20160629,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-064509,BRISTOL MYERS SQUIBB,,43.0,YR,,M,Y,115.9,KG,20160629.0,,OT,US,US,2016,Q2,Adult
116401446,11640144,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q2,Cardiac failure congestive,,2016,Q2,6,F,201509.0,20160616.0,20151019,20160629,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-064509,BRISTOL MYERS SQUIBB,,43.0,YR,,M,Y,115.9,KG,20160629.0,,OT,US,US,2016,Q2,Adult
116401446,11640144,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q2,Decreased appetite,,2016,Q2,6,F,201509.0,20160616.0,20151019,20160629,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-064509,BRISTOL MYERS SQUIBB,,43.0,YR,,M,Y,115.9,KG,20160629.0,,OT,US,US,2016,Q2,Adult
116401446,11640144,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q2,Diplopia,,2016,Q2,6,F,201509.0,20160616.0,20151019,20160629,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-064509,BRISTOL MYERS SQUIBB,,43.0,YR,,M,Y,115.9,KG,20160629.0,,OT,US,US,2016,Q2,Adult
116401446,11640144,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q2,Dyspnoea,,2016,Q2,6,F,201509.0,20160616.0,20151019,20160629,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-064509,BRISTOL MYERS SQUIBB,,43.0,YR,,M,Y,115.9,KG,20160629.0,,OT,US,US,2016,Q2,Adult
116401446,11640144,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q2,Migraine,,2016,Q2,6,F,201509.0,20160616.0,20151019,20160629,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-064509,BRISTOL MYERS SQUIBB,,43.0,YR,,M,Y,115.9,KG,20160629.0,,OT,US,US,2016,Q2,Adult
116401446,11640144,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q2,Nausea,,2016,Q2,6,F,201509.0,20160616.0,20151019,20160629,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-064509,BRISTOL MYERS SQUIBB,,43.0,YR,,M,Y,115.9,KG,20160629.0,,OT,US,US,2016,Q2,Adult
116401446,11640144,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q2,Optic nerve disorder,,2016,Q2,6,F,201509.0,20160616.0,20151019,20160629,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-064509,BRISTOL MYERS SQUIBB,,43.0,YR,,M,Y,115.9,KG,20160629.0,,OT,US,US,2016,Q2,Adult
116401446,11640144,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q2,Pneumonia,,2016,Q2,6,F,201509.0,20160616.0,20151019,20160629,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-064509,BRISTOL MYERS SQUIBB,,43.0,YR,,M,Y,115.9,KG,20160629.0,,OT,US,US,2016,Q2,Adult
116401446,11640144,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q2,Sinus operation,,2016,Q2,6,F,201509.0,20160616.0,20151019,20160629,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-064509,BRISTOL MYERS SQUIBB,,43.0,YR,,M,Y,115.9,KG,20160629.0,,OT,US,US,2016,Q2,Adult
116401446,11640144,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q2,Sinusitis fungal,,2016,Q2,6,F,201509.0,20160616.0,20151019,20160629,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-064509,BRISTOL MYERS SQUIBB,,43.0,YR,,M,Y,115.9,KG,20160629.0,,OT,US,US,2016,Q2,Adult
116401446,11640144,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q2,VIth nerve paralysis,,2016,Q2,6,F,201509.0,20160616.0,20151019,20160629,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-064509,BRISTOL MYERS SQUIBB,,43.0,YR,,M,Y,115.9,KG,20160629.0,,OT,US,US,2016,Q2,Adult
116401446,11640144,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q2,Vomiting,,2016,Q2,6,F,201509.0,20160616.0,20151019,20160629,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-064509,BRISTOL MYERS SQUIBB,,43.0,YR,,M,Y,115.9,KG,20160629.0,,OT,US,US,2016,Q2,Adult
117762699,11776269,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU/ML, UNK",,,,,,,,,,,,2016,Q2,Drug effect incomplete,,2016,Q2,9,F,20150821.0,20160525.0,20151125,20160530,EXP,,US-PFIZER INC-2015389542,PFIZER,,73.0,YR,,F,Y,98.0,KG,20160530.0,,MD,US,US,2016,Q2,Elderly
117762699,11776269,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU/ML, UNK",,,,,,,,,,,,2016,Q2,Lower limb fracture,,2016,Q2,9,F,20150821.0,20160525.0,20151125,20160530,EXP,,US-PFIZER INC-2015389542,PFIZER,,73.0,YR,,F,Y,98.0,KG,20160530.0,,MD,US,US,2016,Q2,Elderly
117762699,11776269,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU/ML, UNK",,,,,,,,,,,,2016,Q2,Road traffic accident,,2016,Q2,9,F,20150821.0,20160525.0,20151125,20160530,EXP,,US-PFIZER INC-2015389542,PFIZER,,73.0,YR,,F,Y,98.0,KG,20160530.0,,MD,US,US,2016,Q2,Elderly
117762699,11776269,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU/ML, UNK",,,,,,,,,,,,2016,Q2,Somnolence,,2016,Q2,9,F,20150821.0,20160525.0,20151125,20160530,EXP,,US-PFIZER INC-2015389542,PFIZER,,73.0,YR,,F,Y,98.0,KG,20160530.0,,MD,US,US,2016,Q2,Elderly
118538412,11853841,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q2,Back pain,,2016,Q2,2,F,201510.0,20160517.0,20151219,20160524,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-078572,BRISTOL MYERS SQUIBB,,67.0,YR,,M,Y,,,20160524.0,,CN,IT,IT,2016,Q2,Elderly
118538412,11853841,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q2,Dyspnoea,,2016,Q2,2,F,201510.0,20160517.0,20151219,20160524,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-078572,BRISTOL MYERS SQUIBB,,67.0,YR,,M,Y,,,20160524.0,,CN,IT,IT,2016,Q2,Elderly
118538412,11853841,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q2,Pain,,2016,Q2,2,F,201510.0,20160517.0,20151219,20160524,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-078572,BRISTOL MYERS SQUIBB,,67.0,YR,,M,Y,,,20160524.0,,CN,IT,IT,2016,Q2,Elderly
118538412,11853841,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q2,Pruritus,,2016,Q2,2,F,201510.0,20160517.0,20151219,20160524,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-078572,BRISTOL MYERS SQUIBB,,67.0,YR,,M,Y,,,20160524.0,,CN,IT,IT,2016,Q2,Elderly
118538412,11853841,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q2,Pyrexia,,2016,Q2,2,F,201510.0,20160517.0,20151219,20160524,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-078572,BRISTOL MYERS SQUIBB,,67.0,YR,,M,Y,,,20160524.0,,CN,IT,IT,2016,Q2,Elderly
118689102,11868910,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"6 UNIT, QD",,,,,,,,6.0,DF,,QD,2016,Q2,Haemorrhagic stroke,,2016,Q2,2,F,20131220.0,20160330.0,20151225,20160405,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-089271,BRISTOL MYERS SQUIBB,,77.0,YR,,M,Y,,,20160405.0,,CN,US,US,2016,Q2,Elderly
118763832,11876383,22,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLN FOR INJECT IN PRE-FILLED SYRINGE,,2016,Q2,Abdominal pain,,2016,Q2,2,F,2011.0,20160407.0,20151229,20160419,EXP,,US-BIOGEN-2015BI00165775,BIOGEN,,60.0,YR,,M,Y,,,20160419.0,,MD,US,US,2016,Q2,Adult
118763832,11876383,22,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLN FOR INJECT IN PRE-FILLED SYRINGE,,2016,Q2,Asthenia,,2016,Q2,2,F,2011.0,20160407.0,20151229,20160419,EXP,,US-BIOGEN-2015BI00165775,BIOGEN,,60.0,YR,,M,Y,,,20160419.0,,MD,US,US,2016,Q2,Adult
118763832,11876383,22,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLN FOR INJECT IN PRE-FILLED SYRINGE,,2016,Q2,Catheterisation cardiac,,2016,Q2,2,F,2011.0,20160407.0,20151229,20160419,EXP,,US-BIOGEN-2015BI00165775,BIOGEN,,60.0,YR,,M,Y,,,20160419.0,,MD,US,US,2016,Q2,Adult
118763832,11876383,22,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLN FOR INJECT IN PRE-FILLED SYRINGE,,2016,Q2,Chest pain,,2016,Q2,2,F,2011.0,20160407.0,20151229,20160419,EXP,,US-BIOGEN-2015BI00165775,BIOGEN,,60.0,YR,,M,Y,,,20160419.0,,MD,US,US,2016,Q2,Adult
118763832,11876383,22,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLN FOR INJECT IN PRE-FILLED SYRINGE,,2016,Q2,Device related infection,,2016,Q2,2,F,2011.0,20160407.0,20151229,20160419,EXP,,US-BIOGEN-2015BI00165775,BIOGEN,,60.0,YR,,M,Y,,,20160419.0,,MD,US,US,2016,Q2,Adult
118763832,11876383,22,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLN FOR INJECT IN PRE-FILLED SYRINGE,,2016,Q2,Drug delivery device implantation,,2016,Q2,2,F,2011.0,20160407.0,20151229,20160419,EXP,,US-BIOGEN-2015BI00165775,BIOGEN,,60.0,YR,,M,Y,,,20160419.0,,MD,US,US,2016,Q2,Adult
118763832,11876383,22,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLN FOR INJECT IN PRE-FILLED SYRINGE,,2016,Q2,Fall,,2016,Q2,2,F,2011.0,20160407.0,20151229,20160419,EXP,,US-BIOGEN-2015BI00165775,BIOGEN,,60.0,YR,,M,Y,,,20160419.0,,MD,US,US,2016,Q2,Adult
118763832,11876383,22,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLN FOR INJECT IN PRE-FILLED SYRINGE,,2016,Q2,Hernia,,2016,Q2,2,F,2011.0,20160407.0,20151229,20160419,EXP,,US-BIOGEN-2015BI00165775,BIOGEN,,60.0,YR,,M,Y,,,20160419.0,,MD,US,US,2016,Q2,Adult
118763832,11876383,22,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLN FOR INJECT IN PRE-FILLED SYRINGE,,2016,Q2,Lethargy,,2016,Q2,2,F,2011.0,20160407.0,20151229,20160419,EXP,,US-BIOGEN-2015BI00165775,BIOGEN,,60.0,YR,,M,Y,,,20160419.0,,MD,US,US,2016,Q2,Adult
118763832,11876383,22,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLN FOR INJECT IN PRE-FILLED SYRINGE,,2016,Q2,Muscle spasms,,2016,Q2,2,F,2011.0,20160407.0,20151229,20160419,EXP,,US-BIOGEN-2015BI00165775,BIOGEN,,60.0,YR,,M,Y,,,20160419.0,,MD,US,US,2016,Q2,Adult
118763832,11876383,22,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLN FOR INJECT IN PRE-FILLED SYRINGE,,2016,Q2,Muscle spasticity,,2016,Q2,2,F,2011.0,20160407.0,20151229,20160419,EXP,,US-BIOGEN-2015BI00165775,BIOGEN,,60.0,YR,,M,Y,,,20160419.0,,MD,US,US,2016,Q2,Adult
118763832,11876383,22,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLN FOR INJECT IN PRE-FILLED SYRINGE,,2016,Q2,Pain in extremity,,2016,Q2,2,F,2011.0,20160407.0,20151229,20160419,EXP,,US-BIOGEN-2015BI00165775,BIOGEN,,60.0,YR,,M,Y,,,20160419.0,,MD,US,US,2016,Q2,Adult
118763832,11876383,22,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLN FOR INJECT IN PRE-FILLED SYRINGE,,2016,Q2,Paraesthesia,,2016,Q2,2,F,2011.0,20160407.0,20151229,20160419,EXP,,US-BIOGEN-2015BI00165775,BIOGEN,,60.0,YR,,M,Y,,,20160419.0,,MD,US,US,2016,Q2,Adult
118763832,11876383,22,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLN FOR INJECT IN PRE-FILLED SYRINGE,,2016,Q2,Pulmonary embolism,,2016,Q2,2,F,2011.0,20160407.0,20151229,20160419,EXP,,US-BIOGEN-2015BI00165775,BIOGEN,,60.0,YR,,M,Y,,,20160419.0,,MD,US,US,2016,Q2,Adult
118763832,11876383,22,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLN FOR INJECT IN PRE-FILLED SYRINGE,,2016,Q2,Urinary retention,,2016,Q2,2,F,2011.0,20160407.0,20151229,20160419,EXP,,US-BIOGEN-2015BI00165775,BIOGEN,,60.0,YR,,M,Y,,,20160419.0,,MD,US,US,2016,Q2,Adult
118763832,11876383,22,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLN FOR INJECT IN PRE-FILLED SYRINGE,,2016,Q2,Urinary tract infection,,2016,Q2,2,F,2011.0,20160407.0,20151229,20160419,EXP,,US-BIOGEN-2015BI00165775,BIOGEN,,60.0,YR,,M,Y,,,20160419.0,,MD,US,US,2016,Q2,Adult
118772758,11877275,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2016,Q2,Chronic obstructive pulmonary disease,,2016,Q2,8,F,20151216.0,20160428.0,20151229,20160510,EXP,,US-ACTELION-A-NJ2015-129119,ACTELION,,64.0,YR,A,F,Y,,,20160510.0,,PH,US,US,2016,Q2,Adult
118772758,11877275,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2016,Q2,Disease progression,,2016,Q2,8,F,20151216.0,20160428.0,20151229,20160510,EXP,,US-ACTELION-A-NJ2015-129119,ACTELION,,64.0,YR,A,F,Y,,,20160510.0,,PH,US,US,2016,Q2,Adult
118772758,11877275,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2016,Q2,Dyspnoea,,2016,Q2,8,F,20151216.0,20160428.0,20151229,20160510,EXP,,US-ACTELION-A-NJ2015-129119,ACTELION,,64.0,YR,A,F,Y,,,20160510.0,,PH,US,US,2016,Q2,Adult
118772758,11877275,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2016,Q2,Dyspnoea exertional,,2016,Q2,8,F,20151216.0,20160428.0,20151229,20160510,EXP,,US-ACTELION-A-NJ2015-129119,ACTELION,,64.0,YR,A,F,Y,,,20160510.0,,PH,US,US,2016,Q2,Adult
118772758,11877275,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2016,Q2,No therapeutic response,,2016,Q2,8,F,20151216.0,20160428.0,20151229,20160510,EXP,,US-ACTELION-A-NJ2015-129119,ACTELION,,64.0,YR,A,F,Y,,,20160510.0,,PH,US,US,2016,Q2,Adult
118772758,11877275,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2016,Q2,Palpitations,,2016,Q2,8,F,20151216.0,20160428.0,20151229,20160510,EXP,,US-ACTELION-A-NJ2015-129119,ACTELION,,64.0,YR,A,F,Y,,,20160510.0,,PH,US,US,2016,Q2,Adult
118772758,11877275,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2016,Q2,Pneumonia,,2016,Q2,8,F,20151216.0,20160428.0,20151229,20160510,EXP,,US-ACTELION-A-NJ2015-129119,ACTELION,,64.0,YR,A,F,Y,,,20160510.0,,PH,US,US,2016,Q2,Adult
118772758,11877275,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2016,Q2,Respiratory failure,,2016,Q2,8,F,20151216.0,20160428.0,20151229,20160510,EXP,,US-ACTELION-A-NJ2015-129119,ACTELION,,64.0,YR,A,F,Y,,,20160510.0,,PH,US,US,2016,Q2,Adult
119191742,11919174,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2016,Q2,Lower gastrointestinal haemorrhage,,2016,Q2,2,F,20130221.0,20160216.0,20160115,20160401,PER,,US-JNJFOC-20151217100,JANSSEN,,70.0,YR,E,M,Y,,,20160401.0,,CN,US,US,2016,Q2,Elderly
119214502,11921450,2,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,BID,2016,Q2,Respiratory failure,,2016,Q2,2,F,201601.0,20160427.0,20160115,20160503,PER,,US-CELGENEUS-USA-2016012134,CELGENE,,71.0,YR,,F,Y,,,20160503.0,,MD,US,US,2016,Q2,Elderly
119337283,11933728,3,C,insuline glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q2,Blood glucose increased,,2016,Q2,3,F,,20160315.0,20160121,20160607,EXP,,NL-BIOGEN-2016BI00175214,BIOGEN,,36.0,YR,,F,Y,,,20160607.0,,OT,NL,NL,2016,Q2,Adult
119337283,11933728,3,C,insuline glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q2,Flushing,,2016,Q2,3,F,,20160315.0,20160121,20160607,EXP,,NL-BIOGEN-2016BI00175214,BIOGEN,,36.0,YR,,F,Y,,,20160607.0,,OT,NL,NL,2016,Q2,Adult
119337283,11933728,3,C,insuline glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q2,Muscle spasms,,2016,Q2,3,F,,20160315.0,20160121,20160607,EXP,,NL-BIOGEN-2016BI00175214,BIOGEN,,36.0,YR,,F,Y,,,20160607.0,,OT,NL,NL,2016,Q2,Adult
119337283,11933728,3,C,insuline glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q2,Palpitations,,2016,Q2,3,F,,20160315.0,20160121,20160607,EXP,,NL-BIOGEN-2016BI00175214,BIOGEN,,36.0,YR,,F,Y,,,20160607.0,,OT,NL,NL,2016,Q2,Adult
119337283,11933728,3,C,insuline glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q2,Vomiting,,2016,Q2,3,F,,20160315.0,20160121,20160607,EXP,,NL-BIOGEN-2016BI00175214,BIOGEN,,36.0,YR,,F,Y,,,20160607.0,,OT,NL,NL,2016,Q2,Adult
119414303,11941430,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"6 IU, UNK",,,,,,,,6.0,IU,,,2016,Q2,Dehydration,,2016,Q2,3,F,20151127.0,20160413.0,20160122,20160419,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-001883,BRISTOL MYERS SQUIBB,,63.0,YR,,M,Y,,,20160419.0,,CN,IT,IT,2016,Q2,Adult
119414303,11941430,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"6 IU, UNK",,,,,,,,6.0,IU,,,2016,Q2,Metabolic acidosis,,2016,Q2,3,F,20151127.0,20160413.0,20160122,20160419,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-001883,BRISTOL MYERS SQUIBB,,63.0,YR,,M,Y,,,20160419.0,,CN,IT,IT,2016,Q2,Adult
119414303,11941430,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"6 IU, UNK",,,,,,,,6.0,IU,,,2016,Q2,Off label use,,2016,Q2,3,F,20151127.0,20160413.0,20160122,20160419,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-001883,BRISTOL MYERS SQUIBB,,63.0,YR,,M,Y,,,20160419.0,,CN,IT,IT,2016,Q2,Adult
119414303,11941430,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"6 IU, UNK",,,,,,,,6.0,IU,,,2016,Q2,Renal failure,,2016,Q2,3,F,20151127.0,20160413.0,20160122,20160419,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-001883,BRISTOL MYERS SQUIBB,,63.0,YR,,M,Y,,,20160419.0,,CN,IT,IT,2016,Q2,Adult
119414303,11941430,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"6 IU, UNK",,,,,,,,6.0,IU,,,2016,Q2,Septic shock,,2016,Q2,3,F,20151127.0,20160413.0,20160122,20160419,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-001883,BRISTOL MYERS SQUIBB,,63.0,YR,,M,Y,,,20160419.0,,CN,IT,IT,2016,Q2,Adult
119831623,11983162,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Oedema,,2016,Q2,3,F,20150724.0,20160412.0,20160201,20160510,EXP,,US-VIFOR (INTERNATIONAL) INC.-VIT-2016-00014,VIFOR,,36.0,YR,,M,Y,106.5,KG,20160510.0,,OT,US,US,2016,Q2,Adult
119831623,11983162,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Pruritus,,2016,Q2,3,F,20150724.0,20160412.0,20160201,20160510,EXP,,US-VIFOR (INTERNATIONAL) INC.-VIT-2016-00014,VIFOR,,36.0,YR,,M,Y,106.5,KG,20160510.0,,OT,US,US,2016,Q2,Adult
119831623,11983162,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Rash,,2016,Q2,3,F,20150724.0,20160412.0,20160201,20160510,EXP,,US-VIFOR (INTERNATIONAL) INC.-VIT-2016-00014,VIFOR,,36.0,YR,,M,Y,106.5,KG,20160510.0,,OT,US,US,2016,Q2,Adult
119937764,11993776,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD (EVERY MORNING)",,,,,,,,12.0,IU,SOLUTION,QD,2016,Q2,Blindness,,2016,Q2,4,F,20150416.0,20160419.0,20160203,20160426,EXP,,PHHY2016CO013734,NOVARTIS,,65.0,YR,,M,Y,82.0,KG,20160426.0,,CN,COUNTRY NOT SPECIFIED,CO,2016,Q2,Elderly
119937764,11993776,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD (EVERY MORNING)",,,,,,,,12.0,IU,SOLUTION,QD,2016,Q2,Blood urine present,,2016,Q2,4,F,20150416.0,20160419.0,20160203,20160426,EXP,,PHHY2016CO013734,NOVARTIS,,65.0,YR,,M,Y,82.0,KG,20160426.0,,CN,COUNTRY NOT SPECIFIED,CO,2016,Q2,Elderly
119937764,11993776,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD (EVERY MORNING)",,,,,,,,12.0,IU,SOLUTION,QD,2016,Q2,Calculus urinary,,2016,Q2,4,F,20150416.0,20160419.0,20160203,20160426,EXP,,PHHY2016CO013734,NOVARTIS,,65.0,YR,,M,Y,82.0,KG,20160426.0,,CN,COUNTRY NOT SPECIFIED,CO,2016,Q2,Elderly
119937764,11993776,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD (EVERY MORNING)",,,,,,,,12.0,IU,SOLUTION,QD,2016,Q2,Dizziness,,2016,Q2,4,F,20150416.0,20160419.0,20160203,20160426,EXP,,PHHY2016CO013734,NOVARTIS,,65.0,YR,,M,Y,82.0,KG,20160426.0,,CN,COUNTRY NOT SPECIFIED,CO,2016,Q2,Elderly
119937764,11993776,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD (EVERY MORNING)",,,,,,,,12.0,IU,SOLUTION,QD,2016,Q2,Headache,,2016,Q2,4,F,20150416.0,20160419.0,20160203,20160426,EXP,,PHHY2016CO013734,NOVARTIS,,65.0,YR,,M,Y,82.0,KG,20160426.0,,CN,COUNTRY NOT SPECIFIED,CO,2016,Q2,Elderly
119937764,11993776,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD (EVERY MORNING)",,,,,,,,12.0,IU,SOLUTION,QD,2016,Q2,Neck pain,,2016,Q2,4,F,20150416.0,20160419.0,20160203,20160426,EXP,,PHHY2016CO013734,NOVARTIS,,65.0,YR,,M,Y,82.0,KG,20160426.0,,CN,COUNTRY NOT SPECIFIED,CO,2016,Q2,Elderly
119937764,11993776,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD (EVERY MORNING)",,,,,,,,12.0,IU,SOLUTION,QD,2016,Q2,Peripheral swelling,,2016,Q2,4,F,20150416.0,20160419.0,20160203,20160426,EXP,,PHHY2016CO013734,NOVARTIS,,65.0,YR,,M,Y,82.0,KG,20160426.0,,CN,COUNTRY NOT SPECIFIED,CO,2016,Q2,Elderly
119937764,11993776,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD (EVERY MORNING)",,,,,,,,12.0,IU,SOLUTION,QD,2016,Q2,Platelet count decreased,,2016,Q2,4,F,20150416.0,20160419.0,20160203,20160426,EXP,,PHHY2016CO013734,NOVARTIS,,65.0,YR,,M,Y,82.0,KG,20160426.0,,CN,COUNTRY NOT SPECIFIED,CO,2016,Q2,Elderly
119937764,11993776,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD (EVERY MORNING)",,,,,,,,12.0,IU,SOLUTION,QD,2016,Q2,Pulmonary congestion,,2016,Q2,4,F,20150416.0,20160419.0,20160203,20160426,EXP,,PHHY2016CO013734,NOVARTIS,,65.0,YR,,M,Y,82.0,KG,20160426.0,,CN,COUNTRY NOT SPECIFIED,CO,2016,Q2,Elderly
119937764,11993776,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD (EVERY MORNING)",,,,,,,,12.0,IU,SOLUTION,QD,2016,Q2,Pyrexia,,2016,Q2,4,F,20150416.0,20160419.0,20160203,20160426,EXP,,PHHY2016CO013734,NOVARTIS,,65.0,YR,,M,Y,82.0,KG,20160426.0,,CN,COUNTRY NOT SPECIFIED,CO,2016,Q2,Elderly
119937764,11993776,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD (EVERY MORNING)",,,,,,,,12.0,IU,SOLUTION,QD,2016,Q2,Renal aneurysm,,2016,Q2,4,F,20150416.0,20160419.0,20160203,20160426,EXP,,PHHY2016CO013734,NOVARTIS,,65.0,YR,,M,Y,82.0,KG,20160426.0,,CN,COUNTRY NOT SPECIFIED,CO,2016,Q2,Elderly
119937764,11993776,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD (EVERY MORNING)",,,,,,,,12.0,IU,SOLUTION,QD,2016,Q2,Respiratory failure,,2016,Q2,4,F,20150416.0,20160419.0,20160203,20160426,EXP,,PHHY2016CO013734,NOVARTIS,,65.0,YR,,M,Y,82.0,KG,20160426.0,,CN,COUNTRY NOT SPECIFIED,CO,2016,Q2,Elderly
119937764,11993776,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD (EVERY MORNING)",,,,,,,,12.0,IU,SOLUTION,QD,2016,Q2,Urinary tract infection,,2016,Q2,4,F,20150416.0,20160419.0,20160203,20160426,EXP,,PHHY2016CO013734,NOVARTIS,,65.0,YR,,M,Y,82.0,KG,20160426.0,,CN,COUNTRY NOT SPECIFIED,CO,2016,Q2,Elderly
120443332,12044333,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2016,Q2,Gastrointestinal haemorrhage,,2016,Q2,2,F,20140412.0,20160328.0,20160208,20160405,EXP,,US-JNJFOC-20160206052,JANSSEN,,72.0,YR,E,M,Y,,,20160405.0,,CN,US,US,2016,Q2,Elderly
120732042,12073204,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Nasal,DAILY AT BEDTIME 110 UNITS,,,,,,,,110.0,IU,,QD,2016,Q2,Drug dose omission,,2016,Q2,2,F,20160122.0,20160229.0,20160212,20160426,EXP,,US-ROCHE-1710117,ROCHE,,50.0,YR,,M,Y,140.0,KG,20160426.0,,MD,US,US,2016,Q2,Adult
120732042,12073204,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Nasal,DAILY AT BEDTIME 110 UNITS,,,,,,,,110.0,IU,,QD,2016,Q2,Fluid retention,,2016,Q2,2,F,20160122.0,20160229.0,20160212,20160426,EXP,,US-ROCHE-1710117,ROCHE,,50.0,YR,,M,Y,140.0,KG,20160426.0,,MD,US,US,2016,Q2,Adult
120732042,12073204,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Nasal,DAILY AT BEDTIME 110 UNITS,,,,,,,,110.0,IU,,QD,2016,Q2,Hypersensitivity,,2016,Q2,2,F,20160122.0,20160229.0,20160212,20160426,EXP,,US-ROCHE-1710117,ROCHE,,50.0,YR,,M,Y,140.0,KG,20160426.0,,MD,US,US,2016,Q2,Adult
120732042,12073204,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Nasal,DAILY AT BEDTIME 110 UNITS,,,,,,,,110.0,IU,,QD,2016,Q2,Ocular hyperaemia,,2016,Q2,2,F,20160122.0,20160229.0,20160212,20160426,EXP,,US-ROCHE-1710117,ROCHE,,50.0,YR,,M,Y,140.0,KG,20160426.0,,MD,US,US,2016,Q2,Adult
120732042,12073204,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Nasal,DAILY AT BEDTIME 110 UNITS,,,,,,,,110.0,IU,,QD,2016,Q2,Oedema peripheral,,2016,Q2,2,F,20160122.0,20160229.0,20160212,20160426,EXP,,US-ROCHE-1710117,ROCHE,,50.0,YR,,M,Y,140.0,KG,20160426.0,,MD,US,US,2016,Q2,Adult
120732042,12073204,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Nasal,DAILY AT BEDTIME 110 UNITS,,,,,,,,110.0,IU,,QD,2016,Q2,Pain,,2016,Q2,2,F,20160122.0,20160229.0,20160212,20160426,EXP,,US-ROCHE-1710117,ROCHE,,50.0,YR,,M,Y,140.0,KG,20160426.0,,MD,US,US,2016,Q2,Adult
120732042,12073204,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Nasal,DAILY AT BEDTIME 110 UNITS,,,,,,,,110.0,IU,,QD,2016,Q2,Rash,,2016,Q2,2,F,20160122.0,20160229.0,20160212,20160426,EXP,,US-ROCHE-1710117,ROCHE,,50.0,YR,,M,Y,140.0,KG,20160426.0,,MD,US,US,2016,Q2,Adult
120732042,12073204,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Nasal,DAILY AT BEDTIME 110 UNITS,,,,,,,,110.0,IU,,QD,2016,Q2,Skin reaction,,2016,Q2,2,F,20160122.0,20160229.0,20160212,20160426,EXP,,US-ROCHE-1710117,ROCHE,,50.0,YR,,M,Y,140.0,KG,20160426.0,,MD,US,US,2016,Q2,Adult
120732042,12073204,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Nasal,DAILY AT BEDTIME 110 UNITS,,,,,,,,110.0,IU,,QD,2016,Q2,Somnolence,,2016,Q2,2,F,20160122.0,20160229.0,20160212,20160426,EXP,,US-ROCHE-1710117,ROCHE,,50.0,YR,,M,Y,140.0,KG,20160426.0,,MD,US,US,2016,Q2,Adult
120893582,12089358,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Anaemia,,2016,Q2,2,F,20151016.0,20160629.0,20160218,20160630,EXP,,US-ABBVIE-16P-163-1560829-00,ABBVIE,,50.0,YR,,F,Y,94.43,KG,20160630.0,,CN,US,US,2016,Q2,Adult
120893582,12089358,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Dizziness,,2016,Q2,2,F,20151016.0,20160629.0,20160218,20160630,EXP,,US-ABBVIE-16P-163-1560829-00,ABBVIE,,50.0,YR,,F,Y,94.43,KG,20160630.0,,CN,US,US,2016,Q2,Adult
120893582,12089358,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Dysfunctional uterine bleeding,,2016,Q2,2,F,20151016.0,20160629.0,20160218,20160630,EXP,,US-ABBVIE-16P-163-1560829-00,ABBVIE,,50.0,YR,,F,Y,94.43,KG,20160630.0,,CN,US,US,2016,Q2,Adult
120893582,12089358,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Dysuria,,2016,Q2,2,F,20151016.0,20160629.0,20160218,20160630,EXP,,US-ABBVIE-16P-163-1560829-00,ABBVIE,,50.0,YR,,F,Y,94.43,KG,20160630.0,,CN,US,US,2016,Q2,Adult
120893582,12089358,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Haematocrit decreased,,2016,Q2,2,F,20151016.0,20160629.0,20160218,20160630,EXP,,US-ABBVIE-16P-163-1560829-00,ABBVIE,,50.0,YR,,F,Y,94.43,KG,20160630.0,,CN,US,US,2016,Q2,Adult
120893582,12089358,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Haemoglobin decreased,,2016,Q2,2,F,20151016.0,20160629.0,20160218,20160630,EXP,,US-ABBVIE-16P-163-1560829-00,ABBVIE,,50.0,YR,,F,Y,94.43,KG,20160630.0,,CN,US,US,2016,Q2,Adult
120893582,12089358,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Headache,,2016,Q2,2,F,20151016.0,20160629.0,20160218,20160630,EXP,,US-ABBVIE-16P-163-1560829-00,ABBVIE,,50.0,YR,,F,Y,94.43,KG,20160630.0,,CN,US,US,2016,Q2,Adult
120893582,12089358,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Hyperglycaemia,,2016,Q2,2,F,20151016.0,20160629.0,20160218,20160630,EXP,,US-ABBVIE-16P-163-1560829-00,ABBVIE,,50.0,YR,,F,Y,94.43,KG,20160630.0,,CN,US,US,2016,Q2,Adult
120893582,12089358,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Nausea,,2016,Q2,2,F,20151016.0,20160629.0,20160218,20160630,EXP,,US-ABBVIE-16P-163-1560829-00,ABBVIE,,50.0,YR,,F,Y,94.43,KG,20160630.0,,CN,US,US,2016,Q2,Adult
120893582,12089358,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Pancytopenia,,2016,Q2,2,F,20151016.0,20160629.0,20160218,20160630,EXP,,US-ABBVIE-16P-163-1560829-00,ABBVIE,,50.0,YR,,F,Y,94.43,KG,20160630.0,,CN,US,US,2016,Q2,Adult
120893582,12089358,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Uterine leiomyoma,,2016,Q2,2,F,20151016.0,20160629.0,20160218,20160630,EXP,,US-ABBVIE-16P-163-1560829-00,ABBVIE,,50.0,YR,,F,Y,94.43,KG,20160630.0,,CN,US,US,2016,Q2,Adult
120893582,12089358,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Vaginal haemorrhage,,2016,Q2,2,F,20151016.0,20160629.0,20160218,20160630,EXP,,US-ABBVIE-16P-163-1560829-00,ABBVIE,,50.0,YR,,F,Y,94.43,KG,20160630.0,,CN,US,US,2016,Q2,Adult
120893582,12089358,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Vulvovaginal pruritus,,2016,Q2,2,F,20151016.0,20160629.0,20160218,20160630,EXP,,US-ABBVIE-16P-163-1560829-00,ABBVIE,,50.0,YR,,F,Y,94.43,KG,20160630.0,,CN,US,US,2016,Q2,Adult
120908192,12090819,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK, 1X/DAY",,,,,,,,,,INJECTION,QD,2016,Q2,Breast cancer,,2016,Q2,2,F,201512.0,20160418.0,20160218,20160427,EXP,,US-PFIZER INC-2016089072,PFIZER,,73.0,YR,,F,Y,,,20160427.0,,CN,US,US,2016,Q2,Elderly
120941735,12094173,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2016,Q2,Dyspnoea,,2016,Q2,5,F,20160202.0,20160615.0,20160219,20160627,EXP,,US-ACTELION-A-NJ2016-131530,ACTELION,,60.0,YR,A,F,Y,,,20160628.0,,OT,US,US,2016,Q2,Adult
120941735,12094173,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2016,Q2,Hypoxia,,2016,Q2,5,F,20160202.0,20160615.0,20160219,20160627,EXP,,US-ACTELION-A-NJ2016-131530,ACTELION,,60.0,YR,A,F,Y,,,20160628.0,,OT,US,US,2016,Q2,Adult
120941735,12094173,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2016,Q2,Pleural effusion,,2016,Q2,5,F,20160202.0,20160615.0,20160219,20160627,EXP,,US-ACTELION-A-NJ2016-131530,ACTELION,,60.0,YR,A,F,Y,,,20160628.0,,OT,US,US,2016,Q2,Adult
120941735,12094173,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2016,Q2,Pulmonary oedema,,2016,Q2,5,F,20160202.0,20160615.0,20160219,20160627,EXP,,US-ACTELION-A-NJ2016-131530,ACTELION,,60.0,YR,A,F,Y,,,20160628.0,,OT,US,US,2016,Q2,Adult
120941735,12094173,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2016,Q2,Respiratory failure,,2016,Q2,5,F,20160202.0,20160615.0,20160219,20160627,EXP,,US-ACTELION-A-NJ2016-131530,ACTELION,,60.0,YR,A,F,Y,,,20160628.0,,OT,US,US,2016,Q2,Adult
120941735,12094173,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2016,Q2,Sleep apnoea syndrome,,2016,Q2,5,F,20160202.0,20160615.0,20160219,20160627,EXP,,US-ACTELION-A-NJ2016-131530,ACTELION,,60.0,YR,A,F,Y,,,20160628.0,,OT,US,US,2016,Q2,Adult
121320162,12132016,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2016,Q2,Gastrointestinal ulcer haemorrhage,,2016,Q2,2,F,20140418.0,20160411.0,20160301,20160507,PER,,US-JNJFOC-20160213558,JANSSEN,,68.0,YR,E,M,Y,,,20160507.0,,CN,US,US,2016,Q2,Elderly
121455513,12145551,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2016,Q2,Acute myocardial infarction,,2016,Q2,3,F,20151215.0,20160419.0,20160304,20160422,EXP,,AU-JNJFOC-20160225034,JANSSEN,,68.0,YR,E,F,Y,,,20160422.0,,CN,AU,AU,2016,Q2,Elderly
121455513,12145551,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2016,Q2,Lower respiratory tract infection,,2016,Q2,3,F,20151215.0,20160419.0,20160304,20160422,EXP,,AU-JNJFOC-20160225034,JANSSEN,,68.0,YR,E,F,Y,,,20160422.0,,CN,AU,AU,2016,Q2,Elderly
121455513,12145551,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2016,Q2,Pericarditis,,2016,Q2,3,F,20151215.0,20160419.0,20160304,20160422,EXP,,AU-JNJFOC-20160225034,JANSSEN,,68.0,YR,E,F,Y,,,20160422.0,,CN,AU,AU,2016,Q2,Elderly
121543302,12154330,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,U,,,,,,FORMULATION UNKNOWN,,2016,Q2,BK virus infection,,2016,Q2,2,F,,20160329.0,20160307,20160406,EXP,,US-ASTELLAS-2016US007633,ASTELLAS,"GUPTA S, BRENNAN DC. PNEUMOCOCCAL 13-VALENT CONJUGATE VACCINE (PREVNAR 13)-ASSOCIATED IMMUNE THROMBOCYTOPENIC PURPURA IN A RENAL TRANSPLANT RECIPIENT: A CASE REPORT. TRANSPLANTATION PROCEEDINGS. 2016;48(1):262-4",77.0,YR,,M,Y,,,20160404.0,,OT,US,US,2016,Q2,Elderly
121543302,12154330,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,U,,,,,,FORMULATION UNKNOWN,,2016,Q2,Immune thrombocytopenic purpura,,2016,Q2,2,F,,20160329.0,20160307,20160406,EXP,,US-ASTELLAS-2016US007633,ASTELLAS,"GUPTA S, BRENNAN DC. PNEUMOCOCCAL 13-VALENT CONJUGATE VACCINE (PREVNAR 13)-ASSOCIATED IMMUNE THROMBOCYTOPENIC PURPURA IN A RENAL TRANSPLANT RECIPIENT: A CASE REPORT. TRANSPLANTATION PROCEEDINGS. 2016;48(1):262-4",77.0,YR,,M,Y,,,20160404.0,,OT,US,US,2016,Q2,Elderly
121637022,12163702,15,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,8 UNITS,,,,,,,,,,INJECTION,QD,2016,Q2,Enterococcal bacteraemia,,2016,Q2,2,F,20160104.0,20160513.0,20160309,20160518,PER,,US-CELGENEUS-USA-2016030370,CELGENE,,71.0,YR,,M,Y,,,20160518.0,,MD,US,US,2016,Q2,Elderly
121637022,12163702,15,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,8 UNITS,,,,,,,,,,INJECTION,QD,2016,Q2,Urinary tract infection enterococcal,,2016,Q2,2,F,20160104.0,20160513.0,20160309,20160518,PER,,US-CELGENEUS-USA-2016030370,CELGENE,,71.0,YR,,M,Y,,,20160518.0,,MD,US,US,2016,Q2,Elderly
121751013,12175101,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 U, 1X/DAY",,,,,,,,,,,QD,2016,Q2,Acute kidney injury,,2016,Q2,3,F,20160302.0,20160411.0,20160314,20160421,EXP,,"US-SMITH AND NEPHEW, INC-2016SMT00215",SMITH AND NEPHEW,,62.0,YR,,M,Y,83.9,KG,20160421.0,,OT,US,US,2016,Q2,Adult
121751013,12175101,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 U, 1X/DAY",,,,,,,,,,,QD,2016,Q2,Chest pain,,2016,Q2,3,F,20160302.0,20160411.0,20160314,20160421,EXP,,"US-SMITH AND NEPHEW, INC-2016SMT00215",SMITH AND NEPHEW,,62.0,YR,,M,Y,83.9,KG,20160421.0,,OT,US,US,2016,Q2,Adult
121751013,12175101,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 U, 1X/DAY",,,,,,,,,,,QD,2016,Q2,Diabetic foot infection,,2016,Q2,3,F,20160302.0,20160411.0,20160314,20160421,EXP,,"US-SMITH AND NEPHEW, INC-2016SMT00215",SMITH AND NEPHEW,,62.0,YR,,M,Y,83.9,KG,20160421.0,,OT,US,US,2016,Q2,Adult
121751013,12175101,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 U, 1X/DAY",,,,,,,,,,,QD,2016,Q2,Foot amputation,,2016,Q2,3,F,20160302.0,20160411.0,20160314,20160421,EXP,,"US-SMITH AND NEPHEW, INC-2016SMT00215",SMITH AND NEPHEW,,62.0,YR,,M,Y,83.9,KG,20160421.0,,OT,US,US,2016,Q2,Adult
121751013,12175101,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 U, 1X/DAY",,,,,,,,,,,QD,2016,Q2,Microcytic anaemia,,2016,Q2,3,F,20160302.0,20160411.0,20160314,20160421,EXP,,"US-SMITH AND NEPHEW, INC-2016SMT00215",SMITH AND NEPHEW,,62.0,YR,,M,Y,83.9,KG,20160421.0,,OT,US,US,2016,Q2,Adult
121751013,12175101,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 U, 1X/DAY",,,,,,,,,,,QD,2016,Q2,Osteomyelitis acute,,2016,Q2,3,F,20160302.0,20160411.0,20160314,20160421,EXP,,"US-SMITH AND NEPHEW, INC-2016SMT00215",SMITH AND NEPHEW,,62.0,YR,,M,Y,83.9,KG,20160421.0,,OT,US,US,2016,Q2,Adult
121751013,12175101,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 U, 1X/DAY",,,,,,,,,,,QD,2016,Q2,Papule,,2016,Q2,3,F,20160302.0,20160411.0,20160314,20160421,EXP,,"US-SMITH AND NEPHEW, INC-2016SMT00215",SMITH AND NEPHEW,,62.0,YR,,M,Y,83.9,KG,20160421.0,,OT,US,US,2016,Q2,Adult
121751013,12175101,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 U, 1X/DAY",,,,,,,,,,,QD,2016,Q2,Sinus tachycardia,,2016,Q2,3,F,20160302.0,20160411.0,20160314,20160421,EXP,,"US-SMITH AND NEPHEW, INC-2016SMT00215",SMITH AND NEPHEW,,62.0,YR,,M,Y,83.9,KG,20160421.0,,OT,US,US,2016,Q2,Adult
121751013,12175101,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 U, 1X/DAY",,,,,,,,,,,QD,2016,Q2,Streptococcal sepsis,,2016,Q2,3,F,20160302.0,20160411.0,20160314,20160421,EXP,,"US-SMITH AND NEPHEW, INC-2016SMT00215",SMITH AND NEPHEW,,62.0,YR,,M,Y,83.9,KG,20160421.0,,OT,US,US,2016,Q2,Adult
121882652,12188265,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 U, QD",,,,,,,,8.0,DF,,QD,2016,Q2,Abdominal pain,,2016,Q2,2,F,20150410.0,20160328.0,20160317,20160407,EXP,,PHHO2015US010179,SANDOZ,,54.0,YR,,M,Y,78.1,KG,20160407.0,,MD,US,US,2016,Q2,Adult
121882652,12188265,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 U, QD",,,,,,,,8.0,DF,,QD,2016,Q2,Acute kidney injury,,2016,Q2,2,F,20150410.0,20160328.0,20160317,20160407,EXP,,PHHO2015US010179,SANDOZ,,54.0,YR,,M,Y,78.1,KG,20160407.0,,MD,US,US,2016,Q2,Adult
121882652,12188265,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 U, QD",,,,,,,,8.0,DF,,QD,2016,Q2,Cephalhaematoma,,2016,Q2,2,F,20150410.0,20160328.0,20160317,20160407,EXP,,PHHO2015US010179,SANDOZ,,54.0,YR,,M,Y,78.1,KG,20160407.0,,MD,US,US,2016,Q2,Adult
121882652,12188265,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 U, QD",,,,,,,,8.0,DF,,QD,2016,Q2,Diarrhoea,,2016,Q2,2,F,20150410.0,20160328.0,20160317,20160407,EXP,,PHHO2015US010179,SANDOZ,,54.0,YR,,M,Y,78.1,KG,20160407.0,,MD,US,US,2016,Q2,Adult
121882652,12188265,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 U, QD",,,,,,,,8.0,DF,,QD,2016,Q2,Escherichia bacteraemia,,2016,Q2,2,F,20150410.0,20160328.0,20160317,20160407,EXP,,PHHO2015US010179,SANDOZ,,54.0,YR,,M,Y,78.1,KG,20160407.0,,MD,US,US,2016,Q2,Adult
121882652,12188265,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 U, QD",,,,,,,,8.0,DF,,QD,2016,Q2,Escherichia sepsis,,2016,Q2,2,F,20150410.0,20160328.0,20160317,20160407,EXP,,PHHO2015US010179,SANDOZ,,54.0,YR,,M,Y,78.1,KG,20160407.0,,MD,US,US,2016,Q2,Adult
121882652,12188265,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 U, QD",,,,,,,,8.0,DF,,QD,2016,Q2,Hyperkalaemia,,2016,Q2,2,F,20150410.0,20160328.0,20160317,20160407,EXP,,PHHO2015US010179,SANDOZ,,54.0,YR,,M,Y,78.1,KG,20160407.0,,MD,US,US,2016,Q2,Adult
121882652,12188265,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 U, QD",,,,,,,,8.0,DF,,QD,2016,Q2,Mental disorder,,2016,Q2,2,F,20150410.0,20160328.0,20160317,20160407,EXP,,PHHO2015US010179,SANDOZ,,54.0,YR,,M,Y,78.1,KG,20160407.0,,MD,US,US,2016,Q2,Adult
121882652,12188265,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 U, QD",,,,,,,,8.0,DF,,QD,2016,Q2,Metabolic acidosis,,2016,Q2,2,F,20150410.0,20160328.0,20160317,20160407,EXP,,PHHO2015US010179,SANDOZ,,54.0,YR,,M,Y,78.1,KG,20160407.0,,MD,US,US,2016,Q2,Adult
121882652,12188265,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 U, QD",,,,,,,,8.0,DF,,QD,2016,Q2,Pneumonia,,2016,Q2,2,F,20150410.0,20160328.0,20160317,20160407,EXP,,PHHO2015US010179,SANDOZ,,54.0,YR,,M,Y,78.1,KG,20160407.0,,MD,US,US,2016,Q2,Adult
121882652,12188265,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 U, QD",,,,,,,,8.0,DF,,QD,2016,Q2,Pulmonary mass,,2016,Q2,2,F,20150410.0,20160328.0,20160317,20160407,EXP,,PHHO2015US010179,SANDOZ,,54.0,YR,,M,Y,78.1,KG,20160407.0,,MD,US,US,2016,Q2,Adult
121882652,12188265,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 U, QD",,,,,,,,8.0,DF,,QD,2016,Q2,Pyelonephritis,,2016,Q2,2,F,20150410.0,20160328.0,20160317,20160407,EXP,,PHHO2015US010179,SANDOZ,,54.0,YR,,M,Y,78.1,KG,20160407.0,,MD,US,US,2016,Q2,Adult
121882652,12188265,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 U, QD",,,,,,,,8.0,DF,,QD,2016,Q2,Pyelonephritis acute,,2016,Q2,2,F,20150410.0,20160328.0,20160317,20160407,EXP,,PHHO2015US010179,SANDOZ,,54.0,YR,,M,Y,78.1,KG,20160407.0,,MD,US,US,2016,Q2,Adult
121882652,12188265,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 U, QD",,,,,,,,8.0,DF,,QD,2016,Q2,Splenomegaly,,2016,Q2,2,F,20150410.0,20160328.0,20160317,20160407,EXP,,PHHO2015US010179,SANDOZ,,54.0,YR,,M,Y,78.1,KG,20160407.0,,MD,US,US,2016,Q2,Adult
121882652,12188265,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 U, QD",,,,,,,,8.0,DF,,QD,2016,Q2,Vomiting,,2016,Q2,2,F,20150410.0,20160328.0,20160317,20160407,EXP,,PHHO2015US010179,SANDOZ,,54.0,YR,,M,Y,78.1,KG,20160407.0,,MD,US,US,2016,Q2,Adult
121976033,12197603,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2016,Q2,Anaemia,,2016,Q2,3,F,20160121.0,20160524.0,20160322,20160531,EXP,,JP-ACTELION-A-CH2016-132896,ACTELION,,75.0,YR,E,F,Y,,,20160531.0,,MD,JP,JP,2016,Q2,Elderly
121976033,12197603,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2016,Q2,Blood creatinine increased,,2016,Q2,3,F,20160121.0,20160524.0,20160322,20160531,EXP,,JP-ACTELION-A-CH2016-132896,ACTELION,,75.0,YR,E,F,Y,,,20160531.0,,MD,JP,JP,2016,Q2,Elderly
121976033,12197603,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2016,Q2,Blood urea increased,,2016,Q2,3,F,20160121.0,20160524.0,20160322,20160531,EXP,,JP-ACTELION-A-CH2016-132896,ACTELION,,75.0,YR,E,F,Y,,,20160531.0,,MD,JP,JP,2016,Q2,Elderly
121976033,12197603,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2016,Q2,Chronic kidney disease,,2016,Q2,3,F,20160121.0,20160524.0,20160322,20160531,EXP,,JP-ACTELION-A-CH2016-132896,ACTELION,,75.0,YR,E,F,Y,,,20160531.0,,MD,JP,JP,2016,Q2,Elderly
121976033,12197603,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2016,Q2,Haematocrit decreased,,2016,Q2,3,F,20160121.0,20160524.0,20160322,20160531,EXP,,JP-ACTELION-A-CH2016-132896,ACTELION,,75.0,YR,E,F,Y,,,20160531.0,,MD,JP,JP,2016,Q2,Elderly
121976033,12197603,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2016,Q2,Haemoglobin decreased,,2016,Q2,3,F,20160121.0,20160524.0,20160322,20160531,EXP,,JP-ACTELION-A-CH2016-132896,ACTELION,,75.0,YR,E,F,Y,,,20160531.0,,MD,JP,JP,2016,Q2,Elderly
121976033,12197603,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2016,Q2,Packed red blood cell transfusion,,2016,Q2,3,F,20160121.0,20160524.0,20160322,20160531,EXP,,JP-ACTELION-A-CH2016-132896,ACTELION,,75.0,YR,E,F,Y,,,20160531.0,,MD,JP,JP,2016,Q2,Elderly
121976033,12197603,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2016,Q2,Platelet count decreased,,2016,Q2,3,F,20160121.0,20160524.0,20160322,20160531,EXP,,JP-ACTELION-A-CH2016-132896,ACTELION,,75.0,YR,E,F,Y,,,20160531.0,,MD,JP,JP,2016,Q2,Elderly
121976033,12197603,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2016,Q2,Platelet transfusion,,2016,Q2,3,F,20160121.0,20160524.0,20160322,20160531,EXP,,JP-ACTELION-A-CH2016-132896,ACTELION,,75.0,YR,E,F,Y,,,20160531.0,,MD,JP,JP,2016,Q2,Elderly
121976033,12197603,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2016,Q2,Pulmonary hypertension,,2016,Q2,3,F,20160121.0,20160524.0,20160322,20160531,EXP,,JP-ACTELION-A-CH2016-132896,ACTELION,,75.0,YR,E,F,Y,,,20160531.0,,MD,JP,JP,2016,Q2,Elderly
121976033,12197603,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2016,Q2,Red blood cell count decreased,,2016,Q2,3,F,20160121.0,20160524.0,20160322,20160531,EXP,,JP-ACTELION-A-CH2016-132896,ACTELION,,75.0,YR,E,F,Y,,,20160531.0,,MD,JP,JP,2016,Q2,Elderly
121979433,12197943,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2016,Q2,Acute prerenal failure,,2016,Q2,3,F,201512.0,20160617.0,20160322,20160622,EXP,,US-JNJFOC-20160221398,JANSSEN,,59.0,YR,A,F,Y,130.18,KG,20160622.0,,OT,US,US,2016,Q2,Adult
121979433,12197943,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2016,Q2,Gastroenteritis,,2016,Q2,3,F,201512.0,20160617.0,20160322,20160622,EXP,,US-JNJFOC-20160221398,JANSSEN,,59.0,YR,A,F,Y,130.18,KG,20160622.0,,OT,US,US,2016,Q2,Adult
121979433,12197943,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2016,Q2,Metabolic acidosis,,2016,Q2,3,F,201512.0,20160617.0,20160322,20160622,EXP,,US-JNJFOC-20160221398,JANSSEN,,59.0,YR,A,F,Y,130.18,KG,20160622.0,,OT,US,US,2016,Q2,Adult
121979433,12197943,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2016,Q2,Urosepsis,,2016,Q2,3,F,201512.0,20160617.0,20160322,20160622,EXP,,US-JNJFOC-20160221398,JANSSEN,,59.0,YR,A,F,Y,130.18,KG,20160622.0,,OT,US,US,2016,Q2,Adult
122073133,12207313,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,14.0,IU,UNSPECIFIED,QD,2016,Q2,Cellulitis of male external genital organ,,2016,Q2,3,F,20151214.0,20160406.0,20160324,20160415,EXP,,JP-JNJFOC-20160321891,JANSSEN,,44.0,YR,A,M,Y,74.0,KG,20160415.0,,OT,JP,JP,2016,Q2,Adult
122104442,12210444,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q2,Acute kidney injury,,2016,Q2,2,F,,20160613.0,20160325,20160623,EXP,,US-ACTAVIS-2016-06393,WATSON,"BAIRD P, LEUNG S, HOANG H, BABALOLA O, DEVOE CE, WANCHOO R ET AL. A CASE OF ACUTE KIDNEY INJURY FROM CRYSTAL NEPHROPATHY SECONDARY TO POMALIDOMIDE AND LEVOFLOXACIN USE. J ONCOL PHARM PRACT. 2016;22(2):357-360.",76.0,YR,,F,Y,,,20160623.0,,MD,US,US,2016,Q2,Elderly
122104442,12210444,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q2,Crystal nephropathy,,2016,Q2,2,F,,20160613.0,20160325,20160623,EXP,,US-ACTAVIS-2016-06393,WATSON,"BAIRD P, LEUNG S, HOANG H, BABALOLA O, DEVOE CE, WANCHOO R ET AL. A CASE OF ACUTE KIDNEY INJURY FROM CRYSTAL NEPHROPATHY SECONDARY TO POMALIDOMIDE AND LEVOFLOXACIN USE. J ONCOL PHARM PRACT. 2016;22(2):357-360.",76.0,YR,,F,Y,,,20160623.0,,MD,US,US,2016,Q2,Elderly
122104442,12210444,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q2,Thrombocytopenia,,2016,Q2,2,F,,20160613.0,20160325,20160623,EXP,,US-ACTAVIS-2016-06393,WATSON,"BAIRD P, LEUNG S, HOANG H, BABALOLA O, DEVOE CE, WANCHOO R ET AL. A CASE OF ACUTE KIDNEY INJURY FROM CRYSTAL NEPHROPATHY SECONDARY TO POMALIDOMIDE AND LEVOFLOXACIN USE. J ONCOL PHARM PRACT. 2016;22(2):357-360.",76.0,YR,,F,Y,,,20160623.0,,MD,US,US,2016,Q2,Elderly
122113503,12211350,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Acute kidney injury,,2016,Q2,3,F,,20160613.0,20160325,20160623,EXP,,US-TEVA-646807USA,TEVA,"BAIRD P, LEUNG S, HOANG H, BABALOLA O, DEVOE CE, WANCHOO R ET AL. A CASE OF ACUTE KIDNEY INJURY FROM CRYSTAL NEPHROPATHY SECONDARY TO POMALIDOMIDE AND LEVOFLOXACIN USE.JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2016; 22(2): 357-360",76.0,YR,,F,Y,,,20160624.0,,MD,US,US,2016,Q2,Elderly
122113503,12211350,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Crystal nephropathy,,2016,Q2,3,F,,20160613.0,20160325,20160623,EXP,,US-TEVA-646807USA,TEVA,"BAIRD P, LEUNG S, HOANG H, BABALOLA O, DEVOE CE, WANCHOO R ET AL. A CASE OF ACUTE KIDNEY INJURY FROM CRYSTAL NEPHROPATHY SECONDARY TO POMALIDOMIDE AND LEVOFLOXACIN USE.JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2016; 22(2): 357-360",76.0,YR,,F,Y,,,20160624.0,,MD,US,US,2016,Q2,Elderly
122113503,12211350,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Thrombocytopenia,,2016,Q2,3,F,,20160613.0,20160325,20160623,EXP,,US-TEVA-646807USA,TEVA,"BAIRD P, LEUNG S, HOANG H, BABALOLA O, DEVOE CE, WANCHOO R ET AL. A CASE OF ACUTE KIDNEY INJURY FROM CRYSTAL NEPHROPATHY SECONDARY TO POMALIDOMIDE AND LEVOFLOXACIN USE.JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2016; 22(2): 357-360",76.0,YR,,F,Y,,,20160624.0,,MD,US,US,2016,Q2,Elderly
122119393,12211939,4,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,20.0,IU,,,2016,Q2,Acute kidney injury,,2016,Q2,3,F,20151019.0,20160601.0,20160325,20160607,EXP,,US-BIOGEN-2015BI160126,BIOGEN,,39.0,YR,,F,Y,69.92,KG,20160607.0,,MD,US,US,2016,Q2,Adult
122119393,12211939,4,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,20.0,IU,,,2016,Q2,Anaemia,,2016,Q2,3,F,20151019.0,20160601.0,20160325,20160607,EXP,,US-BIOGEN-2015BI160126,BIOGEN,,39.0,YR,,F,Y,69.92,KG,20160607.0,,MD,US,US,2016,Q2,Adult
122119393,12211939,4,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,20.0,IU,,,2016,Q2,Diabetic ketoacidosis,,2016,Q2,3,F,20151019.0,20160601.0,20160325,20160607,EXP,,US-BIOGEN-2015BI160126,BIOGEN,,39.0,YR,,F,Y,69.92,KG,20160607.0,,MD,US,US,2016,Q2,Adult
122119393,12211939,4,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,20.0,IU,,,2016,Q2,Hypernatraemia,,2016,Q2,3,F,20151019.0,20160601.0,20160325,20160607,EXP,,US-BIOGEN-2015BI160126,BIOGEN,,39.0,YR,,F,Y,69.92,KG,20160607.0,,MD,US,US,2016,Q2,Adult
122119393,12211939,4,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,20.0,IU,,,2016,Q2,Hypophosphataemia,,2016,Q2,3,F,20151019.0,20160601.0,20160325,20160607,EXP,,US-BIOGEN-2015BI160126,BIOGEN,,39.0,YR,,F,Y,69.92,KG,20160607.0,,MD,US,US,2016,Q2,Adult
122119393,12211939,4,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,20.0,IU,,,2016,Q2,Metabolic encephalopathy,,2016,Q2,3,F,20151019.0,20160601.0,20160325,20160607,EXP,,US-BIOGEN-2015BI160126,BIOGEN,,39.0,YR,,F,Y,69.92,KG,20160607.0,,MD,US,US,2016,Q2,Adult
122119393,12211939,4,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,20.0,IU,,,2016,Q2,Sepsis,,2016,Q2,3,F,20151019.0,20160601.0,20160325,20160607,EXP,,US-BIOGEN-2015BI160126,BIOGEN,,39.0,YR,,F,Y,69.92,KG,20160607.0,,MD,US,US,2016,Q2,Adult
122119393,12211939,4,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,20.0,IU,,,2016,Q2,Urinary tract infection,,2016,Q2,3,F,20151019.0,20160601.0,20160325,20160607,EXP,,US-BIOGEN-2015BI160126,BIOGEN,,39.0,YR,,F,Y,69.92,KG,20160607.0,,MD,US,US,2016,Q2,Adult
122152582,12215258,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,24 U AT NIGHT DOSE:24 UNIT(S),,,,, UNKNOWN,,21081.0,,,,QD,2016,Q2,Diabetic ketoacidosis,,2016,Q2,2,F,2015.0,20160510.0,20160328,20160519,EXP,,GB-SA-2016SA056443,AVENTIS,,21.0,YR,A,M,Y,,,20160519.0,,MD,GB,GB,2016,Q2,Youth
122155933,12215593,4,C,INSULINUM GLARGINE,,2,Subcutaneous,,,,,,,,,,,,,2016,Q2,Angina pectoris,,2016,Q2,3,F,20160226.0,20160429.0,20160328,20160614,EXP,,PL-ASTRAZENECA-2016SE32921,ASTRAZENECA,,23893.0,DY,,M,Y,,,20160614.0,,MD,PL,PL,2016,Q2,Elderly
122301232,12230123,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2016,Q2,Gastrointestinal haemorrhage,,2016,Q2,2,F,20150213.0,20160324.0,20160401,20160507,PER,,US-JNJFOC-20160310943,JANSSEN,,58.0,YR,A,F,Y,,,20160507.0,,CN,US,US,2016,Q2,Adult
122319421,12231942,10,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q2,Gastrointestinal haemorrhage,,2016,Q2,1,I,20151103.0,20160324.0,20160401,20160401,EXP,,US-CELGENE-USA-2016036497,CELGENE,,62.0,YR,,F,Y,94.7,KG,20160401.0,,OT,US,US,2016,Q2,Adult
122319421,12231942,10,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q2,Klebsiella sepsis,,2016,Q2,1,I,20151103.0,20160324.0,20160401,20160401,EXP,,US-CELGENE-USA-2016036497,CELGENE,,62.0,YR,,F,Y,94.7,KG,20160401.0,,OT,US,US,2016,Q2,Adult
122327103,12232710,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"42 IU, QD",,,,,,,,42.0,IU,,QD,2016,Q2,Cough,,2016,Q2,3,F,20160229.0,20160422.0,20160401,20160429,EXP,,US-BIOMARINAP-US-2016-109363,BIOMARIN,,60.0,YR,,M,Y,,,20160429.0,,CN,US,US,2016,Q2,Adult
122327103,12232710,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"42 IU, QD",,,,,,,,42.0,IU,,QD,2016,Q2,Musculoskeletal chest pain,,2016,Q2,3,F,20160229.0,20160422.0,20160401,20160429,EXP,,US-BIOMARINAP-US-2016-109363,BIOMARIN,,60.0,YR,,M,Y,,,20160429.0,,CN,US,US,2016,Q2,Adult
122327103,12232710,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"42 IU, QD",,,,,,,,42.0,IU,,QD,2016,Q2,Upper respiratory tract infection,,2016,Q2,3,F,20160229.0,20160422.0,20160401,20160429,EXP,,US-BIOMARINAP-US-2016-109363,BIOMARIN,,60.0,YR,,M,Y,,,20160429.0,,CN,US,US,2016,Q2,Adult
122327951,12232795,8,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q2,Agranulocytosis,Agranulocytosis,2016,Q2,1,I,,20150617.0,20160402,20160402,PER,,US-LUPIN PHARMACEUTICALS INC.-2015-01903,LUPIN,"ISKANDAR J, VANCE J, KABLINGER A, KAVURU B. TRANSIENT AGRANULOCYTOSIS ASSOCIATED WITH ZIPRASIDONE IN A 45-YEAR-OLD MAN ON HEMODIALYSIS. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY. 2015 JUN;35 (3):347-348.",45.0,YR,,M,Y,,,20160402.0,,MD,US,US,2016,Q2,Adult
122339921,12233992,8,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,9 IU ON EVENING,,,,,,,,,,,,2016,Q2,Hyperammonaemic encephalopathy,,2016,Q2,1,I,,20160321.0,20160404,20160404,EXP,FR-MLMSERVICE-20160322-0214027-1,FR-LUPIN PHARMACEUTICALS INC.-2016-01246,LUPIN,"MICHEL B, WOLFHUGEL E, JAVELOT H, ROSER M, KOBAYASHI H. A CASE OF HYPERAMMONIEMIC ENCEPHALOPATHY: POSSIBLE ROLE OF VALPROIC ACID. THE HOSPITAL PHARMACIST AND CLINICAL. 2016;51:59-62.",69.0,YR,,M,Y,66.0,KG,20160404.0,,OT,FR,FR,2016,Q2,Elderly
122362502,12236250,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,36.0,IU,,QD,2016,Q2,Pneumonia,,2016,Q2,2,F,201603.0,20160419.0,20160404,20160422,EXP,,CA-ABBVIE-16P-028-1593146-00,ABBVIE,,70.0,YR,,M,Y,73.0,KG,20160422.0,,MD,COUNTRY NOT SPECIFIED,CA,2016,Q2,Elderly
122362502,12236250,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,36.0,IU,,QD,2016,Q2,Psoriasis,,2016,Q2,2,F,201603.0,20160419.0,20160404,20160422,EXP,,CA-ABBVIE-16P-028-1593146-00,ABBVIE,,70.0,YR,,M,Y,73.0,KG,20160422.0,,MD,COUNTRY NOT SPECIFIED,CA,2016,Q2,Elderly
122362502,12236250,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,36.0,IU,,QD,2016,Q2,Unevaluable event,,2016,Q2,2,F,201603.0,20160419.0,20160404,20160422,EXP,,CA-ABBVIE-16P-028-1593146-00,ABBVIE,,70.0,YR,,M,Y,73.0,KG,20160422.0,,MD,COUNTRY NOT SPECIFIED,CA,2016,Q2,Elderly
122366231,12236623,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,,2016,Q2,Ketoacidosis,,2016,Q2,1,I,2015.0,20160317.0,20160405,20160405,PER,,US-JNJFOC-20160318576,JANSSEN,,23.0,YR,A,F,Y,,,20160405.0,,PH,US,US,2016,Q2,Youth
122366231,12236623,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,,2016,Q2,Off label use,,2016,Q2,1,I,2015.0,20160317.0,20160405,20160405,PER,,US-JNJFOC-20160318576,JANSSEN,,23.0,YR,A,F,Y,,,20160405.0,,PH,US,US,2016,Q2,Youth
122366231,12236623,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,,2016,Q2,Product use issue,,2016,Q2,1,I,2015.0,20160317.0,20160405,20160405,PER,,US-JNJFOC-20160318576,JANSSEN,,23.0,YR,A,F,Y,,,20160405.0,,PH,US,US,2016,Q2,Youth
122366231,12236623,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,THE DOSE WAS DECREASED 30-10-8-2 (UNITS UNSPECIFIED).,,,,,,,,,,INJECTION,,2016,Q2,Ketoacidosis,,2016,Q2,1,I,2015.0,20160317.0,20160405,20160405,PER,,US-JNJFOC-20160318576,JANSSEN,,23.0,YR,A,F,Y,,,20160405.0,,PH,US,US,2016,Q2,Youth
122366231,12236623,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,THE DOSE WAS DECREASED 30-10-8-2 (UNITS UNSPECIFIED).,,,,,,,,,,INJECTION,,2016,Q2,Off label use,,2016,Q2,1,I,2015.0,20160317.0,20160405,20160405,PER,,US-JNJFOC-20160318576,JANSSEN,,23.0,YR,A,F,Y,,,20160405.0,,PH,US,US,2016,Q2,Youth
122366231,12236623,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,THE DOSE WAS DECREASED 30-10-8-2 (UNITS UNSPECIFIED).,,,,,,,,,,INJECTION,,2016,Q2,Product use issue,,2016,Q2,1,I,2015.0,20160317.0,20160405,20160405,PER,,US-JNJFOC-20160318576,JANSSEN,,23.0,YR,A,F,Y,,,20160405.0,,PH,US,US,2016,Q2,Youth
122403031,12240303,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q2,Gastrointestinal haemorrhage,,2016,Q2,1,I,20150213.0,20160304.0,20160405,20160405,EXP,,US-BAYER-2016-048864,BAYER,,58.0,YR,A,F,Y,,,20160405.0,,CN,US,US,2016,Q2,Adult
122434402,12243440,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"INJECT 4 UNITS INTO SKIN, EVERY EVENING",,,,U,,,,,,,,2016,Q2,Infective pulmonary exacerbation of cystic fibrosis,,2016,Q2,2,F,20160302.0,20160520.0,20160406,20160525,EXP,,US-VERTEX PHARMACEUTICALS-2016-002213,VERTEX,,18.0,YR,,F,Y,,,20160525.0,,OT,US,US,2016,Q2,Youth
122434402,12243440,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"INJECT 4 UNITS INTO SKIN, EVERY EVENING",,,,U,,,,,,,,2016,Q2,Nasopharyngitis,,2016,Q2,2,F,20160302.0,20160520.0,20160406,20160525,EXP,,US-VERTEX PHARMACEUTICALS-2016-002213,VERTEX,,18.0,YR,,F,Y,,,20160525.0,,OT,US,US,2016,Q2,Youth
122461821,12246182,6,C,insulin glargine,INSULIN GLARGINE,1,,"20 IU, QD",,,,,,,,20.0,IU,,QD,2016,Q2,Abdominal distension,,2016,Q2,1,I,,20160328.0,20160407,20160407,EXP,,TR-BAYER-2016-060067,BAYER,"SA? S, KARAKAS, O, SAHIN AB, OZDEMIR B. CESSATION OF ULTRAFILTRATION THERAPY BY TREATING WITH TOLVAPTAN IN A PATIENT WITH HYPERVOLEMIC HYPONATREMIC HEART FAILURE. TURKISH NEPHROLOGY, DIALYSIS AND TRANSPLANTATION JOURNAL. 2016;():1-3",60.0,YR,A,M,Y,,,20160407.0,,OT,TR,TR,2016,Q2,Adult
122461821,12246182,6,C,insulin glargine,INSULIN GLARGINE,1,,"20 IU, QD",,,,,,,,20.0,IU,,QD,2016,Q2,Ascites,,2016,Q2,1,I,,20160328.0,20160407,20160407,EXP,,TR-BAYER-2016-060067,BAYER,"SA? S, KARAKAS, O, SAHIN AB, OZDEMIR B. CESSATION OF ULTRAFILTRATION THERAPY BY TREATING WITH TOLVAPTAN IN A PATIENT WITH HYPERVOLEMIC HYPONATREMIC HEART FAILURE. TURKISH NEPHROLOGY, DIALYSIS AND TRANSPLANTATION JOURNAL. 2016;():1-3",60.0,YR,A,M,Y,,,20160407.0,,OT,TR,TR,2016,Q2,Adult
122461821,12246182,6,C,insulin glargine,INSULIN GLARGINE,1,,"20 IU, QD",,,,,,,,20.0,IU,,QD,2016,Q2,Cardiac failure,,2016,Q2,1,I,,20160328.0,20160407,20160407,EXP,,TR-BAYER-2016-060067,BAYER,"SA? S, KARAKAS, O, SAHIN AB, OZDEMIR B. CESSATION OF ULTRAFILTRATION THERAPY BY TREATING WITH TOLVAPTAN IN A PATIENT WITH HYPERVOLEMIC HYPONATREMIC HEART FAILURE. TURKISH NEPHROLOGY, DIALYSIS AND TRANSPLANTATION JOURNAL. 2016;():1-3",60.0,YR,A,M,Y,,,20160407.0,,OT,TR,TR,2016,Q2,Adult
122461821,12246182,6,C,insulin glargine,INSULIN GLARGINE,1,,"20 IU, QD",,,,,,,,20.0,IU,,QD,2016,Q2,Device related infection,,2016,Q2,1,I,,20160328.0,20160407,20160407,EXP,,TR-BAYER-2016-060067,BAYER,"SA? S, KARAKAS, O, SAHIN AB, OZDEMIR B. CESSATION OF ULTRAFILTRATION THERAPY BY TREATING WITH TOLVAPTAN IN A PATIENT WITH HYPERVOLEMIC HYPONATREMIC HEART FAILURE. TURKISH NEPHROLOGY, DIALYSIS AND TRANSPLANTATION JOURNAL. 2016;():1-3",60.0,YR,A,M,Y,,,20160407.0,,OT,TR,TR,2016,Q2,Adult
122461821,12246182,6,C,insulin glargine,INSULIN GLARGINE,1,,"20 IU, QD",,,,,,,,20.0,IU,,QD,2016,Q2,Dyspnoea exertional,,2016,Q2,1,I,,20160328.0,20160407,20160407,EXP,,TR-BAYER-2016-060067,BAYER,"SA? S, KARAKAS, O, SAHIN AB, OZDEMIR B. CESSATION OF ULTRAFILTRATION THERAPY BY TREATING WITH TOLVAPTAN IN A PATIENT WITH HYPERVOLEMIC HYPONATREMIC HEART FAILURE. TURKISH NEPHROLOGY, DIALYSIS AND TRANSPLANTATION JOURNAL. 2016;():1-3",60.0,YR,A,M,Y,,,20160407.0,,OT,TR,TR,2016,Q2,Adult
122461821,12246182,6,C,insulin glargine,INSULIN GLARGINE,1,,"20 IU, QD",,,,,,,,20.0,IU,,QD,2016,Q2,Hyponatraemia,,2016,Q2,1,I,,20160328.0,20160407,20160407,EXP,,TR-BAYER-2016-060067,BAYER,"SA? S, KARAKAS, O, SAHIN AB, OZDEMIR B. CESSATION OF ULTRAFILTRATION THERAPY BY TREATING WITH TOLVAPTAN IN A PATIENT WITH HYPERVOLEMIC HYPONATREMIC HEART FAILURE. TURKISH NEPHROLOGY, DIALYSIS AND TRANSPLANTATION JOURNAL. 2016;():1-3",60.0,YR,A,M,Y,,,20160407.0,,OT,TR,TR,2016,Q2,Adult
122461821,12246182,6,C,insulin glargine,INSULIN GLARGINE,1,,"20 IU, QD",,,,,,,,20.0,IU,,QD,2016,Q2,Oedema peripheral,,2016,Q2,1,I,,20160328.0,20160407,20160407,EXP,,TR-BAYER-2016-060067,BAYER,"SA? S, KARAKAS, O, SAHIN AB, OZDEMIR B. CESSATION OF ULTRAFILTRATION THERAPY BY TREATING WITH TOLVAPTAN IN A PATIENT WITH HYPERVOLEMIC HYPONATREMIC HEART FAILURE. TURKISH NEPHROLOGY, DIALYSIS AND TRANSPLANTATION JOURNAL. 2016;():1-3",60.0,YR,A,M,Y,,,20160407.0,,OT,TR,TR,2016,Q2,Adult
122461821,12246182,6,C,insulin glargine,INSULIN GLARGINE,1,,"20 IU, QD",,,,,,,,20.0,IU,,QD,2016,Q2,Orthopnoea,,2016,Q2,1,I,,20160328.0,20160407,20160407,EXP,,TR-BAYER-2016-060067,BAYER,"SA? S, KARAKAS, O, SAHIN AB, OZDEMIR B. CESSATION OF ULTRAFILTRATION THERAPY BY TREATING WITH TOLVAPTAN IN A PATIENT WITH HYPERVOLEMIC HYPONATREMIC HEART FAILURE. TURKISH NEPHROLOGY, DIALYSIS AND TRANSPLANTATION JOURNAL. 2016;():1-3",60.0,YR,A,M,Y,,,20160407.0,,OT,TR,TR,2016,Q2,Adult
122461821,12246182,6,C,insulin glargine,INSULIN GLARGINE,1,,"20 IU, QD",,,,,,,,20.0,IU,,QD,2016,Q2,Pleural effusion,,2016,Q2,1,I,,20160328.0,20160407,20160407,EXP,,TR-BAYER-2016-060067,BAYER,"SA? S, KARAKAS, O, SAHIN AB, OZDEMIR B. CESSATION OF ULTRAFILTRATION THERAPY BY TREATING WITH TOLVAPTAN IN A PATIENT WITH HYPERVOLEMIC HYPONATREMIC HEART FAILURE. TURKISH NEPHROLOGY, DIALYSIS AND TRANSPLANTATION JOURNAL. 2016;():1-3",60.0,YR,A,M,Y,,,20160407.0,,OT,TR,TR,2016,Q2,Adult
122478365,12247836,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Cutaneous,DOSAGE IS UNCERTAIN.,,,,,,,,,,,,2016,Q2,Altered state of consciousness,,2016,Q2,5,F,20160320.0,20160506.0,20160408,20160513,EXP,,JP-ROCHE-1735573,ROCHE,,71.0,YR,,M,Y,54.0,KG,20160513.0,,MD,JP,JP,2016,Q2,Elderly
122478365,12247836,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Cutaneous,DOSAGE IS UNCERTAIN.,,,,,,,,,,,,2016,Q2,Dehydration,,2016,Q2,5,F,20160320.0,20160506.0,20160408,20160513,EXP,,JP-ROCHE-1735573,ROCHE,,71.0,YR,,M,Y,54.0,KG,20160513.0,,MD,JP,JP,2016,Q2,Elderly
122478365,12247836,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Cutaneous,DOSAGE IS UNCERTAIN.,,,,,,,,,,,,2016,Q2,Diarrhoea,,2016,Q2,5,F,20160320.0,20160506.0,20160408,20160513,EXP,,JP-ROCHE-1735573,ROCHE,,71.0,YR,,M,Y,54.0,KG,20160513.0,,MD,JP,JP,2016,Q2,Elderly
122478365,12247836,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Cutaneous,DOSAGE IS UNCERTAIN.,,,,,,,,,,,,2016,Q2,Gastroenteritis,,2016,Q2,5,F,20160320.0,20160506.0,20160408,20160513,EXP,,JP-ROCHE-1735573,ROCHE,,71.0,YR,,M,Y,54.0,KG,20160513.0,,MD,JP,JP,2016,Q2,Elderly
122478365,12247836,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Cutaneous,DOSAGE IS UNCERTAIN.,,,,,,,,,,,,2016,Q2,Hepatic failure,,2016,Q2,5,F,20160320.0,20160506.0,20160408,20160513,EXP,,JP-ROCHE-1735573,ROCHE,,71.0,YR,,M,Y,54.0,KG,20160513.0,,MD,JP,JP,2016,Q2,Elderly
122478365,12247836,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Cutaneous,DOSAGE IS UNCERTAIN.,,,,,,,,,,,,2016,Q2,Hyperosmolar hyperglycaemic state,,2016,Q2,5,F,20160320.0,20160506.0,20160408,20160513,EXP,,JP-ROCHE-1735573,ROCHE,,71.0,YR,,M,Y,54.0,KG,20160513.0,,MD,JP,JP,2016,Q2,Elderly
122495831,12249583,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Abdominal pain,,2016,Q2,1,I,,,20160407,20160407,DIR,,,,,57.0,YR,,F,N,122.7,KG,20160406.0,N,CN,US,,2016,Q2,Adult
122495831,12249583,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Diarrhoea,,2016,Q2,1,I,,,20160407,20160407,DIR,,,,,57.0,YR,,F,N,122.7,KG,20160406.0,N,CN,US,,2016,Q2,Adult
122495831,12249583,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Nausea,,2016,Q2,1,I,,,20160407,20160407,DIR,,,,,57.0,YR,,F,N,122.7,KG,20160406.0,N,CN,US,,2016,Q2,Adult
122495831,12249583,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Thrombocytopenia,,2016,Q2,1,I,,,20160407,20160407,DIR,,,,,57.0,YR,,F,N,122.7,KG,20160406.0,N,CN,US,,2016,Q2,Adult
122495831,12249583,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Vomiting,,2016,Q2,1,I,,,20160407,20160407,DIR,,,,,57.0,YR,,F,N,122.7,KG,20160406.0,N,CN,US,,2016,Q2,Adult
122505031,12250503,7,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Bladder cancer,,2016,Q2,1,I,20131001.0,20131024.0,20160408,20160408,EXP,,US-ABBVIE-13P-163-1162131-00,ABBVIE,,85.0,YR,,M,Y,96.0,KG,20160408.0,,MD,COUNTRY NOT SPECIFIED,US,2016,Q2,Elderly
122551281,12255128,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 UNK, NIGHTLY",,,,,,,,,,,,2016,Q2,Aspergillus infection,,2016,Q2,1,I,,20160405.0,20160411,20160411,EXP,,PHHY2016US045597,SANDOZ,HUI J. DOSE-INDEPENDENT CONFUSION INDUCED BY VORICONAZOLE IN A PATIENT WITH ASIAN ANCESTRY AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT. JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2016;22(1):175-8,71.0,YR,,M,Y,,,20160412.0,,OT,US,US,2016,Q2,Elderly
122551281,12255128,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 UNK, NIGHTLY",,,,,,,,,,,,2016,Q2,Pleural effusion,,2016,Q2,1,I,,20160405.0,20160411,20160411,EXP,,PHHY2016US045597,SANDOZ,HUI J. DOSE-INDEPENDENT CONFUSION INDUCED BY VORICONAZOLE IN A PATIENT WITH ASIAN ANCESTRY AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT. JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2016;22(1):175-8,71.0,YR,,M,Y,,,20160412.0,,OT,US,US,2016,Q2,Elderly
122551281,12255128,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 UNK, NIGHTLY",,,,,,,,,,,,2016,Q2,Pneumonia,,2016,Q2,1,I,,20160405.0,20160411,20160411,EXP,,PHHY2016US045597,SANDOZ,HUI J. DOSE-INDEPENDENT CONFUSION INDUCED BY VORICONAZOLE IN A PATIENT WITH ASIAN ANCESTRY AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT. JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2016;22(1):175-8,71.0,YR,,M,Y,,,20160412.0,,OT,US,US,2016,Q2,Elderly
122571671,12257167,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q2,Epstein-Barr virus associated lymphoproliferative disorder,,2016,Q2,1,I,20110923.0,20110928.0,20160412,20160412,EXP,,JP-SA-THYM-1002816,AVENTIS,,66.0,YR,A,F,Y,63.0,KG,20160412.0,,MD,JP,JP,2016,Q2,Elderly
122578472,12257847,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,"(100 UNIT/ML) 3 ML, UNK",,,,,,,,3.0,ML,,,2016,Q2,Bone pain,,2016,Q2,2,F,20130625.0,20160525.0,20160412,20160530,EXP,,NL-AMGEN-NLDSL2016044506,AMGEN,,81.0,YR,E,F,Y,,,20160530.0,,OT,NL,NL,2016,Q2,Elderly
122578472,12257847,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,"(100 UNIT/ML) 3 ML, UNK",,,,,,,,3.0,ML,,,2016,Q2,Fall,,2016,Q2,2,F,20130625.0,20160525.0,20160412,20160530,EXP,,NL-AMGEN-NLDSL2016044506,AMGEN,,81.0,YR,E,F,Y,,,20160530.0,,OT,NL,NL,2016,Q2,Elderly
122578472,12257847,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,"(100 UNIT/ML) 3 ML, UNK",,,,,,,,3.0,ML,,,2016,Q2,Injection site haematoma,,2016,Q2,2,F,20130625.0,20160525.0,20160412,20160530,EXP,,NL-AMGEN-NLDSL2016044506,AMGEN,,81.0,YR,E,F,Y,,,20160530.0,,OT,NL,NL,2016,Q2,Elderly
122578472,12257847,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,"(100 UNIT/ML) 3 ML, UNK",,,,,,,,3.0,ML,,,2016,Q2,Paraesthesia,,2016,Q2,2,F,20130625.0,20160525.0,20160412,20160530,EXP,,NL-AMGEN-NLDSL2016044506,AMGEN,,81.0,YR,E,F,Y,,,20160530.0,,OT,NL,NL,2016,Q2,Elderly
122578472,12257847,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,"(100 UNIT/ML) 3 ML, UNK",,,,,,,,3.0,ML,,,2016,Q2,Pulmonary embolism,,2016,Q2,2,F,20130625.0,20160525.0,20160412,20160530,EXP,,NL-AMGEN-NLDSL2016044506,AMGEN,,81.0,YR,E,F,Y,,,20160530.0,,OT,NL,NL,2016,Q2,Elderly
122626951,12262695,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,INJECTION,,2016,Q2,Hypernatraemia,,2016,Q2,1,I,20151203.0,20160329.0,20160413,20160413,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-025235,BRISTOL MYERS SQUIBB,,73.0,YR,,M,Y,65.0,KG,20160413.0,,CN,JP,JP,2016,Q2,Elderly
122664721,12266472,3,C,INSULIN GLARGINE NOVONORDISK,,2,Subcutaneous,UNK,,,,U,,,,,,,,2016,Q2,Leg amputation,,2016,Q2,1,I,2015.0,20160412.0,20160414,20160414,EXP,,US-ALLERGAN-1653699US,ALLERGAN,,56.0,YR,,M,Y,108.84,KG,20160413.0,,CN,COUNTRY NOT SPECIFIED,US,2016,Q2,Adult
122664721,12266472,3,C,INSULIN GLARGINE NOVONORDISK,,2,Subcutaneous,UNK,,,,U,,,,,,,,2016,Q2,Osteomyelitis,,2016,Q2,1,I,2015.0,20160412.0,20160414,20160414,EXP,,US-ALLERGAN-1653699US,ALLERGAN,,56.0,YR,,M,Y,108.84,KG,20160413.0,,CN,COUNTRY NOT SPECIFIED,US,2016,Q2,Adult
122671461,12267146,6,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2016,Q2,Acute myocardial infarction,,2016,Q2,1,I,20160405.0,20160406.0,20160414,20160414,EXP,,CO-BAXTER-2016BAX018552,BAXTER,,79.0,YR,,F,Y,81.7,KG,20160414.0,,OT,CO,CO,2016,Q2,Elderly
122671461,12267146,6,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2016,Q2,Dehydration,,2016,Q2,1,I,20160405.0,20160406.0,20160414,20160414,EXP,,CO-BAXTER-2016BAX018552,BAXTER,,79.0,YR,,F,Y,81.7,KG,20160414.0,,OT,CO,CO,2016,Q2,Elderly
122671461,12267146,6,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2016,Q2,Diarrhoea,,2016,Q2,1,I,20160405.0,20160406.0,20160414,20160414,EXP,,CO-BAXTER-2016BAX018552,BAXTER,,79.0,YR,,F,Y,81.7,KG,20160414.0,,OT,CO,CO,2016,Q2,Elderly
122673823,12267382,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"20 IU, DAILY",,,,,,,,20.0,IU,,QD,2016,Q2,Haemolytic anaemia,,2016,Q2,3,F,,20160419.0,20160414,20160506,EXP,,US-ACTAVIS-2016-07937,WATSON,"RUGGIERO NA, KISH TD, LEE ML. METFORMIN-INDUCED HEMOLYTIC ANEMIA IN A PATIENT WITH GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY. AM J THER. 2016;23(2):E575-E578.",53.0,YR,,M,Y,,,20160506.0,,PH,US,US,2016,Q2,Adult
122691352,12269135,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"FORMULATION: INJECTION,DOSE PER APPLICATION AND DAILY DOSE:25",,,,,,,,,,,QD,2016,Q2,Acute kidney injury,,2016,Q2,2,F,20160122.0,20160601.0,20160414,20160607,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-22438BP",BOEHRINGER INGELHEIM,,59.0,YR,,F,Y,163.0,KG,20160607.0,,PH,US,US,2016,Q2,Adult
122691352,12269135,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"FORMULATION: INJECTION,DOSE PER APPLICATION AND DAILY DOSE:25",,,,,,,,,,,QD,2016,Q2,Cardiorenal syndrome,,2016,Q2,2,F,20160122.0,20160601.0,20160414,20160607,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-22438BP",BOEHRINGER INGELHEIM,,59.0,YR,,F,Y,163.0,KG,20160607.0,,PH,US,US,2016,Q2,Adult
122691352,12269135,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"FORMULATION: INJECTION,DOSE PER APPLICATION AND DAILY DOSE:25",,,,,,,,,,,QD,2016,Q2,Haemorrhage,,2016,Q2,2,F,20160122.0,20160601.0,20160414,20160607,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-22438BP",BOEHRINGER INGELHEIM,,59.0,YR,,F,Y,163.0,KG,20160607.0,,PH,US,US,2016,Q2,Adult
122691352,12269135,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"FORMULATION: INJECTION, DOSE PER APPLICATION AND DAILY DOSE:30",,,,,,,,,,,QD,2016,Q2,Acute kidney injury,,2016,Q2,2,F,20160122.0,20160601.0,20160414,20160607,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-22438BP",BOEHRINGER INGELHEIM,,59.0,YR,,F,Y,163.0,KG,20160607.0,,PH,US,US,2016,Q2,Adult
122691352,12269135,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"FORMULATION: INJECTION, DOSE PER APPLICATION AND DAILY DOSE:30",,,,,,,,,,,QD,2016,Q2,Cardiorenal syndrome,,2016,Q2,2,F,20160122.0,20160601.0,20160414,20160607,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-22438BP",BOEHRINGER INGELHEIM,,59.0,YR,,F,Y,163.0,KG,20160607.0,,PH,US,US,2016,Q2,Adult
122691352,12269135,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"FORMULATION: INJECTION, DOSE PER APPLICATION AND DAILY DOSE:30",,,,,,,,,,,QD,2016,Q2,Haemorrhage,,2016,Q2,2,F,20160122.0,20160601.0,20160414,20160607,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-22438BP",BOEHRINGER INGELHEIM,,59.0,YR,,F,Y,163.0,KG,20160607.0,,PH,US,US,2016,Q2,Adult
122697402,12269740,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Thrombosis,,2016,Q2,2,F,20160324.0,20160420.0,20160414,20160425,EXP,,US-GILEAD-2016-0208746,GILEAD,,66.0,YR,E,F,Y,93.0,KG,20160425.0,,CN,US,US,2016,Q2,Elderly
122699641,12269964,5,C,GLARGINE INSULIN,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Crystal nephropathy,,2016,Q2,1,I,20160404.0,20160404.0,20160415,20160415,EXP,,US-JUBILANT GENERICS LIMITED-1050595,JUBILANT,"JOURNAL: J ONCOL PHARM PRACT (DOI: 10.1177/1078155214568581)?AUTHOR: BAIRD P, LEUNG S, HOANG H, ET AL.?TITLE: A CASE OF ACUTE KIDNEY INJURY FROM CRYSTAL NEPHROPATHY SECONDARY TO POMALIDOMIDE AND LEVOFLOXACIN USE?VOLUME: 22(2) YEAR: 2016 PAGES: 357-360",76.0,YR,,F,Y,,,20160415.0,,OT,US,US,2016,Q2,Elderly
122699641,12269964,5,C,GLARGINE INSULIN,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Renal tubular necrosis,,2016,Q2,1,I,20160404.0,20160404.0,20160415,20160415,EXP,,US-JUBILANT GENERICS LIMITED-1050595,JUBILANT,"JOURNAL: J ONCOL PHARM PRACT (DOI: 10.1177/1078155214568581)?AUTHOR: BAIRD P, LEUNG S, HOANG H, ET AL.?TITLE: A CASE OF ACUTE KIDNEY INJURY FROM CRYSTAL NEPHROPATHY SECONDARY TO POMALIDOMIDE AND LEVOFLOXACIN USE?VOLUME: 22(2) YEAR: 2016 PAGES: 357-360",76.0,YR,,F,Y,,,20160415.0,,OT,US,US,2016,Q2,Elderly
122709261,12270926,12,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q2,Hypoxia,,2016,Q2,1,I,20150727.0,20150729.0,20160415,20160415,EXP,,US-CELGENEUS-USA-2015080052,CELGENE,,74.0,YR,,M,Y,76.2,KG,20160415.0,,OT,US,US,2016,Q2,Elderly
122709261,12270926,12,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q2,Myocardial infarction,,2016,Q2,1,I,20150727.0,20150729.0,20160415,20160415,EXP,,US-CELGENEUS-USA-2015080052,CELGENE,,74.0,YR,,M,Y,76.2,KG,20160415.0,,OT,US,US,2016,Q2,Elderly
122709261,12270926,12,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q2,Pneumonia,,2016,Q2,1,I,20150727.0,20150729.0,20160415,20160415,EXP,,US-CELGENEUS-USA-2015080052,CELGENE,,74.0,YR,,M,Y,76.2,KG,20160415.0,,OT,US,US,2016,Q2,Elderly
122737311,12273731,15,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Urinary retention,,2016,Q2,1,I,,20150618.0,20160415,20160415,PER,,ADR-2015-01197,MEDTRONIC,,84.0,YR,,M,Y,,,20160415.0,,MD,US,US,2016,Q2,Elderly
122738181,12273818,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"INJECTABLE SOLUTION, ACCORDING TO PRESCRIPTION",,,,,,,,,,,,2016,Q2,Acute respiratory failure,,2016,Q2,1,I,20151005.0,20151203.0,20160415,20160415,EXP,,"IT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2015-BI-68277IT",BOEHRINGER INGELHEIM,,67.0,YR,,M,Y,105.0,KG,20160416.0,,MD,COUNTRY NOT SPECIFIED,IT,2016,Q2,Elderly
122756202,12275620,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q2,Haemolytic anaemia,,2016,Q2,2,F,,20160419.0,20160418,20160428,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-028867,BRISTOL MYERS SQUIBB,,53.0,YR,,M,Y,,,20160428.0,,CN,GB,US,2016,Q2,Adult
122759813,12275981,31,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Dyspnoea,,2016,Q2,3,F,20160321.0,20160503.0,20160418,20160510,EXP,,US-GILEAD-2016-0207391,GILEAD,,63.0,YR,A,F,Y,104.0,KG,20160510.0,,CN,US,US,2016,Q2,Adult
122759813,12275981,31,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Off label use,,2016,Q2,3,F,20160321.0,20160503.0,20160418,20160510,EXP,,US-GILEAD-2016-0207391,GILEAD,,63.0,YR,A,F,Y,104.0,KG,20160510.0,,CN,US,US,2016,Q2,Adult
122775691,12277569,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 U, UNKNOWN",,,,, 5F9521,,,16.0,IU,,,2016,Q2,Blood glucose increased,,2016,Q2,1,I,20160316.0,20160406.0,20160418,20160418,EXP,,GB-ELI_LILLY_AND_COMPANY-GB201604002236,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20160418.0,,CN,GB,GB,2016,Q2,Elderly
122783732,12278373,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Haemolytic anaemia,,2016,Q2,2,F,,20160413.0,20160418,20160428,EXP,,US-BAUSCH-BL-2016-008797,BAUSCH AND LOMB,"RUGGIERO N, KISH T, LEE M. METFORMIN-INDUCED HEMOLYTIC ANEMIA IN A PATIENT WITH GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY. AMERICAN JOURNAL OF THERAPEUTICS. 2016;23(2):E575-E578.",53.0,YR,,M,Y,,,20160428.0,,PH,US,US,2016,Q2,Adult
122783791,12278379,6,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q2,Crystal nephropathy,,2016,Q2,1,I,201312.0,20160404.0,20160418,20160418,EXP,,"US-RISING PHARMACEUTICALS, INC.-2016RIS00040",RISING PHARMACEUTICALS,"BAIRD P, LEUNG S, HOANG H, ET AL.. A CASE OF ACUTE KIDNEY INJURY FROM CRYSTAL NEPHROPATHY SECONDARY TO POMALIDOMIDE AND LEVOFLOXACIN USE. J ONCOL PHARM PRACT (DOI: 10.1177/1078155214568581). 2016;22(2):357-360",76.0,YR,,F,Y,,,20160418.0,,OT,US,US,2016,Q2,Elderly
122783791,12278379,6,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q2,Renal tubular necrosis,,2016,Q2,1,I,201312.0,20160404.0,20160418,20160418,EXP,,"US-RISING PHARMACEUTICALS, INC.-2016RIS00040",RISING PHARMACEUTICALS,"BAIRD P, LEUNG S, HOANG H, ET AL.. A CASE OF ACUTE KIDNEY INJURY FROM CRYSTAL NEPHROPATHY SECONDARY TO POMALIDOMIDE AND LEVOFLOXACIN USE. J ONCOL PHARM PRACT (DOI: 10.1177/1078155214568581). 2016;22(2):357-360",76.0,YR,,F,Y,,,20160418.0,,OT,US,US,2016,Q2,Elderly
122785112,12278511,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2016,Q2,Acute kidney injury,,2016,Q2,2,F,,20160308.0,20160418,20160421,EXP,,US-JNJFOC-20160310223,JANSSEN,"BAIRD P, LEUNG S, HOANG H, BABALOLA O, DEVOE CE, WANCHOO R, ET AL. A CASE OF ACUTE KIDNEY INJURY FROM CRYSTAL NEPHROPATHY SECONDARY TO POMALIDOMIDE AND LEVOFLOXACIN USE. JOURNAL OF ONCOLOGY PHARMACY PRACTICE APR-2016;22 (2):357-360.",76.0,YR,E,F,Y,,,20160418.0,,MD,US,US,2016,Q2,Elderly
122785112,12278511,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2016,Q2,Crystal nephropathy,,2016,Q2,2,F,,20160308.0,20160418,20160421,EXP,,US-JNJFOC-20160310223,JANSSEN,"BAIRD P, LEUNG S, HOANG H, BABALOLA O, DEVOE CE, WANCHOO R, ET AL. A CASE OF ACUTE KIDNEY INJURY FROM CRYSTAL NEPHROPATHY SECONDARY TO POMALIDOMIDE AND LEVOFLOXACIN USE. JOURNAL OF ONCOLOGY PHARMACY PRACTICE APR-2016;22 (2):357-360.",76.0,YR,E,F,Y,,,20160418.0,,MD,US,US,2016,Q2,Elderly
122805992,12280599,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Anaemia,,2016,Q2,2,F,20160325.0,20160415.0,20160419,20160422,EXP,,US-UNITED THERAPEUTICS-UNT-2016-005820,UNITED THERAPEUTICS,,73.0,YR,,F,Y,90.7,KG,20160422.0,,OT,US,US,2016,Q2,Elderly
122805992,12280599,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Bacteraemia,,2016,Q2,2,F,20160325.0,20160415.0,20160419,20160422,EXP,,US-UNITED THERAPEUTICS-UNT-2016-005820,UNITED THERAPEUTICS,,73.0,YR,,F,Y,90.7,KG,20160422.0,,OT,US,US,2016,Q2,Elderly
122805992,12280599,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Cardiac failure congestive,,2016,Q2,2,F,20160325.0,20160415.0,20160419,20160422,EXP,,US-UNITED THERAPEUTICS-UNT-2016-005820,UNITED THERAPEUTICS,,73.0,YR,,F,Y,90.7,KG,20160422.0,,OT,US,US,2016,Q2,Elderly
122805992,12280599,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Chronic obstructive pulmonary disease,,2016,Q2,2,F,20160325.0,20160415.0,20160419,20160422,EXP,,US-UNITED THERAPEUTICS-UNT-2016-005820,UNITED THERAPEUTICS,,73.0,YR,,F,Y,90.7,KG,20160422.0,,OT,US,US,2016,Q2,Elderly
122807291,12280729,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"9 IU, ONCE A DAY IN THE EVENING",,,,U,,,,9.0,IU,,QD,2016,Q2,Hyperammonaemic encephalopathy,,2016,Q2,1,I,,20160324.0,20160419,20160419,EXP,,FR-AUROBINDO-AUR-APL-2016-04448,AUROBINDO,,69.0,YR,,M,Y,66.0,KG,20160416.0,,MD,FR,FR,2016,Q2,Elderly
122807791,12280779,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,20 UNITS,,,,,,,,,,,,2016,Q2,Haemolytic anaemia,,2016,Q2,1,I,,20160405.0,20160419,20160419,EXP,,US-LUPIN PHARMACEUTICALS INC.-2016-01421,LUPIN,"RUGGIERO N, KISH T, LEE M. METFORMIN-INDUCED HEMOLYTIC ANEMIA IN A PATIENT WITH GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY. AMERICAN JOURNAL OF THERAPEUTICS. 2016;23:E575-E578.",53.0,YR,,M,Y,,,20160419.0,,OT,US,US,2016,Q2,Adult
122810162,12281016,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"20 UT, QD",,,,,,,,,,,,2016,Q2,Haemolytic anaemia,,2016,Q2,2,F,,20160420.0,20160419,20160429,EXP,,"US-GLENMARK PHARMACEUTICALS INC, USA.-2016GMK022599",GLENMARK,"RUGGIERO NA, KISH TD, LEE ML. METFORMIN-INDUCED HEMOLYTIC ANEMIA IN A PATIENT WITH GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY. AMERICAN JOURNAL OF THERAPEUTICS. 2016;23(2):E575-E578",53.0,YR,,M,Y,,,20160429.0,,PH,US,US,2016,Q2,Adult
122842692,12284269,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"20 U, QD",,,,,,,,20.0,DF,,QD,2016,Q2,Haemolytic anaemia,,2016,Q2,2,F,,20160416.0,20160420,20160425,EXP,,PHHY2016US049450,SANDOZ,"RUGGIERO NA, KISH TD, LEE ML. METFORMIN-INDUCED HEMOLYTIC ANEMIA IN A PATIENT WITH GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY. AMERICAN JOURNAL OF THERAPEUTICS. 2016;23 (2):E575-8",53.0,YR,,M,Y,,,20160425.0,,OT,US,US,2016,Q2,Adult
122851091,12285109,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Lactic acidosis,,2016,Q2,1,I,,20160413.0,20160420,20160420,EXP,,JP-BAUSCH-BL-2016-008940,BAUSCH AND LOMB,"OZEKI T, KAWATO R, WATANABE M, TAKASUGI K, HAMADA T, NOMURA A, TOMINO T, FUJITA Y, MINATOGUCHI S, MURAI Y, RYUGE A, OYAMA Y, SHIMIZU H. A FATAL CASE OF METFORMIN-ASSOCIATED LACTIC ACIDOSIS. INTERNAL MEDICINE. 2016;55:775-778.",72.0,YR,,F,Y,,,20160420.0,,OT,JP,JP,2016,Q2,Elderly
122851091,12285109,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Overdose,,2016,Q2,1,I,,20160413.0,20160420,20160420,EXP,,JP-BAUSCH-BL-2016-008940,BAUSCH AND LOMB,"OZEKI T, KAWATO R, WATANABE M, TAKASUGI K, HAMADA T, NOMURA A, TOMINO T, FUJITA Y, MINATOGUCHI S, MURAI Y, RYUGE A, OYAMA Y, SHIMIZU H. A FATAL CASE OF METFORMIN-ASSOCIATED LACTIC ACIDOSIS. INTERNAL MEDICINE. 2016;55:775-778.",72.0,YR,,F,Y,,,20160420.0,,OT,JP,JP,2016,Q2,Elderly
122854583,12285458,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"20 UNITS, DAILY",,,,,,,,,,,,2016,Q2,Haemolytic anaemia,,2016,Q2,3,F,,20160419.0,20160420,20160520,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2016US-115134,RANBAXY,,53.0,YR,,M,Y,,,20160520.0,,OT,GB,US,2016,Q2,Adult
122870422,12287042,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Cardiac failure congestive,,2016,Q2,2,F,20160325.0,20160502.0,20160420,20160506,EXP,,US-GILEAD-2016-0209372,GILEAD,,73.0,YR,E,F,Y,89.34,KG,20160506.0,,CN,US,US,2016,Q2,Elderly
122870422,12287042,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Respiratory failure,,2016,Q2,2,F,20160325.0,20160502.0,20160420,20160506,EXP,,US-GILEAD-2016-0209372,GILEAD,,73.0,YR,E,F,Y,89.34,KG,20160506.0,,CN,US,US,2016,Q2,Elderly
122877281,12287728,7,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,10 UNITS,,,,,,,,,,UNKNOWN,QD,2016,Q2,Platelet count decreased,,2016,Q2,1,I,20160411.0,20160411.0,20160420,20160420,PER,,US-CELGENEUS-USA-2016043078,CELGENE,,65.0,YR,,F,Y,71.8,KG,20160420.0,,MD,US,US,2016,Q2,Elderly
122877441,12287744,3,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Haemolytic anaemia,,2016,Q2,1,I,,20160405.0,20160420,20160420,EXP,,US-IPCA LABORATORIES LIMITED-E2B_00000019,IPCA,"RUGGIERO N,KISH T,LEE M. METFORMIN-INDUCED HEMOLYTIC ANEMIA IN A PATIENT WITH GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY. AM J THER 2016;23(2):E575-8.",53.0,YR,,M,Y,,,20160420.0,,PH,US,US,2016,Q2,Adult
122934742,12293474,40,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q2,Generalised oedema,,2016,Q2,2,F,20160303.0,20160510.0,20160421,20160518,EXP,,US-CELGENEUS-USA-2016035057,CELGENE,,55.0,YR,,M,Y,107.7,KG,20160518.0,,OT,US,US,2016,Q2,Adult
122943541,12294354,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 UNITS,,,,,,,,,,,,2016,Q2,Diarrhoea,,2016,Q2,1,I,,20160411.0,20160422,20160422,EXP,,US-ALKEM-001580,ALKEM,"STEBER CJ, PERKINS SL, HARRIS KB. METFORMIN-INDUCED FIXED-DRUG ERUPTION CONFIRMED BY MULTIPLE EXPOSURES. AM J CASE REP. 2016 APR 8;17:231-4.",56.0,YR,,F,Y,118.0,KG,20160422.0,,OT,US,US,2016,Q2,Adult
122943541,12294354,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 UNITS,,,,,,,,,,,,2016,Q2,Fixed drug eruption,Fixed drug eruption,2016,Q2,1,I,,20160411.0,20160422,20160422,EXP,,US-ALKEM-001580,ALKEM,"STEBER CJ, PERKINS SL, HARRIS KB. METFORMIN-INDUCED FIXED-DRUG ERUPTION CONFIRMED BY MULTIPLE EXPOSURES. AM J CASE REP. 2016 APR 8;17:231-4.",56.0,YR,,F,Y,118.0,KG,20160422.0,,OT,US,US,2016,Q2,Adult
122943661,12294366,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 UNITS,,,,,,,,,,,,2016,Q2,Diarrhoea,,2016,Q2,1,I,,20160411.0,20160422,20160422,EXP,,US-INDICUS PHARMA-000408,INDICUS,"STEBER CJ, PERKINS SL, HARRIS KB. METFORMIN-INDUCED FIXED-DRUG ERUPTION CONFIRMED BY MULTIPLE EXPOSURES. AM J CASE REP. 2016 APR 8;17:231-4.",56.0,YR,,F,Y,118.0,KG,20160422.0,,OT,US,US,2016,Q2,Adult
122943661,12294366,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 UNITS,,,,,,,,,,,,2016,Q2,Fixed drug eruption,Fixed drug eruption,2016,Q2,1,I,,20160411.0,20160422,20160422,EXP,,US-INDICUS PHARMA-000408,INDICUS,"STEBER CJ, PERKINS SL, HARRIS KB. METFORMIN-INDUCED FIXED-DRUG ERUPTION CONFIRMED BY MULTIPLE EXPOSURES. AM J CASE REP. 2016 APR 8;17:231-4.",56.0,YR,,F,Y,118.0,KG,20160422.0,,OT,US,US,2016,Q2,Adult
122943721,12294372,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 UNITS,,,,,,,,,,,,2016,Q2,Diarrhoea,,2016,Q2,1,I,,20160411.0,20160422,20160422,EXP,,US-INVENTIA-000108,INVENTIA HEALTHCARE,"STEBER CJ, PERKINS SL, HARRIS KB. METFORMIN-INDUCED FIXED-DRUG ERUPTION CONFIRMED BY MULTIPLE EXPOSURES. AM J CASE REP. 2016 APR 8;17:231-4.",56.0,YR,,F,Y,118.0,KG,20160422.0,,OT,US,US,2016,Q2,Adult
122943721,12294372,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 UNITS,,,,,,,,,,,,2016,Q2,Fixed drug eruption,Fixed drug eruption,2016,Q2,1,I,,20160411.0,20160422,20160422,EXP,,US-INVENTIA-000108,INVENTIA HEALTHCARE,"STEBER CJ, PERKINS SL, HARRIS KB. METFORMIN-INDUCED FIXED-DRUG ERUPTION CONFIRMED BY MULTIPLE EXPOSURES. AM J CASE REP. 2016 APR 8;17:231-4.",56.0,YR,,F,Y,118.0,KG,20160422.0,,OT,US,US,2016,Q2,Adult
123009594,12300959,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Tuberculin test positive,,2016,Q2,4,F,20160201.0,20160622.0,20160425,20160627,EXP,,CO-ABBVIE-16K-036-1612535-00,ABBVIE,,41.0,YR,,F,Y,60.0,KG,20160624.0,,CN,COUNTRY NOT SPECIFIED,CO,2016,Q2,Adult
123009594,12300959,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Ulcerative keratitis,,2016,Q2,4,F,20160201.0,20160622.0,20160425,20160627,EXP,,CO-ABBVIE-16K-036-1612535-00,ABBVIE,,41.0,YR,,F,Y,60.0,KG,20160624.0,,CN,COUNTRY NOT SPECIFIED,CO,2016,Q2,Adult
123022871,12302287,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Gastrointestinal viral infection,,2016,Q2,1,I,20160212.0,20160419.0,20160425,20160425,EXP,,ES-ASTRAZENECA-2016SE42978,ASTRAZENECA,,68.0,YR,,F,Y,,,20160425.0,,PH,ES,ES,2016,Q2,Elderly
123022871,12302287,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Hyperglycaemia,,2016,Q2,1,I,20160212.0,20160419.0,20160425,20160425,EXP,,ES-ASTRAZENECA-2016SE42978,ASTRAZENECA,,68.0,YR,,F,Y,,,20160425.0,,PH,ES,ES,2016,Q2,Elderly
123022871,12302287,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Metabolic acidosis,,2016,Q2,1,I,20160212.0,20160419.0,20160425,20160425,EXP,,ES-ASTRAZENECA-2016SE42978,ASTRAZENECA,,68.0,YR,,F,Y,,,20160425.0,,PH,ES,ES,2016,Q2,Elderly
123022871,12302287,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Urinary tract infection,,2016,Q2,1,I,20160212.0,20160419.0,20160425,20160425,EXP,,ES-ASTRAZENECA-2016SE42978,ASTRAZENECA,,68.0,YR,,F,Y,,,20160425.0,,PH,ES,ES,2016,Q2,Elderly
123048162,12304816,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,20 UNITS DAILY,,,,U,,,,,,,,2016,Q2,Haemolytic anaemia,,2016,Q2,2,F,,20160420.0,20160426,20160504,EXP,,US-AUROBINDO-AUR-APL-2016-04799,AUROBINDO,,53.0,YR,,M,Y,,,20160504.0,,PH,US,US,2016,Q2,Adult
123048171,12304817,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Anaemia,,2016,Q2,1,I,20160406.0,,20160425,20160425,DIR,,,,,68.0,YR,,M,N,101.2,KG,20160422.0,N,PH,US,,2016,Q2,Elderly
123048171,12304817,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Cardiac arrest,,2016,Q2,1,I,20160406.0,,20160425,20160425,DIR,,,,,68.0,YR,,M,N,101.2,KG,20160422.0,N,PH,US,,2016,Q2,Elderly
123048171,12304817,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Cough,,2016,Q2,1,I,20160406.0,,20160425,20160425,DIR,,,,,68.0,YR,,M,N,101.2,KG,20160422.0,N,PH,US,,2016,Q2,Elderly
123048171,12304817,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Diabetic ketoacidosis,,2016,Q2,1,I,20160406.0,,20160425,20160425,DIR,,,,,68.0,YR,,M,N,101.2,KG,20160422.0,N,PH,US,,2016,Q2,Elderly
123048171,12304817,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Dyspnoea,,2016,Q2,1,I,20160406.0,,20160425,20160425,DIR,,,,,68.0,YR,,M,N,101.2,KG,20160422.0,N,PH,US,,2016,Q2,Elderly
123048171,12304817,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Hyperkalaemia,,2016,Q2,1,I,20160406.0,,20160425,20160425,DIR,,,,,68.0,YR,,M,N,101.2,KG,20160422.0,N,PH,US,,2016,Q2,Elderly
123065711,12306571,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,20 UNITS DAILY,,,,U,,,,20.0,IU,,,2016,Q2,Haemolytic anaemia,,2016,Q2,1,I,,20160419.0,20160426,20160426,EXP,,US-APOTEX-2016AP007973,APOTEX,"RUGGIERO NA, KISH TD, LEE ML.. METFORMIN-INDUCED HEMOLYTIC ANEMIA IN A PATIENT WITH GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY.. AM-J-THER. 2016;23(2):E575-E578",53.0,YR,,M,Y,,,20160426.0,,PH,US,US,2016,Q2,Adult
123090982,12309098,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,20 UNITS DAILY,,,,,,,,,,,,2016,Q2,Haemolytic anaemia,,2016,Q2,2,F,,20160420.0,20160427,20160504,EXP,US-MLMSERVICE-20160406-0234180-1,US-ALKEM-001606,ALKEM,"RUGGIERO NA, KISH TD, LEE ML. METFORMIN-INDUCED HEMOLYTIC ANEMIA IN A PATIENT WITH GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY.AMERICAN JOURNAL OF THERAPEUTICS. 2016; 23(2):E575-E578.",53.0,YR,,M,Y,,,20160504.0,,PH,US,US,2016,Q2,Adult
123091612,12309161,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,20 UNITS DAILY,,,,,,,,,,,,2016,Q2,Haemolytic anaemia,,2016,Q2,2,F,,20160420.0,20160427,20160504,EXP,US-MLMSERVICE-20160406-0234180-1,US-INDICUS PHARMA-000413,INDICUS,"RUGGIERO NA, KISH TD, LEE ML. METFORMIN-INDUCED HEMOLYTIC ANEMIA IN A PATIENT WITH GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY.AMERICAN JOURNAL OF THERAPEUTICS. 2016; 23(2):E575-E578.",53.0,YR,,M,Y,,,20160504.0,,PH,US,US,2016,Q2,Adult
123091752,12309175,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,20 UNITS DAILY,,,,,,,,,,,,2016,Q2,Haemolytic anaemia,,2016,Q2,2,F,,20160420.0,20160427,20160504,EXP,US-MLMSERVICE-20160406-0234180-1,US-INVENTIA-000111,INVENTIA HEALTHCARE,"RUGGIERO NA, KISH TD, LEE ML. METFORMIN-INDUCED HEMOLYTIC ANEMIA IN A PATIENT WITH GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY.AMERICAN JOURNAL OF THERAPEUTICS. 2016; 23(2):E575-E578.",53.0,YR,,M,Y,,,20160504.0,,PH,US,US,2016,Q2,Adult
123107131,12310713,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q2,Acute kidney injury,,2016,Q2,1,I,,20160419.0,20160427,20160427,EXP,,PHHY2016US053985,SANDOZ,,76.0,YR,,F,Y,,,20160427.0,,OT,US,US,2016,Q2,Elderly
123107131,12310713,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q2,Crystal nephropathy,,2016,Q2,1,I,,20160419.0,20160427,20160427,EXP,,PHHY2016US053985,SANDOZ,,76.0,YR,,F,Y,,,20160427.0,,OT,US,US,2016,Q2,Elderly
123110611,12311061,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,80.0,IU,,QD,2016,Q2,Diabetic ketoacidosis,,2016,Q2,1,I,,20160421.0,20160427,20160427,EXP,,GB-ASTRAZENECA-2016SE43049,ASTRAZENECA,,56.0,YR,,M,Y,,,20160427.0,,MD,GB,GB,2016,Q2,Adult
123110611,12311061,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,80.0,IU,,QD,2016,Q2,Haemoglobin decreased,,2016,Q2,1,I,,20160421.0,20160427,20160427,EXP,,GB-ASTRAZENECA-2016SE43049,ASTRAZENECA,,56.0,YR,,M,Y,,,20160427.0,,MD,GB,GB,2016,Q2,Adult
123110611,12311061,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,120U,,,,,,,,,,,,2016,Q2,Diabetic ketoacidosis,,2016,Q2,1,I,,20160421.0,20160427,20160427,EXP,,GB-ASTRAZENECA-2016SE43049,ASTRAZENECA,,56.0,YR,,M,Y,,,20160427.0,,MD,GB,GB,2016,Q2,Adult
123110611,12311061,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,120U,,,,,,,,,,,,2016,Q2,Haemoglobin decreased,,2016,Q2,1,I,,20160421.0,20160427,20160427,EXP,,GB-ASTRAZENECA-2016SE43049,ASTRAZENECA,,56.0,YR,,M,Y,,,20160427.0,,MD,GB,GB,2016,Q2,Adult
123112911,12311291,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"300 IU, SINGLE",,,,, UNKNOWN,,,300.0,IU,,,2016,Q2,Hypoglycaemic coma,,2016,Q2,1,I,20160226.0,20160329.0,20160427,20160427,EXP,,ES-NOVOPROD-486758,NOVO NORDISK,,60.0,YR,A,F,Y,98.0,KG,20160427.0,,MD,ES,ES,2016,Q2,Adult
123112911,12311291,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"300 IU, SINGLE",,,,, UNKNOWN,,,300.0,IU,,,2016,Q2,Overdose,,2016,Q2,1,I,20160226.0,20160329.0,20160427,20160427,EXP,,ES-NOVOPROD-486758,NOVO NORDISK,,60.0,YR,A,F,Y,98.0,KG,20160427.0,,MD,ES,ES,2016,Q2,Adult
123112911,12311291,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"300 IU, SINGLE",,,,, UNKNOWN,,,300.0,IU,,,2016,Q2,Suicide attempt,,2016,Q2,1,I,20160226.0,20160329.0,20160427,20160427,EXP,,ES-NOVOPROD-486758,NOVO NORDISK,,60.0,YR,A,F,Y,98.0,KG,20160427.0,,MD,ES,ES,2016,Q2,Adult
123112911,12311291,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"38 IU, QD (AT NIGHT)",,,,, UNKNOWN,,,38.0,IU,,QD,2016,Q2,Hypoglycaemic coma,,2016,Q2,1,I,20160226.0,20160329.0,20160427,20160427,EXP,,ES-NOVOPROD-486758,NOVO NORDISK,,60.0,YR,A,F,Y,98.0,KG,20160427.0,,MD,ES,ES,2016,Q2,Adult
123112911,12311291,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"38 IU, QD (AT NIGHT)",,,,, UNKNOWN,,,38.0,IU,,QD,2016,Q2,Overdose,,2016,Q2,1,I,20160226.0,20160329.0,20160427,20160427,EXP,,ES-NOVOPROD-486758,NOVO NORDISK,,60.0,YR,A,F,Y,98.0,KG,20160427.0,,MD,ES,ES,2016,Q2,Adult
123112911,12311291,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"38 IU, QD (AT NIGHT)",,,,, UNKNOWN,,,38.0,IU,,QD,2016,Q2,Suicide attempt,,2016,Q2,1,I,20160226.0,20160329.0,20160427,20160427,EXP,,ES-NOVOPROD-486758,NOVO NORDISK,,60.0,YR,A,F,Y,98.0,KG,20160427.0,,MD,ES,ES,2016,Q2,Adult
123130104,12313010,3,C,insulin glargine,INSULIN GLARGINE,1,Unknown,20 UNITS DAILY,,,,,,,,,,,,2016,Q2,Haemolytic anaemia,,2016,Q2,4,F,,20160419.0,20160428,20160509,EXP,,US-TEVA-655685USA,TEVA,"RUGGIERO NA, KISH TD, LEE ML. METFORMIN-INDUCED HEMOLYTIC ANEMIA IN A PATIENT WITH GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY. AM-J-THER 2016;23(2):E575-E578.",53.0,YR,,M,Y,,,20160510.0,,PH,US,US,2016,Q2,Adult
123139102,12313910,1,PS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,205692.0,,,INJECTION,,2016,Q2,Erythema multiforme,,2016,Q2,2,F,20160119.0,20160516.0,20160428,20160524,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201603002952,ELI LILLY AND CO,,86.0,YR,,M,Y,47.3,KG,20160524.0,,MD,JP,JP,2016,Q2,Elderly
123139102,12313910,1,PS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,205692.0,,,INJECTION,,2016,Q2,Inguinal hernia,,2016,Q2,2,F,20160119.0,20160516.0,20160428,20160524,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201603002952,ELI LILLY AND CO,,86.0,YR,,M,Y,47.3,KG,20160524.0,,MD,JP,JP,2016,Q2,Elderly
123139102,12313910,1,PS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,205692.0,,,INJECTION,,2016,Q2,Prostate cancer,,2016,Q2,2,F,20160119.0,20160516.0,20160428,20160524,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201603002952,ELI LILLY AND CO,,86.0,YR,,M,Y,47.3,KG,20160524.0,,MD,JP,JP,2016,Q2,Elderly
123155214,12315521,29,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q2,Sepsis,,2016,Q2,4,F,20160226.0,20160601.0,20160428,20160614,EXP,,US-CELGENEUS-USA-2016031499,CELGENE,,68.0,YR,,F,Y,48.0,KG,20160614.0,,MD,US,US,2016,Q2,Elderly
123155214,12315521,29,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q2,Syncope,,2016,Q2,4,F,20160226.0,20160601.0,20160428,20160614,EXP,,US-CELGENEUS-USA-2016031499,CELGENE,,68.0,YR,,F,Y,48.0,KG,20160614.0,,MD,US,US,2016,Q2,Elderly
123155214,12315521,29,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q2,Thrombocytopenia,,2016,Q2,4,F,20160226.0,20160601.0,20160428,20160614,EXP,,US-CELGENEUS-USA-2016031499,CELGENE,,68.0,YR,,F,Y,48.0,KG,20160614.0,,MD,US,US,2016,Q2,Elderly
123155214,12315521,29,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q2,Urinary tract infection,,2016,Q2,4,F,20160226.0,20160601.0,20160428,20160614,EXP,,US-CELGENEUS-USA-2016031499,CELGENE,,68.0,YR,,F,Y,48.0,KG,20160614.0,,MD,US,US,2016,Q2,Elderly
123166683,12316668,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 IU, DAILY",,,,U,,,,14.0,IU,,,2016,Q2,Hypoglycaemia,,2016,Q2,3,F,,20160504.0,20160429,20160519,EXP,,JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-115688,RANBAXY,,72.0,YR,,F,Y,,,20160519.0,,OT,GB,JP,2016,Q2,Elderly
123166683,12316668,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 IU, DAILY",,,,U,,,,14.0,IU,,,2016,Q2,Lactic acidosis,,2016,Q2,3,F,,20160504.0,20160429,20160519,EXP,,JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-115688,RANBAXY,,72.0,YR,,F,Y,,,20160519.0,,OT,GB,JP,2016,Q2,Elderly
123166683,12316668,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 IU, DAILY",,,,U,,,,14.0,IU,,,2016,Q2,Overdose,,2016,Q2,3,F,,20160504.0,20160429,20160519,EXP,,JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-115688,RANBAXY,,72.0,YR,,F,Y,,,20160519.0,,OT,GB,JP,2016,Q2,Elderly
123178211,12317821,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,60 UNITS,,,,,,,,60.0,IU,UNSPECIFIED,,2016,Q2,Ketoacidosis,,2016,Q2,1,I,,20160426.0,20160429,20160429,EXP,,US-JNJFOC-20160425052,JANSSEN,"GELAYE A, HAIDAR A, KASSAB C, KAZMI S, SINHA P. SEVERE KETOACIDOSIS ASSOCIATED WITH CANAGLIFLOZIN (INVOKANA): A SAFETY CONCERN. CASE REPORTS IN CRITICAL CARE 2016.",54.0,YR,A,M,Y,,,20160429.0,,OT,US,US,2016,Q2,Adult
123178211,12317821,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,60 UNITS,,,,,,,,60.0,IU,UNSPECIFIED,,2016,Q2,Off label use,,2016,Q2,1,I,,20160426.0,20160429,20160429,EXP,,US-JNJFOC-20160425052,JANSSEN,"GELAYE A, HAIDAR A, KASSAB C, KAZMI S, SINHA P. SEVERE KETOACIDOSIS ASSOCIATED WITH CANAGLIFLOZIN (INVOKANA): A SAFETY CONCERN. CASE REPORTS IN CRITICAL CARE 2016.",54.0,YR,A,M,Y,,,20160429.0,,OT,US,US,2016,Q2,Adult
123178211,12317821,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,60 UNITS,,,,,,,,60.0,IU,UNSPECIFIED,,2016,Q2,Product use issue,,2016,Q2,1,I,,20160426.0,20160429,20160429,EXP,,US-JNJFOC-20160425052,JANSSEN,"GELAYE A, HAIDAR A, KASSAB C, KAZMI S, SINHA P. SEVERE KETOACIDOSIS ASSOCIATED WITH CANAGLIFLOZIN (INVOKANA): A SAFETY CONCERN. CASE REPORTS IN CRITICAL CARE 2016.",54.0,YR,A,M,Y,,,20160429.0,,OT,US,US,2016,Q2,Adult
123178721,12317872,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,U,,,,,,,,2016,Q2,Acute kidney injury,,2016,Q2,1,I,,20160419.0,20160429,20160429,EXP,,US-APOTEX-2016AP008008,APOTEX,,76.0,YR,,F,Y,,,20160429.0,,OT,US,US,2016,Q2,Elderly
123178721,12317872,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,U,,,,,,,,2016,Q2,Crystal nephropathy,,2016,Q2,1,I,,20160419.0,20160429,20160429,EXP,,US-APOTEX-2016AP008008,APOTEX,,76.0,YR,,F,Y,,,20160429.0,,OT,US,US,2016,Q2,Elderly
123206172,12320617,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 U, QD",,,,,,,,14.0,IU,,QD,2016,Q2,Anuria,,2016,Q2,2,F,,20160428.0,20160429,20160504,EXP,,PHHY2016JP056614,SANDOZ,"OZEKI T, KAWATO R, WATANABE M, MINATOGUCHI S, MURAI Y, RYUGE A ET AL.. A FATAL CASE OF METFORMIN-ASSOCIATED LACTIC ACIDOSIS. INTERNAL MEDICINE. 2016;55(7):775-8",72.0,YR,,F,Y,,,20160504.0,,OT,JP,JP,2016,Q2,Elderly
123206172,12320617,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 U, QD",,,,,,,,14.0,IU,,QD,2016,Q2,Drug level increased,,2016,Q2,2,F,,20160428.0,20160429,20160504,EXP,,PHHY2016JP056614,SANDOZ,"OZEKI T, KAWATO R, WATANABE M, MINATOGUCHI S, MURAI Y, RYUGE A ET AL.. A FATAL CASE OF METFORMIN-ASSOCIATED LACTIC ACIDOSIS. INTERNAL MEDICINE. 2016;55(7):775-8",72.0,YR,,F,Y,,,20160504.0,,OT,JP,JP,2016,Q2,Elderly
123206172,12320617,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 U, QD",,,,,,,,14.0,IU,,QD,2016,Q2,Hypoglycaemia,,2016,Q2,2,F,,20160428.0,20160429,20160504,EXP,,PHHY2016JP056614,SANDOZ,"OZEKI T, KAWATO R, WATANABE M, MINATOGUCHI S, MURAI Y, RYUGE A ET AL.. A FATAL CASE OF METFORMIN-ASSOCIATED LACTIC ACIDOSIS. INTERNAL MEDICINE. 2016;55(7):775-8",72.0,YR,,F,Y,,,20160504.0,,OT,JP,JP,2016,Q2,Elderly
123206172,12320617,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 U, QD",,,,,,,,14.0,IU,,QD,2016,Q2,Hypotension,,2016,Q2,2,F,,20160428.0,20160429,20160504,EXP,,PHHY2016JP056614,SANDOZ,"OZEKI T, KAWATO R, WATANABE M, MINATOGUCHI S, MURAI Y, RYUGE A ET AL.. A FATAL CASE OF METFORMIN-ASSOCIATED LACTIC ACIDOSIS. INTERNAL MEDICINE. 2016;55(7):775-8",72.0,YR,,F,Y,,,20160504.0,,OT,JP,JP,2016,Q2,Elderly
123206172,12320617,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 U, QD",,,,,,,,14.0,IU,,QD,2016,Q2,Hypothermia,,2016,Q2,2,F,,20160428.0,20160429,20160504,EXP,,PHHY2016JP056614,SANDOZ,"OZEKI T, KAWATO R, WATANABE M, MINATOGUCHI S, MURAI Y, RYUGE A ET AL.. A FATAL CASE OF METFORMIN-ASSOCIATED LACTIC ACIDOSIS. INTERNAL MEDICINE. 2016;55(7):775-8",72.0,YR,,F,Y,,,20160504.0,,OT,JP,JP,2016,Q2,Elderly
123206172,12320617,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 U, QD",,,,,,,,14.0,IU,,QD,2016,Q2,Intentional overdose,,2016,Q2,2,F,,20160428.0,20160429,20160504,EXP,,PHHY2016JP056614,SANDOZ,"OZEKI T, KAWATO R, WATANABE M, MINATOGUCHI S, MURAI Y, RYUGE A ET AL.. A FATAL CASE OF METFORMIN-ASSOCIATED LACTIC ACIDOSIS. INTERNAL MEDICINE. 2016;55(7):775-8",72.0,YR,,F,Y,,,20160504.0,,OT,JP,JP,2016,Q2,Elderly
123206172,12320617,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 U, QD",,,,,,,,14.0,IU,,QD,2016,Q2,Lactic acidosis,,2016,Q2,2,F,,20160428.0,20160429,20160504,EXP,,PHHY2016JP056614,SANDOZ,"OZEKI T, KAWATO R, WATANABE M, MINATOGUCHI S, MURAI Y, RYUGE A ET AL.. A FATAL CASE OF METFORMIN-ASSOCIATED LACTIC ACIDOSIS. INTERNAL MEDICINE. 2016;55(7):775-8",72.0,YR,,F,Y,,,20160504.0,,OT,JP,JP,2016,Q2,Elderly
123206172,12320617,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 U, QD",,,,,,,,14.0,IU,,QD,2016,Q2,Toxicity to various agents,,2016,Q2,2,F,,20160428.0,20160429,20160504,EXP,,PHHY2016JP056614,SANDOZ,"OZEKI T, KAWATO R, WATANABE M, MINATOGUCHI S, MURAI Y, RYUGE A ET AL.. A FATAL CASE OF METFORMIN-ASSOCIATED LACTIC ACIDOSIS. INTERNAL MEDICINE. 2016;55(7):775-8",72.0,YR,,F,Y,,,20160504.0,,OT,JP,JP,2016,Q2,Elderly
123206172,12320617,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 U, QD",,,,,,,,14.0,IU,,QD,2016,Q2,Vomiting,,2016,Q2,2,F,,20160428.0,20160429,20160504,EXP,,PHHY2016JP056614,SANDOZ,"OZEKI T, KAWATO R, WATANABE M, MINATOGUCHI S, MURAI Y, RYUGE A ET AL.. A FATAL CASE OF METFORMIN-ASSOCIATED LACTIC ACIDOSIS. INTERNAL MEDICINE. 2016;55(7):775-8",72.0,YR,,F,Y,,,20160504.0,,OT,JP,JP,2016,Q2,Elderly
123247991,12324799,10,C,GLARGINE,,2,,,,,,,,,,,,,,2016,Q2,Hair colour changes,,2016,Q2,1,I,201504.0,20150709.0,20160502,20160502,PER,,US-ABBVIE-15P-163-1427506-00,ABBVIE,,69.0,YR,,M,Y,,,20160502.0,,PH,US,US,2016,Q2,Elderly
123261271,12326127,8,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2016,Q2,Blood pressure fluctuation,,2016,Q2,1,I,20160416.0,20160422.0,20160503,20160503,EXP,,CO-BAXTER-2016BAX021522,BAXTER,,76.0,YR,,M,Y,57.0,KG,20160503.0,,OT,CO,CO,2016,Q2,Elderly
123261271,12326127,8,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2016,Q2,Cardio-respiratory arrest,,2016,Q2,1,I,20160416.0,20160422.0,20160503,20160503,EXP,,CO-BAXTER-2016BAX021522,BAXTER,,76.0,YR,,M,Y,57.0,KG,20160503.0,,OT,CO,CO,2016,Q2,Elderly
123261271,12326127,8,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2016,Q2,Wheezing,,2016,Q2,1,I,20160416.0,20160422.0,20160503,20160503,EXP,,CO-BAXTER-2016BAX021522,BAXTER,,76.0,YR,,M,Y,57.0,KG,20160503.0,,OT,CO,CO,2016,Q2,Elderly
123307021,12330702,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 UNITS, HS + 11 (PRIOR TO CONFUSION)",,,,,,,,,,,,2016,Q2,Confusional state,,2016,Q2,1,I,,20160412.0,20160504,20160504,EXP,,"US-GLENMARK PHARMACEUTICALS INC, USA.-2016GMK022636",GLENMARK,HUI J. DOSE-INDEPENDENT CONFUSION INDUCED BY VORICONAZOLE IN A PATIENT WITH ASIAN ANCESTRY AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT.. JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2016;22(1):175-178,71.0,YR,,M,Y,,,20160504.0,,OT,US,US,2016,Q2,Elderly
123307021,12330702,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 UNITS, HS + 11 (PRIOR TO CONFUSION)",,,,,,,,,,,,2016,Q2,Drug interaction,,2016,Q2,1,I,,20160412.0,20160504,20160504,EXP,,"US-GLENMARK PHARMACEUTICALS INC, USA.-2016GMK022636",GLENMARK,HUI J. DOSE-INDEPENDENT CONFUSION INDUCED BY VORICONAZOLE IN A PATIENT WITH ASIAN ANCESTRY AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT.. JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2016;22(1):175-178,71.0,YR,,M,Y,,,20160504.0,,OT,US,US,2016,Q2,Elderly
123307021,12330702,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 UNITS, HS + 11 (PRIOR TO CONFUSION)",,,,,,,,,,,,2016,Q2,Mental status changes,,2016,Q2,1,I,,20160412.0,20160504,20160504,EXP,,"US-GLENMARK PHARMACEUTICALS INC, USA.-2016GMK022636",GLENMARK,HUI J. DOSE-INDEPENDENT CONFUSION INDUCED BY VORICONAZOLE IN A PATIENT WITH ASIAN ANCESTRY AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT.. JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2016;22(1):175-178,71.0,YR,,M,Y,,,20160504.0,,OT,US,US,2016,Q2,Elderly
123307021,12330702,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 UNITS, HS ON SCT DAY + 17 (IMMEDIATELY PRIOR TO CONFUSION)",,,,,,,,,,,,2016,Q2,Confusional state,,2016,Q2,1,I,,20160412.0,20160504,20160504,EXP,,"US-GLENMARK PHARMACEUTICALS INC, USA.-2016GMK022636",GLENMARK,HUI J. DOSE-INDEPENDENT CONFUSION INDUCED BY VORICONAZOLE IN A PATIENT WITH ASIAN ANCESTRY AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT.. JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2016;22(1):175-178,71.0,YR,,M,Y,,,20160504.0,,OT,US,US,2016,Q2,Elderly
123307021,12330702,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 UNITS, HS ON SCT DAY + 17 (IMMEDIATELY PRIOR TO CONFUSION)",,,,,,,,,,,,2016,Q2,Drug interaction,,2016,Q2,1,I,,20160412.0,20160504,20160504,EXP,,"US-GLENMARK PHARMACEUTICALS INC, USA.-2016GMK022636",GLENMARK,HUI J. DOSE-INDEPENDENT CONFUSION INDUCED BY VORICONAZOLE IN A PATIENT WITH ASIAN ANCESTRY AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT.. JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2016;22(1):175-178,71.0,YR,,M,Y,,,20160504.0,,OT,US,US,2016,Q2,Elderly
123307021,12330702,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 UNITS, HS ON SCT DAY + 17 (IMMEDIATELY PRIOR TO CONFUSION)",,,,,,,,,,,,2016,Q2,Mental status changes,,2016,Q2,1,I,,20160412.0,20160504,20160504,EXP,,"US-GLENMARK PHARMACEUTICALS INC, USA.-2016GMK022636",GLENMARK,HUI J. DOSE-INDEPENDENT CONFUSION INDUCED BY VORICONAZOLE IN A PATIENT WITH ASIAN ANCESTRY AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT.. JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2016;22(1):175-178,71.0,YR,,M,Y,,,20160504.0,,OT,US,US,2016,Q2,Elderly
123323592,12332359,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q2,Cardiac arrest,,2016,Q2,2,F,,20160519.0,20160504,20160603,EXP,,JP-VALIDUS PHARMACEUTICALS LLC-JP-2016VAL001416,VALIDUS,"TOMITA A, SATANI M, SUZUKI K, KAJI A, URUSHITANI S. A CASE OF CARDIAC ARREST FOLLOWING INTRA-ARTICULAR ADMINISTRATION OF LEVOBUPIVACAINE DURING TOTAL KNEE ARTHROPLASTY. JPN J ANESTHESIOL. 2016;65(2):179-83",73.0,YR,,F,Y,,,20160603.0,,OT,JP,JP,2016,Q2,Elderly
123323592,12332359,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q2,Cardiac failure,,2016,Q2,2,F,,20160519.0,20160504,20160603,EXP,,JP-VALIDUS PHARMACEUTICALS LLC-JP-2016VAL001416,VALIDUS,"TOMITA A, SATANI M, SUZUKI K, KAJI A, URUSHITANI S. A CASE OF CARDIAC ARREST FOLLOWING INTRA-ARTICULAR ADMINISTRATION OF LEVOBUPIVACAINE DURING TOTAL KNEE ARTHROPLASTY. JPN J ANESTHESIOL. 2016;65(2):179-83",73.0,YR,,F,Y,,,20160603.0,,OT,JP,JP,2016,Q2,Elderly
123323592,12332359,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q2,Condition aggravated,,2016,Q2,2,F,,20160519.0,20160504,20160603,EXP,,JP-VALIDUS PHARMACEUTICALS LLC-JP-2016VAL001416,VALIDUS,"TOMITA A, SATANI M, SUZUKI K, KAJI A, URUSHITANI S. A CASE OF CARDIAC ARREST FOLLOWING INTRA-ARTICULAR ADMINISTRATION OF LEVOBUPIVACAINE DURING TOTAL KNEE ARTHROPLASTY. JPN J ANESTHESIOL. 2016;65(2):179-83",73.0,YR,,F,Y,,,20160603.0,,OT,JP,JP,2016,Q2,Elderly
123323592,12332359,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q2,Drug ineffective,,2016,Q2,2,F,,20160519.0,20160504,20160603,EXP,,JP-VALIDUS PHARMACEUTICALS LLC-JP-2016VAL001416,VALIDUS,"TOMITA A, SATANI M, SUZUKI K, KAJI A, URUSHITANI S. A CASE OF CARDIAC ARREST FOLLOWING INTRA-ARTICULAR ADMINISTRATION OF LEVOBUPIVACAINE DURING TOTAL KNEE ARTHROPLASTY. JPN J ANESTHESIOL. 2016;65(2):179-83",73.0,YR,,F,Y,,,20160603.0,,OT,JP,JP,2016,Q2,Elderly
123323592,12332359,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q2,Electrocardiogram T wave inversion,,2016,Q2,2,F,,20160519.0,20160504,20160603,EXP,,JP-VALIDUS PHARMACEUTICALS LLC-JP-2016VAL001416,VALIDUS,"TOMITA A, SATANI M, SUZUKI K, KAJI A, URUSHITANI S. A CASE OF CARDIAC ARREST FOLLOWING INTRA-ARTICULAR ADMINISTRATION OF LEVOBUPIVACAINE DURING TOTAL KNEE ARTHROPLASTY. JPN J ANESTHESIOL. 2016;65(2):179-83",73.0,YR,,F,Y,,,20160603.0,,OT,JP,JP,2016,Q2,Elderly
123323592,12332359,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q2,Glomerular filtration rate decreased,,2016,Q2,2,F,,20160519.0,20160504,20160603,EXP,,JP-VALIDUS PHARMACEUTICALS LLC-JP-2016VAL001416,VALIDUS,"TOMITA A, SATANI M, SUZUKI K, KAJI A, URUSHITANI S. A CASE OF CARDIAC ARREST FOLLOWING INTRA-ARTICULAR ADMINISTRATION OF LEVOBUPIVACAINE DURING TOTAL KNEE ARTHROPLASTY. JPN J ANESTHESIOL. 2016;65(2):179-83",73.0,YR,,F,Y,,,20160603.0,,OT,JP,JP,2016,Q2,Elderly
123323592,12332359,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q2,Hypotension,,2016,Q2,2,F,,20160519.0,20160504,20160603,EXP,,JP-VALIDUS PHARMACEUTICALS LLC-JP-2016VAL001416,VALIDUS,"TOMITA A, SATANI M, SUZUKI K, KAJI A, URUSHITANI S. A CASE OF CARDIAC ARREST FOLLOWING INTRA-ARTICULAR ADMINISTRATION OF LEVOBUPIVACAINE DURING TOTAL KNEE ARTHROPLASTY. JPN J ANESTHESIOL. 2016;65(2):179-83",73.0,YR,,F,Y,,,20160603.0,,OT,JP,JP,2016,Q2,Elderly
123323592,12332359,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q2,Lung infiltration,,2016,Q2,2,F,,20160519.0,20160504,20160603,EXP,,JP-VALIDUS PHARMACEUTICALS LLC-JP-2016VAL001416,VALIDUS,"TOMITA A, SATANI M, SUZUKI K, KAJI A, URUSHITANI S. A CASE OF CARDIAC ARREST FOLLOWING INTRA-ARTICULAR ADMINISTRATION OF LEVOBUPIVACAINE DURING TOTAL KNEE ARTHROPLASTY. JPN J ANESTHESIOL. 2016;65(2):179-83",73.0,YR,,F,Y,,,20160603.0,,OT,JP,JP,2016,Q2,Elderly
123323592,12332359,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q2,Pulmonary oedema,,2016,Q2,2,F,,20160519.0,20160504,20160603,EXP,,JP-VALIDUS PHARMACEUTICALS LLC-JP-2016VAL001416,VALIDUS,"TOMITA A, SATANI M, SUZUKI K, KAJI A, URUSHITANI S. A CASE OF CARDIAC ARREST FOLLOWING INTRA-ARTICULAR ADMINISTRATION OF LEVOBUPIVACAINE DURING TOTAL KNEE ARTHROPLASTY. JPN J ANESTHESIOL. 2016;65(2):179-83",73.0,YR,,F,Y,,,20160603.0,,OT,JP,JP,2016,Q2,Elderly
123323592,12332359,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q2,Pulse absent,,2016,Q2,2,F,,20160519.0,20160504,20160603,EXP,,JP-VALIDUS PHARMACEUTICALS LLC-JP-2016VAL001416,VALIDUS,"TOMITA A, SATANI M, SUZUKI K, KAJI A, URUSHITANI S. A CASE OF CARDIAC ARREST FOLLOWING INTRA-ARTICULAR ADMINISTRATION OF LEVOBUPIVACAINE DURING TOTAL KNEE ARTHROPLASTY. JPN J ANESTHESIOL. 2016;65(2):179-83",73.0,YR,,F,Y,,,20160603.0,,OT,JP,JP,2016,Q2,Elderly
123323592,12332359,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q2,Pulseless electrical activity,,2016,Q2,2,F,,20160519.0,20160504,20160603,EXP,,JP-VALIDUS PHARMACEUTICALS LLC-JP-2016VAL001416,VALIDUS,"TOMITA A, SATANI M, SUZUKI K, KAJI A, URUSHITANI S. A CASE OF CARDIAC ARREST FOLLOWING INTRA-ARTICULAR ADMINISTRATION OF LEVOBUPIVACAINE DURING TOTAL KNEE ARTHROPLASTY. JPN J ANESTHESIOL. 2016;65(2):179-83",73.0,YR,,F,Y,,,20160603.0,,OT,JP,JP,2016,Q2,Elderly
123323592,12332359,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q2,Renal failure,,2016,Q2,2,F,,20160519.0,20160504,20160603,EXP,,JP-VALIDUS PHARMACEUTICALS LLC-JP-2016VAL001416,VALIDUS,"TOMITA A, SATANI M, SUZUKI K, KAJI A, URUSHITANI S. A CASE OF CARDIAC ARREST FOLLOWING INTRA-ARTICULAR ADMINISTRATION OF LEVOBUPIVACAINE DURING TOTAL KNEE ARTHROPLASTY. JPN J ANESTHESIOL. 2016;65(2):179-83",73.0,YR,,F,Y,,,20160603.0,,OT,JP,JP,2016,Q2,Elderly
123323592,12332359,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q2,Stress cardiomyopathy,,2016,Q2,2,F,,20160519.0,20160504,20160603,EXP,,JP-VALIDUS PHARMACEUTICALS LLC-JP-2016VAL001416,VALIDUS,"TOMITA A, SATANI M, SUZUKI K, KAJI A, URUSHITANI S. A CASE OF CARDIAC ARREST FOLLOWING INTRA-ARTICULAR ADMINISTRATION OF LEVOBUPIVACAINE DURING TOTAL KNEE ARTHROPLASTY. JPN J ANESTHESIOL. 2016;65(2):179-83",73.0,YR,,F,Y,,,20160603.0,,OT,JP,JP,2016,Q2,Elderly
123323592,12332359,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q2,Toxicity to various agents,,2016,Q2,2,F,,20160519.0,20160504,20160603,EXP,,JP-VALIDUS PHARMACEUTICALS LLC-JP-2016VAL001416,VALIDUS,"TOMITA A, SATANI M, SUZUKI K, KAJI A, URUSHITANI S. A CASE OF CARDIAC ARREST FOLLOWING INTRA-ARTICULAR ADMINISTRATION OF LEVOBUPIVACAINE DURING TOTAL KNEE ARTHROPLASTY. JPN J ANESTHESIOL. 2016;65(2):179-83",73.0,YR,,F,Y,,,20160603.0,,OT,JP,JP,2016,Q2,Elderly
123323592,12332359,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q2,Troponin I increased,,2016,Q2,2,F,,20160519.0,20160504,20160603,EXP,,JP-VALIDUS PHARMACEUTICALS LLC-JP-2016VAL001416,VALIDUS,"TOMITA A, SATANI M, SUZUKI K, KAJI A, URUSHITANI S. A CASE OF CARDIAC ARREST FOLLOWING INTRA-ARTICULAR ADMINISTRATION OF LEVOBUPIVACAINE DURING TOTAL KNEE ARTHROPLASTY. JPN J ANESTHESIOL. 2016;65(2):179-83",73.0,YR,,F,Y,,,20160603.0,,OT,JP,JP,2016,Q2,Elderly
123323592,12332359,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q2,Unresponsive to stimuli,,2016,Q2,2,F,,20160519.0,20160504,20160603,EXP,,JP-VALIDUS PHARMACEUTICALS LLC-JP-2016VAL001416,VALIDUS,"TOMITA A, SATANI M, SUZUKI K, KAJI A, URUSHITANI S. A CASE OF CARDIAC ARREST FOLLOWING INTRA-ARTICULAR ADMINISTRATION OF LEVOBUPIVACAINE DURING TOTAL KNEE ARTHROPLASTY. JPN J ANESTHESIOL. 2016;65(2):179-83",73.0,YR,,F,Y,,,20160603.0,,OT,JP,JP,2016,Q2,Elderly
123323592,12332359,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q2,Urine output decreased,,2016,Q2,2,F,,20160519.0,20160504,20160603,EXP,,JP-VALIDUS PHARMACEUTICALS LLC-JP-2016VAL001416,VALIDUS,"TOMITA A, SATANI M, SUZUKI K, KAJI A, URUSHITANI S. A CASE OF CARDIAC ARREST FOLLOWING INTRA-ARTICULAR ADMINISTRATION OF LEVOBUPIVACAINE DURING TOTAL KNEE ARTHROPLASTY. JPN J ANESTHESIOL. 2016;65(2):179-83",73.0,YR,,F,Y,,,20160603.0,,OT,JP,JP,2016,Q2,Elderly
123323592,12332359,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q2,Ventricular dyskinesia,,2016,Q2,2,F,,20160519.0,20160504,20160603,EXP,,JP-VALIDUS PHARMACEUTICALS LLC-JP-2016VAL001416,VALIDUS,"TOMITA A, SATANI M, SUZUKI K, KAJI A, URUSHITANI S. A CASE OF CARDIAC ARREST FOLLOWING INTRA-ARTICULAR ADMINISTRATION OF LEVOBUPIVACAINE DURING TOTAL KNEE ARTHROPLASTY. JPN J ANESTHESIOL. 2016;65(2):179-83",73.0,YR,,F,Y,,,20160603.0,,OT,JP,JP,2016,Q2,Elderly
123340371,12334037,11,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,"8-12 IU, ONCE DAILY",,,,U,,,,,,FORMULATION UNKNOWN,QD,2016,Q2,Cervical dysplasia,,2016,Q2,1,I,20140513.0,20160428.0,20160504,20160504,EXP,,CA-ASTELLAS-2016US016799,ASTELLAS,,39.0,YR,,F,Y,,,20160504.0,,MD,CA,CA,2016,Q2,Adult
123349541,12334954,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Hyperglycaemia,,2016,Q2,1,I,20151016.0,20160429.0,20160504,20160504,EXP,,US-ABBVIE-16P-163-1618681-00,ABBVIE,,50.0,YR,,F,Y,94.3,KG,20160504.0,,CN,COUNTRY NOT SPECIFIED,US,2016,Q2,Adult
123352891,12335289,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,40.0,IU,,QD,2016,Q2,Diabetic ketoacidosis,,2016,Q2,1,I,20160421.0,20160427.0,20160504,20160504,EXP,,US-ASTRAZENECA-2016SE47366,ASTRAZENECA,,17831.0,DY,,F,Y,,,20160504.0,,MD,US,US,2016,Q2,Elderly
123352891,12335289,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,40.0,IU,,QD,2016,Q2,Urinary tract infection,,2016,Q2,1,I,20160421.0,20160427.0,20160504,20160504,EXP,,US-ASTRAZENECA-2016SE47366,ASTRAZENECA,,17831.0,DY,,F,Y,,,20160504.0,,MD,US,US,2016,Q2,Elderly
123362601,12336260,7,C,Glargine insulin,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q2,Acute kidney injury,,2016,Q2,1,I,,20160421.0,20160505,20160505,EXP,,US-LUPIN PHARMACEUTICALS INC.-2016-01736,LUPIN,"JHAVERI K, BAIRD P, LEUNG S, HOANG H, BABALOLA O, DEVOE C, WANCHOO R. A CASE OF ACUTE KIDNEY INJURY FROM CRYSTAL NEPHROPATHY SECONDARY TO POMALIDOMIDE AND LEVOFLOXACIN USE. JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2015;22(2):357-360.",76.0,YR,,F,Y,,,20160505.0,,OT,US,US,2016,Q2,Elderly
123362601,12336260,7,C,Glargine insulin,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q2,Crystal nephropathy,,2016,Q2,1,I,,20160421.0,20160505,20160505,EXP,,US-LUPIN PHARMACEUTICALS INC.-2016-01736,LUPIN,"JHAVERI K, BAIRD P, LEUNG S, HOANG H, BABALOLA O, DEVOE C, WANCHOO R. A CASE OF ACUTE KIDNEY INJURY FROM CRYSTAL NEPHROPATHY SECONDARY TO POMALIDOMIDE AND LEVOFLOXACIN USE. JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2015;22(2):357-360.",76.0,YR,,F,Y,,,20160505.0,,OT,US,US,2016,Q2,Elderly
123379836,12337983,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Activities of daily living impaired,,2016,Q2,6,F,201603.0,20160612.0,20160505,20160621,EXP,,MX-BAYER-2016-072445,BAYER,,33.0,YR,A,F,Y,103.0,KG,20160621.0,,CN,MX,MX,2016,Q2,Young Adult
123379836,12337983,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Alopecia,,2016,Q2,6,F,201603.0,20160612.0,20160505,20160621,EXP,,MX-BAYER-2016-072445,BAYER,,33.0,YR,A,F,Y,103.0,KG,20160621.0,,CN,MX,MX,2016,Q2,Young Adult
123379836,12337983,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Anger,,2016,Q2,6,F,201603.0,20160612.0,20160505,20160621,EXP,,MX-BAYER-2016-072445,BAYER,,33.0,YR,A,F,Y,103.0,KG,20160621.0,,CN,MX,MX,2016,Q2,Young Adult
123379836,12337983,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Anxiety,,2016,Q2,6,F,201603.0,20160612.0,20160505,20160621,EXP,,MX-BAYER-2016-072445,BAYER,,33.0,YR,A,F,Y,103.0,KG,20160621.0,,CN,MX,MX,2016,Q2,Young Adult
123379836,12337983,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Arthralgia,,2016,Q2,6,F,201603.0,20160612.0,20160505,20160621,EXP,,MX-BAYER-2016-072445,BAYER,,33.0,YR,A,F,Y,103.0,KG,20160621.0,,CN,MX,MX,2016,Q2,Young Adult
123379836,12337983,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Asthenia,,2016,Q2,6,F,201603.0,20160612.0,20160505,20160621,EXP,,MX-BAYER-2016-072445,BAYER,,33.0,YR,A,F,Y,103.0,KG,20160621.0,,CN,MX,MX,2016,Q2,Young Adult
123379836,12337983,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Bone pain,,2016,Q2,6,F,201603.0,20160612.0,20160505,20160621,EXP,,MX-BAYER-2016-072445,BAYER,,33.0,YR,A,F,Y,103.0,KG,20160621.0,,CN,MX,MX,2016,Q2,Young Adult
123379836,12337983,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Burning sensation,,2016,Q2,6,F,201603.0,20160612.0,20160505,20160621,EXP,,MX-BAYER-2016-072445,BAYER,,33.0,YR,A,F,Y,103.0,KG,20160621.0,,CN,MX,MX,2016,Q2,Young Adult
123379836,12337983,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Contusion,,2016,Q2,6,F,201603.0,20160612.0,20160505,20160621,EXP,,MX-BAYER-2016-072445,BAYER,,33.0,YR,A,F,Y,103.0,KG,20160621.0,,CN,MX,MX,2016,Q2,Young Adult
123379836,12337983,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Depressed mood,,2016,Q2,6,F,201603.0,20160612.0,20160505,20160621,EXP,,MX-BAYER-2016-072445,BAYER,,33.0,YR,A,F,Y,103.0,KG,20160621.0,,CN,MX,MX,2016,Q2,Young Adult
123379836,12337983,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Depression,,2016,Q2,6,F,201603.0,20160612.0,20160505,20160621,EXP,,MX-BAYER-2016-072445,BAYER,,33.0,YR,A,F,Y,103.0,KG,20160621.0,,CN,MX,MX,2016,Q2,Young Adult
123379836,12337983,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Discomfort,,2016,Q2,6,F,201603.0,20160612.0,20160505,20160621,EXP,,MX-BAYER-2016-072445,BAYER,,33.0,YR,A,F,Y,103.0,KG,20160621.0,,CN,MX,MX,2016,Q2,Young Adult
123379836,12337983,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Dry mouth,,2016,Q2,6,F,201603.0,20160612.0,20160505,20160621,EXP,,MX-BAYER-2016-072445,BAYER,,33.0,YR,A,F,Y,103.0,KG,20160621.0,,CN,MX,MX,2016,Q2,Young Adult
123379836,12337983,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Dry skin,,2016,Q2,6,F,201603.0,20160612.0,20160505,20160621,EXP,,MX-BAYER-2016-072445,BAYER,,33.0,YR,A,F,Y,103.0,KG,20160621.0,,CN,MX,MX,2016,Q2,Young Adult
123379836,12337983,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Feeling abnormal,,2016,Q2,6,F,201603.0,20160612.0,20160505,20160621,EXP,,MX-BAYER-2016-072445,BAYER,,33.0,YR,A,F,Y,103.0,KG,20160621.0,,CN,MX,MX,2016,Q2,Young Adult
123379836,12337983,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,General physical health deterioration,,2016,Q2,6,F,201603.0,20160612.0,20160505,20160621,EXP,,MX-BAYER-2016-072445,BAYER,,33.0,YR,A,F,Y,103.0,KG,20160621.0,,CN,MX,MX,2016,Q2,Young Adult
123379836,12337983,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Hangover,,2016,Q2,6,F,201603.0,20160612.0,20160505,20160621,EXP,,MX-BAYER-2016-072445,BAYER,,33.0,YR,A,F,Y,103.0,KG,20160621.0,,CN,MX,MX,2016,Q2,Young Adult
123379836,12337983,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Headache,,2016,Q2,6,F,201603.0,20160612.0,20160505,20160621,EXP,,MX-BAYER-2016-072445,BAYER,,33.0,YR,A,F,Y,103.0,KG,20160621.0,,CN,MX,MX,2016,Q2,Young Adult
123379836,12337983,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Insomnia,,2016,Q2,6,F,201603.0,20160612.0,20160505,20160621,EXP,,MX-BAYER-2016-072445,BAYER,,33.0,YR,A,F,Y,103.0,KG,20160621.0,,CN,MX,MX,2016,Q2,Young Adult
123379836,12337983,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Joint swelling,,2016,Q2,6,F,201603.0,20160612.0,20160505,20160621,EXP,,MX-BAYER-2016-072445,BAYER,,33.0,YR,A,F,Y,103.0,KG,20160621.0,,CN,MX,MX,2016,Q2,Young Adult
123379836,12337983,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Malaise,,2016,Q2,6,F,201603.0,20160612.0,20160505,20160621,EXP,,MX-BAYER-2016-072445,BAYER,,33.0,YR,A,F,Y,103.0,KG,20160621.0,,CN,MX,MX,2016,Q2,Young Adult
123379836,12337983,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Mood swings,,2016,Q2,6,F,201603.0,20160612.0,20160505,20160621,EXP,,MX-BAYER-2016-072445,BAYER,,33.0,YR,A,F,Y,103.0,KG,20160621.0,,CN,MX,MX,2016,Q2,Young Adult
123379836,12337983,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Nausea,,2016,Q2,6,F,201603.0,20160612.0,20160505,20160621,EXP,,MX-BAYER-2016-072445,BAYER,,33.0,YR,A,F,Y,103.0,KG,20160621.0,,CN,MX,MX,2016,Q2,Young Adult
123379836,12337983,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Neck mass,,2016,Q2,6,F,201603.0,20160612.0,20160505,20160621,EXP,,MX-BAYER-2016-072445,BAYER,,33.0,YR,A,F,Y,103.0,KG,20160621.0,,CN,MX,MX,2016,Q2,Young Adult
123379836,12337983,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Neck pain,,2016,Q2,6,F,201603.0,20160612.0,20160505,20160621,EXP,,MX-BAYER-2016-072445,BAYER,,33.0,YR,A,F,Y,103.0,KG,20160621.0,,CN,MX,MX,2016,Q2,Young Adult
123379836,12337983,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Syncope,,2016,Q2,6,F,201603.0,20160612.0,20160505,20160621,EXP,,MX-BAYER-2016-072445,BAYER,,33.0,YR,A,F,Y,103.0,KG,20160621.0,,CN,MX,MX,2016,Q2,Young Adult
123379836,12337983,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Throat tightness,,2016,Q2,6,F,201603.0,20160612.0,20160505,20160621,EXP,,MX-BAYER-2016-072445,BAYER,,33.0,YR,A,F,Y,103.0,KG,20160621.0,,CN,MX,MX,2016,Q2,Young Adult
123379836,12337983,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Vomiting,,2016,Q2,6,F,201603.0,20160612.0,20160505,20160621,EXP,,MX-BAYER-2016-072445,BAYER,,33.0,YR,A,F,Y,103.0,KG,20160621.0,,CN,MX,MX,2016,Q2,Young Adult
123394322,12339432,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK, PER SLIDING SCALE",,,,,,,,,,,,2016,Q2,Drug ineffective,,2016,Q2,2,F,201502.0,20151209.0,20160505,20160606,PER,,US-AMGEN-USASP2015132302,AMGEN,,63.0,YR,A,F,Y,,,20160606.0,,PH,US,US,2016,Q2,Adult
123398341,12339834,5,C,Glargine insulin,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q2,Acute kidney injury,,2016,Q2,1,I,,20160425.0,20160506,20160506,EXP,,US-HETERO LABS LTD-1051544,HETERO,"PHYLICIA BAIRD, SAM LEUNG, HUY HOANG, OLAWUMI BABALOLA,CRAIG E DEVOE, RIMDA WANCHOO, AND KENAR D JHAVERI.?A CASE OF ACUTE KIDNEY INJURY FROM CRYSTAL NEPHROPATHY SECONDARY TO POMALIDOMIDE AND LEVOFLOXACIN USE?JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2015, 1-4",76.0,YR,,F,Y,,,20160506.0,,OT,US,US,2016,Q2,Elderly
123398341,12339834,5,C,Glargine insulin,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q2,Crystal nephropathy,,2016,Q2,1,I,,20160425.0,20160506,20160506,EXP,,US-HETERO LABS LTD-1051544,HETERO,"PHYLICIA BAIRD, SAM LEUNG, HUY HOANG, OLAWUMI BABALOLA,CRAIG E DEVOE, RIMDA WANCHOO, AND KENAR D JHAVERI.?A CASE OF ACUTE KIDNEY INJURY FROM CRYSTAL NEPHROPATHY SECONDARY TO POMALIDOMIDE AND LEVOFLOXACIN USE?JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2015, 1-4",76.0,YR,,F,Y,,,20160506.0,,OT,US,US,2016,Q2,Elderly
123412802,12341280,2,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",1360.0,IU,,U,,,,20.0,IU,,QD,2016,Q2,Anti-insulin antibody increased,,2016,Q2,2,F,20160315.0,20160510.0,20160506,20160513,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201603011089,ELI LILLY AND CO,,35.0,YR,,F,Y,72.0,KG,20160513.0,,CN,JP,JP,2016,Q2,Adult
123412802,12341280,2,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",1360.0,IU,,U,,,,20.0,IU,,QD,2016,Q2,Hypoglycaemic coma,,2016,Q2,2,F,20160315.0,20160510.0,20160506,20160513,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201603011089,ELI LILLY AND CO,,35.0,YR,,F,Y,72.0,KG,20160513.0,,CN,JP,JP,2016,Q2,Adult
123412802,12341280,3,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",1360.0,IU,,U,,,,16.0,IU,,QD,2016,Q2,Anti-insulin antibody increased,,2016,Q2,2,F,20160315.0,20160510.0,20160506,20160513,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201603011089,ELI LILLY AND CO,,35.0,YR,,F,Y,72.0,KG,20160513.0,,CN,JP,JP,2016,Q2,Adult
123412802,12341280,3,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",1360.0,IU,,U,,,,16.0,IU,,QD,2016,Q2,Hypoglycaemic coma,,2016,Q2,2,F,20160315.0,20160510.0,20160506,20160513,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201603011089,ELI LILLY AND CO,,35.0,YR,,F,Y,72.0,KG,20160513.0,,CN,JP,JP,2016,Q2,Adult
123438101,12343810,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,20.0,IU,,,2016,Q2,Haemolytic anaemia,Haemolytic anaemia,2016,Q2,1,I,,20160425.0,20160507,20160507,EXP,,US-ZYDUS-010928,ZYDUS PHARM,"RUGGIERO NA, KISH TD, LEE ML. METFORMIN-INDUCED HEMOLYTIC ANEMIA IN A PATIENT WITH GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY. AM-J-THER 2016;23(2):E575-E578.",53.0,YR,,M,Y,,,20160507.0,,OT,US,US,2016,Q2,Adult
123438111,12343811,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,,,,,2016,Q2,Acute kidney injury,Acute kidney injury,2016,Q2,1,I,,20160426.0,20160507,20160507,EXP,,US-ZYDUS-010962,ZYDUS PHARM,"BAIRD P, LEUNG S, HOANG H, BABALOLA O, DEVOE CE, WANCHOO R, ET AL. A CASE OF ACUTE KIDNEY INJURY FROM CRYSTAL NEPHROPATHY SECONDARY TO POMALIDOMIDE AND LEVOFLOXACIN USE. J-ONCOL-PHARM-PRACT 2016;22(2):357-360.",76.0,YR,E,F,Y,,,20160507.0,,OT,US,US,2016,Q2,Elderly
123438111,12343811,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,,,,,2016,Q2,Blood creatinine increased,,2016,Q2,1,I,,20160426.0,20160507,20160507,EXP,,US-ZYDUS-010962,ZYDUS PHARM,"BAIRD P, LEUNG S, HOANG H, BABALOLA O, DEVOE CE, WANCHOO R, ET AL. A CASE OF ACUTE KIDNEY INJURY FROM CRYSTAL NEPHROPATHY SECONDARY TO POMALIDOMIDE AND LEVOFLOXACIN USE. J-ONCOL-PHARM-PRACT 2016;22(2):357-360.",76.0,YR,E,F,Y,,,20160507.0,,OT,US,US,2016,Q2,Elderly
123438111,12343811,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,,,,,2016,Q2,Crystal nephropathy,Crystal nephropathy,2016,Q2,1,I,,20160426.0,20160507,20160507,EXP,,US-ZYDUS-010962,ZYDUS PHARM,"BAIRD P, LEUNG S, HOANG H, BABALOLA O, DEVOE CE, WANCHOO R, ET AL. A CASE OF ACUTE KIDNEY INJURY FROM CRYSTAL NEPHROPATHY SECONDARY TO POMALIDOMIDE AND LEVOFLOXACIN USE. J-ONCOL-PHARM-PRACT 2016;22(2):357-360.",76.0,YR,E,F,Y,,,20160507.0,,OT,US,US,2016,Q2,Elderly
123458721,12345872,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,32.0,IU,,QD,2016,Q2,Abdominal pain,,2016,Q2,1,I,20160423.0,20160428.0,20160509,20160509,EXP,,CO-BAXTER-2016BAX022599,BAXTER,,65.0,YR,,M,Y,58.8,KG,20160509.0,,OT,CO,CO,2016,Q2,Elderly
123458721,12345872,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,32.0,IU,,QD,2016,Q2,Cardio-respiratory arrest,,2016,Q2,1,I,20160423.0,20160428.0,20160509,20160509,EXP,,CO-BAXTER-2016BAX022599,BAXTER,,65.0,YR,,M,Y,58.8,KG,20160509.0,,OT,CO,CO,2016,Q2,Elderly
123507671,12350767,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,ONCE IN THE MORNING,,,,,,,,25.0,DF,UNSPECIFIED,,2016,Q2,Back pain,,2016,Q2,1,I,20150510.0,20160428.0,20160510,20160510,EXP,,CA-JNJFOC-20160427776,JANSSEN,,23.0,YR,A,F,Y,65.7,KG,20160510.0,,MD,CA,CA,2016,Q2,Youth
123507671,12350767,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,ONCE IN THE MORNING,,,,,,,,25.0,DF,UNSPECIFIED,,2016,Q2,Diabetic neuropathy,,2016,Q2,1,I,20150510.0,20160428.0,20160510,20160510,EXP,,CA-JNJFOC-20160427776,JANSSEN,,23.0,YR,A,F,Y,65.7,KG,20160510.0,,MD,CA,CA,2016,Q2,Youth
123526291,12352629,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, 1 IN 1 D",,,,,,,,32.0,IU,,QD,2016,Q2,Acute kidney injury,,2016,Q2,1,I,20160112.0,20160503.0,20160510,20160510,EXP,,US-PFIZER INC-2016244521,PFIZER,,67.0,YR,,M,Y,88.0,KG,20160510.0,,MD,US,US,2016,Q2,Elderly
123526291,12352629,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, 1 IN 1 D",,,,,,,,32.0,IU,,QD,2016,Q2,Condition aggravated,,2016,Q2,1,I,20160112.0,20160503.0,20160510,20160510,EXP,,US-PFIZER INC-2016244521,PFIZER,,67.0,YR,,M,Y,88.0,KG,20160510.0,,MD,US,US,2016,Q2,Elderly
123526291,12352629,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 IU, 1 IN 1 D",,,,,,,,32.0,IU,,QD,2016,Q2,Hepatic cirrhosis,,2016,Q2,1,I,20160112.0,20160503.0,20160510,20160510,EXP,,US-PFIZER INC-2016244521,PFIZER,,67.0,YR,,M,Y,88.0,KG,20160510.0,,MD,US,US,2016,Q2,Elderly
123539251,12353925,5,C,Glargine insulin,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2016,Q2,Acute kidney injury,,2016,Q2,1,I,,20160428.0,20160511,20160511,EXP,,US-ORCHID HEALTHCARE-1051836,ORCHID,"BAIRD P, LEUNG S, HOANG H, BABALOLA O, DEVOE CE, WANCHOO R, JHAVERI KD. A CASE OF ACUTE KIDNEY INJURY FROM CRYSTAL NEPHROPATHY SECONDARY TO POMALIDOMIDE AND LEVOFLOXACIN USE. J ONCOL PHARM PRACT. 2016 APR; 22(2):357-60.",76.0,YR,,F,Y,,,20160511.0,,MD,US,US,2016,Q2,Elderly
123539251,12353925,5,C,Glargine insulin,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2016,Q2,Crystal nephropathy,,2016,Q2,1,I,,20160428.0,20160511,20160511,EXP,,US-ORCHID HEALTHCARE-1051836,ORCHID,"BAIRD P, LEUNG S, HOANG H, BABALOLA O, DEVOE CE, WANCHOO R, JHAVERI KD. A CASE OF ACUTE KIDNEY INJURY FROM CRYSTAL NEPHROPATHY SECONDARY TO POMALIDOMIDE AND LEVOFLOXACIN USE. J ONCOL PHARM PRACT. 2016 APR; 22(2):357-60.",76.0,YR,,F,Y,,,20160511.0,,MD,US,US,2016,Q2,Elderly
123544562,12354456,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"14 UT, QD",,,,,,,,,,,,2016,Q2,Cardiomegaly,,2016,Q2,2,F,,20160517.0,20160511,20160518,EXP,,"JP-GLENMARK PHARMACEUTICALS INC, USA.-2016GMK022824",GLENMARK,"OZEKI T.,KAWATO R.,WATANABE M.,MINATOGUCHI S.,MURAI Y.,RYUGE A.,TAKASUGI K.,HAMADA T.,OYAMA Y.,NOMURA A.,TOMINO T.,SHIMIZU H.,FUJITA Y.. A FATAL CASE OF METFORMIN-ASSOCIATED LACTIC ACIDOSIS.. INTERNAL MEDICINE. 2016;55(7):775-778",72.0,YR,,F,Y,,,20160518.0,,MD,JP,JP,2016,Q2,Elderly
123544562,12354456,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"14 UT, QD",,,,,,,,,,,,2016,Q2,Hypoglycaemia,,2016,Q2,2,F,,20160517.0,20160511,20160518,EXP,,"JP-GLENMARK PHARMACEUTICALS INC, USA.-2016GMK022824",GLENMARK,"OZEKI T.,KAWATO R.,WATANABE M.,MINATOGUCHI S.,MURAI Y.,RYUGE A.,TAKASUGI K.,HAMADA T.,OYAMA Y.,NOMURA A.,TOMINO T.,SHIMIZU H.,FUJITA Y.. A FATAL CASE OF METFORMIN-ASSOCIATED LACTIC ACIDOSIS.. INTERNAL MEDICINE. 2016;55(7):775-778",72.0,YR,,F,Y,,,20160518.0,,MD,JP,JP,2016,Q2,Elderly
123544562,12354456,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"14 UT, QD",,,,,,,,,,,,2016,Q2,Hypotension,,2016,Q2,2,F,,20160517.0,20160511,20160518,EXP,,"JP-GLENMARK PHARMACEUTICALS INC, USA.-2016GMK022824",GLENMARK,"OZEKI T.,KAWATO R.,WATANABE M.,MINATOGUCHI S.,MURAI Y.,RYUGE A.,TAKASUGI K.,HAMADA T.,OYAMA Y.,NOMURA A.,TOMINO T.,SHIMIZU H.,FUJITA Y.. A FATAL CASE OF METFORMIN-ASSOCIATED LACTIC ACIDOSIS.. INTERNAL MEDICINE. 2016;55(7):775-778",72.0,YR,,F,Y,,,20160518.0,,MD,JP,JP,2016,Q2,Elderly
123544562,12354456,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"14 UT, QD",,,,,,,,,,,,2016,Q2,Lactic acidosis,,2016,Q2,2,F,,20160517.0,20160511,20160518,EXP,,"JP-GLENMARK PHARMACEUTICALS INC, USA.-2016GMK022824",GLENMARK,"OZEKI T.,KAWATO R.,WATANABE M.,MINATOGUCHI S.,MURAI Y.,RYUGE A.,TAKASUGI K.,HAMADA T.,OYAMA Y.,NOMURA A.,TOMINO T.,SHIMIZU H.,FUJITA Y.. A FATAL CASE OF METFORMIN-ASSOCIATED LACTIC ACIDOSIS.. INTERNAL MEDICINE. 2016;55(7):775-778",72.0,YR,,F,Y,,,20160518.0,,MD,JP,JP,2016,Q2,Elderly
123544562,12354456,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"14 UT, QD",,,,,,,,,,,,2016,Q2,Overdose,,2016,Q2,2,F,,20160517.0,20160511,20160518,EXP,,"JP-GLENMARK PHARMACEUTICALS INC, USA.-2016GMK022824",GLENMARK,"OZEKI T.,KAWATO R.,WATANABE M.,MINATOGUCHI S.,MURAI Y.,RYUGE A.,TAKASUGI K.,HAMADA T.,OYAMA Y.,NOMURA A.,TOMINO T.,SHIMIZU H.,FUJITA Y.. A FATAL CASE OF METFORMIN-ASSOCIATED LACTIC ACIDOSIS.. INTERNAL MEDICINE. 2016;55(7):775-778",72.0,YR,,F,Y,,,20160518.0,,MD,JP,JP,2016,Q2,Elderly
123544562,12354456,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"14 UT, QD",,,,,,,,,,,,2016,Q2,Pulmonary oedema,,2016,Q2,2,F,,20160517.0,20160511,20160518,EXP,,"JP-GLENMARK PHARMACEUTICALS INC, USA.-2016GMK022824",GLENMARK,"OZEKI T.,KAWATO R.,WATANABE M.,MINATOGUCHI S.,MURAI Y.,RYUGE A.,TAKASUGI K.,HAMADA T.,OYAMA Y.,NOMURA A.,TOMINO T.,SHIMIZU H.,FUJITA Y.. A FATAL CASE OF METFORMIN-ASSOCIATED LACTIC ACIDOSIS.. INTERNAL MEDICINE. 2016;55(7):775-778",72.0,YR,,F,Y,,,20160518.0,,MD,JP,JP,2016,Q2,Elderly
123554751,12355475,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,U, UNKNOWN,,,,,,,2016,Q2,Generalised oedema,,2016,Q2,1,I,,20160502.0,20160511,20160511,EXP,,US-NOVOPROD-490771,NOVO NORDISK,WILLIAM T. MYERS. GENERALIZED ANASARCA IN 15-YEAR-OLD GIRL WITH TYPE 1 DIABETES. PEDIATRICS IN REVIEW / AMERICAN ACADEMY OF PEDIATRICS. 2016;37(2):81-82,15.0,YR,T,F,Y,51.0,KG,20160511.0,,MD,US,US,2016,Q2,Youth
123555771,12355577,10,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Injection site pain,,2016,Q2,1,I,20160302.0,20160509.0,20160511,20160511,EXP,,US-HOSPIRA-3287671,HOSPIRA,,72.0,YR,E,F,Y,103.0,KG,20160511.0,,MD,US,US,2016,Q2,Elderly
123555771,12355577,10,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Myocardial infarction,,2016,Q2,1,I,20160302.0,20160509.0,20160511,20160511,EXP,,US-HOSPIRA-3287671,HOSPIRA,,72.0,YR,E,F,Y,103.0,KG,20160511.0,,MD,US,US,2016,Q2,Elderly
123657562,12365756,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,22.0,IU,UNSPECIFIED,,2016,Q2,Chest pain,,2016,Q2,2,F,,20160506.0,20160513,20160527,EXP,,MX-JNJFOC-20160511023,JANSSEN,,45.0,YR,A,F,Y,,,20160527.0,,CN,MX,MX,2016,Q2,Adult
123657562,12365756,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,22.0,IU,UNSPECIFIED,,2016,Q2,Hypertension,,2016,Q2,2,F,,20160506.0,20160513,20160527,EXP,,MX-JNJFOC-20160511023,JANSSEN,,45.0,YR,A,F,Y,,,20160527.0,,CN,MX,MX,2016,Q2,Adult
123657562,12365756,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2016,Q2,Chest pain,,2016,Q2,2,F,,20160506.0,20160513,20160527,EXP,,MX-JNJFOC-20160511023,JANSSEN,,45.0,YR,A,F,Y,,,20160527.0,,CN,MX,MX,2016,Q2,Adult
123657562,12365756,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2016,Q2,Hypertension,,2016,Q2,2,F,,20160506.0,20160513,20160527,EXP,,MX-JNJFOC-20160511023,JANSSEN,,45.0,YR,A,F,Y,,,20160527.0,,CN,MX,MX,2016,Q2,Adult
123699772,12369977,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 DF,,,,,,,,28.0,DF,SOLUTION FOR INJECTION,,2016,Q2,Toxic skin eruption,,2016,Q2,2,F,20160423.0,20160512.0,20160516,20160519,EXP,,PHHY2016IT063632,SANDOZ,,68.0,YR,,M,Y,79.0,KG,20160520.0,,OT,IT,IT,2016,Q2,Elderly
123713551,12371355,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"24 DF, QD",,,,U, UNKNOWN,,205692.0,24.0,DF,,QD,2016,Q2,Diabetic ketoacidosis,,2016,Q2,1,I,2015.0,20160510.0,20160516,20160516,EXP,,GB-ELI_LILLY_AND_COMPANY-GB201605003143,ELI LILLY AND CO,,21.0,YR,,M,Y,,,20160515.0,,CN,GB,GB,2016,Q2,Youth
123713551,12371355,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"24 DF, QD",,,,U, UNKNOWN,,205692.0,24.0,DF,,QD,2016,Q2,Drug dose omission,,2016,Q2,1,I,2015.0,20160510.0,20160516,20160516,EXP,,GB-ELI_LILLY_AND_COMPANY-GB201605003143,ELI LILLY AND CO,,21.0,YR,,M,Y,,,20160515.0,,CN,GB,GB,2016,Q2,Youth
123730001,12373000,5,C,glargine insulin,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Acute kidney injury,,2016,Q2,1,I,,20160513.0,20160516,20160516,EXP,,US-CLARIS PHARMASERVICES-1052262,CLARIS,"BAIRD P, LEUNG S, HOANG H, BABALOLA O, DEVOE CE, WANCHOO R, JHAVERI KD. A CASE OF ACUTE KIDNEY INJURY FROM CRYSTAL NEPHROPATHY SECONDARY TO POMALIDOMIDE AND LEVOFLOXACIN USE. J ONCOL PHARM PRACT. 2016 APR; 22(2):357-60",76.0,YR,,F,Y,,,20160516.0,,MD,GB,US,2016,Q2,Elderly
123730001,12373000,5,C,glargine insulin,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Drug interaction,,2016,Q2,1,I,,20160513.0,20160516,20160516,EXP,,US-CLARIS PHARMASERVICES-1052262,CLARIS,"BAIRD P, LEUNG S, HOANG H, BABALOLA O, DEVOE CE, WANCHOO R, JHAVERI KD. A CASE OF ACUTE KIDNEY INJURY FROM CRYSTAL NEPHROPATHY SECONDARY TO POMALIDOMIDE AND LEVOFLOXACIN USE. J ONCOL PHARM PRACT. 2016 APR; 22(2):357-60",76.0,YR,,F,Y,,,20160516.0,,MD,GB,US,2016,Q2,Elderly
123730001,12373000,5,C,glargine insulin,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Febrile neutropenia,,2016,Q2,1,I,,20160513.0,20160516,20160516,EXP,,US-CLARIS PHARMASERVICES-1052262,CLARIS,"BAIRD P, LEUNG S, HOANG H, BABALOLA O, DEVOE CE, WANCHOO R, JHAVERI KD. A CASE OF ACUTE KIDNEY INJURY FROM CRYSTAL NEPHROPATHY SECONDARY TO POMALIDOMIDE AND LEVOFLOXACIN USE. J ONCOL PHARM PRACT. 2016 APR; 22(2):357-60",76.0,YR,,F,Y,,,20160516.0,,MD,GB,US,2016,Q2,Elderly
123730001,12373000,5,C,glargine insulin,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Nephropathy,,2016,Q2,1,I,,20160513.0,20160516,20160516,EXP,,US-CLARIS PHARMASERVICES-1052262,CLARIS,"BAIRD P, LEUNG S, HOANG H, BABALOLA O, DEVOE CE, WANCHOO R, JHAVERI KD. A CASE OF ACUTE KIDNEY INJURY FROM CRYSTAL NEPHROPATHY SECONDARY TO POMALIDOMIDE AND LEVOFLOXACIN USE. J ONCOL PHARM PRACT. 2016 APR; 22(2):357-60",76.0,YR,,F,Y,,,20160516.0,,MD,GB,US,2016,Q2,Elderly
123730001,12373000,5,C,glargine insulin,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Pneumonia,,2016,Q2,1,I,,20160513.0,20160516,20160516,EXP,,US-CLARIS PHARMASERVICES-1052262,CLARIS,"BAIRD P, LEUNG S, HOANG H, BABALOLA O, DEVOE CE, WANCHOO R, JHAVERI KD. A CASE OF ACUTE KIDNEY INJURY FROM CRYSTAL NEPHROPATHY SECONDARY TO POMALIDOMIDE AND LEVOFLOXACIN USE. J ONCOL PHARM PRACT. 2016 APR; 22(2):357-60",76.0,YR,,F,Y,,,20160516.0,,MD,GB,US,2016,Q2,Elderly
123730001,12373000,5,C,glargine insulin,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Respiratory syncytial virus test positive,,2016,Q2,1,I,,20160513.0,20160516,20160516,EXP,,US-CLARIS PHARMASERVICES-1052262,CLARIS,"BAIRD P, LEUNG S, HOANG H, BABALOLA O, DEVOE CE, WANCHOO R, JHAVERI KD. A CASE OF ACUTE KIDNEY INJURY FROM CRYSTAL NEPHROPATHY SECONDARY TO POMALIDOMIDE AND LEVOFLOXACIN USE. J ONCOL PHARM PRACT. 2016 APR; 22(2):357-60",76.0,YR,,F,Y,,,20160516.0,,MD,GB,US,2016,Q2,Elderly
123730001,12373000,5,C,glargine insulin,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Thrombocytopenia,,2016,Q2,1,I,,20160513.0,20160516,20160516,EXP,,US-CLARIS PHARMASERVICES-1052262,CLARIS,"BAIRD P, LEUNG S, HOANG H, BABALOLA O, DEVOE CE, WANCHOO R, JHAVERI KD. A CASE OF ACUTE KIDNEY INJURY FROM CRYSTAL NEPHROPATHY SECONDARY TO POMALIDOMIDE AND LEVOFLOXACIN USE. J ONCOL PHARM PRACT. 2016 APR; 22(2):357-60",76.0,YR,,F,Y,,,20160516.0,,MD,GB,US,2016,Q2,Elderly
123755422,12375542,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Hypercapnia,,2016,Q2,2,F,20160404.0,20160518.0,20160517,20160525,EXP,,IT-PFIZER INC-2016252856,PFIZER,,82.0,YR,,M,Y,,,20160525.0,,MD,IT,IT,2016,Q2,Elderly
123755422,12375542,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Respiratory depression,,2016,Q2,2,F,20160404.0,20160518.0,20160517,20160525,EXP,,IT-PFIZER INC-2016252856,PFIZER,,82.0,YR,,M,Y,,,20160525.0,,MD,IT,IT,2016,Q2,Elderly
123755422,12375542,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Sopor,,2016,Q2,2,F,20160404.0,20160518.0,20160517,20160525,EXP,,IT-PFIZER INC-2016252856,PFIZER,,82.0,YR,,M,Y,,,20160525.0,,MD,IT,IT,2016,Q2,Elderly
123762431,12376243,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Blood glucose increased,,2016,Q2,1,I,20160503.0,,20160516,20160516,DIR,,,,,71.0,YR,,M,N,69.4,KG,20160513.0,N,,US,,2016,Q2,Elderly
123762431,12376243,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Dizziness,,2016,Q2,1,I,20160503.0,,20160516,20160516,DIR,,,,,71.0,YR,,M,N,69.4,KG,20160513.0,N,,US,,2016,Q2,Elderly
123762431,12376243,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Hyperhidrosis,,2016,Q2,1,I,20160503.0,,20160516,20160516,DIR,,,,,71.0,YR,,M,N,69.4,KG,20160513.0,N,,US,,2016,Q2,Elderly
123762431,12376243,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Refusal of treatment by patient,,2016,Q2,1,I,20160503.0,,20160516,20160516,DIR,,,,,71.0,YR,,M,N,69.4,KG,20160513.0,N,,US,,2016,Q2,Elderly
123762431,12376243,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Respiratory acidosis,,2016,Q2,1,I,20160503.0,,20160516,20160516,DIR,,,,,71.0,YR,,M,N,69.4,KG,20160513.0,N,,US,,2016,Q2,Elderly
123808371,12380837,4,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"14 IU, QD",,,,U,,,,14.0,IU,,,2016,Q2,Anion gap increased,,2016,Q2,1,I,,20160513.0,20160518,20160518,EXP,,JP-SCIEGEN PHARMACEUTICALS INC-2016SCILIT00121,SCIEGEN,,72.0,YR,,F,Y,,,20160518.0,,MD,JP,JP,2016,Q2,Elderly
123808371,12380837,4,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"14 IU, QD",,,,U,,,,14.0,IU,,,2016,Q2,Anuria,,2016,Q2,1,I,,20160513.0,20160518,20160518,EXP,,JP-SCIEGEN PHARMACEUTICALS INC-2016SCILIT00121,SCIEGEN,,72.0,YR,,F,Y,,,20160518.0,,MD,JP,JP,2016,Q2,Elderly
123808371,12380837,4,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"14 IU, QD",,,,U,,,,14.0,IU,,,2016,Q2,Blood pH decreased,,2016,Q2,1,I,,20160513.0,20160518,20160518,EXP,,JP-SCIEGEN PHARMACEUTICALS INC-2016SCILIT00121,SCIEGEN,,72.0,YR,,F,Y,,,20160518.0,,MD,JP,JP,2016,Q2,Elderly
123808371,12380837,4,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"14 IU, QD",,,,U,,,,14.0,IU,,,2016,Q2,Cardiomegaly,,2016,Q2,1,I,,20160513.0,20160518,20160518,EXP,,JP-SCIEGEN PHARMACEUTICALS INC-2016SCILIT00121,SCIEGEN,,72.0,YR,,F,Y,,,20160518.0,,MD,JP,JP,2016,Q2,Elderly
123808371,12380837,4,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"14 IU, QD",,,,U,,,,14.0,IU,,,2016,Q2,Death,,2016,Q2,1,I,,20160513.0,20160518,20160518,EXP,,JP-SCIEGEN PHARMACEUTICALS INC-2016SCILIT00121,SCIEGEN,,72.0,YR,,F,Y,,,20160518.0,,MD,JP,JP,2016,Q2,Elderly
123808371,12380837,4,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"14 IU, QD",,,,U,,,,14.0,IU,,,2016,Q2,Fall,,2016,Q2,1,I,,20160513.0,20160518,20160518,EXP,,JP-SCIEGEN PHARMACEUTICALS INC-2016SCILIT00121,SCIEGEN,,72.0,YR,,F,Y,,,20160518.0,,MD,JP,JP,2016,Q2,Elderly
123808371,12380837,4,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"14 IU, QD",,,,U,,,,14.0,IU,,,2016,Q2,Hypoglycaemia,,2016,Q2,1,I,,20160513.0,20160518,20160518,EXP,,JP-SCIEGEN PHARMACEUTICALS INC-2016SCILIT00121,SCIEGEN,,72.0,YR,,F,Y,,,20160518.0,,MD,JP,JP,2016,Q2,Elderly
123808371,12380837,4,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"14 IU, QD",,,,U,,,,14.0,IU,,,2016,Q2,Hypotension,,2016,Q2,1,I,,20160513.0,20160518,20160518,EXP,,JP-SCIEGEN PHARMACEUTICALS INC-2016SCILIT00121,SCIEGEN,,72.0,YR,,F,Y,,,20160518.0,,MD,JP,JP,2016,Q2,Elderly
123808371,12380837,4,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"14 IU, QD",,,,U,,,,14.0,IU,,,2016,Q2,Metabolic acidosis,,2016,Q2,1,I,,20160513.0,20160518,20160518,EXP,,JP-SCIEGEN PHARMACEUTICALS INC-2016SCILIT00121,SCIEGEN,,72.0,YR,,F,Y,,,20160518.0,,MD,JP,JP,2016,Q2,Elderly
123808371,12380837,4,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"14 IU, QD",,,,U,,,,14.0,IU,,,2016,Q2,Overdose,,2016,Q2,1,I,,20160513.0,20160518,20160518,EXP,,JP-SCIEGEN PHARMACEUTICALS INC-2016SCILIT00121,SCIEGEN,,72.0,YR,,F,Y,,,20160518.0,,MD,JP,JP,2016,Q2,Elderly
123808371,12380837,4,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"14 IU, QD",,,,U,,,,14.0,IU,,,2016,Q2,Pulmonary oedema,,2016,Q2,1,I,,20160513.0,20160518,20160518,EXP,,JP-SCIEGEN PHARMACEUTICALS INC-2016SCILIT00121,SCIEGEN,,72.0,YR,,F,Y,,,20160518.0,,MD,JP,JP,2016,Q2,Elderly
123808371,12380837,4,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"14 IU, QD",,,,U,,,,14.0,IU,,,2016,Q2,Vomiting,,2016,Q2,1,I,,20160513.0,20160518,20160518,EXP,,JP-SCIEGEN PHARMACEUTICALS INC-2016SCILIT00121,SCIEGEN,,72.0,YR,,F,Y,,,20160518.0,,MD,JP,JP,2016,Q2,Elderly
123815132,12381513,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q2,Hypercapnia,,2016,Q2,2,F,20160404.0,20160518.0,20160518,20160525,EXP,,PHHY2016IT066137,SANDOZ,,82.0,YR,,M,Y,,,20160526.0,,OT,IT,IT,2016,Q2,Elderly
123815132,12381513,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q2,Respiratory depression,,2016,Q2,2,F,20160404.0,20160518.0,20160518,20160525,EXP,,PHHY2016IT066137,SANDOZ,,82.0,YR,,M,Y,,,20160526.0,,OT,IT,IT,2016,Q2,Elderly
123815132,12381513,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q2,Sopor,,2016,Q2,2,F,20160404.0,20160518.0,20160518,20160525,EXP,,PHHY2016IT066137,SANDOZ,,82.0,YR,,M,Y,,,20160526.0,,OT,IT,IT,2016,Q2,Elderly
123820381,12382038,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Drug level decreased,,2016,Q2,1,I,20160510.0,,20160517,20160517,DIR,,,,,49.0,YR,,M,N,113.4,KG,20160516.0,N,PH,US,,2016,Q2,Adult
123837972,12383797,2,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Prurigo,,2016,Q2,2,F,20160315.0,20160524.0,20160519,20160527,EXP,,BR-ROCHE-1760150,ROCHE,,80.0,YR,,M,Y,55.0,KG,20160527.0,,PH,BR,BR,2016,Q2,Elderly
123837972,12383797,2,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Rash,,2016,Q2,2,F,20160315.0,20160524.0,20160519,20160527,EXP,,BR-ROCHE-1760150,ROCHE,,80.0,YR,,M,Y,55.0,KG,20160527.0,,PH,BR,BR,2016,Q2,Elderly
123892721,12389272,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2016,Q2,Hepatitis toxic,,2016,Q2,1,I,20081002.0,20090720.0,20160520,20160520,EXP,,US-PFIZER INC-332496,PFIZER,,82.0,YR,,F,Y,75.7,KG,20160520.0,,MD,US,US,2016,Q2,Elderly
123899652,12389965,10,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,"UNK, DAILY",,,,U,,,,,,,,2016,Q2,Hypercapnia,,2016,Q2,2,F,20160404.0,20160518.0,20160520,20160526,EXP,,IT-PURDUE PHARMA-GBR-2016-0036271,PURDUE,,82.0,YR,,M,Y,,,20160526.0,,MD,IT,IT,2016,Q2,Elderly
123899652,12389965,10,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,"UNK, DAILY",,,,U,,,,,,,,2016,Q2,Respiratory depression,,2016,Q2,2,F,20160404.0,20160518.0,20160520,20160526,EXP,,IT-PURDUE PHARMA-GBR-2016-0036271,PURDUE,,82.0,YR,,M,Y,,,20160526.0,,MD,IT,IT,2016,Q2,Elderly
123899652,12389965,10,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,"UNK, DAILY",,,,U,,,,,,,,2016,Q2,Sopor,,2016,Q2,2,F,20160404.0,20160518.0,20160520,20160526,EXP,,IT-PURDUE PHARMA-GBR-2016-0036271,PURDUE,,82.0,YR,,M,Y,,,20160526.0,,MD,IT,IT,2016,Q2,Elderly
123901911,12390191,1,PS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"8 IU, UNK",,,,,,,205692.0,8.0,IU,,,2016,Q2,Marasmus,,2016,Q2,1,I,20160318.0,20160516.0,20160520,20160520,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201605006165,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20160520.0,,CN,JP,JP,2016,Q2,Elderly
123909112,12390911,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Hypercapnia,,2016,Q2,2,F,20160404.0,20160519.0,20160520,20160602,EXP,IT-MINISAL02-358470,IT-TEVA-660271ACC,TEVA,,82.0,YR,,M,Y,,,20160601.0,,MD,IT,IT,2016,Q2,Elderly
123909112,12390911,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Pyrexia,,2016,Q2,2,F,20160404.0,20160519.0,20160520,20160602,EXP,IT-MINISAL02-358470,IT-TEVA-660271ACC,TEVA,,82.0,YR,,M,Y,,,20160601.0,,MD,IT,IT,2016,Q2,Elderly
123909112,12390911,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Respiratory depression,,2016,Q2,2,F,20160404.0,20160519.0,20160520,20160602,EXP,IT-MINISAL02-358470,IT-TEVA-660271ACC,TEVA,,82.0,YR,,M,Y,,,20160601.0,,MD,IT,IT,2016,Q2,Elderly
123909112,12390911,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Sopor,,2016,Q2,2,F,20160404.0,20160519.0,20160520,20160602,EXP,IT-MINISAL02-358470,IT-TEVA-660271ACC,TEVA,,82.0,YR,,M,Y,,,20160601.0,,MD,IT,IT,2016,Q2,Elderly
123913441,12391344,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q2,Pneumonia,,2016,Q2,1,I,20160406.0,20160516.0,20160520,20160520,EXP,,PT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-038971,BRISTOL MYERS SQUIBB,,65.0,YR,,M,Y,,,20160520.0,,OT,PT,PT,2016,Q2,Elderly
123923531,12392353,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, NIGHTLY",,,,U,,,,10.0,IU,,,2016,Q2,Confusional state,,2016,Q2,1,I,,20160418.0,20160523,20160523,EXP,,US-AUROBINDO-AUR-APL-2016-05234,AUROBINDO,HUI J.. VORICONAZOLE CONFUSION: CASE REPORT. REACTIONS WEEKLY. 2016;1597:211,71.0,YR,,M,Y,,,20160523.0,,OT,US,US,2016,Q2,Elderly
123923531,12392353,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, NIGHTLY",,,,U,,,,10.0,IU,,,2016,Q2,Mental status changes,,2016,Q2,1,I,,20160418.0,20160523,20160523,EXP,,US-AUROBINDO-AUR-APL-2016-05234,AUROBINDO,HUI J.. VORICONAZOLE CONFUSION: CASE REPORT. REACTIONS WEEKLY. 2016;1597:211,71.0,YR,,M,Y,,,20160523.0,,OT,US,US,2016,Q2,Elderly
123923581,12392358,9,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2016,Q2,Fall,,2016,Q2,1,I,20160418.0,20160418.0,20160523,20160523,EXP,,CO-BAXTER-2016BAX020460,BAXTER,,66.0,YR,,F,Y,78.0,KG,20160523.0,,OT,CO,CO,2016,Q2,Elderly
123924322,12392432,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2016,Q2,Hypercapnia,,2016,Q2,2,F,20160404.0,20160519.0,20160523,20160601,EXP,,IT-AUROBINDO-AUR-APL-2016-06067,AUROBINDO,,82.0,YR,,M,Y,,,20160601.0,,MD,IT,IT,2016,Q2,Elderly
123924322,12392432,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2016,Q2,Respiratory depression,,2016,Q2,2,F,20160404.0,20160519.0,20160523,20160601,EXP,,IT-AUROBINDO-AUR-APL-2016-06067,AUROBINDO,,82.0,YR,,M,Y,,,20160601.0,,MD,IT,IT,2016,Q2,Elderly
123924322,12392432,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2016,Q2,Sopor,,2016,Q2,2,F,20160404.0,20160519.0,20160523,20160601,EXP,,IT-AUROBINDO-AUR-APL-2016-06067,AUROBINDO,,82.0,YR,,M,Y,,,20160601.0,,MD,IT,IT,2016,Q2,Elderly
123972091,12397209,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,U,,,,,,INJECTION,,2016,Q2,Hypoglycaemia,,2016,Q2,1,I,20160223.0,20160511.0,20160524,20160524,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605004251,ELI LILLY AND CO,,24.0,YR,,M,Y,,,20160523.0,,CN,IT,IT,2016,Q2,Young Adult
123972091,12397209,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,U,,,,,,INJECTION,,2016,Q2,Incorrect dose administered,,2016,Q2,1,I,20160223.0,20160511.0,20160524,20160524,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605004251,ELI LILLY AND CO,,24.0,YR,,M,Y,,,20160523.0,,CN,IT,IT,2016,Q2,Young Adult
123972091,12397209,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,U,,,,,,INJECTION,,2016,Q2,Vomiting,,2016,Q2,1,I,20160223.0,20160511.0,20160524,20160524,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605004251,ELI LILLY AND CO,,24.0,YR,,M,Y,,,20160523.0,,CN,IT,IT,2016,Q2,Young Adult
123972091,12397209,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,U,,,,,,INJECTION,,2016,Q2,Hypoglycaemia,,2016,Q2,1,I,20160223.0,20160511.0,20160524,20160524,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605004251,ELI LILLY AND CO,,24.0,YR,,M,Y,,,20160523.0,,CN,IT,IT,2016,Q2,Young Adult
123972091,12397209,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,U,,,,,,INJECTION,,2016,Q2,Incorrect dose administered,,2016,Q2,1,I,20160223.0,20160511.0,20160524,20160524,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605004251,ELI LILLY AND CO,,24.0,YR,,M,Y,,,20160523.0,,CN,IT,IT,2016,Q2,Young Adult
123972091,12397209,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,U,,,,,,INJECTION,,2016,Q2,Vomiting,,2016,Q2,1,I,20160223.0,20160511.0,20160524,20160524,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605004251,ELI LILLY AND CO,,24.0,YR,,M,Y,,,20160523.0,,CN,IT,IT,2016,Q2,Young Adult
123973122,12397312,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2016,Q2,Hypercapnia,,2016,Q2,2,F,20160404.0,20160518.0,20160524,20160602,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-117111,RANBAXY,,82.0,YR,,M,Y,,,20160602.0,,OT,IT,IT,2016,Q2,Elderly
123973122,12397312,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2016,Q2,Respiratory depression,,2016,Q2,2,F,20160404.0,20160518.0,20160524,20160602,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-117111,RANBAXY,,82.0,YR,,M,Y,,,20160602.0,,OT,IT,IT,2016,Q2,Elderly
123973122,12397312,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2016,Q2,Sopor,,2016,Q2,2,F,20160404.0,20160518.0,20160524,20160602,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-117111,RANBAXY,,82.0,YR,,M,Y,,,20160602.0,,OT,IT,IT,2016,Q2,Elderly
123978621,12397862,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,Y,,,,43.0,IU,,QD,2016,Q2,Dizziness,,2016,Q2,1,I,20160410.0,,20160523,20160523,DIR,,,,,62.0,YR,,M,N,,,20160505.0,N,PH,US,,2016,Q2,Adult
123978621,12397862,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,Y,,,,43.0,IU,,QD,2016,Q2,Hypoaesthesia,,2016,Q2,1,I,20160410.0,,20160523,20160523,DIR,,,,,62.0,YR,,M,N,,,20160505.0,N,PH,US,,2016,Q2,Adult
123980261,12398026,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Colitis,,2016,Q2,1,I,20160404.0,,20160523,20160523,DIR,,,,,53.0,YR,,M,N,,,20160421.0,N,PH,US,,2016,Q2,Adult
124013741,12401374,2,C,GLARGINE,,2,Unknown,FORMULATION: INJECTION;,,,,,,,,40.0,IU,,,2016,Q2,Diabetic ketoacidosis,,2016,Q2,1,I,,20160517.0,20160525,20160525,EXP,,"PK-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-31834BI",BOEHRINGER INGELHEIM,"RASHID O,FAROOQ S,KIRAN Z,ISLAM N. EUGLYCAEMIC DIABETIC KETOACIDOSIS IN A PATIENT WITH TYPE 2 DIABETES STARTED ON EMPAGLIFLOZIN. BMJ CASE REPORTS 2016;.",42.0,YR,,M,Y,,,20160525.0,,OT,COUNTRY NOT SPECIFIED,PK,2016,Q2,Adult
124013741,12401374,3,C,GLARGINE,,2,Unknown,,,,,,,,,20.0,IU,,,2016,Q2,Diabetic ketoacidosis,,2016,Q2,1,I,,20160517.0,20160525,20160525,EXP,,"PK-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-31834BI",BOEHRINGER INGELHEIM,"RASHID O,FAROOQ S,KIRAN Z,ISLAM N. EUGLYCAEMIC DIABETIC KETOACIDOSIS IN A PATIENT WITH TYPE 2 DIABETES STARTED ON EMPAGLIFLOZIN. BMJ CASE REPORTS 2016;.",42.0,YR,,M,Y,,,20160525.0,,OT,COUNTRY NOT SPECIFIED,PK,2016,Q2,Adult
124095191,12409519,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,70 IU (INTERNATIONAL UNIT) DAILY;,,,,,,,,70.0,IU,INJECTION,QD,2016,Q2,Syncope,,2016,Q2,1,I,20160519.0,20160523.0,20160526,20160526,EXP,,US-TEVA-663033USA,TEVA,,67.0,YR,,M,Y,112.0,KG,20160527.0,,MD,US,US,2016,Q2,Elderly
124114501,12411450,10,C,INSULIN ASPART AND GLARGINE,,2,,,,,,,,,,,,,,2016,Q2,Diabetic ketoacidosis,,2016,Q2,1,I,20160506.0,,20160526,20160526,DIR,,,,,39.0,YR,,F,N,84.0,KG,20160525.0,N,PH,US,,2016,Q2,Adult
124114501,12411450,10,C,INSULIN ASPART AND GLARGINE,,2,,,,,,,,,,,,,,2016,Q2,Pancreatitis acute,,2016,Q2,1,I,20160506.0,,20160526,20160526,DIR,,,,,39.0,YR,,F,N,84.0,KG,20160525.0,N,PH,US,,2016,Q2,Adult
124117322,12411732,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Agranulocytosis,Agranulocytosis,2016,Q2,2,F,,20160527.0,20160527,20160608,EXP,,US-DRREDDYS-USA/USA/16/0080123,DR REDDYS,"ISKANDAR J, VANCE J, KABLINGER A, KAVURU B. TRANSIENT AGRANULOCYTOSIS ASSOCIATED WITH ZIPRASIDONE IN A 45-YEAR-OLD MAN ON HEMODIALYSIS. J CLIN PSYCHOPHARMACOL. 2015;35(3):347-8.",45.0,YR,,M,Y,,,20160608.0,,MD,COUNTRY NOT SPECIFIED,US,2016,Q2,Adult
124243771,12424377,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Agitation,,2016,Q2,1,I,20160503.0,,20160531,20160531,DIR,,,,,71.0,YR,,M,N,69.4,KG,20160503.0,N,,US,,2016,Q2,Elderly
124243771,12424377,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Blood glucose increased,,2016,Q2,1,I,20160503.0,,20160531,20160531,DIR,,,,,71.0,YR,,M,N,69.4,KG,20160503.0,N,,US,,2016,Q2,Elderly
124243771,12424377,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Fall,,2016,Q2,1,I,20160503.0,,20160531,20160531,DIR,,,,,71.0,YR,,M,N,69.4,KG,20160503.0,N,,US,,2016,Q2,Elderly
124243771,12424377,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Loss of consciousness,,2016,Q2,1,I,20160503.0,,20160531,20160531,DIR,,,,,71.0,YR,,M,N,69.4,KG,20160503.0,N,,US,,2016,Q2,Elderly
124243771,12424377,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Refusal of treatment by patient,,2016,Q2,1,I,20160503.0,,20160531,20160531,DIR,,,,,71.0,YR,,M,N,69.4,KG,20160503.0,N,,US,,2016,Q2,Elderly
124243771,12424377,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Respiratory acidosis,,2016,Q2,1,I,20160503.0,,20160531,20160531,DIR,,,,,71.0,YR,,M,N,69.4,KG,20160503.0,N,,US,,2016,Q2,Elderly
124243771,12424377,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Self injurious behaviour,,2016,Q2,1,I,20160503.0,,20160531,20160531,DIR,,,,,71.0,YR,,M,N,69.4,KG,20160503.0,N,,US,,2016,Q2,Elderly
124278551,12427855,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, BID",,,,,,,,14.0,IU,,BID,2016,Q2,Anion gap increased,,2016,Q2,1,I,,20160519.0,20160602,20160602,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-041664,BRISTOL MYERS SQUIBB,"OZEKI,. A FATAL CASE OF METFORMIN-ASSOCIATED LACTIC ACIDOSIS.. INTERNAL MEDICINE. 2016;55 (7):775-778",72.0,YR,,F,Y,,,20160602.0,,MD,JP,JP,2016,Q2,Elderly
124278551,12427855,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, BID",,,,,,,,14.0,IU,,BID,2016,Q2,Anuria,,2016,Q2,1,I,,20160519.0,20160602,20160602,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-041664,BRISTOL MYERS SQUIBB,"OZEKI,. A FATAL CASE OF METFORMIN-ASSOCIATED LACTIC ACIDOSIS.. INTERNAL MEDICINE. 2016;55 (7):775-778",72.0,YR,,F,Y,,,20160602.0,,MD,JP,JP,2016,Q2,Elderly
124278551,12427855,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, BID",,,,,,,,14.0,IU,,BID,2016,Q2,Blood lactic acid increased,,2016,Q2,1,I,,20160519.0,20160602,20160602,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-041664,BRISTOL MYERS SQUIBB,"OZEKI,. A FATAL CASE OF METFORMIN-ASSOCIATED LACTIC ACIDOSIS.. INTERNAL MEDICINE. 2016;55 (7):775-778",72.0,YR,,F,Y,,,20160602.0,,MD,JP,JP,2016,Q2,Elderly
124278551,12427855,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, BID",,,,,,,,14.0,IU,,BID,2016,Q2,Blood pH decreased,,2016,Q2,1,I,,20160519.0,20160602,20160602,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-041664,BRISTOL MYERS SQUIBB,"OZEKI,. A FATAL CASE OF METFORMIN-ASSOCIATED LACTIC ACIDOSIS.. INTERNAL MEDICINE. 2016;55 (7):775-778",72.0,YR,,F,Y,,,20160602.0,,MD,JP,JP,2016,Q2,Elderly
124278551,12427855,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, BID",,,,,,,,14.0,IU,,BID,2016,Q2,Cardiomegaly,,2016,Q2,1,I,,20160519.0,20160602,20160602,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-041664,BRISTOL MYERS SQUIBB,"OZEKI,. A FATAL CASE OF METFORMIN-ASSOCIATED LACTIC ACIDOSIS.. INTERNAL MEDICINE. 2016;55 (7):775-778",72.0,YR,,F,Y,,,20160602.0,,MD,JP,JP,2016,Q2,Elderly
124278551,12427855,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, BID",,,,,,,,14.0,IU,,BID,2016,Q2,Death,,2016,Q2,1,I,,20160519.0,20160602,20160602,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-041664,BRISTOL MYERS SQUIBB,"OZEKI,. A FATAL CASE OF METFORMIN-ASSOCIATED LACTIC ACIDOSIS.. INTERNAL MEDICINE. 2016;55 (7):775-778",72.0,YR,,F,Y,,,20160602.0,,MD,JP,JP,2016,Q2,Elderly
124278551,12427855,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, BID",,,,,,,,14.0,IU,,BID,2016,Q2,Hypoglycaemia,,2016,Q2,1,I,,20160519.0,20160602,20160602,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-041664,BRISTOL MYERS SQUIBB,"OZEKI,. A FATAL CASE OF METFORMIN-ASSOCIATED LACTIC ACIDOSIS.. INTERNAL MEDICINE. 2016;55 (7):775-778",72.0,YR,,F,Y,,,20160602.0,,MD,JP,JP,2016,Q2,Elderly
124278551,12427855,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, BID",,,,,,,,14.0,IU,,BID,2016,Q2,Hypotension,,2016,Q2,1,I,,20160519.0,20160602,20160602,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-041664,BRISTOL MYERS SQUIBB,"OZEKI,. A FATAL CASE OF METFORMIN-ASSOCIATED LACTIC ACIDOSIS.. INTERNAL MEDICINE. 2016;55 (7):775-778",72.0,YR,,F,Y,,,20160602.0,,MD,JP,JP,2016,Q2,Elderly
124278551,12427855,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, BID",,,,,,,,14.0,IU,,BID,2016,Q2,Lactic acidosis,,2016,Q2,1,I,,20160519.0,20160602,20160602,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-041664,BRISTOL MYERS SQUIBB,"OZEKI,. A FATAL CASE OF METFORMIN-ASSOCIATED LACTIC ACIDOSIS.. INTERNAL MEDICINE. 2016;55 (7):775-778",72.0,YR,,F,Y,,,20160602.0,,MD,JP,JP,2016,Q2,Elderly
124278551,12427855,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, BID",,,,,,,,14.0,IU,,BID,2016,Q2,Metabolic acidosis,,2016,Q2,1,I,,20160519.0,20160602,20160602,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-041664,BRISTOL MYERS SQUIBB,"OZEKI,. A FATAL CASE OF METFORMIN-ASSOCIATED LACTIC ACIDOSIS.. INTERNAL MEDICINE. 2016;55 (7):775-778",72.0,YR,,F,Y,,,20160602.0,,MD,JP,JP,2016,Q2,Elderly
124278551,12427855,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, BID",,,,,,,,14.0,IU,,BID,2016,Q2,Overdose,,2016,Q2,1,I,,20160519.0,20160602,20160602,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-041664,BRISTOL MYERS SQUIBB,"OZEKI,. A FATAL CASE OF METFORMIN-ASSOCIATED LACTIC ACIDOSIS.. INTERNAL MEDICINE. 2016;55 (7):775-778",72.0,YR,,F,Y,,,20160602.0,,MD,JP,JP,2016,Q2,Elderly
124278551,12427855,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, BID",,,,,,,,14.0,IU,,BID,2016,Q2,Pulmonary oedema,,2016,Q2,1,I,,20160519.0,20160602,20160602,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-041664,BRISTOL MYERS SQUIBB,"OZEKI,. A FATAL CASE OF METFORMIN-ASSOCIATED LACTIC ACIDOSIS.. INTERNAL MEDICINE. 2016;55 (7):775-778",72.0,YR,,F,Y,,,20160602.0,,MD,JP,JP,2016,Q2,Elderly
124278551,12427855,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, BID",,,,,,,,14.0,IU,,BID,2016,Q2,Renal failure,,2016,Q2,1,I,,20160519.0,20160602,20160602,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-041664,BRISTOL MYERS SQUIBB,"OZEKI,. A FATAL CASE OF METFORMIN-ASSOCIATED LACTIC ACIDOSIS.. INTERNAL MEDICINE. 2016;55 (7):775-778",72.0,YR,,F,Y,,,20160602.0,,MD,JP,JP,2016,Q2,Elderly
124278551,12427855,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, BID",,,,,,,,14.0,IU,,BID,2016,Q2,Vomiting,,2016,Q2,1,I,,20160519.0,20160602,20160602,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-041664,BRISTOL MYERS SQUIBB,"OZEKI,. A FATAL CASE OF METFORMIN-ASSOCIATED LACTIC ACIDOSIS.. INTERNAL MEDICINE. 2016;55 (7):775-778",72.0,YR,,F,Y,,,20160602.0,,MD,JP,JP,2016,Q2,Elderly
124315741,12431574,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Diabetes mellitus inadequate control,,2016,Q2,1,I,20160303.0,,20160602,20160602,DIR,,,,,70.0,YR,,M,N,76.66,KG,20160601.0,Y,CN,US,,2016,Q2,Elderly
124317321,12431732,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Hepatic encephalopathy,,2016,Q2,1,I,20160310.0,,20160602,20160602,DIR,,,,,70.0,YR,,M,N,76.66,KG,20160601.0,Y,CN,US,,2016,Q2,Elderly
124319291,12431929,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Hepatic encephalopathy,,2016,Q2,1,I,20160331.0,,20160602,20160602,DIR,,,,,70.0,YR,,M,N,73.94,KG,20160601.0,Y,CN,US,,2016,Q2,Elderly
124367491,12436749,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"INITIAL DOSE, 10 UNITS BEFORE BEDTIME",,,,U,,,,,,,,2016,Q2,Hyperglycaemia,,2016,Q2,1,I,,20160601.0,20160606,20160606,EXP,,JP-009507513-1606JPN001866,MERCK,,47.0,YR,,M,Y,,,20160606.0,,CN,JP,JP,2016,Q2,Adult
124367491,12436749,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"INITIAL DOSE, 10 UNITS BEFORE BEDTIME",,,,U,,,,,,,,2016,Q2,Malaise,,2016,Q2,1,I,,20160601.0,20160606,20160606,EXP,,JP-009507513-1606JPN001866,MERCK,,47.0,YR,,M,Y,,,20160606.0,,CN,JP,JP,2016,Q2,Adult
124367491,12436749,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"INITIAL DOSE, 10 UNITS BEFORE BEDTIME",,,,U,,,,,,,,2016,Q2,Nausea,,2016,Q2,1,I,,20160601.0,20160606,20160606,EXP,,JP-009507513-1606JPN001866,MERCK,,47.0,YR,,M,Y,,,20160606.0,,CN,JP,JP,2016,Q2,Adult
124367491,12436749,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"INITIAL DOSE, 10 UNITS BEFORE BEDTIME",,,,U,,,,,,,,2016,Q2,Peripheral sensory neuropathy,,2016,Q2,1,I,,20160601.0,20160606,20160606,EXP,,JP-009507513-1606JPN001866,MERCK,,47.0,YR,,M,Y,,,20160606.0,,CN,JP,JP,2016,Q2,Adult
124367491,12436749,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"INITIAL DOSE, 16 UNITS BEFORE BEDTIME",,,,U,,,,,,,,2016,Q2,Hyperglycaemia,,2016,Q2,1,I,,20160601.0,20160606,20160606,EXP,,JP-009507513-1606JPN001866,MERCK,,47.0,YR,,M,Y,,,20160606.0,,CN,JP,JP,2016,Q2,Adult
124367491,12436749,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"INITIAL DOSE, 16 UNITS BEFORE BEDTIME",,,,U,,,,,,,,2016,Q2,Malaise,,2016,Q2,1,I,,20160601.0,20160606,20160606,EXP,,JP-009507513-1606JPN001866,MERCK,,47.0,YR,,M,Y,,,20160606.0,,CN,JP,JP,2016,Q2,Adult
124367491,12436749,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"INITIAL DOSE, 16 UNITS BEFORE BEDTIME",,,,U,,,,,,,,2016,Q2,Nausea,,2016,Q2,1,I,,20160601.0,20160606,20160606,EXP,,JP-009507513-1606JPN001866,MERCK,,47.0,YR,,M,Y,,,20160606.0,,CN,JP,JP,2016,Q2,Adult
124367491,12436749,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"INITIAL DOSE, 16 UNITS BEFORE BEDTIME",,,,U,,,,,,,,2016,Q2,Peripheral sensory neuropathy,,2016,Q2,1,I,,20160601.0,20160606,20160606,EXP,,JP-009507513-1606JPN001866,MERCK,,47.0,YR,,M,Y,,,20160606.0,,CN,JP,JP,2016,Q2,Adult
124380073,12438007,15,C,GLARGINE,,2,,UNK,,,,,,,,,,,,2016,Q2,Cerebrovascular accident,,2016,Q2,3,F,201203.0,20160617.0,20160606,20160621,EXP,,BR-PFIZER INC-2016281754,PFIZER,,65.0,YR,,F,Y,100.0,KG,20160621.0,,CN,BR,BR,2016,Q2,Elderly
124380073,12438007,15,C,GLARGINE,,2,,UNK,,,,,,,,,,,,2016,Q2,Incision site abscess,,2016,Q2,3,F,201203.0,20160617.0,20160606,20160621,EXP,,BR-PFIZER INC-2016281754,PFIZER,,65.0,YR,,F,Y,100.0,KG,20160621.0,,CN,BR,BR,2016,Q2,Elderly
124380073,12438007,15,C,GLARGINE,,2,,UNK,,,,,,,,,,,,2016,Q2,Infarction,,2016,Q2,3,F,201203.0,20160617.0,20160606,20160621,EXP,,BR-PFIZER INC-2016281754,PFIZER,,65.0,YR,,F,Y,100.0,KG,20160621.0,,CN,BR,BR,2016,Q2,Elderly
124380073,12438007,15,C,GLARGINE,,2,,UNK,,,,,,,,,,,,2016,Q2,Kaposi's sarcoma,,2016,Q2,3,F,201203.0,20160617.0,20160606,20160621,EXP,,BR-PFIZER INC-2016281754,PFIZER,,65.0,YR,,F,Y,100.0,KG,20160621.0,,CN,BR,BR,2016,Q2,Elderly
124380073,12438007,15,C,GLARGINE,,2,,UNK,,,,,,,,,,,,2016,Q2,Single functional kidney,,2016,Q2,3,F,201203.0,20160617.0,20160606,20160621,EXP,,BR-PFIZER INC-2016281754,PFIZER,,65.0,YR,,F,Y,100.0,KG,20160621.0,,CN,BR,BR,2016,Q2,Elderly
124381444,12438144,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,120.0,DF,,QD,2016,Q2,Gastroenteritis viral,,2016,Q2,4,F,20160520.0,20160623.0,20160606,20160628,EXP,,NO-GLAXOSMITHKLINE-NO2016075482,GLAXOSMITHKLINE,,67.0,YR,,M,Y,97.3,KG,20160628.0,,MD,NO,NO,2016,Q2,Elderly
124431431,12443143,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100E/ML (PEN 300E+3ML),,,,,,,,,,,QD,2016,Q2,Abdominal wall haematoma,,2016,Q2,1,I,20130625.0,20160530.0,20160607,20160607,EXP,,NL-AMGEN-NLDSL2016071066,AMGEN,,81.0,YR,E,F,Y,,,20160607.0,,OT,NL,NL,2016,Q2,Elderly
124431431,12443143,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100E/ML (PEN 300E+3ML),,,,,,,,,,,QD,2016,Q2,Diarrhoea,,2016,Q2,1,I,20130625.0,20160530.0,20160607,20160607,EXP,,NL-AMGEN-NLDSL2016071066,AMGEN,,81.0,YR,E,F,Y,,,20160607.0,,OT,NL,NL,2016,Q2,Elderly
124431431,12443143,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100E/ML (PEN 300E+3ML),,,,,,,,,,,QD,2016,Q2,Pulmonary embolism,,2016,Q2,1,I,20130625.0,20160530.0,20160607,20160607,EXP,,NL-AMGEN-NLDSL2016071066,AMGEN,,81.0,YR,E,F,Y,,,20160607.0,,OT,NL,NL,2016,Q2,Elderly
124471641,12447164,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,U, UNKNOWN,,,,,,,2016,Q2,Blood glucose abnormal,,2016,Q2,1,I,20160530.0,20160530.0,20160608,20160608,EXP,,BR-NOVOPROD-494600,NOVO NORDISK,,61.0,YR,A,M,Y,,,20160608.0,,CN,BR,BR,2016,Q2,Adult
124471641,12447164,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,U, UNKNOWN,,,,,,,2016,Q2,Blood glucose fluctuation,,2016,Q2,1,I,20160530.0,20160530.0,20160608,20160608,EXP,,BR-NOVOPROD-494600,NOVO NORDISK,,61.0,YR,A,M,Y,,,20160608.0,,CN,BR,BR,2016,Q2,Adult
124471641,12447164,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,U, UNKNOWN,,,,,,,2016,Q2,Coma,,2016,Q2,1,I,20160530.0,20160530.0,20160608,20160608,EXP,,BR-NOVOPROD-494600,NOVO NORDISK,,61.0,YR,A,M,Y,,,20160608.0,,CN,BR,BR,2016,Q2,Adult
124474011,12447401,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Condition aggravated,,2016,Q2,1,I,20160602.0,,20160607,20160607,DIR,,,,,53.0,YR,,F,N,146.0,KG,20160606.0,N,OT,US,,2016,Q2,Adult
124474011,12447401,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Pulmonary embolism,,2016,Q2,1,I,20160602.0,,20160607,20160607,DIR,,,,,53.0,YR,,F,N,146.0,KG,20160606.0,N,OT,US,,2016,Q2,Adult
124526531,12452653,6,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,20 UNITS/DAY,,,,U,,,,,,,,2016,Q2,Altered state of consciousness,,2016,Q2,1,I,,20160527.0,20160609,20160609,EXP,,GB-SCIEGEN PHARMACEUTICALS INC-2016SCILIT00162,SCIEGEN,,32.0,YR,,F,Y,,,20160609.0,,MD,AU,GB,2016,Q2,Young Adult
124526531,12452653,6,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,20 UNITS/DAY,,,,U,,,,,,,,2016,Q2,Areflexia,,2016,Q2,1,I,,20160527.0,20160609,20160609,EXP,,GB-SCIEGEN PHARMACEUTICALS INC-2016SCILIT00162,SCIEGEN,,32.0,YR,,F,Y,,,20160609.0,,MD,AU,GB,2016,Q2,Young Adult
124526531,12452653,6,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,20 UNITS/DAY,,,,U,,,,,,,,2016,Q2,Diabetic ketoacidosis,,2016,Q2,1,I,,20160527.0,20160609,20160609,EXP,,GB-SCIEGEN PHARMACEUTICALS INC-2016SCILIT00162,SCIEGEN,,32.0,YR,,F,Y,,,20160609.0,,MD,AU,GB,2016,Q2,Young Adult
124526531,12452653,6,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,20 UNITS/DAY,,,,U,,,,,,,,2016,Q2,Hyperglycaemia,,2016,Q2,1,I,,20160527.0,20160609,20160609,EXP,,GB-SCIEGEN PHARMACEUTICALS INC-2016SCILIT00162,SCIEGEN,,32.0,YR,,F,Y,,,20160609.0,,MD,AU,GB,2016,Q2,Young Adult
124526531,12452653,6,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,20 UNITS/DAY,,,,U,,,,,,,,2016,Q2,Hypotonia,,2016,Q2,1,I,,20160527.0,20160609,20160609,EXP,,GB-SCIEGEN PHARMACEUTICALS INC-2016SCILIT00162,SCIEGEN,,32.0,YR,,F,Y,,,20160609.0,,MD,AU,GB,2016,Q2,Young Adult
124526531,12452653,6,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,20 UNITS/DAY,,,,U,,,,,,,,2016,Q2,Hypovolaemia,,2016,Q2,1,I,,20160527.0,20160609,20160609,EXP,,GB-SCIEGEN PHARMACEUTICALS INC-2016SCILIT00162,SCIEGEN,,32.0,YR,,F,Y,,,20160609.0,,MD,AU,GB,2016,Q2,Young Adult
124526531,12452653,6,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,20 UNITS/DAY,,,,U,,,,,,,,2016,Q2,Metabolic acidosis,,2016,Q2,1,I,,20160527.0,20160609,20160609,EXP,,GB-SCIEGEN PHARMACEUTICALS INC-2016SCILIT00162,SCIEGEN,,32.0,YR,,F,Y,,,20160609.0,,MD,AU,GB,2016,Q2,Young Adult
124526531,12452653,6,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,20 UNITS/DAY,,,,U,,,,,,,,2016,Q2,Mydriasis,,2016,Q2,1,I,,20160527.0,20160609,20160609,EXP,,GB-SCIEGEN PHARMACEUTICALS INC-2016SCILIT00162,SCIEGEN,,32.0,YR,,F,Y,,,20160609.0,,MD,AU,GB,2016,Q2,Young Adult
124526531,12452653,6,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,20 UNITS/DAY,,,,U,,,,,,,,2016,Q2,Sinus tachycardia,,2016,Q2,1,I,,20160527.0,20160609,20160609,EXP,,GB-SCIEGEN PHARMACEUTICALS INC-2016SCILIT00162,SCIEGEN,,32.0,YR,,F,Y,,,20160609.0,,MD,AU,GB,2016,Q2,Young Adult
124540901,12454090,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"12 IU, QD",,,,,,,,12.0,IU,,QD,2016,Q2,Acute kidney injury,,2016,Q2,1,I,20150820.0,20160520.0,20160610,20160610,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-041234,BRISTOL MYERS SQUIBB,,79.0,YR,,M,Y,,,20160610.0,,CN,DE,DE,2016,Q2,Elderly
124540901,12454090,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"12 IU, QD",,,,,,,,12.0,IU,,QD,2016,Q2,Haemodialysis,,2016,Q2,1,I,20150820.0,20160520.0,20160610,20160610,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-041234,BRISTOL MYERS SQUIBB,,79.0,YR,,M,Y,,,20160610.0,,CN,DE,DE,2016,Q2,Elderly
124540901,12454090,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"12 IU, QD",,,,,,,,12.0,IU,,QD,2016,Q2,Lactic acidosis,,2016,Q2,1,I,20150820.0,20160520.0,20160610,20160610,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-041234,BRISTOL MYERS SQUIBB,,79.0,YR,,M,Y,,,20160610.0,,CN,DE,DE,2016,Q2,Elderly
124622561,12462256,10,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,U,,,,,,,,2016,Q2,Contrast media reaction,,2016,Q2,1,I,20160314.0,20160315.0,20160613,20160613,PER,,"US-CARDINAL HEALTH 414, LLC-1053758",CARDINAL HEALTH,,66.0,YR,,M,Y,50.0,KG,20160613.0,,OT,US,US,2016,Q2,Elderly
124622561,12462256,10,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,U,,,,,,,,2016,Q2,Cyanosis,,2016,Q2,1,I,20160314.0,20160315.0,20160613,20160613,PER,,"US-CARDINAL HEALTH 414, LLC-1053758",CARDINAL HEALTH,,66.0,YR,,M,Y,50.0,KG,20160613.0,,OT,US,US,2016,Q2,Elderly
124622561,12462256,10,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,U,,,,,,,,2016,Q2,Muscle spasms,,2016,Q2,1,I,20160314.0,20160315.0,20160613,20160613,PER,,"US-CARDINAL HEALTH 414, LLC-1053758",CARDINAL HEALTH,,66.0,YR,,M,Y,50.0,KG,20160613.0,,OT,US,US,2016,Q2,Elderly
124622561,12462256,10,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,U,,,,,,,,2016,Q2,Pain in extremity,,2016,Q2,1,I,20160314.0,20160315.0,20160613,20160613,PER,,"US-CARDINAL HEALTH 414, LLC-1053758",CARDINAL HEALTH,,66.0,YR,,M,Y,50.0,KG,20160613.0,,OT,US,US,2016,Q2,Elderly
124622561,12462256,10,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,U,,,,,,,,2016,Q2,Pulse absent,,2016,Q2,1,I,20160314.0,20160315.0,20160613,20160613,PER,,"US-CARDINAL HEALTH 414, LLC-1053758",CARDINAL HEALTH,,66.0,YR,,M,Y,50.0,KG,20160613.0,,OT,US,US,2016,Q2,Elderly
124627401,12462740,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,INJECTION,,2016,Q2,Diarrhoea,Diarrhoea,2016,Q2,1,I,201503.0,20151208.0,20160614,20160614,PER,,US-ZYDUS-009725,ZYDUS PHARM,,71.0,YR,,M,Y,,,20160614.0,,CN,US,US,2016,Q2,Elderly
124692452,12469245,30,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,32 (UNITS UNSPECIFIED),,,,,,,,,,UNSPECIFIED,,2016,Q2,Amputation,,2016,Q2,2,F,20160331.0,20160624.0,20160615,20160630,EXP,,ES-JNJFOC-20160607469,JANSSEN,,61.0,YR,A,M,Y,,,20160630.0,,MD,ES,ES,2016,Q2,Adult
124692452,12469245,30,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,32 (UNITS UNSPECIFIED),,,,,,,,,,UNSPECIFIED,,2016,Q2,Peripheral ischaemia,,2016,Q2,2,F,20160331.0,20160624.0,20160615,20160630,EXP,,ES-JNJFOC-20160607469,JANSSEN,,61.0,YR,A,M,Y,,,20160630.0,,MD,ES,ES,2016,Q2,Adult
124692452,12469245,31,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,30 (UNITS UNSPECIFIED),,,,,,,,,,UNSPECIFIED,,2016,Q2,Amputation,,2016,Q2,2,F,20160331.0,20160624.0,20160615,20160630,EXP,,ES-JNJFOC-20160607469,JANSSEN,,61.0,YR,A,M,Y,,,20160630.0,,MD,ES,ES,2016,Q2,Adult
124692452,12469245,31,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,30 (UNITS UNSPECIFIED),,,,,,,,,,UNSPECIFIED,,2016,Q2,Peripheral ischaemia,,2016,Q2,2,F,20160331.0,20160624.0,20160615,20160630,EXP,,ES-JNJFOC-20160607469,JANSSEN,,61.0,YR,A,M,Y,,,20160630.0,,MD,ES,ES,2016,Q2,Adult
124692452,12469245,32,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,26 (UNITS UNSPECIFIED),,,,,,,,,,UNSPECIFIED,,2016,Q2,Amputation,,2016,Q2,2,F,20160331.0,20160624.0,20160615,20160630,EXP,,ES-JNJFOC-20160607469,JANSSEN,,61.0,YR,A,M,Y,,,20160630.0,,MD,ES,ES,2016,Q2,Adult
124692452,12469245,32,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,26 (UNITS UNSPECIFIED),,,,,,,,,,UNSPECIFIED,,2016,Q2,Peripheral ischaemia,,2016,Q2,2,F,20160331.0,20160624.0,20160615,20160630,EXP,,ES-JNJFOC-20160607469,JANSSEN,,61.0,YR,A,M,Y,,,20160630.0,,MD,ES,ES,2016,Q2,Adult
124692452,12469245,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,26 (UNITS UNSPECIFIED),,,,,,,,,,UNSPECIFIED,,2016,Q2,Amputation,,2016,Q2,2,F,20160331.0,20160624.0,20160615,20160630,EXP,,ES-JNJFOC-20160607469,JANSSEN,,61.0,YR,A,M,Y,,,20160630.0,,MD,ES,ES,2016,Q2,Adult
124692452,12469245,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,26 (UNITS UNSPECIFIED),,,,,,,,,,UNSPECIFIED,,2016,Q2,Peripheral ischaemia,,2016,Q2,2,F,20160331.0,20160624.0,20160615,20160630,EXP,,ES-JNJFOC-20160607469,JANSSEN,,61.0,YR,A,M,Y,,,20160630.0,,MD,ES,ES,2016,Q2,Adult
124692452,12469245,34,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,24 (UNITS UNSPECIFIED),,,,,,,,,,UNSPECIFIED,,2016,Q2,Amputation,,2016,Q2,2,F,20160331.0,20160624.0,20160615,20160630,EXP,,ES-JNJFOC-20160607469,JANSSEN,,61.0,YR,A,M,Y,,,20160630.0,,MD,ES,ES,2016,Q2,Adult
124692452,12469245,34,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,24 (UNITS UNSPECIFIED),,,,,,,,,,UNSPECIFIED,,2016,Q2,Peripheral ischaemia,,2016,Q2,2,F,20160331.0,20160624.0,20160615,20160630,EXP,,ES-JNJFOC-20160607469,JANSSEN,,61.0,YR,A,M,Y,,,20160630.0,,MD,ES,ES,2016,Q2,Adult
124692452,12469245,35,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,22 (UNITS UNSPECIFIED),,,,,,,,,,UNSPECIFIED,,2016,Q2,Amputation,,2016,Q2,2,F,20160331.0,20160624.0,20160615,20160630,EXP,,ES-JNJFOC-20160607469,JANSSEN,,61.0,YR,A,M,Y,,,20160630.0,,MD,ES,ES,2016,Q2,Adult
124692452,12469245,35,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,22 (UNITS UNSPECIFIED),,,,,,,,,,UNSPECIFIED,,2016,Q2,Peripheral ischaemia,,2016,Q2,2,F,20160331.0,20160624.0,20160615,20160630,EXP,,ES-JNJFOC-20160607469,JANSSEN,,61.0,YR,A,M,Y,,,20160630.0,,MD,ES,ES,2016,Q2,Adult
124692452,12469245,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,22 (UNITS UNSPECIFIED),,,,,,,,,,UNSPECIFIED,,2016,Q2,Amputation,,2016,Q2,2,F,20160331.0,20160624.0,20160615,20160630,EXP,,ES-JNJFOC-20160607469,JANSSEN,,61.0,YR,A,M,Y,,,20160630.0,,MD,ES,ES,2016,Q2,Adult
124692452,12469245,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,22 (UNITS UNSPECIFIED),,,,,,,,,,UNSPECIFIED,,2016,Q2,Peripheral ischaemia,,2016,Q2,2,F,20160331.0,20160624.0,20160615,20160630,EXP,,ES-JNJFOC-20160607469,JANSSEN,,61.0,YR,A,M,Y,,,20160630.0,,MD,ES,ES,2016,Q2,Adult
124692452,12469245,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,30 (UNITS UNSPECIFIED),,,,,,,,,,UNSPECIFIED,,2016,Q2,Amputation,,2016,Q2,2,F,20160331.0,20160624.0,20160615,20160630,EXP,,ES-JNJFOC-20160607469,JANSSEN,,61.0,YR,A,M,Y,,,20160630.0,,MD,ES,ES,2016,Q2,Adult
124692452,12469245,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,30 (UNITS UNSPECIFIED),,,,,,,,,,UNSPECIFIED,,2016,Q2,Peripheral ischaemia,,2016,Q2,2,F,20160331.0,20160624.0,20160615,20160630,EXP,,ES-JNJFOC-20160607469,JANSSEN,,61.0,YR,A,M,Y,,,20160630.0,,MD,ES,ES,2016,Q2,Adult
124692452,12469245,38,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,24 (UNITS UNSPECIFIED),,,,,,,,,,UNSPECIFIED,,2016,Q2,Amputation,,2016,Q2,2,F,20160331.0,20160624.0,20160615,20160630,EXP,,ES-JNJFOC-20160607469,JANSSEN,,61.0,YR,A,M,Y,,,20160630.0,,MD,ES,ES,2016,Q2,Adult
124692452,12469245,38,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,24 (UNITS UNSPECIFIED),,,,,,,,,,UNSPECIFIED,,2016,Q2,Peripheral ischaemia,,2016,Q2,2,F,20160331.0,20160624.0,20160615,20160630,EXP,,ES-JNJFOC-20160607469,JANSSEN,,61.0,YR,A,M,Y,,,20160630.0,,MD,ES,ES,2016,Q2,Adult
124692452,12469245,39,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,26 (UNITS UNSPECIFIED),,,,,,,,,,UNSPECIFIED,,2016,Q2,Amputation,,2016,Q2,2,F,20160331.0,20160624.0,20160615,20160630,EXP,,ES-JNJFOC-20160607469,JANSSEN,,61.0,YR,A,M,Y,,,20160630.0,,MD,ES,ES,2016,Q2,Adult
124692452,12469245,39,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,26 (UNITS UNSPECIFIED),,,,,,,,,,UNSPECIFIED,,2016,Q2,Peripheral ischaemia,,2016,Q2,2,F,20160331.0,20160624.0,20160615,20160630,EXP,,ES-JNJFOC-20160607469,JANSSEN,,61.0,YR,A,M,Y,,,20160630.0,,MD,ES,ES,2016,Q2,Adult
124692452,12469245,40,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,24 (UNITS UNSPECIFIED),,,,,,,,,,UNSPECIFIED,,2016,Q2,Amputation,,2016,Q2,2,F,20160331.0,20160624.0,20160615,20160630,EXP,,ES-JNJFOC-20160607469,JANSSEN,,61.0,YR,A,M,Y,,,20160630.0,,MD,ES,ES,2016,Q2,Adult
124692452,12469245,40,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,24 (UNITS UNSPECIFIED),,,,,,,,,,UNSPECIFIED,,2016,Q2,Peripheral ischaemia,,2016,Q2,2,F,20160331.0,20160624.0,20160615,20160630,EXP,,ES-JNJFOC-20160607469,JANSSEN,,61.0,YR,A,M,Y,,,20160630.0,,MD,ES,ES,2016,Q2,Adult
124747551,12474755,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"1 DF, UNK",,,,,,,,1.0,DF,,,2016,Q2,Blood creatinine increased,,2016,Q2,1,I,20160303.0,20160304.0,20160617,20160617,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-017312,BRISTOL MYERS SQUIBB,,55.0,YR,,F,Y,,,20160617.0,,MD,US,US,2016,Q2,Adult
124747551,12474755,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"1 DF, UNK",,,,,,,,1.0,DF,,,2016,Q2,Blood pressure increased,,2016,Q2,1,I,20160303.0,20160304.0,20160617,20160617,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-017312,BRISTOL MYERS SQUIBB,,55.0,YR,,F,Y,,,20160617.0,,MD,US,US,2016,Q2,Adult
124747551,12474755,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"1 DF, UNK",,,,,,,,1.0,DF,,,2016,Q2,Haemodialysis,,2016,Q2,1,I,20160303.0,20160304.0,20160617,20160617,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-017312,BRISTOL MYERS SQUIBB,,55.0,YR,,F,Y,,,20160617.0,,MD,US,US,2016,Q2,Adult
124747551,12474755,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"1 DF, UNK",,,,,,,,1.0,DF,,,2016,Q2,Headache,,2016,Q2,1,I,20160303.0,20160304.0,20160617,20160617,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-017312,BRISTOL MYERS SQUIBB,,55.0,YR,,F,Y,,,20160617.0,,MD,US,US,2016,Q2,Adult
124764202,12476420,15,C,insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q2,Febrile neutropenia,,2016,Q2,2,F,20160606.0,20160615.0,20160617,20160630,EXP,,ES-CELGENEUS-ESP-2016062304,CELGENE,,75.0,YR,,M,Y,,,20160630.0,,OT,ES,ES,2016,Q2,Elderly
124771631,12477163,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,10.0,IU,INJECTION,QD,2016,Q2,Blood glucose increased,,2016,Q2,1,I,2015.0,20160226.0,20160617,20160617,EXP,,CN-ASTRAZENECA-2016SE22464,ASTRAZENECA,,42.0,YR,,M,Y,75.0,KG,20160617.0,,CN,CN,CN,2016,Q2,Adult
124771631,12477163,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,10.0,IU,INJECTION,QD,2016,Q2,Fatigue,,2016,Q2,1,I,2015.0,20160226.0,20160617,20160617,EXP,,CN-ASTRAZENECA-2016SE22464,ASTRAZENECA,,42.0,YR,,M,Y,75.0,KG,20160617.0,,CN,CN,CN,2016,Q2,Adult
124771631,12477163,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,10.0,IU,INJECTION,QD,2016,Q2,Feeling abnormal,,2016,Q2,1,I,2015.0,20160226.0,20160617,20160617,EXP,,CN-ASTRAZENECA-2016SE22464,ASTRAZENECA,,42.0,YR,,M,Y,75.0,KG,20160617.0,,CN,CN,CN,2016,Q2,Adult
124771631,12477163,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,10.0,IU,INJECTION,QD,2016,Q2,Hyperglycaemia,,2016,Q2,1,I,2015.0,20160226.0,20160617,20160617,EXP,,CN-ASTRAZENECA-2016SE22464,ASTRAZENECA,,42.0,YR,,M,Y,75.0,KG,20160617.0,,CN,CN,CN,2016,Q2,Adult
124771631,12477163,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,10.0,IU,INJECTION,QD,2016,Q2,Lipids increased,,2016,Q2,1,I,2015.0,20160226.0,20160617,20160617,EXP,,CN-ASTRAZENECA-2016SE22464,ASTRAZENECA,,42.0,YR,,M,Y,75.0,KG,20160617.0,,CN,CN,CN,2016,Q2,Adult
124771631,12477163,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,10.0,IU,INJECTION,QD,2016,Q2,Nausea,,2016,Q2,1,I,2015.0,20160226.0,20160617,20160617,EXP,,CN-ASTRAZENECA-2016SE22464,ASTRAZENECA,,42.0,YR,,M,Y,75.0,KG,20160617.0,,CN,CN,CN,2016,Q2,Adult
124771631,12477163,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,10.0,IU,INJECTION,QD,2016,Q2,Weight decreased,,2016,Q2,1,I,2015.0,20160226.0,20160617,20160617,EXP,,CN-ASTRAZENECA-2016SE22464,ASTRAZENECA,,42.0,YR,,M,Y,75.0,KG,20160617.0,,CN,CN,CN,2016,Q2,Adult
124771631,12477163,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,15.0,IU,INJECTION,QD,2016,Q2,Blood glucose increased,,2016,Q2,1,I,2015.0,20160226.0,20160617,20160617,EXP,,CN-ASTRAZENECA-2016SE22464,ASTRAZENECA,,42.0,YR,,M,Y,75.0,KG,20160617.0,,CN,CN,CN,2016,Q2,Adult
124771631,12477163,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,15.0,IU,INJECTION,QD,2016,Q2,Fatigue,,2016,Q2,1,I,2015.0,20160226.0,20160617,20160617,EXP,,CN-ASTRAZENECA-2016SE22464,ASTRAZENECA,,42.0,YR,,M,Y,75.0,KG,20160617.0,,CN,CN,CN,2016,Q2,Adult
124771631,12477163,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,15.0,IU,INJECTION,QD,2016,Q2,Feeling abnormal,,2016,Q2,1,I,2015.0,20160226.0,20160617,20160617,EXP,,CN-ASTRAZENECA-2016SE22464,ASTRAZENECA,,42.0,YR,,M,Y,75.0,KG,20160617.0,,CN,CN,CN,2016,Q2,Adult
124771631,12477163,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,15.0,IU,INJECTION,QD,2016,Q2,Hyperglycaemia,,2016,Q2,1,I,2015.0,20160226.0,20160617,20160617,EXP,,CN-ASTRAZENECA-2016SE22464,ASTRAZENECA,,42.0,YR,,M,Y,75.0,KG,20160617.0,,CN,CN,CN,2016,Q2,Adult
124771631,12477163,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,15.0,IU,INJECTION,QD,2016,Q2,Lipids increased,,2016,Q2,1,I,2015.0,20160226.0,20160617,20160617,EXP,,CN-ASTRAZENECA-2016SE22464,ASTRAZENECA,,42.0,YR,,M,Y,75.0,KG,20160617.0,,CN,CN,CN,2016,Q2,Adult
124771631,12477163,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,15.0,IU,INJECTION,QD,2016,Q2,Nausea,,2016,Q2,1,I,2015.0,20160226.0,20160617,20160617,EXP,,CN-ASTRAZENECA-2016SE22464,ASTRAZENECA,,42.0,YR,,M,Y,75.0,KG,20160617.0,,CN,CN,CN,2016,Q2,Adult
124771631,12477163,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,15.0,IU,INJECTION,QD,2016,Q2,Weight decreased,,2016,Q2,1,I,2015.0,20160226.0,20160617,20160617,EXP,,CN-ASTRAZENECA-2016SE22464,ASTRAZENECA,,42.0,YR,,M,Y,75.0,KG,20160617.0,,CN,CN,CN,2016,Q2,Adult
124812241,12481224,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,35 UNITS DAILY,,,,,,,,,,,QD,2016,Q2,Abnormal behaviour,,2016,Q2,1,I,,20160607.0,20160620,20160620,EXP,,"US-IMPAX LABORATORIES, INC-2016-IPXL-00624",IMPAX,,80.0,YR,,M,Y,,,20160620.0,,OT,US,US,2016,Q2,Elderly
124812241,12481224,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,35 UNITS DAILY,,,,,,,,,,,QD,2016,Q2,Altered state of consciousness,,2016,Q2,1,I,,20160607.0,20160620,20160620,EXP,,"US-IMPAX LABORATORIES, INC-2016-IPXL-00624",IMPAX,,80.0,YR,,M,Y,,,20160620.0,,OT,US,US,2016,Q2,Elderly
124812241,12481224,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,35 UNITS DAILY,,,,,,,,,,,QD,2016,Q2,Drug-disease interaction,,2016,Q2,1,I,,20160607.0,20160620,20160620,EXP,,"US-IMPAX LABORATORIES, INC-2016-IPXL-00624",IMPAX,,80.0,YR,,M,Y,,,20160620.0,,OT,US,US,2016,Q2,Elderly
124812241,12481224,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,35 UNITS DAILY,,,,,,,,,,,QD,2016,Q2,Dyskinesia,,2016,Q2,1,I,,20160607.0,20160620,20160620,EXP,,"US-IMPAX LABORATORIES, INC-2016-IPXL-00624",IMPAX,,80.0,YR,,M,Y,,,20160620.0,,OT,US,US,2016,Q2,Elderly
124812241,12481224,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,35 UNITS DAILY,,,,,,,,,,,QD,2016,Q2,Toxicity to various agents,,2016,Q2,1,I,,20160607.0,20160620,20160620,EXP,,"US-IMPAX LABORATORIES, INC-2016-IPXL-00624",IMPAX,,80.0,YR,,M,Y,,,20160620.0,,OT,US,US,2016,Q2,Elderly
124841191,12484119,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2016,Q2,Pigmentation disorder,,2016,Q2,1,I,,20160120.0,20160621,20160621,PER,,US-APOTEX-2016AP006238,APOTEX,"SOHAIL U, ALMASHHRAWI A, RAHMAN R, ASHRAF I, COBERLY J, NGUYEN D, ET AL.. MYSTERIOUS BLACK CRYSTALLINE PIGMENT IN THE DUODENUM.. AM-J-GASTROENTEROL. 2015;110 (SUPPL. 1):S437 ABSTR. 1009.",72.0,YR,,F,Y,,,20160621.0,,MD,US,US,2016,Q2,Elderly
124842671,12484267,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q2,Chorea,,2016,Q2,1,I,,20160612.0,20160621,20160621,EXP,,PHHY2016IL081205,SANDOZ,"LEIBOWITZ A, GREENBERG G, GROSSMAN E, SHAFRAN I.. DIABETIC STRIATOPATHY-DOES IT EXIST IN NON-ASIAN SUBJECTS?. EUROPEAN JOURNAL OF INTERNAL MEDICINE. 2016;1-4",81.0,YR,,M,Y,,,20160621.0,,OT,IL,IL,2016,Q2,Elderly
124842671,12484267,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q2,Diabetes mellitus inadequate control,,2016,Q2,1,I,,20160612.0,20160621,20160621,EXP,,PHHY2016IL081205,SANDOZ,"LEIBOWITZ A, GREENBERG G, GROSSMAN E, SHAFRAN I.. DIABETIC STRIATOPATHY-DOES IT EXIST IN NON-ASIAN SUBJECTS?. EUROPEAN JOURNAL OF INTERNAL MEDICINE. 2016;1-4",81.0,YR,,M,Y,,,20160621.0,,OT,IL,IL,2016,Q2,Elderly
124842671,12484267,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q2,Diabetic neuropathy,,2016,Q2,1,I,,20160612.0,20160621,20160621,EXP,,PHHY2016IL081205,SANDOZ,"LEIBOWITZ A, GREENBERG G, GROSSMAN E, SHAFRAN I.. DIABETIC STRIATOPATHY-DOES IT EXIST IN NON-ASIAN SUBJECTS?. EUROPEAN JOURNAL OF INTERNAL MEDICINE. 2016;1-4",81.0,YR,,M,Y,,,20160621.0,,OT,IL,IL,2016,Q2,Elderly
124928401,12492840,23,C, INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Acute myocardial infarction,,2016,Q2,1,I,20160414.0,,20160623,20160623,DIR,,,,,66.0,YR,,F,N,,,20160516.0,N,PH,US,,2016,Q2,Elderly
124928401,12492840,23,C, INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Coronary artery disease,,2016,Q2,1,I,20160414.0,,20160623,20160623,DIR,,,,,66.0,YR,,F,N,,,20160516.0,N,PH,US,,2016,Q2,Elderly
124928401,12492840,23,C, INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Fluid overload,,2016,Q2,1,I,20160414.0,,20160623,20160623,DIR,,,,,66.0,YR,,F,N,,,20160516.0,N,PH,US,,2016,Q2,Elderly
124928401,12492840,23,C, INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Troponin increased,,2016,Q2,1,I,20160414.0,,20160623,20160623,DIR,,,,,66.0,YR,,F,N,,,20160516.0,N,PH,US,,2016,Q2,Elderly
124929021,12492902,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q2,Acute kidney injury,,2016,Q2,1,I,,20160315.0,20160623,20160623,EXP,US-MLMSERVICE-20160317-0203803-1,US-PFIZER INC-2016174153,PFIZER,,76.0,YR,,F,Y,,,20160623.0,,OT,GB,US,2016,Q2,Elderly
124929021,12492902,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q2,Crystal nephropathy,,2016,Q2,1,I,,20160315.0,20160623,20160623,EXP,US-MLMSERVICE-20160317-0203803-1,US-PFIZER INC-2016174153,PFIZER,,76.0,YR,,F,Y,,,20160623.0,,OT,GB,US,2016,Q2,Elderly
124929021,12492902,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q2,Thrombocytopenia,,2016,Q2,1,I,,20160315.0,20160623,20160623,EXP,US-MLMSERVICE-20160317-0203803-1,US-PFIZER INC-2016174153,PFIZER,,76.0,YR,,F,Y,,,20160623.0,,OT,GB,US,2016,Q2,Elderly
124954981,12495498,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q2,Crystal nephropathy,,2016,Q2,1,I,,20160315.0,20160624,20160624,EXP,US-MLMSERVICE-20160317-0203803-1,US-PFIZER INC-3226280,PFIZER,,76.0,YR,,F,Y,,,20160624.0,,OT,GB,US,2016,Q2,Elderly
124954981,12495498,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q2,Renal tubular necrosis,,2016,Q2,1,I,,20160315.0,20160624,20160624,EXP,US-MLMSERVICE-20160317-0203803-1,US-PFIZER INC-3226280,PFIZER,,76.0,YR,,F,Y,,,20160624.0,,OT,GB,US,2016,Q2,Elderly
125011431,12501143,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2016,Q2,Acute myocardial infarction,,2016,Q2,1,I,20160615.0,20160617.0,20160627,20160627,EXP,,CO-BAXTER-2016BAX032512,BAXTER,,73.0,YR,,M,Y,73.8,KG,20160627.0,,OT,CO,CO,2016,Q2,Elderly
125011431,12501143,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2016,Q2,Death,,2016,Q2,1,I,20160615.0,20160617.0,20160627,20160627,EXP,,CO-BAXTER-2016BAX032512,BAXTER,,73.0,YR,,M,Y,73.8,KG,20160627.0,,OT,CO,CO,2016,Q2,Elderly
125020121,12502012,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,U,,,,30.0,IU,,QD,2016,Q2,Blood creatine phosphokinase increased,,2016,Q2,1,I,20160428.0,20160621.0,20160627,20160627,PER,,US-ELI_LILLY_AND_COMPANY-US201606007587,ELI LILLY AND CO,,73.0,YR,,F,Y,104.0,KG,20160627.0,,CN,US,US,2016,Q2,Elderly
125020121,12502012,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,U,,,,30.0,IU,,QD,2016,Q2,Serotonin syndrome,,2016,Q2,1,I,20160428.0,20160621.0,20160627,20160627,PER,,US-ELI_LILLY_AND_COMPANY-US201606007587,ELI LILLY AND CO,,73.0,YR,,F,Y,104.0,KG,20160627.0,,CN,US,US,2016,Q2,Elderly
125020121,12502012,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,U,,,,30.0,IU,,QD,2016,Q2,White blood cell count increased,,2016,Q2,1,I,20160428.0,20160621.0,20160627,20160627,PER,,US-ELI_LILLY_AND_COMPANY-US201606007587,ELI LILLY AND CO,,73.0,YR,,F,Y,104.0,KG,20160627.0,,CN,US,US,2016,Q2,Elderly
125038761,12503876,2,SS,GLARGINE INSULIN,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Hypoglycaemia,,2016,Q2,1,I,20160623.0,,20160627,20160627,DIR,,,,,72.0,YR,,M,N,87.0,KG,20160624.0,N,PH,US,,2016,Q2,Elderly
125045241,12504524,3,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q2,Chronic kidney disease,,2016,Q2,1,I,,20160622.0,20160628,20160628,EXP,,IT-GILEAD-2016-0220438,GILEAD,,58.0,YR,A,M,Y,61.0,KG,20160628.0,,MD,IT,IT,2016,Q2,Adult
125045241,12504524,3,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q2,Proteinuria,,2016,Q2,1,I,,20160622.0,20160628,20160628,EXP,,IT-GILEAD-2016-0220438,GILEAD,,58.0,YR,A,M,Y,61.0,KG,20160628.0,,MD,IT,IT,2016,Q2,Adult
125078481,12507848,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Anaemia,,2016,Q2,1,I,20160322.0,,20160628,20160628,DIR,,,,,57.0,YR,,M,N,86.8,KG,20160627.0,N,CN,US,,2016,Q2,Adult
125110971,12511097,13,C,GLARGINE,,2,Subcutaneous,70 UNITS BID,,,,,,,,,,,,2016,Q2,Gastroenteritis,,2016,Q2,1,I,20130715.0,20160419.0,20160629,20160629,EXP,,US-ASTRAZENECA-2016SE41980,ASTRAZENECA,,66.0,YR,,M,Y,117.0,KG,20160629.0,,MD,US,US,2016,Q2,Elderly
125200411,12520041,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 IU, DAILY",,,,,,,,40.0,IU,INJECTION,,2016,Q2,Crying,,2016,Q2,1,I,,20160210.0,20160630,20160630,PER,,US-PFIZER INC-2016085839,PFIZER,,54.0,YR,,F,Y,,,20160630.0,,MD,US,US,2016,Q2,Adult
125203141,12520314,17,C,GLARGINE INSULIN,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q2,Death,,2016,Q2,1,I,20160613.0,,20160630,20160630,DIR,,,,,57.0,YR,,M,N,,,20160629.0,Y,PH,US,,2016,Q2,Adult
80379605,8037960,39,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 UNITS, TWO TIMES A DAY",,,,,,,,,,,,2016,Q2,Cardiac disorder,,2016,Q2,5,F,20150522.0,20160615.0,20110715,20160623,EXP,,US-ASTRAZENECA-2011SE40566,ASTRAZENECA,,59.0,YR,,M,Y,,,20160623.0,,CN,US,US,2016,Q2,Adult
80379605,8037960,39,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 UNITS, TWO TIMES A DAY",,,,,,,,,,,,2016,Q2,Drug dose omission,,2016,Q2,5,F,20150522.0,20160615.0,20110715,20160623,EXP,,US-ASTRAZENECA-2011SE40566,ASTRAZENECA,,59.0,YR,,M,Y,,,20160623.0,,CN,US,US,2016,Q2,Adult
80379605,8037960,39,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 UNITS, TWO TIMES A DAY",,,,,,,,,,,,2016,Q2,Drug hypersensitivity,,2016,Q2,5,F,20150522.0,20160615.0,20110715,20160623,EXP,,US-ASTRAZENECA-2011SE40566,ASTRAZENECA,,59.0,YR,,M,Y,,,20160623.0,,CN,US,US,2016,Q2,Adult
80379605,8037960,39,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 UNITS, TWO TIMES A DAY",,,,,,,,,,,,2016,Q2,Gastric disorder,,2016,Q2,5,F,20150522.0,20160615.0,20110715,20160623,EXP,,US-ASTRAZENECA-2011SE40566,ASTRAZENECA,,59.0,YR,,M,Y,,,20160623.0,,CN,US,US,2016,Q2,Adult
80379605,8037960,39,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 UNITS, TWO TIMES A DAY",,,,,,,,,,,,2016,Q2,Gastric ulcer haemorrhage,,2016,Q2,5,F,20150522.0,20160615.0,20110715,20160623,EXP,,US-ASTRAZENECA-2011SE40566,ASTRAZENECA,,59.0,YR,,M,Y,,,20160623.0,,CN,US,US,2016,Q2,Adult
80379605,8037960,39,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 UNITS, TWO TIMES A DAY",,,,,,,,,,,,2016,Q2,Off label use,,2016,Q2,5,F,20150522.0,20160615.0,20110715,20160623,EXP,,US-ASTRAZENECA-2011SE40566,ASTRAZENECA,,59.0,YR,,M,Y,,,20160623.0,,CN,US,US,2016,Q2,Adult
87099615,8709961,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 UNITS UNDER THE SKIN AT BEDTIME,,,,,,,,,,,,2016,Q2,Angina pectoris,,2016,Q2,5,F,200703.0,20160615.0,20120806,20160623,EXP,,US-ASTRAZENECA-2012SE54040,ASTRAZENECA,,661.0,MON,,M,Y,74.8,KG,20160624.0,,,US,US,2016,Q2,Elderly
87099615,8709961,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 UNITS UNDER THE SKIN AT BEDTIME,,,,,,,,,,,,2016,Q2,Cardiac failure congestive,,2016,Q2,5,F,200703.0,20160615.0,20120806,20160623,EXP,,US-ASTRAZENECA-2012SE54040,ASTRAZENECA,,661.0,MON,,M,Y,74.8,KG,20160624.0,,,US,US,2016,Q2,Elderly
87099615,8709961,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 UNITS UNDER THE SKIN AT BEDTIME,,,,,,,,,,,,2016,Q2,Cardiovascular disorder,,2016,Q2,5,F,200703.0,20160615.0,20120806,20160623,EXP,,US-ASTRAZENECA-2012SE54040,ASTRAZENECA,,661.0,MON,,M,Y,74.8,KG,20160624.0,,,US,US,2016,Q2,Elderly
87099615,8709961,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 UNITS UNDER THE SKIN AT BEDTIME,,,,,,,,,,,,2016,Q2,Coronary artery disease,,2016,Q2,5,F,200703.0,20160615.0,20120806,20160623,EXP,,US-ASTRAZENECA-2012SE54040,ASTRAZENECA,,661.0,MON,,M,Y,74.8,KG,20160624.0,,,US,US,2016,Q2,Elderly
87099615,8709961,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 UNITS UNDER THE SKIN AT BEDTIME,,,,,,,,,,,,2016,Q2,Emotional distress,,2016,Q2,5,F,200703.0,20160615.0,20120806,20160623,EXP,,US-ASTRAZENECA-2012SE54040,ASTRAZENECA,,661.0,MON,,M,Y,74.8,KG,20160624.0,,,US,US,2016,Q2,Elderly
87099615,8709961,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 UNITS UNDER THE SKIN AT BEDTIME,,,,,,,,,,,,2016,Q2,Hypertension,,2016,Q2,5,F,200703.0,20160615.0,20120806,20160623,EXP,,US-ASTRAZENECA-2012SE54040,ASTRAZENECA,,661.0,MON,,M,Y,74.8,KG,20160624.0,,,US,US,2016,Q2,Elderly
87099615,8709961,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 UNITS UNDER THE SKIN AT BEDTIME,,,,,,,,,,,,2016,Q2,Myocardial infarction,,2016,Q2,5,F,200703.0,20160615.0,20120806,20160623,EXP,,US-ASTRAZENECA-2012SE54040,ASTRAZENECA,,661.0,MON,,M,Y,74.8,KG,20160624.0,,,US,US,2016,Q2,Elderly
87099615,8709961,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 UNITS UNDER THE SKIN AT BEDTIME,,,,,,,,,,,,2016,Q2,Type 2 diabetes mellitus,,2016,Q2,5,F,200703.0,20160615.0,20120806,20160623,EXP,,US-ASTRAZENECA-2012SE54040,ASTRAZENECA,,661.0,MON,,M,Y,74.8,KG,20160624.0,,,US,US,2016,Q2,Elderly
99891526,9989152,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q2,Syncope,,2016,Q2,6,F,20140305.0,20160608.0,20140310,20160614,EXP,,JP-ROCHE-1360598,ROCHE,,83.0,YR,,F,Y,50.9,KG,20160614.0,,MD,JP,JP,2016,Q2,Elderly
99891526,9989152,27,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q2,Syncope,,2016,Q2,6,F,20140305.0,20160608.0,20140310,20160614,EXP,,JP-ROCHE-1360598,ROCHE,,83.0,YR,,F,Y,50.9,KG,20160614.0,,MD,JP,JP,2016,Q2,Elderly
100086192,10008619,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"1DF: 30U,DOSE DECREASED FROM 75U TO 66U.",,,Y,,,,,1.0,DF,,QD,2016,Q3,Demyelination,,2016,Q3,2,F,,20160801.0,20140313,20160801,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-20469003,BRISTOL MYERS SQUIBB,,58.0,YR,,M,Y,,,20160801.0,,CN,DE,CN,2016,Q3,Adult
100086192,10008619,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"1DF: 30U,DOSE DECREASED FROM 75U TO 66U.",,,Y,,,,,1.0,DF,,QD,2016,Q3,Diabetic neuropathy,,2016,Q3,2,F,,20160801.0,20140313,20160801,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-20469003,BRISTOL MYERS SQUIBB,,58.0,YR,,M,Y,,,20160801.0,,CN,DE,CN,2016,Q3,Adult
100486793,10048679,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,Y,,,,,,,,,2016,Q3,Drug-induced liver injury,,2016,Q3,3,F,,20160711.0,20140331,20160714,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-20564225,BRISTOL MYERS SQUIBB,,41.0,YR,,M,Y,,,20160714.0,,CN,DE,DE,2016,Q3,Adult
103846515,10384651,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, QD",62.0,IU,,,,,,14.0,IU,,QD,2016,Q3,Blood urea increased,,2016,Q3,5,F,20140803.0,20160630.0,20140814,20160711,EXP,,KR-OTSUKA-JP-2014-16603,OTSUKA,,75.0,YR,,F,Y,,,20160711.0,,MD,KR,KR,2016,Q3,Elderly
103846515,10384651,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, QD",62.0,IU,,,,,,14.0,IU,,QD,2016,Q3,Hyperglycaemia,,2016,Q3,5,F,20140803.0,20160630.0,20140814,20160711,EXP,,KR-OTSUKA-JP-2014-16603,OTSUKA,,75.0,YR,,F,Y,,,20160711.0,,MD,KR,KR,2016,Q3,Elderly
103846515,10384651,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, QD",62.0,IU,,,,,,14.0,IU,,QD,2016,Q3,Pulmonary oedema,,2016,Q3,5,F,20140803.0,20160630.0,20140814,20160711,EXP,,KR-OTSUKA-JP-2014-16603,OTSUKA,,75.0,YR,,F,Y,,,20160711.0,,MD,KR,KR,2016,Q3,Elderly
103846515,10384651,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",62.0,IU,,,,,,20.0,IU,,QD,2016,Q3,Blood urea increased,,2016,Q3,5,F,20140803.0,20160630.0,20140814,20160711,EXP,,KR-OTSUKA-JP-2014-16603,OTSUKA,,75.0,YR,,F,Y,,,20160711.0,,MD,KR,KR,2016,Q3,Elderly
103846515,10384651,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",62.0,IU,,,,,,20.0,IU,,QD,2016,Q3,Hyperglycaemia,,2016,Q3,5,F,20140803.0,20160630.0,20140814,20160711,EXP,,KR-OTSUKA-JP-2014-16603,OTSUKA,,75.0,YR,,F,Y,,,20160711.0,,MD,KR,KR,2016,Q3,Elderly
103846515,10384651,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",62.0,IU,,,,,,20.0,IU,,QD,2016,Q3,Pulmonary oedema,,2016,Q3,5,F,20140803.0,20160630.0,20140814,20160711,EXP,,KR-OTSUKA-JP-2014-16603,OTSUKA,,75.0,YR,,F,Y,,,20160711.0,,MD,KR,KR,2016,Q3,Elderly
103846515,10384651,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU, QD",62.0,IU,,,,,,28.0,IU,,QD,2016,Q3,Blood urea increased,,2016,Q3,5,F,20140803.0,20160630.0,20140814,20160711,EXP,,KR-OTSUKA-JP-2014-16603,OTSUKA,,75.0,YR,,F,Y,,,20160711.0,,MD,KR,KR,2016,Q3,Elderly
103846515,10384651,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU, QD",62.0,IU,,,,,,28.0,IU,,QD,2016,Q3,Hyperglycaemia,,2016,Q3,5,F,20140803.0,20160630.0,20140814,20160711,EXP,,KR-OTSUKA-JP-2014-16603,OTSUKA,,75.0,YR,,F,Y,,,20160711.0,,MD,KR,KR,2016,Q3,Elderly
103846515,10384651,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU, QD",62.0,IU,,,,,,28.0,IU,,QD,2016,Q3,Pulmonary oedema,,2016,Q3,5,F,20140803.0,20160630.0,20140814,20160711,EXP,,KR-OTSUKA-JP-2014-16603,OTSUKA,,75.0,YR,,F,Y,,,20160711.0,,MD,KR,KR,2016,Q3,Elderly
104283664,10428366,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intramuscular,"60 UNITS, QD",,,,,,,,60.0,IU,,QD,2016,Q3,Acute kidney injury,,2016,Q3,4,F,20130716.0,20160824.0,20140903,20160901,EXP,,US-ASTRAZENECA-2013SE62390,ASTRAZENECA,,68.0,YR,,M,Y,135.0,KG,20160901.0,,MD,US,US,2016,Q3,Elderly
104283664,10428366,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intramuscular,"60 UNITS, QD",,,,,,,,60.0,IU,,QD,2016,Q3,Non-cardiac chest pain,,2016,Q3,4,F,20130716.0,20160824.0,20140903,20160901,EXP,,US-ASTRAZENECA-2013SE62390,ASTRAZENECA,,68.0,YR,,M,Y,135.0,KG,20160901.0,,MD,US,US,2016,Q3,Elderly
1068374210,10683742,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2016,Q3,Hyperglycaemia,,2016,Q3,10,F,20141213.0,20160728.0,20141230,20160802,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2014-001999,BRISTOL MYERS SQUIBB,,55.0,YR,,F,Y,45.0,KG,20160802.0,,OT,US,US,2016,Q3,Adult
1068374210,10683742,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2016,Q3,Hypophysitis,,2016,Q3,10,F,20141213.0,20160728.0,20141230,20160802,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2014-001999,BRISTOL MYERS SQUIBB,,55.0,YR,,F,Y,45.0,KG,20160802.0,,OT,US,US,2016,Q3,Adult
1068374210,10683742,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2016,Q3,Pulmonary embolism,,2016,Q3,10,F,20141213.0,20160728.0,20141230,20160802,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2014-001999,BRISTOL MYERS SQUIBB,,55.0,YR,,F,Y,45.0,KG,20160802.0,,OT,US,US,2016,Q3,Adult
107513722,10751372,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q3,Drug-induced liver injury,,2016,Q3,2,F,,20160729.0,20150130,20160729,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2014-006857,BRISTOL MYERS SQUIBB,,41.0,YR,,M,Y,,,20160729.0,,CN,DE,US,2016,Q3,Adult
108303895,10830389,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"80 IU, 2X/DAY",,,,,,,,80.0,IU,INJECTION,BID,2016,Q3,Influenza,,2016,Q3,5,F,,20160919.0,20150219,20160926,PER,,US-PFIZER INC-2014318762,PFIZER,,68.0,YR,,M,Y,,,20160926.0,,MD,US,US,2016,Q3,Elderly
109704632,10970463,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2016,Q3,Glucose-6-phosphate dehydrogenase deficiency,,2016,Q3,2,F,,20160727.0,20150331,20160727,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-020155,BRISTOL MYERS SQUIBB,,53.0,YR,,M,Y,,,20160727.0,,CN,DE,US,2016,Q3,Adult
109704632,10970463,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2016,Q3,Haemolytic anaemia,,2016,Q3,2,F,,20160727.0,20150331,20160727,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-020155,BRISTOL MYERS SQUIBB,,53.0,YR,,M,Y,,,20160727.0,,CN,DE,US,2016,Q3,Adult
110398604,11039860,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q3,Upper gastrointestinal haemorrhage,,2016,Q3,4,F,201410.0,20160725.0,20150416,20160912,PER,,US-JNJFOC-20150118944,JANSSEN,,70.0,YR,E,M,Y,,,20160912.0,,CN,US,US,2016,Q3,Elderly
111166874,11116687,3,C,Insuline Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Basal ganglia infarction,,2016,Q3,4,F,20150423.0,20160809.0,20150515,20160817,EXP,,US-ARIAD-2015US004933,ARIAD,,77.0,YR,,M,Y,99.0,KG,20160817.0,,CN,US,US,2016,Q3,Elderly
112636422,11263642,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 UNITS, ONCE A DAY",,,,U,,,,,,,QD,2016,Q3,Dizziness,,2016,Q3,2,F,20150605.0,20160809.0,20150713,20160823,EXP,,DK-AUROBINDO-AUR-APL-2015-05658,AUROBINDO,,66.0,YR,,M,Y,,,20160823.0,,OT,DK,DK,2016,Q3,Elderly
112636422,11263642,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 UNITS, ONCE A DAY",,,,U,,,,,,,QD,2016,Q3,Malaise,,2016,Q3,2,F,20150605.0,20160809.0,20150713,20160823,EXP,,DK-AUROBINDO-AUR-APL-2015-05658,AUROBINDO,,66.0,YR,,M,Y,,,20160823.0,,OT,DK,DK,2016,Q3,Elderly
112636422,11263642,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 UNITS, ONCE A DAY",,,,U,,,,,,,QD,2016,Q3,Sinus bradycardia,,2016,Q3,2,F,20150605.0,20160809.0,20150713,20160823,EXP,,DK-AUROBINDO-AUR-APL-2015-05658,AUROBINDO,,66.0,YR,,M,Y,,,20160823.0,,OT,DK,DK,2016,Q3,Elderly
112684936,11268493,28,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2016,Q3,Ecchymosis,,2016,Q3,6,F,2014.0,20160822.0,20150714,20160912,PER,,US-JNJFOC-20150616688,JANSSEN,,69.0,YR,E,M,Y,,,20160912.0,,CN,US,US,2016,Q3,Elderly
112684936,11268493,28,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2016,Q3,Extradural haematoma,,2016,Q3,6,F,2014.0,20160822.0,20150714,20160912,PER,,US-JNJFOC-20150616688,JANSSEN,,69.0,YR,E,M,Y,,,20160912.0,,CN,US,US,2016,Q3,Elderly
112684936,11268493,28,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2016,Q3,Gastrointestinal haemorrhage,,2016,Q3,6,F,2014.0,20160822.0,20150714,20160912,PER,,US-JNJFOC-20150616688,JANSSEN,,69.0,YR,E,M,Y,,,20160912.0,,CN,US,US,2016,Q3,Elderly
112684936,11268493,28,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2016,Q3,Internal haemorrhage,,2016,Q3,6,F,2014.0,20160822.0,20150714,20160912,PER,,US-JNJFOC-20150616688,JANSSEN,,69.0,YR,E,M,Y,,,20160912.0,,CN,US,US,2016,Q3,Elderly
113467933,11346793,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,,,SOLUTION FOR INJECTION,,2016,Q3,Anti-insulin antibody increased,,2016,Q3,3,F,,20160825.0,20150806,20160825,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-051410,BRISTOL MYERS SQUIBB,,75.0,YR,,M,Y,,,20160825.0,,MD,JP,JP,2016,Q3,Elderly
113467933,11346793,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,,,SOLUTION FOR INJECTION,,2016,Q3,Hypoglycaemia,,2016,Q3,3,F,,20160825.0,20150806,20160825,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-051410,BRISTOL MYERS SQUIBB,,75.0,YR,,M,Y,,,20160825.0,,MD,JP,JP,2016,Q3,Elderly
113467933,11346793,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,,,SOLUTION FOR INJECTION,,2016,Q3,Vomiting,,2016,Q3,3,F,,20160825.0,20150806,20160825,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-051410,BRISTOL MYERS SQUIBB,,75.0,YR,,M,Y,,,20160825.0,,MD,JP,JP,2016,Q3,Elderly
113467933,11346793,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,,,SOLUTION FOR INJECTION,,2016,Q3,Weight decreased,,2016,Q3,3,F,,20160825.0,20150806,20160825,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-051410,BRISTOL MYERS SQUIBB,,75.0,YR,,M,Y,,,20160825.0,,MD,JP,JP,2016,Q3,Elderly
113704684,11370468,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNKNOWN,,,U,,,,,,,,,2016,Q3,Amnesia,,2016,Q3,4,F,201506.0,20160912.0,20150812,20160920,PER,,US-ELI_LILLY_AND_COMPANY-US201508002995,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20160920.0,,CN,US,US,2016,Q3,Elderly
113704684,11370468,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNKNOWN,,,U,,,,,,,,,2016,Q3,Blood glucose increased,,2016,Q3,4,F,201506.0,20160912.0,20150812,20160920,PER,,US-ELI_LILLY_AND_COMPANY-US201508002995,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20160920.0,,CN,US,US,2016,Q3,Elderly
113704684,11370468,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNKNOWN,,,U,,,,,,,,,2016,Q3,Incorrect dose administered,,2016,Q3,4,F,201506.0,20160912.0,20150812,20160920,PER,,US-ELI_LILLY_AND_COMPANY-US201508002995,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20160920.0,,CN,US,US,2016,Q3,Elderly
113704684,11370468,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNKNOWN,,,U,,,,,,,,,2016,Q3,Underdose,,2016,Q3,4,F,201506.0,20160912.0,20150812,20160920,PER,,US-ELI_LILLY_AND_COMPANY-US201508002995,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20160920.0,,CN,US,US,2016,Q3,Elderly
114345483,11434548,4,C,Insulin glargine,INSULIN GLARGINE,1,,"18 U, QD",,,,,,,,,,,QD,2016,Q3,Abdominal pain,,2016,Q3,3,F,20141128.0,20160831.0,20150831,20160912,EXP,,FR-AEGERION PHARMACEUTICAL INC.-AEGR001749,AEGERION,,48.0,YR,,F,Y,91.0,KG,20160912.0,,OT,FR,FR,2016,Q3,Adult
114345483,11434548,4,C,Insulin glargine,INSULIN GLARGINE,1,,"18 U, QD",,,,,,,,,,,QD,2016,Q3,Adenocarcinoma pancreas,,2016,Q3,3,F,20141128.0,20160831.0,20150831,20160912,EXP,,FR-AEGERION PHARMACEUTICAL INC.-AEGR001749,AEGERION,,48.0,YR,,F,Y,91.0,KG,20160912.0,,OT,FR,FR,2016,Q3,Adult
114345483,11434548,4,C,Insulin glargine,INSULIN GLARGINE,1,,"18 U, QD",,,,,,,,,,,QD,2016,Q3,Metastases to liver,,2016,Q3,3,F,20141128.0,20160831.0,20150831,20160912,EXP,,FR-AEGERION PHARMACEUTICAL INC.-AEGR001749,AEGERION,,48.0,YR,,F,Y,91.0,KG,20160912.0,,OT,FR,FR,2016,Q3,Adult
115330495,11533049,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q3,Ecchymosis,,2016,Q3,5,F,2014.0,20160822.0,20150921,20160901,EXP,,US-BAYER-2015-366996,BAYER,,69.0,YR,E,M,Y,,,20160901.0,,OT,US,US,2016,Q3,Elderly
115330495,11533049,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q3,Extradural haematoma,,2016,Q3,5,F,2014.0,20160822.0,20150921,20160901,EXP,,US-BAYER-2015-366996,BAYER,,69.0,YR,E,M,Y,,,20160901.0,,OT,US,US,2016,Q3,Elderly
115330495,11533049,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q3,Gastrointestinal haemorrhage,,2016,Q3,5,F,2014.0,20160822.0,20150921,20160901,EXP,,US-BAYER-2015-366996,BAYER,,69.0,YR,E,M,Y,,,20160901.0,,OT,US,US,2016,Q3,Elderly
115330495,11533049,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q3,Internal haemorrhage,,2016,Q3,5,F,2014.0,20160822.0,20150921,20160901,EXP,,US-BAYER-2015-366996,BAYER,,69.0,YR,E,M,Y,,,20160901.0,,OT,US,US,2016,Q3,Elderly
115752452,11575245,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,10.0,IU,INJECTION,QD,2016,Q3,Cytomegalovirus test positive,,2016,Q3,2,F,20060814.0,20160712.0,20150930,20160720,EXP,,JP-ASTELLAS-2007JP001997,ASTELLAS,"KENMOCHI T, ASANO T, SAIGO K, MARUYAMA M, AKUTSU N, IWASHITA C, ET AL.. ADAPTATION AND TREATMENT RESULTS OF LIVING DONOR PANCREAS TRANSPLANTATION FOR SEVERE TYPE I DIABETES MELLITUS. TRANSPLANTATION. 2008;43(S):250",32.0,YR,,F,Y,47.0,KG,20160720.0,,,COUNTRY NOT SPECIFIED,JP,2016,Q3,Young Adult
115752452,11575245,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,10.0,IU,INJECTION,QD,2016,Q3,Pancreatic leak,,2016,Q3,2,F,20060814.0,20160712.0,20150930,20160720,EXP,,JP-ASTELLAS-2007JP001997,ASTELLAS,"KENMOCHI T, ASANO T, SAIGO K, MARUYAMA M, AKUTSU N, IWASHITA C, ET AL.. ADAPTATION AND TREATMENT RESULTS OF LIVING DONOR PANCREAS TRANSPLANTATION FOR SEVERE TYPE I DIABETES MELLITUS. TRANSPLANTATION. 2008;43(S):250",32.0,YR,,F,Y,47.0,KG,20160720.0,,,COUNTRY NOT SPECIFIED,JP,2016,Q3,Young Adult
115752452,11575245,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,10.0,IU,INJECTION,QD,2016,Q3,Pancytopenia,,2016,Q3,2,F,20060814.0,20160712.0,20150930,20160720,EXP,,JP-ASTELLAS-2007JP001997,ASTELLAS,"KENMOCHI T, ASANO T, SAIGO K, MARUYAMA M, AKUTSU N, IWASHITA C, ET AL.. ADAPTATION AND TREATMENT RESULTS OF LIVING DONOR PANCREAS TRANSPLANTATION FOR SEVERE TYPE I DIABETES MELLITUS. TRANSPLANTATION. 2008;43(S):250",32.0,YR,,F,Y,47.0,KG,20160720.0,,,COUNTRY NOT SPECIFIED,JP,2016,Q3,Young Adult
115752452,11575245,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,10.0,IU,INJECTION,QD,2016,Q3,Renal impairment,,2016,Q3,2,F,20060814.0,20160712.0,20150930,20160720,EXP,,JP-ASTELLAS-2007JP001997,ASTELLAS,"KENMOCHI T, ASANO T, SAIGO K, MARUYAMA M, AKUTSU N, IWASHITA C, ET AL.. ADAPTATION AND TREATMENT RESULTS OF LIVING DONOR PANCREAS TRANSPLANTATION FOR SEVERE TYPE I DIABETES MELLITUS. TRANSPLANTATION. 2008;43(S):250",32.0,YR,,F,Y,47.0,KG,20160720.0,,,COUNTRY NOT SPECIFIED,JP,2016,Q3,Young Adult
118518687,11851868,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,,,,,,,,,,,,,2016,Q3,Acute kidney injury,Acute kidney injury,2016,Q3,7,F,20150729.0,20160820.0,20151218,20160824,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2015-BI-52879BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,96.0,KG,20160824.0,,MD,COUNTRY NOT SPECIFIED,US,2016,Q3,Elderly
118518687,11851868,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,,,,,,,,,,,,,2016,Q3,Respiratory failure,,2016,Q3,7,F,20150729.0,20160820.0,20151218,20160824,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2015-BI-52879BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,96.0,KG,20160824.0,,MD,COUNTRY NOT SPECIFIED,US,2016,Q3,Elderly
118518687,11851868,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,,,,,,,,,,,,,2016,Q3,Rhabdomyolysis,,2016,Q3,7,F,20150729.0,20160820.0,20151218,20160824,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2015-BI-52879BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,96.0,KG,20160824.0,,MD,COUNTRY NOT SPECIFIED,US,2016,Q3,Elderly
118518687,11851868,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,,,,,,,,,,,,,2016,Q3,Spinal column stenosis,,2016,Q3,7,F,20150729.0,20160820.0,20151218,20160824,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2015-BI-52879BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,96.0,KG,20160824.0,,MD,COUNTRY NOT SPECIFIED,US,2016,Q3,Elderly
118518687,11851868,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,,,,,,,,,,,,,2016,Q3,Spinal epidural haematoma,,2016,Q3,7,F,20150729.0,20160820.0,20151218,20160824,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2015-BI-52879BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,96.0,KG,20160824.0,,MD,COUNTRY NOT SPECIFIED,US,2016,Q3,Elderly
119937765,11993776,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD (EVERY MORNING)",,,U,,,,,12.0,IU,SOLUTION,QD,2016,Q3,Blindness,,2016,Q3,5,F,20150416.0,20160808.0,20160203,20160816,EXP,,PHHY2016CO013734,NOVARTIS,,65.0,YR,,M,Y,83.0,KG,20160816.0,,CN,COUNTRY NOT SPECIFIED,CO,2016,Q3,Elderly
119937765,11993776,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD (EVERY MORNING)",,,U,,,,,12.0,IU,SOLUTION,QD,2016,Q3,Blood urine present,,2016,Q3,5,F,20150416.0,20160808.0,20160203,20160816,EXP,,PHHY2016CO013734,NOVARTIS,,65.0,YR,,M,Y,83.0,KG,20160816.0,,CN,COUNTRY NOT SPECIFIED,CO,2016,Q3,Elderly
119937765,11993776,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD (EVERY MORNING)",,,U,,,,,12.0,IU,SOLUTION,QD,2016,Q3,Calculus urinary,,2016,Q3,5,F,20150416.0,20160808.0,20160203,20160816,EXP,,PHHY2016CO013734,NOVARTIS,,65.0,YR,,M,Y,83.0,KG,20160816.0,,CN,COUNTRY NOT SPECIFIED,CO,2016,Q3,Elderly
119937765,11993776,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD (EVERY MORNING)",,,U,,,,,12.0,IU,SOLUTION,QD,2016,Q3,Dizziness,,2016,Q3,5,F,20150416.0,20160808.0,20160203,20160816,EXP,,PHHY2016CO013734,NOVARTIS,,65.0,YR,,M,Y,83.0,KG,20160816.0,,CN,COUNTRY NOT SPECIFIED,CO,2016,Q3,Elderly
119937765,11993776,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD (EVERY MORNING)",,,U,,,,,12.0,IU,SOLUTION,QD,2016,Q3,Headache,,2016,Q3,5,F,20150416.0,20160808.0,20160203,20160816,EXP,,PHHY2016CO013734,NOVARTIS,,65.0,YR,,M,Y,83.0,KG,20160816.0,,CN,COUNTRY NOT SPECIFIED,CO,2016,Q3,Elderly
119937765,11993776,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD (EVERY MORNING)",,,U,,,,,12.0,IU,SOLUTION,QD,2016,Q3,Neck pain,,2016,Q3,5,F,20150416.0,20160808.0,20160203,20160816,EXP,,PHHY2016CO013734,NOVARTIS,,65.0,YR,,M,Y,83.0,KG,20160816.0,,CN,COUNTRY NOT SPECIFIED,CO,2016,Q3,Elderly
119937765,11993776,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD (EVERY MORNING)",,,U,,,,,12.0,IU,SOLUTION,QD,2016,Q3,Peripheral swelling,,2016,Q3,5,F,20150416.0,20160808.0,20160203,20160816,EXP,,PHHY2016CO013734,NOVARTIS,,65.0,YR,,M,Y,83.0,KG,20160816.0,,CN,COUNTRY NOT SPECIFIED,CO,2016,Q3,Elderly
119937765,11993776,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD (EVERY MORNING)",,,U,,,,,12.0,IU,SOLUTION,QD,2016,Q3,Platelet count decreased,,2016,Q3,5,F,20150416.0,20160808.0,20160203,20160816,EXP,,PHHY2016CO013734,NOVARTIS,,65.0,YR,,M,Y,83.0,KG,20160816.0,,CN,COUNTRY NOT SPECIFIED,CO,2016,Q3,Elderly
119937765,11993776,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD (EVERY MORNING)",,,U,,,,,12.0,IU,SOLUTION,QD,2016,Q3,Pulmonary congestion,,2016,Q3,5,F,20150416.0,20160808.0,20160203,20160816,EXP,,PHHY2016CO013734,NOVARTIS,,65.0,YR,,M,Y,83.0,KG,20160816.0,,CN,COUNTRY NOT SPECIFIED,CO,2016,Q3,Elderly
119937765,11993776,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD (EVERY MORNING)",,,U,,,,,12.0,IU,SOLUTION,QD,2016,Q3,Pyrexia,,2016,Q3,5,F,20150416.0,20160808.0,20160203,20160816,EXP,,PHHY2016CO013734,NOVARTIS,,65.0,YR,,M,Y,83.0,KG,20160816.0,,CN,COUNTRY NOT SPECIFIED,CO,2016,Q3,Elderly
119937765,11993776,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD (EVERY MORNING)",,,U,,,,,12.0,IU,SOLUTION,QD,2016,Q3,Renal aneurysm,,2016,Q3,5,F,20150416.0,20160808.0,20160203,20160816,EXP,,PHHY2016CO013734,NOVARTIS,,65.0,YR,,M,Y,83.0,KG,20160816.0,,CN,COUNTRY NOT SPECIFIED,CO,2016,Q3,Elderly
119937765,11993776,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD (EVERY MORNING)",,,U,,,,,12.0,IU,SOLUTION,QD,2016,Q3,Renal disorder,,2016,Q3,5,F,20150416.0,20160808.0,20160203,20160816,EXP,,PHHY2016CO013734,NOVARTIS,,65.0,YR,,M,Y,83.0,KG,20160816.0,,CN,COUNTRY NOT SPECIFIED,CO,2016,Q3,Elderly
119937765,11993776,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD (EVERY MORNING)",,,U,,,,,12.0,IU,SOLUTION,QD,2016,Q3,Respiratory failure,,2016,Q3,5,F,20150416.0,20160808.0,20160203,20160816,EXP,,PHHY2016CO013734,NOVARTIS,,65.0,YR,,M,Y,83.0,KG,20160816.0,,CN,COUNTRY NOT SPECIFIED,CO,2016,Q3,Elderly
119937765,11993776,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD (EVERY MORNING)",,,U,,,,,12.0,IU,SOLUTION,QD,2016,Q3,Urinary tract infection,,2016,Q3,5,F,20150416.0,20160808.0,20160203,20160816,EXP,,PHHY2016CO013734,NOVARTIS,,65.0,YR,,M,Y,83.0,KG,20160816.0,,CN,COUNTRY NOT SPECIFIED,CO,2016,Q3,Elderly
120965012,12096501,3,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2016,Q3,Renal impairment,,2016,Q3,2,F,,20160825.0,20160220,20160825,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-010417,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,,,20160825.0,,CN,JP,JP,2016,Q3,Elderly
121254543,12125454,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,10.0,IU,,,2016,Q3,Chills,,2016,Q3,3,F,20150711.0,20160628.0,20160229,20160705,EXP,,IN-ROCHE-1644975,ROCHE,,44.0,YR,,M,Y,,,20160705.0,,CN,IN,IN,2016,Q3,Adult
121254543,12125454,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,10.0,IU,,,2016,Q3,Death,,2016,Q3,3,F,20150711.0,20160628.0,20160229,20160705,EXP,,IN-ROCHE-1644975,ROCHE,,44.0,YR,,M,Y,,,20160705.0,,CN,IN,IN,2016,Q3,Adult
121254543,12125454,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,10.0,IU,,,2016,Q3,Decreased appetite,,2016,Q3,3,F,20150711.0,20160628.0,20160229,20160705,EXP,,IN-ROCHE-1644975,ROCHE,,44.0,YR,,M,Y,,,20160705.0,,CN,IN,IN,2016,Q3,Adult
121254543,12125454,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,10.0,IU,,,2016,Q3,Infection,,2016,Q3,3,F,20150711.0,20160628.0,20160229,20160705,EXP,,IN-ROCHE-1644975,ROCHE,,44.0,YR,,M,Y,,,20160705.0,,CN,IN,IN,2016,Q3,Adult
121254543,12125454,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,10.0,IU,,,2016,Q3,Peripheral swelling,,2016,Q3,3,F,20150711.0,20160628.0,20160229,20160705,EXP,,IN-ROCHE-1644975,ROCHE,,44.0,YR,,M,Y,,,20160705.0,,CN,IN,IN,2016,Q3,Adult
121254543,12125454,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,10.0,IU,,,2016,Q3,Pyrexia,,2016,Q3,3,F,20150711.0,20160628.0,20160229,20160705,EXP,,IN-ROCHE-1644975,ROCHE,,44.0,YR,,M,Y,,,20160705.0,,CN,IN,IN,2016,Q3,Adult
121254543,12125454,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,10.0,IU,,,2016,Q3,Tuberculosis,,2016,Q3,3,F,20150711.0,20160628.0,20160229,20160705,EXP,,IN-ROCHE-1644975,ROCHE,,44.0,YR,,M,Y,,,20160705.0,,CN,IN,IN,2016,Q3,Adult
121254543,12125454,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,10.0,IU,,,2016,Q3,Vomiting,,2016,Q3,3,F,20150711.0,20160628.0,20160229,20160705,EXP,,IN-ROCHE-1644975,ROCHE,,44.0,YR,,M,Y,,,20160705.0,,CN,IN,IN,2016,Q3,Adult
121689962,12168996,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,20.0,IU,,QD,2016,Q3,Renal failure,,2016,Q3,2,F,20151218.0,20160906.0,20160310,20160913,EXP,,FR-ASTRAZENECA-2016SE23307,ASTRAZENECA,,28513.0,DY,,M,Y,,,20160914.0,,MD,FR,FR,2016,Q3,Elderly
121833164,12183316,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,8 U,,,U,,,,,8.0,IU,INJECTION,QD,2016,Q3,Dehydration,,2016,Q3,4,F,20160214.0,20160713.0,20160316,20160718,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-15480NB",BOEHRINGER INGELHEIM,,78.0,YR,,M,Y,,,20160719.0,,MD,JP,JP,2016,Q3,Elderly
121833164,12183316,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,8 U,,,U,,,,,8.0,IU,INJECTION,QD,2016,Q3,Enterocolitis,,2016,Q3,4,F,20160214.0,20160713.0,20160316,20160718,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-15480NB",BOEHRINGER INGELHEIM,,78.0,YR,,M,Y,,,20160719.0,,MD,JP,JP,2016,Q3,Elderly
121833164,12183316,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,8 U,,,U,,,,,8.0,IU,INJECTION,QD,2016,Q3,Marasmus,,2016,Q3,4,F,20160214.0,20160713.0,20160316,20160718,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-15480NB",BOEHRINGER INGELHEIM,,78.0,YR,,M,Y,,,20160719.0,,MD,JP,JP,2016,Q3,Elderly
122155934,12215593,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2016,Q3,Angina pectoris,,2016,Q3,4,F,20160131.0,20160908.0,20160328,20160909,EXP,,PL-ASTRAZENECA-2016SE32921,ASTRAZENECA,,23867.0,DY,,M,Y,,,20160909.0,,MD,PL,PL,2016,Q3,Elderly
122518412,12251841,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Dyspnoea,,2016,Q3,2,F,20160227.0,20160801.0,20160411,20160803,EXP,,US-BEH-2016060794,CSL BEHRING,,54.0,YR,A,M,Y,136.8,KG,20160803.0,,OT,US,US,2016,Q3,Adult
122518412,12251841,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Nasopharyngitis,,2016,Q3,2,F,20160227.0,20160801.0,20160411,20160803,EXP,,US-BEH-2016060794,CSL BEHRING,,54.0,YR,A,M,Y,136.8,KG,20160803.0,,OT,US,US,2016,Q3,Adult
122697403,12269740,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Seizure,,2016,Q3,3,F,20160324.0,20160825.0,20160414,20160829,EXP,,US-GILEAD-2016-0208746,GILEAD,,66.0,YR,E,F,Y,93.0,KG,20160829.0,,CN,US,US,2016,Q3,Elderly
122697403,12269740,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Thrombosis,,2016,Q3,3,F,20160324.0,20160825.0,20160414,20160829,EXP,,US-GILEAD-2016-0208746,GILEAD,,66.0,YR,E,F,Y,93.0,KG,20160829.0,,CN,US,US,2016,Q3,Elderly
122703172,12270317,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,12.0,IU,,QD,2016,Q3,Gastritis,,2016,Q3,2,F,20160208.0,20160725.0,20160415,20160802,EXP,,PL-ASTRAZENECA-2016SE38097,ASTRAZENECA,,23875.0,DY,,M,Y,,,20160803.0,,MD,PL,PL,2016,Q3,Elderly
123049783,12304978,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"INJECT 26 UNITS UNDER SKIN, AT BEDTIME",,,,U,,,,,,FORMULATION UNKNOWN,QD,2016,Q3,Anxiety,,2016,Q3,3,F,20160419.0,20160803.0,20160426,20160811,EXP,,US-ASTELLAS-2016US015793,ASTELLAS,,74.0,YR,,M,Y,,,20160811.0,,OT,US,US,2016,Q3,Elderly
123049783,12304978,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"INJECT 26 UNITS UNDER SKIN, AT BEDTIME",,,,U,,,,,,FORMULATION UNKNOWN,QD,2016,Q3,Aphasia,,2016,Q3,3,F,20160419.0,20160803.0,20160426,20160811,EXP,,US-ASTELLAS-2016US015793,ASTELLAS,,74.0,YR,,M,Y,,,20160811.0,,OT,US,US,2016,Q3,Elderly
123049783,12304978,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"INJECT 26 UNITS UNDER SKIN, AT BEDTIME",,,,U,,,,,,FORMULATION UNKNOWN,QD,2016,Q3,Cognitive disorder,,2016,Q3,3,F,20160419.0,20160803.0,20160426,20160811,EXP,,US-ASTELLAS-2016US015793,ASTELLAS,,74.0,YR,,M,Y,,,20160811.0,,OT,US,US,2016,Q3,Elderly
123049783,12304978,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"INJECT 26 UNITS UNDER SKIN, AT BEDTIME",,,,U,,,,,,FORMULATION UNKNOWN,QD,2016,Q3,Confusional state,,2016,Q3,3,F,20160419.0,20160803.0,20160426,20160811,EXP,,US-ASTELLAS-2016US015793,ASTELLAS,,74.0,YR,,M,Y,,,20160811.0,,OT,US,US,2016,Q3,Elderly
123049783,12304978,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"INJECT 26 UNITS UNDER SKIN, AT BEDTIME",,,,U,,,,,,FORMULATION UNKNOWN,QD,2016,Q3,Delirium,,2016,Q3,3,F,20160419.0,20160803.0,20160426,20160811,EXP,,US-ASTELLAS-2016US015793,ASTELLAS,,74.0,YR,,M,Y,,,20160811.0,,OT,US,US,2016,Q3,Elderly
123049783,12304978,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"INJECT 26 UNITS UNDER SKIN, AT BEDTIME",,,,U,,,,,,FORMULATION UNKNOWN,QD,2016,Q3,Hypoaesthesia,,2016,Q3,3,F,20160419.0,20160803.0,20160426,20160811,EXP,,US-ASTELLAS-2016US015793,ASTELLAS,,74.0,YR,,M,Y,,,20160811.0,,OT,US,US,2016,Q3,Elderly
123049783,12304978,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"INJECT 26 UNITS UNDER SKIN, AT BEDTIME",,,,U,,,,,,FORMULATION UNKNOWN,QD,2016,Q3,Insomnia,,2016,Q3,3,F,20160419.0,20160803.0,20160426,20160811,EXP,,US-ASTELLAS-2016US015793,ASTELLAS,,74.0,YR,,M,Y,,,20160811.0,,OT,US,US,2016,Q3,Elderly
123201943,12320194,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,38.0,IU,,QD,2016,Q3,Gastritis erosive,,2016,Q3,3,F,20160414.0,20160701.0,20160430,20160708,EXP,,CO-ASTRAZENECA-2016SE44474,ASTRAZENECA,,28373.0,DY,,M,Y,,,20160708.0,,MD,CO,CO,2016,Q3,Elderly
123238783,12323878,8,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,50 UNITS AM; 70 PM,,,,,,,,,,UNKNOWN,,2016,Q3,Arrhythmia,,2016,Q3,3,F,201602.0,20160803.0,20160502,20160815,EXP,,US-CELGENEUS-USA-2016045089,CELGENE,,50.0,YR,,F,Y,,,20160815.0,,OT,US,US,2016,Q3,Adult
123238783,12323878,8,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,50 UNITS AM; 70 PM,,,,,,,,,,UNKNOWN,,2016,Q3,Sinusitis,,2016,Q3,3,F,201602.0,20160803.0,20160502,20160815,EXP,,US-CELGENEUS-USA-2016045089,CELGENE,,50.0,YR,,F,Y,,,20160815.0,,OT,US,US,2016,Q3,Adult
123373312,12337331,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 UNIT(S),SUBCUTANEOUS,DAILY WITH BREAKFAST",,,,,,,,,,,,2016,Q3,Acute kidney injury,,2016,Q3,2,F,20160315.0,20160808.0,20160505,20160817,EXP,,US-ASTRAZENECA-2016SE46905,ASTRAZENECA,,17957.0,DY,,M,Y,96.2,KG,20160817.0,,,US,US,2016,Q3,Elderly
123373312,12337331,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 UNIT(S),SUBCUTANEOUS,DAILY WITH BREAKFAST",,,,,,,,,,,,2016,Q3,Atelectasis,,2016,Q3,2,F,20160315.0,20160808.0,20160505,20160817,EXP,,US-ASTRAZENECA-2016SE46905,ASTRAZENECA,,17957.0,DY,,M,Y,96.2,KG,20160817.0,,,US,US,2016,Q3,Elderly
123373312,12337331,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 UNIT(S),SUBCUTANEOUS,DAILY WITH BREAKFAST",,,,,,,,,,,,2016,Q3,Diabetes mellitus inadequate control,,2016,Q3,2,F,20160315.0,20160808.0,20160505,20160817,EXP,,US-ASTRAZENECA-2016SE46905,ASTRAZENECA,,17957.0,DY,,M,Y,96.2,KG,20160817.0,,,US,US,2016,Q3,Elderly
123373312,12337331,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 UNIT(S),SUBCUTANEOUS,DAILY WITH BREAKFAST",,,,,,,,,,,,2016,Q3,Diabetic ketoacidosis,,2016,Q3,2,F,20160315.0,20160808.0,20160505,20160817,EXP,,US-ASTRAZENECA-2016SE46905,ASTRAZENECA,,17957.0,DY,,M,Y,96.2,KG,20160817.0,,,US,US,2016,Q3,Elderly
123373312,12337331,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 UNIT(S),SUBCUTANEOUS,DAILY WITH BREAKFAST",,,,,,,,,,,,2016,Q3,Glycosylated haemoglobin increased,,2016,Q3,2,F,20160315.0,20160808.0,20160505,20160817,EXP,,US-ASTRAZENECA-2016SE46905,ASTRAZENECA,,17957.0,DY,,M,Y,96.2,KG,20160817.0,,,US,US,2016,Q3,Elderly
123373312,12337331,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 UNIT(S),SUBCUTANEOUS,DAILY WITH BREAKFAST",,,,,,,,,,,,2016,Q3,Hyperglycaemia,,2016,Q3,2,F,20160315.0,20160808.0,20160505,20160817,EXP,,US-ASTRAZENECA-2016SE46905,ASTRAZENECA,,17957.0,DY,,M,Y,96.2,KG,20160817.0,,,US,US,2016,Q3,Elderly
123373312,12337331,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 UNIT(S),SUBCUTANEOUS,DAILY WITH BREAKFAST",,,,,,,,,,,,2016,Q3,Hyperkalaemia,,2016,Q3,2,F,20160315.0,20160808.0,20160505,20160817,EXP,,US-ASTRAZENECA-2016SE46905,ASTRAZENECA,,17957.0,DY,,M,Y,96.2,KG,20160817.0,,,US,US,2016,Q3,Elderly
123373312,12337331,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 UNIT(S),SUBCUTANEOUS,DAILY WITH BREAKFAST",,,,,,,,,,,,2016,Q3,Hypertension,,2016,Q3,2,F,20160315.0,20160808.0,20160505,20160817,EXP,,US-ASTRAZENECA-2016SE46905,ASTRAZENECA,,17957.0,DY,,M,Y,96.2,KG,20160817.0,,,US,US,2016,Q3,Elderly
123373312,12337331,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 UNIT(S),SUBCUTANEOUS,DAILY WITH BREAKFAST",,,,,,,,,,,,2016,Q3,Hypophosphataemia,,2016,Q3,2,F,20160315.0,20160808.0,20160505,20160817,EXP,,US-ASTRAZENECA-2016SE46905,ASTRAZENECA,,17957.0,DY,,M,Y,96.2,KG,20160817.0,,,US,US,2016,Q3,Elderly
123373312,12337331,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 UNIT(S),SUBCUTANEOUS,DAILY WITH BREAKFAST",,,,,,,,,,,,2016,Q3,Metabolic acidosis,,2016,Q3,2,F,20160315.0,20160808.0,20160505,20160817,EXP,,US-ASTRAZENECA-2016SE46905,ASTRAZENECA,,17957.0,DY,,M,Y,96.2,KG,20160817.0,,,US,US,2016,Q3,Elderly
123373312,12337331,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 UNIT(S),SUBCUTANEOUS,DAILY WITH BREAKFAST",,,,,,,,,,,,2016,Q3,Pulmonary fibrosis,,2016,Q3,2,F,20160315.0,20160808.0,20160505,20160817,EXP,,US-ASTRAZENECA-2016SE46905,ASTRAZENECA,,17957.0,DY,,M,Y,96.2,KG,20160817.0,,,US,US,2016,Q3,Elderly
123373312,12337331,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 UNIT(S),SUBCUTANEOUS,DAILY WITH BREAKFAST",,,,,,,,,,,,2016,Q3,Tachycardia,,2016,Q3,2,F,20160315.0,20160808.0,20160505,20160817,EXP,,US-ASTRAZENECA-2016SE46905,ASTRAZENECA,,17957.0,DY,,M,Y,96.2,KG,20160817.0,,,US,US,2016,Q3,Elderly
123494112,12349411,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2016,Q3,Nephropathy,,2016,Q3,2,F,,20160620.0,20160510,20160704,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-035555,BRISTOL MYERS SQUIBB,,19.0,YR,,M,Y,,,20160704.0,,CN,CN,CN,2016,Q3,Youth
123789633,12378963,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Abdominal pain,,2016,Q3,3,F,201603.0,20160426.0,20160517,20160901,EXP,,US-RELYPSA-RLY2016000265,RELYPSA,,58.0,YR,,M,Y,,,20160901.0,,CN,US,US,2016,Q3,Adult
123789633,12378963,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Asthenia,,2016,Q3,3,F,201603.0,20160426.0,20160517,20160901,EXP,,US-RELYPSA-RLY2016000265,RELYPSA,,58.0,YR,,M,Y,,,20160901.0,,CN,US,US,2016,Q3,Adult
123789633,12378963,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Bowel movement irregularity,,2016,Q3,3,F,201603.0,20160426.0,20160517,20160901,EXP,,US-RELYPSA-RLY2016000265,RELYPSA,,58.0,YR,,M,Y,,,20160901.0,,CN,US,US,2016,Q3,Adult
123789633,12378963,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Constipation,,2016,Q3,3,F,201603.0,20160426.0,20160517,20160901,EXP,,US-RELYPSA-RLY2016000265,RELYPSA,,58.0,YR,,M,Y,,,20160901.0,,CN,US,US,2016,Q3,Adult
123789633,12378963,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Dyspepsia,,2016,Q3,3,F,201603.0,20160426.0,20160517,20160901,EXP,,US-RELYPSA-RLY2016000265,RELYPSA,,58.0,YR,,M,Y,,,20160901.0,,CN,US,US,2016,Q3,Adult
123863712,12386371,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 U, QD",,,Y,,,,,10.0,DF,,QD,2016,Q3,Diarrhoea,,2016,Q3,2,F,,20160420.0,20160519,20160802,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-036605,BRISTOL MYERS SQUIBB,,56.0,YR,,F,Y,118.0,KG,20160802.0,,OT,US,US,2016,Q3,Adult
123863712,12386371,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 U, QD",,,Y,,,,,10.0,DF,,QD,2016,Q3,Fixed drug eruption,,2016,Q3,2,F,,20160420.0,20160519,20160802,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-036605,BRISTOL MYERS SQUIBB,,56.0,YR,,F,Y,118.0,KG,20160802.0,,OT,US,US,2016,Q3,Adult
123863712,12386371,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 U, QD",,,Y,,,,,10.0,DF,,QD,2016,Q3,Pain,,2016,Q3,2,F,,20160420.0,20160519,20160802,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-036605,BRISTOL MYERS SQUIBB,,56.0,YR,,F,Y,118.0,KG,20160802.0,,OT,US,US,2016,Q3,Adult
123892024,12389202,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2016,Q3,Lactic acidosis,,2016,Q3,4,F,,20160614.0,20160520,20160713,EXP,,JP-009507513-1605JPN009936,MERCK,,72.0,YR,,F,Y,,,20160713.0,,OT,JP,JP,2016,Q3,Elderly
123899653,12389965,10,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,"UNK, DAILY",,,,U,,,,,,,,2016,Q3,Hypercapnia,,2016,Q3,3,F,20160404.0,20160811.0,20160520,20160826,EXP,,IT-PURDUE PHARMA-GBR-2016-0036271,PURDUE,,82.0,YR,,M,Y,,,20160826.0,,MD,IT,IT,2016,Q3,Elderly
123899653,12389965,10,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,"UNK, DAILY",,,,U,,,,,,,,2016,Q3,Hypoxia,,2016,Q3,3,F,20160404.0,20160811.0,20160520,20160826,EXP,,IT-PURDUE PHARMA-GBR-2016-0036271,PURDUE,,82.0,YR,,M,Y,,,20160826.0,,MD,IT,IT,2016,Q3,Elderly
123899653,12389965,10,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,"UNK, DAILY",,,,U,,,,,,,,2016,Q3,Respiratory acidosis,,2016,Q3,3,F,20160404.0,20160811.0,20160520,20160826,EXP,,IT-PURDUE PHARMA-GBR-2016-0036271,PURDUE,,82.0,YR,,M,Y,,,20160826.0,,MD,IT,IT,2016,Q3,Elderly
123899653,12389965,10,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,"UNK, DAILY",,,,U,,,,,,,,2016,Q3,Sopor,,2016,Q3,3,F,20160404.0,20160811.0,20160520,20160826,EXP,,IT-PURDUE PHARMA-GBR-2016-0036271,PURDUE,,82.0,YR,,M,Y,,,20160826.0,,MD,IT,IT,2016,Q3,Elderly
124124013,12412401,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q3,Agranulocytosis,Agranulocytosis,2016,Q3,3,F,,20160714.0,20160527,20160719,EXP,,US-PFIZER INC-2016274551,PFIZER,"ISKANDAR, J.. TRANSIENT AGRANULOCYTOSIS ASSOCIATED WITH ZIPRASIDONE IN A 45-YEAR-OLD MAN ON HEMODIALYSIS. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY. 2015;35(3):347-348",45.0,YR,,M,Y,,,20160719.0,,MD,US,US,2016,Q3,Adult
124124024,12412402,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q3,Agranulocytosis,,2016,Q3,4,F,,20160713.0,20160527,20160721,EXP,,US-PFIZER INC-2016274629,PFIZER,"MANCANO, M. ZIPROSIDONE-INDUCED TRANSIENT AGRANULOCYTOSIS DELAYED ONSET OF CARDIAC ADVERSE EFFECTS WITH FINGOLIMOD TELMISARTAN-INDUCED MYOTOXICITY SEVERE DILATED CARDIOMYOPATHY INDUCED BY ADALIMUMAB AND USTEKINUMAB. HOSPITAL PHARMACY. 2015;50(10):855-858",45.0,YR,,M,Y,,,20160721.0,,PH,US,US,2016,Q3,Adult
124172432,12417243,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"10 U, UNK",,,U,U,,,,10.0,IU,INJECTION,QD,2016,Q3,Cardiac arrest,,2016,Q3,2,F,20140822.0,20160714.0,20160530,20160725,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605006247,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20160722.0,,CN,IT,IT,2016,Q3,Elderly
124172432,12417243,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"10 U, UNK",,,U,U,,,,10.0,IU,INJECTION,QD,2016,Q3,Face injury,,2016,Q3,2,F,20140822.0,20160714.0,20160530,20160725,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605006247,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20160722.0,,CN,IT,IT,2016,Q3,Elderly
124172432,12417243,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"10 U, UNK",,,U,U,,,,10.0,IU,INJECTION,QD,2016,Q3,Hyperglycaemia,,2016,Q3,2,F,20140822.0,20160714.0,20160530,20160725,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605006247,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20160722.0,,CN,IT,IT,2016,Q3,Elderly
124172432,12417243,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"10 U, UNK",,,U,U,,,,10.0,IU,INJECTION,QD,2016,Q3,Hypoglycaemic coma,,2016,Q3,2,F,20140822.0,20160714.0,20160530,20160725,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605006247,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20160722.0,,CN,IT,IT,2016,Q3,Elderly
124172432,12417243,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"10 U, UNK",,,U,U,,,,10.0,IU,INJECTION,QD,2016,Q3,Hypoglycaemic unconsciousness,,2016,Q3,2,F,20140822.0,20160714.0,20160530,20160725,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605006247,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20160722.0,,CN,IT,IT,2016,Q3,Elderly
124172432,12417243,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"10 U, UNK",,,U,U,,,,10.0,IU,INJECTION,QD,2016,Q3,Loss of consciousness,,2016,Q3,2,F,20140822.0,20160714.0,20160530,20160725,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605006247,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20160722.0,,CN,IT,IT,2016,Q3,Elderly
124172432,12417243,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"10 U, UNK",,,U,U,,,,10.0,IU,INJECTION,QD,2016,Q3,Prothrombin time shortened,,2016,Q3,2,F,20140822.0,20160714.0,20160530,20160725,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605006247,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20160722.0,,CN,IT,IT,2016,Q3,Elderly
124172432,12417243,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"10 U, UNK",,,U,U,,,,10.0,IU,INJECTION,QD,2016,Q3,Syncope,,2016,Q3,2,F,20140822.0,20160714.0,20160530,20160725,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605006247,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20160722.0,,CN,IT,IT,2016,Q3,Elderly
124172432,12417243,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, QD",,,U,U,,,,12.0,IU,INJECTION,QD,2016,Q3,Cardiac arrest,,2016,Q3,2,F,20140822.0,20160714.0,20160530,20160725,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605006247,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20160722.0,,CN,IT,IT,2016,Q3,Elderly
124172432,12417243,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, QD",,,U,U,,,,12.0,IU,INJECTION,QD,2016,Q3,Face injury,,2016,Q3,2,F,20140822.0,20160714.0,20160530,20160725,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605006247,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20160722.0,,CN,IT,IT,2016,Q3,Elderly
124172432,12417243,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, QD",,,U,U,,,,12.0,IU,INJECTION,QD,2016,Q3,Hyperglycaemia,,2016,Q3,2,F,20140822.0,20160714.0,20160530,20160725,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605006247,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20160722.0,,CN,IT,IT,2016,Q3,Elderly
124172432,12417243,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, QD",,,U,U,,,,12.0,IU,INJECTION,QD,2016,Q3,Hypoglycaemic coma,,2016,Q3,2,F,20140822.0,20160714.0,20160530,20160725,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605006247,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20160722.0,,CN,IT,IT,2016,Q3,Elderly
124172432,12417243,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, QD",,,U,U,,,,12.0,IU,INJECTION,QD,2016,Q3,Hypoglycaemic unconsciousness,,2016,Q3,2,F,20140822.0,20160714.0,20160530,20160725,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605006247,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20160722.0,,CN,IT,IT,2016,Q3,Elderly
124172432,12417243,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, QD",,,U,U,,,,12.0,IU,INJECTION,QD,2016,Q3,Loss of consciousness,,2016,Q3,2,F,20140822.0,20160714.0,20160530,20160725,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605006247,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20160722.0,,CN,IT,IT,2016,Q3,Elderly
124172432,12417243,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, QD",,,U,U,,,,12.0,IU,INJECTION,QD,2016,Q3,Prothrombin time shortened,,2016,Q3,2,F,20140822.0,20160714.0,20160530,20160725,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605006247,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20160722.0,,CN,IT,IT,2016,Q3,Elderly
124172432,12417243,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, QD",,,U,U,,,,12.0,IU,INJECTION,QD,2016,Q3,Syncope,,2016,Q3,2,F,20140822.0,20160714.0,20160530,20160725,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605006247,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20160722.0,,CN,IT,IT,2016,Q3,Elderly
124306422,12430642,4,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,25.0,IU,UNKNOWN,QD,2016,Q3,Diabetic ketoacidosis,,2016,Q3,2,F,20160506.0,20160708.0,20160602,20160716,EXP,,US-BIOGEN-2016BI00240856,BIOGEN,,40.0,YR,,F,Y,65.83,KG,20160716.0,,MD,US,US,2016,Q3,Adult
124312713,12431271,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"50 UNIT, UNK",,,U,,,,,50.0,DF,,,2016,Q3,Brain neoplasm,,2016,Q3,3,F,20160512.0,20160726.0,20160603,20160803,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-042557,BRISTOL MYERS SQUIBB,,74.0,YR,,M,Y,,,20160803.0,,MD,US,US,2016,Q3,Elderly
124369032,12436903,8,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,13.0,IU,,,2016,Q3,Brain death,,2016,Q3,2,F,201605.0,20160622.0,20160606,20160701,EXP,,CO-BAXTER-2016BAX028280,BAXTER,,69.0,YR,,M,Y,60.4,KG,20160701.0,,OT,CO,CO,2016,Q3,Elderly
124369032,12436903,8,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,13.0,IU,,,2016,Q3,Herpes virus infection,,2016,Q3,2,F,201605.0,20160622.0,20160606,20160701,EXP,,CO-BAXTER-2016BAX028280,BAXTER,,69.0,YR,,M,Y,60.4,KG,20160701.0,,OT,CO,CO,2016,Q3,Elderly
124369032,12436903,8,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,13.0,IU,,,2016,Q3,Meningoencephalitis herpetic,,2016,Q3,2,F,201605.0,20160622.0,20160606,20160701,EXP,,CO-BAXTER-2016BAX028280,BAXTER,,69.0,YR,,M,Y,60.4,KG,20160701.0,,OT,CO,CO,2016,Q3,Elderly
124369202,12436920,11,C,Glargine insulin,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2016,Q3,Cerebrovascular accident,,2016,Q3,2,F,201605.0,20160623.0,20160606,20160701,EXP,,CO-BAXTER-2016BAX028096,BAXTER,,65.0,YR,,M,Y,61.0,KG,20160701.0,,OT,CO,CO,2016,Q3,Elderly
124369202,12436920,11,C,Glargine insulin,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2016,Q3,Pneumonia,,2016,Q3,2,F,201605.0,20160623.0,20160606,20160701,EXP,,CO-BAXTER-2016BAX028096,BAXTER,,65.0,YR,,M,Y,61.0,KG,20160701.0,,OT,CO,CO,2016,Q3,Elderly
124544134,12454413,15,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,U,,,,,,,,2016,Q3,Erysipelas,,2016,Q3,4,F,20160531.0,20160712.0,20160610,20160718,EXP,,CZ-UCBSA-2016021382,UCB,,68.0,YR,,M,Y,124.0,KG,20160718.0,,MD,CZ,CZ,2016,Q3,Elderly
124657522,12465752,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2016,Q3,Haemoglobin decreased,,2016,Q3,2,F,20160422.0,20160705.0,20160614,20160712,EXP,,DE-JNJFOC-20160608294,JANSSEN,,89.0,YR,E,F,Y,,,20160712.0,,MD,DE,DE,2016,Q3,Elderly
124657522,12465752,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2016,Q3,Pallor,,2016,Q3,2,F,20160422.0,20160705.0,20160614,20160712,EXP,,DE-JNJFOC-20160608294,JANSSEN,,89.0,YR,E,F,Y,,,20160712.0,,MD,DE,DE,2016,Q3,Elderly
124657522,12465752,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2016,Q3,Skin induration,,2016,Q3,2,F,20160422.0,20160705.0,20160614,20160712,EXP,,DE-JNJFOC-20160608294,JANSSEN,,89.0,YR,E,F,Y,,,20160712.0,,MD,DE,DE,2016,Q3,Elderly
124690422,12469042,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,IN AM,,,,,,,,30.0,IU,INJECTION,QD,2016,Q3,Dizziness,,2016,Q3,2,F,20160601.0,20160722.0,20160615,20160801,EXP,,US-BIOGEN-2016BI00250002,BIOGEN,,48.0,YR,,M,Y,,,20160801.0,,MD,US,US,2016,Q3,Adult
124690422,12469042,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,IN AM,,,,,,,,30.0,IU,INJECTION,QD,2016,Q3,Fall,,2016,Q3,2,F,20160601.0,20160722.0,20160615,20160801,EXP,,US-BIOGEN-2016BI00250002,BIOGEN,,48.0,YR,,M,Y,,,20160801.0,,MD,US,US,2016,Q3,Adult
124690422,12469042,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,IN AM,,,,,,,,30.0,IU,INJECTION,QD,2016,Q3,Femur fracture,,2016,Q3,2,F,20160601.0,20160722.0,20160615,20160801,EXP,,US-BIOGEN-2016BI00250002,BIOGEN,,48.0,YR,,M,Y,,,20160801.0,,MD,US,US,2016,Q3,Adult
124690422,12469042,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,IN AM,,,,,,,,30.0,IU,INJECTION,QD,2016,Q3,Postural orthostatic tachycardia syndrome,,2016,Q3,2,F,20160601.0,20160722.0,20160615,20160801,EXP,,US-BIOGEN-2016BI00250002,BIOGEN,,48.0,YR,,M,Y,,,20160801.0,,MD,US,US,2016,Q3,Adult
124690422,12469042,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,IN AM,,,,,,,,30.0,IU,INJECTION,QD,2016,Q3,Relapsing-remitting multiple sclerosis,,2016,Q3,2,F,20160601.0,20160722.0,20160615,20160801,EXP,,US-BIOGEN-2016BI00250002,BIOGEN,,48.0,YR,,M,Y,,,20160801.0,,MD,US,US,2016,Q3,Adult
124690422,12469042,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,IN AM,,,,,,,,30.0,IU,INJECTION,QD,2016,Q3,Tachycardia,,2016,Q3,2,F,20160601.0,20160722.0,20160615,20160801,EXP,,US-BIOGEN-2016BI00250002,BIOGEN,,48.0,YR,,M,Y,,,20160801.0,,MD,US,US,2016,Q3,Adult
124690422,12469042,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,IN AM,,,,,,,,30.0,IU,INJECTION,QD,2016,Q3,Treatment failure,,2016,Q3,2,F,20160601.0,20160722.0,20160615,20160801,EXP,,US-BIOGEN-2016BI00250002,BIOGEN,,48.0,YR,,M,Y,,,20160801.0,,MD,US,US,2016,Q3,Adult
124690422,12469042,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,IN AM,,,,,,,,30.0,IU,INJECTION,QD,2016,Q3,Urinary tract infection,,2016,Q3,2,F,20160601.0,20160722.0,20160615,20160801,EXP,,US-BIOGEN-2016BI00250002,BIOGEN,,48.0,YR,,M,Y,,,20160801.0,,MD,US,US,2016,Q3,Adult
124690422,12469042,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,AT BEDTIME,,,,,,,,40.0,IU,INJECTION,QD,2016,Q3,Dizziness,,2016,Q3,2,F,20160601.0,20160722.0,20160615,20160801,EXP,,US-BIOGEN-2016BI00250002,BIOGEN,,48.0,YR,,M,Y,,,20160801.0,,MD,US,US,2016,Q3,Adult
124690422,12469042,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,AT BEDTIME,,,,,,,,40.0,IU,INJECTION,QD,2016,Q3,Fall,,2016,Q3,2,F,20160601.0,20160722.0,20160615,20160801,EXP,,US-BIOGEN-2016BI00250002,BIOGEN,,48.0,YR,,M,Y,,,20160801.0,,MD,US,US,2016,Q3,Adult
124690422,12469042,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,AT BEDTIME,,,,,,,,40.0,IU,INJECTION,QD,2016,Q3,Femur fracture,,2016,Q3,2,F,20160601.0,20160722.0,20160615,20160801,EXP,,US-BIOGEN-2016BI00250002,BIOGEN,,48.0,YR,,M,Y,,,20160801.0,,MD,US,US,2016,Q3,Adult
124690422,12469042,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,AT BEDTIME,,,,,,,,40.0,IU,INJECTION,QD,2016,Q3,Postural orthostatic tachycardia syndrome,,2016,Q3,2,F,20160601.0,20160722.0,20160615,20160801,EXP,,US-BIOGEN-2016BI00250002,BIOGEN,,48.0,YR,,M,Y,,,20160801.0,,MD,US,US,2016,Q3,Adult
124690422,12469042,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,AT BEDTIME,,,,,,,,40.0,IU,INJECTION,QD,2016,Q3,Relapsing-remitting multiple sclerosis,,2016,Q3,2,F,20160601.0,20160722.0,20160615,20160801,EXP,,US-BIOGEN-2016BI00250002,BIOGEN,,48.0,YR,,M,Y,,,20160801.0,,MD,US,US,2016,Q3,Adult
124690422,12469042,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,AT BEDTIME,,,,,,,,40.0,IU,INJECTION,QD,2016,Q3,Tachycardia,,2016,Q3,2,F,20160601.0,20160722.0,20160615,20160801,EXP,,US-BIOGEN-2016BI00250002,BIOGEN,,48.0,YR,,M,Y,,,20160801.0,,MD,US,US,2016,Q3,Adult
124690422,12469042,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,AT BEDTIME,,,,,,,,40.0,IU,INJECTION,QD,2016,Q3,Treatment failure,,2016,Q3,2,F,20160601.0,20160722.0,20160615,20160801,EXP,,US-BIOGEN-2016BI00250002,BIOGEN,,48.0,YR,,M,Y,,,20160801.0,,MD,US,US,2016,Q3,Adult
124690422,12469042,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,AT BEDTIME,,,,,,,,40.0,IU,INJECTION,QD,2016,Q3,Urinary tract infection,,2016,Q3,2,F,20160601.0,20160722.0,20160615,20160801,EXP,,US-BIOGEN-2016BI00250002,BIOGEN,,48.0,YR,,M,Y,,,20160801.0,,MD,US,US,2016,Q3,Adult
124842172,12484217,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"50 U, BID (UNDER THE SKIN) (MORNING AND NIGHT)",,,U,,,,,50.0,DF,,BID,2016,Q3,Abdominal distension,,2016,Q3,2,F,20160615.0,20160628.0,20160621,20160707,EXP,,PHEH2016US015170,NOVARTIS,,62.0,YR,,M,Y,151.5,KG,20160708.0,,MD,US,US,2016,Q3,Adult
124842172,12484217,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"50 U, BID (UNDER THE SKIN) (MORNING AND NIGHT)",,,U,,,,,50.0,DF,,BID,2016,Q3,Abdominal pain,,2016,Q3,2,F,20160615.0,20160628.0,20160621,20160707,EXP,,PHEH2016US015170,NOVARTIS,,62.0,YR,,M,Y,151.5,KG,20160708.0,,MD,US,US,2016,Q3,Adult
124842172,12484217,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"50 U, BID (UNDER THE SKIN) (MORNING AND NIGHT)",,,U,,,,,50.0,DF,,BID,2016,Q3,Blood chloride decreased,,2016,Q3,2,F,20160615.0,20160628.0,20160621,20160707,EXP,,PHEH2016US015170,NOVARTIS,,62.0,YR,,M,Y,151.5,KG,20160708.0,,MD,US,US,2016,Q3,Adult
124842172,12484217,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"50 U, BID (UNDER THE SKIN) (MORNING AND NIGHT)",,,U,,,,,50.0,DF,,BID,2016,Q3,Blood glucose increased,,2016,Q3,2,F,20160615.0,20160628.0,20160621,20160707,EXP,,PHEH2016US015170,NOVARTIS,,62.0,YR,,M,Y,151.5,KG,20160708.0,,MD,US,US,2016,Q3,Adult
124842172,12484217,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"50 U, BID (UNDER THE SKIN) (MORNING AND NIGHT)",,,U,,,,,50.0,DF,,BID,2016,Q3,Blood pressure increased,,2016,Q3,2,F,20160615.0,20160628.0,20160621,20160707,EXP,,PHEH2016US015170,NOVARTIS,,62.0,YR,,M,Y,151.5,KG,20160708.0,,MD,US,US,2016,Q3,Adult
124842172,12484217,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"50 U, BID (UNDER THE SKIN) (MORNING AND NIGHT)",,,U,,,,,50.0,DF,,BID,2016,Q3,Blood urea increased,,2016,Q3,2,F,20160615.0,20160628.0,20160621,20160707,EXP,,PHEH2016US015170,NOVARTIS,,62.0,YR,,M,Y,151.5,KG,20160708.0,,MD,US,US,2016,Q3,Adult
124842172,12484217,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"50 U, BID (UNDER THE SKIN) (MORNING AND NIGHT)",,,U,,,,,50.0,DF,,BID,2016,Q3,Gastrointestinal necrosis,,2016,Q3,2,F,20160615.0,20160628.0,20160621,20160707,EXP,,PHEH2016US015170,NOVARTIS,,62.0,YR,,M,Y,151.5,KG,20160708.0,,MD,US,US,2016,Q3,Adult
124842172,12484217,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"50 U, BID (UNDER THE SKIN) (MORNING AND NIGHT)",,,U,,,,,50.0,DF,,BID,2016,Q3,Haemoglobin decreased,,2016,Q3,2,F,20160615.0,20160628.0,20160621,20160707,EXP,,PHEH2016US015170,NOVARTIS,,62.0,YR,,M,Y,151.5,KG,20160708.0,,MD,US,US,2016,Q3,Adult
124842172,12484217,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"50 U, BID (UNDER THE SKIN) (MORNING AND NIGHT)",,,U,,,,,50.0,DF,,BID,2016,Q3,Haemorrhage,,2016,Q3,2,F,20160615.0,20160628.0,20160621,20160707,EXP,,PHEH2016US015170,NOVARTIS,,62.0,YR,,M,Y,151.5,KG,20160708.0,,MD,US,US,2016,Q3,Adult
124842172,12484217,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"50 U, BID (UNDER THE SKIN) (MORNING AND NIGHT)",,,U,,,,,50.0,DF,,BID,2016,Q3,Malaise,,2016,Q3,2,F,20160615.0,20160628.0,20160621,20160707,EXP,,PHEH2016US015170,NOVARTIS,,62.0,YR,,M,Y,151.5,KG,20160708.0,,MD,US,US,2016,Q3,Adult
124842172,12484217,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"50 U, BID (UNDER THE SKIN) (MORNING AND NIGHT)",,,U,,,,,50.0,DF,,BID,2016,Q3,Pain,,2016,Q3,2,F,20160615.0,20160628.0,20160621,20160707,EXP,,PHEH2016US015170,NOVARTIS,,62.0,YR,,M,Y,151.5,KG,20160708.0,,MD,US,US,2016,Q3,Adult
124842172,12484217,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"50 U, BID (UNDER THE SKIN) (MORNING AND NIGHT)",,,U,,,,,50.0,DF,,BID,2016,Q3,Platelet count decreased,,2016,Q3,2,F,20160615.0,20160628.0,20160621,20160707,EXP,,PHEH2016US015170,NOVARTIS,,62.0,YR,,M,Y,151.5,KG,20160708.0,,MD,US,US,2016,Q3,Adult
124842172,12484217,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"50 U, BID (UNDER THE SKIN) (MORNING AND NIGHT)",,,U,,,,,50.0,DF,,BID,2016,Q3,Protein total decreased,,2016,Q3,2,F,20160615.0,20160628.0,20160621,20160707,EXP,,PHEH2016US015170,NOVARTIS,,62.0,YR,,M,Y,151.5,KG,20160708.0,,MD,US,US,2016,Q3,Adult
124842172,12484217,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"50 U, BID (UNDER THE SKIN) (MORNING AND NIGHT)",,,U,,,,,50.0,DF,,BID,2016,Q3,Septic shock,,2016,Q3,2,F,20160615.0,20160628.0,20160621,20160707,EXP,,PHEH2016US015170,NOVARTIS,,62.0,YR,,M,Y,151.5,KG,20160708.0,,MD,US,US,2016,Q3,Adult
124842172,12484217,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"50 U, BID (UNDER THE SKIN) (MORNING AND NIGHT)",,,U,,,,,50.0,DF,,BID,2016,Q3,Small intestinal obstruction,,2016,Q3,2,F,20160615.0,20160628.0,20160621,20160707,EXP,,PHEH2016US015170,NOVARTIS,,62.0,YR,,M,Y,151.5,KG,20160708.0,,MD,US,US,2016,Q3,Adult
124842172,12484217,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"50 U, BID (UNDER THE SKIN) (MORNING AND NIGHT)",,,U,,,,,50.0,DF,,BID,2016,Q3,White blood cell count decreased,,2016,Q3,2,F,20160615.0,20160628.0,20160621,20160707,EXP,,PHEH2016US015170,NOVARTIS,,62.0,YR,,M,Y,151.5,KG,20160708.0,,MD,US,US,2016,Q3,Adult
124997086,12499708,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 U, QHS",,,,,,,,30.0,DF,,,2016,Q3,Acute kidney injury,,2016,Q3,6,F,20160613.0,20160906.0,20160627,20160916,EXP,,PHHO2016US008777,SANDOZ,,65.0,YR,,F,Y,72.6,KG,20160916.0,,OT,US,US,2016,Q3,Elderly
124997086,12499708,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 U, QHS",,,,,,,,30.0,DF,,,2016,Q3,Asthenia,,2016,Q3,6,F,20160613.0,20160906.0,20160627,20160916,EXP,,PHHO2016US008777,SANDOZ,,65.0,YR,,F,Y,72.6,KG,20160916.0,,OT,US,US,2016,Q3,Elderly
124997086,12499708,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 U, QHS",,,,,,,,30.0,DF,,,2016,Q3,Conversion disorder,,2016,Q3,6,F,20160613.0,20160906.0,20160627,20160916,EXP,,PHHO2016US008777,SANDOZ,,65.0,YR,,F,Y,72.6,KG,20160916.0,,OT,US,US,2016,Q3,Elderly
124997086,12499708,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 U, QHS",,,,,,,,30.0,DF,,,2016,Q3,Dehydration,,2016,Q3,6,F,20160613.0,20160906.0,20160627,20160916,EXP,,PHHO2016US008777,SANDOZ,,65.0,YR,,F,Y,72.6,KG,20160916.0,,OT,US,US,2016,Q3,Elderly
125036842,12503684,6,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"100 IU, QD",,,,U,,,,100.0,IU,,QD,2016,Q3,Seizure,,2016,Q3,2,F,20160613.0,20160705.0,20160628,20160719,EXP,,US-ACORDA-ACO_125224_2016,ACORDA,,40.0,YR,,M,Y,,,20160719.0,,OT,US,US,2016,Q3,Adult
125040873,12504087,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 U,,,,,,,,26.0,IU,,QD,2016,Q3,Tongue oedema,,2016,Q3,3,F,20160421.0,20160922.0,20160628,20160926,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-41228BP",BOEHRINGER INGELHEIM,,57.0,YR,,M,Y,104.0,KG,20160926.0,,MD,US,US,2016,Q3,Adult
125110972,12511097,13,C,GLARGINE,,2,Subcutaneous,70 UNITS BID,,,,,,,,,,,,2016,Q3,Gastroenteritis,,2016,Q3,2,F,20130715.0,20160920.0,20160629,20160928,EXP,,US-ASTRAZENECA-2016SE41980,ASTRAZENECA,,66.0,YR,,M,Y,117.0,KG,20160928.0,,MD,US,US,2016,Q3,Elderly
125119552,12511955,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,80.0,IU,INJECTION,,2016,Q3,Gastrointestinal haemorrhage,,2016,Q3,2,F,20141028.0,20160727.0,20160630,20160912,PER,,US-JNJFOC-20160507595,JANSSEN,,77.0,YR,E,F,Y,,,20160912.0,,MD,US,US,2016,Q3,Elderly
125135723,12513572,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,UNSPECIFIED,,2016,Q3,Gastrointestinal haemorrhage,,2016,Q3,3,F,20130926.0,20160912.0,20160630,20160921,PER,,US-JNJFOC-20160525789,JANSSEN,,51.0,YR,A,F,Y,178.63,KG,20160921.0,,CN,US,US,2016,Q3,Adult
125221783,12522178,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Erythema multiforme,,2016,Q3,3,F,20151214.0,20160805.0,20160701,20160812,EXP,,JP-ASTRAZENECA-2016SE71116,ASTRAZENECA,,43.0,YR,,F,Y,72.0,KG,20160812.0,,MD,JP,JP,2016,Q3,Adult
125221783,12522178,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Xeroderma,,2016,Q3,3,F,20151214.0,20160805.0,20160701,20160812,EXP,,JP-ASTRAZENECA-2016SE71116,ASTRAZENECA,,43.0,YR,,F,Y,72.0,KG,20160812.0,,MD,JP,JP,2016,Q3,Adult
125242101,12524210,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q3,Acute kidney injury,,2016,Q3,1,I,,20160620.0,20160704,20160704,EXP,,"US-GLENMARK PHARMACEUTICALS INC, USA.-2016GMK023468",GLENMARK,"BAIRD P, LEUNG S, HOANG H, BABALOLA O, DEVOE CE, WANCHOO R.. A CASE OF ACUTE KIDNEY INJURY FROM CRYSTAL NEPHROPATHY SECONDARY TO POMALIDOMIDE AND LEVOFLOXACIN USE.. JOURNAL OF ONCOLOGY PHARMACY PRACTICE.. 2016;22(2):357-360",76.0,YR,,F,Y,,,20160704.0,,MD,US,US,2016,Q3,Elderly
125242101,12524210,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q3,Crystal nephropathy,,2016,Q3,1,I,,20160620.0,20160704,20160704,EXP,,"US-GLENMARK PHARMACEUTICALS INC, USA.-2016GMK023468",GLENMARK,"BAIRD P, LEUNG S, HOANG H, BABALOLA O, DEVOE CE, WANCHOO R.. A CASE OF ACUTE KIDNEY INJURY FROM CRYSTAL NEPHROPATHY SECONDARY TO POMALIDOMIDE AND LEVOFLOXACIN USE.. JOURNAL OF ONCOLOGY PHARMACY PRACTICE.. 2016;22(2):357-360",76.0,YR,,F,Y,,,20160704.0,,MD,US,US,2016,Q3,Elderly
125242101,12524210,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q3,Thrombocytopenia,,2016,Q3,1,I,,20160620.0,20160704,20160704,EXP,,"US-GLENMARK PHARMACEUTICALS INC, USA.-2016GMK023468",GLENMARK,"BAIRD P, LEUNG S, HOANG H, BABALOLA O, DEVOE CE, WANCHOO R.. A CASE OF ACUTE KIDNEY INJURY FROM CRYSTAL NEPHROPATHY SECONDARY TO POMALIDOMIDE AND LEVOFLOXACIN USE.. JOURNAL OF ONCOLOGY PHARMACY PRACTICE.. 2016;22(2):357-360",76.0,YR,,F,Y,,,20160704.0,,MD,US,US,2016,Q3,Elderly
125275202,12527520,6,C,insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,26.0,IU,UNKNOWN,,2016,Q3,Anaemia,,2016,Q3,2,F,20140910.0,20160621.0,20160705,20160706,EXP,,ES-CELGENEUS-ESP-2014113013,CELGENE,,67.0,YR,,M,Y,71.0,KG,20160706.0,,OT,ES,ES,2016,Q3,Elderly
125275202,12527520,6,C,insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,26.0,IU,UNKNOWN,,2016,Q3,Lung adenocarcinoma,,2016,Q3,2,F,20140910.0,20160621.0,20160705,20160706,EXP,,ES-CELGENEUS-ESP-2014113013,CELGENE,,67.0,YR,,M,Y,71.0,KG,20160706.0,,OT,ES,ES,2016,Q3,Elderly
125275202,12527520,6,C,insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,26.0,IU,UNKNOWN,,2016,Q3,Neutropenia,,2016,Q3,2,F,20140910.0,20160621.0,20160705,20160706,EXP,,ES-CELGENEUS-ESP-2014113013,CELGENE,,67.0,YR,,M,Y,71.0,KG,20160706.0,,OT,ES,ES,2016,Q3,Elderly
125275202,12527520,6,C,insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,26.0,IU,UNKNOWN,,2016,Q3,Thrombocytopenia,,2016,Q3,2,F,20140910.0,20160621.0,20160705,20160706,EXP,,ES-CELGENEUS-ESP-2014113013,CELGENE,,67.0,YR,,M,Y,71.0,KG,20160706.0,,OT,ES,ES,2016,Q3,Elderly
125359851,12535985,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Hypoglycaemia,,2016,Q3,1,I,20160523.0,,20160706,20160706,DIR,,,,,50.0,YR,,F,N,183.0,LBS,20160625.0,N,CN,US,,2016,Q3,Adult
125359851,12535985,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Visual impairment,,2016,Q3,1,I,20160523.0,,20160706,20160706,DIR,,,,,50.0,YR,,F,N,183.0,LBS,20160625.0,N,CN,US,,2016,Q3,Adult
125373771,12537377,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD",,,,,,,,12.0,IU,,QD,2016,Q3,Mental status changes,,2016,Q3,1,I,20160420.0,20160422.0,20160707,20160707,EXP,,US-PFIZER INC-2016228186,PFIZER,,77.0,YR,,M,Y,88.0,KG,20160707.0,,OT,US,US,2016,Q3,Elderly
125373771,12537377,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD",,,,,,,,12.0,IU,,QD,2016,Q3,Ventricular tachycardia,,2016,Q3,1,I,20160420.0,20160422.0,20160707,20160707,EXP,,US-PFIZER INC-2016228186,PFIZER,,77.0,YR,,M,Y,88.0,KG,20160707.0,,OT,US,US,2016,Q3,Elderly
125403251,12540325,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Blood creatinine increased,,2016,Q3,1,I,20160115.0,,20160707,20160707,DIR,,,,,60.0,YR,,M,N,100.0,KG,20160706.0,N,CN,US,,2016,Q3,Adult
125403251,12540325,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Dizziness,,2016,Q3,1,I,20160115.0,,20160707,20160707,DIR,,,,,60.0,YR,,M,N,100.0,KG,20160706.0,N,CN,US,,2016,Q3,Adult
125403251,12540325,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Dizziness postural,,2016,Q3,1,I,20160115.0,,20160707,20160707,DIR,,,,,60.0,YR,,M,N,100.0,KG,20160706.0,N,CN,US,,2016,Q3,Adult
125403251,12540325,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Injury,,2016,Q3,1,I,20160115.0,,20160707,20160707,DIR,,,,,60.0,YR,,M,N,100.0,KG,20160706.0,N,CN,US,,2016,Q3,Adult
125403251,12540325,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Loss of consciousness,,2016,Q3,1,I,20160115.0,,20160707,20160707,DIR,,,,,60.0,YR,,M,N,100.0,KG,20160706.0,N,CN,US,,2016,Q3,Adult
125403251,12540325,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Myocardial infarction,,2016,Q3,1,I,20160115.0,,20160707,20160707,DIR,,,,,60.0,YR,,M,N,100.0,KG,20160706.0,N,CN,US,,2016,Q3,Adult
125403251,12540325,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Stenosis,,2016,Q3,1,I,20160115.0,,20160707,20160707,DIR,,,,,60.0,YR,,M,N,100.0,KG,20160706.0,N,CN,US,,2016,Q3,Adult
125403321,12540332,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Dehydration,,2016,Q3,1,I,20160701.0,,20160707,20160707,DIR,,,,,58.0,YR,,M,N,74.6,KG,20160706.0,N,OT,US,,2016,Q3,Adult
125403321,12540332,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Hyperglycaemia,,2016,Q3,1,I,20160701.0,,20160707,20160707,DIR,,,,,58.0,YR,,M,N,74.6,KG,20160706.0,N,OT,US,,2016,Q3,Adult
125403321,12540332,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Nausea,,2016,Q3,1,I,20160701.0,,20160707,20160707,DIR,,,,,58.0,YR,,M,N,74.6,KG,20160706.0,N,OT,US,,2016,Q3,Adult
125403321,12540332,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Vomiting,,2016,Q3,1,I,20160701.0,,20160707,20160707,DIR,,,,,58.0,YR,,M,N,74.6,KG,20160706.0,N,OT,US,,2016,Q3,Adult
125410111,12541011,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Intestinal obstruction,,2016,Q3,1,I,20160630.0,20160701.0,20160708,20160708,EXP,,US-EISAI MEDICAL RESEARCH-EC-2016-018264,EISAI,,63.0,YR,,F,Y,75.71,KG,20160708.0,,MD,US,US,2016,Q3,Adult
125411092,12541109,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,APPROXIMATELY A YEAR AND A HALF; TOTAL DAILY DOSE: 1 DOSE DAILY (1 DOSE EVERY 24 HOURS)),,,,U,,,,1.0,DF,INJECTION,QD,2016,Q3,Anaemia,,2016,Q3,2,F,201606.0,20160706.0,20160708,20160712,EXP,,MX-009507513-1607MEX002428,MERCK,,59.0,YR,,F,Y,60.0,KG,20160712.0,,OT,MX,MX,2016,Q3,Adult
125411092,12541109,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,APPROXIMATELY A YEAR AND A HALF; TOTAL DAILY DOSE: 1 DOSE DAILY (1 DOSE EVERY 24 HOURS)),,,,U,,,,1.0,DF,INJECTION,QD,2016,Q3,Arthralgia,,2016,Q3,2,F,201606.0,20160706.0,20160708,20160712,EXP,,MX-009507513-1607MEX002428,MERCK,,59.0,YR,,F,Y,60.0,KG,20160712.0,,OT,MX,MX,2016,Q3,Adult
125411092,12541109,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,APPROXIMATELY A YEAR AND A HALF; TOTAL DAILY DOSE: 1 DOSE DAILY (1 DOSE EVERY 24 HOURS)),,,,U,,,,1.0,DF,INJECTION,QD,2016,Q3,Asterixis,,2016,Q3,2,F,201606.0,20160706.0,20160708,20160712,EXP,,MX-009507513-1607MEX002428,MERCK,,59.0,YR,,F,Y,60.0,KG,20160712.0,,OT,MX,MX,2016,Q3,Adult
125411092,12541109,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,APPROXIMATELY A YEAR AND A HALF; TOTAL DAILY DOSE: 1 DOSE DAILY (1 DOSE EVERY 24 HOURS)),,,,U,,,,1.0,DF,INJECTION,QD,2016,Q3,Chills,,2016,Q3,2,F,201606.0,20160706.0,20160708,20160712,EXP,,MX-009507513-1607MEX002428,MERCK,,59.0,YR,,F,Y,60.0,KG,20160712.0,,OT,MX,MX,2016,Q3,Adult
125411092,12541109,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,APPROXIMATELY A YEAR AND A HALF; TOTAL DAILY DOSE: 1 DOSE DAILY (1 DOSE EVERY 24 HOURS)),,,,U,,,,1.0,DF,INJECTION,QD,2016,Q3,Malaise,,2016,Q3,2,F,201606.0,20160706.0,20160708,20160712,EXP,,MX-009507513-1607MEX002428,MERCK,,59.0,YR,,F,Y,60.0,KG,20160712.0,,OT,MX,MX,2016,Q3,Adult
125411092,12541109,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,APPROXIMATELY A YEAR AND A HALF; TOTAL DAILY DOSE: 1 DOSE DAILY (1 DOSE EVERY 24 HOURS)),,,,U,,,,1.0,DF,INJECTION,QD,2016,Q3,Myalgia,,2016,Q3,2,F,201606.0,20160706.0,20160708,20160712,EXP,,MX-009507513-1607MEX002428,MERCK,,59.0,YR,,F,Y,60.0,KG,20160712.0,,OT,MX,MX,2016,Q3,Adult
125411092,12541109,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,APPROXIMATELY A YEAR AND A HALF; TOTAL DAILY DOSE: 1 DOSE DAILY (1 DOSE EVERY 24 HOURS)),,,,U,,,,1.0,DF,INJECTION,QD,2016,Q3,Pyrexia,,2016,Q3,2,F,201606.0,20160706.0,20160708,20160712,EXP,,MX-009507513-1607MEX002428,MERCK,,59.0,YR,,F,Y,60.0,KG,20160712.0,,OT,MX,MX,2016,Q3,Adult
125413142,12541314,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,Y,,,,,,,UNSPECIFIED,,2016,Q3,Cardiac failure congestive,,2016,Q3,2,F,20160525.0,20160805.0,20160708,20160811,EXP,,US-JNJFOC-20160627539,JANSSEN,,60.0,YR,A,M,Y,119.9,KG,20160811.0,,MD,US,US,2016,Q3,Adult
125413142,12541314,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,Y,,,,,,,UNSPECIFIED,,2016,Q3,Lower gastrointestinal haemorrhage,,2016,Q3,2,F,20160525.0,20160805.0,20160708,20160811,EXP,,US-JNJFOC-20160627539,JANSSEN,,60.0,YR,A,M,Y,119.9,KG,20160811.0,,MD,US,US,2016,Q3,Adult
125413142,12541314,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,Y,,,,,,,UNSPECIFIED,,2016,Q3,Myocardial infarction,,2016,Q3,2,F,20160525.0,20160805.0,20160708,20160811,EXP,,US-JNJFOC-20160627539,JANSSEN,,60.0,YR,A,M,Y,119.9,KG,20160811.0,,MD,US,US,2016,Q3,Adult
125423441,12542344,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 IU/ML DAILY,,,,,,,,,,,,2016,Q3,Drug intolerance,,2016,Q3,1,I,20160321.0,20160702.0,20160708,20160708,EXP,,MX-ASTRAZENECA-2016SE73798,ASTRAZENECA,,26076.0,DY,,M,Y,,,20160709.0,,MD,MX,MX,2016,Q3,Elderly
125454261,12545426,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 U,,,,,,,,20.0,IU,,QD,2016,Q3,Eye discharge,,2016,Q3,1,I,201601.0,20160704.0,20160711,20160711,EXP,,"CN-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-44707CS",BOEHRINGER INGELHEIM,,79.0,YR,,F,Y,,,20160711.0,,CN,CN,CN,2016,Q3,Elderly
125454261,12545426,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 U,,,,,,,,20.0,IU,,QD,2016,Q3,Face oedema,,2016,Q3,1,I,201601.0,20160704.0,20160711,20160711,EXP,,"CN-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-44707CS",BOEHRINGER INGELHEIM,,79.0,YR,,F,Y,,,20160711.0,,CN,CN,CN,2016,Q3,Elderly
125455361,12545536,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,,2016,Q3,Diabetes mellitus inadequate control,,2016,Q3,1,I,201602.0,20160308.0,20160711,20160711,EXP,,GB-JNJFOC-20160311662,JANSSEN,,76.0,YR,E,F,Y,,,20160711.0,,CN,GB,GB,2016,Q3,Elderly
125455361,12545536,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,,2016,Q3,Impetigo,,2016,Q3,1,I,201602.0,20160308.0,20160711,20160711,EXP,,GB-JNJFOC-20160311662,JANSSEN,,76.0,YR,E,F,Y,,,20160711.0,,CN,GB,GB,2016,Q3,Elderly
125455361,12545536,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,,2016,Q3,Rash,,2016,Q3,1,I,201602.0,20160308.0,20160711,20160711,EXP,,GB-JNJFOC-20160311662,JANSSEN,,76.0,YR,E,F,Y,,,20160711.0,,CN,GB,GB,2016,Q3,Elderly
125464422,12546442,4,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD",,,,U,,,,,,,QD,2016,Q3,Blood pressure decreased,,2016,Q3,2,F,2016.0,20160923.0,20160711,20160929,EXP,,US-EMERGENT BIOSOLUTIONS-16BA00098SP,EMERGENT BIOSOLUTIONS,,70.0,YR,,M,Y,72.0,KG,20160929.0,,PH,US,US,2016,Q3,Elderly
125464422,12546442,4,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD",,,,U,,,,,,,QD,2016,Q3,Bradycardia,,2016,Q3,2,F,2016.0,20160923.0,20160711,20160929,EXP,,US-EMERGENT BIOSOLUTIONS-16BA00098SP,EMERGENT BIOSOLUTIONS,,70.0,YR,,M,Y,72.0,KG,20160929.0,,PH,US,US,2016,Q3,Elderly
125464422,12546442,4,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD",,,,U,,,,,,,QD,2016,Q3,Pneumonia,,2016,Q3,2,F,2016.0,20160923.0,20160711,20160929,EXP,,US-EMERGENT BIOSOLUTIONS-16BA00098SP,EMERGENT BIOSOLUTIONS,,70.0,YR,,M,Y,72.0,KG,20160929.0,,PH,US,US,2016,Q3,Elderly
125482912,12548291,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2016,Q3,Toxic epidermal necrolysis,,2016,Q3,2,F,20160615.0,20160729.0,20160712,20160808,EXP,,GB-PURDUE PHARMA-GBR-2016-0037655,PURDUE,,71.0,YR,,M,Y,,,20160802.0,,PH,GB,GB,2016,Q3,Elderly
125497612,12549761,8,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2016,Q3,Pneumonia,,2016,Q3,2,F,20160621.0,20160805.0,20160712,20160811,EXP,,CO-BAXTER-2016BAX036063,BAXTER,,66.0,YR,,F,Y,118.0,KG,20160811.0,,OT,CO,CO,2016,Q3,Elderly
125528381,12552838,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Burkholderia test positive,,2016,Q3,1,I,20160207.0,,20160712,20160712,DIR,,,,,83.0,YR,,F,N,76.0,KG,20160711.0,N,PH,US,,2016,Q3,Elderly
125528381,12552838,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,General physical health deterioration,,2016,Q3,1,I,20160207.0,,20160712,20160712,DIR,,,,,83.0,YR,,F,N,76.0,KG,20160711.0,N,PH,US,,2016,Q3,Elderly
125528381,12552838,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Hypotension,,2016,Q3,1,I,20160207.0,,20160712,20160712,DIR,,,,,83.0,YR,,F,N,76.0,KG,20160711.0,N,PH,US,,2016,Q3,Elderly
125528381,12552838,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Ischaemic hepatitis,,2016,Q3,1,I,20160207.0,,20160712,20160712,DIR,,,,,83.0,YR,,F,N,76.0,KG,20160711.0,N,PH,US,,2016,Q3,Elderly
125528381,12552838,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Shock,,2016,Q3,1,I,20160207.0,,20160712,20160712,DIR,,,,,83.0,YR,,F,N,76.0,KG,20160711.0,N,PH,US,,2016,Q3,Elderly
125546823,12554682,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Cardiac failure congestive,,2016,Q3,3,F,201606.0,20160826.0,20160713,20160902,EXP,,US-RELYPSA-RLY2016001316,RELYPSA,,78.0,YR,,M,Y,,,20160902.0,,CN,US,US,2016,Q3,Elderly
125546823,12554682,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Renal failure,,2016,Q3,3,F,201606.0,20160826.0,20160713,20160902,EXP,,US-RELYPSA-RLY2016001316,RELYPSA,,78.0,YR,,M,Y,,,20160902.0,,CN,US,US,2016,Q3,Elderly
125546823,12554682,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Cardiac failure congestive,,2016,Q3,3,F,201606.0,20160826.0,20160713,20160902,EXP,,US-RELYPSA-RLY2016001316,RELYPSA,,78.0,YR,,M,Y,,,20160902.0,,CN,US,US,2016,Q3,Elderly
125546823,12554682,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Renal failure,,2016,Q3,3,F,201606.0,20160826.0,20160713,20160902,EXP,,US-RELYPSA-RLY2016001316,RELYPSA,,78.0,YR,,M,Y,,,20160902.0,,CN,US,US,2016,Q3,Elderly
125598571,12559857,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, 1X/DAY",,,,, 5BD57A,,,,,INJECTION,,2016,Q3,Blood glucose fluctuation,,2016,Q3,1,I,20160113.0,20160707.0,20160715,20160715,EXP,,CN-PFIZER INC-2016340807,PFIZER,,54.0,YR,,M,Y,76.0,KG,20160715.0,,OT,CN,CN,2016,Q3,Adult
125598571,12559857,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, 1X/DAY",,,,, 5BD57A,,,,,INJECTION,,2016,Q3,Hepatic enzyme increased,,2016,Q3,1,I,20160113.0,20160707.0,20160715,20160715,EXP,,CN-PFIZER INC-2016340807,PFIZER,,54.0,YR,,M,Y,76.0,KG,20160715.0,,OT,CN,CN,2016,Q3,Adult
125598571,12559857,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"15 U, 1X/DAY",,,,,,,,,,INJECTION,,2016,Q3,Blood glucose fluctuation,,2016,Q3,1,I,20160113.0,20160707.0,20160715,20160715,EXP,,CN-PFIZER INC-2016340807,PFIZER,,54.0,YR,,M,Y,76.0,KG,20160715.0,,OT,CN,CN,2016,Q3,Adult
125598571,12559857,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"15 U, 1X/DAY",,,,,,,,,,INJECTION,,2016,Q3,Hepatic enzyme increased,,2016,Q3,1,I,20160113.0,20160707.0,20160715,20160715,EXP,,CN-PFIZER INC-2016340807,PFIZER,,54.0,YR,,M,Y,76.0,KG,20160715.0,,OT,CN,CN,2016,Q3,Adult
125598571,12559857,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"20 U, 1X/DAY",,,,,,,,,,INJECTION,,2016,Q3,Blood glucose fluctuation,,2016,Q3,1,I,20160113.0,20160707.0,20160715,20160715,EXP,,CN-PFIZER INC-2016340807,PFIZER,,54.0,YR,,M,Y,76.0,KG,20160715.0,,OT,CN,CN,2016,Q3,Adult
125598571,12559857,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"20 U, 1X/DAY",,,,,,,,,,INJECTION,,2016,Q3,Hepatic enzyme increased,,2016,Q3,1,I,20160113.0,20160707.0,20160715,20160715,EXP,,CN-PFIZER INC-2016340807,PFIZER,,54.0,YR,,M,Y,76.0,KG,20160715.0,,OT,CN,CN,2016,Q3,Adult
125608283,12560828,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,U,,,,18.0,IU,FORMULATION UNKNOWN,QD,2016,Q3,Cardio-respiratory arrest,,2016,Q3,3,F,20160706.0,20160823.0,20160715,20160830,EXP,,US-ASTELLAS-2016US026158,ASTELLAS,,58.0,YR,,M,Y,,,20160830.0,,PH,US,US,2016,Q3,Adult
125608283,12560828,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,U,,,,18.0,IU,FORMULATION UNKNOWN,QD,2016,Q3,Endotracheal intubation,,2016,Q3,3,F,20160706.0,20160823.0,20160715,20160830,EXP,,US-ASTELLAS-2016US026158,ASTELLAS,,58.0,YR,,M,Y,,,20160830.0,,PH,US,US,2016,Q3,Adult
125608283,12560828,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,U,,,,18.0,IU,FORMULATION UNKNOWN,QD,2016,Q3,Hypersensitivity,,2016,Q3,3,F,20160706.0,20160823.0,20160715,20160830,EXP,,US-ASTELLAS-2016US026158,ASTELLAS,,58.0,YR,,M,Y,,,20160830.0,,PH,US,US,2016,Q3,Adult
125608283,12560828,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,U,,,,18.0,IU,FORMULATION UNKNOWN,QD,2016,Q3,Pulse absent,,2016,Q3,3,F,20160706.0,20160823.0,20160715,20160830,EXP,,US-ASTELLAS-2016US026158,ASTELLAS,,58.0,YR,,M,Y,,,20160830.0,,PH,US,US,2016,Q3,Adult
125609103,12560910,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2016,Q3,Anaemia,,2016,Q3,3,F,20160115.0,20160725.0,20160715,20160803,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-055908,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,99.1,KG,20160803.0,,CN,US,US,2016,Q3,Adult
125609103,12560910,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2016,Q3,Blood creatinine increased,,2016,Q3,3,F,20160115.0,20160725.0,20160715,20160803,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-055908,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,99.1,KG,20160803.0,,CN,US,US,2016,Q3,Adult
125609103,12560910,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2016,Q3,Dizziness,,2016,Q3,3,F,20160115.0,20160725.0,20160715,20160803,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-055908,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,99.1,KG,20160803.0,,CN,US,US,2016,Q3,Adult
125609103,12560910,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2016,Q3,Loss of consciousness,,2016,Q3,3,F,20160115.0,20160725.0,20160715,20160803,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-055908,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,99.1,KG,20160803.0,,CN,US,US,2016,Q3,Adult
125609103,12560910,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2016,Q3,Myocardial infarction,,2016,Q3,3,F,20160115.0,20160725.0,20160715,20160803,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-055908,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,99.1,KG,20160803.0,,CN,US,US,2016,Q3,Adult
125609103,12560910,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2016,Q3,Stent placement,,2016,Q3,3,F,20160115.0,20160725.0,20160715,20160803,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-055908,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,99.1,KG,20160803.0,,CN,US,US,2016,Q3,Adult
125620443,12562044,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Dehydration,,2016,Q3,3,F,20160520.0,20160825.0,20160715,20160907,EXP,,US-TEVA-676466USA,TEVA,,73.0,YR,,M,Y,108.0,KG,20160907.0,,MD,US,US,2016,Q3,Elderly
125621821,12562182,6,C,insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,18.0,IU,SOLUTION FOR INFUSION,,2016,Q3,Sudden death,,2016,Q3,1,I,201607.0,20160708.0,20160715,20160715,EXP,,CO-BAXTER-2016BAX037270,BAXTER,,76.0,YR,,M,Y,68.0,KG,20160715.0,,OT,CO,CO,2016,Q3,Elderly
125640111,12564011,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,26.0,IU,,,2016,Q3,Acute myocardial infarction,,2016,Q3,1,I,,20160714.0,20160718,20160718,EXP,,CO-BAXTER-2016BAX038155,BAXTER,,76.0,YR,,M,Y,55.0,KG,20160718.0,,OT,CO,CO,2016,Q3,Elderly
125662622,12566262,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"20 IU, NIGHTLY",,,D,U,,,,20.0,IU,FORMULATION UNKNOWN,,2016,Q3,Acute kidney injury,,2016,Q3,2,F,20160325.0,20160908.0,20160718,20160916,EXP,,US-ASTELLAS-2016US012317,ASTELLAS,,54.0,YR,,F,Y,,,20160916.0,,MD,US,US,2016,Q3,Adult
125662622,12566262,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"20 IU, NIGHTLY",,,D,U,,,,20.0,IU,FORMULATION UNKNOWN,,2016,Q3,Acute myocardial infarction,,2016,Q3,2,F,20160325.0,20160908.0,20160718,20160916,EXP,,US-ASTELLAS-2016US012317,ASTELLAS,,54.0,YR,,F,Y,,,20160916.0,,MD,US,US,2016,Q3,Adult
125662622,12566262,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"20 IU, NIGHTLY",,,D,U,,,,20.0,IU,FORMULATION UNKNOWN,,2016,Q3,Atrioventricular block complete,,2016,Q3,2,F,20160325.0,20160908.0,20160718,20160916,EXP,,US-ASTELLAS-2016US012317,ASTELLAS,,54.0,YR,,F,Y,,,20160916.0,,MD,US,US,2016,Q3,Adult
125662622,12566262,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"20 IU, NIGHTLY",,,D,U,,,,20.0,IU,FORMULATION UNKNOWN,,2016,Q3,Cardiac arrest,,2016,Q3,2,F,20160325.0,20160908.0,20160718,20160916,EXP,,US-ASTELLAS-2016US012317,ASTELLAS,,54.0,YR,,F,Y,,,20160916.0,,MD,US,US,2016,Q3,Adult
125662622,12566262,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"20 IU, NIGHTLY",,,D,U,,,,20.0,IU,FORMULATION UNKNOWN,,2016,Q3,Pneumonia,,2016,Q3,2,F,20160325.0,20160908.0,20160718,20160916,EXP,,US-ASTELLAS-2016US012317,ASTELLAS,,54.0,YR,,F,Y,,,20160916.0,,MD,US,US,2016,Q3,Adult
125662622,12566262,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"20 IU, NIGHTLY",,,D,U,,,,20.0,IU,FORMULATION UNKNOWN,,2016,Q3,Sepsis,,2016,Q3,2,F,20160325.0,20160908.0,20160718,20160916,EXP,,US-ASTELLAS-2016US012317,ASTELLAS,,54.0,YR,,F,Y,,,20160916.0,,MD,US,US,2016,Q3,Adult
125662622,12566262,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 IU, ONCE DAILY (EVERY MORNING)",,,D,U,,,,24.0,IU,FORMULATION UNKNOWN,QD,2016,Q3,Acute kidney injury,,2016,Q3,2,F,20160325.0,20160908.0,20160718,20160916,EXP,,US-ASTELLAS-2016US012317,ASTELLAS,,54.0,YR,,F,Y,,,20160916.0,,MD,US,US,2016,Q3,Adult
125662622,12566262,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 IU, ONCE DAILY (EVERY MORNING)",,,D,U,,,,24.0,IU,FORMULATION UNKNOWN,QD,2016,Q3,Acute myocardial infarction,,2016,Q3,2,F,20160325.0,20160908.0,20160718,20160916,EXP,,US-ASTELLAS-2016US012317,ASTELLAS,,54.0,YR,,F,Y,,,20160916.0,,MD,US,US,2016,Q3,Adult
125662622,12566262,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 IU, ONCE DAILY (EVERY MORNING)",,,D,U,,,,24.0,IU,FORMULATION UNKNOWN,QD,2016,Q3,Atrioventricular block complete,,2016,Q3,2,F,20160325.0,20160908.0,20160718,20160916,EXP,,US-ASTELLAS-2016US012317,ASTELLAS,,54.0,YR,,F,Y,,,20160916.0,,MD,US,US,2016,Q3,Adult
125662622,12566262,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 IU, ONCE DAILY (EVERY MORNING)",,,D,U,,,,24.0,IU,FORMULATION UNKNOWN,QD,2016,Q3,Cardiac arrest,,2016,Q3,2,F,20160325.0,20160908.0,20160718,20160916,EXP,,US-ASTELLAS-2016US012317,ASTELLAS,,54.0,YR,,F,Y,,,20160916.0,,MD,US,US,2016,Q3,Adult
125662622,12566262,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 IU, ONCE DAILY (EVERY MORNING)",,,D,U,,,,24.0,IU,FORMULATION UNKNOWN,QD,2016,Q3,Pneumonia,,2016,Q3,2,F,20160325.0,20160908.0,20160718,20160916,EXP,,US-ASTELLAS-2016US012317,ASTELLAS,,54.0,YR,,F,Y,,,20160916.0,,MD,US,US,2016,Q3,Adult
125662622,12566262,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 IU, ONCE DAILY (EVERY MORNING)",,,D,U,,,,24.0,IU,FORMULATION UNKNOWN,QD,2016,Q3,Sepsis,,2016,Q3,2,F,20160325.0,20160908.0,20160718,20160916,EXP,,US-ASTELLAS-2016US012317,ASTELLAS,,54.0,YR,,F,Y,,,20160916.0,,MD,US,US,2016,Q3,Adult
125670562,12567056,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,30.0,IU,,,2016,Q3,Diabetic ketoacidosis,,2016,Q3,2,F,20160612.0,20160815.0,20160718,20160822,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-46054BP",BOEHRINGER INGELHEIM,,37.0,YR,,F,Y,121.4,KG,20160822.0,,MD,US,US,2016,Q3,Adult
125671332,12567133,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, UNKNOWN,,21081.0,,,,QD,2016,Q3,Hypoglycaemia,,2016,Q3,2,F,20140811.0,20160712.0,20160718,20160721,EXP,,IT-SA-2016SA128242,AVENTIS,,73.0,YR,E,M,Y,60.0,KG,20160721.0,,MD,IT,IT,2016,Q3,Elderly
125671332,12567133,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, UNKNOWN,,21081.0,,,,QD,2016,Q3,Loss of consciousness,,2016,Q3,2,F,20140811.0,20160712.0,20160718,20160721,EXP,,IT-SA-2016SA128242,AVENTIS,,73.0,YR,E,M,Y,60.0,KG,20160721.0,,MD,IT,IT,2016,Q3,Elderly
125671332,12567133,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, UNKNOWN,,21081.0,,,,QD,2016,Q3,Malaise,,2016,Q3,2,F,20140811.0,20160712.0,20160718,20160721,EXP,,IT-SA-2016SA128242,AVENTIS,,73.0,YR,E,M,Y,60.0,KG,20160721.0,,MD,IT,IT,2016,Q3,Elderly
125671332,12567133,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, UNKNOWN,,21081.0,,,,QD,2016,Q3,Presyncope,,2016,Q3,2,F,20140811.0,20160712.0,20160718,20160721,EXP,,IT-SA-2016SA128242,AVENTIS,,73.0,YR,E,M,Y,60.0,KG,20160721.0,,MD,IT,IT,2016,Q3,Elderly
125683192,12568319,42,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,5.0,IU,INJECTION,QD,2016,Q3,Pneumonia pseudomonal,,2016,Q3,2,F,20160703.0,20160817.0,20160718,20160824,PER,,US-CELGENEUS-USA-2016073675,CELGENE,,73.0,YR,,F,Y,74.9,KG,20160824.0,,OT,US,US,2016,Q3,Elderly
125807051,12580705,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,ONCE IN THE MORNING (24 UNITS),,,U,,,,,,,,,2016,Q3,Diabetic ketoacidosis,,2016,Q3,1,I,,20160711.0,20160721,20160721,EXP,,JP-WATSON-2016-15884,WATSON,"GOCHO N, AOKI E, OKADA C, OMURA K, HIRASHIMA T, SUZUKI N ET AL. NON-OCCLUSIVE MESENTERIC ISCHEMIA WITH DIABETIC KETOACIDOSIS AND LACTIC ACIDOSIS FOLLOWING THE ADMINISTRATION OF A SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITOR. INTERN MED. 2016;55(13):1755-1760.",60.0,YR,,M,Y,72.8,KG,20160721.0,,MD,JP,JP,2016,Q3,Adult
125807051,12580705,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,ONCE IN THE MORNING (24 UNITS),,,U,,,,,,,,,2016,Q3,Lactic acidosis,,2016,Q3,1,I,,20160711.0,20160721,20160721,EXP,,JP-WATSON-2016-15884,WATSON,"GOCHO N, AOKI E, OKADA C, OMURA K, HIRASHIMA T, SUZUKI N ET AL. NON-OCCLUSIVE MESENTERIC ISCHEMIA WITH DIABETIC KETOACIDOSIS AND LACTIC ACIDOSIS FOLLOWING THE ADMINISTRATION OF A SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITOR. INTERN MED. 2016;55(13):1755-1760.",60.0,YR,,M,Y,72.8,KG,20160721.0,,MD,JP,JP,2016,Q3,Adult
125808203,12580820,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,IN THE MORNING,,,,,,,,24.0,IU,UNSPECIFIED,QD,2016,Q3,Diabetic ketoacidosis,,2016,Q3,3,F,,20160720.0,20160721,20160802,EXP,,JP-JNJFOC-20160716430,JANSSEN,"GOCHO N, AOKI E, OKADA C, OMURA K, HIRASHIMA T, SUZUKI N, ET AL. NON-OCCLUSIVE MESENTERIC ISCHEMIA WITH DIABETIC KETOACIDOSIS AND LACTIC ACIDOSIS FOLLOWING THE ADMINISTRATION OF A SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITOR.. INTERNAL MEDICINE 2016;55/13:1755-1760.",60.0,YR,A,M,Y,72.8,KG,20160802.0,,MD,JP,JP,2016,Q3,Adult
125808203,12580820,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,IN THE MORNING,,,,,,,,24.0,IU,UNSPECIFIED,QD,2016,Q3,Intestinal ischaemia,,2016,Q3,3,F,,20160720.0,20160721,20160802,EXP,,JP-JNJFOC-20160716430,JANSSEN,"GOCHO N, AOKI E, OKADA C, OMURA K, HIRASHIMA T, SUZUKI N, ET AL. NON-OCCLUSIVE MESENTERIC ISCHEMIA WITH DIABETIC KETOACIDOSIS AND LACTIC ACIDOSIS FOLLOWING THE ADMINISTRATION OF A SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITOR.. INTERNAL MEDICINE 2016;55/13:1755-1760.",60.0,YR,A,M,Y,72.8,KG,20160802.0,,MD,JP,JP,2016,Q3,Adult
125808203,12580820,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,IN THE MORNING,,,,,,,,24.0,IU,UNSPECIFIED,QD,2016,Q3,Lactic acidosis,,2016,Q3,3,F,,20160720.0,20160721,20160802,EXP,,JP-JNJFOC-20160716430,JANSSEN,"GOCHO N, AOKI E, OKADA C, OMURA K, HIRASHIMA T, SUZUKI N, ET AL. NON-OCCLUSIVE MESENTERIC ISCHEMIA WITH DIABETIC KETOACIDOSIS AND LACTIC ACIDOSIS FOLLOWING THE ADMINISTRATION OF A SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITOR.. INTERNAL MEDICINE 2016;55/13:1755-1760.",60.0,YR,A,M,Y,72.8,KG,20160802.0,,MD,JP,JP,2016,Q3,Adult
125808863,12580886,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intramuscular,"60 UNITS, QD",,,,,,,,60.0,IU,,QD,2016,Q3,Acute kidney injury,,2016,Q3,3,F,20130716.0,20160824.0,20160721,20160830,EXP,,US-PFIZER INC-2013209122,PFIZER,,68.0,YR,,M,Y,135.0,KG,20160830.0,,MD,US,US,2016,Q3,Elderly
125808863,12580886,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intramuscular,"60 UNITS, QD",,,,,,,,60.0,IU,,QD,2016,Q3,Non-cardiac chest pain,,2016,Q3,3,F,20130716.0,20160824.0,20160721,20160830,EXP,,US-PFIZER INC-2013209122,PFIZER,,68.0,YR,,M,Y,135.0,KG,20160830.0,,MD,US,US,2016,Q3,Elderly
125814072,12581407,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Hospitalisation,,2016,Q3,2,F,20160719.0,20160719.0,20160721,20160901,EXP,,US-RELYPSA-RLY2016001514,RELYPSA,,66.0,YR,,F,Y,,,20160901.0,,CN,US,US,2016,Q3,Elderly
125814422,12581442,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,7.0,IU,INJECTION,QD,2016,Q3,No adverse event,,2016,Q3,2,F,,20160825.0,20160721,20160902,EXP,,JP-ASTRAZENECA-2016SE77545,ASTRAZENECA,,74.0,YR,,M,Y,52.0,KG,20160902.0,,MD,JP,JP,2016,Q3,Elderly
125815201,12581520,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,ONCE IN THE MORNING (24 UNITS),,,,,,,,,,,,2016,Q3,Diabetic ketoacidosis,,2016,Q3,1,I,,20160711.0,20160721,20160721,EXP,,JP-BAUSCH-BL-2016-017249,BAUSCH AND LOMB,"GOCHO N, AOKI E, OKADA C, OMURA K, HIRASHIMA T, SUZUKI N. NON-OCCLUSIVE MESENTERIC ISCHEMIA WITH DIABETIC KETOACIDOSIS AND LACTIC ACIDOSIS FOLLOWING THE ADMINISTRATION OF A SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITOR. INTERNAL MEDICINE. 2016;55(13):1755-1760.",60.0,YR,,M,Y,72.8,KG,20160721.0,,MD,JP,JP,2016,Q3,Adult
125815201,12581520,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,ONCE IN THE MORNING (24 UNITS),,,,,,,,,,,,2016,Q3,Lactic acidosis,,2016,Q3,1,I,,20160711.0,20160721,20160721,EXP,,JP-BAUSCH-BL-2016-017249,BAUSCH AND LOMB,"GOCHO N, AOKI E, OKADA C, OMURA K, HIRASHIMA T, SUZUKI N. NON-OCCLUSIVE MESENTERIC ISCHEMIA WITH DIABETIC KETOACIDOSIS AND LACTIC ACIDOSIS FOLLOWING THE ADMINISTRATION OF A SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITOR. INTERNAL MEDICINE. 2016;55(13):1755-1760.",60.0,YR,,M,Y,72.8,KG,20160721.0,,MD,JP,JP,2016,Q3,Adult
125823731,12582373,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UT, UONCE IN THE MORNING (24 UNITS)",,,,,,,,,,,,2016,Q3,Diabetic ketoacidosis,,2016,Q3,1,I,,20160718.0,20160722,20160722,EXP,,"JP-GLENMARK PHARMACEUTICALS INC, USA.-2016GMK023701",GLENMARK,"GOCHO N, AOKI E, OKADA C, OMURA K, HIRASHIMA T, SUZUKI N ET AL. NON-OCCLUSIVE MESENTERIC ISCHEMIA WITH DIABETIC KETOACIDOSIS AND LACTIC ACIDOSIS FOLLOWING THE ADMINISTRATION OF A SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITOR.INTERNAL MEDICINE. 2016;55(13):1755-1760",60.0,YR,,M,Y,72.8,KG,20160722.0,,MD,JP,JP,2016,Q3,Adult
125823731,12582373,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UT, UONCE IN THE MORNING (24 UNITS)",,,,,,,,,,,,2016,Q3,Lactic acidosis,,2016,Q3,1,I,,20160718.0,20160722,20160722,EXP,,"JP-GLENMARK PHARMACEUTICALS INC, USA.-2016GMK023701",GLENMARK,"GOCHO N, AOKI E, OKADA C, OMURA K, HIRASHIMA T, SUZUKI N ET AL. NON-OCCLUSIVE MESENTERIC ISCHEMIA WITH DIABETIC KETOACIDOSIS AND LACTIC ACIDOSIS FOLLOWING THE ADMINISTRATION OF A SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITOR.INTERNAL MEDICINE. 2016;55(13):1755-1760",60.0,YR,,M,Y,72.8,KG,20160722.0,,MD,JP,JP,2016,Q3,Adult
125860141,12586014,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,ONCE IN THE MORNING (24 UNITS),,,,,,,,,,,,2016,Q3,Diabetic ketoacidosis,,2016,Q3,1,I,,20160711.0,20160725,20160725,EXP,,JP-INDICUS PHARMA-000433,INDICUS,"GOCHO N, AOKI E, OKADA C, OMURA K, HIRASHIMA T, SUZUKI N, ET AL. NON-OCCLUSIVE MESENTERIC ISCHEMIA WITH DIABETIC KETOACIDOSIS AND LACTIC ACIDOSIS FOLLOWING THE ADMINISTRATION OF A SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITOR. INTERN MED. 2016; 55(13):1755-60.",60.0,YR,,M,Y,72.8,KG,20160725.0,,MD,JP,JP,2016,Q3,Adult
125860141,12586014,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,ONCE IN THE MORNING (24 UNITS),,,,,,,,,,,,2016,Q3,Disseminated intravascular coagulation,,2016,Q3,1,I,,20160711.0,20160725,20160725,EXP,,JP-INDICUS PHARMA-000433,INDICUS,"GOCHO N, AOKI E, OKADA C, OMURA K, HIRASHIMA T, SUZUKI N, ET AL. NON-OCCLUSIVE MESENTERIC ISCHEMIA WITH DIABETIC KETOACIDOSIS AND LACTIC ACIDOSIS FOLLOWING THE ADMINISTRATION OF A SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITOR. INTERN MED. 2016; 55(13):1755-60.",60.0,YR,,M,Y,72.8,KG,20160725.0,,MD,JP,JP,2016,Q3,Adult
125860141,12586014,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,ONCE IN THE MORNING (24 UNITS),,,,,,,,,,,,2016,Q3,Gastrointestinal necrosis,,2016,Q3,1,I,,20160711.0,20160725,20160725,EXP,,JP-INDICUS PHARMA-000433,INDICUS,"GOCHO N, AOKI E, OKADA C, OMURA K, HIRASHIMA T, SUZUKI N, ET AL. NON-OCCLUSIVE MESENTERIC ISCHEMIA WITH DIABETIC KETOACIDOSIS AND LACTIC ACIDOSIS FOLLOWING THE ADMINISTRATION OF A SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITOR. INTERN MED. 2016; 55(13):1755-60.",60.0,YR,,M,Y,72.8,KG,20160725.0,,MD,JP,JP,2016,Q3,Adult
125860141,12586014,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,ONCE IN THE MORNING (24 UNITS),,,,,,,,,,,,2016,Q3,Intestinal ischaemia,,2016,Q3,1,I,,20160711.0,20160725,20160725,EXP,,JP-INDICUS PHARMA-000433,INDICUS,"GOCHO N, AOKI E, OKADA C, OMURA K, HIRASHIMA T, SUZUKI N, ET AL. NON-OCCLUSIVE MESENTERIC ISCHEMIA WITH DIABETIC KETOACIDOSIS AND LACTIC ACIDOSIS FOLLOWING THE ADMINISTRATION OF A SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITOR. INTERN MED. 2016; 55(13):1755-60.",60.0,YR,,M,Y,72.8,KG,20160725.0,,MD,JP,JP,2016,Q3,Adult
125860141,12586014,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,ONCE IN THE MORNING (24 UNITS),,,,,,,,,,,,2016,Q3,Lactic acidosis,,2016,Q3,1,I,,20160711.0,20160725,20160725,EXP,,JP-INDICUS PHARMA-000433,INDICUS,"GOCHO N, AOKI E, OKADA C, OMURA K, HIRASHIMA T, SUZUKI N, ET AL. NON-OCCLUSIVE MESENTERIC ISCHEMIA WITH DIABETIC KETOACIDOSIS AND LACTIC ACIDOSIS FOLLOWING THE ADMINISTRATION OF A SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITOR. INTERN MED. 2016; 55(13):1755-60.",60.0,YR,,M,Y,72.8,KG,20160725.0,,MD,JP,JP,2016,Q3,Adult
125860141,12586014,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,ONCE IN THE MORNING (24 UNITS),,,,,,,,,,,,2016,Q3,Shock,,2016,Q3,1,I,,20160711.0,20160725,20160725,EXP,,JP-INDICUS PHARMA-000433,INDICUS,"GOCHO N, AOKI E, OKADA C, OMURA K, HIRASHIMA T, SUZUKI N, ET AL. NON-OCCLUSIVE MESENTERIC ISCHEMIA WITH DIABETIC KETOACIDOSIS AND LACTIC ACIDOSIS FOLLOWING THE ADMINISTRATION OF A SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITOR. INTERN MED. 2016; 55(13):1755-60.",60.0,YR,,M,Y,72.8,KG,20160725.0,,MD,JP,JP,2016,Q3,Adult
125860621,12586062,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,ONCE IN THE MORNING (24 UNITS),,,U,U,,,,,,,,2016,Q3,Diabetic ketoacidosis,,2016,Q3,1,I,,20160711.0,20160725,20160725,EXP,,JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-120747,RANBAXY,,60.0,YR,,M,Y,72.8,KG,20160725.0,,OT,GB,JP,2016,Q3,Adult
125860621,12586062,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,ONCE IN THE MORNING (24 UNITS),,,U,U,,,,,,,,2016,Q3,Lactic acidosis,,2016,Q3,1,I,,20160711.0,20160725,20160725,EXP,,JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-120747,RANBAXY,,60.0,YR,,M,Y,72.8,KG,20160725.0,,OT,GB,JP,2016,Q3,Adult
125860651,12586065,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,ONCE IN THE MORNING (24 UNITS),,,,,,,,,,,,2016,Q3,Diabetic ketoacidosis,,2016,Q3,1,I,,20160711.0,20160725,20160725,EXP,,JP-INVENTIA-000131,INVENTIA HEALTHCARE,"GOCHO N, AOKI E, OKADA C, OMURA K, HIRASHIMA T, SUZUKI N, ET AL. NON-OCCLUSIVE MESENTERIC ISCHEMIA WITH DIABETIC KETOACIDOSIS AND LACTIC ACIDOSIS FOLLOWING THE ADMINISTRATION OF A SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITOR. INTERN MED. 2016; 55(13):1755-60.",60.0,YR,,M,Y,72.8,KG,20160725.0,,MD,JP,JP,2016,Q3,Adult
125860651,12586065,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,ONCE IN THE MORNING (24 UNITS),,,,,,,,,,,,2016,Q3,Disseminated intravascular coagulation,,2016,Q3,1,I,,20160711.0,20160725,20160725,EXP,,JP-INVENTIA-000131,INVENTIA HEALTHCARE,"GOCHO N, AOKI E, OKADA C, OMURA K, HIRASHIMA T, SUZUKI N, ET AL. NON-OCCLUSIVE MESENTERIC ISCHEMIA WITH DIABETIC KETOACIDOSIS AND LACTIC ACIDOSIS FOLLOWING THE ADMINISTRATION OF A SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITOR. INTERN MED. 2016; 55(13):1755-60.",60.0,YR,,M,Y,72.8,KG,20160725.0,,MD,JP,JP,2016,Q3,Adult
125860651,12586065,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,ONCE IN THE MORNING (24 UNITS),,,,,,,,,,,,2016,Q3,Gastrointestinal necrosis,,2016,Q3,1,I,,20160711.0,20160725,20160725,EXP,,JP-INVENTIA-000131,INVENTIA HEALTHCARE,"GOCHO N, AOKI E, OKADA C, OMURA K, HIRASHIMA T, SUZUKI N, ET AL. NON-OCCLUSIVE MESENTERIC ISCHEMIA WITH DIABETIC KETOACIDOSIS AND LACTIC ACIDOSIS FOLLOWING THE ADMINISTRATION OF A SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITOR. INTERN MED. 2016; 55(13):1755-60.",60.0,YR,,M,Y,72.8,KG,20160725.0,,MD,JP,JP,2016,Q3,Adult
125860651,12586065,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,ONCE IN THE MORNING (24 UNITS),,,,,,,,,,,,2016,Q3,Intestinal ischaemia,,2016,Q3,1,I,,20160711.0,20160725,20160725,EXP,,JP-INVENTIA-000131,INVENTIA HEALTHCARE,"GOCHO N, AOKI E, OKADA C, OMURA K, HIRASHIMA T, SUZUKI N, ET AL. NON-OCCLUSIVE MESENTERIC ISCHEMIA WITH DIABETIC KETOACIDOSIS AND LACTIC ACIDOSIS FOLLOWING THE ADMINISTRATION OF A SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITOR. INTERN MED. 2016; 55(13):1755-60.",60.0,YR,,M,Y,72.8,KG,20160725.0,,MD,JP,JP,2016,Q3,Adult
125860651,12586065,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,ONCE IN THE MORNING (24 UNITS),,,,,,,,,,,,2016,Q3,Lactic acidosis,,2016,Q3,1,I,,20160711.0,20160725,20160725,EXP,,JP-INVENTIA-000131,INVENTIA HEALTHCARE,"GOCHO N, AOKI E, OKADA C, OMURA K, HIRASHIMA T, SUZUKI N, ET AL. NON-OCCLUSIVE MESENTERIC ISCHEMIA WITH DIABETIC KETOACIDOSIS AND LACTIC ACIDOSIS FOLLOWING THE ADMINISTRATION OF A SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITOR. INTERN MED. 2016; 55(13):1755-60.",60.0,YR,,M,Y,72.8,KG,20160725.0,,MD,JP,JP,2016,Q3,Adult
125860651,12586065,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,ONCE IN THE MORNING (24 UNITS),,,,,,,,,,,,2016,Q3,Shock,,2016,Q3,1,I,,20160711.0,20160725,20160725,EXP,,JP-INVENTIA-000131,INVENTIA HEALTHCARE,"GOCHO N, AOKI E, OKADA C, OMURA K, HIRASHIMA T, SUZUKI N, ET AL. NON-OCCLUSIVE MESENTERIC ISCHEMIA WITH DIABETIC KETOACIDOSIS AND LACTIC ACIDOSIS FOLLOWING THE ADMINISTRATION OF A SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITOR. INTERN MED. 2016; 55(13):1755-60.",60.0,YR,,M,Y,72.8,KG,20160725.0,,MD,JP,JP,2016,Q3,Adult
125922301,12592230,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,INJECTION,,2016,Q3,Asthenia,,2016,Q3,1,I,20140811.0,20160715.0,20160726,20160726,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-059918,BRISTOL MYERS SQUIBB,,74.0,YR,,M,Y,60.0,KG,20160726.0,,CN,IT,IT,2016,Q3,Elderly
125922301,12592230,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,INJECTION,,2016,Q3,Fall,,2016,Q3,1,I,20140811.0,20160715.0,20160726,20160726,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-059918,BRISTOL MYERS SQUIBB,,74.0,YR,,M,Y,60.0,KG,20160726.0,,CN,IT,IT,2016,Q3,Elderly
125922301,12592230,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,INJECTION,,2016,Q3,Hypoglycaemia,,2016,Q3,1,I,20140811.0,20160715.0,20160726,20160726,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-059918,BRISTOL MYERS SQUIBB,,74.0,YR,,M,Y,60.0,KG,20160726.0,,CN,IT,IT,2016,Q3,Elderly
125922301,12592230,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,INJECTION,,2016,Q3,Loss of consciousness,,2016,Q3,1,I,20140811.0,20160715.0,20160726,20160726,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-059918,BRISTOL MYERS SQUIBB,,74.0,YR,,M,Y,60.0,KG,20160726.0,,CN,IT,IT,2016,Q3,Elderly
125922301,12592230,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,INJECTION,,2016,Q3,Malaise,,2016,Q3,1,I,20140811.0,20160715.0,20160726,20160726,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-059918,BRISTOL MYERS SQUIBB,,74.0,YR,,M,Y,60.0,KG,20160726.0,,CN,IT,IT,2016,Q3,Elderly
125922301,12592230,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,INJECTION,,2016,Q3,Presyncope,,2016,Q3,1,I,20140811.0,20160715.0,20160726,20160726,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-059918,BRISTOL MYERS SQUIBB,,74.0,YR,,M,Y,60.0,KG,20160726.0,,CN,IT,IT,2016,Q3,Elderly
125922301,12592230,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,INJECTION,,2016,Q3,Thrombocytopenia,,2016,Q3,1,I,20140811.0,20160715.0,20160726,20160726,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-059918,BRISTOL MYERS SQUIBB,,74.0,YR,,M,Y,60.0,KG,20160726.0,,CN,IT,IT,2016,Q3,Elderly
125922301,12592230,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,INJECTION,,2016,Q3,Vision blurred,,2016,Q3,1,I,20140811.0,20160715.0,20160726,20160726,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-059918,BRISTOL MYERS SQUIBB,,74.0,YR,,M,Y,60.0,KG,20160726.0,,CN,IT,IT,2016,Q3,Elderly
125922301,12592230,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,INJECTION,,2016,Q3,Weight decreased,,2016,Q3,1,I,20140811.0,20160715.0,20160726,20160726,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-059918,BRISTOL MYERS SQUIBB,,74.0,YR,,M,Y,60.0,KG,20160726.0,,CN,IT,IT,2016,Q3,Elderly
125935611,12593561,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 IU, QD",,,,,,,,15.0,IU,,QD,2016,Q3,Hypocoagulable state,,2016,Q3,1,I,20150309.0,20160714.0,20160726,20160726,EXP,ES-AGEMED-410765344,ES-BAYER-2016-137746,BAYER,,84.0,YR,E,F,Y,,,20160726.0,,MD,ES,ES,2016,Q3,Elderly
125935611,12593561,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 IU, QD",,,,,,,,15.0,IU,,QD,2016,Q3,Shock haemorrhagic,,2016,Q3,1,I,20150309.0,20160714.0,20160726,20160726,EXP,ES-AGEMED-410765344,ES-BAYER-2016-137746,BAYER,,84.0,YR,E,F,Y,,,20160726.0,,MD,ES,ES,2016,Q3,Elderly
125940791,12594079,4,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Diabetic ketoacidosis,,2016,Q3,1,I,,20160711.0,20160726,20160726,EXP,,JP-IPCA LABORATORIES LIMITED-IPC201607-000635,IPCA,"GOCHO N,AOKI E,OKADA C,OMURA K,HIRASHIMA T,SUZUKI N. NON-OCCLUSIVE MESENTERIC ISCHEMIA WITH DIABETIC KETOACIDOSIS AND LACTIC ACIDOSIS FOLLOWING THE ADMINISTRATION OF A SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITOR. INTERN MED 2016;55(13):1755-60.",60.0,YR,,M,Y,72.8,KG,20160726.0,,MD,JP,JP,2016,Q3,Adult
125940791,12594079,4,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Lactic acidosis,,2016,Q3,1,I,,20160711.0,20160726,20160726,EXP,,JP-IPCA LABORATORIES LIMITED-IPC201607-000635,IPCA,"GOCHO N,AOKI E,OKADA C,OMURA K,HIRASHIMA T,SUZUKI N. NON-OCCLUSIVE MESENTERIC ISCHEMIA WITH DIABETIC KETOACIDOSIS AND LACTIC ACIDOSIS FOLLOWING THE ADMINISTRATION OF A SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITOR. INTERN MED 2016;55(13):1755-60.",60.0,YR,,M,Y,72.8,KG,20160726.0,,MD,JP,JP,2016,Q3,Adult
125940791,12594079,5,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Diabetic ketoacidosis,,2016,Q3,1,I,,20160711.0,20160726,20160726,EXP,,JP-IPCA LABORATORIES LIMITED-IPC201607-000635,IPCA,"GOCHO N,AOKI E,OKADA C,OMURA K,HIRASHIMA T,SUZUKI N. NON-OCCLUSIVE MESENTERIC ISCHEMIA WITH DIABETIC KETOACIDOSIS AND LACTIC ACIDOSIS FOLLOWING THE ADMINISTRATION OF A SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITOR. INTERN MED 2016;55(13):1755-60.",60.0,YR,,M,Y,72.8,KG,20160726.0,,MD,JP,JP,2016,Q3,Adult
125940791,12594079,5,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Lactic acidosis,,2016,Q3,1,I,,20160711.0,20160726,20160726,EXP,,JP-IPCA LABORATORIES LIMITED-IPC201607-000635,IPCA,"GOCHO N,AOKI E,OKADA C,OMURA K,HIRASHIMA T,SUZUKI N. NON-OCCLUSIVE MESENTERIC ISCHEMIA WITH DIABETIC KETOACIDOSIS AND LACTIC ACIDOSIS FOLLOWING THE ADMINISTRATION OF A SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITOR. INTERN MED 2016;55(13):1755-60.",60.0,YR,,M,Y,72.8,KG,20160726.0,,MD,JP,JP,2016,Q3,Adult
125975894,12597589,16,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,100 MILLIGRAM,,,,,,,,1.0,IU,INJECTION,,2016,Q3,Rash pruritic,,2016,Q3,4,F,20160808.0,20160909.0,20160726,20160920,EXP,,US-CELGENEUS-USA-2016075140,CELGENE,,57.0,YR,,F,Y,,,20160920.0,,MD,US,US,2016,Q3,Adult
125975894,12597589,16,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,100 MILLIGRAM,,,,,,,,1.0,IU,INJECTION,,2016,Q3,Skin discolouration,,2016,Q3,4,F,20160808.0,20160909.0,20160726,20160920,EXP,,US-CELGENEUS-USA-2016075140,CELGENE,,57.0,YR,,F,Y,,,20160920.0,,MD,US,US,2016,Q3,Adult
125975894,12597589,16,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,100 MILLIGRAM,,,,,,,,1.0,IU,INJECTION,,2016,Q3,Skin exfoliation,,2016,Q3,4,F,20160808.0,20160909.0,20160726,20160920,EXP,,US-CELGENEUS-USA-2016075140,CELGENE,,57.0,YR,,F,Y,,,20160920.0,,MD,US,US,2016,Q3,Adult
125995371,12599537,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 UNIT, QD",,,,,,,,24.0,DF,INJECTION,QD,2016,Q3,Acute kidney injury,,2016,Q3,1,I,,20160713.0,20160727,20160727,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-059723,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,73.0,KG,20160727.0,,CN,GB,JP,2016,Q3,Adult
125995371,12599537,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 UNIT, QD",,,,,,,,24.0,DF,INJECTION,QD,2016,Q3,Dehydration,,2016,Q3,1,I,,20160713.0,20160727,20160727,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-059723,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,73.0,KG,20160727.0,,CN,GB,JP,2016,Q3,Adult
125995371,12599537,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 UNIT, QD",,,,,,,,24.0,DF,INJECTION,QD,2016,Q3,Diabetes mellitus inadequate control,,2016,Q3,1,I,,20160713.0,20160727,20160727,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-059723,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,73.0,KG,20160727.0,,CN,GB,JP,2016,Q3,Adult
125995371,12599537,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 UNIT, QD",,,,,,,,24.0,DF,INJECTION,QD,2016,Q3,Diabetic ketoacidosis,,2016,Q3,1,I,,20160713.0,20160727,20160727,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-059723,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,73.0,KG,20160727.0,,CN,GB,JP,2016,Q3,Adult
125995371,12599537,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 UNIT, QD",,,,,,,,24.0,DF,INJECTION,QD,2016,Q3,Drug prescribing error,,2016,Q3,1,I,,20160713.0,20160727,20160727,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-059723,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,73.0,KG,20160727.0,,CN,GB,JP,2016,Q3,Adult
125995371,12599537,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 UNIT, QD",,,,,,,,24.0,DF,INJECTION,QD,2016,Q3,Exploratory operation,,2016,Q3,1,I,,20160713.0,20160727,20160727,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-059723,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,73.0,KG,20160727.0,,CN,GB,JP,2016,Q3,Adult
125995371,12599537,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 UNIT, QD",,,,,,,,24.0,DF,INJECTION,QD,2016,Q3,Haemodialysis,,2016,Q3,1,I,,20160713.0,20160727,20160727,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-059723,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,73.0,KG,20160727.0,,CN,GB,JP,2016,Q3,Adult
125995371,12599537,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 UNIT, QD",,,,,,,,24.0,DF,INJECTION,QD,2016,Q3,Intestinal ischaemia,,2016,Q3,1,I,,20160713.0,20160727,20160727,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-059723,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,73.0,KG,20160727.0,,CN,GB,JP,2016,Q3,Adult
125995371,12599537,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 UNIT, QD",,,,,,,,24.0,DF,INJECTION,QD,2016,Q3,Intestinal resection,,2016,Q3,1,I,,20160713.0,20160727,20160727,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-059723,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,73.0,KG,20160727.0,,CN,GB,JP,2016,Q3,Adult
125995371,12599537,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 UNIT, QD",,,,,,,,24.0,DF,INJECTION,QD,2016,Q3,Lactic acidosis,,2016,Q3,1,I,,20160713.0,20160727,20160727,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-059723,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,73.0,KG,20160727.0,,CN,GB,JP,2016,Q3,Adult
125995371,12599537,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 UNIT, QD",,,,,,,,24.0,DF,INJECTION,QD,2016,Q3,Weight decreased,,2016,Q3,1,I,,20160713.0,20160727,20160727,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-059723,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,73.0,KG,20160727.0,,CN,GB,JP,2016,Q3,Adult
125996341,12599634,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,ONCE IN THE MORNING (24 UNITS),,,U,,,,,,,,,2016,Q3,Diabetic ketoacidosis,,2016,Q3,1,I,,20160719.0,20160727,20160727,EXP,,PHHY2016JP099208,SANDOZ,"GOCHO N, AOKI E, OKADA C, OMURA K, HIRASHIMA T, SUZUKI N ET AL.. NON-OCCLUSIVE MESENTERIC ISCHEMIA WITH DIABETIC KETOACIDOSIS AND LACTIC ACIDOSIS FOLLOWING THE ADMINISTRATION OF A SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITOR. INTERNAL MEDICINE. 2016;55(13):1755-60",60.0,YR,,M,Y,72.8,KG,20160727.0,,OT,JP,JP,2016,Q3,Adult
125996341,12599634,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,ONCE IN THE MORNING (24 UNITS),,,U,,,,,,,,,2016,Q3,Lactic acidosis,,2016,Q3,1,I,,20160719.0,20160727,20160727,EXP,,PHHY2016JP099208,SANDOZ,"GOCHO N, AOKI E, OKADA C, OMURA K, HIRASHIMA T, SUZUKI N ET AL.. NON-OCCLUSIVE MESENTERIC ISCHEMIA WITH DIABETIC KETOACIDOSIS AND LACTIC ACIDOSIS FOLLOWING THE ADMINISTRATION OF A SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITOR. INTERNAL MEDICINE. 2016;55(13):1755-60",60.0,YR,,M,Y,72.8,KG,20160727.0,,OT,JP,JP,2016,Q3,Adult
126017581,12601758,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Accidental overdose,,2016,Q3,1,I,20160628.0,,20160727,20160727,DIR,,,,,51.0,YR,,M,N,,,20160630.0,N,PH,US,,2016,Q3,Adult
126017581,12601758,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Blood glucose decreased,,2016,Q3,1,I,20160628.0,,20160727,20160727,DIR,,,,,51.0,YR,,M,N,,,20160630.0,N,PH,US,,2016,Q3,Adult
126017581,12601758,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Dizziness,,2016,Q3,1,I,20160628.0,,20160727,20160727,DIR,,,,,51.0,YR,,M,N,,,20160630.0,N,PH,US,,2016,Q3,Adult
126017581,12601758,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Loss of consciousness,,2016,Q3,1,I,20160628.0,,20160727,20160727,DIR,,,,,51.0,YR,,M,N,,,20160630.0,N,PH,US,,2016,Q3,Adult
126017581,12601758,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Syncope,,2016,Q3,1,I,20160628.0,,20160727,20160727,DIR,,,,,51.0,YR,,M,N,,,20160630.0,N,PH,US,,2016,Q3,Adult
126019401,12601940,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Hypoglycaemia,,2016,Q3,1,I,20160619.0,,20160727,20160727,DIR,,,,,30.0,YR,,F,N,,,20160624.0,N,PH,US,,2016,Q3,Young Adult
126024571,12602457,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 UNITS AT BEDTIME SC,,,Y,Y,,,,20.0,DF,,HS,2016,Q3,Hypoglycaemia,,2016,Q3,1,I,20160601.0,,20160727,20160727,DIR,,,,,65.0,YR,,M,N,,,20160606.0,N,PH,US,,2016,Q3,Elderly
126024731,12602473,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,N,Y,,,,10.0,IU,,HS,2016,Q3,Hypoglycaemia,,2016,Q3,1,I,20160608.0,,20160727,20160727,DIR,,,,,63.0,YR,,F,N,,,20160610.0,N,PH,US,,2016,Q3,Adult
126024851,12602485,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Dyspnoea,,2016,Q3,1,I,20160612.0,,20160727,20160727,DIR,,,,,32.0,YR,,M,N,,,20160615.0,N,PH,US,,2016,Q3,Young Adult
126024851,12602485,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Hypoglycaemia,,2016,Q3,1,I,20160612.0,,20160727,20160727,DIR,,,,,32.0,YR,,M,N,,,20160615.0,N,PH,US,,2016,Q3,Young Adult
126024851,12602485,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Infection,,2016,Q3,1,I,20160612.0,,20160727,20160727,DIR,,,,,32.0,YR,,M,N,,,20160615.0,N,PH,US,,2016,Q3,Young Adult
126024851,12602485,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Transplant rejection,,2016,Q3,1,I,20160612.0,,20160727,20160727,DIR,,,,,32.0,YR,,M,N,,,20160615.0,N,PH,US,,2016,Q3,Young Adult
126025151,12602515,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Electrocardiogram QT prolonged,,2016,Q3,1,I,20160124.0,,20160727,20160727,DIR,,,,,70.0,YR,,F,N,,,20160621.0,N,PH,US,,2016,Q3,Elderly
126028731,12602873,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,22.0,IU,,,2016,Q3,Death,,2016,Q3,1,I,20160721.0,20160725.0,20160728,20160728,EXP,,CO-BAXTER-2016BAX039983,BAXTER,,64.0,YR,,M,Y,88.0,KG,20160728.0,,OT,CO,CO,2016,Q3,Adult
126031352,12603135,1,PS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,205692.0,,,,,2016,Q3,Death,,2016,Q3,2,F,201606.0,20160805.0,20160728,20160809,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201607010189,ELI LILLY AND CO,,44.0,YR,,M,Y,102.0,KG,20160808.0,,CN,JP,JP,2016,Q3,Adult
126032671,12603267,7,C,Insulin glargine,INSULIN GLARGINE,1,,"UNK, ONCE DAILY (QD)",,,,U,,,,,,,QD,2016,Q3,Pulmonary fibrosis,,2016,Q3,1,I,201512.0,20160720.0,20160728,20160728,EXP,,AR-UCBSA-2016027546,UCB,,82.0,YR,,F,Y,,,20160728.0,,CN,AR,AR,2016,Q3,Elderly
126058441,12605844,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/ML,,,,,,,,,,,,2016,Q3,Blood glucose increased,,2016,Q3,1,I,20160429.0,20160722.0,20160729,20160729,PER,,US-ASTRAZENECA-2016SE80658,ASTRAZENECA,,60.0,YR,,F,Y,80.8,KG,20160729.0,,,US,US,2016,Q3,Adult
126058441,12605844,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/ML,,,,,,,,,,,,2016,Q3,Rhabdomyolysis,,2016,Q3,1,I,20160429.0,20160722.0,20160729,20160729,PER,,US-ASTRAZENECA-2016SE80658,ASTRAZENECA,,60.0,YR,,F,Y,80.8,KG,20160729.0,,,US,US,2016,Q3,Adult
126058441,12605844,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/ML,,,,,,,,,,,,2016,Q3,Blood glucose increased,,2016,Q3,1,I,20160429.0,20160722.0,20160729,20160729,PER,,US-ASTRAZENECA-2016SE80658,ASTRAZENECA,,60.0,YR,,F,Y,80.8,KG,20160729.0,,,US,US,2016,Q3,Adult
126058441,12605844,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U/ML,,,,,,,,,,,,2016,Q3,Rhabdomyolysis,,2016,Q3,1,I,20160429.0,20160722.0,20160729,20160729,PER,,US-ASTRAZENECA-2016SE80658,ASTRAZENECA,,60.0,YR,,F,Y,80.8,KG,20160729.0,,,US,US,2016,Q3,Adult
126114431,12611443,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q3,Dyskinesia,,2016,Q3,1,I,20160623.0,20160726.0,20160801,20160801,EXP,GB-MHRA-EYC 00142764,GB-PFIZER INC-2016362402,PFIZER,,79.0,YR,,F,Y,,,20160801.0,,PH,GB,GB,2016,Q3,Elderly
126114431,12611443,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q3,Product use issue,,2016,Q3,1,I,20160623.0,20160726.0,20160801,20160801,EXP,GB-MHRA-EYC 00142764,GB-PFIZER INC-2016362402,PFIZER,,79.0,YR,,F,Y,,,20160801.0,,PH,GB,GB,2016,Q3,Elderly
126216193,12621619,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Ascites,,2016,Q3,3,F,20160727.0,20160823.0,20160804,20160906,EXP,,US-BAYER-2016-150728,BAYER,,60.0,YR,A,M,Y,163.3,KG,20160906.0,,CN,US,US,2016,Q3,Adult
126216193,12621619,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Fluid retention,,2016,Q3,3,F,20160727.0,20160823.0,20160804,20160906,EXP,,US-BAYER-2016-150728,BAYER,,60.0,YR,A,M,Y,163.3,KG,20160906.0,,CN,US,US,2016,Q3,Adult
126216193,12621619,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Oedema,,2016,Q3,3,F,20160727.0,20160823.0,20160804,20160906,EXP,,US-BAYER-2016-150728,BAYER,,60.0,YR,A,M,Y,163.3,KG,20160906.0,,CN,US,US,2016,Q3,Adult
126216193,12621619,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Oedema peripheral,,2016,Q3,3,F,20160727.0,20160823.0,20160804,20160906,EXP,,US-BAYER-2016-150728,BAYER,,60.0,YR,A,M,Y,163.3,KG,20160906.0,,CN,US,US,2016,Q3,Adult
126216193,12621619,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Off label use,,2016,Q3,3,F,20160727.0,20160823.0,20160804,20160906,EXP,,US-BAYER-2016-150728,BAYER,,60.0,YR,A,M,Y,163.3,KG,20160906.0,,CN,US,US,2016,Q3,Adult
126216193,12621619,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Weight decreased,,2016,Q3,3,F,20160727.0,20160823.0,20160804,20160906,EXP,,US-BAYER-2016-150728,BAYER,,60.0,YR,A,M,Y,163.3,KG,20160906.0,,CN,US,US,2016,Q3,Adult
126221911,12622191,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,ONCE IN THE MORNING (24 UNITS),,,,,,,,,,,,2016,Q3,Acute kidney injury,,2016,Q3,1,I,,20160718.0,20160804,20160804,EXP,JP-MLMSERVICE-20160712-0351467-1,JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2016-00080,ALKEM,,60.0,YR,,M,Y,72.8,KG,20160804.0,,MD,JP,JP,2016,Q3,Adult
126221911,12622191,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,ONCE IN THE MORNING (24 UNITS),,,,,,,,,,,,2016,Q3,Amylase increased,,2016,Q3,1,I,,20160718.0,20160804,20160804,EXP,JP-MLMSERVICE-20160712-0351467-1,JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2016-00080,ALKEM,,60.0,YR,,M,Y,72.8,KG,20160804.0,,MD,JP,JP,2016,Q3,Adult
126221911,12622191,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,ONCE IN THE MORNING (24 UNITS),,,,,,,,,,,,2016,Q3,Diabetic ketoacidosis,,2016,Q3,1,I,,20160718.0,20160804,20160804,EXP,JP-MLMSERVICE-20160712-0351467-1,JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2016-00080,ALKEM,,60.0,YR,,M,Y,72.8,KG,20160804.0,,MD,JP,JP,2016,Q3,Adult
126221911,12622191,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,ONCE IN THE MORNING (24 UNITS),,,,,,,,,,,,2016,Q3,Disseminated intravascular coagulation,,2016,Q3,1,I,,20160718.0,20160804,20160804,EXP,JP-MLMSERVICE-20160712-0351467-1,JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2016-00080,ALKEM,,60.0,YR,,M,Y,72.8,KG,20160804.0,,MD,JP,JP,2016,Q3,Adult
126221911,12622191,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,ONCE IN THE MORNING (24 UNITS),,,,,,,,,,,,2016,Q3,Gastrointestinal necrosis,,2016,Q3,1,I,,20160718.0,20160804,20160804,EXP,JP-MLMSERVICE-20160712-0351467-1,JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2016-00080,ALKEM,,60.0,YR,,M,Y,72.8,KG,20160804.0,,MD,JP,JP,2016,Q3,Adult
126221911,12622191,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,ONCE IN THE MORNING (24 UNITS),,,,,,,,,,,,2016,Q3,Haemodialysis,,2016,Q3,1,I,,20160718.0,20160804,20160804,EXP,JP-MLMSERVICE-20160712-0351467-1,JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2016-00080,ALKEM,,60.0,YR,,M,Y,72.8,KG,20160804.0,,MD,JP,JP,2016,Q3,Adult
126221911,12622191,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,ONCE IN THE MORNING (24 UNITS),,,,,,,,,,,,2016,Q3,Intestinal ischaemia,,2016,Q3,1,I,,20160718.0,20160804,20160804,EXP,JP-MLMSERVICE-20160712-0351467-1,JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2016-00080,ALKEM,,60.0,YR,,M,Y,72.8,KG,20160804.0,,MD,JP,JP,2016,Q3,Adult
126221911,12622191,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,ONCE IN THE MORNING (24 UNITS),,,,,,,,,,,,2016,Q3,Lactic acidosis,,2016,Q3,1,I,,20160718.0,20160804,20160804,EXP,JP-MLMSERVICE-20160712-0351467-1,JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2016-00080,ALKEM,,60.0,YR,,M,Y,72.8,KG,20160804.0,,MD,JP,JP,2016,Q3,Adult
126221911,12622191,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,ONCE IN THE MORNING (24 UNITS),,,,,,,,,,,,2016,Q3,Lipase increased,,2016,Q3,1,I,,20160718.0,20160804,20160804,EXP,JP-MLMSERVICE-20160712-0351467-1,JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2016-00080,ALKEM,,60.0,YR,,M,Y,72.8,KG,20160804.0,,MD,JP,JP,2016,Q3,Adult
126221911,12622191,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,ONCE IN THE MORNING (24 UNITS),,,,,,,,,,,,2016,Q3,Shock,,2016,Q3,1,I,,20160718.0,20160804,20160804,EXP,JP-MLMSERVICE-20160712-0351467-1,JP-ALKEM LABORATORIES LIMITED-JP-ALKEM-2016-00080,ALKEM,,60.0,YR,,M,Y,72.8,KG,20160804.0,,MD,JP,JP,2016,Q3,Adult
126229761,12622976,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,0.25 U/KG,,,,, UNK,,21081.0,,,,,2016,Q3,Acanthosis nigricans,,2016,Q3,1,I,,20160724.0,20160804,20160804,EXP,,EC-SA-2016SA137190,AVENTIS,"PASQUEL M, ONTANEDA A, JARA N, DURAN P, NARVAEZ L, PASQUEL FJ. SEVERE ACANTHOSIS NIGRICANS AND DIABETES RESOLUTION AFTER IMMUNOSUPPRESION IN LATIN-AMERICAN FEMALE WITH MULTIPLE AUTOIMMUNE DISORDERS. 96TH ANNUAL MEETING AND EXPO OF THE ENDOCRINE SOCIETY; 2014 JUN 21-24; CHICAGO, IL, UNITED STATES. ENDOCR REV. 2014 JAN;35 SUPPL 3.",36.0,YR,A,F,Y,,,20160804.0,,OT,EC,EC,2016,Q3,Adult
126229761,12622976,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,0.25 U/KG,,,,, UNK,,21081.0,,,,,2016,Q3,Blood glucose increased,,2016,Q3,1,I,,20160724.0,20160804,20160804,EXP,,EC-SA-2016SA137190,AVENTIS,"PASQUEL M, ONTANEDA A, JARA N, DURAN P, NARVAEZ L, PASQUEL FJ. SEVERE ACANTHOSIS NIGRICANS AND DIABETES RESOLUTION AFTER IMMUNOSUPPRESION IN LATIN-AMERICAN FEMALE WITH MULTIPLE AUTOIMMUNE DISORDERS. 96TH ANNUAL MEETING AND EXPO OF THE ENDOCRINE SOCIETY; 2014 JUN 21-24; CHICAGO, IL, UNITED STATES. ENDOCR REV. 2014 JAN;35 SUPPL 3.",36.0,YR,A,F,Y,,,20160804.0,,OT,EC,EC,2016,Q3,Adult
126229761,12622976,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,0.25 U/KG,,,,, UNK,,21081.0,,,,,2016,Q3,Cachexia,,2016,Q3,1,I,,20160724.0,20160804,20160804,EXP,,EC-SA-2016SA137190,AVENTIS,"PASQUEL M, ONTANEDA A, JARA N, DURAN P, NARVAEZ L, PASQUEL FJ. SEVERE ACANTHOSIS NIGRICANS AND DIABETES RESOLUTION AFTER IMMUNOSUPPRESION IN LATIN-AMERICAN FEMALE WITH MULTIPLE AUTOIMMUNE DISORDERS. 96TH ANNUAL MEETING AND EXPO OF THE ENDOCRINE SOCIETY; 2014 JUN 21-24; CHICAGO, IL, UNITED STATES. ENDOCR REV. 2014 JAN;35 SUPPL 3.",36.0,YR,A,F,Y,,,20160804.0,,OT,EC,EC,2016,Q3,Adult
126229761,12622976,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,0.25 U/KG,,,,, UNK,,21081.0,,,,,2016,Q3,Dehydration,,2016,Q3,1,I,,20160724.0,20160804,20160804,EXP,,EC-SA-2016SA137190,AVENTIS,"PASQUEL M, ONTANEDA A, JARA N, DURAN P, NARVAEZ L, PASQUEL FJ. SEVERE ACANTHOSIS NIGRICANS AND DIABETES RESOLUTION AFTER IMMUNOSUPPRESION IN LATIN-AMERICAN FEMALE WITH MULTIPLE AUTOIMMUNE DISORDERS. 96TH ANNUAL MEETING AND EXPO OF THE ENDOCRINE SOCIETY; 2014 JUN 21-24; CHICAGO, IL, UNITED STATES. ENDOCR REV. 2014 JAN;35 SUPPL 3.",36.0,YR,A,F,Y,,,20160804.0,,OT,EC,EC,2016,Q3,Adult
126229761,12622976,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,0.25 U/KG,,,,, UNK,,21081.0,,,,,2016,Q3,Fructosamine increased,,2016,Q3,1,I,,20160724.0,20160804,20160804,EXP,,EC-SA-2016SA137190,AVENTIS,"PASQUEL M, ONTANEDA A, JARA N, DURAN P, NARVAEZ L, PASQUEL FJ. SEVERE ACANTHOSIS NIGRICANS AND DIABETES RESOLUTION AFTER IMMUNOSUPPRESION IN LATIN-AMERICAN FEMALE WITH MULTIPLE AUTOIMMUNE DISORDERS. 96TH ANNUAL MEETING AND EXPO OF THE ENDOCRINE SOCIETY; 2014 JUN 21-24; CHICAGO, IL, UNITED STATES. ENDOCR REV. 2014 JAN;35 SUPPL 3.",36.0,YR,A,F,Y,,,20160804.0,,OT,EC,EC,2016,Q3,Adult
126229761,12622976,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,0.25 U/KG,,,,, UNK,,21081.0,,,,,2016,Q3,Glycosylated haemoglobin increased,,2016,Q3,1,I,,20160724.0,20160804,20160804,EXP,,EC-SA-2016SA137190,AVENTIS,"PASQUEL M, ONTANEDA A, JARA N, DURAN P, NARVAEZ L, PASQUEL FJ. SEVERE ACANTHOSIS NIGRICANS AND DIABETES RESOLUTION AFTER IMMUNOSUPPRESION IN LATIN-AMERICAN FEMALE WITH MULTIPLE AUTOIMMUNE DISORDERS. 96TH ANNUAL MEETING AND EXPO OF THE ENDOCRINE SOCIETY; 2014 JUN 21-24; CHICAGO, IL, UNITED STATES. ENDOCR REV. 2014 JAN;35 SUPPL 3.",36.0,YR,A,F,Y,,,20160804.0,,OT,EC,EC,2016,Q3,Adult
126229761,12622976,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,0.25 U/KG,,,,, UNK,,21081.0,,,,,2016,Q3,Incorrect dose administered,,2016,Q3,1,I,,20160724.0,20160804,20160804,EXP,,EC-SA-2016SA137190,AVENTIS,"PASQUEL M, ONTANEDA A, JARA N, DURAN P, NARVAEZ L, PASQUEL FJ. SEVERE ACANTHOSIS NIGRICANS AND DIABETES RESOLUTION AFTER IMMUNOSUPPRESION IN LATIN-AMERICAN FEMALE WITH MULTIPLE AUTOIMMUNE DISORDERS. 96TH ANNUAL MEETING AND EXPO OF THE ENDOCRINE SOCIETY; 2014 JUN 21-24; CHICAGO, IL, UNITED STATES. ENDOCR REV. 2014 JAN;35 SUPPL 3.",36.0,YR,A,F,Y,,,20160804.0,,OT,EC,EC,2016,Q3,Adult
126229761,12622976,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,0.25 U/KG,,,,, UNK,,21081.0,,,,,2016,Q3,Insulin resistance syndrome,,2016,Q3,1,I,,20160724.0,20160804,20160804,EXP,,EC-SA-2016SA137190,AVENTIS,"PASQUEL M, ONTANEDA A, JARA N, DURAN P, NARVAEZ L, PASQUEL FJ. SEVERE ACANTHOSIS NIGRICANS AND DIABETES RESOLUTION AFTER IMMUNOSUPPRESION IN LATIN-AMERICAN FEMALE WITH MULTIPLE AUTOIMMUNE DISORDERS. 96TH ANNUAL MEETING AND EXPO OF THE ENDOCRINE SOCIETY; 2014 JUN 21-24; CHICAGO, IL, UNITED STATES. ENDOCR REV. 2014 JAN;35 SUPPL 3.",36.0,YR,A,F,Y,,,20160804.0,,OT,EC,EC,2016,Q3,Adult
126229761,12622976,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,0.25 U/KG,,,,, UNK,,21081.0,,,,,2016,Q3,Ketonuria,,2016,Q3,1,I,,20160724.0,20160804,20160804,EXP,,EC-SA-2016SA137190,AVENTIS,"PASQUEL M, ONTANEDA A, JARA N, DURAN P, NARVAEZ L, PASQUEL FJ. SEVERE ACANTHOSIS NIGRICANS AND DIABETES RESOLUTION AFTER IMMUNOSUPPRESION IN LATIN-AMERICAN FEMALE WITH MULTIPLE AUTOIMMUNE DISORDERS. 96TH ANNUAL MEETING AND EXPO OF THE ENDOCRINE SOCIETY; 2014 JUN 21-24; CHICAGO, IL, UNITED STATES. ENDOCR REV. 2014 JAN;35 SUPPL 3.",36.0,YR,A,F,Y,,,20160804.0,,OT,EC,EC,2016,Q3,Adult
126229761,12622976,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,0.25 U/KG,,,,, UNK,,21081.0,,,,,2016,Q3,Skin lesion,,2016,Q3,1,I,,20160724.0,20160804,20160804,EXP,,EC-SA-2016SA137190,AVENTIS,"PASQUEL M, ONTANEDA A, JARA N, DURAN P, NARVAEZ L, PASQUEL FJ. SEVERE ACANTHOSIS NIGRICANS AND DIABETES RESOLUTION AFTER IMMUNOSUPPRESION IN LATIN-AMERICAN FEMALE WITH MULTIPLE AUTOIMMUNE DISORDERS. 96TH ANNUAL MEETING AND EXPO OF THE ENDOCRINE SOCIETY; 2014 JUN 21-24; CHICAGO, IL, UNITED STATES. ENDOCR REV. 2014 JAN;35 SUPPL 3.",36.0,YR,A,F,Y,,,20160804.0,,OT,EC,EC,2016,Q3,Adult
126257221,12625722,27,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Blood creatinine increased,,2016,Q3,1,I,20160423.0,,20160804,20160804,DIR,,,,,55.0,YR,,F,N,116.3,KG,20160803.0,N,PH,US,,2016,Q3,Adult
126257221,12625722,27,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Renal injury,,2016,Q3,1,I,20160423.0,,20160804,20160804,DIR,,,,,55.0,YR,,F,N,116.3,KG,20160803.0,N,PH,US,,2016,Q3,Adult
126258642,12625864,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,U,,,,18.0,IU,FORMULATION UNKNOWN,QD,2016,Q3,Abdominal pain,,2016,Q3,2,F,201606.0,20160916.0,20160805,20160923,EXP,,CA-ASTELLAS-2016US029562,ASTELLAS,,85.0,YR,,M,Y,,,20160923.0,,OT,CA,CA,2016,Q3,Elderly
126258642,12625864,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,U,,,,18.0,IU,FORMULATION UNKNOWN,QD,2016,Q3,Decreased appetite,,2016,Q3,2,F,201606.0,20160916.0,20160805,20160923,EXP,,CA-ASTELLAS-2016US029562,ASTELLAS,,85.0,YR,,M,Y,,,20160923.0,,OT,CA,CA,2016,Q3,Elderly
126258642,12625864,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,U,,,,18.0,IU,FORMULATION UNKNOWN,QD,2016,Q3,Drug intolerance,,2016,Q3,2,F,201606.0,20160916.0,20160805,20160923,EXP,,CA-ASTELLAS-2016US029562,ASTELLAS,,85.0,YR,,M,Y,,,20160923.0,,OT,CA,CA,2016,Q3,Elderly
126258642,12625864,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,U,,,,18.0,IU,FORMULATION UNKNOWN,QD,2016,Q3,Nausea,,2016,Q3,2,F,201606.0,20160916.0,20160805,20160923,EXP,,CA-ASTELLAS-2016US029562,ASTELLAS,,85.0,YR,,M,Y,,,20160923.0,,OT,CA,CA,2016,Q3,Elderly
126258642,12625864,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,U,,,,18.0,IU,FORMULATION UNKNOWN,QD,2016,Q3,Prostatic specific antigen abnormal,,2016,Q3,2,F,201606.0,20160916.0,20160805,20160923,EXP,,CA-ASTELLAS-2016US029562,ASTELLAS,,85.0,YR,,M,Y,,,20160923.0,,OT,CA,CA,2016,Q3,Elderly
126293251,12629325,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q3,Upper gastrointestinal haemorrhage,,2016,Q3,1,I,201410.0,20150115.0,20160808,20160808,EXP,,US-BAYER-2015-021323,BAYER,,70.0,YR,E,M,Y,,,20160808.0,,CN,US,US,2016,Q3,Elderly
126305601,12630560,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"80 IU, QD",,,,,,,,80.0,IU,,QD,2016,Q3,Gastrointestinal haemorrhage,,2016,Q3,1,I,20141028.0,20160506.0,20160808,20160808,EXP,,US-BAYER-2016-092876,BAYER,,77.0,YR,E,F,Y,,,20160808.0,,MD,US,US,2016,Q3,Elderly
126398061,12639806,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"50 IU, UNK",,,,,,,,50.0,IU,,,2016,Q3,Hypoglycaemia,,2016,Q3,1,I,,20160727.0,20160810,20160810,EXP,,US-APOTEX-2016AP010205,APOTEX,"NI D, KHOSLA SG, NYLEN ES.. SERTRALINE INDUCED HYPOGLYCEMIA IN A TYPE II DIABETIC PATIENT.. ENDOCR-REV. 2014;35:ABSTR. SAT-1017",58.0,YR,,M,Y,,,20160810.0,,OT,US,US,2016,Q3,Adult
126398061,12639806,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"70 IU, UNK",,,,,,,,70.0,IU,,,2016,Q3,Hypoglycaemia,,2016,Q3,1,I,,20160727.0,20160810,20160810,EXP,,US-APOTEX-2016AP010205,APOTEX,"NI D, KHOSLA SG, NYLEN ES.. SERTRALINE INDUCED HYPOGLYCEMIA IN A TYPE II DIABETIC PATIENT.. ENDOCR-REV. 2014;35:ABSTR. SAT-1017",58.0,YR,,M,Y,,,20160810.0,,OT,US,US,2016,Q3,Adult
126398151,12639815,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 IU, AS DIRECTED",,,,U,,,,40.0,IU,FORMULATION UNKNOWN,,2016,Q3,Arthritis,,2016,Q3,1,I,201601.0,20160418.0,20160810,20160810,EXP,,GB-ASTELLAS-2016US015516,ASTELLAS,,71.0,YR,,M,Y,113.0,KG,20160810.0,,MD,GB,GB,2016,Q3,Elderly
126398151,12639815,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 IU, AS DIRECTED",,,,U,,,,40.0,IU,FORMULATION UNKNOWN,,2016,Q3,Mobility decreased,,2016,Q3,1,I,201601.0,20160418.0,20160810,20160810,EXP,,GB-ASTELLAS-2016US015516,ASTELLAS,,71.0,YR,,M,Y,113.0,KG,20160810.0,,MD,GB,GB,2016,Q3,Elderly
126398151,12639815,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 IU, AS DIRECTED",,,,U,,,,40.0,IU,FORMULATION UNKNOWN,,2016,Q3,Procedural pain,,2016,Q3,1,I,201601.0,20160418.0,20160810,20160810,EXP,,GB-ASTELLAS-2016US015516,ASTELLAS,,71.0,YR,,M,Y,113.0,KG,20160810.0,,MD,GB,GB,2016,Q3,Elderly
126408181,12640818,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q3,Acute kidney injury,,2016,Q3,1,I,20160325.0,20160802.0,20160810,20160810,EXP,,US-ENDO PHARMACEUTICALS INC.-2016-004945,ENDO,,54.0,YR,,F,Y,91.0,KG,20160810.0,,MD,US,US,2016,Q3,Adult
126408181,12640818,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q3,Acute myocardial infarction,,2016,Q3,1,I,20160325.0,20160802.0,20160810,20160810,EXP,,US-ENDO PHARMACEUTICALS INC.-2016-004945,ENDO,,54.0,YR,,F,Y,91.0,KG,20160810.0,,MD,US,US,2016,Q3,Adult
126408181,12640818,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q3,Atrioventricular block complete,,2016,Q3,1,I,20160325.0,20160802.0,20160810,20160810,EXP,,US-ENDO PHARMACEUTICALS INC.-2016-004945,ENDO,,54.0,YR,,F,Y,91.0,KG,20160810.0,,MD,US,US,2016,Q3,Adult
126408181,12640818,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q3,Cardiac arrest,,2016,Q3,1,I,20160325.0,20160802.0,20160810,20160810,EXP,,US-ENDO PHARMACEUTICALS INC.-2016-004945,ENDO,,54.0,YR,,F,Y,91.0,KG,20160810.0,,MD,US,US,2016,Q3,Adult
126408181,12640818,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q3,Pneumonia,,2016,Q3,1,I,20160325.0,20160802.0,20160810,20160810,EXP,,US-ENDO PHARMACEUTICALS INC.-2016-004945,ENDO,,54.0,YR,,F,Y,91.0,KG,20160810.0,,MD,US,US,2016,Q3,Adult
126408181,12640818,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q3,Sepsis,,2016,Q3,1,I,20160325.0,20160802.0,20160810,20160810,EXP,,US-ENDO PHARMACEUTICALS INC.-2016-004945,ENDO,,54.0,YR,,F,Y,91.0,KG,20160810.0,,MD,US,US,2016,Q3,Adult
126458491,12645849,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2016,Q3,Actinomycosis,,2016,Q3,1,I,,20160804.0,20160811,20160811,EXP,,PHHY2016US109228,SANDOZ,"WAGNER JL, BELL AM.. ACUTE HEPATIC INJURY WITH AMPHOTERICIN B DEOXYCHOLATE IN AN IMMUNOCOMPETENT PATIENT. JOURNAL OF PHARMACOLOGY AND PHARMACOTHERAPEUTICS. 2016;7(2):112-4",39.0,YR,,M,Y,,,20160811.0,,OT,US,US,2016,Q3,Adult
126458491,12645849,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2016,Q3,Leukocytosis,,2016,Q3,1,I,,20160804.0,20160811,20160811,EXP,,PHHY2016US109228,SANDOZ,"WAGNER JL, BELL AM.. ACUTE HEPATIC INJURY WITH AMPHOTERICIN B DEOXYCHOLATE IN AN IMMUNOCOMPETENT PATIENT. JOURNAL OF PHARMACOLOGY AND PHARMACOTHERAPEUTICS. 2016;7(2):112-4",39.0,YR,,M,Y,,,20160811.0,,OT,US,US,2016,Q3,Adult
126466961,12646696,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,50 UNITS DAILY AND 20 UNITS AT BEDTIME,,,Y,, UNKNOWN,,,70.0,DF,,,2016,Q3,Hyperosmolar hyperglycaemic state,Hyperosmolar hyperglycaemic state,2016,Q3,1,I,,20160803.0,20160812,20160812,EXP,,US-ZYDUS-011867,ZYDUS PHARM,"NI D, KHOSLA SG, NYLEN ES. SERTRALINE INDUCED HYPOGLYCEMIA IN A TYPE II DIABETIC PATIENT. ENDOCR-REV 2014;35 ABSTR. SAT-1017.",58.0,YR,,M,Y,,,20160812.0,,MD,US,US,2016,Q3,Adult
126466961,12646696,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,50 UNITS DAILY AND 20 UNITS AT BEDTIME,,,Y,, UNKNOWN,,,70.0,DF,,,2016,Q3,Hypoglycaemia,Hypoglycaemia,2016,Q3,1,I,,20160803.0,20160812,20160812,EXP,,US-ZYDUS-011867,ZYDUS PHARM,"NI D, KHOSLA SG, NYLEN ES. SERTRALINE INDUCED HYPOGLYCEMIA IN A TYPE II DIABETIC PATIENT. ENDOCR-REV 2014;35 ABSTR. SAT-1017.",58.0,YR,,M,Y,,,20160812.0,,MD,US,US,2016,Q3,Adult
126484731,12648473,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,BASAL BOLUS,,,U,, UNK,,21081.0,,,,QD,2016,Q3,Apraxia,,2016,Q3,1,I,2009.0,20160729.0,20160812,20160812,EXP,,GB-SA-2016SA140920,AVENTIS,"CRABTREE T, ALTAAN S, TARIK A. EARLY-ONSET DEMENTIA IN TYPE 1 DIABETES MELLITUS. PRACTICAL DIABETES 2016;33(4):133-4.",48.0,YR,A,M,Y,,,20160812.0,,OT,GB,GB,2016,Q3,Adult
126484731,12648473,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,BASAL BOLUS,,,U,, UNK,,21081.0,,,,QD,2016,Q3,Atrophy,,2016,Q3,1,I,2009.0,20160729.0,20160812,20160812,EXP,,GB-SA-2016SA140920,AVENTIS,"CRABTREE T, ALTAAN S, TARIK A. EARLY-ONSET DEMENTIA IN TYPE 1 DIABETES MELLITUS. PRACTICAL DIABETES 2016;33(4):133-4.",48.0,YR,A,M,Y,,,20160812.0,,OT,GB,GB,2016,Q3,Adult
126484731,12648473,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,BASAL BOLUS,,,U,, UNK,,21081.0,,,,QD,2016,Q3,Cognitive disorder,,2016,Q3,1,I,2009.0,20160729.0,20160812,20160812,EXP,,GB-SA-2016SA140920,AVENTIS,"CRABTREE T, ALTAAN S, TARIK A. EARLY-ONSET DEMENTIA IN TYPE 1 DIABETES MELLITUS. PRACTICAL DIABETES 2016;33(4):133-4.",48.0,YR,A,M,Y,,,20160812.0,,OT,GB,GB,2016,Q3,Adult
126484731,12648473,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,BASAL BOLUS,,,U,, UNK,,21081.0,,,,QD,2016,Q3,Dementia Alzheimer's type,,2016,Q3,1,I,2009.0,20160729.0,20160812,20160812,EXP,,GB-SA-2016SA140920,AVENTIS,"CRABTREE T, ALTAAN S, TARIK A. EARLY-ONSET DEMENTIA IN TYPE 1 DIABETES MELLITUS. PRACTICAL DIABETES 2016;33(4):133-4.",48.0,YR,A,M,Y,,,20160812.0,,OT,GB,GB,2016,Q3,Adult
126484731,12648473,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,BASAL BOLUS,,,U,, UNK,,21081.0,,,,QD,2016,Q3,Depression,,2016,Q3,1,I,2009.0,20160729.0,20160812,20160812,EXP,,GB-SA-2016SA140920,AVENTIS,"CRABTREE T, ALTAAN S, TARIK A. EARLY-ONSET DEMENTIA IN TYPE 1 DIABETES MELLITUS. PRACTICAL DIABETES 2016;33(4):133-4.",48.0,YR,A,M,Y,,,20160812.0,,OT,GB,GB,2016,Q3,Adult
126484731,12648473,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,BASAL BOLUS,,,U,, UNK,,21081.0,,,,QD,2016,Q3,Hypoglycaemia,,2016,Q3,1,I,2009.0,20160729.0,20160812,20160812,EXP,,GB-SA-2016SA140920,AVENTIS,"CRABTREE T, ALTAAN S, TARIK A. EARLY-ONSET DEMENTIA IN TYPE 1 DIABETES MELLITUS. PRACTICAL DIABETES 2016;33(4):133-4.",48.0,YR,A,M,Y,,,20160812.0,,OT,GB,GB,2016,Q3,Adult
126484731,12648473,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,BASAL BOLUS,,,U,, UNK,,21081.0,,,,QD,2016,Q3,Hypoglycaemic seizure,,2016,Q3,1,I,2009.0,20160729.0,20160812,20160812,EXP,,GB-SA-2016SA140920,AVENTIS,"CRABTREE T, ALTAAN S, TARIK A. EARLY-ONSET DEMENTIA IN TYPE 1 DIABETES MELLITUS. PRACTICAL DIABETES 2016;33(4):133-4.",48.0,YR,A,M,Y,,,20160812.0,,OT,GB,GB,2016,Q3,Adult
126484731,12648473,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,BASAL BOLUS,,,U,, UNK,,21081.0,,,,QD,2016,Q3,Intentional product misuse,,2016,Q3,1,I,2009.0,20160729.0,20160812,20160812,EXP,,GB-SA-2016SA140920,AVENTIS,"CRABTREE T, ALTAAN S, TARIK A. EARLY-ONSET DEMENTIA IN TYPE 1 DIABETES MELLITUS. PRACTICAL DIABETES 2016;33(4):133-4.",48.0,YR,A,M,Y,,,20160812.0,,OT,GB,GB,2016,Q3,Adult
126484731,12648473,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,ONCE IN THE MORNING AND ONCE IN THE BEDTIME,,,U,, UNK,,21081.0,,,,BID,2016,Q3,Apraxia,,2016,Q3,1,I,2009.0,20160729.0,20160812,20160812,EXP,,GB-SA-2016SA140920,AVENTIS,"CRABTREE T, ALTAAN S, TARIK A. EARLY-ONSET DEMENTIA IN TYPE 1 DIABETES MELLITUS. PRACTICAL DIABETES 2016;33(4):133-4.",48.0,YR,A,M,Y,,,20160812.0,,OT,GB,GB,2016,Q3,Adult
126484731,12648473,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,ONCE IN THE MORNING AND ONCE IN THE BEDTIME,,,U,, UNK,,21081.0,,,,BID,2016,Q3,Atrophy,,2016,Q3,1,I,2009.0,20160729.0,20160812,20160812,EXP,,GB-SA-2016SA140920,AVENTIS,"CRABTREE T, ALTAAN S, TARIK A. EARLY-ONSET DEMENTIA IN TYPE 1 DIABETES MELLITUS. PRACTICAL DIABETES 2016;33(4):133-4.",48.0,YR,A,M,Y,,,20160812.0,,OT,GB,GB,2016,Q3,Adult
126484731,12648473,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,ONCE IN THE MORNING AND ONCE IN THE BEDTIME,,,U,, UNK,,21081.0,,,,BID,2016,Q3,Cognitive disorder,,2016,Q3,1,I,2009.0,20160729.0,20160812,20160812,EXP,,GB-SA-2016SA140920,AVENTIS,"CRABTREE T, ALTAAN S, TARIK A. EARLY-ONSET DEMENTIA IN TYPE 1 DIABETES MELLITUS. PRACTICAL DIABETES 2016;33(4):133-4.",48.0,YR,A,M,Y,,,20160812.0,,OT,GB,GB,2016,Q3,Adult
126484731,12648473,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,ONCE IN THE MORNING AND ONCE IN THE BEDTIME,,,U,, UNK,,21081.0,,,,BID,2016,Q3,Dementia Alzheimer's type,,2016,Q3,1,I,2009.0,20160729.0,20160812,20160812,EXP,,GB-SA-2016SA140920,AVENTIS,"CRABTREE T, ALTAAN S, TARIK A. EARLY-ONSET DEMENTIA IN TYPE 1 DIABETES MELLITUS. PRACTICAL DIABETES 2016;33(4):133-4.",48.0,YR,A,M,Y,,,20160812.0,,OT,GB,GB,2016,Q3,Adult
126484731,12648473,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,ONCE IN THE MORNING AND ONCE IN THE BEDTIME,,,U,, UNK,,21081.0,,,,BID,2016,Q3,Depression,,2016,Q3,1,I,2009.0,20160729.0,20160812,20160812,EXP,,GB-SA-2016SA140920,AVENTIS,"CRABTREE T, ALTAAN S, TARIK A. EARLY-ONSET DEMENTIA IN TYPE 1 DIABETES MELLITUS. PRACTICAL DIABETES 2016;33(4):133-4.",48.0,YR,A,M,Y,,,20160812.0,,OT,GB,GB,2016,Q3,Adult
126484731,12648473,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,ONCE IN THE MORNING AND ONCE IN THE BEDTIME,,,U,, UNK,,21081.0,,,,BID,2016,Q3,Hypoglycaemia,,2016,Q3,1,I,2009.0,20160729.0,20160812,20160812,EXP,,GB-SA-2016SA140920,AVENTIS,"CRABTREE T, ALTAAN S, TARIK A. EARLY-ONSET DEMENTIA IN TYPE 1 DIABETES MELLITUS. PRACTICAL DIABETES 2016;33(4):133-4.",48.0,YR,A,M,Y,,,20160812.0,,OT,GB,GB,2016,Q3,Adult
126484731,12648473,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,ONCE IN THE MORNING AND ONCE IN THE BEDTIME,,,U,, UNK,,21081.0,,,,BID,2016,Q3,Hypoglycaemic seizure,,2016,Q3,1,I,2009.0,20160729.0,20160812,20160812,EXP,,GB-SA-2016SA140920,AVENTIS,"CRABTREE T, ALTAAN S, TARIK A. EARLY-ONSET DEMENTIA IN TYPE 1 DIABETES MELLITUS. PRACTICAL DIABETES 2016;33(4):133-4.",48.0,YR,A,M,Y,,,20160812.0,,OT,GB,GB,2016,Q3,Adult
126484731,12648473,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,ONCE IN THE MORNING AND ONCE IN THE BEDTIME,,,U,, UNK,,21081.0,,,,BID,2016,Q3,Intentional product misuse,,2016,Q3,1,I,2009.0,20160729.0,20160812,20160812,EXP,,GB-SA-2016SA140920,AVENTIS,"CRABTREE T, ALTAAN S, TARIK A. EARLY-ONSET DEMENTIA IN TYPE 1 DIABETES MELLITUS. PRACTICAL DIABETES 2016;33(4):133-4.",48.0,YR,A,M,Y,,,20160812.0,,OT,GB,GB,2016,Q3,Adult
126486061,12648606,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,,2016,Q3,Diabetic foot,,2016,Q3,1,I,201607.0,20160803.0,20160812,20160812,EXP,,CO-BAXTER-2016BAX041610,BAXTER,,75.0,YR,,M,Y,60.0,KG,20160812.0,,OT,CO,CO,2016,Q3,Elderly
126486061,12648606,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,,2016,Q3,Dyspnoea,,2016,Q3,1,I,201607.0,20160803.0,20160812,20160812,EXP,,CO-BAXTER-2016BAX041610,BAXTER,,75.0,YR,,M,Y,60.0,KG,20160812.0,,OT,CO,CO,2016,Q3,Elderly
126486061,12648606,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,,2016,Q3,Sepsis,,2016,Q3,1,I,201607.0,20160803.0,20160812,20160812,EXP,,CO-BAXTER-2016BAX041610,BAXTER,,75.0,YR,,M,Y,60.0,KG,20160812.0,,OT,CO,CO,2016,Q3,Elderly
126493951,12649395,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 U, UNK",,,Y,,,,,8.0,DF,INJECTION,,2016,Q3,Blood glucose increased,,2016,Q3,1,I,2011.0,20160729.0,20160812,20160812,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-065170,BRISTOL MYERS SQUIBB,,34.0,YR,,F,Y,70.0,KG,20160812.0,,OT,CN,CN,2016,Q3,Young Adult
126493951,12649395,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 U, UNK",,,Y,,,,,8.0,DF,INJECTION,,2016,Q3,Cholecystectomy,,2016,Q3,1,I,2011.0,20160729.0,20160812,20160812,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-065170,BRISTOL MYERS SQUIBB,,34.0,YR,,F,Y,70.0,KG,20160812.0,,OT,CN,CN,2016,Q3,Young Adult
126493951,12649395,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 U, UNK",,,Y,,,,,8.0,DF,INJECTION,,2016,Q3,Hepatic function abnormal,,2016,Q3,1,I,2011.0,20160729.0,20160812,20160812,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-065170,BRISTOL MYERS SQUIBB,,34.0,YR,,F,Y,70.0,KG,20160812.0,,OT,CN,CN,2016,Q3,Young Adult
126493951,12649395,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 U, UNK",,,Y,,,,,8.0,DF,INJECTION,,2016,Q3,Hypothyroidism,,2016,Q3,1,I,2011.0,20160729.0,20160812,20160812,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-065170,BRISTOL MYERS SQUIBB,,34.0,YR,,F,Y,70.0,KG,20160812.0,,OT,CN,CN,2016,Q3,Young Adult
126493951,12649395,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 U, UNK",,,Y,,,,,8.0,DF,INJECTION,,2016,Q3,Maternal exposure during pregnancy,,2016,Q3,1,I,2011.0,20160729.0,20160812,20160812,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-065170,BRISTOL MYERS SQUIBB,,34.0,YR,,F,Y,70.0,KG,20160812.0,,OT,CN,CN,2016,Q3,Young Adult
126493951,12649395,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 U, UNK",,,Y,,,,,8.0,DF,INJECTION,,2016,Q3,Normal newborn,,2016,Q3,1,I,2011.0,20160729.0,20160812,20160812,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-065170,BRISTOL MYERS SQUIBB,,34.0,YR,,F,Y,70.0,KG,20160812.0,,OT,CN,CN,2016,Q3,Young Adult
126493951,12649395,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 U, UNK",,,Y,,,,,8.0,DF,INJECTION,,2016,Q3,Polycystic ovaries,,2016,Q3,1,I,2011.0,20160729.0,20160812,20160812,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-065170,BRISTOL MYERS SQUIBB,,34.0,YR,,F,Y,70.0,KG,20160812.0,,OT,CN,CN,2016,Q3,Young Adult
126493951,12649395,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 U, UNK",,,Y,,,,,24.0,DF,INJECTION,,2016,Q3,Blood glucose increased,,2016,Q3,1,I,2011.0,20160729.0,20160812,20160812,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-065170,BRISTOL MYERS SQUIBB,,34.0,YR,,F,Y,70.0,KG,20160812.0,,OT,CN,CN,2016,Q3,Young Adult
126493951,12649395,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 U, UNK",,,Y,,,,,24.0,DF,INJECTION,,2016,Q3,Cholecystectomy,,2016,Q3,1,I,2011.0,20160729.0,20160812,20160812,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-065170,BRISTOL MYERS SQUIBB,,34.0,YR,,F,Y,70.0,KG,20160812.0,,OT,CN,CN,2016,Q3,Young Adult
126493951,12649395,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 U, UNK",,,Y,,,,,24.0,DF,INJECTION,,2016,Q3,Hepatic function abnormal,,2016,Q3,1,I,2011.0,20160729.0,20160812,20160812,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-065170,BRISTOL MYERS SQUIBB,,34.0,YR,,F,Y,70.0,KG,20160812.0,,OT,CN,CN,2016,Q3,Young Adult
126493951,12649395,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 U, UNK",,,Y,,,,,24.0,DF,INJECTION,,2016,Q3,Hypothyroidism,,2016,Q3,1,I,2011.0,20160729.0,20160812,20160812,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-065170,BRISTOL MYERS SQUIBB,,34.0,YR,,F,Y,70.0,KG,20160812.0,,OT,CN,CN,2016,Q3,Young Adult
126493951,12649395,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 U, UNK",,,Y,,,,,24.0,DF,INJECTION,,2016,Q3,Maternal exposure during pregnancy,,2016,Q3,1,I,2011.0,20160729.0,20160812,20160812,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-065170,BRISTOL MYERS SQUIBB,,34.0,YR,,F,Y,70.0,KG,20160812.0,,OT,CN,CN,2016,Q3,Young Adult
126493951,12649395,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 U, UNK",,,Y,,,,,24.0,DF,INJECTION,,2016,Q3,Normal newborn,,2016,Q3,1,I,2011.0,20160729.0,20160812,20160812,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-065170,BRISTOL MYERS SQUIBB,,34.0,YR,,F,Y,70.0,KG,20160812.0,,OT,CN,CN,2016,Q3,Young Adult
126493951,12649395,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 U, UNK",,,Y,,,,,24.0,DF,INJECTION,,2016,Q3,Polycystic ovaries,,2016,Q3,1,I,2011.0,20160729.0,20160812,20160812,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-065170,BRISTOL MYERS SQUIBB,,34.0,YR,,F,Y,70.0,KG,20160812.0,,OT,CN,CN,2016,Q3,Young Adult
126583712,12658371,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,10.0,IU,,,2016,Q3,Diabetic foot,,2016,Q3,2,F,20160802.0,20160906.0,20160817,20160915,EXP,,CO-BAXTER-2016BAX042124,BAXTER,,59.0,YR,,M,Y,68.0,KG,20160915.0,,OT,CO,CO,2016,Q3,Adult
126583712,12658371,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,10.0,IU,,,2016,Q3,Sepsis,,2016,Q3,2,F,20160802.0,20160906.0,20160817,20160915,EXP,,CO-BAXTER-2016BAX042124,BAXTER,,59.0,YR,,M,Y,68.0,KG,20160915.0,,OT,CO,CO,2016,Q3,Adult
126605852,12660585,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,TOUJEO SOLOSTAR,,,,,,,,,,,,2016,Q3,Blood potassium increased,,2016,Q3,2,F,20160413.0,20160422.0,20160817,20160901,EXP,,US-RELYPSA-RLY2016000497,RELYPSA,,60.0,YR,,F,Y,,,20160901.0,,CN,US,US,2016,Q3,Adult
126611852,12661185,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Flatulence,,2016,Q3,2,F,20160421.0,20160518.0,20160817,20160901,EXP,,US-RELYPSA-RLY2016000632,RELYPSA,,77.0,YR,,M,Y,,,20160901.0,,CN,US,US,2016,Q3,Elderly
126611852,12661185,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Frequent bowel movements,,2016,Q3,2,F,20160421.0,20160518.0,20160817,20160901,EXP,,US-RELYPSA-RLY2016000632,RELYPSA,,77.0,YR,,M,Y,,,20160901.0,,CN,US,US,2016,Q3,Elderly
126612572,12661257,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Constipation,,2016,Q3,2,F,201605.0,20160523.0,20160817,20160901,EXP,,US-RELYPSA-RLY2016000803,RELYPSA,,81.0,YR,,M,Y,,,20160901.0,,CN,US,US,2016,Q3,Elderly
126612572,12661257,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Flatulence,,2016,Q3,2,F,201605.0,20160523.0,20160817,20160901,EXP,,US-RELYPSA-RLY2016000803,RELYPSA,,81.0,YR,,M,Y,,,20160901.0,,CN,US,US,2016,Q3,Elderly
126617735,12661773,24,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q3,Large intestine perforation,,2016,Q3,5,F,20160804.0,20160922.0,20160817,20160928,EXP,,US-CELGENEUS-USA-2016083335,CELGENE,,67.0,YR,,M,Y,86.49,KG,20160928.0,,MD,US,US,2016,Q3,Elderly
126627971,12662797,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,70 UNITS AT BEDTIME,,,U,U,,,,,,,,2016,Q3,Treatment failure,,2016,Q3,1,I,,20160803.0,20160818,20160818,EXP,,US-APOTEX-2016AP010486,APOTEX,"KAUFMAN MB, PHAM T, PARAMESWARAN L, CHOY M. PRASUGREL HYPERSENSITIVITY WITH RESPIRATORY DISTRESS AND RASH. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY. 2016;73(14):1051-1057",61.0,YR,,F,Y,97.0,KG,20160818.0,,PH,US,US,2016,Q3,Adult
126627971,12662797,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,70 UNITS AT BEDTIME,,,U,U,,,,,,,,2016,Q3,Vascular stent thrombosis,,2016,Q3,1,I,,20160803.0,20160818,20160818,EXP,,US-APOTEX-2016AP010486,APOTEX,"KAUFMAN MB, PHAM T, PARAMESWARAN L, CHOY M. PRASUGREL HYPERSENSITIVITY WITH RESPIRATORY DISTRESS AND RASH. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY. 2016;73(14):1051-1057",61.0,YR,,F,Y,97.0,KG,20160818.0,,PH,US,US,2016,Q3,Adult
126641401,12664140,8,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"60 UNITS, QD",,,,,,,,,,,QD,2016,Q3,Decreased appetite,,2016,Q3,1,I,201506.0,20160224.0,20160818,20160818,PER,,US-AEGERION PHARMACEUTICAL INC.-AEGR002441,AEGERION,,74.0,YR,,M,Y,,,20160818.0,,MD,US,US,2016,Q3,Elderly
126641401,12664140,8,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"60 UNITS, QD",,,,,,,,,,,QD,2016,Q3,Off label use,,2016,Q3,1,I,201506.0,20160224.0,20160818,20160818,PER,,US-AEGERION PHARMACEUTICAL INC.-AEGR002441,AEGERION,,74.0,YR,,M,Y,,,20160818.0,,MD,US,US,2016,Q3,Elderly
126641401,12664140,8,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"60 UNITS, QD",,,,,,,,,,,QD,2016,Q3,Pruritus,,2016,Q3,1,I,201506.0,20160224.0,20160818,20160818,PER,,US-AEGERION PHARMACEUTICAL INC.-AEGR002441,AEGERION,,74.0,YR,,M,Y,,,20160818.0,,MD,US,US,2016,Q3,Elderly
126665921,12666592,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,Y,,,,,,,,,2016,Q3,Acute kidney injury,,2016,Q3,1,I,20160516.0,20160803.0,20160819,20160819,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-064253,BRISTOL MYERS SQUIBB,,71.0,YR,,F,Y,74.3,KG,20160819.0,,MD,US,US,2016,Q3,Elderly
126665921,12666592,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,Y,,,,,,,,,2016,Q3,Cardiac failure congestive,,2016,Q3,1,I,20160516.0,20160803.0,20160819,20160819,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-064253,BRISTOL MYERS SQUIBB,,71.0,YR,,F,Y,74.3,KG,20160819.0,,MD,US,US,2016,Q3,Elderly
126665921,12666592,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,Y,,,,,,,,,2016,Q3,Haemodialysis,,2016,Q3,1,I,20160516.0,20160803.0,20160819,20160819,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-064253,BRISTOL MYERS SQUIBB,,71.0,YR,,F,Y,74.3,KG,20160819.0,,MD,US,US,2016,Q3,Elderly
126665921,12666592,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,Y,,,,,,,,,2016,Q3,Toxicity to various agents,,2016,Q3,1,I,20160516.0,20160803.0,20160819,20160819,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-064253,BRISTOL MYERS SQUIBB,,71.0,YR,,F,Y,74.3,KG,20160819.0,,MD,US,US,2016,Q3,Elderly
126665921,12666592,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,Y,,,,,,,,,2016,Q3,Acute kidney injury,,2016,Q3,1,I,20160516.0,20160803.0,20160819,20160819,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-064253,BRISTOL MYERS SQUIBB,,71.0,YR,,F,Y,74.3,KG,20160819.0,,MD,US,US,2016,Q3,Elderly
126665921,12666592,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,Y,,,,,,,,,2016,Q3,Cardiac failure congestive,,2016,Q3,1,I,20160516.0,20160803.0,20160819,20160819,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-064253,BRISTOL MYERS SQUIBB,,71.0,YR,,F,Y,74.3,KG,20160819.0,,MD,US,US,2016,Q3,Elderly
126665921,12666592,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,Y,,,,,,,,,2016,Q3,Haemodialysis,,2016,Q3,1,I,20160516.0,20160803.0,20160819,20160819,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-064253,BRISTOL MYERS SQUIBB,,71.0,YR,,F,Y,74.3,KG,20160819.0,,MD,US,US,2016,Q3,Elderly
126665921,12666592,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,Y,,,,,,,,,2016,Q3,Toxicity to various agents,,2016,Q3,1,I,20160516.0,20160803.0,20160819,20160819,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-064253,BRISTOL MYERS SQUIBB,,71.0,YR,,F,Y,74.3,KG,20160819.0,,MD,US,US,2016,Q3,Elderly
126685262,12668526,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 UNITS SUBCU Q.H.S.,,,,,,,,,,,,2016,Q3,Posterior reversible encephalopathy syndrome,,2016,Q3,2,F,201608.0,20160825.0,20160819,20160901,EXP,,CA-ASTRAZENECA-2016SE87586,ASTRAZENECA,,72.0,YR,,M,Y,,,20160902.0,,PH,CA,CA,2016,Q3,Elderly
126694361,12669436,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU/ML, UNK, (LNJECT UNDER THE SKIN)",,,,,,,,,,SOLUTION FOR INJECTION,,2016,Q3,Acute kidney injury,,2016,Q3,1,I,,20160808.0,20160819,20160819,EXP,,US-PFIZER INC-2016381090,PFIZER,,70.0,YR,,M,Y,90.25,KG,20160819.0,,MD,US,US,2016,Q3,Elderly
126694361,12669436,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU/ML, UNK, (LNJECT UNDER THE SKIN)",,,,,,,,,,SOLUTION FOR INJECTION,,2016,Q3,Acute myeloid leukaemia,,2016,Q3,1,I,,20160808.0,20160819,20160819,EXP,,US-PFIZER INC-2016381090,PFIZER,,70.0,YR,,M,Y,90.25,KG,20160819.0,,MD,US,US,2016,Q3,Elderly
126694361,12669436,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU/ML, UNK, (LNJECT UNDER THE SKIN)",,,,,,,,,,SOLUTION FOR INJECTION,,2016,Q3,Disease recurrence,,2016,Q3,1,I,,20160808.0,20160819,20160819,EXP,,US-PFIZER INC-2016381090,PFIZER,,70.0,YR,,M,Y,90.25,KG,20160819.0,,MD,US,US,2016,Q3,Elderly
126694361,12669436,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU/ML, UNK, (LNJECT UNDER THE SKIN)",,,,,,,,,,SOLUTION FOR INJECTION,,2016,Q3,Dyspnoea exertional,,2016,Q3,1,I,,20160808.0,20160819,20160819,EXP,,US-PFIZER INC-2016381090,PFIZER,,70.0,YR,,M,Y,90.25,KG,20160819.0,,MD,US,US,2016,Q3,Elderly
126694361,12669436,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU/ML, UNK, (LNJECT UNDER THE SKIN)",,,,,,,,,,SOLUTION FOR INJECTION,,2016,Q3,Fatigue,,2016,Q3,1,I,,20160808.0,20160819,20160819,EXP,,US-PFIZER INC-2016381090,PFIZER,,70.0,YR,,M,Y,90.25,KG,20160819.0,,MD,US,US,2016,Q3,Elderly
126694361,12669436,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU/ML, UNK, (LNJECT UNDER THE SKIN)",,,,,,,,,,SOLUTION FOR INJECTION,,2016,Q3,Muscle spasms,,2016,Q3,1,I,,20160808.0,20160819,20160819,EXP,,US-PFIZER INC-2016381090,PFIZER,,70.0,YR,,M,Y,90.25,KG,20160819.0,,MD,US,US,2016,Q3,Elderly
126694361,12669436,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU/ML, UNK, (LNJECT UNDER THE SKIN)",,,,,,,,,,SOLUTION FOR INJECTION,,2016,Q3,Sepsis,,2016,Q3,1,I,,20160808.0,20160819,20160819,EXP,,US-PFIZER INC-2016381090,PFIZER,,70.0,YR,,M,Y,90.25,KG,20160819.0,,MD,US,US,2016,Q3,Elderly
126743121,12674312,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,QD,2016,Q3,Mycetoma mycotic,,2016,Q3,1,I,,20160818.0,20160822,20160822,EXP,,US-FRESENIUS KABI-FK201605677,FRESENIUS KABI,"WAGNER J,BELL A. ACUTE HEPATIC INJURY WITH AMPHOTERICIN B DEOXYCHOLATE IN AN IMMUNOCOMPETENT PATIENT. JOURNAL OF PHARMACOLOGY AND PHARMACOTHERAPEUTICS 2016 APR;NO. 2:112-114.",39.0,YR,,M,Y,,,20160822.0,,OT,US,US,2016,Q3,Adult
126761621,12676162,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 IU, 1X/DAY (NIGHTLY)",,,,,,,,15.0,IU,,QD,2016,Q3,Cardiac disorder,,2016,Q3,1,I,,20160608.0,20160823,20160823,EXP,,US-PFIZER INC-2016295775,PFIZER,,58.0,YR,,F,Y,73.1,KG,20160823.0,,OT,US,US,2016,Q3,Adult
126761621,12676162,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 IU, 1X/DAY (NIGHTLY)",,,,,,,,15.0,IU,,QD,2016,Q3,Chest pain,,2016,Q3,1,I,,20160608.0,20160823,20160823,EXP,,US-PFIZER INC-2016295775,PFIZER,,58.0,YR,,F,Y,73.1,KG,20160823.0,,OT,US,US,2016,Q3,Adult
126761621,12676162,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 IU, 1X/DAY (NIGHTLY)",,,,,,,,15.0,IU,,QD,2016,Q3,Drug tolerance decreased,,2016,Q3,1,I,,20160608.0,20160823,20160823,EXP,,US-PFIZER INC-2016295775,PFIZER,,58.0,YR,,F,Y,73.1,KG,20160823.0,,OT,US,US,2016,Q3,Adult
126761621,12676162,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 IU, 1X/DAY (NIGHTLY)",,,,,,,,15.0,IU,,QD,2016,Q3,Feeding disorder,,2016,Q3,1,I,,20160608.0,20160823,20160823,EXP,,US-PFIZER INC-2016295775,PFIZER,,58.0,YR,,F,Y,73.1,KG,20160823.0,,OT,US,US,2016,Q3,Adult
126761761,12676176,7,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,2 UNITS EVERY EVENING,,,,,,,,,,,QD,2016,Q3,Mycetoma mycotic,,2016,Q3,1,I,,20160809.0,20160823,20160823,EXP,,US-LUPIN PHARMACEUTICALS INC.-2016-03797,LUPIN,"WAGNER J, BELL A. ACUTE HEPATIC INJURY WITH AMPHOTERICIN B DEOXYCHOLATE IN AN IMMUNOCOMPETENT PATIENT. JOURNAL OF PHARMACOLOGY AND PHARMACOTHERAPEUTICS. 2016;7(2):112-114.",39.0,YR,,M,Y,,,20160823.0,,OT,US,US,2016,Q3,Adult
126797191,12679719,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Status epilepticus,,2016,Q3,1,I,20160821.0,,20160823,20160823,DIR,,,,,67.0,YR,,M,N,72.7,KG,20160822.0,N,PH,US,,2016,Q3,Elderly
126801962,12680196,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, PRN",,,,,,,,,,,,2016,Q3,Myalgia,,2016,Q3,2,F,20160505.0,20160818.0,20160824,20160922,EXP,,PHHY2016KR115427,NOVARTIS,,31.0,YR,,M,Y,,,20160922.0,,MD,KR,KR,2016,Q3,Young Adult
126815462,12681546,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"BRAEKFAST - 15U, DINNER-11U",,,U,, UNK,,21081.0,,,,TID,2016,Q3,Autonomic nervous system imbalance,,2016,Q3,2,F,,20160907.0,20160824,20160914,EXP,,JP-SA-2016SA153425,AVENTIS,"MATSUSHITA Y, TAKATA Y, MATSUDA A, KAWAMURA R, ONUMA H, ONUMA H. A CASE OF TYPE 1 DIABETES WHOSE PROFILE OF AUTONOMIC NERVE ACTIVITY DURING NOCTURNAL HYPOGLYCEMIA WAS ANALYZED BY CONTINUOUS GLUCOSE MONITORING AND HOLTER ELECTROCARDIOGRAPHY. J JAPAN DIAB SOC. 2016 JUL;59(7):475-81.",77.0,YR,E,M,Y,73.0,KG,20160914.0,,MD,JP,JP,2016,Q3,Elderly
126815462,12681546,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"BRAEKFAST - 15U, DINNER-11U",,,U,, UNK,,21081.0,,,,TID,2016,Q3,Autonomic neuropathy,,2016,Q3,2,F,,20160907.0,20160824,20160914,EXP,,JP-SA-2016SA153425,AVENTIS,"MATSUSHITA Y, TAKATA Y, MATSUDA A, KAWAMURA R, ONUMA H, ONUMA H. A CASE OF TYPE 1 DIABETES WHOSE PROFILE OF AUTONOMIC NERVE ACTIVITY DURING NOCTURNAL HYPOGLYCEMIA WAS ANALYZED BY CONTINUOUS GLUCOSE MONITORING AND HOLTER ELECTROCARDIOGRAPHY. J JAPAN DIAB SOC. 2016 JUL;59(7):475-81.",77.0,YR,E,M,Y,73.0,KG,20160914.0,,MD,JP,JP,2016,Q3,Elderly
126815462,12681546,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"BRAEKFAST - 15U, DINNER-11U",,,U,, UNK,,21081.0,,,,TID,2016,Q3,Electrocardiogram QT prolonged,,2016,Q3,2,F,,20160907.0,20160824,20160914,EXP,,JP-SA-2016SA153425,AVENTIS,"MATSUSHITA Y, TAKATA Y, MATSUDA A, KAWAMURA R, ONUMA H, ONUMA H. A CASE OF TYPE 1 DIABETES WHOSE PROFILE OF AUTONOMIC NERVE ACTIVITY DURING NOCTURNAL HYPOGLYCEMIA WAS ANALYZED BY CONTINUOUS GLUCOSE MONITORING AND HOLTER ELECTROCARDIOGRAPHY. J JAPAN DIAB SOC. 2016 JUL;59(7):475-81.",77.0,YR,E,M,Y,73.0,KG,20160914.0,,MD,JP,JP,2016,Q3,Elderly
126815462,12681546,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"BRAEKFAST - 15U, DINNER-11U",,,U,, UNK,,21081.0,,,,TID,2016,Q3,Hypoglycaemia,,2016,Q3,2,F,,20160907.0,20160824,20160914,EXP,,JP-SA-2016SA153425,AVENTIS,"MATSUSHITA Y, TAKATA Y, MATSUDA A, KAWAMURA R, ONUMA H, ONUMA H. A CASE OF TYPE 1 DIABETES WHOSE PROFILE OF AUTONOMIC NERVE ACTIVITY DURING NOCTURNAL HYPOGLYCEMIA WAS ANALYZED BY CONTINUOUS GLUCOSE MONITORING AND HOLTER ELECTROCARDIOGRAPHY. J JAPAN DIAB SOC. 2016 JUL;59(7):475-81.",77.0,YR,E,M,Y,73.0,KG,20160914.0,,MD,JP,JP,2016,Q3,Elderly
126815462,12681546,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"BRAEKFAST - 15U, DINNER-11U",,,U,, UNK,,21081.0,,,,TID,2016,Q3,Sinus tachycardia,,2016,Q3,2,F,,20160907.0,20160824,20160914,EXP,,JP-SA-2016SA153425,AVENTIS,"MATSUSHITA Y, TAKATA Y, MATSUDA A, KAWAMURA R, ONUMA H, ONUMA H. A CASE OF TYPE 1 DIABETES WHOSE PROFILE OF AUTONOMIC NERVE ACTIVITY DURING NOCTURNAL HYPOGLYCEMIA WAS ANALYZED BY CONTINUOUS GLUCOSE MONITORING AND HOLTER ELECTROCARDIOGRAPHY. J JAPAN DIAB SOC. 2016 JUL;59(7):475-81.",77.0,YR,E,M,Y,73.0,KG,20160914.0,,MD,JP,JP,2016,Q3,Elderly
126815462,12681546,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"BRAEKFAST - 15U, DINNER-11U",,,U,, UNK,,21081.0,,,,TID,2016,Q3,Ventricular extrasystoles,,2016,Q3,2,F,,20160907.0,20160824,20160914,EXP,,JP-SA-2016SA153425,AVENTIS,"MATSUSHITA Y, TAKATA Y, MATSUDA A, KAWAMURA R, ONUMA H, ONUMA H. A CASE OF TYPE 1 DIABETES WHOSE PROFILE OF AUTONOMIC NERVE ACTIVITY DURING NOCTURNAL HYPOGLYCEMIA WAS ANALYZED BY CONTINUOUS GLUCOSE MONITORING AND HOLTER ELECTROCARDIOGRAPHY. J JAPAN DIAB SOC. 2016 JUL;59(7):475-81.",77.0,YR,E,M,Y,73.0,KG,20160914.0,,MD,JP,JP,2016,Q3,Elderly
126815462,12681546,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"BRAEKFAST - 12-13U, EVENING-6-8U",,,U,, UNK,,21081.0,,,,TID,2016,Q3,Autonomic nervous system imbalance,,2016,Q3,2,F,,20160907.0,20160824,20160914,EXP,,JP-SA-2016SA153425,AVENTIS,"MATSUSHITA Y, TAKATA Y, MATSUDA A, KAWAMURA R, ONUMA H, ONUMA H. A CASE OF TYPE 1 DIABETES WHOSE PROFILE OF AUTONOMIC NERVE ACTIVITY DURING NOCTURNAL HYPOGLYCEMIA WAS ANALYZED BY CONTINUOUS GLUCOSE MONITORING AND HOLTER ELECTROCARDIOGRAPHY. J JAPAN DIAB SOC. 2016 JUL;59(7):475-81.",77.0,YR,E,M,Y,73.0,KG,20160914.0,,MD,JP,JP,2016,Q3,Elderly
126815462,12681546,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"BRAEKFAST - 12-13U, EVENING-6-8U",,,U,, UNK,,21081.0,,,,TID,2016,Q3,Autonomic neuropathy,,2016,Q3,2,F,,20160907.0,20160824,20160914,EXP,,JP-SA-2016SA153425,AVENTIS,"MATSUSHITA Y, TAKATA Y, MATSUDA A, KAWAMURA R, ONUMA H, ONUMA H. A CASE OF TYPE 1 DIABETES WHOSE PROFILE OF AUTONOMIC NERVE ACTIVITY DURING NOCTURNAL HYPOGLYCEMIA WAS ANALYZED BY CONTINUOUS GLUCOSE MONITORING AND HOLTER ELECTROCARDIOGRAPHY. J JAPAN DIAB SOC. 2016 JUL;59(7):475-81.",77.0,YR,E,M,Y,73.0,KG,20160914.0,,MD,JP,JP,2016,Q3,Elderly
126815462,12681546,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"BRAEKFAST - 12-13U, EVENING-6-8U",,,U,, UNK,,21081.0,,,,TID,2016,Q3,Electrocardiogram QT prolonged,,2016,Q3,2,F,,20160907.0,20160824,20160914,EXP,,JP-SA-2016SA153425,AVENTIS,"MATSUSHITA Y, TAKATA Y, MATSUDA A, KAWAMURA R, ONUMA H, ONUMA H. A CASE OF TYPE 1 DIABETES WHOSE PROFILE OF AUTONOMIC NERVE ACTIVITY DURING NOCTURNAL HYPOGLYCEMIA WAS ANALYZED BY CONTINUOUS GLUCOSE MONITORING AND HOLTER ELECTROCARDIOGRAPHY. J JAPAN DIAB SOC. 2016 JUL;59(7):475-81.",77.0,YR,E,M,Y,73.0,KG,20160914.0,,MD,JP,JP,2016,Q3,Elderly
126815462,12681546,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"BRAEKFAST - 12-13U, EVENING-6-8U",,,U,, UNK,,21081.0,,,,TID,2016,Q3,Hypoglycaemia,,2016,Q3,2,F,,20160907.0,20160824,20160914,EXP,,JP-SA-2016SA153425,AVENTIS,"MATSUSHITA Y, TAKATA Y, MATSUDA A, KAWAMURA R, ONUMA H, ONUMA H. A CASE OF TYPE 1 DIABETES WHOSE PROFILE OF AUTONOMIC NERVE ACTIVITY DURING NOCTURNAL HYPOGLYCEMIA WAS ANALYZED BY CONTINUOUS GLUCOSE MONITORING AND HOLTER ELECTROCARDIOGRAPHY. J JAPAN DIAB SOC. 2016 JUL;59(7):475-81.",77.0,YR,E,M,Y,73.0,KG,20160914.0,,MD,JP,JP,2016,Q3,Elderly
126815462,12681546,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"BRAEKFAST - 12-13U, EVENING-6-8U",,,U,, UNK,,21081.0,,,,TID,2016,Q3,Sinus tachycardia,,2016,Q3,2,F,,20160907.0,20160824,20160914,EXP,,JP-SA-2016SA153425,AVENTIS,"MATSUSHITA Y, TAKATA Y, MATSUDA A, KAWAMURA R, ONUMA H, ONUMA H. A CASE OF TYPE 1 DIABETES WHOSE PROFILE OF AUTONOMIC NERVE ACTIVITY DURING NOCTURNAL HYPOGLYCEMIA WAS ANALYZED BY CONTINUOUS GLUCOSE MONITORING AND HOLTER ELECTROCARDIOGRAPHY. J JAPAN DIAB SOC. 2016 JUL;59(7):475-81.",77.0,YR,E,M,Y,73.0,KG,20160914.0,,MD,JP,JP,2016,Q3,Elderly
126815462,12681546,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"BRAEKFAST - 12-13U, EVENING-6-8U",,,U,, UNK,,21081.0,,,,TID,2016,Q3,Ventricular extrasystoles,,2016,Q3,2,F,,20160907.0,20160824,20160914,EXP,,JP-SA-2016SA153425,AVENTIS,"MATSUSHITA Y, TAKATA Y, MATSUDA A, KAWAMURA R, ONUMA H, ONUMA H. A CASE OF TYPE 1 DIABETES WHOSE PROFILE OF AUTONOMIC NERVE ACTIVITY DURING NOCTURNAL HYPOGLYCEMIA WAS ANALYZED BY CONTINUOUS GLUCOSE MONITORING AND HOLTER ELECTROCARDIOGRAPHY. J JAPAN DIAB SOC. 2016 JUL;59(7):475-81.",77.0,YR,E,M,Y,73.0,KG,20160914.0,,MD,JP,JP,2016,Q3,Elderly
126834791,12683479,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Acute kidney injury,,2016,Q3,1,I,20160718.0,,20160824,20160824,DIR,,,,,40.0,YR,,F,N,102.5,KG,20160823.0,N,PH,US,,2016,Q3,Adult
126834791,12683479,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Dialysis,,2016,Q3,1,I,20160718.0,,20160824,20160824,DIR,,,,,40.0,YR,,F,N,102.5,KG,20160823.0,N,PH,US,,2016,Q3,Adult
126834791,12683479,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Hypotension,,2016,Q3,1,I,20160718.0,,20160824,20160824,DIR,,,,,40.0,YR,,F,N,102.5,KG,20160823.0,N,PH,US,,2016,Q3,Adult
126834791,12683479,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Infusion,,2016,Q3,1,I,20160718.0,,20160824,20160824,DIR,,,,,40.0,YR,,F,N,102.5,KG,20160823.0,N,PH,US,,2016,Q3,Adult
126834791,12683479,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Infusion related reaction,,2016,Q3,1,I,20160718.0,,20160824,20160824,DIR,,,,,40.0,YR,,F,N,102.5,KG,20160823.0,N,PH,US,,2016,Q3,Adult
126834791,12683479,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Linear IgA disease,,2016,Q3,1,I,20160718.0,,20160824,20160824,DIR,,,,,40.0,YR,,F,N,102.5,KG,20160823.0,N,PH,US,,2016,Q3,Adult
126834791,12683479,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Rash,,2016,Q3,1,I,20160718.0,,20160824,20160824,DIR,,,,,40.0,YR,,F,N,102.5,KG,20160823.0,N,PH,US,,2016,Q3,Adult
126892091,12689209,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q3,Epistaxis,,2016,Q3,1,I,,20160816.0,20160826,20160826,EXP,,TR-BAYER-2016-166042,BAYER,"KAYA T, Y?CEL M, ERASLAN ?, CINEMRE H, TAMER A.. SEVERE HYPONATREMIA, EPISTAXIS, AND FLUOXETINE.. JOURNAL OF AYUB MEDICAL COLLEGE, ABBOTTABAD : JAM. 2016; 28(1):204-205. 2016;28(1):204-205",66.0,YR,E,F,Y,,,20160826.0,,MD,TR,TR,2016,Q3,Elderly
126892091,12689209,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q3,Hyponatraemia,,2016,Q3,1,I,,20160816.0,20160826,20160826,EXP,,TR-BAYER-2016-166042,BAYER,"KAYA T, Y?CEL M, ERASLAN ?, CINEMRE H, TAMER A.. SEVERE HYPONATREMIA, EPISTAXIS, AND FLUOXETINE.. JOURNAL OF AYUB MEDICAL COLLEGE, ABBOTTABAD : JAM. 2016; 28(1):204-205. 2016;28(1):204-205",66.0,YR,E,F,Y,,,20160826.0,,MD,TR,TR,2016,Q3,Elderly
126929862,12692986,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2016,Q3,Epistaxis,,2016,Q3,2,F,,20160830.0,20160829,20160913,EXP,,TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-122852,RANBAXY,,66.0,YR,,F,Y,,,20160913.0,,OT,GB,TR,2016,Q3,Elderly
126929862,12692986,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2016,Q3,Hyponatraemia,,2016,Q3,2,F,,20160830.0,20160829,20160913,EXP,,TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-122852,RANBAXY,,66.0,YR,,F,Y,,,20160913.0,,OT,GB,TR,2016,Q3,Elderly
126959191,12695919,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"300 IU/ML, UNK",,,,U,,,,,,,,2016,Q3,Oedema,,2016,Q3,1,I,,20160816.0,20160829,20160829,EXP,,US-ACTELION-A-NJ2016-140969,ACTELION,,76.0,YR,E,F,Y,,,20160829.0,,OT,US,US,2016,Q3,Elderly
126959191,12695919,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"300 IU/ML, UNK",,,,U,,,,,,,,2016,Q3,Pleurisy,,2016,Q3,1,I,,20160816.0,20160829,20160829,EXP,,US-ACTELION-A-NJ2016-140969,ACTELION,,76.0,YR,E,F,Y,,,20160829.0,,OT,US,US,2016,Q3,Elderly
126978421,12697842,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Rhabdomyolysis,,2016,Q3,1,I,20140502.0,,20160829,20160829,DIR,,,,,63.0,YR,,F,N,141.0,LBS,20160826.0,N,PH,US,,2016,Q3,Adult
126978421,12697842,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Therapy change,,2016,Q3,1,I,20140502.0,,20160829,20160829,DIR,,,,,63.0,YR,,F,N,141.0,LBS,20160826.0,N,PH,US,,2016,Q3,Adult
127016341,12701634,1,PS,"INSULIN GLARGINE, 100UNITS/ML",INSULIN GLARGINE,1,Subcutaneous,,,,Y,Y,,,,0.12,ML,,QD,2016,Q3,Fatigue,,2016,Q3,1,I,20160713.0,,20160830,20160830,DIR,,,,,46.0,YR,,M,N,284.0,LBS,20160829.0,N,PH,US,,2016,Q3,Adult
127016341,12701634,1,PS,"INSULIN GLARGINE, 100UNITS/ML",INSULIN GLARGINE,1,Subcutaneous,,,,Y,Y,,,,0.12,ML,,QD,2016,Q3,Paraesthesia,,2016,Q3,1,I,20160713.0,,20160830,20160830,DIR,,,,,46.0,YR,,M,N,284.0,LBS,20160829.0,N,PH,US,,2016,Q3,Adult
127016341,12701634,1,PS,"INSULIN GLARGINE, 100UNITS/ML",INSULIN GLARGINE,1,Subcutaneous,,,,Y,Y,,,,0.12,ML,,QD,2016,Q3,Sensory disturbance,,2016,Q3,1,I,20160713.0,,20160830,20160830,DIR,,,,,46.0,YR,,M,N,284.0,LBS,20160829.0,N,PH,US,,2016,Q3,Adult
127016341,12701634,1,PS,"INSULIN GLARGINE, 100UNITS/ML",INSULIN GLARGINE,1,Subcutaneous,,,,Y,Y,,,,0.12,ML,,QD,2016,Q3,Vision blurred,,2016,Q3,1,I,20160713.0,,20160830,20160830,DIR,,,,,46.0,YR,,M,N,284.0,LBS,20160829.0,N,PH,US,,2016,Q3,Adult
127054072,12705407,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2016,Q3,Acute myocardial infarction,,2016,Q3,2,F,201608.0,20160822.0,20160901,20160903,EXP,,CO-BAXTER-2016BAX044401,BAXTER,,76.0,YR,,M,Y,79.0,KG,20160903.0,,OT,CO,CO,2016,Q3,Elderly
127054072,12705407,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2016,Q3,Anophthalmos,,2016,Q3,2,F,201608.0,20160822.0,20160901,20160903,EXP,,CO-BAXTER-2016BAX044401,BAXTER,,76.0,YR,,M,Y,79.0,KG,20160903.0,,OT,CO,CO,2016,Q3,Elderly
127054072,12705407,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2016,Q3,General physical health deterioration,,2016,Q3,2,F,201608.0,20160822.0,20160901,20160903,EXP,,CO-BAXTER-2016BAX044401,BAXTER,,76.0,YR,,M,Y,79.0,KG,20160903.0,,OT,CO,CO,2016,Q3,Elderly
127054072,12705407,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2016,Q3,Limb injury,,2016,Q3,2,F,201608.0,20160822.0,20160901,20160903,EXP,,CO-BAXTER-2016BAX044401,BAXTER,,76.0,YR,,M,Y,79.0,KG,20160903.0,,OT,CO,CO,2016,Q3,Elderly
127059651,12705965,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Diabetic ketoacidosis,,2016,Q3,1,I,20160321.0,,20160831,20160831,DIR,,,,,76.0,YR,,M,N,90.0,KG,20160830.0,N,PH,US,,2016,Q3,Elderly
127059651,12705965,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Nausea,,2016,Q3,1,I,20160321.0,,20160831,20160831,DIR,,,,,76.0,YR,,M,N,90.0,KG,20160830.0,N,PH,US,,2016,Q3,Elderly
127059651,12705965,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Vomiting,,2016,Q3,1,I,20160321.0,,20160831,20160831,DIR,,,,,76.0,YR,,M,N,90.0,KG,20160830.0,N,PH,US,,2016,Q3,Elderly
127076061,12707606,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 U, QD",,,,,,,,46.0,DF,,QD,2016,Q3,Diabetes mellitus,,2016,Q3,1,I,20160816.0,20160823.0,20160901,20160901,EXP,,PHHO2016US012352,SANDOZ,,66.0,YR,,M,Y,97.78,KG,20160901.0,,OT,US,US,2016,Q3,Elderly
127076061,12707606,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 U, QD",,,,,,,,46.0,DF,,QD,2016,Q3,Hyperosmolar hyperglycaemic state,,2016,Q3,1,I,20160816.0,20160823.0,20160901,20160901,EXP,,PHHO2016US012352,SANDOZ,,66.0,YR,,M,Y,97.78,KG,20160901.0,,OT,US,US,2016,Q3,Elderly
127076061,12707606,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 U, QD",,,,,,,,46.0,DF,,QD,2016,Q3,Hypokalaemia,,2016,Q3,1,I,20160816.0,20160823.0,20160901,20160901,EXP,,PHHO2016US012352,SANDOZ,,66.0,YR,,M,Y,97.78,KG,20160901.0,,OT,US,US,2016,Q3,Elderly
127091791,12709179,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,23.0,IU,,QD,2016,Q3,Cardiovascular disorder,,2016,Q3,1,I,20160822.0,20160823.0,20160901,20160901,EXP,,CO-BAXTER-2016BAX044452,BAXTER,,63.0,YR,,F,Y,67.0,KG,20160901.0,,OT,CO,CO,2016,Q3,Adult
127098351,12709835,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Eczema,,2016,Q3,1,I,20160820.0,,20160902,20160902,DIR,,,FDA-CTU,,74.0,YR,,M,N,267.0,LBS,,N,,US,US,2016,Q3,Elderly
127105821,12710582,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 U, QD",,,Y,U,,,,10.0,DF,INJECTION,QD,2016,Q3,Oedema,,2016,Q3,1,I,20160417.0,20160826.0,20160902,20160902,EXP,,CN-NOVOPROD-508012,NOVO NORDISK,,67.0,YR,E,M,Y,,,20160902.0,,OT,CN,CN,2016,Q3,Elderly
127108521,12710852,5,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q3,Gastrointestinal tract mucosal pigmentation,,2016,Q3,1,I,,20160127.0,20160902,20160902,PER,,US-LUPIN PHARMACEUTICALS INC.-2016-00564,LUPIN,"SOHAIL U, ALMASHHRAWI A, RAHMAN R, ASHRAF L, COBERLY J, NGUYEN D, BECHTOLD M. MYSTERIOUS BLACK CRYSTALLINE PIGMENT IN THE DUODENUM.. AM-J-GASTROENTEROL. 2015;110(SUP1):S437.",72.0,YR,,F,Y,,,20160819.0,,MD,US,US,2016,Q3,Elderly
127133631,12713363,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Angina pectoris,Angina pectoris,2016,Q3,1,I,201602.0,20160513.0,20160902,20160902,PER,,US-ZYDUS-011163,ZYDUS PHARM,,66.0,YR,,M,Y,,,20160902.0,,CN,US,US,2016,Q3,Elderly
127133631,12713363,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Drug ineffective,Drug ineffective,2016,Q3,1,I,201602.0,20160513.0,20160902,20160902,PER,,US-ZYDUS-011163,ZYDUS PHARM,,66.0,YR,,M,Y,,,20160902.0,,CN,US,US,2016,Q3,Elderly
127133631,12713363,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Palpitations,Palpitations,2016,Q3,1,I,201602.0,20160513.0,20160902,20160902,PER,,US-ZYDUS-011163,ZYDUS PHARM,,66.0,YR,,M,Y,,,20160902.0,,CN,US,US,2016,Q3,Elderly
127164321,12716432,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,U,,,,,,FORMULATION UNKNOWN,,2016,Q3,Back pain,,2016,Q3,1,I,20160828.0,20160829.0,20160906,20160906,EXP,,US-ASTELLAS-2016US033600,ASTELLAS,,51.0,YR,,M,Y,,,20160906.0,,OT,US,US,2016,Q3,Adult
127164321,12716432,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,U,,,,,,FORMULATION UNKNOWN,,2016,Q3,Cervical vertebral fracture,,2016,Q3,1,I,20160828.0,20160829.0,20160906,20160906,EXP,,US-ASTELLAS-2016US033600,ASTELLAS,,51.0,YR,,M,Y,,,20160906.0,,OT,US,US,2016,Q3,Adult
127164321,12716432,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,U,,,,,,FORMULATION UNKNOWN,,2016,Q3,Ligament injury,,2016,Q3,1,I,20160828.0,20160829.0,20160906,20160906,EXP,,US-ASTELLAS-2016US033600,ASTELLAS,,51.0,YR,,M,Y,,,20160906.0,,OT,US,US,2016,Q3,Adult
127164321,12716432,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,U,,,,,,FORMULATION UNKNOWN,,2016,Q3,Malignant neoplasm progression,,2016,Q3,1,I,20160828.0,20160829.0,20160906,20160906,EXP,,US-ASTELLAS-2016US033600,ASTELLAS,,51.0,YR,,M,Y,,,20160906.0,,OT,US,US,2016,Q3,Adult
127164321,12716432,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,U,,,,,,FORMULATION UNKNOWN,,2016,Q3,Pathological fracture,,2016,Q3,1,I,20160828.0,20160829.0,20160906,20160906,EXP,,US-ASTELLAS-2016US033600,ASTELLAS,,51.0,YR,,M,Y,,,20160906.0,,OT,US,US,2016,Q3,Adult
127164321,12716432,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,U,,,,,,FORMULATION UNKNOWN,,2016,Q3,Road traffic accident,,2016,Q3,1,I,20160828.0,20160829.0,20160906,20160906,EXP,,US-ASTELLAS-2016US033600,ASTELLAS,,51.0,YR,,M,Y,,,20160906.0,,OT,US,US,2016,Q3,Adult
127164321,12716432,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,U,,,,,,FORMULATION UNKNOWN,,2016,Q3,Spinal pain,,2016,Q3,1,I,20160828.0,20160829.0,20160906,20160906,EXP,,US-ASTELLAS-2016US033600,ASTELLAS,,51.0,YR,,M,Y,,,20160906.0,,OT,US,US,2016,Q3,Adult
127185381,12718538,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2016,Q3,Pain,,2016,Q3,1,I,,20160830.0,20160906,20160906,EXP,,KR-ELI_LILLY_AND_COMPANY-KR201609000449,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20160906.0,,CN,KR,KR,2016,Q3,Adult
127185381,12718538,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2016,Q3,Pain in extremity,,2016,Q3,1,I,,20160830.0,20160906,20160906,EXP,,KR-ELI_LILLY_AND_COMPANY-KR201609000449,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20160906.0,,CN,KR,KR,2016,Q3,Adult
127185381,12718538,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2016,Q3,Tremor,,2016,Q3,1,I,,20160830.0,20160906,20160906,EXP,,KR-ELI_LILLY_AND_COMPANY-KR201609000449,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20160906.0,,CN,KR,KR,2016,Q3,Adult
127185381,12718538,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2016,Q3,Urinary tract infection,,2016,Q3,1,I,,20160830.0,20160906,20160906,EXP,,KR-ELI_LILLY_AND_COMPANY-KR201609000449,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20160906.0,,CN,KR,KR,2016,Q3,Adult
127195564,12719556,30,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, QD",,,U,U,,,,,,,,2016,Q3,Anaphylactic reaction,,2016,Q3,4,F,,20160912.0,20160907,20160923,EXP,,CA-APOTEX-2016AP011032,APOTEX,,70.0,YR,,F,Y,,,20160923.0,,CN,CA,CA,2016,Q3,Elderly
127195564,12719556,30,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, QD",,,U,U,,,,,,,,2016,Q3,Diarrhoea,,2016,Q3,4,F,,20160912.0,20160907,20160923,EXP,,CA-APOTEX-2016AP011032,APOTEX,,70.0,YR,,F,Y,,,20160923.0,,CN,CA,CA,2016,Q3,Elderly
127195564,12719556,30,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, QD",,,U,U,,,,,,,,2016,Q3,Drug intolerance,,2016,Q3,4,F,,20160912.0,20160907,20160923,EXP,,CA-APOTEX-2016AP011032,APOTEX,,70.0,YR,,F,Y,,,20160923.0,,CN,CA,CA,2016,Q3,Elderly
127195564,12719556,30,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, QD",,,U,U,,,,,,,,2016,Q3,Nerve block,,2016,Q3,4,F,,20160912.0,20160907,20160923,EXP,,CA-APOTEX-2016AP011032,APOTEX,,70.0,YR,,F,Y,,,20160923.0,,CN,CA,CA,2016,Q3,Elderly
127226061,12722606,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2016,Q3,Renal colic,,2016,Q3,1,I,20160809.0,20160830.0,20160907,20160907,EXP,,PHHY2016FR119387,NOVARTIS,,36.0,YR,,M,Y,,,20160907.0,,OT,FR,FR,2016,Q3,Adult
127236681,12723668,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Fluid overload,,2016,Q3,1,I,20160711.0,,20160906,20160906,DIR,,,FDA-CTU,,55.0,YR,,F,N,97.7,KG,20160906.0,Y,CN,US,US,2016,Q3,Adult
127236681,12723668,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Hepatic enzyme increased,,2016,Q3,1,I,20160711.0,,20160906,20160906,DIR,,,FDA-CTU,,55.0,YR,,F,N,97.7,KG,20160906.0,Y,CN,US,US,2016,Q3,Adult
127236681,12723668,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Hyperkalaemia,,2016,Q3,1,I,20160711.0,,20160906,20160906,DIR,,,FDA-CTU,,55.0,YR,,F,N,97.7,KG,20160906.0,Y,CN,US,US,2016,Q3,Adult
127236681,12723668,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Hypoglycaemia,,2016,Q3,1,I,20160711.0,,20160906,20160906,DIR,,,FDA-CTU,,55.0,YR,,F,N,97.7,KG,20160906.0,Y,CN,US,US,2016,Q3,Adult
127253831,12725383,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2016,Q3,Ascites,,2016,Q3,1,I,,20160824.0,20160908,20160908,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-CA-2016VAL002575,VALIDUS,"REIMCHE R., SALCEDO D.,. CANADIAN PALLIATIVE COMMUNITY MILRINONE INFUSIONS: A CASE SERIES. CAN J CARDIOVASC NURS. 2016;26(1):9-13",73.0,YR,,M,Y,,,20160908.0,,OT,CA,CA,2016,Q3,Elderly
127253831,12725383,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2016,Q3,Blood creatinine increased,,2016,Q3,1,I,,20160824.0,20160908,20160908,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-CA-2016VAL002575,VALIDUS,"REIMCHE R., SALCEDO D.,. CANADIAN PALLIATIVE COMMUNITY MILRINONE INFUSIONS: A CASE SERIES. CAN J CARDIOVASC NURS. 2016;26(1):9-13",73.0,YR,,M,Y,,,20160908.0,,OT,CA,CA,2016,Q3,Elderly
127253831,12725383,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2016,Q3,Drug ineffective,,2016,Q3,1,I,,20160824.0,20160908,20160908,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-CA-2016VAL002575,VALIDUS,"REIMCHE R., SALCEDO D.,. CANADIAN PALLIATIVE COMMUNITY MILRINONE INFUSIONS: A CASE SERIES. CAN J CARDIOVASC NURS. 2016;26(1):9-13",73.0,YR,,M,Y,,,20160908.0,,OT,CA,CA,2016,Q3,Elderly
127253831,12725383,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2016,Q3,Dyspnoea,,2016,Q3,1,I,,20160824.0,20160908,20160908,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-CA-2016VAL002575,VALIDUS,"REIMCHE R., SALCEDO D.,. CANADIAN PALLIATIVE COMMUNITY MILRINONE INFUSIONS: A CASE SERIES. CAN J CARDIOVASC NURS. 2016;26(1):9-13",73.0,YR,,M,Y,,,20160908.0,,OT,CA,CA,2016,Q3,Elderly
127253831,12725383,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2016,Q3,Weight increased,,2016,Q3,1,I,,20160824.0,20160908,20160908,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-CA-2016VAL002575,VALIDUS,"REIMCHE R., SALCEDO D.,. CANADIAN PALLIATIVE COMMUNITY MILRINONE INFUSIONS: A CASE SERIES. CAN J CARDIOVASC NURS. 2016;26(1):9-13",73.0,YR,,M,Y,,,20160908.0,,OT,CA,CA,2016,Q3,Elderly
127253831,12725383,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2016,Q3,Wheezing,,2016,Q3,1,I,,20160824.0,20160908,20160908,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-CA-2016VAL002575,VALIDUS,"REIMCHE R., SALCEDO D.,. CANADIAN PALLIATIVE COMMUNITY MILRINONE INFUSIONS: A CASE SERIES. CAN J CARDIOVASC NURS. 2016;26(1):9-13",73.0,YR,,M,Y,,,20160908.0,,OT,CA,CA,2016,Q3,Elderly
127275181,12727518,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,20.0,IU,INJECTION,,2016,Q3,Diabetic ketoacidosis,,2016,Q3,1,I,,20160831.0,20160909,20160909,EXP,,PK-BAUSCH-BL-2016-021856,BAUSCH AND LOMB,"RASHID O, FAROOQ S, KIRAN Z, ISLAM N. EUGLYCAEMIC DIABETIC KETOACIDOSIS IN A PATIENT WITH TYPE 2 DIABETES STARTED ON EMPAGLIFLOZIN. BMJ CASE REPORTS. 2016;.",42.0,YR,,M,Y,,,20160909.0,,MD,PK,PK,2016,Q3,Adult
127275181,12727518,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,40.0,IU,INJECTION,,2016,Q3,Diabetic ketoacidosis,,2016,Q3,1,I,,20160831.0,20160909,20160909,EXP,,PK-BAUSCH-BL-2016-021856,BAUSCH AND LOMB,"RASHID O, FAROOQ S, KIRAN Z, ISLAM N. EUGLYCAEMIC DIABETIC KETOACIDOSIS IN A PATIENT WITH TYPE 2 DIABETES STARTED ON EMPAGLIFLOZIN. BMJ CASE REPORTS. 2016;.",42.0,YR,,M,Y,,,20160909.0,,MD,PK,PK,2016,Q3,Adult
127288661,12728866,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,,,,,,,,,28.0,IU,UNSPECIFIED,QD,2016,Q3,Contusion,,2016,Q3,1,I,20160307.0,20160829.0,20160909,20160909,EXP,,JP-JNJFOC-20160908299,JANSSEN,,61.0,YR,A,M,Y,76.0,KG,20160909.0,,OT,JP,JP,2016,Q3,Adult
127288661,12728866,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,,,,,,,,,14.0,IU,UNSPECIFIED,QD,2016,Q3,Contusion,,2016,Q3,1,I,20160307.0,20160829.0,20160909,20160909,EXP,,JP-JNJFOC-20160908299,JANSSEN,,61.0,YR,A,M,Y,76.0,KG,20160909.0,,OT,JP,JP,2016,Q3,Adult
127289951,12728995,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 U,,,,,,,,30.0,IU,,QD,2016,Q3,Coagulopathy,,2016,Q3,1,I,,20160902.0,20160909,20160909,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-58061BI",BOEHRINGER INGELHEIM,"MARINO K,SANTIAGO R,DEW R,BERLINER N,CONNORS J,CONNELL N,ET AL. MANAGEMENT OF DABIGATRAN-ASSOCIATED BLEEDING WITH TWO DOSES OF IDARUCIZUMAB PLUS HEMODIALYSIS. PHARMACOTHERAPY 2016;.",58.0,YR,,F,Y,163.0,KG,20160909.0,,OT,COUNTRY NOT SPECIFIED,US,2016,Q3,Adult
127289951,12728995,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 U,,,,,,,,30.0,IU,,QD,2016,Q3,Diabetic nephropathy,,2016,Q3,1,I,,20160902.0,20160909,20160909,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-58061BI",BOEHRINGER INGELHEIM,"MARINO K,SANTIAGO R,DEW R,BERLINER N,CONNORS J,CONNELL N,ET AL. MANAGEMENT OF DABIGATRAN-ASSOCIATED BLEEDING WITH TWO DOSES OF IDARUCIZUMAB PLUS HEMODIALYSIS. PHARMACOTHERAPY 2016;.",58.0,YR,,F,Y,163.0,KG,20160909.0,,OT,COUNTRY NOT SPECIFIED,US,2016,Q3,Adult
127289951,12728995,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 U,,,,,,,,30.0,IU,,QD,2016,Q3,End stage renal disease,,2016,Q3,1,I,,20160902.0,20160909,20160909,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-58061BI",BOEHRINGER INGELHEIM,"MARINO K,SANTIAGO R,DEW R,BERLINER N,CONNORS J,CONNELL N,ET AL. MANAGEMENT OF DABIGATRAN-ASSOCIATED BLEEDING WITH TWO DOSES OF IDARUCIZUMAB PLUS HEMODIALYSIS. PHARMACOTHERAPY 2016;.",58.0,YR,,F,Y,163.0,KG,20160909.0,,OT,COUNTRY NOT SPECIFIED,US,2016,Q3,Adult
127289951,12728995,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 U,,,,,,,,30.0,IU,,QD,2016,Q3,Renal tubular necrosis,,2016,Q3,1,I,,20160902.0,20160909,20160909,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-58061BI",BOEHRINGER INGELHEIM,"MARINO K,SANTIAGO R,DEW R,BERLINER N,CONNORS J,CONNELL N,ET AL. MANAGEMENT OF DABIGATRAN-ASSOCIATED BLEEDING WITH TWO DOSES OF IDARUCIZUMAB PLUS HEMODIALYSIS. PHARMACOTHERAPY 2016;.",58.0,YR,,F,Y,163.0,KG,20160909.0,,OT,COUNTRY NOT SPECIFIED,US,2016,Q3,Adult
127295501,12729550,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2016,Q3,Off label use,,2016,Q3,1,I,,20160906.0,20160909,20160909,EXP,,IT-JNJFOC-20160905655,JANSSEN,"DRAGO F, GASPARINI G, MARENCO S, PICCIOTTO A, PARODI A. PORPHYRIN ELEVATION IN A PATIENT ON TREATMENT WITH SIMEPREVIR: COULD IT BE A POSSIBLEEXPLANATION FOR SIMEPREVIR-ASSOCIATED PHOTOSENSITIVITY?. AMERICAN JOURNAL OF GASTROENTEROLOGY 2016;111 (9):1368.",61.0,YR,A,M,Y,,,20160909.0,,MD,IT,IT,2016,Q3,Adult
127295501,12729550,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2016,Q3,Porphyria non-acute,,2016,Q3,1,I,,20160906.0,20160909,20160909,EXP,,IT-JNJFOC-20160905655,JANSSEN,"DRAGO F, GASPARINI G, MARENCO S, PICCIOTTO A, PARODI A. PORPHYRIN ELEVATION IN A PATIENT ON TREATMENT WITH SIMEPREVIR: COULD IT BE A POSSIBLEEXPLANATION FOR SIMEPREVIR-ASSOCIATED PHOTOSENSITIVITY?. AMERICAN JOURNAL OF GASTROENTEROLOGY 2016;111 (9):1368.",61.0,YR,A,M,Y,,,20160909.0,,MD,IT,IT,2016,Q3,Adult
127295501,12729550,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2016,Q3,Product use issue,,2016,Q3,1,I,,20160906.0,20160909,20160909,EXP,,IT-JNJFOC-20160905655,JANSSEN,"DRAGO F, GASPARINI G, MARENCO S, PICCIOTTO A, PARODI A. PORPHYRIN ELEVATION IN A PATIENT ON TREATMENT WITH SIMEPREVIR: COULD IT BE A POSSIBLEEXPLANATION FOR SIMEPREVIR-ASSOCIATED PHOTOSENSITIVITY?. AMERICAN JOURNAL OF GASTROENTEROLOGY 2016;111 (9):1368.",61.0,YR,A,M,Y,,,20160909.0,,MD,IT,IT,2016,Q3,Adult
127337391,12733739,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2016,Q3,Gastrointestinal haemorrhage,,2016,Q3,1,I,20150816.0,20160714.0,20160912,20160912,PER,,US-JNJFOC-20160712866,JANSSEN,,70.0,YR,E,F,Y,74.3,KG,20160912.0,,MD,US,US,2016,Q3,Elderly
127337391,12733739,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2016,Q3,Gastrointestinal haemorrhage,,2016,Q3,1,I,20150816.0,20160714.0,20160912,20160912,PER,,US-JNJFOC-20160712866,JANSSEN,,70.0,YR,E,F,Y,74.3,KG,20160912.0,,MD,US,US,2016,Q3,Elderly
127377702,12737770,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,UNSPECIFIED,,2016,Q3,Diabetic ketoacidosis,,2016,Q3,2,F,20160907.0,20160920.0,20160913,20160923,EXP,,CA-JNJFOC-20160909177,JANSSEN,,75.0,YR,E,F,Y,64.7,KG,20160923.0,,MD,CA,CA,2016,Q3,Elderly
127381781,12738178,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,10.0,IU,UNSPECIFIED,,2016,Q3,Sudden death,,2016,Q3,1,I,,20160907.0,20160913,20160913,EXP,,US-JNJFOC-20160910461,JANSSEN,"WAHIDI N, JOHNSON KM, BRENZEL A, LEON JD. TWO SUDDEN AND UNEXPECTED DEATHS OF PATIENTS WITH SCHIZOPHRENIA ASSOCIATED WITH INTRAMUSCULAR INJECTIONS OF ANTIPSYCHOTICS AND PRACTICE GUIDELINES TO LIMIT THE USE  OF HIGH DOSES OF INTRAMUSCULAR ANTIPSYCHOTICS. CASE REPORTS IN PSYCHIATRY 2016.",42.0,YR,A,F,Y,131.54,KG,20160913.0,,OT,US,US,2016,Q3,Adult
127381781,12738178,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,10.0,IU,UNSPECIFIED,,2016,Q3,Torsade de pointes,,2016,Q3,1,I,,20160907.0,20160913,20160913,EXP,,US-JNJFOC-20160910461,JANSSEN,"WAHIDI N, JOHNSON KM, BRENZEL A, LEON JD. TWO SUDDEN AND UNEXPECTED DEATHS OF PATIENTS WITH SCHIZOPHRENIA ASSOCIATED WITH INTRAMUSCULAR INJECTIONS OF ANTIPSYCHOTICS AND PRACTICE GUIDELINES TO LIMIT THE USE  OF HIGH DOSES OF INTRAMUSCULAR ANTIPSYCHOTICS. CASE REPORTS IN PSYCHIATRY 2016.",42.0,YR,A,F,Y,131.54,KG,20160913.0,,OT,US,US,2016,Q3,Adult
127414991,12741499,1,PS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,U,,,205692.0,,,,,2016,Q3,Liver disorder,,2016,Q3,1,I,,20160727.0,20160914,20160914,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201607012292,ELI LILLY AND CO,,40.0,YR,,,Y,,,20160914.0,,CN,JP,JP,2016,Q3,Adult
127456431,12745643,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"650 MG, Q4H",,,,, UNKNOWN,,,650.0,MG,,,2016,Q3,Chest pain,,2016,Q3,1,I,20130811.0,20160912.0,20160915,20160915,EXP,,US-PURDUE PHARMA-USA-2016-0133530,PURDUE,,68.0,YR,,M,Y,135.0,KG,20160914.0,,MD,US,US,2016,Q3,Elderly
127456431,12745643,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"650 MG, Q4H",,,,, UNKNOWN,,,650.0,MG,,,2016,Q3,Hypotension,,2016,Q3,1,I,20130811.0,20160912.0,20160915,20160915,EXP,,US-PURDUE PHARMA-USA-2016-0133530,PURDUE,,68.0,YR,,M,Y,135.0,KG,20160914.0,,MD,US,US,2016,Q3,Elderly
127459891,12745989,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Cardiac failure congestive,,2016,Q3,1,I,20160623.0,,20160906,20160906,DIR,,,FDA-CTU,,55.0,YR,,F,N,97.7,KG,20160906.0,Y,CN,US,US,2016,Q3,Adult
127459891,12745989,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Cholelithiasis,,2016,Q3,1,I,20160623.0,,20160906,20160906,DIR,,,FDA-CTU,,55.0,YR,,F,N,97.7,KG,20160906.0,Y,CN,US,US,2016,Q3,Adult
127459891,12745989,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Coronary artery disease,,2016,Q3,1,I,20160623.0,,20160906,20160906,DIR,,,FDA-CTU,,55.0,YR,,F,N,97.7,KG,20160906.0,Y,CN,US,US,2016,Q3,Adult
127459891,12745989,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Hyperkalaemia,,2016,Q3,1,I,20160623.0,,20160906,20160906,DIR,,,FDA-CTU,,55.0,YR,,F,N,97.7,KG,20160906.0,Y,CN,US,US,2016,Q3,Adult
127459891,12745989,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Hypotension,,2016,Q3,1,I,20160623.0,,20160906,20160906,DIR,,,FDA-CTU,,55.0,YR,,F,N,97.7,KG,20160906.0,Y,CN,US,US,2016,Q3,Adult
127459891,12745989,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Peptic ulcer,,2016,Q3,1,I,20160623.0,,20160906,20160906,DIR,,,FDA-CTU,,55.0,YR,,F,N,97.7,KG,20160906.0,Y,CN,US,US,2016,Q3,Adult
127459891,12745989,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Therapy cessation,,2016,Q3,1,I,20160623.0,,20160906,20160906,DIR,,,FDA-CTU,,55.0,YR,,F,N,97.7,KG,20160906.0,Y,CN,US,US,2016,Q3,Adult
127459891,12745989,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Tooth abscess,,2016,Q3,1,I,20160623.0,,20160906,20160906,DIR,,,FDA-CTU,,55.0,YR,,F,N,97.7,KG,20160906.0,Y,CN,US,US,2016,Q3,Adult
127459891,12745989,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Ultrasound scan abnormal,,2016,Q3,1,I,20160623.0,,20160906,20160906,DIR,,,FDA-CTU,,55.0,YR,,F,N,97.7,KG,20160906.0,Y,CN,US,US,2016,Q3,Adult
127459891,12745989,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Vertigo,,2016,Q3,1,I,20160623.0,,20160906,20160906,DIR,,,FDA-CTU,,55.0,YR,,F,N,97.7,KG,20160906.0,Y,CN,US,US,2016,Q3,Adult
127477401,12747740,5,C,Insulin glargine,INSULIN GLARGINE,1,,,,,Y,,,,,40.0,IU,INJECTION,,2016,Q3,Diabetic ketoacidosis,,2016,Q3,1,I,,20160831.0,20160915,20160915,EXP,,PK-IPCA LABORATORIES LIMITED-E2B_00000031,IPCA,"RASHID O,FAROOQ S,KIRAN Z,ISLAM N. EUGLYCAEMIC DIABETIC KETOACIDOSIS IN A PATIENT WITH TYPE 2 DIABETES STARTED ON EMPAGLI?OZIN. BMJ CASE REP 2016;2016:1-3.",42.0,YR,,M,Y,,,20160915.0,,MD,PK,PK,2016,Q3,Adult
127477401,12747740,6,C,Insulin glargine,INSULIN GLARGINE,1,,,,,Y,,,,,20.0,IU,,,2016,Q3,Diabetic ketoacidosis,,2016,Q3,1,I,,20160831.0,20160915,20160915,EXP,,PK-IPCA LABORATORIES LIMITED-E2B_00000031,IPCA,"RASHID O,FAROOQ S,KIRAN Z,ISLAM N. EUGLYCAEMIC DIABETIC KETOACIDOSIS IN A PATIENT WITH TYPE 2 DIABETES STARTED ON EMPAGLI?OZIN. BMJ CASE REP 2016;2016:1-3.",42.0,YR,,M,Y,,,20160915.0,,MD,PK,PK,2016,Q3,Adult
127501051,12750105,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Vitrectomy,,2016,Q3,1,I,20160910.0,20160913.0,20160915,20160915,EXP,,CO-ABBVIE-16P-036-1728192-00,ABBVIE,,42.0,YR,,M,Y,63.0,KG,20160915.0,,CN,COUNTRY NOT SPECIFIED,CO,2016,Q3,Adult
127524701,12752470,5,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,50.0,IU,,QD,2016,Q3,Acute myocardial infarction,,2016,Q3,1,I,20160828.0,20160906.0,20160916,20160916,EXP,,CO-BAXTER-2016BAX046570,BAXTER,,69.0,YR,,M,Y,75.0,KG,20160915.0,,OT,CO,CO,2016,Q3,Elderly
127524701,12752470,5,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,50.0,IU,,QD,2016,Q3,Encephalopathy,,2016,Q3,1,I,20160828.0,20160906.0,20160916,20160916,EXP,,CO-BAXTER-2016BAX046570,BAXTER,,69.0,YR,,M,Y,75.0,KG,20160915.0,,OT,CO,CO,2016,Q3,Elderly
127524701,12752470,5,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,50.0,IU,,QD,2016,Q3,Pneumonia,,2016,Q3,1,I,20160828.0,20160906.0,20160916,20160916,EXP,,CO-BAXTER-2016BAX046570,BAXTER,,69.0,YR,,M,Y,75.0,KG,20160915.0,,OT,CO,CO,2016,Q3,Elderly
127549011,12754901,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 DF, QD",,,,,,,,12.0,DF,,QD,2016,Q3,Blood creatine phosphokinase increased,,2016,Q3,1,I,20101029.0,20110825.0,20160916,20160916,EXP,,CN-OTSUKA-JP-2011-11406,OTSUKA,,49.0,YR,,M,Y,,,20160916.0,,MD,CN,CN,2016,Q3,Adult
127549011,12754901,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 DF, QD",,,,,,,,12.0,DF,,QD,2016,Q3,Hypoglycaemia,,2016,Q3,1,I,20101029.0,20110825.0,20160916,20160916,EXP,,CN-OTSUKA-JP-2011-11406,OTSUKA,,49.0,YR,,M,Y,,,20160916.0,,MD,CN,CN,2016,Q3,Adult
127563111,12756311,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Abdominal pain,,2016,Q3,1,I,2016.0,20160906.0,20160916,20160916,EXP,,US-009507513-1609USA003295,MERCK,,55.0,YR,,F,Y,97.7,KG,20160916.0,,CN,US,US,2016,Q3,Adult
127563111,12756311,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Blood pressure decreased,,2016,Q3,1,I,2016.0,20160906.0,20160916,20160916,EXP,,US-009507513-1609USA003295,MERCK,,55.0,YR,,F,Y,97.7,KG,20160916.0,,CN,US,US,2016,Q3,Adult
127563111,12756311,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Cardiac failure congestive,,2016,Q3,1,I,2016.0,20160906.0,20160916,20160916,EXP,,US-009507513-1609USA003295,MERCK,,55.0,YR,,F,Y,97.7,KG,20160916.0,,CN,US,US,2016,Q3,Adult
127563111,12756311,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Cholelithiasis,,2016,Q3,1,I,2016.0,20160906.0,20160916,20160916,EXP,,US-009507513-1609USA003295,MERCK,,55.0,YR,,F,Y,97.7,KG,20160916.0,,CN,US,US,2016,Q3,Adult
127563111,12756311,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Constipation,,2016,Q3,1,I,2016.0,20160906.0,20160916,20160916,EXP,,US-009507513-1609USA003295,MERCK,,55.0,YR,,F,Y,97.7,KG,20160916.0,,CN,US,US,2016,Q3,Adult
127563111,12756311,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Coronary artery disease,,2016,Q3,1,I,2016.0,20160906.0,20160916,20160916,EXP,,US-009507513-1609USA003295,MERCK,,55.0,YR,,F,Y,97.7,KG,20160916.0,,CN,US,US,2016,Q3,Adult
127563111,12756311,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Diarrhoea,,2016,Q3,1,I,2016.0,20160906.0,20160916,20160916,EXP,,US-009507513-1609USA003295,MERCK,,55.0,YR,,F,Y,97.7,KG,20160916.0,,CN,US,US,2016,Q3,Adult
127563111,12756311,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Fluid overload,,2016,Q3,1,I,2016.0,20160906.0,20160916,20160916,EXP,,US-009507513-1609USA003295,MERCK,,55.0,YR,,F,Y,97.7,KG,20160916.0,,CN,US,US,2016,Q3,Adult
127563111,12756311,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Hepatic cirrhosis,,2016,Q3,1,I,2016.0,20160906.0,20160916,20160916,EXP,,US-009507513-1609USA003295,MERCK,,55.0,YR,,F,Y,97.7,KG,20160916.0,,CN,US,US,2016,Q3,Adult
127563111,12756311,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Hepatic steatosis,,2016,Q3,1,I,2016.0,20160906.0,20160916,20160916,EXP,,US-009507513-1609USA003295,MERCK,,55.0,YR,,F,Y,97.7,KG,20160916.0,,CN,US,US,2016,Q3,Adult
127563111,12756311,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Hyperkalaemia,,2016,Q3,1,I,2016.0,20160906.0,20160916,20160916,EXP,,US-009507513-1609USA003295,MERCK,,55.0,YR,,F,Y,97.7,KG,20160916.0,,CN,US,US,2016,Q3,Adult
127563111,12756311,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Hypoalbuminaemia,,2016,Q3,1,I,2016.0,20160906.0,20160916,20160916,EXP,,US-009507513-1609USA003295,MERCK,,55.0,YR,,F,Y,97.7,KG,20160916.0,,CN,US,US,2016,Q3,Adult
127563111,12756311,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Hypoglycaemia,,2016,Q3,1,I,2016.0,20160906.0,20160916,20160916,EXP,,US-009507513-1609USA003295,MERCK,,55.0,YR,,F,Y,97.7,KG,20160916.0,,CN,US,US,2016,Q3,Adult
127563111,12756311,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Ileus,,2016,Q3,1,I,2016.0,20160906.0,20160916,20160916,EXP,,US-009507513-1609USA003295,MERCK,,55.0,YR,,F,Y,97.7,KG,20160916.0,,CN,US,US,2016,Q3,Adult
127563111,12756311,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Liver function test increased,,2016,Q3,1,I,2016.0,20160906.0,20160916,20160916,EXP,,US-009507513-1609USA003295,MERCK,,55.0,YR,,F,Y,97.7,KG,20160916.0,,CN,US,US,2016,Q3,Adult
127563111,12756311,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Lymphadenopathy,,2016,Q3,1,I,2016.0,20160906.0,20160916,20160916,EXP,,US-009507513-1609USA003295,MERCK,,55.0,YR,,F,Y,97.7,KG,20160916.0,,CN,US,US,2016,Q3,Adult
127563111,12756311,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Peptic ulcer,,2016,Q3,1,I,2016.0,20160906.0,20160916,20160916,EXP,,US-009507513-1609USA003295,MERCK,,55.0,YR,,F,Y,97.7,KG,20160916.0,,CN,US,US,2016,Q3,Adult
127563111,12756311,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Splenomegaly,,2016,Q3,1,I,2016.0,20160906.0,20160916,20160916,EXP,,US-009507513-1609USA003295,MERCK,,55.0,YR,,F,Y,97.7,KG,20160916.0,,CN,US,US,2016,Q3,Adult
127563111,12756311,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Tooth abscess,,2016,Q3,1,I,2016.0,20160906.0,20160916,20160916,EXP,,US-009507513-1609USA003295,MERCK,,55.0,YR,,F,Y,97.7,KG,20160916.0,,CN,US,US,2016,Q3,Adult
127563111,12756311,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Uterine leiomyoma,,2016,Q3,1,I,2016.0,20160906.0,20160916,20160916,EXP,,US-009507513-1609USA003295,MERCK,,55.0,YR,,F,Y,97.7,KG,20160916.0,,CN,US,US,2016,Q3,Adult
127563111,12756311,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Vertigo,,2016,Q3,1,I,2016.0,20160906.0,20160916,20160916,EXP,,US-009507513-1609USA003295,MERCK,,55.0,YR,,F,Y,97.7,KG,20160916.0,,CN,US,US,2016,Q3,Adult
127576841,12757684,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"HE HAD, FOR 6 YEARS, BEEN TAKING INJECTION GLARGINE",,,Y,,,,,40.0,IU,INJECTION,,2016,Q3,Diabetic ketoacidosis,,2016,Q3,1,I,,20160516.0,20160919,20160919,EXP,PK-MLMSERVICE-20160901-0311838-1,PK-INDICUS PHARMA-000450,INDICUS,"RASHID O, FAROOQ S, KIRAN Z, ISLAM N. EUGLYCAEMIC DIABETIC KETOACIDOSIS IN A PATIENT WITH TYPE 2 DIABETES STARTED ON EMPAGLIFLOZIN. BMJ CASE REPORTS, ARTICLE NUMBER 215340; 2016.",42.0,YR,,M,Y,,,20160919.0,,MD,PK,PK,2016,Q3,Adult
127577201,12757720,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"HE HAD, FOR 6 YEARS, BEEN TAKING INJECTION GLARGINE",,,,,,,,40.0,IU,INJECTION,,2016,Q3,Diabetic ketoacidosis,,2016,Q3,1,I,,20160516.0,20160919,20160919,EXP,PK-MLMSERVICE-20160901-0311838-1,PK-INVENTIA-000138,INVENTIA HEALTHCARE,"RASHID O, FAROOQ S, KIRAN Z, ISLAM N. EUGLYCAEMIC DIABETIC KETOACIDOSIS IN A PATIENT WITH TYPE 2 DIABETES STARTED ON EMPAGLIFLOZIN. BMJ CASE REPORTS, ARTICLE NUMBER 215340; 2016.",42.0,YR,,M,Y,,,20160919.0,,MD,PK,PK,2016,Q3,Adult
127590731,12759073,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"10 UNITS, DAILY",,,,,,,,10.0,IU,,,2016,Q3,Torsade de pointes,,2016,Q3,1,I,,20160912.0,20160919,20160919,EXP,,US-PFIZER INC-2016429576,PFIZER,"WAHIDI, N.. TWO SUDDEN AND UNEXPECTED DEATHS OF PATIENTS WITH SCHIZOPHRENIA ASSOCIATED WITH INTRAMUSCULAR INJECTIONS OF ANTIPSYCHOTICS AND PRACTICE GUIDELINES TO LIMIT THE USE OF HIGH DOSES OF INTRAMUSCULAR ANTIPSYCHOTICS. CASE REPORTS PSYCHIATRY. 2016;2016:10.1155/2016/9406813",42.0,YR,,F,Y,131.5,KG,20160919.0,,OT,US,US,2016,Q3,Adult
127609151,12760915,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 IU,,,Y,,,,,,,INJECTION,,2016,Q3,Diabetic ketoacidosis,,2016,Q3,1,I,,20160906.0,20160919,20160919,EXP,PK-MLMSERVICE-20160901-0311838-1,PK-ALKEM LABORATORIES LIMITED-PK-ALKEM-2016-00184,ALKEM,,42.0,YR,,M,Y,,,20160919.0,,MD,PK,PK,2016,Q3,Adult
127609151,12760915,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,20 IU,,,Y,,,,,,,INJECTION,,2016,Q3,Diabetic ketoacidosis,,2016,Q3,1,I,,20160906.0,20160919,20160919,EXP,PK-MLMSERVICE-20160901-0311838-1,PK-ALKEM LABORATORIES LIMITED-PK-ALKEM-2016-00184,ALKEM,,42.0,YR,,M,Y,,,20160919.0,,MD,PK,PK,2016,Q3,Adult
127619641,12761964,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE:20 UNIT(S),,,D,, UNKNOWN,,21081.0,,,,QD,2016,Q3,Intentional overdose,,2016,Q3,1,I,20150813.0,20160915.0,20160920,20160920,EXP,,AU-SA-2016SA171252,AVENTIS,,60.0,YR,A,M,Y,51.0,KG,20160920.0,,OT,AU,AU,2016,Q3,Adult
127634671,12763467,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"60 U, QD",,,U,,,,,60.0,IU,,QD,2016,Q3,Diabetes mellitus inadequate control,,2016,Q3,1,I,20160829.0,20160912.0,20160920,20160920,PER,,US-ELI_LILLY_AND_COMPANY-US201609004988,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20160920.0,,CN,US,US,2016,Q3,Adult
127642481,12764248,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q3,Nausea,,2016,Q3,1,I,20160217.0,20160509.0,20160920,20160920,PER,,US-PFIZER INC-3287667,PFIZER,,59.0,YR,,F,Y,95.0,KG,20160920.0,,OT,US,US,2016,Q3,Adult
127643831,12764383,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2016,Q3,Blindness,,2016,Q3,1,I,2012.0,20160913.0,20160920,20160920,EXP,,BR-ELI_LILLY_AND_COMPANY-BR201609004813,ELI LILLY AND CO,,52.0,YR,,F,Y,94.0,KG,20160919.0,,CN,BR,BR,2016,Q3,Adult
127643831,12764383,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2016,Q3,Blood glucose decreased,,2016,Q3,1,I,2012.0,20160913.0,20160920,20160920,EXP,,BR-ELI_LILLY_AND_COMPANY-BR201609004813,ELI LILLY AND CO,,52.0,YR,,F,Y,94.0,KG,20160919.0,,CN,BR,BR,2016,Q3,Adult
127643831,12764383,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2016,Q3,Blood glucose increased,,2016,Q3,1,I,2012.0,20160913.0,20160920,20160920,EXP,,BR-ELI_LILLY_AND_COMPANY-BR201609004813,ELI LILLY AND CO,,52.0,YR,,F,Y,94.0,KG,20160919.0,,CN,BR,BR,2016,Q3,Adult
127643831,12764383,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2016,Q3,Diabetic metabolic decompensation,,2016,Q3,1,I,2012.0,20160913.0,20160920,20160920,EXP,,BR-ELI_LILLY_AND_COMPANY-BR201609004813,ELI LILLY AND CO,,52.0,YR,,F,Y,94.0,KG,20160919.0,,CN,BR,BR,2016,Q3,Adult
127643831,12764383,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2016,Q3,Drug ineffective,,2016,Q3,1,I,2012.0,20160913.0,20160920,20160920,EXP,,BR-ELI_LILLY_AND_COMPANY-BR201609004813,ELI LILLY AND CO,,52.0,YR,,F,Y,94.0,KG,20160919.0,,CN,BR,BR,2016,Q3,Adult
127643831,12764383,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2016,Q3,Incorrect product storage,,2016,Q3,1,I,2012.0,20160913.0,20160920,20160920,EXP,,BR-ELI_LILLY_AND_COMPANY-BR201609004813,ELI LILLY AND CO,,52.0,YR,,F,Y,94.0,KG,20160919.0,,CN,BR,BR,2016,Q3,Adult
127643831,12764383,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2016,Q3,Weight decreased,,2016,Q3,1,I,2012.0,20160913.0,20160920,20160920,EXP,,BR-ELI_LILLY_AND_COMPANY-BR201609004813,ELI LILLY AND CO,,52.0,YR,,F,Y,94.0,KG,20160919.0,,CN,BR,BR,2016,Q3,Adult
127729701,12772970,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,3900 MILLIGRAM DAILY;,,,,,,,,650.0,MG,,Q4H,2016,Q3,Chest pain,,2016,Q3,1,I,20160811.0,20160912.0,20160922,20160922,EXP,,US-TEVA-694873USA,TEVA,,68.0,YR,,M,Y,135.16,KG,20160923.0,,MD,US,US,2016,Q3,Elderly
127729701,12772970,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,3900 MILLIGRAM DAILY;,,,,,,,,650.0,MG,,Q4H,2016,Q3,Hypotension,,2016,Q3,1,I,20160811.0,20160912.0,20160922,20160922,EXP,,US-TEVA-694873USA,TEVA,,68.0,YR,,M,Y,135.16,KG,20160923.0,,MD,US,US,2016,Q3,Elderly
127736591,12773659,3,SS,Glargine insulin,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,,2016,Q3,Generalised oedema,,2016,Q3,1,I,20160819.0,20160819.0,20160923,20160923,EXP,,CO-BAXTER-2016BAX043964,BAXTER,,69.0,YR,,F,Y,55.4,KG,20160923.0,,OT,CO,CO,2016,Q3,Elderly
127736591,12773659,3,SS,Glargine insulin,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,,2016,Q3,Hypoglycaemia,,2016,Q3,1,I,20160819.0,20160819.0,20160923,20160923,EXP,,CO-BAXTER-2016BAX043964,BAXTER,,69.0,YR,,F,Y,55.4,KG,20160923.0,,OT,CO,CO,2016,Q3,Elderly
127736591,12773659,3,SS,Glargine insulin,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,,2016,Q3,Post procedural oedema,,2016,Q3,1,I,20160819.0,20160819.0,20160923,20160923,EXP,,CO-BAXTER-2016BAX043964,BAXTER,,69.0,YR,,F,Y,55.4,KG,20160923.0,,OT,CO,CO,2016,Q3,Elderly
127750011,12775001,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q3,Abnormal behaviour,,2016,Q3,1,I,201505.0,20160915.0,20160923,20160923,EXP,,AU-PFIZER INC-2016443356,PFIZER,,67.0,YR,,F,Y,,,20160923.0,,OT,AU,AU,2016,Q3,Elderly
127750011,12775001,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q3,Blood parathyroid hormone increased,,2016,Q3,1,I,201505.0,20160915.0,20160923,20160923,EXP,,AU-PFIZER INC-2016443356,PFIZER,,67.0,YR,,F,Y,,,20160923.0,,OT,AU,AU,2016,Q3,Elderly
127750011,12775001,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q3,Depression,,2016,Q3,1,I,201505.0,20160915.0,20160923,20160923,EXP,,AU-PFIZER INC-2016443356,PFIZER,,67.0,YR,,F,Y,,,20160923.0,,OT,AU,AU,2016,Q3,Elderly
127750011,12775001,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q3,Dry mouth,,2016,Q3,1,I,201505.0,20160915.0,20160923,20160923,EXP,,AU-PFIZER INC-2016443356,PFIZER,,67.0,YR,,F,Y,,,20160923.0,,OT,AU,AU,2016,Q3,Elderly
127750011,12775001,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q3,Dry skin,,2016,Q3,1,I,201505.0,20160915.0,20160923,20160923,EXP,,AU-PFIZER INC-2016443356,PFIZER,,67.0,YR,,F,Y,,,20160923.0,,OT,AU,AU,2016,Q3,Elderly
127750011,12775001,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q3,Dysarthria,,2016,Q3,1,I,201505.0,20160915.0,20160923,20160923,EXP,,AU-PFIZER INC-2016443356,PFIZER,,67.0,YR,,F,Y,,,20160923.0,,OT,AU,AU,2016,Q3,Elderly
127750011,12775001,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q3,Eye swelling,,2016,Q3,1,I,201505.0,20160915.0,20160923,20160923,EXP,,AU-PFIZER INC-2016443356,PFIZER,,67.0,YR,,F,Y,,,20160923.0,,OT,AU,AU,2016,Q3,Elderly
127750011,12775001,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q3,Hypercalcaemia,,2016,Q3,1,I,201505.0,20160915.0,20160923,20160923,EXP,,AU-PFIZER INC-2016443356,PFIZER,,67.0,YR,,F,Y,,,20160923.0,,OT,AU,AU,2016,Q3,Elderly
127750011,12775001,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q3,Hypoglycaemia,,2016,Q3,1,I,201505.0,20160915.0,20160923,20160923,EXP,,AU-PFIZER INC-2016443356,PFIZER,,67.0,YR,,F,Y,,,20160923.0,,OT,AU,AU,2016,Q3,Elderly
127750011,12775001,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q3,Hypokalaemia,,2016,Q3,1,I,201505.0,20160915.0,20160923,20160923,EXP,,AU-PFIZER INC-2016443356,PFIZER,,67.0,YR,,F,Y,,,20160923.0,,OT,AU,AU,2016,Q3,Elderly
127750011,12775001,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q3,Insomnia,,2016,Q3,1,I,201505.0,20160915.0,20160923,20160923,EXP,,AU-PFIZER INC-2016443356,PFIZER,,67.0,YR,,F,Y,,,20160923.0,,OT,AU,AU,2016,Q3,Elderly
127750011,12775001,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q3,Iron deficiency anaemia,,2016,Q3,1,I,201505.0,20160915.0,20160923,20160923,EXP,,AU-PFIZER INC-2016443356,PFIZER,,67.0,YR,,F,Y,,,20160923.0,,OT,AU,AU,2016,Q3,Elderly
127750011,12775001,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q3,Pruritus,,2016,Q3,1,I,201505.0,20160915.0,20160923,20160923,EXP,,AU-PFIZER INC-2016443356,PFIZER,,67.0,YR,,F,Y,,,20160923.0,,OT,AU,AU,2016,Q3,Elderly
127750011,12775001,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q3,Swelling face,,2016,Q3,1,I,201505.0,20160915.0,20160923,20160923,EXP,,AU-PFIZER INC-2016443356,PFIZER,,67.0,YR,,F,Y,,,20160923.0,,OT,AU,AU,2016,Q3,Elderly
127757561,12775756,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,30 UNITS,,,,,,,,,,,,2016,Q3,Disease progression,,2016,Q3,1,I,20160812.0,20160815.0,20160923,20160923,EXP,,US-ROCHE-1814808,ROCHE,,73.0,YR,,M,Y,71.51,KG,20160923.0,,MD,US,US,2016,Q3,Elderly
127759482,12775948,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Off label use,,2016,Q3,2,F,,20160920.0,20160923,20160930,EXP,,IT-GILEAD-2016-0234336,GILEAD,,61.0,YR,A,M,Y,,,20160930.0,,OT,IT,IT,2016,Q3,Adult
127759482,12775948,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Photosensitivity reaction,,2016,Q3,2,F,,20160920.0,20160923,20160930,EXP,,IT-GILEAD-2016-0234336,GILEAD,,61.0,YR,A,M,Y,,,20160930.0,,OT,IT,IT,2016,Q3,Adult
127759482,12775948,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Porphyria non-acute,,2016,Q3,2,F,,20160920.0,20160923,20160930,EXP,,IT-GILEAD-2016-0234336,GILEAD,,61.0,YR,A,M,Y,,,20160930.0,,OT,IT,IT,2016,Q3,Adult
127759482,12775948,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Product use issue,,2016,Q3,2,F,,20160920.0,20160923,20160930,EXP,,IT-GILEAD-2016-0234336,GILEAD,,61.0,YR,A,M,Y,,,20160930.0,,OT,IT,IT,2016,Q3,Adult
127771541,12777154,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,36 UNITS,,,U,,,,,36.0,IU,,,2016,Q3,Hypoglycaemia,,2016,Q3,1,I,,20160914.0,20160924,20160924,EXP,,GB-BAXTER-2016BAX049380,BAXTER,"OEI E, SAMAD N, VISSER A, CHOWDHURY T, FAN S. USE OF CONTINUOUS GLUCOSE MONITORING IN PATIENTS WITH DIABETES ON PERITONEAL DIALYSIS: POOR CORRELATION WITH HBA1C AND HIGH INCIDENCE OF HYPOGLYCAEMIA. DIABETIC MEDICINE. 2016 JAN 01;33 (9):E17-E20.",58.0,YR,,M,Y,,,20160923.0,,OT,GB,GB,2016,Q3,Adult
127808291,12780829,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,NIGHTLY,,,Y,Y, UNK,,21081.0,,,,QD,2016,Q3,Bradykinesia,,2016,Q3,1,I,,20160914.0,20160926,20160926,EXP,,US-SA-2016SA171880,AVENTIS,"LIZARRAGA KJ, ADAMS D, ALEXANDRE LC, SINGER C. RELATIVE HYPOGLYCEMIA INDUCES ACUTE CHOREA FOLLOWED BY CHRONIC PARKINSONISM IN A DIABETIC PATIENT ON HEMODIALYSIS: A CASE WITH SEQUENTIAL CLINICO-RADIOLOGICAL CORRELATE. 20TH INTERNATIONAL CONGRESS OF PARKINSON^S DISEASE AND MOVEMENT DISORDERS; 2016 JUN 19-23; BERLIN, GERMANY. MOV DISORD. 2016 JUN 01;31 SUPPL 2:S288. DOI: 10.1002/MDS.26688",47.0,YR,A,M,Y,,,20160926.0,,OT,US,US,2016,Q3,Adult
127808291,12780829,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,NIGHTLY,,,Y,Y, UNK,,21081.0,,,,QD,2016,Q3,Cerebral haemorrhage,,2016,Q3,1,I,,20160914.0,20160926,20160926,EXP,,US-SA-2016SA171880,AVENTIS,"LIZARRAGA KJ, ADAMS D, ALEXANDRE LC, SINGER C. RELATIVE HYPOGLYCEMIA INDUCES ACUTE CHOREA FOLLOWED BY CHRONIC PARKINSONISM IN A DIABETIC PATIENT ON HEMODIALYSIS: A CASE WITH SEQUENTIAL CLINICO-RADIOLOGICAL CORRELATE. 20TH INTERNATIONAL CONGRESS OF PARKINSON^S DISEASE AND MOVEMENT DISORDERS; 2016 JUN 19-23; BERLIN, GERMANY. MOV DISORD. 2016 JUN 01;31 SUPPL 2:S288. DOI: 10.1002/MDS.26688",47.0,YR,A,M,Y,,,20160926.0,,OT,US,US,2016,Q3,Adult
127808291,12780829,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,NIGHTLY,,,Y,Y, UNK,,21081.0,,,,QD,2016,Q3,Chorea,Chorea,2016,Q3,1,I,,20160914.0,20160926,20160926,EXP,,US-SA-2016SA171880,AVENTIS,"LIZARRAGA KJ, ADAMS D, ALEXANDRE LC, SINGER C. RELATIVE HYPOGLYCEMIA INDUCES ACUTE CHOREA FOLLOWED BY CHRONIC PARKINSONISM IN A DIABETIC PATIENT ON HEMODIALYSIS: A CASE WITH SEQUENTIAL CLINICO-RADIOLOGICAL CORRELATE. 20TH INTERNATIONAL CONGRESS OF PARKINSON^S DISEASE AND MOVEMENT DISORDERS; 2016 JUN 19-23; BERLIN, GERMANY. MOV DISORD. 2016 JUN 01;31 SUPPL 2:S288. DOI: 10.1002/MDS.26688",47.0,YR,A,M,Y,,,20160926.0,,OT,US,US,2016,Q3,Adult
127808291,12780829,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,NIGHTLY,,,Y,Y, UNK,,21081.0,,,,QD,2016,Q3,Cytotoxic oedema,,2016,Q3,1,I,,20160914.0,20160926,20160926,EXP,,US-SA-2016SA171880,AVENTIS,"LIZARRAGA KJ, ADAMS D, ALEXANDRE LC, SINGER C. RELATIVE HYPOGLYCEMIA INDUCES ACUTE CHOREA FOLLOWED BY CHRONIC PARKINSONISM IN A DIABETIC PATIENT ON HEMODIALYSIS: A CASE WITH SEQUENTIAL CLINICO-RADIOLOGICAL CORRELATE. 20TH INTERNATIONAL CONGRESS OF PARKINSON^S DISEASE AND MOVEMENT DISORDERS; 2016 JUN 19-23; BERLIN, GERMANY. MOV DISORD. 2016 JUN 01;31 SUPPL 2:S288. DOI: 10.1002/MDS.26688",47.0,YR,A,M,Y,,,20160926.0,,OT,US,US,2016,Q3,Adult
127808291,12780829,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,NIGHTLY,,,Y,Y, UNK,,21081.0,,,,QD,2016,Q3,Hypoglycaemia,Hypoglycaemia,2016,Q3,1,I,,20160914.0,20160926,20160926,EXP,,US-SA-2016SA171880,AVENTIS,"LIZARRAGA KJ, ADAMS D, ALEXANDRE LC, SINGER C. RELATIVE HYPOGLYCEMIA INDUCES ACUTE CHOREA FOLLOWED BY CHRONIC PARKINSONISM IN A DIABETIC PATIENT ON HEMODIALYSIS: A CASE WITH SEQUENTIAL CLINICO-RADIOLOGICAL CORRELATE. 20TH INTERNATIONAL CONGRESS OF PARKINSON^S DISEASE AND MOVEMENT DISORDERS; 2016 JUN 19-23; BERLIN, GERMANY. MOV DISORD. 2016 JUN 01;31 SUPPL 2:S288. DOI: 10.1002/MDS.26688",47.0,YR,A,M,Y,,,20160926.0,,OT,US,US,2016,Q3,Adult
127808291,12780829,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,NIGHTLY,,,Y,Y, UNK,,21081.0,,,,QD,2016,Q3,Parkinsonism,,2016,Q3,1,I,,20160914.0,20160926,20160926,EXP,,US-SA-2016SA171880,AVENTIS,"LIZARRAGA KJ, ADAMS D, ALEXANDRE LC, SINGER C. RELATIVE HYPOGLYCEMIA INDUCES ACUTE CHOREA FOLLOWED BY CHRONIC PARKINSONISM IN A DIABETIC PATIENT ON HEMODIALYSIS: A CASE WITH SEQUENTIAL CLINICO-RADIOLOGICAL CORRELATE. 20TH INTERNATIONAL CONGRESS OF PARKINSON^S DISEASE AND MOVEMENT DISORDERS; 2016 JUN 19-23; BERLIN, GERMANY. MOV DISORD. 2016 JUN 01;31 SUPPL 2:S288. DOI: 10.1002/MDS.26688",47.0,YR,A,M,Y,,,20160926.0,,OT,US,US,2016,Q3,Adult
127808291,12780829,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,NIGHTLY,,,Y,Y, UNK,,21081.0,,,,QD,2016,Q3,Vasogenic cerebral oedema,,2016,Q3,1,I,,20160914.0,20160926,20160926,EXP,,US-SA-2016SA171880,AVENTIS,"LIZARRAGA KJ, ADAMS D, ALEXANDRE LC, SINGER C. RELATIVE HYPOGLYCEMIA INDUCES ACUTE CHOREA FOLLOWED BY CHRONIC PARKINSONISM IN A DIABETIC PATIENT ON HEMODIALYSIS: A CASE WITH SEQUENTIAL CLINICO-RADIOLOGICAL CORRELATE. 20TH INTERNATIONAL CONGRESS OF PARKINSON^S DISEASE AND MOVEMENT DISORDERS; 2016 JUN 19-23; BERLIN, GERMANY. MOV DISORD. 2016 JUN 01;31 SUPPL 2:S288. DOI: 10.1002/MDS.26688",47.0,YR,A,M,Y,,,20160926.0,,OT,US,US,2016,Q3,Adult
127808291,12780829,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,Y,Y, UNK,,21081.0,,,,,2016,Q3,Bradykinesia,,2016,Q3,1,I,,20160914.0,20160926,20160926,EXP,,US-SA-2016SA171880,AVENTIS,"LIZARRAGA KJ, ADAMS D, ALEXANDRE LC, SINGER C. RELATIVE HYPOGLYCEMIA INDUCES ACUTE CHOREA FOLLOWED BY CHRONIC PARKINSONISM IN A DIABETIC PATIENT ON HEMODIALYSIS: A CASE WITH SEQUENTIAL CLINICO-RADIOLOGICAL CORRELATE. 20TH INTERNATIONAL CONGRESS OF PARKINSON^S DISEASE AND MOVEMENT DISORDERS; 2016 JUN 19-23; BERLIN, GERMANY. MOV DISORD. 2016 JUN 01;31 SUPPL 2:S288. DOI: 10.1002/MDS.26688",47.0,YR,A,M,Y,,,20160926.0,,OT,US,US,2016,Q3,Adult
127808291,12780829,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,Y,Y, UNK,,21081.0,,,,,2016,Q3,Cerebral haemorrhage,,2016,Q3,1,I,,20160914.0,20160926,20160926,EXP,,US-SA-2016SA171880,AVENTIS,"LIZARRAGA KJ, ADAMS D, ALEXANDRE LC, SINGER C. RELATIVE HYPOGLYCEMIA INDUCES ACUTE CHOREA FOLLOWED BY CHRONIC PARKINSONISM IN A DIABETIC PATIENT ON HEMODIALYSIS: A CASE WITH SEQUENTIAL CLINICO-RADIOLOGICAL CORRELATE. 20TH INTERNATIONAL CONGRESS OF PARKINSON^S DISEASE AND MOVEMENT DISORDERS; 2016 JUN 19-23; BERLIN, GERMANY. MOV DISORD. 2016 JUN 01;31 SUPPL 2:S288. DOI: 10.1002/MDS.26688",47.0,YR,A,M,Y,,,20160926.0,,OT,US,US,2016,Q3,Adult
127808291,12780829,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,Y,Y, UNK,,21081.0,,,,,2016,Q3,Chorea,Chorea,2016,Q3,1,I,,20160914.0,20160926,20160926,EXP,,US-SA-2016SA171880,AVENTIS,"LIZARRAGA KJ, ADAMS D, ALEXANDRE LC, SINGER C. RELATIVE HYPOGLYCEMIA INDUCES ACUTE CHOREA FOLLOWED BY CHRONIC PARKINSONISM IN A DIABETIC PATIENT ON HEMODIALYSIS: A CASE WITH SEQUENTIAL CLINICO-RADIOLOGICAL CORRELATE. 20TH INTERNATIONAL CONGRESS OF PARKINSON^S DISEASE AND MOVEMENT DISORDERS; 2016 JUN 19-23; BERLIN, GERMANY. MOV DISORD. 2016 JUN 01;31 SUPPL 2:S288. DOI: 10.1002/MDS.26688",47.0,YR,A,M,Y,,,20160926.0,,OT,US,US,2016,Q3,Adult
127808291,12780829,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,Y,Y, UNK,,21081.0,,,,,2016,Q3,Cytotoxic oedema,,2016,Q3,1,I,,20160914.0,20160926,20160926,EXP,,US-SA-2016SA171880,AVENTIS,"LIZARRAGA KJ, ADAMS D, ALEXANDRE LC, SINGER C. RELATIVE HYPOGLYCEMIA INDUCES ACUTE CHOREA FOLLOWED BY CHRONIC PARKINSONISM IN A DIABETIC PATIENT ON HEMODIALYSIS: A CASE WITH SEQUENTIAL CLINICO-RADIOLOGICAL CORRELATE. 20TH INTERNATIONAL CONGRESS OF PARKINSON^S DISEASE AND MOVEMENT DISORDERS; 2016 JUN 19-23; BERLIN, GERMANY. MOV DISORD. 2016 JUN 01;31 SUPPL 2:S288. DOI: 10.1002/MDS.26688",47.0,YR,A,M,Y,,,20160926.0,,OT,US,US,2016,Q3,Adult
127808291,12780829,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,Y,Y, UNK,,21081.0,,,,,2016,Q3,Hypoglycaemia,Hypoglycaemia,2016,Q3,1,I,,20160914.0,20160926,20160926,EXP,,US-SA-2016SA171880,AVENTIS,"LIZARRAGA KJ, ADAMS D, ALEXANDRE LC, SINGER C. RELATIVE HYPOGLYCEMIA INDUCES ACUTE CHOREA FOLLOWED BY CHRONIC PARKINSONISM IN A DIABETIC PATIENT ON HEMODIALYSIS: A CASE WITH SEQUENTIAL CLINICO-RADIOLOGICAL CORRELATE. 20TH INTERNATIONAL CONGRESS OF PARKINSON^S DISEASE AND MOVEMENT DISORDERS; 2016 JUN 19-23; BERLIN, GERMANY. MOV DISORD. 2016 JUN 01;31 SUPPL 2:S288. DOI: 10.1002/MDS.26688",47.0,YR,A,M,Y,,,20160926.0,,OT,US,US,2016,Q3,Adult
127808291,12780829,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,Y,Y, UNK,,21081.0,,,,,2016,Q3,Parkinsonism,,2016,Q3,1,I,,20160914.0,20160926,20160926,EXP,,US-SA-2016SA171880,AVENTIS,"LIZARRAGA KJ, ADAMS D, ALEXANDRE LC, SINGER C. RELATIVE HYPOGLYCEMIA INDUCES ACUTE CHOREA FOLLOWED BY CHRONIC PARKINSONISM IN A DIABETIC PATIENT ON HEMODIALYSIS: A CASE WITH SEQUENTIAL CLINICO-RADIOLOGICAL CORRELATE. 20TH INTERNATIONAL CONGRESS OF PARKINSON^S DISEASE AND MOVEMENT DISORDERS; 2016 JUN 19-23; BERLIN, GERMANY. MOV DISORD. 2016 JUN 01;31 SUPPL 2:S288. DOI: 10.1002/MDS.26688",47.0,YR,A,M,Y,,,20160926.0,,OT,US,US,2016,Q3,Adult
127808291,12780829,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,Y,Y, UNK,,21081.0,,,,,2016,Q3,Vasogenic cerebral oedema,,2016,Q3,1,I,,20160914.0,20160926,20160926,EXP,,US-SA-2016SA171880,AVENTIS,"LIZARRAGA KJ, ADAMS D, ALEXANDRE LC, SINGER C. RELATIVE HYPOGLYCEMIA INDUCES ACUTE CHOREA FOLLOWED BY CHRONIC PARKINSONISM IN A DIABETIC PATIENT ON HEMODIALYSIS: A CASE WITH SEQUENTIAL CLINICO-RADIOLOGICAL CORRELATE. 20TH INTERNATIONAL CONGRESS OF PARKINSON^S DISEASE AND MOVEMENT DISORDERS; 2016 JUN 19-23; BERLIN, GERMANY. MOV DISORD. 2016 JUN 01;31 SUPPL 2:S288. DOI: 10.1002/MDS.26688",47.0,YR,A,M,Y,,,20160926.0,,OT,US,US,2016,Q3,Adult
127849631,12784963,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Fatigue,Fatigue,2016,Q3,1,I,20150919.0,20150923.0,20160927,20160927,PER,,US-IGSA-GTI003545,GRIFOLS,,69.0,YR,E,M,Y,110.0,KG,20160927.0,,CN,US,US,2016,Q3,Elderly
127896831,12789683,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE:16 UNIT(S),,,Y,, UNKNOWN,,21081.0,,,INJECTION,QD,2016,Q3,Diabetic retinal oedema,,2016,Q3,1,I,2014.0,20160916.0,20160928,20160928,EXP,,RU-SA-2016SA174765,AVENTIS,"OVSYANNIKOVA AK, RYMAR OD, SHAKHTSHNEIDER EV, KLIMONTOV VV, KOROLEVA EA, MYAKINA NE, ET AL. ABCC8-RELATED MATURITY-ONSET DIABETES OF THE YOUNG (MODY12): CLINICAL FEATURES AND TREATMENT PERSPECTIVE. DIABETES THER. 2016;7:591-600. DOI: 10.1007/S13300-016-0192-9. ACCESSED: 2016 AUG 18.",27.0,YR,A,M,Y,,,20160928.0,,OT,RU,RU,2016,Q3,Young Adult
127896831,12789683,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE:16 UNIT(S),,,Y,, UNKNOWN,,21081.0,,,INJECTION,QD,2016,Q3,Diabetic retinopathy,,2016,Q3,1,I,2014.0,20160916.0,20160928,20160928,EXP,,RU-SA-2016SA174765,AVENTIS,"OVSYANNIKOVA AK, RYMAR OD, SHAKHTSHNEIDER EV, KLIMONTOV VV, KOROLEVA EA, MYAKINA NE, ET AL. ABCC8-RELATED MATURITY-ONSET DIABETES OF THE YOUNG (MODY12): CLINICAL FEATURES AND TREATMENT PERSPECTIVE. DIABETES THER. 2016;7:591-600. DOI: 10.1007/S13300-016-0192-9. ACCESSED: 2016 AUG 18.",27.0,YR,A,M,Y,,,20160928.0,,OT,RU,RU,2016,Q3,Young Adult
127896831,12789683,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE:16 UNIT(S),,,Y,, UNKNOWN,,21081.0,,,INJECTION,QD,2016,Q3,Hypoglycaemia,,2016,Q3,1,I,2014.0,20160916.0,20160928,20160928,EXP,,RU-SA-2016SA174765,AVENTIS,"OVSYANNIKOVA AK, RYMAR OD, SHAKHTSHNEIDER EV, KLIMONTOV VV, KOROLEVA EA, MYAKINA NE, ET AL. ABCC8-RELATED MATURITY-ONSET DIABETES OF THE YOUNG (MODY12): CLINICAL FEATURES AND TREATMENT PERSPECTIVE. DIABETES THER. 2016;7:591-600. DOI: 10.1007/S13300-016-0192-9. ACCESSED: 2016 AUG 18.",27.0,YR,A,M,Y,,,20160928.0,,OT,RU,RU,2016,Q3,Young Adult
127896831,12789683,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE:16 UNIT(S),,,Y,, UNKNOWN,,21081.0,,,INJECTION,QD,2016,Q3,Visual acuity reduced,,2016,Q3,1,I,2014.0,20160916.0,20160928,20160928,EXP,,RU-SA-2016SA174765,AVENTIS,"OVSYANNIKOVA AK, RYMAR OD, SHAKHTSHNEIDER EV, KLIMONTOV VV, KOROLEVA EA, MYAKINA NE, ET AL. ABCC8-RELATED MATURITY-ONSET DIABETES OF THE YOUNG (MODY12): CLINICAL FEATURES AND TREATMENT PERSPECTIVE. DIABETES THER. 2016;7:591-600. DOI: 10.1007/S13300-016-0192-9. ACCESSED: 2016 AUG 18.",27.0,YR,A,M,Y,,,20160928.0,,OT,RU,RU,2016,Q3,Young Adult
127896831,12789683,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE:16 UNIT(S),,,Y,, UNKNOWN,,21081.0,,,INJECTION,QD,2016,Q3,Weight increased,,2016,Q3,1,I,2014.0,20160916.0,20160928,20160928,EXP,,RU-SA-2016SA174765,AVENTIS,"OVSYANNIKOVA AK, RYMAR OD, SHAKHTSHNEIDER EV, KLIMONTOV VV, KOROLEVA EA, MYAKINA NE, ET AL. ABCC8-RELATED MATURITY-ONSET DIABETES OF THE YOUNG (MODY12): CLINICAL FEATURES AND TREATMENT PERSPECTIVE. DIABETES THER. 2016;7:591-600. DOI: 10.1007/S13300-016-0192-9. ACCESSED: 2016 AUG 18.",27.0,YR,A,M,Y,,,20160928.0,,OT,RU,RU,2016,Q3,Young Adult
127896831,12789683,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE:13 UNIT(S),,,Y,, UNKNOWN,,21081.0,,,INJECTION,QD,2016,Q3,Diabetic retinal oedema,,2016,Q3,1,I,2014.0,20160916.0,20160928,20160928,EXP,,RU-SA-2016SA174765,AVENTIS,"OVSYANNIKOVA AK, RYMAR OD, SHAKHTSHNEIDER EV, KLIMONTOV VV, KOROLEVA EA, MYAKINA NE, ET AL. ABCC8-RELATED MATURITY-ONSET DIABETES OF THE YOUNG (MODY12): CLINICAL FEATURES AND TREATMENT PERSPECTIVE. DIABETES THER. 2016;7:591-600. DOI: 10.1007/S13300-016-0192-9. ACCESSED: 2016 AUG 18.",27.0,YR,A,M,Y,,,20160928.0,,OT,RU,RU,2016,Q3,Young Adult
127896831,12789683,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE:13 UNIT(S),,,Y,, UNKNOWN,,21081.0,,,INJECTION,QD,2016,Q3,Diabetic retinopathy,,2016,Q3,1,I,2014.0,20160916.0,20160928,20160928,EXP,,RU-SA-2016SA174765,AVENTIS,"OVSYANNIKOVA AK, RYMAR OD, SHAKHTSHNEIDER EV, KLIMONTOV VV, KOROLEVA EA, MYAKINA NE, ET AL. ABCC8-RELATED MATURITY-ONSET DIABETES OF THE YOUNG (MODY12): CLINICAL FEATURES AND TREATMENT PERSPECTIVE. DIABETES THER. 2016;7:591-600. DOI: 10.1007/S13300-016-0192-9. ACCESSED: 2016 AUG 18.",27.0,YR,A,M,Y,,,20160928.0,,OT,RU,RU,2016,Q3,Young Adult
127896831,12789683,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE:13 UNIT(S),,,Y,, UNKNOWN,,21081.0,,,INJECTION,QD,2016,Q3,Hypoglycaemia,,2016,Q3,1,I,2014.0,20160916.0,20160928,20160928,EXP,,RU-SA-2016SA174765,AVENTIS,"OVSYANNIKOVA AK, RYMAR OD, SHAKHTSHNEIDER EV, KLIMONTOV VV, KOROLEVA EA, MYAKINA NE, ET AL. ABCC8-RELATED MATURITY-ONSET DIABETES OF THE YOUNG (MODY12): CLINICAL FEATURES AND TREATMENT PERSPECTIVE. DIABETES THER. 2016;7:591-600. DOI: 10.1007/S13300-016-0192-9. ACCESSED: 2016 AUG 18.",27.0,YR,A,M,Y,,,20160928.0,,OT,RU,RU,2016,Q3,Young Adult
127896831,12789683,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE:13 UNIT(S),,,Y,, UNKNOWN,,21081.0,,,INJECTION,QD,2016,Q3,Visual acuity reduced,,2016,Q3,1,I,2014.0,20160916.0,20160928,20160928,EXP,,RU-SA-2016SA174765,AVENTIS,"OVSYANNIKOVA AK, RYMAR OD, SHAKHTSHNEIDER EV, KLIMONTOV VV, KOROLEVA EA, MYAKINA NE, ET AL. ABCC8-RELATED MATURITY-ONSET DIABETES OF THE YOUNG (MODY12): CLINICAL FEATURES AND TREATMENT PERSPECTIVE. DIABETES THER. 2016;7:591-600. DOI: 10.1007/S13300-016-0192-9. ACCESSED: 2016 AUG 18.",27.0,YR,A,M,Y,,,20160928.0,,OT,RU,RU,2016,Q3,Young Adult
127896831,12789683,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE:13 UNIT(S),,,Y,, UNKNOWN,,21081.0,,,INJECTION,QD,2016,Q3,Weight increased,,2016,Q3,1,I,2014.0,20160916.0,20160928,20160928,EXP,,RU-SA-2016SA174765,AVENTIS,"OVSYANNIKOVA AK, RYMAR OD, SHAKHTSHNEIDER EV, KLIMONTOV VV, KOROLEVA EA, MYAKINA NE, ET AL. ABCC8-RELATED MATURITY-ONSET DIABETES OF THE YOUNG (MODY12): CLINICAL FEATURES AND TREATMENT PERSPECTIVE. DIABETES THER. 2016;7:591-600. DOI: 10.1007/S13300-016-0192-9. ACCESSED: 2016 AUG 18.",27.0,YR,A,M,Y,,,20160928.0,,OT,RU,RU,2016,Q3,Young Adult
127896831,12789683,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,Y,, UNKNOWN,,21081.0,,,INJECTION,,2016,Q3,Diabetic retinal oedema,,2016,Q3,1,I,2014.0,20160916.0,20160928,20160928,EXP,,RU-SA-2016SA174765,AVENTIS,"OVSYANNIKOVA AK, RYMAR OD, SHAKHTSHNEIDER EV, KLIMONTOV VV, KOROLEVA EA, MYAKINA NE, ET AL. ABCC8-RELATED MATURITY-ONSET DIABETES OF THE YOUNG (MODY12): CLINICAL FEATURES AND TREATMENT PERSPECTIVE. DIABETES THER. 2016;7:591-600. DOI: 10.1007/S13300-016-0192-9. ACCESSED: 2016 AUG 18.",27.0,YR,A,M,Y,,,20160928.0,,OT,RU,RU,2016,Q3,Young Adult
127896831,12789683,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,Y,, UNKNOWN,,21081.0,,,INJECTION,,2016,Q3,Diabetic retinopathy,,2016,Q3,1,I,2014.0,20160916.0,20160928,20160928,EXP,,RU-SA-2016SA174765,AVENTIS,"OVSYANNIKOVA AK, RYMAR OD, SHAKHTSHNEIDER EV, KLIMONTOV VV, KOROLEVA EA, MYAKINA NE, ET AL. ABCC8-RELATED MATURITY-ONSET DIABETES OF THE YOUNG (MODY12): CLINICAL FEATURES AND TREATMENT PERSPECTIVE. DIABETES THER. 2016;7:591-600. DOI: 10.1007/S13300-016-0192-9. ACCESSED: 2016 AUG 18.",27.0,YR,A,M,Y,,,20160928.0,,OT,RU,RU,2016,Q3,Young Adult
127896831,12789683,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,Y,, UNKNOWN,,21081.0,,,INJECTION,,2016,Q3,Hypoglycaemia,,2016,Q3,1,I,2014.0,20160916.0,20160928,20160928,EXP,,RU-SA-2016SA174765,AVENTIS,"OVSYANNIKOVA AK, RYMAR OD, SHAKHTSHNEIDER EV, KLIMONTOV VV, KOROLEVA EA, MYAKINA NE, ET AL. ABCC8-RELATED MATURITY-ONSET DIABETES OF THE YOUNG (MODY12): CLINICAL FEATURES AND TREATMENT PERSPECTIVE. DIABETES THER. 2016;7:591-600. DOI: 10.1007/S13300-016-0192-9. ACCESSED: 2016 AUG 18.",27.0,YR,A,M,Y,,,20160928.0,,OT,RU,RU,2016,Q3,Young Adult
127896831,12789683,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,Y,, UNKNOWN,,21081.0,,,INJECTION,,2016,Q3,Visual acuity reduced,,2016,Q3,1,I,2014.0,20160916.0,20160928,20160928,EXP,,RU-SA-2016SA174765,AVENTIS,"OVSYANNIKOVA AK, RYMAR OD, SHAKHTSHNEIDER EV, KLIMONTOV VV, KOROLEVA EA, MYAKINA NE, ET AL. ABCC8-RELATED MATURITY-ONSET DIABETES OF THE YOUNG (MODY12): CLINICAL FEATURES AND TREATMENT PERSPECTIVE. DIABETES THER. 2016;7:591-600. DOI: 10.1007/S13300-016-0192-9. ACCESSED: 2016 AUG 18.",27.0,YR,A,M,Y,,,20160928.0,,OT,RU,RU,2016,Q3,Young Adult
127896831,12789683,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,Y,, UNKNOWN,,21081.0,,,INJECTION,,2016,Q3,Weight increased,,2016,Q3,1,I,2014.0,20160916.0,20160928,20160928,EXP,,RU-SA-2016SA174765,AVENTIS,"OVSYANNIKOVA AK, RYMAR OD, SHAKHTSHNEIDER EV, KLIMONTOV VV, KOROLEVA EA, MYAKINA NE, ET AL. ABCC8-RELATED MATURITY-ONSET DIABETES OF THE YOUNG (MODY12): CLINICAL FEATURES AND TREATMENT PERSPECTIVE. DIABETES THER. 2016;7:591-600. DOI: 10.1007/S13300-016-0192-9. ACCESSED: 2016 AUG 18.",27.0,YR,A,M,Y,,,20160928.0,,OT,RU,RU,2016,Q3,Young Adult
127904141,12790414,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK MG, UNK",,,,,,,,,,,,2016,Q3,Hyperglycaemia,,2016,Q3,1,I,20160909.0,20160921.0,20160928,20160928,EXP,GB-MHRA-EYC 00145376,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-078071,BRISTOL MYERS SQUIBB,,92.0,YR,,M,Y,,,20160928.0,,CN,GB,GB,2016,Q3,Elderly
127912041,12791204,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2016,Q3,Abdominal distension,,2016,Q3,1,I,,20160914.0,20160929,20160929,EXP,,IT-AUROBINDO-AUR-APL-2016-11938,AUROBINDO,FEDERICA D^ANGELO. DAPAGLIFLOZIN: INNOVATION AND THERAPEUTIC EFFICACY CLINICAL CASE. 2016;16:88-89,65.0,YR,,F,Y,78.0,KG,20160929.0,,OT,IT,IT,2016,Q3,Elderly
127912041,12791204,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2016,Q3,Fatigue,,2016,Q3,1,I,,20160914.0,20160929,20160929,EXP,,IT-AUROBINDO-AUR-APL-2016-11938,AUROBINDO,FEDERICA D^ANGELO. DAPAGLIFLOZIN: INNOVATION AND THERAPEUTIC EFFICACY CLINICAL CASE. 2016;16:88-89,65.0,YR,,F,Y,78.0,KG,20160929.0,,OT,IT,IT,2016,Q3,Elderly
127912041,12791204,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2016,Q3,Glycosylated haemoglobin increased,,2016,Q3,1,I,,20160914.0,20160929,20160929,EXP,,IT-AUROBINDO-AUR-APL-2016-11938,AUROBINDO,FEDERICA D^ANGELO. DAPAGLIFLOZIN: INNOVATION AND THERAPEUTIC EFFICACY CLINICAL CASE. 2016;16:88-89,65.0,YR,,F,Y,78.0,KG,20160929.0,,OT,IT,IT,2016,Q3,Elderly
127912041,12791204,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2016,Q3,High density lipoprotein decreased,,2016,Q3,1,I,,20160914.0,20160929,20160929,EXP,,IT-AUROBINDO-AUR-APL-2016-11938,AUROBINDO,FEDERICA D^ANGELO. DAPAGLIFLOZIN: INNOVATION AND THERAPEUTIC EFFICACY CLINICAL CASE. 2016;16:88-89,65.0,YR,,F,Y,78.0,KG,20160929.0,,OT,IT,IT,2016,Q3,Elderly
127912041,12791204,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2016,Q3,Somnolence,,2016,Q3,1,I,,20160914.0,20160929,20160929,EXP,,IT-AUROBINDO-AUR-APL-2016-11938,AUROBINDO,FEDERICA D^ANGELO. DAPAGLIFLOZIN: INNOVATION AND THERAPEUTIC EFFICACY CLINICAL CASE. 2016;16:88-89,65.0,YR,,F,Y,78.0,KG,20160929.0,,OT,IT,IT,2016,Q3,Elderly
127913921,12791392,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12 UNITS,,,,,,,,12.0,DF,,,2016,Q3,Erysipelas,,2016,Q3,1,I,20160830.0,20160921.0,20160929,20160929,EXP,,PHHY2016DE133689,NOVARTIS,,62.0,YR,,M,Y,84.0,KG,20160929.0,,OT,DE,DE,2016,Q3,Adult
127978761,12797876,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 IU, UNK",,,Y,,,,,5.0,IU,,,2016,Q3,Diarrhoea,,2016,Q3,1,I,20160728.0,20160801.0,20160930,20160930,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-063759,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,,,20160930.0,,CN,JP,JP,2016,Q3,Elderly
127978761,12797876,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 IU, UNK",,,Y,,,,,5.0,IU,,,2016,Q3,Hypoglycaemia,,2016,Q3,1,I,20160728.0,20160801.0,20160930,20160930,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-063759,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,,,20160930.0,,CN,JP,JP,2016,Q3,Elderly
127978761,12797876,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"7 IU, UNK",,,Y,,,,,7.0,IU,,,2016,Q3,Diarrhoea,,2016,Q3,1,I,20160728.0,20160801.0,20160930,20160930,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-063759,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,,,20160930.0,,CN,JP,JP,2016,Q3,Elderly
127978761,12797876,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"7 IU, UNK",,,Y,,,,,7.0,IU,,,2016,Q3,Hypoglycaemia,,2016,Q3,1,I,20160728.0,20160801.0,20160930,20160930,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-063759,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,,,20160930.0,,CN,JP,JP,2016,Q3,Elderly
127978761,12797876,12,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"3 IU, UNK",,,Y,,,,,3.0,IU,,,2016,Q3,Diarrhoea,,2016,Q3,1,I,20160728.0,20160801.0,20160930,20160930,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-063759,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,,,20160930.0,,CN,JP,JP,2016,Q3,Elderly
127978761,12797876,12,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"3 IU, UNK",,,Y,,,,,3.0,IU,,,2016,Q3,Hypoglycaemia,,2016,Q3,1,I,20160728.0,20160801.0,20160930,20160930,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-063759,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,,,20160930.0,,CN,JP,JP,2016,Q3,Elderly
127981481,12798148,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,, UNK,,21081.0,,,,,2016,Q3,Myocardial infarction,,2016,Q3,1,I,,20160926.0,20160930,20160930,EXP,,SA-SA-2016SA179316,AVENTIS,,73.0,YR,E,F,Y,76.0,KG,20160930.0,,MD,SA,SA,2016,Q3,Elderly
127981641,12798164,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q3,Porphyria non-acute,,2016,Q3,1,I,,20160920.0,20160930,20160930,EXP,,IT-BAUSCH-BL-2016-023970,BAUSCH AND LOMB,"DRAGO F, GASPARINI G, MARENCO S, PICCIOTTO A, PARODI A. PORPHYRIN ELEVATION IN A PATIENT ON TREATMENT WITH SIMEPREVIR: COULD IT BE A POSSIBLE EXPLANATION FOR SIMEPREVIR-ASSOCIATED PHOTOSENSITIVITY. AMERICAN JOURNAL OF GASTROENTEROLOGY. 2016;111 (9):1368.",61.0,YR,,M,Y,,,20160930.0,,MD,IT,IT,2016,Q3,Adult
69688344,6968834,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2016,Q3,Myocardial infarction,,2016,Q3,4,F,20090330.0,20160831.0,20090414,20160907,EXP,,US-PFIZER INC-2009192070,PFIZER,"CAMIDGE, D.. SUNITINIB COMBINED WITH PEMETREXED AND CISPLATIN: RESULTS OF A PHASE I DOSE-ESCALATION AND PHARMACOKINETIC STUDY IN PATIENTS WITH ADVANCED SOLID MALIGNANCIES, WITH AN EXPANDED COHORT IN NONSMALL CELL LUNG CANCER AND MESOTHELIOMA. CANCER CHEMOTHERAPY AND PHARMACOLOGY. 2013;71 (2):307-319",66.0,YR,,M,Y,81.63,KG,20160907.0,,OT,US,US,2016,Q3,Elderly
71349493,7134949,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q3,Amniotic cavity infection,,2016,Q3,3,F,,20160824.0,20090930,20160824,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-14790364,BRISTOL MYERS SQUIBB,,35.0,YR,,F,Y,160.54,KG,20160824.0,,OT,US,US,2016,Q3,Adult
71349493,7134949,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q3,Caesarean section,,2016,Q3,3,F,,20160824.0,20090930,20160824,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-14790364,BRISTOL MYERS SQUIBB,,35.0,YR,,F,Y,160.54,KG,20160824.0,,OT,US,US,2016,Q3,Adult
71349493,7134949,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q3,Live birth,,2016,Q3,3,F,,20160824.0,20090930,20160824,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-14790364,BRISTOL MYERS SQUIBB,,35.0,YR,,F,Y,160.54,KG,20160824.0,,OT,US,US,2016,Q3,Adult
71349493,7134949,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q3,Maternal exposure during pregnancy,,2016,Q3,3,F,,20160824.0,20090930,20160824,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-14790364,BRISTOL MYERS SQUIBB,,35.0,YR,,F,Y,160.54,KG,20160824.0,,OT,US,US,2016,Q3,Adult
71349493,7134949,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q3,Pre-eclampsia,,2016,Q3,3,F,,20160824.0,20090930,20160824,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-14790364,BRISTOL MYERS SQUIBB,,35.0,YR,,F,Y,160.54,KG,20160824.0,,OT,US,US,2016,Q3,Adult
71349493,7134949,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q3,Urinary tract infection,,2016,Q3,3,F,,20160824.0,20090930,20160824,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-14790364,BRISTOL MYERS SQUIBB,,35.0,YR,,F,Y,160.54,KG,20160824.0,,OT,US,US,2016,Q3,Adult
886635410,8866354,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,16 UNITS IN EVENING,,,,,,,,,,,,2016,Q3,Arthralgia,,2016,Q3,10,F,2012.0,20160718.0,20121025,20160720,EXP,,CA-ROCHE-1143495,ROCHE,,55.0,YR,,F,Y,76.0,KG,20160720.0,,MD,CA,CA,2016,Q3,Adult
886635410,8866354,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,16 UNITS IN EVENING,,,,,,,,,,,,2016,Q3,Blood glucose abnormal,,2016,Q3,10,F,2012.0,20160718.0,20121025,20160720,EXP,,CA-ROCHE-1143495,ROCHE,,55.0,YR,,F,Y,76.0,KG,20160720.0,,MD,CA,CA,2016,Q3,Adult
886635410,8866354,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,16 UNITS IN EVENING,,,,,,,,,,,,2016,Q3,Chest pain,,2016,Q3,10,F,2012.0,20160718.0,20121025,20160720,EXP,,CA-ROCHE-1143495,ROCHE,,55.0,YR,,F,Y,76.0,KG,20160720.0,,MD,CA,CA,2016,Q3,Adult
886635410,8866354,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,16 UNITS IN EVENING,,,,,,,,,,,,2016,Q3,Dysarthria,,2016,Q3,10,F,2012.0,20160718.0,20121025,20160720,EXP,,CA-ROCHE-1143495,ROCHE,,55.0,YR,,F,Y,76.0,KG,20160720.0,,MD,CA,CA,2016,Q3,Adult
886635410,8866354,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,16 UNITS IN EVENING,,,,,,,,,,,,2016,Q3,Facial paralysis,,2016,Q3,10,F,2012.0,20160718.0,20121025,20160720,EXP,,CA-ROCHE-1143495,ROCHE,,55.0,YR,,F,Y,76.0,KG,20160720.0,,MD,CA,CA,2016,Q3,Adult
886635410,8866354,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,16 UNITS IN EVENING,,,,,,,,,,,,2016,Q3,Facial paresis,,2016,Q3,10,F,2012.0,20160718.0,20121025,20160720,EXP,,CA-ROCHE-1143495,ROCHE,,55.0,YR,,F,Y,76.0,KG,20160720.0,,MD,CA,CA,2016,Q3,Adult
886635410,8866354,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,16 UNITS IN EVENING,,,,,,,,,,,,2016,Q3,Fibromyalgia,,2016,Q3,10,F,2012.0,20160718.0,20121025,20160720,EXP,,CA-ROCHE-1143495,ROCHE,,55.0,YR,,F,Y,76.0,KG,20160720.0,,MD,CA,CA,2016,Q3,Adult
886635410,8866354,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,16 UNITS IN EVENING,,,,,,,,,,,,2016,Q3,Grip strength decreased,,2016,Q3,10,F,2012.0,20160718.0,20121025,20160720,EXP,,CA-ROCHE-1143495,ROCHE,,55.0,YR,,F,Y,76.0,KG,20160720.0,,MD,CA,CA,2016,Q3,Adult
886635410,8866354,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,16 UNITS IN EVENING,,,,,,,,,,,,2016,Q3,Headache,,2016,Q3,10,F,2012.0,20160718.0,20121025,20160720,EXP,,CA-ROCHE-1143495,ROCHE,,55.0,YR,,F,Y,76.0,KG,20160720.0,,MD,CA,CA,2016,Q3,Adult
886635410,8866354,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,16 UNITS IN EVENING,,,,,,,,,,,,2016,Q3,Infusion related reaction,,2016,Q3,10,F,2012.0,20160718.0,20121025,20160720,EXP,,CA-ROCHE-1143495,ROCHE,,55.0,YR,,F,Y,76.0,KG,20160720.0,,MD,CA,CA,2016,Q3,Adult
886635410,8866354,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,16 UNITS IN EVENING,,,,,,,,,,,,2016,Q3,Joint stiffness,,2016,Q3,10,F,2012.0,20160718.0,20121025,20160720,EXP,,CA-ROCHE-1143495,ROCHE,,55.0,YR,,F,Y,76.0,KG,20160720.0,,MD,CA,CA,2016,Q3,Adult
886635410,8866354,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,16 UNITS IN EVENING,,,,,,,,,,,,2016,Q3,Joint swelling,,2016,Q3,10,F,2012.0,20160718.0,20121025,20160720,EXP,,CA-ROCHE-1143495,ROCHE,,55.0,YR,,F,Y,76.0,KG,20160720.0,,MD,CA,CA,2016,Q3,Adult
886635410,8866354,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,16 UNITS IN EVENING,,,,,,,,,,,,2016,Q3,Musculoskeletal pain,,2016,Q3,10,F,2012.0,20160718.0,20121025,20160720,EXP,,CA-ROCHE-1143495,ROCHE,,55.0,YR,,F,Y,76.0,KG,20160720.0,,MD,CA,CA,2016,Q3,Adult
886635410,8866354,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,16 UNITS IN EVENING,,,,,,,,,,,,2016,Q3,Nasopharyngitis,,2016,Q3,10,F,2012.0,20160718.0,20121025,20160720,EXP,,CA-ROCHE-1143495,ROCHE,,55.0,YR,,F,Y,76.0,KG,20160720.0,,MD,CA,CA,2016,Q3,Adult
886635410,8866354,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,16 UNITS IN EVENING,,,,,,,,,,,,2016,Q3,Nausea,,2016,Q3,10,F,2012.0,20160718.0,20121025,20160720,EXP,,CA-ROCHE-1143495,ROCHE,,55.0,YR,,F,Y,76.0,KG,20160720.0,,MD,CA,CA,2016,Q3,Adult
886635410,8866354,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,16 UNITS IN EVENING,,,,,,,,,,,,2016,Q3,Osteoarthritis,,2016,Q3,10,F,2012.0,20160718.0,20121025,20160720,EXP,,CA-ROCHE-1143495,ROCHE,,55.0,YR,,F,Y,76.0,KG,20160720.0,,MD,CA,CA,2016,Q3,Adult
886635410,8866354,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,16 UNITS IN EVENING,,,,,,,,,,,,2016,Q3,Syncope,,2016,Q3,10,F,2012.0,20160718.0,20121025,20160720,EXP,,CA-ROCHE-1143495,ROCHE,,55.0,YR,,F,Y,76.0,KG,20160720.0,,MD,CA,CA,2016,Q3,Adult
95069782,9506978,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UP TO 3,300 UNITS (ELEVEN 100-UNITS/ML 3-ML PENS)",,,U,,,,,,,,,2016,Q3,Hypoglycaemia,,2016,Q3,2,F,,20160727.0,20130909,20160811,EXP,,US-RANBAXY-2013US-72719,RANBAXY,"GROTH CM, BANZON ER. OCTREOTIDE FOR THE TREATMENT OF HYPOGLYCEMIA AFTER INSULIN GLARGINE OVERDOSE. J EMERG MED. 2013;AUG;45(2):194-8",56.0,YR,,M,Y,,,20160811.0,,PH,US,US,2016,Q3,Adult
95069782,9506978,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UP TO 3,300 UNITS (ELEVEN 100-UNITS/ML 3-ML PENS)",,,U,,,,,,,,,2016,Q3,Intentional overdose,,2016,Q3,2,F,,20160727.0,20130909,20160811,EXP,,US-RANBAXY-2013US-72719,RANBAXY,"GROTH CM, BANZON ER. OCTREOTIDE FOR THE TREATMENT OF HYPOGLYCEMIA AFTER INSULIN GLARGINE OVERDOSE. J EMERG MED. 2013;AUG;45(2):194-8",56.0,YR,,M,Y,,,20160811.0,,PH,US,US,2016,Q3,Adult
95069782,9506978,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UP TO 3,300 UNITS (ELEVEN 100-UNITS/ML 3-ML PENS)",,,U,,,,,,,,,2016,Q3,Suicide attempt,,2016,Q3,2,F,,20160727.0,20130909,20160811,EXP,,US-RANBAXY-2013US-72719,RANBAXY,"GROTH CM, BANZON ER. OCTREOTIDE FOR THE TREATMENT OF HYPOGLYCEMIA AFTER INSULIN GLARGINE OVERDOSE. J EMERG MED. 2013;AUG;45(2):194-8",56.0,YR,,M,Y,,,20160811.0,,PH,US,US,2016,Q3,Adult
969136412,9691364,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,10 UN,,,,,,,,,,,QD,2016,Q3,Pneumonia,,2016,Q3,12,F,20130726.0,20160916.0,20131115,20160920,EXP,,CO-ROCHE-1256034,ROCHE,,73.0,YR,,M,Y,67.5,KG,20160920.0,,MD,CO,CO,2016,Q3,Elderly
969136412,9691364,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,10 UN,,,,,,,,,,,QD,2016,Q3,Septic shock,,2016,Q3,12,F,20130726.0,20160916.0,20131115,20160920,EXP,,CO-ROCHE-1256034,ROCHE,,73.0,YR,,M,Y,67.5,KG,20160920.0,,MD,CO,CO,2016,Q3,Elderly
969136412,9691364,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UN,,,,,,,,,,,QD,2016,Q3,Pneumonia,,2016,Q3,12,F,20130726.0,20160916.0,20131115,20160920,EXP,,CO-ROCHE-1256034,ROCHE,,73.0,YR,,M,Y,67.5,KG,20160920.0,,MD,CO,CO,2016,Q3,Elderly
969136412,9691364,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UN,,,,,,,,,,,QD,2016,Q3,Septic shock,,2016,Q3,12,F,20130726.0,20160916.0,20131115,20160920,EXP,,CO-ROCHE-1256034,ROCHE,,73.0,YR,,M,Y,67.5,KG,20160920.0,,MD,CO,CO,2016,Q3,Elderly
98398213,9839821,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,INJECTION,,,U,,,,,,,,,2016,Q3,Ileus,,2016,Q3,3,F,,20160726.0,20140124,20160726,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-20073185,BRISTOL MYERS SQUIBB,,78.0,YR,,M,Y,,,20160726.0,,CN,JP,JP,2016,Q3,Elderly
108303896,10830389,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"80 IU, 2X/DAY",,,,,,,,80.0,IU,INJECTION,BID,2016,Q4,Influenza,,2016,Q4,6,F,,20161219.0,20150219,20161229,PER,,US-PFIZER INC-2014318762,PFIZER,,68.0,YR,,M,Y,,,20161229.0,,MD,US,US,2016,Q4,Elderly
116608815,11660881,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2016,Q4,Diarrhoea,,2016,Q4,5,F,20150826.0,20161116.0,20151026,20161121,EXP,,ES-GILEAD-2015-0170180,GILEAD,,69.0,YR,E,M,Y,84.4,KG,20161121.0,,OT,ES,ES,2016,Q4,Elderly
116608815,11660881,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2016,Q4,Intestinal sepsis,,2016,Q4,5,F,20150826.0,20161116.0,20151026,20161121,EXP,,ES-GILEAD-2015-0170180,GILEAD,,69.0,YR,E,M,Y,84.4,KG,20161121.0,,OT,ES,ES,2016,Q4,Elderly
116608815,11660881,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2016,Q4,Metabolic acidosis,,2016,Q4,5,F,20150826.0,20161116.0,20151026,20161121,EXP,,ES-GILEAD-2015-0170180,GILEAD,,69.0,YR,E,M,Y,84.4,KG,20161121.0,,OT,ES,ES,2016,Q4,Elderly
116608815,11660881,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2016,Q4,Septic shock,,2016,Q4,5,F,20150826.0,20161116.0,20151026,20161121,EXP,,ES-GILEAD-2015-0170180,GILEAD,,69.0,YR,E,M,Y,84.4,KG,20161121.0,,OT,ES,ES,2016,Q4,Elderly
118990422,11899042,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"35 IU, 1X/DAY (AT BEDTIME)",,,,,,,,35.0,IU,,QD,2016,Q4,Urinary tract infection,,2016,Q4,2,F,,20161121.0,20160108,20161128,PER,,US-PFIZER INC-2015478101,PFIZER,,65.0,YR,,F,Y,,,20161128.0,,MD,US,US,2016,Q4,Elderly
119900713,11990071,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2016,Q4,Colitis,,2016,Q4,3,F,,20161207.0,20160202,20161219,EXP,,PHHY2016US010329,SANDOZ,"DESAI M, KHOV N, YANG Z, REIPRICH AJ, MATHEW A, LEVENICK JM.. CRYSTAL-ASSOCIATED COLITIS WITH ULCERATION LEADING TO HEMATOCHEZIA AND ABDOMINAL PAIN. CASE REPORTS IN GASTROENTEROLOGY. 2016;10:332?337",45.0,YR,,F,Y,,,20161220.0,,OT,US,US,2016,Q4,Adult
119900713,11990071,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2016,Q4,Haematochezia,,2016,Q4,3,F,,20161207.0,20160202,20161219,EXP,,PHHY2016US010329,SANDOZ,"DESAI M, KHOV N, YANG Z, REIPRICH AJ, MATHEW A, LEVENICK JM.. CRYSTAL-ASSOCIATED COLITIS WITH ULCERATION LEADING TO HEMATOCHEZIA AND ABDOMINAL PAIN. CASE REPORTS IN GASTROENTEROLOGY. 2016;10:332?337",45.0,YR,,F,Y,,,20161220.0,,OT,US,US,2016,Q4,Adult
1209417310,12094173,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2016,Q4,Dyspnoea,,2016,Q4,10,F,20160202.0,20161130.0,20160219,20161212,EXP,,US-ACTELION-A-NJ2016-131530,ACTELION,,60.0,YR,A,F,Y,,,20161212.0,,OT,US,US,2016,Q4,Adult
1209417310,12094173,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2016,Q4,Fluid overload,,2016,Q4,10,F,20160202.0,20161130.0,20160219,20161212,EXP,,US-ACTELION-A-NJ2016-131530,ACTELION,,60.0,YR,A,F,Y,,,20161212.0,,OT,US,US,2016,Q4,Adult
1209417310,12094173,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2016,Q4,Fluid retention,,2016,Q4,10,F,20160202.0,20161130.0,20160219,20161212,EXP,,US-ACTELION-A-NJ2016-131530,ACTELION,,60.0,YR,A,F,Y,,,20161212.0,,OT,US,US,2016,Q4,Adult
1209417310,12094173,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2016,Q4,Hypoxia,,2016,Q4,10,F,20160202.0,20161130.0,20160219,20161212,EXP,,US-ACTELION-A-NJ2016-131530,ACTELION,,60.0,YR,A,F,Y,,,20161212.0,,OT,US,US,2016,Q4,Adult
1209417310,12094173,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2016,Q4,Localised oedema,,2016,Q4,10,F,20160202.0,20161130.0,20160219,20161212,EXP,,US-ACTELION-A-NJ2016-131530,ACTELION,,60.0,YR,A,F,Y,,,20161212.0,,OT,US,US,2016,Q4,Adult
1209417310,12094173,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2016,Q4,Oedema,,2016,Q4,10,F,20160202.0,20161130.0,20160219,20161212,EXP,,US-ACTELION-A-NJ2016-131530,ACTELION,,60.0,YR,A,F,Y,,,20161212.0,,OT,US,US,2016,Q4,Adult
1209417310,12094173,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2016,Q4,Oedema peripheral,,2016,Q4,10,F,20160202.0,20161130.0,20160219,20161212,EXP,,US-ACTELION-A-NJ2016-131530,ACTELION,,60.0,YR,A,F,Y,,,20161212.0,,OT,US,US,2016,Q4,Adult
1209417310,12094173,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2016,Q4,Pleural effusion,,2016,Q4,10,F,20160202.0,20161130.0,20160219,20161212,EXP,,US-ACTELION-A-NJ2016-131530,ACTELION,,60.0,YR,A,F,Y,,,20161212.0,,OT,US,US,2016,Q4,Adult
1209417310,12094173,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2016,Q4,Pulmonary arterial hypertension,,2016,Q4,10,F,20160202.0,20161130.0,20160219,20161212,EXP,,US-ACTELION-A-NJ2016-131530,ACTELION,,60.0,YR,A,F,Y,,,20161212.0,,OT,US,US,2016,Q4,Adult
1209417310,12094173,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2016,Q4,Pulmonary oedema,,2016,Q4,10,F,20160202.0,20161130.0,20160219,20161212,EXP,,US-ACTELION-A-NJ2016-131530,ACTELION,,60.0,YR,A,F,Y,,,20161212.0,,OT,US,US,2016,Q4,Adult
1209417310,12094173,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2016,Q4,Respiratory failure,,2016,Q4,10,F,20160202.0,20161130.0,20160219,20161212,EXP,,US-ACTELION-A-NJ2016-131530,ACTELION,,60.0,YR,A,F,Y,,,20161212.0,,OT,US,US,2016,Q4,Adult
1209417310,12094173,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2016,Q4,Sleep apnoea syndrome,,2016,Q4,10,F,20160202.0,20161130.0,20160219,20161212,EXP,,US-ACTELION-A-NJ2016-131530,ACTELION,,60.0,YR,A,F,Y,,,20161212.0,,OT,US,US,2016,Q4,Adult
1209417310,12094173,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2016,Q4,Weight decreased,,2016,Q4,10,F,20160202.0,20161130.0,20160219,20161212,EXP,,US-ACTELION-A-NJ2016-131530,ACTELION,,60.0,YR,A,F,Y,,,20161212.0,,OT,US,US,2016,Q4,Adult
121095354,12109535,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, UNK",,,,,,,,12.0,IU,INJECTION,,2016,Q4,Adrenal insufficiency,,2016,Q4,4,F,20160202.0,20161220.0,20160224,20161226,EXP,,JP-GILEAD-2016-0197467,GILEAD,,77.0,YR,E,M,Y,69.0,KG,20161226.0,,MD,JP,JP,2016,Q4,Elderly
121095354,12109535,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, UNK",,,,,,,,12.0,IU,INJECTION,,2016,Q4,Cerebral atrophy,,2016,Q4,4,F,20160202.0,20161220.0,20160224,20161226,EXP,,JP-GILEAD-2016-0197467,GILEAD,,77.0,YR,E,M,Y,69.0,KG,20161226.0,,MD,JP,JP,2016,Q4,Elderly
121095354,12109535,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, UNK",,,,,,,,12.0,IU,INJECTION,,2016,Q4,Cerebral haemorrhage,,2016,Q4,4,F,20160202.0,20161220.0,20160224,20161226,EXP,,JP-GILEAD-2016-0197467,GILEAD,,77.0,YR,E,M,Y,69.0,KG,20161226.0,,MD,JP,JP,2016,Q4,Elderly
121095354,12109535,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, UNK",,,,,,,,12.0,IU,INJECTION,,2016,Q4,Cerebral infarction,,2016,Q4,4,F,20160202.0,20161220.0,20160224,20161226,EXP,,JP-GILEAD-2016-0197467,GILEAD,,77.0,YR,E,M,Y,69.0,KG,20161226.0,,MD,JP,JP,2016,Q4,Elderly
121487853,12148785,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,20.0,IU,INJECTION,QD,2016,Q4,Decreased appetite,,2016,Q4,3,F,20160120.0,20160304.0,20160304,20161129,EXP,,JP-ASTRAZENECA-2016SE12665,ASTRAZENECA,,19041.0,DY,,M,Y,78.0,KG,20161129.0,,MD,JP,JP,2016,Q4,Elderly
121487853,12148785,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,20.0,IU,INJECTION,QD,2016,Q4,Interstitial lung disease,,2016,Q4,3,F,20160120.0,20160304.0,20160304,20161129,EXP,,JP-ASTRAZENECA-2016SE12665,ASTRAZENECA,,19041.0,DY,,M,Y,78.0,KG,20161129.0,,MD,JP,JP,2016,Q4,Elderly
121487853,12148785,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,20.0,IU,INJECTION,QD,2016,Q4,Pharyngitis,,2016,Q4,3,F,20160120.0,20160304.0,20160304,20161129,EXP,,JP-ASTRAZENECA-2016SE12665,ASTRAZENECA,,19041.0,DY,,M,Y,78.0,KG,20161129.0,,MD,JP,JP,2016,Q4,Elderly
121487853,12148785,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,20.0,IU,INJECTION,QD,2016,Q4,Pyrexia,,2016,Q4,3,F,20160120.0,20160304.0,20160304,20161129,EXP,,JP-ASTRAZENECA-2016SE12665,ASTRAZENECA,,19041.0,DY,,M,Y,78.0,KG,20161129.0,,MD,JP,JP,2016,Q4,Elderly
121487853,12148785,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,10.0,IU,INJECTION,QD,2016,Q4,Decreased appetite,,2016,Q4,3,F,20160120.0,20160304.0,20160304,20161129,EXP,,JP-ASTRAZENECA-2016SE12665,ASTRAZENECA,,19041.0,DY,,M,Y,78.0,KG,20161129.0,,MD,JP,JP,2016,Q4,Elderly
121487853,12148785,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,10.0,IU,INJECTION,QD,2016,Q4,Interstitial lung disease,,2016,Q4,3,F,20160120.0,20160304.0,20160304,20161129,EXP,,JP-ASTRAZENECA-2016SE12665,ASTRAZENECA,,19041.0,DY,,M,Y,78.0,KG,20161129.0,,MD,JP,JP,2016,Q4,Elderly
121487853,12148785,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,10.0,IU,INJECTION,QD,2016,Q4,Pharyngitis,,2016,Q4,3,F,20160120.0,20160304.0,20160304,20161129,EXP,,JP-ASTRAZENECA-2016SE12665,ASTRAZENECA,,19041.0,DY,,M,Y,78.0,KG,20161129.0,,MD,JP,JP,2016,Q4,Elderly
121487853,12148785,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,10.0,IU,INJECTION,QD,2016,Q4,Pyrexia,,2016,Q4,3,F,20160120.0,20160304.0,20160304,20161129,EXP,,JP-ASTRAZENECA-2016SE12665,ASTRAZENECA,,19041.0,DY,,M,Y,78.0,KG,20161129.0,,MD,JP,JP,2016,Q4,Elderly
121882653,12188265,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 U, QD",,,,,,,,8.0,DF,,QD,2016,Q4,Abdominal pain,,2016,Q4,3,F,20150410.0,20161027.0,20160317,20161108,EXP,,PHHO2015US010179,SANDOZ,,54.0,YR,,M,Y,78.1,KG,20161108.0,,MD,US,US,2016,Q4,Adult
121882653,12188265,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 U, QD",,,,,,,,8.0,DF,,QD,2016,Q4,Acute kidney injury,,2016,Q4,3,F,20150410.0,20161027.0,20160317,20161108,EXP,,PHHO2015US010179,SANDOZ,,54.0,YR,,M,Y,78.1,KG,20161108.0,,MD,US,US,2016,Q4,Adult
121882653,12188265,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 U, QD",,,,,,,,8.0,DF,,QD,2016,Q4,Cephalhaematoma,,2016,Q4,3,F,20150410.0,20161027.0,20160317,20161108,EXP,,PHHO2015US010179,SANDOZ,,54.0,YR,,M,Y,78.1,KG,20161108.0,,MD,US,US,2016,Q4,Adult
121882653,12188265,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 U, QD",,,,,,,,8.0,DF,,QD,2016,Q4,Diarrhoea,,2016,Q4,3,F,20150410.0,20161027.0,20160317,20161108,EXP,,PHHO2015US010179,SANDOZ,,54.0,YR,,M,Y,78.1,KG,20161108.0,,MD,US,US,2016,Q4,Adult
121882653,12188265,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 U, QD",,,,,,,,8.0,DF,,QD,2016,Q4,Escherichia bacteraemia,,2016,Q4,3,F,20150410.0,20161027.0,20160317,20161108,EXP,,PHHO2015US010179,SANDOZ,,54.0,YR,,M,Y,78.1,KG,20161108.0,,MD,US,US,2016,Q4,Adult
121882653,12188265,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 U, QD",,,,,,,,8.0,DF,,QD,2016,Q4,Escherichia sepsis,,2016,Q4,3,F,20150410.0,20161027.0,20160317,20161108,EXP,,PHHO2015US010179,SANDOZ,,54.0,YR,,M,Y,78.1,KG,20161108.0,,MD,US,US,2016,Q4,Adult
121882653,12188265,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 U, QD",,,,,,,,8.0,DF,,QD,2016,Q4,Hyperkalaemia,,2016,Q4,3,F,20150410.0,20161027.0,20160317,20161108,EXP,,PHHO2015US010179,SANDOZ,,54.0,YR,,M,Y,78.1,KG,20161108.0,,MD,US,US,2016,Q4,Adult
121882653,12188265,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 U, QD",,,,,,,,8.0,DF,,QD,2016,Q4,Mental disorder,,2016,Q4,3,F,20150410.0,20161027.0,20160317,20161108,EXP,,PHHO2015US010179,SANDOZ,,54.0,YR,,M,Y,78.1,KG,20161108.0,,MD,US,US,2016,Q4,Adult
121882653,12188265,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 U, QD",,,,,,,,8.0,DF,,QD,2016,Q4,Metabolic acidosis,,2016,Q4,3,F,20150410.0,20161027.0,20160317,20161108,EXP,,PHHO2015US010179,SANDOZ,,54.0,YR,,M,Y,78.1,KG,20161108.0,,MD,US,US,2016,Q4,Adult
121882653,12188265,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 U, QD",,,,,,,,8.0,DF,,QD,2016,Q4,Pneumonia,,2016,Q4,3,F,20150410.0,20161027.0,20160317,20161108,EXP,,PHHO2015US010179,SANDOZ,,54.0,YR,,M,Y,78.1,KG,20161108.0,,MD,US,US,2016,Q4,Adult
121882653,12188265,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 U, QD",,,,,,,,8.0,DF,,QD,2016,Q4,Pulmonary mass,,2016,Q4,3,F,20150410.0,20161027.0,20160317,20161108,EXP,,PHHO2015US010179,SANDOZ,,54.0,YR,,M,Y,78.1,KG,20161108.0,,MD,US,US,2016,Q4,Adult
121882653,12188265,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 U, QD",,,,,,,,8.0,DF,,QD,2016,Q4,Pyelonephritis,,2016,Q4,3,F,20150410.0,20161027.0,20160317,20161108,EXP,,PHHO2015US010179,SANDOZ,,54.0,YR,,M,Y,78.1,KG,20161108.0,,MD,US,US,2016,Q4,Adult
121882653,12188265,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 U, QD",,,,,,,,8.0,DF,,QD,2016,Q4,Pyelonephritis acute,,2016,Q4,3,F,20150410.0,20161027.0,20160317,20161108,EXP,,PHHO2015US010179,SANDOZ,,54.0,YR,,M,Y,78.1,KG,20161108.0,,MD,US,US,2016,Q4,Adult
121882653,12188265,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 U, QD",,,,,,,,8.0,DF,,QD,2016,Q4,Splenomegaly,,2016,Q4,3,F,20150410.0,20161027.0,20160317,20161108,EXP,,PHHO2015US010179,SANDOZ,,54.0,YR,,M,Y,78.1,KG,20161108.0,,MD,US,US,2016,Q4,Adult
121882653,12188265,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 U, QD",,,,,,,,8.0,DF,,QD,2016,Q4,Vomiting,,2016,Q4,3,F,20150410.0,20161027.0,20160317,20161108,EXP,,PHHO2015US010179,SANDOZ,,54.0,YR,,M,Y,78.1,KG,20161108.0,,MD,US,US,2016,Q4,Adult
122112832,12211283,19,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,40 MILLIGRAM,,,,,,,,22.0,IU,INJECTION,BID,2016,Q4,Drug intolerance,,2016,Q4,2,F,20160208.0,20161012.0,20160325,20161020,PER,,US-CELGENEUS-USA-2016030635,CELGENE,,60.0,YR,,F,Y,131.66,KG,20161020.0,,MD,US,US,2016,Q4,Adult
122112832,12211283,19,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,40 MILLIGRAM,,,,,,,,22.0,IU,INJECTION,BID,2016,Q4,Klebsiella bacteraemia,,2016,Q4,2,F,20160208.0,20161012.0,20160325,20161020,PER,,US-CELGENEUS-USA-2016030635,CELGENE,,60.0,YR,,F,Y,131.66,KG,20161020.0,,MD,US,US,2016,Q4,Adult
122112832,12211283,19,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,40 MILLIGRAM,,,,,,,,22.0,IU,INJECTION,BID,2016,Q4,Klebsiella infection,,2016,Q4,2,F,20160208.0,20161012.0,20160325,20161020,PER,,US-CELGENEUS-USA-2016030635,CELGENE,,60.0,YR,,F,Y,131.66,KG,20161020.0,,MD,US,US,2016,Q4,Adult
122112832,12211283,19,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,40 MILLIGRAM,,,,,,,,22.0,IU,INJECTION,BID,2016,Q4,Neutrophil count decreased,,2016,Q4,2,F,20160208.0,20161012.0,20160325,20161020,PER,,US-CELGENEUS-USA-2016030635,CELGENE,,60.0,YR,,F,Y,131.66,KG,20161020.0,,MD,US,US,2016,Q4,Adult
122709264,12270926,12,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q4,Myocardial infarction,,2016,Q4,4,F,20150727.0,20161025.0,20160415,20161101,EXP,,US-CELGENEUS-USA-2015080052,CELGENE,,74.0,YR,,M,Y,76.2,KG,20161101.0,,OT,US,US,2016,Q4,Elderly
122709264,12270926,12,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q4,Pneumonia,,2016,Q4,4,F,20150727.0,20161025.0,20160415,20161101,EXP,,US-CELGENEUS-USA-2015080052,CELGENE,,74.0,YR,,M,Y,76.2,KG,20161101.0,,OT,US,US,2016,Q4,Elderly
123280993,12328099,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q4,Drug ineffective,,2016,Q4,3,F,201510.0,20160816.0,20160503,20161103,PER,,"US-IMPAX LABORATORIES, INC-2016-IPXL-00359",IMPAX,,67.0,YR,,M,Y,86.0,KG,20161103.0,,CN,US,US,2016,Q4,Elderly
123280993,12328099,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q4,Drug resistance,,2016,Q4,3,F,201510.0,20160816.0,20160503,20161103,PER,,"US-IMPAX LABORATORIES, INC-2016-IPXL-00359",IMPAX,,67.0,YR,,M,Y,86.0,KG,20161103.0,,CN,US,US,2016,Q4,Elderly
123280993,12328099,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q4,Gait disturbance,,2016,Q4,3,F,201510.0,20160816.0,20160503,20161103,PER,,"US-IMPAX LABORATORIES, INC-2016-IPXL-00359",IMPAX,,67.0,YR,,M,Y,86.0,KG,20161103.0,,CN,US,US,2016,Q4,Elderly
123280993,12328099,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q4,Hallucination,,2016,Q4,3,F,201510.0,20160816.0,20160503,20161103,PER,,"US-IMPAX LABORATORIES, INC-2016-IPXL-00359",IMPAX,,67.0,YR,,M,Y,86.0,KG,20161103.0,,CN,US,US,2016,Q4,Elderly
123280993,12328099,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q4,Muscular weakness,,2016,Q4,3,F,201510.0,20160816.0,20160503,20161103,PER,,"US-IMPAX LABORATORIES, INC-2016-IPXL-00359",IMPAX,,67.0,YR,,M,Y,86.0,KG,20161103.0,,CN,US,US,2016,Q4,Elderly
123280993,12328099,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q4,Myalgia,,2016,Q4,3,F,201510.0,20160816.0,20160503,20161103,PER,,"US-IMPAX LABORATORIES, INC-2016-IPXL-00359",IMPAX,,67.0,YR,,M,Y,86.0,KG,20161103.0,,CN,US,US,2016,Q4,Elderly
123280993,12328099,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q4,Pain,,2016,Q4,3,F,201510.0,20160816.0,20160503,20161103,PER,,"US-IMPAX LABORATORIES, INC-2016-IPXL-00359",IMPAX,,67.0,YR,,M,Y,86.0,KG,20161103.0,,CN,US,US,2016,Q4,Elderly
123280993,12328099,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q4,Weight decreased,,2016,Q4,3,F,201510.0,20160816.0,20160503,20161103,PER,,"US-IMPAX LABORATORIES, INC-2016-IPXL-00359",IMPAX,,67.0,YR,,M,Y,86.0,KG,20161103.0,,CN,US,US,2016,Q4,Elderly
123319995,12331999,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, DAILY",,,,,,,,18.0,IU,,,2016,Q4,Asthenia,,2016,Q4,5,F,2016.0,20161028.0,20160504,20161104,EXP,,US-PFIZER INC-2016153133,PFIZER,,75.0,YR,,F,Y,90.7,KG,20161104.0,,MD,US,US,2016,Q4,Elderly
123319995,12331999,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, DAILY",,,,,,,,18.0,IU,,,2016,Q4,Coronary artery occlusion,,2016,Q4,5,F,2016.0,20161028.0,20160504,20161104,EXP,,US-PFIZER INC-2016153133,PFIZER,,75.0,YR,,F,Y,90.7,KG,20161104.0,,MD,US,US,2016,Q4,Elderly
123319995,12331999,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, DAILY",,,,,,,,18.0,IU,,,2016,Q4,Fatigue,,2016,Q4,5,F,2016.0,20161028.0,20160504,20161104,EXP,,US-PFIZER INC-2016153133,PFIZER,,75.0,YR,,F,Y,90.7,KG,20161104.0,,MD,US,US,2016,Q4,Elderly
123319995,12331999,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, DAILY",,,,,,,,18.0,IU,,,2016,Q4,Haemoglobin decreased,,2016,Q4,5,F,2016.0,20161028.0,20160504,20161104,EXP,,US-PFIZER INC-2016153133,PFIZER,,75.0,YR,,F,Y,90.7,KG,20161104.0,,MD,US,US,2016,Q4,Elderly
123319995,12331999,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, DAILY",,,,,,,,18.0,IU,,,2016,Q4,Platelet count decreased,,2016,Q4,5,F,2016.0,20161028.0,20160504,20161104,EXP,,US-PFIZER INC-2016153133,PFIZER,,75.0,YR,,F,Y,90.7,KG,20161104.0,,MD,US,US,2016,Q4,Elderly
124193033,12419303,179,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q4,Hypoxia,,2016,Q4,3,F,20160125.0,20161020.0,20160531,20161102,EXP,,JP-CELGENEUS-JPN-2016015997,CELGENE,,67.0,YR,,M,Y,71.9,KG,20161102.0,,OT,JP,JP,2016,Q4,Elderly
124193033,12419303,179,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q4,Organising pneumonia,,2016,Q4,3,F,20160125.0,20161020.0,20160531,20161102,EXP,,JP-CELGENEUS-JPN-2016015997,CELGENE,,67.0,YR,,M,Y,71.9,KG,20161102.0,,OT,JP,JP,2016,Q4,Elderly
124193033,12419303,179,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q4,Pneumonia influenzal,,2016,Q4,3,F,20160125.0,20161020.0,20160531,20161102,EXP,,JP-CELGENEUS-JPN-2016015997,CELGENE,,67.0,YR,,M,Y,71.9,KG,20161102.0,,OT,JP,JP,2016,Q4,Elderly
124320497,12432049,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 DF, QHS",,,U,,,,,1.0,DF,,QD,2016,Q4,Cellulitis,,2016,Q4,7,F,20160523.0,20161006.0,20160603,20161020,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-041952,BRISTOL MYERS SQUIBB,,45.0,YR,,F,Y,189.1,KG,20161020.0,,OT,US,US,2016,Q4,Adult
124320497,12432049,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 DF, QHS",,,U,,,,,1.0,DF,,QD,2016,Q4,Multiple organ dysfunction syndrome,,2016,Q4,7,F,20160523.0,20161006.0,20160603,20161020,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-041952,BRISTOL MYERS SQUIBB,,45.0,YR,,F,Y,189.1,KG,20161020.0,,OT,US,US,2016,Q4,Adult
124884403,12488440,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,18 UNITS IN THE EVENING,,,,,,,,,,,,2016,Q4,Amylase increased,,2016,Q4,3,F,20160608.0,20161008.0,20160622,20161014,EXP,,CN-ASTRAZENECA-2016SE66393,ASTRAZENECA,,68.0,YR,,M,Y,,,20161014.0,,CN,CN,CN,2016,Q4,Elderly
124884403,12488440,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,18 UNITS IN THE EVENING,,,,,,,,,,,,2016,Q4,Diarrhoea,,2016,Q4,3,F,20160608.0,20161008.0,20160622,20161014,EXP,,CN-ASTRAZENECA-2016SE66393,ASTRAZENECA,,68.0,YR,,M,Y,,,20161014.0,,CN,CN,CN,2016,Q4,Elderly
124884403,12488440,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,18 UNITS IN THE EVENING,,,,,,,,,,,,2016,Q4,Drug ineffective,,2016,Q4,3,F,20160608.0,20161008.0,20160622,20161014,EXP,,CN-ASTRAZENECA-2016SE66393,ASTRAZENECA,,68.0,YR,,M,Y,,,20161014.0,,CN,CN,CN,2016,Q4,Elderly
124884403,12488440,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,18 UNITS IN THE EVENING,,,,,,,,,,,,2016,Q4,Intentional product misuse,,2016,Q4,3,F,20160608.0,20161008.0,20160622,20161014,EXP,,CN-ASTRAZENECA-2016SE66393,ASTRAZENECA,,68.0,YR,,M,Y,,,20161014.0,,CN,CN,CN,2016,Q4,Elderly
125394993,12539499,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"1 DF, UNK",,,U,,,,,1.0,DF,,,2016,Q4,Death,,2016,Q4,3,F,20160617.0,20160624.0,20160708,20161028,EXP,,US-ALKERMES INC.-ALK-2016-001739,ALKERMES,,59.0,YR,A,F,Y,,,20161028.0,,CN,US,US,2016,Q4,Adult
125464423,12546442,4,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD",,,,U,,,,,,,QD,2016,Q4,Blood pressure decreased,,2016,Q4,3,F,20160624.0,20161213.0,20160711,20161215,EXP,,US-EMERGENT BIOSOLUTIONS-16BA00098SP,EMERGENT BIOSOLUTIONS,,69.0,YR,,M,Y,72.0,KG,20161215.0,,PH,US,US,2016,Q4,Elderly
125464423,12546442,4,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD",,,,U,,,,,,,QD,2016,Q4,Bradycardia,,2016,Q4,3,F,20160624.0,20161213.0,20160711,20161215,EXP,,US-EMERGENT BIOSOLUTIONS-16BA00098SP,EMERGENT BIOSOLUTIONS,,69.0,YR,,M,Y,72.0,KG,20161215.0,,PH,US,US,2016,Q4,Elderly
125497724,12549772,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,24.0,IU,UNSPECIFIED,,2016,Q4,Diabetic ketoacidosis,,2016,Q4,4,F,,20161021.0,20160712,20161101,EXP,,ES-JNJFOC-20160708466,JANSSEN,"DI?GUEZ FELECHOSA M, SU?REZ GUTI?RREZ L. DIABETIC KETOACIDOSIS ASSOCIATED TO CANAGLIFLOZIN TREATMENT: CANAGLIFLOZIN INDUCED DIABETIC KETOACIDOSIS . ENDOCRINOLOG?A Y NUTRICI?N  23-JUN-2016;63 (8):430-1.",60.0,YR,A,M,Y,,,20161101.0,,MD,ES,ES,2016,Q4,Adult
125497724,12549772,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,24.0,IU,UNSPECIFIED,,2016,Q4,Off label use,,2016,Q4,4,F,,20161021.0,20160712,20161101,EXP,,ES-JNJFOC-20160708466,JANSSEN,"DI?GUEZ FELECHOSA M, SU?REZ GUTI?RREZ L. DIABETIC KETOACIDOSIS ASSOCIATED TO CANAGLIFLOZIN TREATMENT: CANAGLIFLOZIN INDUCED DIABETIC KETOACIDOSIS . ENDOCRINOLOG?A Y NUTRICI?N  23-JUN-2016;63 (8):430-1.",60.0,YR,A,M,Y,,,20161101.0,,MD,ES,ES,2016,Q4,Adult
125497724,12549772,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,24.0,IU,UNSPECIFIED,,2016,Q4,Product use issue,,2016,Q4,4,F,,20161021.0,20160712,20161101,EXP,,ES-JNJFOC-20160708466,JANSSEN,"DI?GUEZ FELECHOSA M, SU?REZ GUTI?RREZ L. DIABETIC KETOACIDOSIS ASSOCIATED TO CANAGLIFLOZIN TREATMENT: CANAGLIFLOZIN INDUCED DIABETIC KETOACIDOSIS . ENDOCRINOLOG?A Y NUTRICI?N  23-JUN-2016;63 (8):430-1.",60.0,YR,A,M,Y,,,20161101.0,,MD,ES,ES,2016,Q4,Adult
125497724,12549772,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,30.0,IU,UNSPECIFIED,QD,2016,Q4,Diabetic ketoacidosis,,2016,Q4,4,F,,20161021.0,20160712,20161101,EXP,,ES-JNJFOC-20160708466,JANSSEN,"DI?GUEZ FELECHOSA M, SU?REZ GUTI?RREZ L. DIABETIC KETOACIDOSIS ASSOCIATED TO CANAGLIFLOZIN TREATMENT: CANAGLIFLOZIN INDUCED DIABETIC KETOACIDOSIS . ENDOCRINOLOG?A Y NUTRICI?N  23-JUN-2016;63 (8):430-1.",60.0,YR,A,M,Y,,,20161101.0,,MD,ES,ES,2016,Q4,Adult
125497724,12549772,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,30.0,IU,UNSPECIFIED,QD,2016,Q4,Off label use,,2016,Q4,4,F,,20161021.0,20160712,20161101,EXP,,ES-JNJFOC-20160708466,JANSSEN,"DI?GUEZ FELECHOSA M, SU?REZ GUTI?RREZ L. DIABETIC KETOACIDOSIS ASSOCIATED TO CANAGLIFLOZIN TREATMENT: CANAGLIFLOZIN INDUCED DIABETIC KETOACIDOSIS . ENDOCRINOLOG?A Y NUTRICI?N  23-JUN-2016;63 (8):430-1.",60.0,YR,A,M,Y,,,20161101.0,,MD,ES,ES,2016,Q4,Adult
125497724,12549772,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,30.0,IU,UNSPECIFIED,QD,2016,Q4,Product use issue,,2016,Q4,4,F,,20161021.0,20160712,20161101,EXP,,ES-JNJFOC-20160708466,JANSSEN,"DI?GUEZ FELECHOSA M, SU?REZ GUTI?RREZ L. DIABETIC KETOACIDOSIS ASSOCIATED TO CANAGLIFLOZIN TREATMENT: CANAGLIFLOZIN INDUCED DIABETIC KETOACIDOSIS . ENDOCRINOLOG?A Y NUTRICI?N  23-JUN-2016;63 (8):430-1.",60.0,YR,A,M,Y,,,20161101.0,,MD,ES,ES,2016,Q4,Adult
125501824,12550182,32,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,22.0,IU,UNKNOWN,QD,2016,Q4,Acute kidney injury,,2016,Q4,4,F,20160703.0,20161108.0,20160712,20161117,EXP,,US-CELGENEUS-USA-2016071640,CELGENE,,61.0,YR,,F,Y,133.02,KG,20161117.0,,MD,US,US,2016,Q4,Adult
125501824,12550182,32,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,22.0,IU,UNKNOWN,QD,2016,Q4,Back pain,,2016,Q4,4,F,20160703.0,20161108.0,20160712,20161117,EXP,,US-CELGENEUS-USA-2016071640,CELGENE,,61.0,YR,,F,Y,133.02,KG,20161117.0,,MD,US,US,2016,Q4,Adult
125501824,12550182,32,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,22.0,IU,UNKNOWN,QD,2016,Q4,Neutropenic sepsis,,2016,Q4,4,F,20160703.0,20161108.0,20160712,20161117,EXP,,US-CELGENEUS-USA-2016071640,CELGENE,,61.0,YR,,F,Y,133.02,KG,20161117.0,,MD,US,US,2016,Q4,Adult
125501824,12550182,32,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,22.0,IU,UNKNOWN,QD,2016,Q4,Pneumonia,,2016,Q4,4,F,20160703.0,20161108.0,20160712,20161117,EXP,,US-CELGENEUS-USA-2016071640,CELGENE,,61.0,YR,,F,Y,133.02,KG,20161117.0,,MD,US,US,2016,Q4,Adult
125651854,12565185,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 UNIT, 1X/DAY (EVERY EVENING)",,,,,,,,4.0,DF,INJECTION,QD,2016,Q4,Blister,,2016,Q4,4,F,2016.0,20161003.0,20160718,20161007,EXP,,US-PFIZER INC-2016180788,PFIZER,,62.0,YR,,M,Y,105.0,KG,20161007.0,,CN,US,US,2016,Q4,Adult
125651854,12565185,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 UNIT, 1X/DAY (EVERY EVENING)",,,,,,,,4.0,DF,INJECTION,QD,2016,Q4,Blood blister,,2016,Q4,4,F,2016.0,20161003.0,20160718,20161007,EXP,,US-PFIZER INC-2016180788,PFIZER,,62.0,YR,,M,Y,105.0,KG,20161007.0,,CN,US,US,2016,Q4,Adult
125651854,12565185,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 UNIT, 1X/DAY (EVERY EVENING)",,,,,,,,4.0,DF,INJECTION,QD,2016,Q4,Dermatitis bullous,,2016,Q4,4,F,2016.0,20161003.0,20160718,20161007,EXP,,US-PFIZER INC-2016180788,PFIZER,,62.0,YR,,M,Y,105.0,KG,20161007.0,,CN,US,US,2016,Q4,Adult
125651854,12565185,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 UNIT, 1X/DAY (EVERY EVENING)",,,,,,,,4.0,DF,INJECTION,QD,2016,Q4,Hypersensitivity,,2016,Q4,4,F,2016.0,20161003.0,20160718,20161007,EXP,,US-PFIZER INC-2016180788,PFIZER,,62.0,YR,,M,Y,105.0,KG,20161007.0,,CN,US,US,2016,Q4,Adult
125651854,12565185,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 UNIT, 1X/DAY (EVERY EVENING)",,,,,,,,4.0,DF,INJECTION,QD,2016,Q4,Macule,,2016,Q4,4,F,2016.0,20161003.0,20160718,20161007,EXP,,US-PFIZER INC-2016180788,PFIZER,,62.0,YR,,M,Y,105.0,KG,20161007.0,,CN,US,US,2016,Q4,Adult
125651854,12565185,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 UNIT, 1X/DAY (EVERY EVENING)",,,,,,,,4.0,DF,INJECTION,QD,2016,Q4,Photosensitivity reaction,,2016,Q4,4,F,2016.0,20161003.0,20160718,20161007,EXP,,US-PFIZER INC-2016180788,PFIZER,,62.0,YR,,M,Y,105.0,KG,20161007.0,,CN,US,US,2016,Q4,Adult
125651854,12565185,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 UNIT, 1X/DAY (EVERY EVENING)",,,,,,,,4.0,DF,INJECTION,QD,2016,Q4,Porphyria non-acute,,2016,Q4,4,F,2016.0,20161003.0,20160718,20161007,EXP,,US-PFIZER INC-2016180788,PFIZER,,62.0,YR,,M,Y,105.0,KG,20161007.0,,CN,US,US,2016,Q4,Adult
125651854,12565185,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 UNIT, 1X/DAY (EVERY EVENING)",,,,,,,,4.0,DF,INJECTION,QD,2016,Q4,Rash,,2016,Q4,4,F,2016.0,20161003.0,20160718,20161007,EXP,,US-PFIZER INC-2016180788,PFIZER,,62.0,YR,,M,Y,105.0,KG,20161007.0,,CN,US,US,2016,Q4,Adult
125651854,12565185,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 UNIT, 1X/DAY (EVERY EVENING)",,,,,,,,4.0,DF,INJECTION,QD,2016,Q4,Skin lesion,,2016,Q4,4,F,2016.0,20161003.0,20160718,20161007,EXP,,US-PFIZER INC-2016180788,PFIZER,,62.0,YR,,M,Y,105.0,KG,20161007.0,,CN,US,US,2016,Q4,Adult
125891482,12589148,9,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,,,,,2016,Q4,Atrial fibrillation,,2016,Q4,2,F,20160601.0,20160819.0,20160725,20161017,PER,,US-JNJFOC-20160608109,JANSSEN,,82.0,YR,E,M,Y,,,20161017.0,,CN,US,US,2016,Q4,Elderly
126258643,12625864,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,U,,,,18.0,IU,FORMULATION UNKNOWN,QD,2016,Q4,Abdominal pain,,2016,Q4,3,F,20160408.0,20161108.0,20160805,20161111,EXP,,CA-ASTELLAS-2016US029562,ASTELLAS,,85.0,YR,,M,Y,,,20161111.0,,OT,CA,CA,2016,Q4,Elderly
126258643,12625864,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,U,,,,18.0,IU,FORMULATION UNKNOWN,QD,2016,Q4,Asthenia,,2016,Q4,3,F,20160408.0,20161108.0,20160805,20161111,EXP,,CA-ASTELLAS-2016US029562,ASTELLAS,,85.0,YR,,M,Y,,,20161111.0,,OT,CA,CA,2016,Q4,Elderly
126258643,12625864,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,U,,,,18.0,IU,FORMULATION UNKNOWN,QD,2016,Q4,Death,,2016,Q4,3,F,20160408.0,20161108.0,20160805,20161111,EXP,,CA-ASTELLAS-2016US029562,ASTELLAS,,85.0,YR,,M,Y,,,20161111.0,,OT,CA,CA,2016,Q4,Elderly
126258643,12625864,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,U,,,,18.0,IU,FORMULATION UNKNOWN,QD,2016,Q4,Decreased appetite,,2016,Q4,3,F,20160408.0,20161108.0,20160805,20161111,EXP,,CA-ASTELLAS-2016US029562,ASTELLAS,,85.0,YR,,M,Y,,,20161111.0,,OT,CA,CA,2016,Q4,Elderly
126258643,12625864,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,U,,,,18.0,IU,FORMULATION UNKNOWN,QD,2016,Q4,Diarrhoea,,2016,Q4,3,F,20160408.0,20161108.0,20160805,20161111,EXP,,CA-ASTELLAS-2016US029562,ASTELLAS,,85.0,YR,,M,Y,,,20161111.0,,OT,CA,CA,2016,Q4,Elderly
126258643,12625864,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,U,,,,18.0,IU,FORMULATION UNKNOWN,QD,2016,Q4,Drug intolerance,,2016,Q4,3,F,20160408.0,20161108.0,20160805,20161111,EXP,,CA-ASTELLAS-2016US029562,ASTELLAS,,85.0,YR,,M,Y,,,20161111.0,,OT,CA,CA,2016,Q4,Elderly
126258643,12625864,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,U,,,,18.0,IU,FORMULATION UNKNOWN,QD,2016,Q4,Malignant neoplasm progression,,2016,Q4,3,F,20160408.0,20161108.0,20160805,20161111,EXP,,CA-ASTELLAS-2016US029562,ASTELLAS,,85.0,YR,,M,Y,,,20161111.0,,OT,CA,CA,2016,Q4,Elderly
126258643,12625864,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,U,,,,18.0,IU,FORMULATION UNKNOWN,QD,2016,Q4,Nausea,,2016,Q4,3,F,20160408.0,20161108.0,20160805,20161111,EXP,,CA-ASTELLAS-2016US029562,ASTELLAS,,85.0,YR,,M,Y,,,20161111.0,,OT,CA,CA,2016,Q4,Elderly
126258643,12625864,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,U,,,,18.0,IU,FORMULATION UNKNOWN,QD,2016,Q4,Pneumonia,,2016,Q4,3,F,20160408.0,20161108.0,20160805,20161111,EXP,,CA-ASTELLAS-2016US029562,ASTELLAS,,85.0,YR,,M,Y,,,20161111.0,,OT,CA,CA,2016,Q4,Elderly
126258643,12625864,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,U,,,,18.0,IU,FORMULATION UNKNOWN,QD,2016,Q4,Prostatic specific antigen abnormal,,2016,Q4,3,F,20160408.0,20161108.0,20160805,20161111,EXP,,CA-ASTELLAS-2016US029562,ASTELLAS,,85.0,YR,,M,Y,,,20161111.0,,OT,CA,CA,2016,Q4,Elderly
126258643,12625864,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,U,,,,18.0,IU,FORMULATION UNKNOWN,QD,2016,Q4,Vomiting,,2016,Q4,3,F,20160408.0,20161108.0,20160805,20161111,EXP,,CA-ASTELLAS-2016US029562,ASTELLAS,,85.0,YR,,M,Y,,,20161111.0,,OT,CA,CA,2016,Q4,Elderly
126281273,12628127,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"2 UNIT, UNK",,,U,,,,,2.0,DF,,,2016,Q4,Arthralgia,,2016,Q4,3,F,201507.0,20161029.0,20160808,20161102,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-063615,BRISTOL MYERS SQUIBB,,69.0,YR,,M,Y,93.0,KG,20161102.0,,OT,US,US,2016,Q4,Elderly
126281273,12628127,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"2 UNIT, UNK",,,U,,,,,2.0,DF,,,2016,Q4,Dyspnoea,,2016,Q4,3,F,201507.0,20161029.0,20160808,20161102,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-063615,BRISTOL MYERS SQUIBB,,69.0,YR,,M,Y,93.0,KG,20161102.0,,OT,US,US,2016,Q4,Elderly
126415232,12641523,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q4,Adenovirus infection,,2016,Q4,2,F,201607.0,20161013.0,20160810,20161017,EXP,,US-INCYTE CORPORATION-2016IN004927,INCYTE,,11.0,YR,,F,Y,79.7,KG,20161017.0,,CN,US,US,2016,Q4,Child
126415232,12641523,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q4,BK virus infection,,2016,Q4,2,F,201607.0,20161013.0,20160810,20161017,EXP,,US-INCYTE CORPORATION-2016IN004927,INCYTE,,11.0,YR,,F,Y,79.7,KG,20161017.0,,CN,US,US,2016,Q4,Child
126415232,12641523,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q4,Enterococcal sepsis,,2016,Q4,2,F,201607.0,20161013.0,20160810,20161017,EXP,,US-INCYTE CORPORATION-2016IN004927,INCYTE,,11.0,YR,,F,Y,79.7,KG,20161017.0,,CN,US,US,2016,Q4,Child
126415232,12641523,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q4,Multiple organ dysfunction syndrome,,2016,Q4,2,F,201607.0,20161013.0,20160810,20161017,EXP,,US-INCYTE CORPORATION-2016IN004927,INCYTE,,11.0,YR,,F,Y,79.7,KG,20161017.0,,CN,US,US,2016,Q4,Child
126415232,12641523,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q4,Neutropenia,,2016,Q4,2,F,201607.0,20161013.0,20160810,20161017,EXP,,US-INCYTE CORPORATION-2016IN004927,INCYTE,,11.0,YR,,F,Y,79.7,KG,20161017.0,,CN,US,US,2016,Q4,Child
126415232,12641523,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q4,Off label use,,2016,Q4,2,F,201607.0,20161013.0,20160810,20161017,EXP,,US-INCYTE CORPORATION-2016IN004927,INCYTE,,11.0,YR,,F,Y,79.7,KG,20161017.0,,CN,US,US,2016,Q4,Child
126415232,12641523,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q4,Pseudomonas infection,,2016,Q4,2,F,201607.0,20161013.0,20160810,20161017,EXP,,US-INCYTE CORPORATION-2016IN004927,INCYTE,,11.0,YR,,F,Y,79.7,KG,20161017.0,,CN,US,US,2016,Q4,Child
126415232,12641523,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q4,Renal failure,,2016,Q4,2,F,201607.0,20161013.0,20160810,20161017,EXP,,US-INCYTE CORPORATION-2016IN004927,INCYTE,,11.0,YR,,F,Y,79.7,KG,20161017.0,,CN,US,US,2016,Q4,Child
126415232,12641523,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q4,Respiratory failure,,2016,Q4,2,F,201607.0,20161013.0,20160810,20161017,EXP,,US-INCYTE CORPORATION-2016IN004927,INCYTE,,11.0,YR,,F,Y,79.7,KG,20161017.0,,CN,US,US,2016,Q4,Child
126612783,12661278,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Diarrhoea,,2016,Q4,3,F,201605.0,20160926.0,20160817,20161106,PER,,US-RELYPSA-RLY2016000788,RELYPSA,,63.0,YR,,F,Y,,,20161102.0,,CN,US,US,2016,Q4,Adult
126612783,12661278,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Malaise,,2016,Q4,3,F,201605.0,20160926.0,20160817,20161106,PER,,US-RELYPSA-RLY2016000788,RELYPSA,,63.0,YR,,F,Y,,,20161102.0,,CN,US,US,2016,Q4,Adult
126617736,12661773,27,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q4,Duodenal ulcer haemorrhage,,2016,Q4,6,F,20160804.0,20161122.0,20160817,20161129,EXP,,US-CELGENEUS-USA-2016083335,CELGENE,,67.0,YR,,M,Y,74.9,KG,20161129.0,,MD,US,US,2016,Q4,Elderly
126617736,12661773,27,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q4,Large intestine perforation,,2016,Q4,6,F,20160804.0,20161122.0,20160817,20161129,EXP,,US-CELGENEUS-USA-2016083335,CELGENE,,67.0,YR,,M,Y,74.9,KG,20161129.0,,MD,US,US,2016,Q4,Elderly
126663952,12666395,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,U,,,,,,,,,2016,Q4,Anticipatory anxiety,,2016,Q4,2,F,201101.0,20161019.0,20160818,20161101,EXP,,BR-ELI_LILLY_AND_COMPANY-BR201608006660,ELI LILLY AND CO,,30.0,YR,,F,Y,56.0,KG,20161031.0,,CN,BR,BR,2016,Q4,Young Adult
126663952,12666395,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,U,,,,,,,,,2016,Q4,Exposure during breast feeding,,2016,Q4,2,F,201101.0,20161019.0,20160818,20161101,EXP,,BR-ELI_LILLY_AND_COMPANY-BR201608006660,ELI LILLY AND CO,,30.0,YR,,F,Y,56.0,KG,20161031.0,,CN,BR,BR,2016,Q4,Young Adult
126663952,12666395,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,U,,,,,,,,,2016,Q4,Glycosylated haemoglobin increased,,2016,Q4,2,F,201101.0,20161019.0,20160818,20161101,EXP,,BR-ELI_LILLY_AND_COMPANY-BR201608006660,ELI LILLY AND CO,,30.0,YR,,F,Y,56.0,KG,20161031.0,,CN,BR,BR,2016,Q4,Young Adult
126663952,12666395,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,U,,,,,,,,,2016,Q4,Hyperglycaemia,,2016,Q4,2,F,201101.0,20161019.0,20160818,20161101,EXP,,BR-ELI_LILLY_AND_COMPANY-BR201608006660,ELI LILLY AND CO,,30.0,YR,,F,Y,56.0,KG,20161031.0,,CN,BR,BR,2016,Q4,Young Adult
126663952,12666395,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,U,,,,,,,,,2016,Q4,Hypoglycaemia,,2016,Q4,2,F,201101.0,20161019.0,20160818,20161101,EXP,,BR-ELI_LILLY_AND_COMPANY-BR201608006660,ELI LILLY AND CO,,30.0,YR,,F,Y,56.0,KG,20161031.0,,CN,BR,BR,2016,Q4,Young Adult
126663952,12666395,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,U,,,,,,,,,2016,Q4,Incorrect drug administration duration,,2016,Q4,2,F,201101.0,20161019.0,20160818,20161101,EXP,,BR-ELI_LILLY_AND_COMPANY-BR201608006660,ELI LILLY AND CO,,30.0,YR,,F,Y,56.0,KG,20161031.0,,CN,BR,BR,2016,Q4,Young Adult
126663952,12666395,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,U,,,,,,,,,2016,Q4,Maternal exposure during pregnancy,,2016,Q4,2,F,201101.0,20161019.0,20160818,20161101,EXP,,BR-ELI_LILLY_AND_COMPANY-BR201608006660,ELI LILLY AND CO,,30.0,YR,,F,Y,56.0,KG,20161031.0,,CN,BR,BR,2016,Q4,Young Adult
126888925,12688892,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q4,Cardiac arrest,,2016,Q4,5,F,20160809.0,20161031.0,20160825,20161105,EXP,,JP-ASTRAZENECA-2016SE89841,ASTRAZENECA,,15394.0,DY,,M,Y,,,20161105.0,,MD,JP,JP,2016,Q4,Elderly
126888925,12688892,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q4,Diabetic hyperglycaemic coma,,2016,Q4,5,F,20160809.0,20161031.0,20160825,20161105,EXP,,JP-ASTRAZENECA-2016SE89841,ASTRAZENECA,,15394.0,DY,,M,Y,,,20161105.0,,MD,JP,JP,2016,Q4,Elderly
127001653,12700165,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2016,Q4,Abasia,,2016,Q4,3,F,20160817.0,20161212.0,20160830,20161221,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-069653,BRISTOL MYERS SQUIBB,,76.0,YR,,M,Y,136.0,KG,20161221.0,,MD,US,US,2016,Q4,Elderly
127001653,12700165,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2016,Q4,Chest pain,,2016,Q4,3,F,20160817.0,20161212.0,20160830,20161221,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-069653,BRISTOL MYERS SQUIBB,,76.0,YR,,M,Y,136.0,KG,20161221.0,,MD,US,US,2016,Q4,Elderly
127001653,12700165,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2016,Q4,Dizziness,,2016,Q4,3,F,20160817.0,20161212.0,20160830,20161221,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-069653,BRISTOL MYERS SQUIBB,,76.0,YR,,M,Y,136.0,KG,20161221.0,,MD,US,US,2016,Q4,Elderly
127001653,12700165,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2016,Q4,Gastrointestinal disorder,,2016,Q4,3,F,20160817.0,20161212.0,20160830,20161221,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-069653,BRISTOL MYERS SQUIBB,,76.0,YR,,M,Y,136.0,KG,20161221.0,,MD,US,US,2016,Q4,Elderly
127050733,12705073,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"300 UNIT/ML (1.5 ML) INPN, UNK",,,,,,,,1.5,ML,,,2016,Q4,Arthralgia,,2016,Q4,3,F,2003.0,20161108.0,20160831,20161117,EXP,,US-AMGEN-USASP2016108137,AMGEN,,49.0,YR,A,F,Y,76.0,KG,20161117.0,,MD,US,US,2016,Q4,Adult
127050733,12705073,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"300 UNIT/ML (1.5 ML) INPN, UNK",,,,,,,,1.5,ML,,,2016,Q4,Arthritis,,2016,Q4,3,F,2003.0,20161108.0,20160831,20161117,EXP,,US-AMGEN-USASP2016108137,AMGEN,,49.0,YR,A,F,Y,76.0,KG,20161117.0,,MD,US,US,2016,Q4,Adult
127050733,12705073,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"300 UNIT/ML (1.5 ML) INPN, UNK",,,,,,,,1.5,ML,,,2016,Q4,Blood creatinine increased,,2016,Q4,3,F,2003.0,20161108.0,20160831,20161117,EXP,,US-AMGEN-USASP2016108137,AMGEN,,49.0,YR,A,F,Y,76.0,KG,20161117.0,,MD,US,US,2016,Q4,Adult
127050733,12705073,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"300 UNIT/ML (1.5 ML) INPN, UNK",,,,,,,,1.5,ML,,,2016,Q4,Body mass index abnormal,,2016,Q4,3,F,2003.0,20161108.0,20160831,20161117,EXP,,US-AMGEN-USASP2016108137,AMGEN,,49.0,YR,A,F,Y,76.0,KG,20161117.0,,MD,US,US,2016,Q4,Adult
127050733,12705073,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"300 UNIT/ML (1.5 ML) INPN, UNK",,,,,,,,1.5,ML,,,2016,Q4,Chest discomfort,,2016,Q4,3,F,2003.0,20161108.0,20160831,20161117,EXP,,US-AMGEN-USASP2016108137,AMGEN,,49.0,YR,A,F,Y,76.0,KG,20161117.0,,MD,US,US,2016,Q4,Adult
127050733,12705073,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"300 UNIT/ML (1.5 ML) INPN, UNK",,,,,,,,1.5,ML,,,2016,Q4,Chest pain,,2016,Q4,3,F,2003.0,20161108.0,20160831,20161117,EXP,,US-AMGEN-USASP2016108137,AMGEN,,49.0,YR,A,F,Y,76.0,KG,20161117.0,,MD,US,US,2016,Q4,Adult
127050733,12705073,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"300 UNIT/ML (1.5 ML) INPN, UNK",,,,,,,,1.5,ML,,,2016,Q4,Enzyme level abnormal,,2016,Q4,3,F,2003.0,20161108.0,20160831,20161117,EXP,,US-AMGEN-USASP2016108137,AMGEN,,49.0,YR,A,F,Y,76.0,KG,20161117.0,,MD,US,US,2016,Q4,Adult
127050733,12705073,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"300 UNIT/ML (1.5 ML) INPN, UNK",,,,,,,,1.5,ML,,,2016,Q4,Exostosis,,2016,Q4,3,F,2003.0,20161108.0,20160831,20161117,EXP,,US-AMGEN-USASP2016108137,AMGEN,,49.0,YR,A,F,Y,76.0,KG,20161117.0,,MD,US,US,2016,Q4,Adult
127050733,12705073,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"300 UNIT/ML (1.5 ML) INPN, UNK",,,,,,,,1.5,ML,,,2016,Q4,Fatigue,,2016,Q4,3,F,2003.0,20161108.0,20160831,20161117,EXP,,US-AMGEN-USASP2016108137,AMGEN,,49.0,YR,A,F,Y,76.0,KG,20161117.0,,MD,US,US,2016,Q4,Adult
127050733,12705073,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"300 UNIT/ML (1.5 ML) INPN, UNK",,,,,,,,1.5,ML,,,2016,Q4,Headache,,2016,Q4,3,F,2003.0,20161108.0,20160831,20161117,EXP,,US-AMGEN-USASP2016108137,AMGEN,,49.0,YR,A,F,Y,76.0,KG,20161117.0,,MD,US,US,2016,Q4,Adult
127050733,12705073,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"300 UNIT/ML (1.5 ML) INPN, UNK",,,,,,,,1.5,ML,,,2016,Q4,Hepatic enzyme increased,,2016,Q4,3,F,2003.0,20161108.0,20160831,20161117,EXP,,US-AMGEN-USASP2016108137,AMGEN,,49.0,YR,A,F,Y,76.0,KG,20161117.0,,MD,US,US,2016,Q4,Adult
127050733,12705073,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"300 UNIT/ML (1.5 ML) INPN, UNK",,,,,,,,1.5,ML,,,2016,Q4,Hepatocellular carcinoma,,2016,Q4,3,F,2003.0,20161108.0,20160831,20161117,EXP,,US-AMGEN-USASP2016108137,AMGEN,,49.0,YR,A,F,Y,76.0,KG,20161117.0,,MD,US,US,2016,Q4,Adult
127050733,12705073,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"300 UNIT/ML (1.5 ML) INPN, UNK",,,,,,,,1.5,ML,,,2016,Q4,Hyperglycaemia,,2016,Q4,3,F,2003.0,20161108.0,20160831,20161117,EXP,,US-AMGEN-USASP2016108137,AMGEN,,49.0,YR,A,F,Y,76.0,KG,20161117.0,,MD,US,US,2016,Q4,Adult
127050733,12705073,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"300 UNIT/ML (1.5 ML) INPN, UNK",,,,,,,,1.5,ML,,,2016,Q4,Hypertension,,2016,Q4,3,F,2003.0,20161108.0,20160831,20161117,EXP,,US-AMGEN-USASP2016108137,AMGEN,,49.0,YR,A,F,Y,76.0,KG,20161117.0,,MD,US,US,2016,Q4,Adult
127050733,12705073,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"300 UNIT/ML (1.5 ML) INPN, UNK",,,,,,,,1.5,ML,,,2016,Q4,Hypoglycaemia,,2016,Q4,3,F,2003.0,20161108.0,20160831,20161117,EXP,,US-AMGEN-USASP2016108137,AMGEN,,49.0,YR,A,F,Y,76.0,KG,20161117.0,,MD,US,US,2016,Q4,Adult
127050733,12705073,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"300 UNIT/ML (1.5 ML) INPN, UNK",,,,,,,,1.5,ML,,,2016,Q4,Joint effusion,,2016,Q4,3,F,2003.0,20161108.0,20160831,20161117,EXP,,US-AMGEN-USASP2016108137,AMGEN,,49.0,YR,A,F,Y,76.0,KG,20161117.0,,MD,US,US,2016,Q4,Adult
127050733,12705073,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"300 UNIT/ML (1.5 ML) INPN, UNK",,,,,,,,1.5,ML,,,2016,Q4,Joint range of motion decreased,,2016,Q4,3,F,2003.0,20161108.0,20160831,20161117,EXP,,US-AMGEN-USASP2016108137,AMGEN,,49.0,YR,A,F,Y,76.0,KG,20161117.0,,MD,US,US,2016,Q4,Adult
127050733,12705073,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"300 UNIT/ML (1.5 ML) INPN, UNK",,,,,,,,1.5,ML,,,2016,Q4,Laboratory test abnormal,,2016,Q4,3,F,2003.0,20161108.0,20160831,20161117,EXP,,US-AMGEN-USASP2016108137,AMGEN,,49.0,YR,A,F,Y,76.0,KG,20161117.0,,MD,US,US,2016,Q4,Adult
127050733,12705073,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"300 UNIT/ML (1.5 ML) INPN, UNK",,,,,,,,1.5,ML,,,2016,Q4,Liver function test abnormal,,2016,Q4,3,F,2003.0,20161108.0,20160831,20161117,EXP,,US-AMGEN-USASP2016108137,AMGEN,,49.0,YR,A,F,Y,76.0,KG,20161117.0,,MD,US,US,2016,Q4,Adult
127050733,12705073,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"300 UNIT/ML (1.5 ML) INPN, UNK",,,,,,,,1.5,ML,,,2016,Q4,Malaise,,2016,Q4,3,F,2003.0,20161108.0,20160831,20161117,EXP,,US-AMGEN-USASP2016108137,AMGEN,,49.0,YR,A,F,Y,76.0,KG,20161117.0,,MD,US,US,2016,Q4,Adult
127050733,12705073,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"300 UNIT/ML (1.5 ML) INPN, UNK",,,,,,,,1.5,ML,,,2016,Q4,Mobility decreased,,2016,Q4,3,F,2003.0,20161108.0,20160831,20161117,EXP,,US-AMGEN-USASP2016108137,AMGEN,,49.0,YR,A,F,Y,76.0,KG,20161117.0,,MD,US,US,2016,Q4,Adult
127050733,12705073,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"300 UNIT/ML (1.5 ML) INPN, UNK",,,,,,,,1.5,ML,,,2016,Q4,Musculoskeletal stiffness,,2016,Q4,3,F,2003.0,20161108.0,20160831,20161117,EXP,,US-AMGEN-USASP2016108137,AMGEN,,49.0,YR,A,F,Y,76.0,KG,20161117.0,,MD,US,US,2016,Q4,Adult
127050733,12705073,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"300 UNIT/ML (1.5 ML) INPN, UNK",,,,,,,,1.5,ML,,,2016,Q4,Obesity,,2016,Q4,3,F,2003.0,20161108.0,20160831,20161117,EXP,,US-AMGEN-USASP2016108137,AMGEN,,49.0,YR,A,F,Y,76.0,KG,20161117.0,,MD,US,US,2016,Q4,Adult
127050733,12705073,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"300 UNIT/ML (1.5 ML) INPN, UNK",,,,,,,,1.5,ML,,,2016,Q4,Osteoarthritis,,2016,Q4,3,F,2003.0,20161108.0,20160831,20161117,EXP,,US-AMGEN-USASP2016108137,AMGEN,,49.0,YR,A,F,Y,76.0,KG,20161117.0,,MD,US,US,2016,Q4,Adult
127050733,12705073,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"300 UNIT/ML (1.5 ML) INPN, UNK",,,,,,,,1.5,ML,,,2016,Q4,Osteopenia,,2016,Q4,3,F,2003.0,20161108.0,20160831,20161117,EXP,,US-AMGEN-USASP2016108137,AMGEN,,49.0,YR,A,F,Y,76.0,KG,20161117.0,,MD,US,US,2016,Q4,Adult
127050733,12705073,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"300 UNIT/ML (1.5 ML) INPN, UNK",,,,,,,,1.5,ML,,,2016,Q4,Pain,,2016,Q4,3,F,2003.0,20161108.0,20160831,20161117,EXP,,US-AMGEN-USASP2016108137,AMGEN,,49.0,YR,A,F,Y,76.0,KG,20161117.0,,MD,US,US,2016,Q4,Adult
127050733,12705073,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"300 UNIT/ML (1.5 ML) INPN, UNK",,,,,,,,1.5,ML,,,2016,Q4,Pain in extremity,,2016,Q4,3,F,2003.0,20161108.0,20160831,20161117,EXP,,US-AMGEN-USASP2016108137,AMGEN,,49.0,YR,A,F,Y,76.0,KG,20161117.0,,MD,US,US,2016,Q4,Adult
127050733,12705073,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"300 UNIT/ML (1.5 ML) INPN, UNK",,,,,,,,1.5,ML,,,2016,Q4,Palpitations,,2016,Q4,3,F,2003.0,20161108.0,20160831,20161117,EXP,,US-AMGEN-USASP2016108137,AMGEN,,49.0,YR,A,F,Y,76.0,KG,20161117.0,,MD,US,US,2016,Q4,Adult
127050733,12705073,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"300 UNIT/ML (1.5 ML) INPN, UNK",,,,,,,,1.5,ML,,,2016,Q4,Psoriasis,,2016,Q4,3,F,2003.0,20161108.0,20160831,20161117,EXP,,US-AMGEN-USASP2016108137,AMGEN,,49.0,YR,A,F,Y,76.0,KG,20161117.0,,MD,US,US,2016,Q4,Adult
127050733,12705073,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"300 UNIT/ML (1.5 ML) INPN, UNK",,,,,,,,1.5,ML,,,2016,Q4,Pulmonary mass,,2016,Q4,3,F,2003.0,20161108.0,20160831,20161117,EXP,,US-AMGEN-USASP2016108137,AMGEN,,49.0,YR,A,F,Y,76.0,KG,20161117.0,,MD,US,US,2016,Q4,Adult
127050733,12705073,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"300 UNIT/ML (1.5 ML) INPN, UNK",,,,,,,,1.5,ML,,,2016,Q4,Swelling,,2016,Q4,3,F,2003.0,20161108.0,20160831,20161117,EXP,,US-AMGEN-USASP2016108137,AMGEN,,49.0,YR,A,F,Y,76.0,KG,20161117.0,,MD,US,US,2016,Q4,Adult
127050733,12705073,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"300 UNIT/ML (1.5 ML) INPN, UNK",,,,,,,,1.5,ML,,,2016,Q4,Synovitis,,2016,Q4,3,F,2003.0,20161108.0,20160831,20161117,EXP,,US-AMGEN-USASP2016108137,AMGEN,,49.0,YR,A,F,Y,76.0,KG,20161117.0,,MD,US,US,2016,Q4,Adult
127050733,12705073,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"300 UNIT/ML (1.5 ML) INPN, UNK",,,,,,,,1.5,ML,,,2016,Q4,Tenosynovitis,,2016,Q4,3,F,2003.0,20161108.0,20160831,20161117,EXP,,US-AMGEN-USASP2016108137,AMGEN,,49.0,YR,A,F,Y,76.0,KG,20161117.0,,MD,US,US,2016,Q4,Adult
127050733,12705073,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"300 UNIT/ML (1.5 ML) INPN, UNK",,,,,,,,1.5,ML,,,2016,Q4,Treatment failure,,2016,Q4,3,F,2003.0,20161108.0,20160831,20161117,EXP,,US-AMGEN-USASP2016108137,AMGEN,,49.0,YR,A,F,Y,76.0,KG,20161117.0,,MD,US,US,2016,Q4,Adult
127050733,12705073,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"300 UNIT/ML (1.5 ML) INPN, UNK",,,,,,,,1.5,ML,,,2016,Q4,Type 2 diabetes mellitus,,2016,Q4,3,F,2003.0,20161108.0,20160831,20161117,EXP,,US-AMGEN-USASP2016108137,AMGEN,,49.0,YR,A,F,Y,76.0,KG,20161117.0,,MD,US,US,2016,Q4,Adult
127071626,12707162,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,12 UNIT,,,,,,,,,,,,2016,Q4,Cholecystitis acute,,2016,Q4,6,F,20160823.0,20161010.0,20160901,20161017,EXP,,PHHO2016TR012526,NOVARTIS,,39.0,YR,,F,Y,62.0,KG,20161017.0,,MD,COUNTRY NOT SPECIFIED,TR,2016,Q4,Adult
127071626,12707162,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,12 UNIT,,,,,,,,,,,,2016,Q4,Hypoglycaemia,,2016,Q4,6,F,20160823.0,20161010.0,20160901,20161017,EXP,,PHHO2016TR012526,NOVARTIS,,39.0,YR,,F,Y,62.0,KG,20161017.0,,MD,COUNTRY NOT SPECIFIED,TR,2016,Q4,Adult
127072254,12707225,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2016,Q4,Blood thyroid stimulating hormone decreased,,2016,Q4,4,F,20160315.0,20161219.0,20160901,20161226,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-071481,BRISTOL MYERS SQUIBB,,63.0,YR,,M,Y,,,20161226.0,,MD,JP,JP,2016,Q4,Adult
127072254,12707225,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2016,Q4,Lung disorder,,2016,Q4,4,F,20160315.0,20161219.0,20160901,20161226,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-071481,BRISTOL MYERS SQUIBB,,63.0,YR,,M,Y,,,20161226.0,,MD,JP,JP,2016,Q4,Adult
127072254,12707225,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2016,Q4,Malignant neoplasm progression,,2016,Q4,4,F,20160315.0,20161219.0,20160901,20161226,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-071481,BRISTOL MYERS SQUIBB,,63.0,YR,,M,Y,,,20161226.0,,MD,JP,JP,2016,Q4,Adult
127122164,12712216,18,C,Insulin Glargine,INSULIN GLARGINE,1,Other,,,,,,,,,,,INJECTION,,2016,Q4,Pleural effusion,,2016,Q4,4,F,20160817.0,20160928.0,20160902,20161005,EXP,,US-CELGENEUS-USA-2016087782,CELGENE,,61.0,YR,,M,Y,110.8,KG,20161005.0,,OT,US,US,2016,Q4,Adult
127250242,12725024,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q4,Activities of daily living impaired,,2016,Q4,2,F,20130918.0,20161024.0,20160908,20161026,EXP,,US-PFIZER INC-2016422406,PFIZER,,66.0,YR,,M,Y,,,20161026.0,,LW,US,US,2016,Q4,Elderly
127250242,12725024,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q4,Deep vein thrombosis,,2016,Q4,2,F,20130918.0,20161024.0,20160908,20161026,EXP,,US-PFIZER INC-2016422406,PFIZER,,66.0,YR,,M,Y,,,20161026.0,,LW,US,US,2016,Q4,Elderly
127250242,12725024,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q4,Fear,,2016,Q4,2,F,20130918.0,20161024.0,20160908,20161026,EXP,,US-PFIZER INC-2016422406,PFIZER,,66.0,YR,,M,Y,,,20161026.0,,LW,US,US,2016,Q4,Elderly
127250242,12725024,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q4,General physical health deterioration,,2016,Q4,2,F,20130918.0,20161024.0,20160908,20161026,EXP,,US-PFIZER INC-2016422406,PFIZER,,66.0,YR,,M,Y,,,20161026.0,,LW,US,US,2016,Q4,Elderly
127250242,12725024,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q4,Mobility decreased,,2016,Q4,2,F,20130918.0,20161024.0,20160908,20161026,EXP,,US-PFIZER INC-2016422406,PFIZER,,66.0,YR,,M,Y,,,20161026.0,,LW,US,US,2016,Q4,Elderly
127250242,12725024,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q4,Pulmonary embolism,,2016,Q4,2,F,20130918.0,20161024.0,20160908,20161026,EXP,,US-PFIZER INC-2016422406,PFIZER,,66.0,YR,,M,Y,,,20161026.0,,LW,US,US,2016,Q4,Elderly
127250242,12725024,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q4,Pulmonary thrombosis,,2016,Q4,2,F,20130918.0,20161024.0,20160908,20161026,EXP,,US-PFIZER INC-2016422406,PFIZER,,66.0,YR,,M,Y,,,20161026.0,,LW,US,US,2016,Q4,Elderly
127250242,12725024,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q4,Total lung capacity decreased,,2016,Q4,2,F,20130918.0,20161024.0,20160908,20161026,EXP,,US-PFIZER INC-2016422406,PFIZER,,66.0,YR,,M,Y,,,20161026.0,,LW,US,US,2016,Q4,Elderly
127250242,12725024,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q4,Walking aid user,,2016,Q4,2,F,20130918.0,20161024.0,20160908,20161026,EXP,,US-PFIZER INC-2016422406,PFIZER,,66.0,YR,,M,Y,,,20161026.0,,LW,US,US,2016,Q4,Elderly
127304563,12730456,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,PRIOR TO BED,,,,,,,,25.0,IU,,,2016,Q4,Hyperglycaemia,,2016,Q4,3,F,,20161206.0,20160909,20161208,PER,,JP-BAUSCH-BL-2016-019045,BAUSCH AND LOMB,"HORASAWA S, OSAME K, KAWASUMI K, SAITO S, BANDO H, OHASHI K. EFFICACY OF IPRAGLIFLOZIN IN PATIENTS WITH STEROID-INDUCED HYPERGLYCEMIA DURING CANCER CHEMOTHERAPY. GAN TO KAGAKU RYOHO. CANCER + CHEMOTHERAPY. 2016;43(5):645-647.",47.0,YR,,M,Y,,,20161208.0,,PH,JP,JP,2016,Q4,Adult
127304563,12730456,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,PRIOR TO BED,,,,,,,,25.0,IU,,,2016,Q4,Malaise,,2016,Q4,3,F,,20161206.0,20160909,20161208,PER,,JP-BAUSCH-BL-2016-019045,BAUSCH AND LOMB,"HORASAWA S, OSAME K, KAWASUMI K, SAITO S, BANDO H, OHASHI K. EFFICACY OF IPRAGLIFLOZIN IN PATIENTS WITH STEROID-INDUCED HYPERGLYCEMIA DURING CANCER CHEMOTHERAPY. GAN TO KAGAKU RYOHO. CANCER + CHEMOTHERAPY. 2016;43(5):645-647.",47.0,YR,,M,Y,,,20161208.0,,PH,JP,JP,2016,Q4,Adult
127304563,12730456,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,PRIOR TO BED,,,,,,,,25.0,IU,,,2016,Q4,Nausea,,2016,Q4,3,F,,20161206.0,20160909,20161208,PER,,JP-BAUSCH-BL-2016-019045,BAUSCH AND LOMB,"HORASAWA S, OSAME K, KAWASUMI K, SAITO S, BANDO H, OHASHI K. EFFICACY OF IPRAGLIFLOZIN IN PATIENTS WITH STEROID-INDUCED HYPERGLYCEMIA DURING CANCER CHEMOTHERAPY. GAN TO KAGAKU RYOHO. CANCER + CHEMOTHERAPY. 2016;43(5):645-647.",47.0,YR,,M,Y,,,20161208.0,,PH,JP,JP,2016,Q4,Adult
127304563,12730456,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,PRIOR TO BED,,,,,,,,25.0,IU,,,2016,Q4,Peripheral sensory neuropathy,,2016,Q4,3,F,,20161206.0,20160909,20161208,PER,,JP-BAUSCH-BL-2016-019045,BAUSCH AND LOMB,"HORASAWA S, OSAME K, KAWASUMI K, SAITO S, BANDO H, OHASHI K. EFFICACY OF IPRAGLIFLOZIN IN PATIENTS WITH STEROID-INDUCED HYPERGLYCEMIA DURING CANCER CHEMOTHERAPY. GAN TO KAGAKU RYOHO. CANCER + CHEMOTHERAPY. 2016;43(5):645-647.",47.0,YR,,M,Y,,,20161208.0,,PH,JP,JP,2016,Q4,Adult
127304563,12730456,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,PRIOR TO BED,,,,,,,,10.0,IU,,,2016,Q4,Hyperglycaemia,,2016,Q4,3,F,,20161206.0,20160909,20161208,PER,,JP-BAUSCH-BL-2016-019045,BAUSCH AND LOMB,"HORASAWA S, OSAME K, KAWASUMI K, SAITO S, BANDO H, OHASHI K. EFFICACY OF IPRAGLIFLOZIN IN PATIENTS WITH STEROID-INDUCED HYPERGLYCEMIA DURING CANCER CHEMOTHERAPY. GAN TO KAGAKU RYOHO. CANCER + CHEMOTHERAPY. 2016;43(5):645-647.",47.0,YR,,M,Y,,,20161208.0,,PH,JP,JP,2016,Q4,Adult
127304563,12730456,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,PRIOR TO BED,,,,,,,,10.0,IU,,,2016,Q4,Malaise,,2016,Q4,3,F,,20161206.0,20160909,20161208,PER,,JP-BAUSCH-BL-2016-019045,BAUSCH AND LOMB,"HORASAWA S, OSAME K, KAWASUMI K, SAITO S, BANDO H, OHASHI K. EFFICACY OF IPRAGLIFLOZIN IN PATIENTS WITH STEROID-INDUCED HYPERGLYCEMIA DURING CANCER CHEMOTHERAPY. GAN TO KAGAKU RYOHO. CANCER + CHEMOTHERAPY. 2016;43(5):645-647.",47.0,YR,,M,Y,,,20161208.0,,PH,JP,JP,2016,Q4,Adult
127304563,12730456,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,PRIOR TO BED,,,,,,,,10.0,IU,,,2016,Q4,Nausea,,2016,Q4,3,F,,20161206.0,20160909,20161208,PER,,JP-BAUSCH-BL-2016-019045,BAUSCH AND LOMB,"HORASAWA S, OSAME K, KAWASUMI K, SAITO S, BANDO H, OHASHI K. EFFICACY OF IPRAGLIFLOZIN IN PATIENTS WITH STEROID-INDUCED HYPERGLYCEMIA DURING CANCER CHEMOTHERAPY. GAN TO KAGAKU RYOHO. CANCER + CHEMOTHERAPY. 2016;43(5):645-647.",47.0,YR,,M,Y,,,20161208.0,,PH,JP,JP,2016,Q4,Adult
127304563,12730456,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,PRIOR TO BED,,,,,,,,10.0,IU,,,2016,Q4,Peripheral sensory neuropathy,,2016,Q4,3,F,,20161206.0,20160909,20161208,PER,,JP-BAUSCH-BL-2016-019045,BAUSCH AND LOMB,"HORASAWA S, OSAME K, KAWASUMI K, SAITO S, BANDO H, OHASHI K. EFFICACY OF IPRAGLIFLOZIN IN PATIENTS WITH STEROID-INDUCED HYPERGLYCEMIA DURING CANCER CHEMOTHERAPY. GAN TO KAGAKU RYOHO. CANCER + CHEMOTHERAPY. 2016;43(5):645-647.",47.0,YR,,M,Y,,,20161208.0,,PH,JP,JP,2016,Q4,Adult
127304563,12730456,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,PRIOR TO BED,,,,,,,,16.0,IU,,,2016,Q4,Hyperglycaemia,,2016,Q4,3,F,,20161206.0,20160909,20161208,PER,,JP-BAUSCH-BL-2016-019045,BAUSCH AND LOMB,"HORASAWA S, OSAME K, KAWASUMI K, SAITO S, BANDO H, OHASHI K. EFFICACY OF IPRAGLIFLOZIN IN PATIENTS WITH STEROID-INDUCED HYPERGLYCEMIA DURING CANCER CHEMOTHERAPY. GAN TO KAGAKU RYOHO. CANCER + CHEMOTHERAPY. 2016;43(5):645-647.",47.0,YR,,M,Y,,,20161208.0,,PH,JP,JP,2016,Q4,Adult
127304563,12730456,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,PRIOR TO BED,,,,,,,,16.0,IU,,,2016,Q4,Malaise,,2016,Q4,3,F,,20161206.0,20160909,20161208,PER,,JP-BAUSCH-BL-2016-019045,BAUSCH AND LOMB,"HORASAWA S, OSAME K, KAWASUMI K, SAITO S, BANDO H, OHASHI K. EFFICACY OF IPRAGLIFLOZIN IN PATIENTS WITH STEROID-INDUCED HYPERGLYCEMIA DURING CANCER CHEMOTHERAPY. GAN TO KAGAKU RYOHO. CANCER + CHEMOTHERAPY. 2016;43(5):645-647.",47.0,YR,,M,Y,,,20161208.0,,PH,JP,JP,2016,Q4,Adult
127304563,12730456,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,PRIOR TO BED,,,,,,,,16.0,IU,,,2016,Q4,Nausea,,2016,Q4,3,F,,20161206.0,20160909,20161208,PER,,JP-BAUSCH-BL-2016-019045,BAUSCH AND LOMB,"HORASAWA S, OSAME K, KAWASUMI K, SAITO S, BANDO H, OHASHI K. EFFICACY OF IPRAGLIFLOZIN IN PATIENTS WITH STEROID-INDUCED HYPERGLYCEMIA DURING CANCER CHEMOTHERAPY. GAN TO KAGAKU RYOHO. CANCER + CHEMOTHERAPY. 2016;43(5):645-647.",47.0,YR,,M,Y,,,20161208.0,,PH,JP,JP,2016,Q4,Adult
127304563,12730456,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,PRIOR TO BED,,,,,,,,16.0,IU,,,2016,Q4,Peripheral sensory neuropathy,,2016,Q4,3,F,,20161206.0,20160909,20161208,PER,,JP-BAUSCH-BL-2016-019045,BAUSCH AND LOMB,"HORASAWA S, OSAME K, KAWASUMI K, SAITO S, BANDO H, OHASHI K. EFFICACY OF IPRAGLIFLOZIN IN PATIENTS WITH STEROID-INDUCED HYPERGLYCEMIA DURING CANCER CHEMOTHERAPY. GAN TO KAGAKU RYOHO. CANCER + CHEMOTHERAPY. 2016;43(5):645-647.",47.0,YR,,M,Y,,,20161208.0,,PH,JP,JP,2016,Q4,Adult
127360863,12736086,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,8.0,IU,UNSPECIFIED,QD,2016,Q4,Dehydration,,2016,Q4,3,F,20160901.0,20160930.0,20160912,20161010,EXP,,JP-JNJFOC-20160909179,JANSSEN,,91.0,YR,E,F,Y,41.0,KG,20161010.0,,OT,JP,JP,2016,Q4,Elderly
127375866,12737586,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Anaemia,,2016,Q4,6,F,20160901.0,20161028.0,20160912,20161102,EXP,,US-GILEAD-2016-0232862,GILEAD,,56.0,YR,A,F,Y,56.0,KG,20161102.0,,CN,US,US,2016,Q4,Adult
127375866,12737586,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Gastritis erosive,,2016,Q4,6,F,20160901.0,20161028.0,20160912,20161102,EXP,,US-GILEAD-2016-0232862,GILEAD,,56.0,YR,A,F,Y,56.0,KG,20161102.0,,CN,US,US,2016,Q4,Adult
127375866,12737586,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Generalised oedema,,2016,Q4,6,F,20160901.0,20161028.0,20160912,20161102,EXP,,US-GILEAD-2016-0232862,GILEAD,,56.0,YR,A,F,Y,56.0,KG,20161102.0,,CN,US,US,2016,Q4,Adult
127375866,12737586,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Pain in extremity,,2016,Q4,6,F,20160901.0,20161028.0,20160912,20161102,EXP,,US-GILEAD-2016-0232862,GILEAD,,56.0,YR,A,F,Y,56.0,KG,20161102.0,,CN,US,US,2016,Q4,Adult
127375866,12737586,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Right ventricular failure,,2016,Q4,6,F,20160901.0,20161028.0,20160912,20161102,EXP,,US-GILEAD-2016-0232862,GILEAD,,56.0,YR,A,F,Y,56.0,KG,20161102.0,,CN,US,US,2016,Q4,Adult
127375866,12737586,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Upper gastrointestinal haemorrhage,,2016,Q4,6,F,20160901.0,20161028.0,20160912,20161102,EXP,,US-GILEAD-2016-0232862,GILEAD,,56.0,YR,A,F,Y,56.0,KG,20161102.0,,CN,US,US,2016,Q4,Adult
127422052,12742205,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, PRN",,,,,,,,,,,,2016,Q4,Gastric ulcer,,2016,Q4,2,F,20160513.0,20161020.0,20160914,20161026,EXP,,PHHY2016KR125327,NOVARTIS,,31.0,YR,,M,Y,,,20161026.0,,MD,KR,KR,2016,Q4,Young Adult
127555372,12755537,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,UNSPECIFIED,,2016,Q4,Acute hepatic failure,,2016,Q4,2,F,20160317.0,20161004.0,20160916,20161007,EXP,,GB-JNJFOC-20160915384,JANSSEN,,69.0,YR,E,M,Y,,,20161007.0,,PH,GB,GB,2016,Q4,Elderly
127555372,12755537,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,UNSPECIFIED,,2016,Q4,Acute kidney injury,,2016,Q4,2,F,20160317.0,20161004.0,20160916,20161007,EXP,,GB-JNJFOC-20160915384,JANSSEN,,69.0,YR,E,M,Y,,,20161007.0,,PH,GB,GB,2016,Q4,Elderly
127555372,12755537,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,UNSPECIFIED,,2016,Q4,Coagulopathy,,2016,Q4,2,F,20160317.0,20161004.0,20160916,20161007,EXP,,GB-JNJFOC-20160915384,JANSSEN,,69.0,YR,E,M,Y,,,20161007.0,,PH,GB,GB,2016,Q4,Elderly
127576382,12757638,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"40 U, UNK",,,Y,,,,,40.0,DF,INJECTION,,2016,Q4,Diabetic ketoacidosis,,2016,Q4,2,F,,20160919.0,20160919,20161003,EXP,,PK-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-073938,BRISTOL MYERS SQUIBB,,42.0,YR,,M,Y,,,20161003.0,,CN,GB,PK,2016,Q4,Adult
127576382,12757638,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"20 U, UNK",,,Y,,,,,20.0,DF,INJECTION,,2016,Q4,Diabetic ketoacidosis,,2016,Q4,2,F,,20160919.0,20160919,20161003,EXP,,PK-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-073938,BRISTOL MYERS SQUIBB,,42.0,YR,,M,Y,,,20161003.0,,CN,GB,PK,2016,Q4,Adult
127599802,12759980,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"(300UNIT/ML, INPN) 1.5 ML, UNK",,,,,,,,1.5,ML,,,2016,Q4,No adverse event,,2016,Q4,2,F,,20161011.0,20160919,20161017,PER,,US-PFIZER INC-2016434073,PFIZER,,29.0,YR,,F,Y,47.2,KG,20161017.0,,MD,US,US,2016,Q4,Young Adult
127604734,12760473,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Abasia,,2016,Q4,4,F,20160807.0,20161116.0,20160919,20161118,EXP,,JP-ABBVIE-16P-087-1697363-00,ABBVIE,,72.0,YR,,F,Y,,,20161118.0,,MD,JP,JP,2016,Q4,Elderly
127604734,12760473,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Apathy,,2016,Q4,4,F,20160807.0,20161116.0,20160919,20161118,EXP,,JP-ABBVIE-16P-087-1697363-00,ABBVIE,,72.0,YR,,F,Y,,,20161118.0,,MD,JP,JP,2016,Q4,Elderly
127604734,12760473,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Asthenia,,2016,Q4,4,F,20160807.0,20161116.0,20160919,20161118,EXP,,JP-ABBVIE-16P-087-1697363-00,ABBVIE,,72.0,YR,,F,Y,,,20161118.0,,MD,JP,JP,2016,Q4,Elderly
127604734,12760473,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Dizziness,,2016,Q4,4,F,20160807.0,20161116.0,20160919,20161118,EXP,,JP-ABBVIE-16P-087-1697363-00,ABBVIE,,72.0,YR,,F,Y,,,20161118.0,,MD,JP,JP,2016,Q4,Elderly
127604734,12760473,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Drug interaction,,2016,Q4,4,F,20160807.0,20161116.0,20160919,20161118,EXP,,JP-ABBVIE-16P-087-1697363-00,ABBVIE,,72.0,YR,,F,Y,,,20161118.0,,MD,JP,JP,2016,Q4,Elderly
127604734,12760473,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Dyspraxia,,2016,Q4,4,F,20160807.0,20161116.0,20160919,20161118,EXP,,JP-ABBVIE-16P-087-1697363-00,ABBVIE,,72.0,YR,,F,Y,,,20161118.0,,MD,JP,JP,2016,Q4,Elderly
127604734,12760473,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Hypophagia,,2016,Q4,4,F,20160807.0,20161116.0,20160919,20161118,EXP,,JP-ABBVIE-16P-087-1697363-00,ABBVIE,,72.0,YR,,F,Y,,,20161118.0,,MD,JP,JP,2016,Q4,Elderly
127604734,12760473,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Loss of control of legs,,2016,Q4,4,F,20160807.0,20161116.0,20160919,20161118,EXP,,JP-ABBVIE-16P-087-1697363-00,ABBVIE,,72.0,YR,,F,Y,,,20161118.0,,MD,JP,JP,2016,Q4,Elderly
127604734,12760473,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Muscular weakness,,2016,Q4,4,F,20160807.0,20161116.0,20160919,20161118,EXP,,JP-ABBVIE-16P-087-1697363-00,ABBVIE,,72.0,YR,,F,Y,,,20161118.0,,MD,JP,JP,2016,Q4,Elderly
127625035,12762503,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 IU, 1X/DAY",,,,,,,,15.0,IU,,QD,2016,Q4,Colon cancer,,2016,Q4,5,F,20160617.0,20161206.0,20160920,20161213,EXP,,RU-PFIZER INC-2016395259,PFIZER,,66.0,YR,,M,Y,119.0,KG,20161213.0,,OT,RU,RU,2016,Q4,Elderly
127625035,12762503,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 IU, 1X/DAY",,,,,,,,15.0,IU,,QD,2016,Q4,Disease progression,,2016,Q4,5,F,20160617.0,20161206.0,20160920,20161213,EXP,,RU-PFIZER INC-2016395259,PFIZER,,66.0,YR,,M,Y,119.0,KG,20161213.0,,OT,RU,RU,2016,Q4,Elderly
127625035,12762503,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 IU, 1X/DAY",,,,,,,,15.0,IU,,QD,2016,Q4,Embolism,,2016,Q4,5,F,20160617.0,20161206.0,20160920,20161213,EXP,,RU-PFIZER INC-2016395259,PFIZER,,66.0,YR,,M,Y,119.0,KG,20161213.0,,OT,RU,RU,2016,Q4,Elderly
127625035,12762503,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 IU, 1X/DAY",,,,,,,,15.0,IU,,QD,2016,Q4,Metastases to liver,,2016,Q4,5,F,20160617.0,20161206.0,20160920,20161213,EXP,,RU-PFIZER INC-2016395259,PFIZER,,66.0,YR,,M,Y,119.0,KG,20161213.0,,OT,RU,RU,2016,Q4,Elderly
127625035,12762503,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 IU, 1X/DAY",,,,,,,,15.0,IU,,QD,2016,Q4,Metastases to lung,,2016,Q4,5,F,20160617.0,20161206.0,20160920,20161213,EXP,,RU-PFIZER INC-2016395259,PFIZER,,66.0,YR,,M,Y,119.0,KG,20161213.0,,OT,RU,RU,2016,Q4,Elderly
127625035,12762503,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 IU, 1X/DAY",,,,,,,,15.0,IU,,QD,2016,Q4,Rectal cancer,,2016,Q4,5,F,20160617.0,20161206.0,20160920,20161213,EXP,,RU-PFIZER INC-2016395259,PFIZER,,66.0,YR,,M,Y,119.0,KG,20161213.0,,OT,RU,RU,2016,Q4,Elderly
127643833,12764383,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"80 DF, TID",,,U,,,,,80.0,DF,,TID,2016,Q4,Arthralgia,,2016,Q4,3,F,2012.0,20161121.0,20160920,20161123,EXP,,BR-ELI_LILLY_AND_COMPANY-BR201609004813,ELI LILLY AND CO,,52.0,YR,,F,Y,94.0,KG,20161123.0,,CN,BR,BR,2016,Q4,Adult
127643833,12764383,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"80 DF, TID",,,U,,,,,80.0,DF,,TID,2016,Q4,Blindness,,2016,Q4,3,F,2012.0,20161121.0,20160920,20161123,EXP,,BR-ELI_LILLY_AND_COMPANY-BR201609004813,ELI LILLY AND CO,,52.0,YR,,F,Y,94.0,KG,20161123.0,,CN,BR,BR,2016,Q4,Adult
127643833,12764383,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"80 DF, TID",,,U,,,,,80.0,DF,,TID,2016,Q4,Blood glucose decreased,,2016,Q4,3,F,2012.0,20161121.0,20160920,20161123,EXP,,BR-ELI_LILLY_AND_COMPANY-BR201609004813,ELI LILLY AND CO,,52.0,YR,,F,Y,94.0,KG,20161123.0,,CN,BR,BR,2016,Q4,Adult
127643833,12764383,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"80 DF, TID",,,U,,,,,80.0,DF,,TID,2016,Q4,Blood glucose increased,,2016,Q4,3,F,2012.0,20161121.0,20160920,20161123,EXP,,BR-ELI_LILLY_AND_COMPANY-BR201609004813,ELI LILLY AND CO,,52.0,YR,,F,Y,94.0,KG,20161123.0,,CN,BR,BR,2016,Q4,Adult
127643833,12764383,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"80 DF, TID",,,U,,,,,80.0,DF,,TID,2016,Q4,Diabetic metabolic decompensation,,2016,Q4,3,F,2012.0,20161121.0,20160920,20161123,EXP,,BR-ELI_LILLY_AND_COMPANY-BR201609004813,ELI LILLY AND CO,,52.0,YR,,F,Y,94.0,KG,20161123.0,,CN,BR,BR,2016,Q4,Adult
127643833,12764383,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"80 DF, TID",,,U,,,,,80.0,DF,,TID,2016,Q4,Drug ineffective,,2016,Q4,3,F,2012.0,20161121.0,20160920,20161123,EXP,,BR-ELI_LILLY_AND_COMPANY-BR201609004813,ELI LILLY AND CO,,52.0,YR,,F,Y,94.0,KG,20161123.0,,CN,BR,BR,2016,Q4,Adult
127643833,12764383,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"80 DF, TID",,,U,,,,,80.0,DF,,TID,2016,Q4,Fatigue,,2016,Q4,3,F,2012.0,20161121.0,20160920,20161123,EXP,,BR-ELI_LILLY_AND_COMPANY-BR201609004813,ELI LILLY AND CO,,52.0,YR,,F,Y,94.0,KG,20161123.0,,CN,BR,BR,2016,Q4,Adult
127643833,12764383,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"80 DF, TID",,,U,,,,,80.0,DF,,TID,2016,Q4,Incorrect product storage,,2016,Q4,3,F,2012.0,20161121.0,20160920,20161123,EXP,,BR-ELI_LILLY_AND_COMPANY-BR201609004813,ELI LILLY AND CO,,52.0,YR,,F,Y,94.0,KG,20161123.0,,CN,BR,BR,2016,Q4,Adult
127643833,12764383,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"80 DF, TID",,,U,,,,,80.0,DF,,TID,2016,Q4,Weight increased,,2016,Q4,3,F,2012.0,20161121.0,20160920,20161123,EXP,,BR-ELI_LILLY_AND_COMPANY-BR201609004813,ELI LILLY AND CO,,52.0,YR,,F,Y,94.0,KG,20161123.0,,CN,BR,BR,2016,Q4,Adult
127670595,12767059,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,INJECT 5 UNITS DAILY IN MORNING,,,,U,,,,,,,,2016,Q4,Avulsion fracture,,2016,Q4,5,F,201609.0,20161028.0,20160921,20161108,EXP,,US-ACTELION-A-NJ2016-142310,ACTELION,,50.0,YR,A,F,Y,,,20161108.0,,OT,US,US,2016,Q4,Adult
127670595,12767059,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,INJECT 5 UNITS DAILY IN MORNING,,,,U,,,,,,,,2016,Q4,Fall,,2016,Q4,5,F,201609.0,20161028.0,20160921,20161108,EXP,,US-ACTELION-A-NJ2016-142310,ACTELION,,50.0,YR,A,F,Y,,,20161108.0,,OT,US,US,2016,Q4,Adult
127670595,12767059,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,INJECT 5 UNITS DAILY IN MORNING,,,,U,,,,,,,,2016,Q4,Immune thrombocytopenic purpura,,2016,Q4,5,F,201609.0,20161028.0,20160921,20161108,EXP,,US-ACTELION-A-NJ2016-142310,ACTELION,,50.0,YR,A,F,Y,,,20161108.0,,OT,US,US,2016,Q4,Adult
127670595,12767059,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,INJECT 5 UNITS DAILY IN MORNING,,,,U,,,,,,,,2016,Q4,Ligament sprain,,2016,Q4,5,F,201609.0,20161028.0,20160921,20161108,EXP,,US-ACTELION-A-NJ2016-142310,ACTELION,,50.0,YR,A,F,Y,,,20161108.0,,OT,US,US,2016,Q4,Adult
127670595,12767059,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,INJECT 5 UNITS DAILY IN MORNING,,,,U,,,,,,,,2016,Q4,Limb injury,,2016,Q4,5,F,201609.0,20161028.0,20160921,20161108,EXP,,US-ACTELION-A-NJ2016-142310,ACTELION,,50.0,YR,A,F,Y,,,20161108.0,,OT,US,US,2016,Q4,Adult
127670595,12767059,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,INJECT 5 UNITS DAILY IN MORNING,,,,U,,,,,,,,2016,Q4,Lower limb fracture,,2016,Q4,5,F,201609.0,20161028.0,20160921,20161108,EXP,,US-ACTELION-A-NJ2016-142310,ACTELION,,50.0,YR,A,F,Y,,,20161108.0,,OT,US,US,2016,Q4,Adult
127670595,12767059,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,INJECT 5 UNITS DAILY IN MORNING,,,,U,,,,,,,,2016,Q4,Platelet count decreased,,2016,Q4,5,F,201609.0,20161028.0,20160921,20161108,EXP,,US-ACTELION-A-NJ2016-142310,ACTELION,,50.0,YR,A,F,Y,,,20161108.0,,OT,US,US,2016,Q4,Adult
127675632,12767563,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q4,Cardiac failure congestive,,2016,Q4,2,F,20160526.0,20161006.0,20160921,20161017,EXP,,US-SA-2016SA173565,AVENTIS,,75.0,YR,E,M,Y,100.0,KG,20161017.0,,OT,IT,IT,2016,Q4,Elderly
127675632,12767563,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q4,Dyspnoea,,2016,Q4,2,F,20160526.0,20161006.0,20160921,20161017,EXP,,US-SA-2016SA173565,AVENTIS,,75.0,YR,E,M,Y,100.0,KG,20161017.0,,OT,IT,IT,2016,Q4,Elderly
127675632,12767563,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q4,Pulmonary hypertension,,2016,Q4,2,F,20160526.0,20161006.0,20160921,20161017,EXP,,US-SA-2016SA173565,AVENTIS,,75.0,YR,E,M,Y,100.0,KG,20161017.0,,OT,IT,IT,2016,Q4,Elderly
127681913,12768191,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 UNIT, TOTAL DAILY DOSE",,,,,,,,,,,,2016,Q4,Fall,,2016,Q4,3,F,20160828.0,20161005.0,20160921,20161011,EXP,,US-UNITED THERAPEUTICS-UNT-2016-013800,UNITED THERAPEUTICS,,72.0,YR,,M,Y,95.69,KG,20161011.0,,CN,US,US,2016,Q4,Elderly
127681913,12768191,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 UNIT, TOTAL DAILY DOSE",,,,,,,,,,,,2016,Q4,Fluid overload,,2016,Q4,3,F,20160828.0,20161005.0,20160921,20161011,EXP,,US-UNITED THERAPEUTICS-UNT-2016-013800,UNITED THERAPEUTICS,,72.0,YR,,M,Y,95.69,KG,20161011.0,,CN,US,US,2016,Q4,Elderly
127681913,12768191,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 UNIT, TOTAL DAILY DOSE",,,,,,,,,,,,2016,Q4,Joint injury,,2016,Q4,3,F,20160828.0,20161005.0,20160921,20161011,EXP,,US-UNITED THERAPEUTICS-UNT-2016-013800,UNITED THERAPEUTICS,,72.0,YR,,M,Y,95.69,KG,20161011.0,,CN,US,US,2016,Q4,Elderly
127681913,12768191,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 UNIT, TOTAL DAILY DOSE",,,,,,,,,,,,2016,Q4,Off label use,,2016,Q4,3,F,20160828.0,20161005.0,20160921,20161011,EXP,,US-UNITED THERAPEUTICS-UNT-2016-013800,UNITED THERAPEUTICS,,72.0,YR,,M,Y,95.69,KG,20161011.0,,CN,US,US,2016,Q4,Elderly
127681913,12768191,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 UNIT, TOTAL DAILY DOSE",,,,,,,,,,,,2016,Q4,Oxygen saturation decreased,,2016,Q4,3,F,20160828.0,20161005.0,20160921,20161011,EXP,,US-UNITED THERAPEUTICS-UNT-2016-013800,UNITED THERAPEUTICS,,72.0,YR,,M,Y,95.69,KG,20161011.0,,CN,US,US,2016,Q4,Elderly
127868273,12786827,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UI/ML- ML,,,,,,,,46.0,DF,SOLUTION FOR INJECTION IN PRE-FILLED PEN,,2016,Q4,Abdominal pain upper,,2016,Q4,3,F,20160801.0,20161104.0,20160928,20161107,EXP,,CO-ABBVIE-16K-036-1736767-00,ABBVIE,,64.0,YR,,F,Y,55.0,KG,20161107.0,,CN,CO,CO,2016,Q4,Adult
127868273,12786827,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UI/ML- ML,,,,,,,,46.0,DF,SOLUTION FOR INJECTION IN PRE-FILLED PEN,,2016,Q4,Back pain,,2016,Q4,3,F,20160801.0,20161104.0,20160928,20161107,EXP,,CO-ABBVIE-16K-036-1736767-00,ABBVIE,,64.0,YR,,F,Y,55.0,KG,20161107.0,,CN,CO,CO,2016,Q4,Adult
127868273,12786827,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UI/ML- ML,,,,,,,,46.0,DF,SOLUTION FOR INJECTION IN PRE-FILLED PEN,,2016,Q4,Cholelithiasis,,2016,Q4,3,F,20160801.0,20161104.0,20160928,20161107,EXP,,CO-ABBVIE-16K-036-1736767-00,ABBVIE,,64.0,YR,,F,Y,55.0,KG,20161107.0,,CN,CO,CO,2016,Q4,Adult
127868273,12786827,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UI/ML- ML,,,,,,,,46.0,DF,SOLUTION FOR INJECTION IN PRE-FILLED PEN,,2016,Q4,Drug ineffective,,2016,Q4,3,F,20160801.0,20161104.0,20160928,20161107,EXP,,CO-ABBVIE-16K-036-1736767-00,ABBVIE,,64.0,YR,,F,Y,55.0,KG,20161107.0,,CN,CO,CO,2016,Q4,Adult
127868273,12786827,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UI/ML- ML,,,,,,,,46.0,DF,SOLUTION FOR INJECTION IN PRE-FILLED PEN,,2016,Q4,Hepatic steatosis,,2016,Q4,3,F,20160801.0,20161104.0,20160928,20161107,EXP,,CO-ABBVIE-16K-036-1736767-00,ABBVIE,,64.0,YR,,F,Y,55.0,KG,20161107.0,,CN,CO,CO,2016,Q4,Adult
127868273,12786827,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UI/ML- ML,,,,,,,,46.0,DF,SOLUTION FOR INJECTION IN PRE-FILLED PEN,,2016,Q4,Splenomegaly,,2016,Q4,3,F,20160801.0,20161104.0,20160928,20161107,EXP,,CO-ABBVIE-16K-036-1736767-00,ABBVIE,,64.0,YR,,F,Y,55.0,KG,20161107.0,,CN,CO,CO,2016,Q4,Adult
127965212,12796521,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Anaemia,,2016,Q4,2,F,,20160928.0,20160929,20161006,EXP,,IT-009507513-1609ITA010031,MERCK,,61.0,YR,,M,Y,,,20161006.0,,MD,IT,IT,2016,Q4,Adult
127965212,12796521,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Porphyria non-acute,,2016,Q4,2,F,,20160928.0,20160929,20161006,EXP,,IT-009507513-1609ITA010031,MERCK,,61.0,YR,,M,Y,,,20161006.0,,MD,IT,IT,2016,Q4,Adult
127999163,12799916,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 U, QD (44-0-0)",,,U,U, UNKNOWN,,,44.0,DF,,QD,2016,Q4,Craniocerebral injury,,2016,Q4,3,F,2010.0,20161028.0,20160930,20161108,EXP,,ES-NOVOPROD-511118,NOVO NORDISK,,75.0,YR,E,M,Y,,,20161108.0,,MD,ES,ES,2016,Q4,Elderly
127999163,12799916,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 U, QD (44-0-0)",,,U,U, UNKNOWN,,,44.0,DF,,QD,2016,Q4,Hypoglycaemia,,2016,Q4,3,F,2010.0,20161028.0,20160930,20161108,EXP,,ES-NOVOPROD-511118,NOVO NORDISK,,75.0,YR,E,M,Y,,,20161108.0,,MD,ES,ES,2016,Q4,Elderly
127999163,12799916,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 U, QD (44-0-0)",,,U,U, UNKNOWN,,,44.0,DF,,QD,2016,Q4,Macular oedema,,2016,Q4,3,F,2010.0,20161028.0,20160930,20161108,EXP,,ES-NOVOPROD-511118,NOVO NORDISK,,75.0,YR,E,M,Y,,,20161108.0,,MD,ES,ES,2016,Q4,Elderly
127999163,12799916,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 U, QD (44-0-0)",,,U,U, UNKNOWN,,,44.0,DF,,QD,2016,Q4,Skin ulcer,,2016,Q4,3,F,2010.0,20161028.0,20160930,20161108,EXP,,ES-NOVOPROD-511118,NOVO NORDISK,,75.0,YR,E,M,Y,,,20161108.0,,MD,ES,ES,2016,Q4,Elderly
127999163,12799916,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U, UNKNOWN,,,,,,,2016,Q4,Craniocerebral injury,,2016,Q4,3,F,2010.0,20161028.0,20160930,20161108,EXP,,ES-NOVOPROD-511118,NOVO NORDISK,,75.0,YR,E,M,Y,,,20161108.0,,MD,ES,ES,2016,Q4,Elderly
127999163,12799916,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U, UNKNOWN,,,,,,,2016,Q4,Hypoglycaemia,,2016,Q4,3,F,2010.0,20161028.0,20160930,20161108,EXP,,ES-NOVOPROD-511118,NOVO NORDISK,,75.0,YR,E,M,Y,,,20161108.0,,MD,ES,ES,2016,Q4,Elderly
127999163,12799916,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U, UNKNOWN,,,,,,,2016,Q4,Macular oedema,,2016,Q4,3,F,2010.0,20161028.0,20160930,20161108,EXP,,ES-NOVOPROD-511118,NOVO NORDISK,,75.0,YR,E,M,Y,,,20161108.0,,MD,ES,ES,2016,Q4,Elderly
127999163,12799916,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U, UNKNOWN,,,,,,,2016,Q4,Skin ulcer,,2016,Q4,3,F,2010.0,20161028.0,20160930,20161108,EXP,,ES-NOVOPROD-511118,NOVO NORDISK,,75.0,YR,E,M,Y,,,20161108.0,,MD,ES,ES,2016,Q4,Elderly
127999163,12799916,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"22 U, QD",,,U,U, UNKNOWN,,,22.0,DF,,QD,2016,Q4,Craniocerebral injury,,2016,Q4,3,F,2010.0,20161028.0,20160930,20161108,EXP,,ES-NOVOPROD-511118,NOVO NORDISK,,75.0,YR,E,M,Y,,,20161108.0,,MD,ES,ES,2016,Q4,Elderly
127999163,12799916,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"22 U, QD",,,U,U, UNKNOWN,,,22.0,DF,,QD,2016,Q4,Hypoglycaemia,,2016,Q4,3,F,2010.0,20161028.0,20160930,20161108,EXP,,ES-NOVOPROD-511118,NOVO NORDISK,,75.0,YR,E,M,Y,,,20161108.0,,MD,ES,ES,2016,Q4,Elderly
127999163,12799916,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"22 U, QD",,,U,U, UNKNOWN,,,22.0,DF,,QD,2016,Q4,Macular oedema,,2016,Q4,3,F,2010.0,20161028.0,20160930,20161108,EXP,,ES-NOVOPROD-511118,NOVO NORDISK,,75.0,YR,E,M,Y,,,20161108.0,,MD,ES,ES,2016,Q4,Elderly
127999163,12799916,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"22 U, QD",,,U,U, UNKNOWN,,,22.0,DF,,QD,2016,Q4,Skin ulcer,,2016,Q4,3,F,2010.0,20161028.0,20160930,20161108,EXP,,ES-NOVOPROD-511118,NOVO NORDISK,,75.0,YR,E,M,Y,,,20161108.0,,MD,ES,ES,2016,Q4,Elderly
128023821,12802382,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Anaemia,,2016,Q4,1,I,,20160919.0,20161003,20161003,EXP,,IT-ROCHE-1832059,ROCHE,"DRAGO F, GASPARINI G, MARENCO S, PICCIOTTO A AND PARODI A. PORPHYRIN ELEVATION IN A PATIENT ON TREATMENT WITH SIMEPREVIR: COULD IT BE A POSSIBLE EXPLANATION FOR SIMEPREVIR-ASSOCIATED PHOTOSENSITIVITY?. AMERICAN JOURNAL OF GASTROENTEROLOGY 2016 SEP 01;111 (9):1368-.",61.0,YR,,M,Y,,,20161003.0,,MD,IT,IT,2016,Q4,Adult
128023821,12802382,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Hepatitis C,,2016,Q4,1,I,,20160919.0,20161003,20161003,EXP,,IT-ROCHE-1832059,ROCHE,"DRAGO F, GASPARINI G, MARENCO S, PICCIOTTO A AND PARODI A. PORPHYRIN ELEVATION IN A PATIENT ON TREATMENT WITH SIMEPREVIR: COULD IT BE A POSSIBLE EXPLANATION FOR SIMEPREVIR-ASSOCIATED PHOTOSENSITIVITY?. AMERICAN JOURNAL OF GASTROENTEROLOGY 2016 SEP 01;111 (9):1368-.",61.0,YR,,M,Y,,,20161003.0,,MD,IT,IT,2016,Q4,Adult
128023821,12802382,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Porphyria non-acute,,2016,Q4,1,I,,20160919.0,20161003,20161003,EXP,,IT-ROCHE-1832059,ROCHE,"DRAGO F, GASPARINI G, MARENCO S, PICCIOTTO A AND PARODI A. PORPHYRIN ELEVATION IN A PATIENT ON TREATMENT WITH SIMEPREVIR: COULD IT BE A POSSIBLE EXPLANATION FOR SIMEPREVIR-ASSOCIATED PHOTOSENSITIVITY?. AMERICAN JOURNAL OF GASTROENTEROLOGY 2016 SEP 01;111 (9):1368-.",61.0,YR,,M,Y,,,20161003.0,,MD,IT,IT,2016,Q4,Adult
128048161,12804816,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,205692.0,,,,,2016,Q4,Hyperglycaemia,,2016,Q4,1,I,20160909.0,20160921.0,20161003,20161003,EXP,GB-MHRA-EYC 00145376,GB-ELI_LILLY_AND_COMPANY-GB201609007570,ELI LILLY AND CO,,92.0,YR,,M,Y,,,20161003.0,,CN,GB,GB,2016,Q4,Elderly
128170251,12817025,6,C,Insulin Glargine,INSULIN GLARGINE,1,Oral,,,,,,,,,,,,,2016,Q4,Cardiac disorder,,2016,Q4,1,I,201609.0,20160927.0,20161006,20161006,EXP,,CO-BAXTER-2016BAX050192,BAXTER,,75.0,YR,,F,Y,70.0,KG,20161006.0,,OT,CO,CO,2016,Q4,Elderly
128170251,12817025,6,C,Insulin Glargine,INSULIN GLARGINE,1,Oral,,,,,,,,,,,,,2016,Q4,Delirium,,2016,Q4,1,I,201609.0,20160927.0,20161006,20161006,EXP,,CO-BAXTER-2016BAX050192,BAXTER,,75.0,YR,,F,Y,70.0,KG,20161006.0,,OT,CO,CO,2016,Q4,Elderly
128170251,12817025,6,C,Insulin Glargine,INSULIN GLARGINE,1,Oral,,,,,,,,,,,,,2016,Q4,Diarrhoea,,2016,Q4,1,I,201609.0,20160927.0,20161006,20161006,EXP,,CO-BAXTER-2016BAX050192,BAXTER,,75.0,YR,,F,Y,70.0,KG,20161006.0,,OT,CO,CO,2016,Q4,Elderly
128170251,12817025,6,C,Insulin Glargine,INSULIN GLARGINE,1,Oral,,,,,,,,,,,,,2016,Q4,Peritonitis bacterial,,2016,Q4,1,I,201609.0,20160927.0,20161006,20161006,EXP,,CO-BAXTER-2016BAX050192,BAXTER,,75.0,YR,,F,Y,70.0,KG,20161006.0,,OT,CO,CO,2016,Q4,Elderly
128227242,12822724,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2016,Q4,Blister,,2016,Q4,2,F,,20161024.0,20161007,20161107,EXP,,IT-AUROBINDO-AUR-APL-2016-12421,AUROBINDO,,61.0,YR,,M,Y,,,20161107.0,,MD,IT,IT,2016,Q4,Adult
128227242,12822724,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2016,Q4,Erythema,,2016,Q4,2,F,,20161024.0,20161007,20161107,EXP,,IT-AUROBINDO-AUR-APL-2016-12421,AUROBINDO,,61.0,YR,,M,Y,,,20161107.0,,MD,IT,IT,2016,Q4,Adult
128227242,12822724,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2016,Q4,Lip erosion,,2016,Q4,2,F,,20161024.0,20161007,20161107,EXP,,IT-AUROBINDO-AUR-APL-2016-12421,AUROBINDO,,61.0,YR,,M,Y,,,20161107.0,,MD,IT,IT,2016,Q4,Adult
128227242,12822724,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2016,Q4,Porphyria non-acute,,2016,Q4,2,F,,20161024.0,20161007,20161107,EXP,,IT-AUROBINDO-AUR-APL-2016-12421,AUROBINDO,,61.0,YR,,M,Y,,,20161107.0,,MD,IT,IT,2016,Q4,Adult
128227242,12822724,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2016,Q4,Skin exfoliation,,2016,Q4,2,F,,20161024.0,20161007,20161107,EXP,,IT-AUROBINDO-AUR-APL-2016-12421,AUROBINDO,,61.0,YR,,M,Y,,,20161107.0,,MD,IT,IT,2016,Q4,Adult
128227242,12822724,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2016,Q4,Skin lesion,,2016,Q4,2,F,,20161024.0,20161007,20161107,EXP,,IT-AUROBINDO-AUR-APL-2016-12421,AUROBINDO,,61.0,YR,,M,Y,,,20161107.0,,MD,IT,IT,2016,Q4,Adult
128264191,12826419,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2016,Q4,Cholecystitis,,2016,Q4,1,I,20160923.0,20160926.0,20161006,20161006,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-080557,BRISTOL MYERS SQUIBB,,38.0,YR,,M,Y,81.0,KG,20161006.0,,OT,US,US,2016,Q4,Adult
128264221,12826422,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,,,,,,30.0,IU,,QD,2016,Q4,Haematuria,,2016,Q4,1,I,20160130.0,20160922.0,20161006,20161006,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-078713,BRISTOL MYERS SQUIBB,,79.0,YR,,M,Y,79.0,KG,20161006.0,,MD,US,US,2016,Q4,Elderly
128264221,12826422,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,,,,,,30.0,IU,,QD,2016,Q4,Thrombosis,,2016,Q4,1,I,20160130.0,20160922.0,20161006,20161006,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-078713,BRISTOL MYERS SQUIBB,,79.0,YR,,M,Y,79.0,KG,20161006.0,,MD,US,US,2016,Q4,Elderly
128306257,12830625,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DAILY DOSE: 8U/1,,,,,,,,,,,QD,2016,Q4,Acute pulmonary oedema,,2016,Q4,7,F,20160513.0,20161213.0,20161007,20161215,EXP,,"MX-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-43654BI",BOEHRINGER INGELHEIM,,70.0,YR,,M,Y,67.0,KG,20161215.0,,MD,MX,MX,2016,Q4,Elderly
128306257,12830625,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DAILY DOSE: 8U/1,,,,,,,,,,,QD,2016,Q4,Chest wall tumour,,2016,Q4,7,F,20160513.0,20161213.0,20161007,20161215,EXP,,"MX-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-43654BI",BOEHRINGER INGELHEIM,,70.0,YR,,M,Y,67.0,KG,20161215.0,,MD,MX,MX,2016,Q4,Elderly
128306257,12830625,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DAILY DOSE: 8U/1,,,,,,,,,,,QD,2016,Q4,Electrolyte imbalance,,2016,Q4,7,F,20160513.0,20161213.0,20161007,20161215,EXP,,"MX-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-43654BI",BOEHRINGER INGELHEIM,,70.0,YR,,M,Y,67.0,KG,20161215.0,,MD,MX,MX,2016,Q4,Elderly
128306257,12830625,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DAILY DOSE: 8U/1,,,,,,,,,,,QD,2016,Q4,Gastrointestinal haemorrhage,,2016,Q4,7,F,20160513.0,20161213.0,20161007,20161215,EXP,,"MX-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-43654BI",BOEHRINGER INGELHEIM,,70.0,YR,,M,Y,67.0,KG,20161215.0,,MD,MX,MX,2016,Q4,Elderly
128306257,12830625,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DAILY DOSE: 8U/1,,,,,,,,,,,QD,2016,Q4,Hyperkalaemia,,2016,Q4,7,F,20160513.0,20161213.0,20161007,20161215,EXP,,"MX-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-43654BI",BOEHRINGER INGELHEIM,,70.0,YR,,M,Y,67.0,KG,20161215.0,,MD,MX,MX,2016,Q4,Elderly
128306257,12830625,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DAILY DOSE: 8U/1,,,,,,,,,,,QD,2016,Q4,Hyperosmolar state,,2016,Q4,7,F,20160513.0,20161213.0,20161007,20161215,EXP,,"MX-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-43654BI",BOEHRINGER INGELHEIM,,70.0,YR,,M,Y,67.0,KG,20161215.0,,MD,MX,MX,2016,Q4,Elderly
128306257,12830625,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DAILY DOSE: 8U/1,,,,,,,,,,,QD,2016,Q4,Pneumonia,,2016,Q4,7,F,20160513.0,20161213.0,20161007,20161215,EXP,,"MX-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-43654BI",BOEHRINGER INGELHEIM,,70.0,YR,,M,Y,67.0,KG,20161215.0,,MD,MX,MX,2016,Q4,Elderly
128306257,12830625,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DAILY DOSE: 8U/1,,,,,,,,,,,QD,2016,Q4,Renal failure,,2016,Q4,7,F,20160513.0,20161213.0,20161007,20161215,EXP,,"MX-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-43654BI",BOEHRINGER INGELHEIM,,70.0,YR,,M,Y,67.0,KG,20161215.0,,MD,MX,MX,2016,Q4,Elderly
128306257,12830625,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DAILY DOSE: 8U/1,,,,,,,,,,,QD,2016,Q4,Urinary tract infection,,2016,Q4,7,F,20160513.0,20161213.0,20161007,20161215,EXP,,"MX-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-43654BI",BOEHRINGER INGELHEIM,,70.0,YR,,M,Y,67.0,KG,20161215.0,,MD,MX,MX,2016,Q4,Elderly
128313053,12831305,6,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,10.0,IU,,QD,2016,Q4,Chronic kidney disease,,2016,Q4,3,F,20160702.0,20161020.0,20161008,20161027,EXP,,"CO-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-45703BI",BOEHRINGER INGELHEIM,,59.0,YR,,F,Y,48.0,KG,20161028.0,,MD,CO,CO,2016,Q4,Adult
128313053,12831305,6,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,10.0,IU,,QD,2016,Q4,Pneumonia,,2016,Q4,3,F,20160702.0,20161020.0,20161008,20161027,EXP,,"CO-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-45703BI",BOEHRINGER INGELHEIM,,59.0,YR,,F,Y,48.0,KG,20161028.0,,MD,CO,CO,2016,Q4,Adult
128313053,12831305,7,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Oral,,,,,,,,,500.0,MG,,QD,2016,Q4,Chronic kidney disease,,2016,Q4,3,F,20160702.0,20161020.0,20161008,20161027,EXP,,"CO-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-45703BI",BOEHRINGER INGELHEIM,,59.0,YR,,F,Y,48.0,KG,20161028.0,,MD,CO,CO,2016,Q4,Adult
128313053,12831305,7,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Oral,,,,,,,,,500.0,MG,,QD,2016,Q4,Pneumonia,,2016,Q4,3,F,20160702.0,20161020.0,20161008,20161027,EXP,,"CO-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-45703BI",BOEHRINGER INGELHEIM,,59.0,YR,,F,Y,48.0,KG,20161028.0,,MD,CO,CO,2016,Q4,Adult
128313072,12831307,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,26.0,IU,,QD,2016,Q4,Chronic kidney disease,,2016,Q4,2,F,20160621.0,20161004.0,20161008,20161012,EXP,,"AR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-56069BI",BOEHRINGER INGELHEIM,,67.0,YR,,M,Y,78.0,KG,20161012.0,,MD,AR,AR,2016,Q4,Elderly
128333342,12833334,8,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Oral,,,,,,,,,30.0,IU,,QD,2016,Q4,Basal cell carcinoma,,2016,Q4,2,F,20151027.0,20161008.0,20161010,20161014,EXP,,"AR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-15862BI",BOEHRINGER INGELHEIM,,68.0,YR,,M,Y,84.5,KG,20161015.0,,MD,AR,AR,2016,Q4,Elderly
128342562,12834256,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 UNITS PRIOR TO BED.,,,,,,,,,,,,2016,Q4,Hyperglycaemia,,2016,Q4,2,F,,20161206.0,20161010,20161208,EXP,,JP-BAUSCH-BL-2016-024800,BAUSCH AND LOMB,"HORASAWA S, OSAME K, KAWASUMI K, SAITO S, BANDO H, OHASHI K. EFFICACY OF IPRAGLIFLOZIN IN PATIENTS WITH STEROID-INDUCED HYPERGLYCEMIA DURING CANCER CHEMOTHERAPY. GAN TO KAGAKU RYOHO. CANCER AND CHEMOTHERAPY. 2016 MAY 01;43(5):645-647.",47.0,YR,,M,Y,,,20161208.0,,OT,JP,JP,2016,Q4,Adult
128342562,12834256,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 UNITS PRIOR TO BED.,,,,,,,,,,,,2016,Q4,Malaise,,2016,Q4,2,F,,20161206.0,20161010,20161208,EXP,,JP-BAUSCH-BL-2016-024800,BAUSCH AND LOMB,"HORASAWA S, OSAME K, KAWASUMI K, SAITO S, BANDO H, OHASHI K. EFFICACY OF IPRAGLIFLOZIN IN PATIENTS WITH STEROID-INDUCED HYPERGLYCEMIA DURING CANCER CHEMOTHERAPY. GAN TO KAGAKU RYOHO. CANCER AND CHEMOTHERAPY. 2016 MAY 01;43(5):645-647.",47.0,YR,,M,Y,,,20161208.0,,OT,JP,JP,2016,Q4,Adult
128342562,12834256,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 UNITS PRIOR TO BED.,,,,,,,,,,,,2016,Q4,Peripheral sensory neuropathy,,2016,Q4,2,F,,20161206.0,20161010,20161208,EXP,,JP-BAUSCH-BL-2016-024800,BAUSCH AND LOMB,"HORASAWA S, OSAME K, KAWASUMI K, SAITO S, BANDO H, OHASHI K. EFFICACY OF IPRAGLIFLOZIN IN PATIENTS WITH STEROID-INDUCED HYPERGLYCEMIA DURING CANCER CHEMOTHERAPY. GAN TO KAGAKU RYOHO. CANCER AND CHEMOTHERAPY. 2016 MAY 01;43(5):645-647.",47.0,YR,,M,Y,,,20161208.0,,OT,JP,JP,2016,Q4,Adult
128362121,12836212,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q4,Gastrointestinal haemorrhage,,2016,Q4,1,I,20160401.0,20160928.0,20161011,20161011,EXP,,US-SA-2016SA184640,AVENTIS,,68.0,YR,E,M,Y,67.0,KG,20161011.0,,PH,US,US,2016,Q4,Elderly
128362121,12836212,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q4,Stoma site infection,,2016,Q4,1,I,20160401.0,20160928.0,20161011,20161011,EXP,,US-SA-2016SA184640,AVENTIS,,68.0,YR,E,M,Y,67.0,KG,20161011.0,,PH,US,US,2016,Q4,Elderly
128402981,12840298,2,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,15.0,IU,,QD,2016,Q4,Chronic obstructive pulmonary disease,,2016,Q4,1,I,20160827.0,20160930.0,20161012,20161012,EXP,,"AR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-065294",BOEHRINGER INGELHEIM,,63.0,YR,,M,Y,80.0,KG,20161012.0,,MD,AR,AR,2016,Q4,Adult
128402981,12840298,2,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,15.0,IU,,QD,2016,Q4,Sinus node dysfunction,,2016,Q4,1,I,20160827.0,20160930.0,20161012,20161012,EXP,,"AR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-065294",BOEHRINGER INGELHEIM,,63.0,YR,,M,Y,80.0,KG,20161012.0,,MD,AR,AR,2016,Q4,Adult
128413331,12841333,2,C,GLARGINE INSULINE,,2,Subcutaneous,,,,,,,,,26.0,IU,,QD,2016,Q4,Atrial fibrillation,,2016,Q4,1,I,20160807.0,20160930.0,20161012,20161012,EXP,,"CL-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-065351",BOEHRINGER INGELHEIM,,61.0,YR,,M,Y,76.5,KG,20161012.0,,MD,CL,CL,2016,Q4,Adult
128413331,12841333,3,C,GLARGINE INSULINE,,2,Subcutaneous,,,,,,,,,22.0,IU,,QD,2016,Q4,Atrial fibrillation,,2016,Q4,1,I,20160807.0,20160930.0,20161012,20161012,EXP,,"CL-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-065351",BOEHRINGER INGELHEIM,,61.0,YR,,M,Y,76.5,KG,20161012.0,,MD,CL,CL,2016,Q4,Adult
128413331,12841333,4,C,GLARGINE INSULINE,,2,Subcutaneous,,,,,,,,,24.0,IU,,QD,2016,Q4,Atrial fibrillation,,2016,Q4,1,I,20160807.0,20160930.0,20161012,20161012,EXP,,"CL-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-065351",BOEHRINGER INGELHEIM,,61.0,YR,,M,Y,76.5,KG,20161012.0,,MD,CL,CL,2016,Q4,Adult
128415422,12841542,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,FORMULATION: INJECTION,,,,,,,,6.0,IU,,QD,2016,Q4,Intervertebral disc protrusion,,2016,Q4,2,F,20160711.0,20161014.0,20161012,20161026,EXP,,"CN-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-49345BI",BOEHRINGER INGELHEIM,,75.0,YR,,M,Y,62.0,KG,20161027.0,,MD,CN,CN,2016,Q4,Elderly
128415422,12841542,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,FORMULATION: INJECTION,,,,,,,,6.0,IU,,QD,2016,Q4,Spinal osteoarthritis,,2016,Q4,2,F,20160711.0,20161014.0,20161012,20161026,EXP,,"CN-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-49345BI",BOEHRINGER INGELHEIM,,75.0,YR,,M,Y,62.0,KG,20161027.0,,MD,CN,CN,2016,Q4,Elderly
128433481,12843348,20,C,INEINSULIN GLARGINE,,2,,,,,,,,,,,,,,2016,Q4,Acute kidney injury,,2016,Q4,1,I,20160729.0,,20161013,20161013,DIR,,,FDA-CTU,,55.0,YR,,M,N,59.0,KG,20161007.0,N,MD,US,US,2016,Q4,Adult
128433481,12843348,20,C,INEINSULIN GLARGINE,,2,,,,,,,,,,,,,,2016,Q4,Depression,,2016,Q4,1,I,20160729.0,,20161013,20161013,DIR,,,FDA-CTU,,55.0,YR,,M,N,59.0,KG,20161007.0,N,MD,US,US,2016,Q4,Adult
128433481,12843348,20,C,INEINSULIN GLARGINE,,2,,,,,,,,,,,,,,2016,Q4,Glycosylated haemoglobin increased,,2016,Q4,1,I,20160729.0,,20161013,20161013,DIR,,,FDA-CTU,,55.0,YR,,M,N,59.0,KG,20161007.0,N,MD,US,US,2016,Q4,Adult
128443062,12844306,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q4,Breast cancer,,2016,Q4,2,F,201609.0,20161025.0,20161013,20161027,EXP,,CA-SA-2016SA182788,AVENTIS,,79.0,YR,E,F,Y,,,20161027.0,,CN,CA,CA,2016,Q4,Elderly
128443062,12844306,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q4,Hepatic enzyme increased,,2016,Q4,2,F,201609.0,20161025.0,20161013,20161027,EXP,,CA-SA-2016SA182788,AVENTIS,,79.0,YR,E,F,Y,,,20161027.0,,CN,CA,CA,2016,Q4,Elderly
128443062,12844306,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q4,Post procedural infection,,2016,Q4,2,F,201609.0,20161025.0,20161013,20161027,EXP,,CA-SA-2016SA182788,AVENTIS,,79.0,YR,E,F,Y,,,20161027.0,,CN,CA,CA,2016,Q4,Elderly
128443062,12844306,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q4,Skin disorder,,2016,Q4,2,F,201609.0,20161025.0,20161013,20161027,EXP,,CA-SA-2016SA182788,AVENTIS,,79.0,YR,E,F,Y,,,20161027.0,,CN,CA,CA,2016,Q4,Elderly
128443062,12844306,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q4,Urinary tract infection,,2016,Q4,2,F,201609.0,20161025.0,20161013,20161027,EXP,,CA-SA-2016SA182788,AVENTIS,,79.0,YR,E,F,Y,,,20161027.0,,CN,CA,CA,2016,Q4,Elderly
128449133,12844913,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,FORMULATION: INJECTION; STRENGTH: 100UNT/ML,,,,,,,,3.0,ML,,,2016,Q4,Dyspnoea,,2016,Q4,3,F,20150520.0,20161012.0,20161013,20161025,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-11553BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,61.8,KG,20161025.0,,MD,US,US,2016,Q4,Elderly
128449133,12844913,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,FORMULATION: INJECTION; STRENGTH: 100UNT/ML,,,,,,,,3.0,ML,,,2016,Q4,Dyspnoea exertional,,2016,Q4,3,F,20150520.0,20161012.0,20161013,20161025,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-11553BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,61.8,KG,20161025.0,,MD,US,US,2016,Q4,Elderly
128449133,12844913,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,FORMULATION: INJECTION; STRENGTH: 100UNT/ML,,,,,,,,3.0,ML,,,2016,Q4,End stage renal disease,,2016,Q4,3,F,20150520.0,20161012.0,20161013,20161025,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-11553BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,61.8,KG,20161025.0,,MD,US,US,2016,Q4,Elderly
128449133,12844913,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,FORMULATION: INJECTION; STRENGTH: 100UNT/ML,,,,,,,,3.0,ML,,,2016,Q4,Fluid overload,,2016,Q4,3,F,20150520.0,20161012.0,20161013,20161025,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-11553BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,61.8,KG,20161025.0,,MD,US,US,2016,Q4,Elderly
128449133,12844913,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,FORMULATION: INJECTION; STRENGTH: 100UNT/ML,,,,,,,,3.0,ML,,,2016,Q4,Glomerular filtration rate decreased,,2016,Q4,3,F,20150520.0,20161012.0,20161013,20161025,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-11553BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,61.8,KG,20161025.0,,MD,US,US,2016,Q4,Elderly
128449133,12844913,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,FORMULATION: INJECTION; STRENGTH: 100UNT/ML,,,,,,,,3.0,ML,,,2016,Q4,Hyperkalaemia,,2016,Q4,3,F,20150520.0,20161012.0,20161013,20161025,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-11553BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,61.8,KG,20161025.0,,MD,US,US,2016,Q4,Elderly
128449133,12844913,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,FORMULATION: INJECTION; STRENGTH: 100UNT/ML,,,,,,,,3.0,ML,,,2016,Q4,Pleural effusion,,2016,Q4,3,F,20150520.0,20161012.0,20161013,20161025,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-11553BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,61.8,KG,20161025.0,,MD,US,US,2016,Q4,Elderly
128449133,12844913,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,FORMULATION: INJECTION; STRENGTH: 100UNT/ML,,,,,,,,3.0,ML,,,2016,Q4,Pulmonary oedema,,2016,Q4,3,F,20150520.0,20161012.0,20161013,20161025,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-11553BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,61.8,KG,20161025.0,,MD,US,US,2016,Q4,Elderly
128449133,12844913,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,12.0,IU,,QD,2016,Q4,Dyspnoea,,2016,Q4,3,F,20150520.0,20161012.0,20161013,20161025,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-11553BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,61.8,KG,20161025.0,,MD,US,US,2016,Q4,Elderly
128449133,12844913,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,12.0,IU,,QD,2016,Q4,Dyspnoea exertional,,2016,Q4,3,F,20150520.0,20161012.0,20161013,20161025,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-11553BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,61.8,KG,20161025.0,,MD,US,US,2016,Q4,Elderly
128449133,12844913,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,12.0,IU,,QD,2016,Q4,End stage renal disease,,2016,Q4,3,F,20150520.0,20161012.0,20161013,20161025,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-11553BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,61.8,KG,20161025.0,,MD,US,US,2016,Q4,Elderly
128449133,12844913,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,12.0,IU,,QD,2016,Q4,Fluid overload,,2016,Q4,3,F,20150520.0,20161012.0,20161013,20161025,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-11553BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,61.8,KG,20161025.0,,MD,US,US,2016,Q4,Elderly
128449133,12844913,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,12.0,IU,,QD,2016,Q4,Glomerular filtration rate decreased,,2016,Q4,3,F,20150520.0,20161012.0,20161013,20161025,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-11553BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,61.8,KG,20161025.0,,MD,US,US,2016,Q4,Elderly
128449133,12844913,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,12.0,IU,,QD,2016,Q4,Hyperkalaemia,,2016,Q4,3,F,20150520.0,20161012.0,20161013,20161025,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-11553BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,61.8,KG,20161025.0,,MD,US,US,2016,Q4,Elderly
128449133,12844913,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,12.0,IU,,QD,2016,Q4,Pleural effusion,,2016,Q4,3,F,20150520.0,20161012.0,20161013,20161025,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-11553BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,61.8,KG,20161025.0,,MD,US,US,2016,Q4,Elderly
128449133,12844913,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,12.0,IU,,QD,2016,Q4,Pulmonary oedema,,2016,Q4,3,F,20150520.0,20161012.0,20161013,20161025,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-11553BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,61.8,KG,20161025.0,,MD,US,US,2016,Q4,Elderly
128449133,12844913,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,14.0,IU,,QD,2016,Q4,Dyspnoea,,2016,Q4,3,F,20150520.0,20161012.0,20161013,20161025,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-11553BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,61.8,KG,20161025.0,,MD,US,US,2016,Q4,Elderly
128449133,12844913,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,14.0,IU,,QD,2016,Q4,Dyspnoea exertional,,2016,Q4,3,F,20150520.0,20161012.0,20161013,20161025,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-11553BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,61.8,KG,20161025.0,,MD,US,US,2016,Q4,Elderly
128449133,12844913,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,14.0,IU,,QD,2016,Q4,End stage renal disease,,2016,Q4,3,F,20150520.0,20161012.0,20161013,20161025,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-11553BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,61.8,KG,20161025.0,,MD,US,US,2016,Q4,Elderly
128449133,12844913,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,14.0,IU,,QD,2016,Q4,Fluid overload,,2016,Q4,3,F,20150520.0,20161012.0,20161013,20161025,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-11553BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,61.8,KG,20161025.0,,MD,US,US,2016,Q4,Elderly
128449133,12844913,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,14.0,IU,,QD,2016,Q4,Glomerular filtration rate decreased,,2016,Q4,3,F,20150520.0,20161012.0,20161013,20161025,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-11553BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,61.8,KG,20161025.0,,MD,US,US,2016,Q4,Elderly
128449133,12844913,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,14.0,IU,,QD,2016,Q4,Hyperkalaemia,,2016,Q4,3,F,20150520.0,20161012.0,20161013,20161025,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-11553BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,61.8,KG,20161025.0,,MD,US,US,2016,Q4,Elderly
128449133,12844913,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,14.0,IU,,QD,2016,Q4,Pleural effusion,,2016,Q4,3,F,20150520.0,20161012.0,20161013,20161025,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-11553BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,61.8,KG,20161025.0,,MD,US,US,2016,Q4,Elderly
128449133,12844913,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,14.0,IU,,QD,2016,Q4,Pulmonary oedema,,2016,Q4,3,F,20150520.0,20161012.0,20161013,20161025,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-11553BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,61.8,KG,20161025.0,,MD,US,US,2016,Q4,Elderly
128449133,12844913,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,15.0,IU,,QD,2016,Q4,Dyspnoea,,2016,Q4,3,F,20150520.0,20161012.0,20161013,20161025,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-11553BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,61.8,KG,20161025.0,,MD,US,US,2016,Q4,Elderly
128449133,12844913,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,15.0,IU,,QD,2016,Q4,Dyspnoea exertional,,2016,Q4,3,F,20150520.0,20161012.0,20161013,20161025,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-11553BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,61.8,KG,20161025.0,,MD,US,US,2016,Q4,Elderly
128449133,12844913,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,15.0,IU,,QD,2016,Q4,End stage renal disease,,2016,Q4,3,F,20150520.0,20161012.0,20161013,20161025,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-11553BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,61.8,KG,20161025.0,,MD,US,US,2016,Q4,Elderly
128449133,12844913,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,15.0,IU,,QD,2016,Q4,Fluid overload,,2016,Q4,3,F,20150520.0,20161012.0,20161013,20161025,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-11553BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,61.8,KG,20161025.0,,MD,US,US,2016,Q4,Elderly
128449133,12844913,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,15.0,IU,,QD,2016,Q4,Glomerular filtration rate decreased,,2016,Q4,3,F,20150520.0,20161012.0,20161013,20161025,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-11553BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,61.8,KG,20161025.0,,MD,US,US,2016,Q4,Elderly
128449133,12844913,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,15.0,IU,,QD,2016,Q4,Hyperkalaemia,,2016,Q4,3,F,20150520.0,20161012.0,20161013,20161025,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-11553BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,61.8,KG,20161025.0,,MD,US,US,2016,Q4,Elderly
128449133,12844913,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,15.0,IU,,QD,2016,Q4,Pleural effusion,,2016,Q4,3,F,20150520.0,20161012.0,20161013,20161025,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-11553BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,61.8,KG,20161025.0,,MD,US,US,2016,Q4,Elderly
128449133,12844913,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,15.0,IU,,QD,2016,Q4,Pulmonary oedema,,2016,Q4,3,F,20150520.0,20161012.0,20161013,20161025,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-11553BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,61.8,KG,20161025.0,,MD,US,US,2016,Q4,Elderly
128449133,12844913,27,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,10.0,IU,,QD,2016,Q4,Dyspnoea,,2016,Q4,3,F,20150520.0,20161012.0,20161013,20161025,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-11553BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,61.8,KG,20161025.0,,MD,US,US,2016,Q4,Elderly
128449133,12844913,27,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,10.0,IU,,QD,2016,Q4,Dyspnoea exertional,,2016,Q4,3,F,20150520.0,20161012.0,20161013,20161025,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-11553BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,61.8,KG,20161025.0,,MD,US,US,2016,Q4,Elderly
128449133,12844913,27,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,10.0,IU,,QD,2016,Q4,End stage renal disease,,2016,Q4,3,F,20150520.0,20161012.0,20161013,20161025,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-11553BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,61.8,KG,20161025.0,,MD,US,US,2016,Q4,Elderly
128449133,12844913,27,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,10.0,IU,,QD,2016,Q4,Fluid overload,,2016,Q4,3,F,20150520.0,20161012.0,20161013,20161025,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-11553BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,61.8,KG,20161025.0,,MD,US,US,2016,Q4,Elderly
128449133,12844913,27,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,10.0,IU,,QD,2016,Q4,Glomerular filtration rate decreased,,2016,Q4,3,F,20150520.0,20161012.0,20161013,20161025,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-11553BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,61.8,KG,20161025.0,,MD,US,US,2016,Q4,Elderly
128449133,12844913,27,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,10.0,IU,,QD,2016,Q4,Hyperkalaemia,,2016,Q4,3,F,20150520.0,20161012.0,20161013,20161025,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-11553BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,61.8,KG,20161025.0,,MD,US,US,2016,Q4,Elderly
128449133,12844913,27,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,10.0,IU,,QD,2016,Q4,Pleural effusion,,2016,Q4,3,F,20150520.0,20161012.0,20161013,20161025,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-11553BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,61.8,KG,20161025.0,,MD,US,US,2016,Q4,Elderly
128449133,12844913,27,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,10.0,IU,,QD,2016,Q4,Pulmonary oedema,,2016,Q4,3,F,20150520.0,20161012.0,20161013,20161025,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-11553BI",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,61.8,KG,20161025.0,,MD,US,US,2016,Q4,Elderly
128450393,12845039,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,TOTAL DAILY DOSE: 50 UNITS,,,,,,,,,,,QD,2016,Q4,Deafness neurosensory,,2016,Q4,3,F,20150604.0,20161014.0,20161013,20161027,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-56613BI",BOEHRINGER INGELHEIM,,76.0,YR,,M,Y,78.0,KG,20161027.0,,MD,US,US,2016,Q4,Elderly
128450393,12845039,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,TOTAL DAILY DOSE: 50 UNITS,,,,,,,,,,,QD,2016,Q4,Heart disease congenital,,2016,Q4,3,F,20150604.0,20161014.0,20161013,20161027,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-56613BI",BOEHRINGER INGELHEIM,,76.0,YR,,M,Y,78.0,KG,20161027.0,,MD,US,US,2016,Q4,Elderly
128458672,12845867,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20-35 UNIT, UNK",,,,,,,,,,,,2016,Q4,Abscess oral,,2016,Q4,2,F,20160701.0,20161223.0,20161013,20161227,EXP,,US-AMGEN-USACT2016137967,AMGEN,,69.0,YR,E,F,Y,66.4,KG,20161227.0,,MD,US,US,2016,Q4,Elderly
128460121,12846012,12,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,10 U,,,,,,,,,,,,2016,Q4,Cough,,2016,Q4,1,I,,20160510.0,20161014,20161014,PER,,US-LUPIN PHARMACEUTICALS INC.-2016-02033,LUPIN,"STEBER C, PERKINS S, HARRIS K. METFORMIN-INDUCED FIXED-DRUG ERUPTION CONFIRMED BY MULTIPLE EXPOSURES. AM-J-CASE-REP. 2016;17:231-234.",56.0,YR,,F,Y,118.0,KG,20161013.0,,OT,US,US,2016,Q4,Adult
128460121,12846012,12,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,10 U,,,,,,,,,,,,2016,Q4,Diarrhoea,,2016,Q4,1,I,,20160510.0,20161014,20161014,PER,,US-LUPIN PHARMACEUTICALS INC.-2016-02033,LUPIN,"STEBER C, PERKINS S, HARRIS K. METFORMIN-INDUCED FIXED-DRUG ERUPTION CONFIRMED BY MULTIPLE EXPOSURES. AM-J-CASE-REP. 2016;17:231-234.",56.0,YR,,F,Y,118.0,KG,20161013.0,,OT,US,US,2016,Q4,Adult
128460121,12846012,12,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,10 U,,,,,,,,,,,,2016,Q4,Fixed drug eruption,,2016,Q4,1,I,,20160510.0,20161014,20161014,PER,,US-LUPIN PHARMACEUTICALS INC.-2016-02033,LUPIN,"STEBER C, PERKINS S, HARRIS K. METFORMIN-INDUCED FIXED-DRUG ERUPTION CONFIRMED BY MULTIPLE EXPOSURES. AM-J-CASE-REP. 2016;17:231-234.",56.0,YR,,F,Y,118.0,KG,20161013.0,,OT,US,US,2016,Q4,Adult
128495042,12849504,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,28 UNITS AT NIGHT,,,,,,,,28.0,IU,,,2016,Q4,Pulseless electrical activity,,2016,Q4,2,F,,20161024.0,20161014,20161101,EXP,,US-PFIZER INC-2016480368,PFIZER,"KLINE,R.. POSTINDUCTION PACED PULSELESS ELECTRICAL ACTIVITY IN A PATIENT WITH A HISTORY OF OROPHARYNGEAL INSTRUMENTATION- INDUCED REFLEX CIRCULATORY COLLAPSE.. OCHSNER JOURNAL. 2016;16(3):315-320",54.0,YR,,F,Y,122.0,KG,20161101.0,,MD,US,US,2016,Q4,Adult
128525452,12852545,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,28 UNITS AT NIGHT,,,D,,,,,28.0,IU,UNSPECIFIED,,2016,Q4,Pulseless electrical activity,,2016,Q4,2,F,,20161018.0,20161017,20161020,EXP,,US-JNJFOC-20161011457,JANSSEN,"KLINE RJ, PHAM K, LABRIE-BROWN CL, MANCUSO K, LELORIER P, RIOPELLE J, ET AL. POSTINDUCTION PACED PULSELESS ELECTRICAL ACTIVITY IN A PATIENT WITH A HISTORY OF OROPHARYNGEAL INSTRUMENTATION- INDUCED REFLEX CIRCULATORY COLLAPSE. OCHSNER JOURNAL 2016;16/3:315-320.",54.0,YR,A,F,Y,122.0,KG,20161020.0,,MD,US,US,2016,Q4,Adult
128548092,12854809,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2016,Q4,Colitis,,2016,Q4,2,F,20160924.0,20161027.0,20161017,20161103,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-080879,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,119.7,KG,20161103.0,,OT,US,US,2016,Q4,Adult
128573411,12857341,2,C,Glargine injection,,2,,,,,,,,,,,,,,2016,Q4,Diabetes mellitus inadequate control,,2016,Q4,1,I,2015.0,20161006.0,20161018,20161018,EXP,,NZ-LEO PHARMA-244272,LEO PHARM,,63.0,YR,,M,Y,,,20161018.0,,CN,NZ,NZ,2016,Q4,Adult
128573411,12857341,2,C,Glargine injection,,2,,,,,,,,,,,,,,2016,Q4,Psoriasis,,2016,Q4,1,I,2015.0,20161006.0,20161018,20161018,EXP,,NZ-LEO PHARMA-244272,LEO PHARM,,63.0,YR,,M,Y,,,20161018.0,,CN,NZ,NZ,2016,Q4,Adult
128573411,12857341,2,C,Glargine injection,,2,,,,,,,,,,,,,,2016,Q4,Pustular psoriasis,,2016,Q4,1,I,2015.0,20161006.0,20161018,20161018,EXP,,NZ-LEO PHARMA-244272,LEO PHARM,,63.0,YR,,M,Y,,,20161018.0,,CN,NZ,NZ,2016,Q4,Adult
128576631,12857663,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Cholelithiasis,,2016,Q4,1,I,20160611.0,20161010.0,20161018,20161018,EXP,,GB-ASTRAZENECA-2016SF07246,ASTRAZENECA,,65.0,YR,,F,Y,112.0,KG,20161018.0,,MD,GB,GB,2016,Q4,Elderly
128576631,12857663,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Pancreatitis,,2016,Q4,1,I,20160611.0,20161010.0,20161018,20161018,EXP,,GB-ASTRAZENECA-2016SF07246,ASTRAZENECA,,65.0,YR,,F,Y,112.0,KG,20161018.0,,MD,GB,GB,2016,Q4,Elderly
128611351,12861135,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE:26 UNIT(S),,,D,, UNK,,21081.0,,,INJECTION,TID,2016,Q4,Blood glucose decreased,,2016,Q4,1,I,,20161012.0,20161019,20161019,EXP,,JP-SA-2016SA189440,AVENTIS,"WADA E, KINOSHITA T, HOUDAI Y, KURIMOTO H, YAMAGUCHI K, KATO T, ET AL. A CASE OF TYPE 2 DIABETES MELLITUS WHERE A MASSIVE DOSE OF INSULIN, INCLUDING ABOUT 3300 UNITS OF SUSTAINED-RELEASE TYPE, WAS INJECTED IN A SUICIDE ATTEMPT. THE 90TH CHUBU REGIONAL MEETING OF THE JAPAN DIABETES SOCIETY; 2016 OCT 02; NAGOYA-SHI, AICHI PREFECTURE",52.0,YR,A,M,Y,130.0,KG,20161019.0,,OT,JP,JP,2016,Q4,Adult
128611351,12861135,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE:26 UNIT(S),,,D,, UNK,,21081.0,,,INJECTION,TID,2016,Q4,Injection site reaction,,2016,Q4,1,I,,20161012.0,20161019,20161019,EXP,,JP-SA-2016SA189440,AVENTIS,"WADA E, KINOSHITA T, HOUDAI Y, KURIMOTO H, YAMAGUCHI K, KATO T, ET AL. A CASE OF TYPE 2 DIABETES MELLITUS WHERE A MASSIVE DOSE OF INSULIN, INCLUDING ABOUT 3300 UNITS OF SUSTAINED-RELEASE TYPE, WAS INJECTED IN A SUICIDE ATTEMPT. THE 90TH CHUBU REGIONAL MEETING OF THE JAPAN DIABETES SOCIETY; 2016 OCT 02; NAGOYA-SHI, AICHI PREFECTURE",52.0,YR,A,M,Y,130.0,KG,20161019.0,,OT,JP,JP,2016,Q4,Adult
128611351,12861135,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE:26 UNIT(S),,,D,, UNK,,21081.0,,,INJECTION,TID,2016,Q4,Intentional overdose,,2016,Q4,1,I,,20161012.0,20161019,20161019,EXP,,JP-SA-2016SA189440,AVENTIS,"WADA E, KINOSHITA T, HOUDAI Y, KURIMOTO H, YAMAGUCHI K, KATO T, ET AL. A CASE OF TYPE 2 DIABETES MELLITUS WHERE A MASSIVE DOSE OF INSULIN, INCLUDING ABOUT 3300 UNITS OF SUSTAINED-RELEASE TYPE, WAS INJECTED IN A SUICIDE ATTEMPT. THE 90TH CHUBU REGIONAL MEETING OF THE JAPAN DIABETES SOCIETY; 2016 OCT 02; NAGOYA-SHI, AICHI PREFECTURE",52.0,YR,A,M,Y,130.0,KG,20161019.0,,OT,JP,JP,2016,Q4,Adult
128611351,12861135,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE:26 UNIT(S),,,D,, UNK,,21081.0,,,INJECTION,TID,2016,Q4,Overdose,,2016,Q4,1,I,,20161012.0,20161019,20161019,EXP,,JP-SA-2016SA189440,AVENTIS,"WADA E, KINOSHITA T, HOUDAI Y, KURIMOTO H, YAMAGUCHI K, KATO T, ET AL. A CASE OF TYPE 2 DIABETES MELLITUS WHERE A MASSIVE DOSE OF INSULIN, INCLUDING ABOUT 3300 UNITS OF SUSTAINED-RELEASE TYPE, WAS INJECTED IN A SUICIDE ATTEMPT. THE 90TH CHUBU REGIONAL MEETING OF THE JAPAN DIABETES SOCIETY; 2016 OCT 02; NAGOYA-SHI, AICHI PREFECTURE",52.0,YR,A,M,Y,130.0,KG,20161019.0,,OT,JP,JP,2016,Q4,Adult
128611351,12861135,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE:26 UNIT(S),,,D,, UNK,,21081.0,,,INJECTION,TID,2016,Q4,Scar,,2016,Q4,1,I,,20161012.0,20161019,20161019,EXP,,JP-SA-2016SA189440,AVENTIS,"WADA E, KINOSHITA T, HOUDAI Y, KURIMOTO H, YAMAGUCHI K, KATO T, ET AL. A CASE OF TYPE 2 DIABETES MELLITUS WHERE A MASSIVE DOSE OF INSULIN, INCLUDING ABOUT 3300 UNITS OF SUSTAINED-RELEASE TYPE, WAS INJECTED IN A SUICIDE ATTEMPT. THE 90TH CHUBU REGIONAL MEETING OF THE JAPAN DIABETES SOCIETY; 2016 OCT 02; NAGOYA-SHI, AICHI PREFECTURE",52.0,YR,A,M,Y,130.0,KG,20161019.0,,OT,JP,JP,2016,Q4,Adult
128611351,12861135,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE:26 UNIT(S),,,D,, UNK,,21081.0,,,INJECTION,TID,2016,Q4,Blood glucose decreased,,2016,Q4,1,I,,20161012.0,20161019,20161019,EXP,,JP-SA-2016SA189440,AVENTIS,"WADA E, KINOSHITA T, HOUDAI Y, KURIMOTO H, YAMAGUCHI K, KATO T, ET AL. A CASE OF TYPE 2 DIABETES MELLITUS WHERE A MASSIVE DOSE OF INSULIN, INCLUDING ABOUT 3300 UNITS OF SUSTAINED-RELEASE TYPE, WAS INJECTED IN A SUICIDE ATTEMPT. THE 90TH CHUBU REGIONAL MEETING OF THE JAPAN DIABETES SOCIETY; 2016 OCT 02; NAGOYA-SHI, AICHI PREFECTURE",52.0,YR,A,M,Y,130.0,KG,20161019.0,,OT,JP,JP,2016,Q4,Adult
128611351,12861135,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE:26 UNIT(S),,,D,, UNK,,21081.0,,,INJECTION,TID,2016,Q4,Injection site reaction,,2016,Q4,1,I,,20161012.0,20161019,20161019,EXP,,JP-SA-2016SA189440,AVENTIS,"WADA E, KINOSHITA T, HOUDAI Y, KURIMOTO H, YAMAGUCHI K, KATO T, ET AL. A CASE OF TYPE 2 DIABETES MELLITUS WHERE A MASSIVE DOSE OF INSULIN, INCLUDING ABOUT 3300 UNITS OF SUSTAINED-RELEASE TYPE, WAS INJECTED IN A SUICIDE ATTEMPT. THE 90TH CHUBU REGIONAL MEETING OF THE JAPAN DIABETES SOCIETY; 2016 OCT 02; NAGOYA-SHI, AICHI PREFECTURE",52.0,YR,A,M,Y,130.0,KG,20161019.0,,OT,JP,JP,2016,Q4,Adult
128611351,12861135,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE:26 UNIT(S),,,D,, UNK,,21081.0,,,INJECTION,TID,2016,Q4,Intentional overdose,,2016,Q4,1,I,,20161012.0,20161019,20161019,EXP,,JP-SA-2016SA189440,AVENTIS,"WADA E, KINOSHITA T, HOUDAI Y, KURIMOTO H, YAMAGUCHI K, KATO T, ET AL. A CASE OF TYPE 2 DIABETES MELLITUS WHERE A MASSIVE DOSE OF INSULIN, INCLUDING ABOUT 3300 UNITS OF SUSTAINED-RELEASE TYPE, WAS INJECTED IN A SUICIDE ATTEMPT. THE 90TH CHUBU REGIONAL MEETING OF THE JAPAN DIABETES SOCIETY; 2016 OCT 02; NAGOYA-SHI, AICHI PREFECTURE",52.0,YR,A,M,Y,130.0,KG,20161019.0,,OT,JP,JP,2016,Q4,Adult
128611351,12861135,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE:26 UNIT(S),,,D,, UNK,,21081.0,,,INJECTION,TID,2016,Q4,Overdose,,2016,Q4,1,I,,20161012.0,20161019,20161019,EXP,,JP-SA-2016SA189440,AVENTIS,"WADA E, KINOSHITA T, HOUDAI Y, KURIMOTO H, YAMAGUCHI K, KATO T, ET AL. A CASE OF TYPE 2 DIABETES MELLITUS WHERE A MASSIVE DOSE OF INSULIN, INCLUDING ABOUT 3300 UNITS OF SUSTAINED-RELEASE TYPE, WAS INJECTED IN A SUICIDE ATTEMPT. THE 90TH CHUBU REGIONAL MEETING OF THE JAPAN DIABETES SOCIETY; 2016 OCT 02; NAGOYA-SHI, AICHI PREFECTURE",52.0,YR,A,M,Y,130.0,KG,20161019.0,,OT,JP,JP,2016,Q4,Adult
128611351,12861135,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE:26 UNIT(S),,,D,, UNK,,21081.0,,,INJECTION,TID,2016,Q4,Scar,,2016,Q4,1,I,,20161012.0,20161019,20161019,EXP,,JP-SA-2016SA189440,AVENTIS,"WADA E, KINOSHITA T, HOUDAI Y, KURIMOTO H, YAMAGUCHI K, KATO T, ET AL. A CASE OF TYPE 2 DIABETES MELLITUS WHERE A MASSIVE DOSE OF INSULIN, INCLUDING ABOUT 3300 UNITS OF SUSTAINED-RELEASE TYPE, WAS INJECTED IN A SUICIDE ATTEMPT. THE 90TH CHUBU REGIONAL MEETING OF THE JAPAN DIABETES SOCIETY; 2016 OCT 02; NAGOYA-SHI, AICHI PREFECTURE",52.0,YR,A,M,Y,130.0,KG,20161019.0,,OT,JP,JP,2016,Q4,Adult
128611351,12861135,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,, UNK,,21081.0,,,INJECTION,,2016,Q4,Blood glucose decreased,,2016,Q4,1,I,,20161012.0,20161019,20161019,EXP,,JP-SA-2016SA189440,AVENTIS,"WADA E, KINOSHITA T, HOUDAI Y, KURIMOTO H, YAMAGUCHI K, KATO T, ET AL. A CASE OF TYPE 2 DIABETES MELLITUS WHERE A MASSIVE DOSE OF INSULIN, INCLUDING ABOUT 3300 UNITS OF SUSTAINED-RELEASE TYPE, WAS INJECTED IN A SUICIDE ATTEMPT. THE 90TH CHUBU REGIONAL MEETING OF THE JAPAN DIABETES SOCIETY; 2016 OCT 02; NAGOYA-SHI, AICHI PREFECTURE",52.0,YR,A,M,Y,130.0,KG,20161019.0,,OT,JP,JP,2016,Q4,Adult
128611351,12861135,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,, UNK,,21081.0,,,INJECTION,,2016,Q4,Injection site reaction,,2016,Q4,1,I,,20161012.0,20161019,20161019,EXP,,JP-SA-2016SA189440,AVENTIS,"WADA E, KINOSHITA T, HOUDAI Y, KURIMOTO H, YAMAGUCHI K, KATO T, ET AL. A CASE OF TYPE 2 DIABETES MELLITUS WHERE A MASSIVE DOSE OF INSULIN, INCLUDING ABOUT 3300 UNITS OF SUSTAINED-RELEASE TYPE, WAS INJECTED IN A SUICIDE ATTEMPT. THE 90TH CHUBU REGIONAL MEETING OF THE JAPAN DIABETES SOCIETY; 2016 OCT 02; NAGOYA-SHI, AICHI PREFECTURE",52.0,YR,A,M,Y,130.0,KG,20161019.0,,OT,JP,JP,2016,Q4,Adult
128611351,12861135,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,, UNK,,21081.0,,,INJECTION,,2016,Q4,Intentional overdose,,2016,Q4,1,I,,20161012.0,20161019,20161019,EXP,,JP-SA-2016SA189440,AVENTIS,"WADA E, KINOSHITA T, HOUDAI Y, KURIMOTO H, YAMAGUCHI K, KATO T, ET AL. A CASE OF TYPE 2 DIABETES MELLITUS WHERE A MASSIVE DOSE OF INSULIN, INCLUDING ABOUT 3300 UNITS OF SUSTAINED-RELEASE TYPE, WAS INJECTED IN A SUICIDE ATTEMPT. THE 90TH CHUBU REGIONAL MEETING OF THE JAPAN DIABETES SOCIETY; 2016 OCT 02; NAGOYA-SHI, AICHI PREFECTURE",52.0,YR,A,M,Y,130.0,KG,20161019.0,,OT,JP,JP,2016,Q4,Adult
128611351,12861135,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,, UNK,,21081.0,,,INJECTION,,2016,Q4,Overdose,,2016,Q4,1,I,,20161012.0,20161019,20161019,EXP,,JP-SA-2016SA189440,AVENTIS,"WADA E, KINOSHITA T, HOUDAI Y, KURIMOTO H, YAMAGUCHI K, KATO T, ET AL. A CASE OF TYPE 2 DIABETES MELLITUS WHERE A MASSIVE DOSE OF INSULIN, INCLUDING ABOUT 3300 UNITS OF SUSTAINED-RELEASE TYPE, WAS INJECTED IN A SUICIDE ATTEMPT. THE 90TH CHUBU REGIONAL MEETING OF THE JAPAN DIABETES SOCIETY; 2016 OCT 02; NAGOYA-SHI, AICHI PREFECTURE",52.0,YR,A,M,Y,130.0,KG,20161019.0,,OT,JP,JP,2016,Q4,Adult
128611351,12861135,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,, UNK,,21081.0,,,INJECTION,,2016,Q4,Scar,,2016,Q4,1,I,,20161012.0,20161019,20161019,EXP,,JP-SA-2016SA189440,AVENTIS,"WADA E, KINOSHITA T, HOUDAI Y, KURIMOTO H, YAMAGUCHI K, KATO T, ET AL. A CASE OF TYPE 2 DIABETES MELLITUS WHERE A MASSIVE DOSE OF INSULIN, INCLUDING ABOUT 3300 UNITS OF SUSTAINED-RELEASE TYPE, WAS INJECTED IN A SUICIDE ATTEMPT. THE 90TH CHUBU REGIONAL MEETING OF THE JAPAN DIABETES SOCIETY; 2016 OCT 02; NAGOYA-SHI, AICHI PREFECTURE",52.0,YR,A,M,Y,130.0,KG,20161019.0,,OT,JP,JP,2016,Q4,Adult
128611351,12861135,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,, UNK,,21081.0,,,INJECTION,,2016,Q4,Blood glucose decreased,,2016,Q4,1,I,,20161012.0,20161019,20161019,EXP,,JP-SA-2016SA189440,AVENTIS,"WADA E, KINOSHITA T, HOUDAI Y, KURIMOTO H, YAMAGUCHI K, KATO T, ET AL. A CASE OF TYPE 2 DIABETES MELLITUS WHERE A MASSIVE DOSE OF INSULIN, INCLUDING ABOUT 3300 UNITS OF SUSTAINED-RELEASE TYPE, WAS INJECTED IN A SUICIDE ATTEMPT. THE 90TH CHUBU REGIONAL MEETING OF THE JAPAN DIABETES SOCIETY; 2016 OCT 02; NAGOYA-SHI, AICHI PREFECTURE",52.0,YR,A,M,Y,130.0,KG,20161019.0,,OT,JP,JP,2016,Q4,Adult
128611351,12861135,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,, UNK,,21081.0,,,INJECTION,,2016,Q4,Injection site reaction,,2016,Q4,1,I,,20161012.0,20161019,20161019,EXP,,JP-SA-2016SA189440,AVENTIS,"WADA E, KINOSHITA T, HOUDAI Y, KURIMOTO H, YAMAGUCHI K, KATO T, ET AL. A CASE OF TYPE 2 DIABETES MELLITUS WHERE A MASSIVE DOSE OF INSULIN, INCLUDING ABOUT 3300 UNITS OF SUSTAINED-RELEASE TYPE, WAS INJECTED IN A SUICIDE ATTEMPT. THE 90TH CHUBU REGIONAL MEETING OF THE JAPAN DIABETES SOCIETY; 2016 OCT 02; NAGOYA-SHI, AICHI PREFECTURE",52.0,YR,A,M,Y,130.0,KG,20161019.0,,OT,JP,JP,2016,Q4,Adult
128611351,12861135,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,, UNK,,21081.0,,,INJECTION,,2016,Q4,Intentional overdose,,2016,Q4,1,I,,20161012.0,20161019,20161019,EXP,,JP-SA-2016SA189440,AVENTIS,"WADA E, KINOSHITA T, HOUDAI Y, KURIMOTO H, YAMAGUCHI K, KATO T, ET AL. A CASE OF TYPE 2 DIABETES MELLITUS WHERE A MASSIVE DOSE OF INSULIN, INCLUDING ABOUT 3300 UNITS OF SUSTAINED-RELEASE TYPE, WAS INJECTED IN A SUICIDE ATTEMPT. THE 90TH CHUBU REGIONAL MEETING OF THE JAPAN DIABETES SOCIETY; 2016 OCT 02; NAGOYA-SHI, AICHI PREFECTURE",52.0,YR,A,M,Y,130.0,KG,20161019.0,,OT,JP,JP,2016,Q4,Adult
128611351,12861135,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,, UNK,,21081.0,,,INJECTION,,2016,Q4,Overdose,,2016,Q4,1,I,,20161012.0,20161019,20161019,EXP,,JP-SA-2016SA189440,AVENTIS,"WADA E, KINOSHITA T, HOUDAI Y, KURIMOTO H, YAMAGUCHI K, KATO T, ET AL. A CASE OF TYPE 2 DIABETES MELLITUS WHERE A MASSIVE DOSE OF INSULIN, INCLUDING ABOUT 3300 UNITS OF SUSTAINED-RELEASE TYPE, WAS INJECTED IN A SUICIDE ATTEMPT. THE 90TH CHUBU REGIONAL MEETING OF THE JAPAN DIABETES SOCIETY; 2016 OCT 02; NAGOYA-SHI, AICHI PREFECTURE",52.0,YR,A,M,Y,130.0,KG,20161019.0,,OT,JP,JP,2016,Q4,Adult
128611351,12861135,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,, UNK,,21081.0,,,INJECTION,,2016,Q4,Scar,,2016,Q4,1,I,,20161012.0,20161019,20161019,EXP,,JP-SA-2016SA189440,AVENTIS,"WADA E, KINOSHITA T, HOUDAI Y, KURIMOTO H, YAMAGUCHI K, KATO T, ET AL. A CASE OF TYPE 2 DIABETES MELLITUS WHERE A MASSIVE DOSE OF INSULIN, INCLUDING ABOUT 3300 UNITS OF SUSTAINED-RELEASE TYPE, WAS INJECTED IN A SUICIDE ATTEMPT. THE 90TH CHUBU REGIONAL MEETING OF THE JAPAN DIABETES SOCIETY; 2016 OCT 02; NAGOYA-SHI, AICHI PREFECTURE",52.0,YR,A,M,Y,130.0,KG,20161019.0,,OT,JP,JP,2016,Q4,Adult
128631913,12863191,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2016,Q4,Cardiac failure congestive,,2016,Q4,3,F,20160411.0,20161122.0,20161019,20161128,EXP,,US-GILEAD-2016-0238527,GILEAD,,63.0,YR,A,M,Y,,,20161128.0,,CN,US,US,2016,Q4,Adult
128631913,12863191,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2016,Q4,Cardiomyopathy,,2016,Q4,3,F,20160411.0,20161122.0,20161019,20161128,EXP,,US-GILEAD-2016-0238527,GILEAD,,63.0,YR,A,M,Y,,,20161128.0,,CN,US,US,2016,Q4,Adult
128631913,12863191,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2016,Q4,Cerebrovascular accident,,2016,Q4,3,F,20160411.0,20161122.0,20161019,20161128,EXP,,US-GILEAD-2016-0238527,GILEAD,,63.0,YR,A,M,Y,,,20161128.0,,CN,US,US,2016,Q4,Adult
128631913,12863191,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2016,Q4,Chest pain,,2016,Q4,3,F,20160411.0,20161122.0,20161019,20161128,EXP,,US-GILEAD-2016-0238527,GILEAD,,63.0,YR,A,M,Y,,,20161128.0,,CN,US,US,2016,Q4,Adult
128631913,12863191,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2016,Q4,Coronary artery bypass,,2016,Q4,3,F,20160411.0,20161122.0,20161019,20161128,EXP,,US-GILEAD-2016-0238527,GILEAD,,63.0,YR,A,M,Y,,,20161128.0,,CN,US,US,2016,Q4,Adult
128631913,12863191,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2016,Q4,Ejection fraction decreased,,2016,Q4,3,F,20160411.0,20161122.0,20161019,20161128,EXP,,US-GILEAD-2016-0238527,GILEAD,,63.0,YR,A,M,Y,,,20161128.0,,CN,US,US,2016,Q4,Adult
128631913,12863191,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2016,Q4,Implantable defibrillator insertion,,2016,Q4,3,F,20160411.0,20161122.0,20161019,20161128,EXP,,US-GILEAD-2016-0238527,GILEAD,,63.0,YR,A,M,Y,,,20161128.0,,CN,US,US,2016,Q4,Adult
128631913,12863191,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2016,Q4,Myocardial infarction,,2016,Q4,3,F,20160411.0,20161122.0,20161019,20161128,EXP,,US-GILEAD-2016-0238527,GILEAD,,63.0,YR,A,M,Y,,,20161128.0,,CN,US,US,2016,Q4,Adult
128645821,12864582,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,Y,,,,14.0,DF,,QD,2016,Q4,Blood glucose decreased,,2016,Q4,1,I,20160816.0,,20161018,20161018,DIR,,,FDA-CTU,,26.0,YR,,F,N,,,20160819.0,N,PH,US,US,2016,Q4,Young Adult
128784902,12878490,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2016,Q4,BK virus infection,,2016,Q4,2,F,20160923.0,20161122.0,20161024,20161129,PER,,PHHY2016US145408,SANDOZ,,42.0,YR,,M,Y,101.0,KG,20161129.0,,CN,US,US,2016,Q4,Adult
128829252,12882925,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,IN THE NIGHT,,,,,,,,,,,,2016,Q4,Acute myocardial infarction,,2016,Q4,2,F,20161002.0,20161128.0,20161025,20161201,EXP,,CO-ABBVIE-16P-036-1762742-00,ABBVIE,,78.0,YR,,F,Y,78.0,KG,20161201.0,,CN,CO,CO,2016,Q4,Elderly
128829252,12882925,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,IN THE NIGHT,,,,,,,,,,,,2016,Q4,Haematuria,,2016,Q4,2,F,20161002.0,20161128.0,20161025,20161201,EXP,,CO-ABBVIE-16P-036-1762742-00,ABBVIE,,78.0,YR,,F,Y,78.0,KG,20161201.0,,CN,CO,CO,2016,Q4,Elderly
128832422,12883242,11,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q4,Cardiac arrest,,2016,Q4,2,F,20151117.0,20161020.0,20161025,20161101,EXP,,US-CELGENEUS-USA-2015116772,CELGENE,,61.0,YR,,M,Y,,,20161031.0,,MD,US,US,2016,Q4,Adult
128832422,12883242,11,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q4,Hyperkalaemia,,2016,Q4,2,F,20151117.0,20161020.0,20161025,20161101,EXP,,US-CELGENEUS-USA-2015116772,CELGENE,,61.0,YR,,M,Y,,,20161031.0,,MD,US,US,2016,Q4,Adult
128832422,12883242,11,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q4,Neutrophil count decreased,,2016,Q4,2,F,20151117.0,20161020.0,20161025,20161101,EXP,,US-CELGENEUS-USA-2015116772,CELGENE,,61.0,YR,,M,Y,,,20161031.0,,MD,US,US,2016,Q4,Adult
128832422,12883242,11,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q4,Renal failure,,2016,Q4,2,F,20151117.0,20161020.0,20161025,20161101,EXP,,US-CELGENEUS-USA-2015116772,CELGENE,,61.0,YR,,M,Y,,,20161031.0,,MD,US,US,2016,Q4,Adult
128832422,12883242,11,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q4,Respiratory distress,,2016,Q4,2,F,20151117.0,20161020.0,20161025,20161101,EXP,,US-CELGENEUS-USA-2015116772,CELGENE,,61.0,YR,,M,Y,,,20161031.0,,MD,US,US,2016,Q4,Adult
128832422,12883242,11,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q4,White blood cell count decreased,,2016,Q4,2,F,20151117.0,20161020.0,20161025,20161101,EXP,,US-CELGENEUS-USA-2015116772,CELGENE,,61.0,YR,,M,Y,,,20161031.0,,MD,US,US,2016,Q4,Adult
128848132,12884813,8,C,GLARGINE,,2,Unknown,,,,,,,,,,,,,2016,Q4,Discomfort,,2016,Q4,2,F,20161007.0,20161110.0,20161026,20161120,EXP,,US-ROCHE-1843936,ROCHE,,78.0,YR,,M,Y,53.7,KG,20161120.0,,MD,US,US,2016,Q4,Elderly
128848132,12884813,8,C,GLARGINE,,2,Unknown,,,,,,,,,,,,,2016,Q4,Faeces discoloured,,2016,Q4,2,F,20161007.0,20161110.0,20161026,20161120,EXP,,US-ROCHE-1843936,ROCHE,,78.0,YR,,M,Y,53.7,KG,20161120.0,,MD,US,US,2016,Q4,Elderly
128848132,12884813,8,C,GLARGINE,,2,Unknown,,,,,,,,,,,,,2016,Q4,Upper gastrointestinal haemorrhage,,2016,Q4,2,F,20161007.0,20161110.0,20161026,20161120,EXP,,US-ROCHE-1843936,ROCHE,,78.0,YR,,M,Y,53.7,KG,20161120.0,,MD,US,US,2016,Q4,Elderly
128850842,12885084,5,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q4,Enterocolitis,,2016,Q4,2,F,20160322.0,20161018.0,20161026,20161031,EXP,,US-CELGENEUS-USA-2016041246,CELGENE,,76.0,YR,,M,Y,47.22,KG,20161031.0,,MD,US,US,2016,Q4,Elderly
128850842,12885084,5,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q4,Neutropenia,,2016,Q4,2,F,20160322.0,20161018.0,20161026,20161031,EXP,,US-CELGENEUS-USA-2016041246,CELGENE,,76.0,YR,,M,Y,47.22,KG,20161031.0,,MD,US,US,2016,Q4,Elderly
128850842,12885084,5,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q4,Thrombocytopenia,,2016,Q4,2,F,20160322.0,20161018.0,20161026,20161031,EXP,,US-CELGENEUS-USA-2016041246,CELGENE,,76.0,YR,,M,Y,47.22,KG,20161031.0,,MD,US,US,2016,Q4,Elderly
128853981,12885398,2,C,INSULIN GLARGINE (LANTUS SOLOSTAR),,2,,,,,,,,,,,,,,2016,Q4,Acute respiratory failure,,2016,Q4,1,I,20160508.0,,20161025,20161025,DIR,US-FDA-354119,,FDA-CTU,,64.0,YR,,F,N,172.0,KG,20161025.0,N,PH,US,US,2016,Q4,Adult
128853981,12885398,2,C,INSULIN GLARGINE (LANTUS SOLOSTAR),,2,,,,,,,,,,,,,,2016,Q4,Angioedema,,2016,Q4,1,I,20160508.0,,20161025,20161025,DIR,US-FDA-354119,,FDA-CTU,,64.0,YR,,F,N,172.0,KG,20161025.0,N,PH,US,US,2016,Q4,Adult
128853981,12885398,2,C,INSULIN GLARGINE (LANTUS SOLOSTAR),,2,,,,,,,,,,,,,,2016,Q4,Drooling,,2016,Q4,1,I,20160508.0,,20161025,20161025,DIR,US-FDA-354119,,FDA-CTU,,64.0,YR,,F,N,172.0,KG,20161025.0,N,PH,US,US,2016,Q4,Adult
128853981,12885398,2,C,INSULIN GLARGINE (LANTUS SOLOSTAR),,2,,,,,,,,,,,,,,2016,Q4,Lip swelling,,2016,Q4,1,I,20160508.0,,20161025,20161025,DIR,US-FDA-354119,,FDA-CTU,,64.0,YR,,F,N,172.0,KG,20161025.0,N,PH,US,US,2016,Q4,Adult
128853981,12885398,2,C,INSULIN GLARGINE (LANTUS SOLOSTAR),,2,,,,,,,,,,,,,,2016,Q4,Mouth swelling,,2016,Q4,1,I,20160508.0,,20161025,20161025,DIR,US-FDA-354119,,FDA-CTU,,64.0,YR,,F,N,172.0,KG,20161025.0,N,PH,US,US,2016,Q4,Adult
128853981,12885398,2,C,INSULIN GLARGINE (LANTUS SOLOSTAR),,2,,,,,,,,,,,,,,2016,Q4,Pneumonia,,2016,Q4,1,I,20160508.0,,20161025,20161025,DIR,US-FDA-354119,,FDA-CTU,,64.0,YR,,F,N,172.0,KG,20161025.0,N,PH,US,US,2016,Q4,Adult
128853981,12885398,2,C,INSULIN GLARGINE (LANTUS SOLOSTAR),,2,,,,,,,,,,,,,,2016,Q4,Speech disorder,,2016,Q4,1,I,20160508.0,,20161025,20161025,DIR,US-FDA-354119,,FDA-CTU,,64.0,YR,,F,N,172.0,KG,20161025.0,N,PH,US,US,2016,Q4,Adult
128853981,12885398,2,C,INSULIN GLARGINE (LANTUS SOLOSTAR),,2,,,,,,,,,,,,,,2016,Q4,Swollen tongue,,2016,Q4,1,I,20160508.0,,20161025,20161025,DIR,US-FDA-354119,,FDA-CTU,,64.0,YR,,F,N,172.0,KG,20161025.0,N,PH,US,US,2016,Q4,Adult
128859801,12885980,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,UNSPECIFIED,,2016,Q4,Diabetic ketoacidosis,,2016,Q4,1,I,201509.0,20161020.0,20161026,20161026,EXP,,US-JNJFOC-20161020054,JANSSEN,,52.0,YR,A,M,Y,,,20161026.0,,CN,US,US,2016,Q4,Adult
128859801,12885980,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,UNSPECIFIED,,2016,Q4,Leukocytosis,,2016,Q4,1,I,201509.0,20161020.0,20161026,20161026,EXP,,US-JNJFOC-20161020054,JANSSEN,,52.0,YR,A,M,Y,,,20161026.0,,CN,US,US,2016,Q4,Adult
128859801,12885980,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,UNSPECIFIED,,2016,Q4,Renal impairment,,2016,Q4,1,I,201509.0,20161020.0,20161026,20161026,EXP,,US-JNJFOC-20161020054,JANSSEN,,52.0,YR,A,M,Y,,,20161026.0,,CN,US,US,2016,Q4,Adult
128859801,12885980,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,UNSPECIFIED,,2016,Q4,Treatment noncompliance,,2016,Q4,1,I,201509.0,20161020.0,20161026,20161026,EXP,,US-JNJFOC-20161020054,JANSSEN,,52.0,YR,A,M,Y,,,20161026.0,,CN,US,US,2016,Q4,Adult
128872971,12887297,10,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2016,Q4,Diarrhoea haemorrhagic,,2016,Q4,1,I,20160409.0,20160419.0,20161026,20161026,PER,,US-JAZZ-2016-US-007364,JAZZ,,15.0,YR,,F,Y,39.0,KG,20161026.0,,OT,US,US,2016,Q4,Youth
128881571,12888157,8,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,20.0,IU,,QD,2016,Q4,Death,,2016,Q4,1,I,20160414.0,20161018.0,20161027,20161027,EXP,,CO-BAXTER-2016BAX053828,BAXTER,,63.0,YR,,M,Y,73.5,KG,20161027.0,,OT,CO,CO,2016,Q4,Adult
128938061,12893806,1,PS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,U,,,205692.0,,,,,2016,Q4,Pneumonia,,2016,Q4,1,I,20161018.0,20161025.0,20161028,20161028,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201610008613,ELI LILLY AND CO,,89.0,YR,,F,Y,,,20161027.0,,CN,JP,JP,2016,Q4,Elderly
128950842,12895084,5,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,"16 IU, DAILY (BEFORE LUNCH)",,,,,,,,16.0,IU,,,2016,Q4,Infarction,,2016,Q4,2,F,,20161121.0,20161029,20161125,EXP,,CO-AMGEN-COLSP2016149933,AMGEN,,71.0,YR,E,M,Y,,,20161125.0,,CN,CO,CO,2016,Q4,Elderly
128976871,12897687,4,C,Insulin glargine novonordisk,,2,,"20 UNIT, QD",,,,U,,,,,,,QD,2016,Q4,Pneumonia,,2016,Q4,1,I,20160904.0,20161021.0,20161031,20161031,EXP,,US-EMERGENT BIOSOLUTIONS-16BA00134SP,EMERGENT BIOSOLUTIONS,,49.0,YR,,M,Y,61.92,KG,20161031.0,,PH,US,US,2016,Q4,Adult
128976871,12897687,4,C,Insulin glargine novonordisk,,2,,"20 UNIT, QD",,,,U,,,,,,,QD,2016,Q4,Pyrexia,,2016,Q4,1,I,20160904.0,20161021.0,20161031,20161031,EXP,,US-EMERGENT BIOSOLUTIONS-16BA00134SP,EMERGENT BIOSOLUTIONS,,49.0,YR,,M,Y,61.92,KG,20161031.0,,PH,US,US,2016,Q4,Adult
128976871,12897687,4,C,Insulin glargine novonordisk,,2,,"20 UNIT, QD",,,,U,,,,,,,QD,2016,Q4,Tachycardia,,2016,Q4,1,I,20160904.0,20161021.0,20161031,20161031,EXP,,US-EMERGENT BIOSOLUTIONS-16BA00134SP,EMERGENT BIOSOLUTIONS,,49.0,YR,,M,Y,61.92,KG,20161031.0,,PH,US,US,2016,Q4,Adult
129021303,12902130,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, DAILY [1.5ML],[EACH ML CONTAINS 300 UNITS]",,,,,,,,10.0,IU,INJECTION,,2016,Q4,Burning sensation,,2016,Q4,3,F,,20161101.0,20161102,20161104,PER,,US-PFIZER INC-2016318371,PFIZER,,67.0,YR,,M,Y,,,20161104.0,,MD,US,US,2016,Q4,Elderly
129045532,12904553,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"35 U, BID",,,N,U,,,,35.0,DF,,BID,2016,Q4,Blood glucose increased,,2016,Q4,2,F,201608.0,20161114.0,20161102,20161123,EXP,,US-NOVOPROD-516640,NOVO NORDISK,,12.0,YR,C,F,Y,,,20161123.0,,OT,US,US,2016,Q4,Child
129045532,12904553,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"35 U, BID",,,N,U,,,,35.0,DF,,BID,2016,Q4,Drug ineffective,,2016,Q4,2,F,201608.0,20161114.0,20161102,20161123,EXP,,US-NOVOPROD-516640,NOVO NORDISK,,12.0,YR,C,F,Y,,,20161123.0,,OT,US,US,2016,Q4,Child
129045532,12904553,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"35 U, BID",,,N,U,,,,35.0,DF,,BID,2016,Q4,Hyperglycaemia,,2016,Q4,2,F,201608.0,20161114.0,20161102,20161123,EXP,,US-NOVOPROD-516640,NOVO NORDISK,,12.0,YR,C,F,Y,,,20161123.0,,OT,US,US,2016,Q4,Child
129045532,12904553,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"35 U, BID",,,N,U,,,,35.0,DF,,BID,2016,Q4,Product quality issue,,2016,Q4,2,F,201608.0,20161114.0,20161102,20161123,EXP,,US-NOVOPROD-516640,NOVO NORDISK,,12.0,YR,C,F,Y,,,20161123.0,,OT,US,US,2016,Q4,Child
129045532,12904553,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"35 U, BID",,,N,U,,,,35.0,DF,,BID,2016,Q4,Urine ketone body present,,2016,Q4,2,F,201608.0,20161114.0,20161102,20161123,EXP,,US-NOVOPROD-516640,NOVO NORDISK,,12.0,YR,C,F,Y,,,20161123.0,,OT,US,US,2016,Q4,Child
129095292,12909529,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 UNIT, QD",,,U,,,,,10.0,DF,,QD,2016,Q4,Diabetic ketoacidosis,,2016,Q4,2,F,20160726.0,20161107.0,20161104,20161114,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-062782,BRISTOL MYERS SQUIBB,,66.0,YR,,F,Y,66.2,KG,20161114.0,,OT,CA,CA,2016,Q4,Elderly
129095292,12909529,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 UNIT, QD",,,U,,,,,10.0,DF,,QD,2016,Q4,Pleural effusion,,2016,Q4,2,F,20160726.0,20161107.0,20161104,20161114,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-062782,BRISTOL MYERS SQUIBB,,66.0,YR,,F,Y,66.2,KG,20161114.0,,OT,CA,CA,2016,Q4,Elderly
129095292,12909529,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 UNIT, QD",,,U,,,,,10.0,DF,,QD,2016,Q4,Pneumonia,,2016,Q4,2,F,20160726.0,20161107.0,20161104,20161114,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-062782,BRISTOL MYERS SQUIBB,,66.0,YR,,F,Y,66.2,KG,20161114.0,,OT,CA,CA,2016,Q4,Elderly
129158541,12915854,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Acute kidney injury,,2016,Q4,1,I,20160729.0,,20161103,20161103,DIR,,,FDA-CTU,,62.0,YR,,F,N,99.8,KG,20161024.0,N,MD,US,US,2016,Q4,Adult
129158541,12915854,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Cerebral small vessel ischaemic disease,,2016,Q4,1,I,20160729.0,,20161103,20161103,DIR,,,FDA-CTU,,62.0,YR,,F,N,99.8,KG,20161024.0,N,MD,US,US,2016,Q4,Adult
129158541,12915854,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Hypokalaemia,,2016,Q4,1,I,20160729.0,,20161103,20161103,DIR,,,FDA-CTU,,62.0,YR,,F,N,99.8,KG,20161024.0,N,MD,US,US,2016,Q4,Adult
129158541,12915854,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Mental status changes,,2016,Q4,1,I,20160729.0,,20161103,20161103,DIR,,,FDA-CTU,,62.0,YR,,F,N,99.8,KG,20161024.0,N,MD,US,US,2016,Q4,Adult
129158541,12915854,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Respiratory failure,,2016,Q4,1,I,20160729.0,,20161103,20161103,DIR,,,FDA-CTU,,62.0,YR,,F,N,99.8,KG,20161024.0,N,MD,US,US,2016,Q4,Adult
129169792,12916979,13,C,insulin glargine,INSULIN GLARGINE,1,Unknown,TAKING FOR MANY YEARS,,,U,,,,,,,,,2016,Q4,Anaemia,,2016,Q4,2,F,,20161109.0,20161107,20161109,EXP,,IT-TEVA-708757ISR,TEVA,"DRAGO F, GASPARINI G, MARENCO S, PICCIOTTO A, PARODI A. PORPHYRIN ELEVATION IN A PATIENT ON TREATMENT WITH SIMEPREVIR: COULD IT BE A POSSIBLE EXPLANATION FOR SIMEPREVIR-ASSOCIATED PHOTOSENSITIVITY?. AM-J-GASTROENTEROL 2016;111(9):1368.",61.0,YR,,M,Y,,,20161109.0,,MD,IT,IT,2016,Q4,Adult
129169792,12916979,13,C,insulin glargine,INSULIN GLARGINE,1,Unknown,TAKING FOR MANY YEARS,,,U,,,,,,,,,2016,Q4,Porphyria non-acute,,2016,Q4,2,F,,20161109.0,20161107,20161109,EXP,,IT-TEVA-708757ISR,TEVA,"DRAGO F, GASPARINI G, MARENCO S, PICCIOTTO A, PARODI A. PORPHYRIN ELEVATION IN A PATIENT ON TREATMENT WITH SIMEPREVIR: COULD IT BE A POSSIBLE EXPLANATION FOR SIMEPREVIR-ASSOCIATED PHOTOSENSITIVITY?. AM-J-GASTROENTEROL 2016;111(9):1368.",61.0,YR,,M,Y,,,20161109.0,,MD,IT,IT,2016,Q4,Adult
129171112,12917111,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2016,Q4,Dyspnoea,,2016,Q4,2,F,20161017.0,20161212.0,20161107,20161219,EXP,,GB-VERTEX PHARMACEUTICALS-2016-006224,VERTEX,,17.0,YR,,F,Y,,,20161219.0,,OT,GB,GB,2016,Q4,Youth
129171112,12917111,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2016,Q4,Haemoptysis,,2016,Q4,2,F,20161017.0,20161212.0,20161107,20161219,EXP,,GB-VERTEX PHARMACEUTICALS-2016-006224,VERTEX,,17.0,YR,,F,Y,,,20161219.0,,OT,GB,GB,2016,Q4,Youth
129171112,12917111,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2016,Q4,Pulmonary function test decreased,,2016,Q4,2,F,20161017.0,20161212.0,20161107,20161219,EXP,,GB-VERTEX PHARMACEUTICALS-2016-006224,VERTEX,,17.0,YR,,F,Y,,,20161219.0,,OT,GB,GB,2016,Q4,Youth
129171112,12917111,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2016,Q4,Pyrexia,,2016,Q4,2,F,20161017.0,20161212.0,20161107,20161219,EXP,,GB-VERTEX PHARMACEUTICALS-2016-006224,VERTEX,,17.0,YR,,F,Y,,,20161219.0,,OT,GB,GB,2016,Q4,Youth
129171112,12917111,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2016,Q4,Respiration abnormal,,2016,Q4,2,F,20161017.0,20161212.0,20161107,20161219,EXP,,GB-VERTEX PHARMACEUTICALS-2016-006224,VERTEX,,17.0,YR,,F,Y,,,20161219.0,,OT,GB,GB,2016,Q4,Youth
129171112,12917111,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2016,Q4,Sputum increased,,2016,Q4,2,F,20161017.0,20161212.0,20161107,20161219,EXP,,GB-VERTEX PHARMACEUTICALS-2016-006224,VERTEX,,17.0,YR,,F,Y,,,20161219.0,,OT,GB,GB,2016,Q4,Youth
129171112,12917111,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2016,Q4,Sputum retention,,2016,Q4,2,F,20161017.0,20161212.0,20161107,20161219,EXP,,GB-VERTEX PHARMACEUTICALS-2016-006224,VERTEX,,17.0,YR,,F,Y,,,20161219.0,,OT,GB,GB,2016,Q4,Youth
129173191,12917319,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Anaemia,,2016,Q4,1,I,20160101.0,,20161104,20161104,DIR,US-FDA-354940,,FDA-CTU,,58.0,YR,,F,N,63.0,KG,20161104.0,N,OT,US,US,2016,Q4,Adult
129173191,12917319,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Gastritis haemorrhagic,,2016,Q4,1,I,20160101.0,,20161104,20161104,DIR,US-FDA-354940,,FDA-CTU,,58.0,YR,,F,N,63.0,KG,20161104.0,N,OT,US,US,2016,Q4,Adult
129173191,12917319,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,International normalised ratio increased,,2016,Q4,1,I,20160101.0,,20161104,20161104,DIR,US-FDA-354940,,FDA-CTU,,58.0,YR,,F,N,63.0,KG,20161104.0,N,OT,US,US,2016,Q4,Adult
129206352,12920635,1,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",,,,,,,,20.0,IU,,QD,2016,Q4,Anti-insulin antibody positive,,2016,Q4,2,F,201610.0,20161111.0,20161107,20161116,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201610009812,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20161115.0,,CN,JP,JP,2016,Q4,Elderly
129206352,12920635,1,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",,,,,,,,20.0,IU,,QD,2016,Q4,Drug ineffective,,2016,Q4,2,F,201610.0,20161111.0,20161107,20161116,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201610009812,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20161115.0,,CN,JP,JP,2016,Q4,Elderly
129206352,12920635,1,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",,,,,,,,20.0,IU,,QD,2016,Q4,Hypoglycaemia,,2016,Q4,2,F,201610.0,20161111.0,20161107,20161116,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201610009812,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20161115.0,,CN,JP,JP,2016,Q4,Elderly
129275761,12927576,1,PS,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,Y,D,,,,,,,HS,2016,Q4,Hypoglycaemia,,2016,Q4,1,I,20161031.0,,20161109,20161109,DIR,US-FDA-355349,,FDA-CTU,,72.0,YR,,F,N,154.9,KG,20161109.0,N,PH,US,US,2016,Q4,Elderly
129275761,12927576,1,PS,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,Y,D,,,,,,,HS,2016,Q4,Therapy cessation,,2016,Q4,1,I,20161031.0,,20161109,20161109,DIR,US-FDA-355349,,FDA-CTU,,72.0,YR,,F,N,154.9,KG,20161109.0,N,PH,US,US,2016,Q4,Elderly
129277521,12927752,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,8 UNITS (0.25 UNITS/KG/DAY) AT BEDTIME,,,,, UNKNOWN,,,,,,,2016,Q4,Hypoglycaemia,,2016,Q4,1,I,,20151124.0,20161109,20161109,PER,,MY-LUPIN PHARMACEUTICALS INC.-2015-03921,LUPIN,"NOR N, JALALUDIN M, HARUN F. MISDIAGNOSIS OF TYPE 1 DIABETES MELLITUS. INTERNATIONAL JOURNAL OF PEDIATRIC ENDOCRINOLOGY. 2013 OCT 03;2013(SUP1):P23.",8.0,YR,,M,Y,,,20161108.0,,OT,MY,MY,2016,Q4,Child
129278011,12927801,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,ONCE IN THE MORNING (24 UNITS),,,,,,,,,,,QD,2016,Q4,Lactic acidosis,,2016,Q4,1,I,,20160720.0,20161109,20161109,PER,,JP-LUPIN PHARMACEUTICALS INC.-2016-03368,LUPIN,"GOCHO N, AOKI E, OKADA C, OMURA K, HIRASHIMA T, SUZUKI N, TANAKA H, OMORI Y. NON-OCCLUSIVE MESENTERIC ISCHEMIA WITH DIABETIC KETOACIDOSIS AND LACTIC ACIDOSIS FOLLOWING THE ADMINISTRATION OF A SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITOR. INTERNAL MEDICINE. 2016;55:1755-1760.",60.0,YR,,M,Y,72.8,KG,20161108.0,,MD,JP,JP,2016,Q4,Adult
129278671,12927867,4,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q4,Asthenia,,2016,Q4,1,I,,20160913.0,20161110,20161110,PER,,IT-LUPIN PHARMACEUTICALS INC.-2016-04387,LUPIN,D^ANGELO F. DAPAGLIFLOZIN: INNOVATION AND THERAPEUTIC EFFICACY. A CLINICAL CASE.. MEDIA. 2016;16:88-89.,65.0,YR,,F,Y,78.0,KG,20161108.0,,OT,IT,IT,2016,Q4,Elderly
129278671,12927867,4,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q4,Glycosylated haemoglobin increased,,2016,Q4,1,I,,20160913.0,20161110,20161110,PER,,IT-LUPIN PHARMACEUTICALS INC.-2016-04387,LUPIN,D^ANGELO F. DAPAGLIFLOZIN: INNOVATION AND THERAPEUTIC EFFICACY. A CLINICAL CASE.. MEDIA. 2016;16:88-89.,65.0,YR,,F,Y,78.0,KG,20161108.0,,OT,IT,IT,2016,Q4,Elderly
129278671,12927867,4,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q4,High density lipoprotein increased,,2016,Q4,1,I,,20160913.0,20161110,20161110,PER,,IT-LUPIN PHARMACEUTICALS INC.-2016-04387,LUPIN,D^ANGELO F. DAPAGLIFLOZIN: INNOVATION AND THERAPEUTIC EFFICACY. A CLINICAL CASE.. MEDIA. 2016;16:88-89.,65.0,YR,,F,Y,78.0,KG,20161108.0,,OT,IT,IT,2016,Q4,Elderly
129278671,12927867,4,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q4,Somnolence,,2016,Q4,1,I,,20160913.0,20161110,20161110,PER,,IT-LUPIN PHARMACEUTICALS INC.-2016-04387,LUPIN,D^ANGELO F. DAPAGLIFLOZIN: INNOVATION AND THERAPEUTIC EFFICACY. A CLINICAL CASE.. MEDIA. 2016;16:88-89.,65.0,YR,,F,Y,78.0,KG,20161108.0,,OT,IT,IT,2016,Q4,Elderly
129340281,12934028,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,8.0,IU,,QD,2016,Q4,Abdominal pain,,2016,Q4,1,I,2013.0,20161108.0,20161111,20161111,EXP,,CN-SA-2016SA204399,AVENTIS,,70.0,YR,E,F,Y,,,20161111.0,,CN,CN,CN,2016,Q4,Elderly
129340281,12934028,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,8.0,IU,,QD,2016,Q4,Arteriosclerosis,,2016,Q4,1,I,2013.0,20161108.0,20161111,20161111,EXP,,CN-SA-2016SA204399,AVENTIS,,70.0,YR,E,F,Y,,,20161111.0,,CN,CN,CN,2016,Q4,Elderly
129340281,12934028,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,8.0,IU,,QD,2016,Q4,Blood glucose increased,,2016,Q4,1,I,2013.0,20161108.0,20161111,20161111,EXP,,CN-SA-2016SA204399,AVENTIS,,70.0,YR,E,F,Y,,,20161111.0,,CN,CN,CN,2016,Q4,Elderly
129340281,12934028,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,8.0,IU,,QD,2016,Q4,Blood pressure increased,,2016,Q4,1,I,2013.0,20161108.0,20161111,20161111,EXP,,CN-SA-2016SA204399,AVENTIS,,70.0,YR,E,F,Y,,,20161111.0,,CN,CN,CN,2016,Q4,Elderly
129340281,12934028,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,8.0,IU,,QD,2016,Q4,Diabetic nephropathy,,2016,Q4,1,I,2013.0,20161108.0,20161111,20161111,EXP,,CN-SA-2016SA204399,AVENTIS,,70.0,YR,E,F,Y,,,20161111.0,,CN,CN,CN,2016,Q4,Elderly
129340281,12934028,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,8.0,IU,,QD,2016,Q4,Dizziness,,2016,Q4,1,I,2013.0,20161108.0,20161111,20161111,EXP,,CN-SA-2016SA204399,AVENTIS,,70.0,YR,E,F,Y,,,20161111.0,,CN,CN,CN,2016,Q4,Elderly
129340281,12934028,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,8.0,IU,,QD,2016,Q4,Drug dose omission,,2016,Q4,1,I,2013.0,20161108.0,20161111,20161111,EXP,,CN-SA-2016SA204399,AVENTIS,,70.0,YR,E,F,Y,,,20161111.0,,CN,CN,CN,2016,Q4,Elderly
129340281,12934028,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,8.0,IU,,QD,2016,Q4,Dysuria,,2016,Q4,1,I,2013.0,20161108.0,20161111,20161111,EXP,,CN-SA-2016SA204399,AVENTIS,,70.0,YR,E,F,Y,,,20161111.0,,CN,CN,CN,2016,Q4,Elderly
129340281,12934028,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,8.0,IU,,QD,2016,Q4,Glycosylated haemoglobin increased,,2016,Q4,1,I,2013.0,20161108.0,20161111,20161111,EXP,,CN-SA-2016SA204399,AVENTIS,,70.0,YR,E,F,Y,,,20161111.0,,CN,CN,CN,2016,Q4,Elderly
129340281,12934028,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,8.0,IU,,QD,2016,Q4,Intentional product misuse,,2016,Q4,1,I,2013.0,20161108.0,20161111,20161111,EXP,,CN-SA-2016SA204399,AVENTIS,,70.0,YR,E,F,Y,,,20161111.0,,CN,CN,CN,2016,Q4,Elderly
129340281,12934028,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,8.0,IU,,QD,2016,Q4,Oedema peripheral,,2016,Q4,1,I,2013.0,20161108.0,20161111,20161111,EXP,,CN-SA-2016SA204399,AVENTIS,,70.0,YR,E,F,Y,,,20161111.0,,CN,CN,CN,2016,Q4,Elderly
129340281,12934028,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,8.0,IU,,QD,2016,Q4,Pain,,2016,Q4,1,I,2013.0,20161108.0,20161111,20161111,EXP,,CN-SA-2016SA204399,AVENTIS,,70.0,YR,E,F,Y,,,20161111.0,,CN,CN,CN,2016,Q4,Elderly
129340281,12934028,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,8.0,IU,,QD,2016,Q4,Pain in extremity,,2016,Q4,1,I,2013.0,20161108.0,20161111,20161111,EXP,,CN-SA-2016SA204399,AVENTIS,,70.0,YR,E,F,Y,,,20161111.0,,CN,CN,CN,2016,Q4,Elderly
129340281,12934028,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,8.0,IU,,QD,2016,Q4,Renal atrophy,,2016,Q4,1,I,2013.0,20161108.0,20161111,20161111,EXP,,CN-SA-2016SA204399,AVENTIS,,70.0,YR,E,F,Y,,,20161111.0,,CN,CN,CN,2016,Q4,Elderly
129340281,12934028,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,8.0,IU,,QD,2016,Q4,Thoracic vertebral fracture,,2016,Q4,1,I,2013.0,20161108.0,20161111,20161111,EXP,,CN-SA-2016SA204399,AVENTIS,,70.0,YR,E,F,Y,,,20161111.0,,CN,CN,CN,2016,Q4,Elderly
129340281,12934028,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,8.0,IU,,QD,2016,Q4,Vomiting projectile,,2016,Q4,1,I,2013.0,20161108.0,20161111,20161111,EXP,,CN-SA-2016SA204399,AVENTIS,,70.0,YR,E,F,Y,,,20161111.0,,CN,CN,CN,2016,Q4,Elderly
129340815,12934081,10,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,90 IU (INTERNATIONAL UNIT),,,,,,,,45.0,IU,INJECTION,BID,2016,Q4,Acute myocardial infarction,,2016,Q4,5,F,20161028.0,20161220.0,20161111,20161229,EXP,,US-CELGENEUS-USA-2016110904,CELGENE,,69.0,YR,,M,Y,99.88,KG,20161229.0,,MD,US,US,2016,Q4,Elderly
129340815,12934081,10,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,90 IU (INTERNATIONAL UNIT),,,,,,,,45.0,IU,INJECTION,BID,2016,Q4,Cerebrovascular accident,,2016,Q4,5,F,20161028.0,20161220.0,20161111,20161229,EXP,,US-CELGENEUS-USA-2016110904,CELGENE,,69.0,YR,,M,Y,99.88,KG,20161229.0,,MD,US,US,2016,Q4,Elderly
129350891,12935089,7,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q4,Lactic acidosis,,2016,Q4,1,I,,20160209.0,20161113,20161113,PER,,DK-LUPIN PHARMACEUTICALS INC.-2016-00703,LUPIN,"STORGAARD H, BAGGER J, KNOP F, VILSBOLL T, RUNGBY J. DIABETIC KETOACIDOSIS IN A PATIENT WITH TYPE 2 DIABETES AFTER INITIATION OF SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITOR TREATMENT. BASIC AND CLINICAL PHARMACOLOGY AND TOXICOLOGY. 2016;118 (2):168-170.",44.0,YR,,M,Y,,,20161111.0,,OT,DK,DK,2016,Q4,Adult
129350891,12935089,8,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2016,Q4,Lactic acidosis,,2016,Q4,1,I,,20160209.0,20161113,20161113,PER,,DK-LUPIN PHARMACEUTICALS INC.-2016-00703,LUPIN,"STORGAARD H, BAGGER J, KNOP F, VILSBOLL T, RUNGBY J. DIABETIC KETOACIDOSIS IN A PATIENT WITH TYPE 2 DIABETES AFTER INITIATION OF SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITOR TREATMENT. BASIC AND CLINICAL PHARMACOLOGY AND TOXICOLOGY. 2016;118 (2):168-170.",44.0,YR,,M,Y,,,20161111.0,,OT,DK,DK,2016,Q4,Adult
129350901,12935090,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,14 UNITS,,,,,,,,,,,,2016,Q4,Lactic acidosis,,2016,Q4,1,I,,20160414.0,20161113,20161113,PER,JP-MLMSERVICE-20160416-0245046-1,JP-LUPIN PHARMACEUTICALS INC.-2016-01649,LUPIN,"OZEKI T, KAWATO R, WATANABE M, MINATOGUCHI S, MURAI Y, RYUGE A, TAKASUGI K, HAMADA T, OYAMA Y, NOMURA A, TOMINO T, SHIMIZU H, FUJITA Y. A FATAL CASE OF METFORMIN-ASSOCIATED LACTIC ACIDOSIS. INTERNAL MEDICINE. 2016;55(7):775-778.",72.0,YR,,F,Y,,,20161111.0,,MD,JP,JP,2016,Q4,Elderly
129417901,12941790,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,30.0,IU,INJECTION,QD,2016,Q4,Diabetic ketoacidosis,,2016,Q4,1,I,20160308.0,20161109.0,20161115,20161115,EXP,,US-JNJFOC-20161112797,JANSSEN,,51.0,YR,A,M,Y,,,20161115.0,,CN,US,US,2016,Q4,Adult
129419314,12941931,11,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNITS,,,,,,,,5.0,IU,INJECTION,QD,2016,Q4,Neutropenia,,2016,Q4,4,F,20160606.0,20161216.0,20161114,20161229,EXP,,US-CELGENEUS-USA-2016061277,CELGENE,,79.0,YR,,F,Y,,,20161229.0,,OT,US,US,2016,Q4,Elderly
129419314,12941931,11,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNITS,,,,,,,,5.0,IU,INJECTION,QD,2016,Q4,Pneumonia,,2016,Q4,4,F,20160606.0,20161216.0,20161114,20161229,EXP,,US-CELGENEUS-USA-2016061277,CELGENE,,79.0,YR,,F,Y,,,20161229.0,,OT,US,US,2016,Q4,Elderly
129419314,12941931,11,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNITS,,,,,,,,5.0,IU,INJECTION,QD,2016,Q4,Sepsis,,2016,Q4,4,F,20160606.0,20161216.0,20161114,20161229,EXP,,US-CELGENEUS-USA-2016061277,CELGENE,,79.0,YR,,F,Y,,,20161229.0,,OT,US,US,2016,Q4,Elderly
129421633,12942163,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,98.0,IU,,QD,2016,Q4,Hypertension,,2016,Q4,3,F,20161019.0,20161110.0,20161114,20161119,EXP,,US-ASTRAZENECA-2016SF17404,ASTRAZENECA,,21614.0,DY,,F,Y,,,20161119.0,,MD,US,US,2016,Q4,Elderly
129421633,12942163,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,98.0,IU,,QD,2016,Q4,Nausea,,2016,Q4,3,F,20161019.0,20161110.0,20161114,20161119,EXP,,US-ASTRAZENECA-2016SF17404,ASTRAZENECA,,21614.0,DY,,F,Y,,,20161119.0,,MD,US,US,2016,Q4,Elderly
129421633,12942163,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,98.0,IU,,QD,2016,Q4,Vomiting,,2016,Q4,3,F,20161019.0,20161110.0,20161114,20161119,EXP,,US-ASTRAZENECA-2016SF17404,ASTRAZENECA,,21614.0,DY,,F,Y,,,20161119.0,,MD,US,US,2016,Q4,Elderly
129430262,12943026,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"62 U, 1X/DAY",,,,,,,,,,,QD,2016,Q4,Gangrene,,2016,Q4,2,F,201610.0,20161206.0,20161115,20161219,EXP,,"US-SMITH AND NEPHEW, INC-2016SMT00964",SMITH AND NEPHEW,,50.0,YR,,F,Y,124.72,KG,20161219.0,,OT,US,US,2016,Q4,Adult
129430262,12943026,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"62 U, 1X/DAY",,,,,,,,,,,QD,2016,Q4,Osteomyelitis,,2016,Q4,2,F,201610.0,20161206.0,20161115,20161219,EXP,,"US-SMITH AND NEPHEW, INC-2016SMT00964",SMITH AND NEPHEW,,50.0,YR,,F,Y,124.72,KG,20161219.0,,OT,US,US,2016,Q4,Adult
129430262,12943026,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"62 U, 1X/DAY",,,,,,,,,,,QD,2016,Q4,Pain,,2016,Q4,2,F,201610.0,20161206.0,20161115,20161219,EXP,,"US-SMITH AND NEPHEW, INC-2016SMT00964",SMITH AND NEPHEW,,50.0,YR,,F,Y,124.72,KG,20161219.0,,OT,US,US,2016,Q4,Adult
129430262,12943026,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"62 U, 1X/DAY",,,,,,,,,,,QD,2016,Q4,Peripheral arterial occlusive disease,,2016,Q4,2,F,201610.0,20161206.0,20161115,20161219,EXP,,"US-SMITH AND NEPHEW, INC-2016SMT00964",SMITH AND NEPHEW,,50.0,YR,,F,Y,124.72,KG,20161219.0,,OT,US,US,2016,Q4,Adult
129430262,12943026,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"62 U, 1X/DAY",,,,,,,,,,,QD,2016,Q4,Toe amputation,,2016,Q4,2,F,201610.0,20161206.0,20161115,20161219,EXP,,"US-SMITH AND NEPHEW, INC-2016SMT00964",SMITH AND NEPHEW,,50.0,YR,,F,Y,124.72,KG,20161219.0,,OT,US,US,2016,Q4,Adult
129455482,12945548,1,PS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",,,U,U,,,205692.0,20.0,IU,,QD,2016,Q4,Diabetes mellitus inadequate control,,2016,Q4,2,F,,20161129.0,20161115,20161205,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201611003679,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20161205.0,,CN,JP,JP,2016,Q4,Elderly
129455482,12945548,1,PS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",,,U,U,,,205692.0,20.0,IU,,QD,2016,Q4,Hypoglycaemic encephalopathy,,2016,Q4,2,F,,20161129.0,20161115,20161205,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201611003679,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20161205.0,,CN,JP,JP,2016,Q4,Elderly
129459692,12945969,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,15.0,IU,,QD,2016,Q4,Ovarian endometrioid carcinoma,,2016,Q4,2,F,20160822.0,20161114.0,20161116,20161118,EXP,,US-ASTRAZENECA-2016SF21403,ASTRAZENECA,,26916.0,DY,,F,Y,80.7,KG,20161118.0,,MD,US,US,2016,Q4,Elderly
129525001,12952500,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 U, QD",,,,, UNKNOWN,,,25.0,DF,,QD,2016,Q4,Device breakage,,2016,Q4,1,I,20160716.0,20160718.0,20161117,20161117,PER,,US-NOVOPROD-502456,NOVO NORDISK,,19.0,YR,A,M,Y,,,20161117.0,,OT,US,US,2016,Q4,Youth
129525001,12952500,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 U, QD",,,,, UNKNOWN,,,25.0,DF,,QD,2016,Q4,Diabetic ketoacidosis,,2016,Q4,1,I,20160716.0,20160718.0,20161117,20161117,PER,,US-NOVOPROD-502456,NOVO NORDISK,,19.0,YR,A,M,Y,,,20161117.0,,OT,US,US,2016,Q4,Youth
129525001,12952500,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 U, QD",,,,, UNKNOWN,,,25.0,DF,,QD,2016,Q4,Drug dose omission,,2016,Q4,1,I,20160716.0,20160718.0,20161117,20161117,PER,,US-NOVOPROD-502456,NOVO NORDISK,,19.0,YR,A,M,Y,,,20161117.0,,OT,US,US,2016,Q4,Youth
129557001,12955700,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Cardiac failure congestive,,2016,Q4,1,I,20161028.0,,20161117,20161117,DIR,,,FDA-CTU,,75.0,YR,,F,N,,,20161028.0,N,PH,US,US,2016,Q4,Elderly
129557001,12955700,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Pemphigoid,,2016,Q4,1,I,20161028.0,,20161117,20161117,DIR,,,FDA-CTU,,75.0,YR,,F,N,,,20161028.0,N,PH,US,US,2016,Q4,Elderly
129563681,12956368,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Cardiac operation,,2016,Q4,1,I,201610.0,20161107.0,20161118,20161118,EXP,,US-RELYPSA-RLY2016003658,RELYPSA,,66.0,YR,,M,Y,,,20161118.0,,CN,US,US,2016,Q4,Elderly
129566611,12956661,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Abdominal pain,,2016,Q4,1,I,,20161109.0,20161118,20161118,EXP,,US-SA-2016SA206897,AVENTIS,"DESAI M, REIPRICH A, KHOV N, YANG Z, MATHEW A, LEVENICK J. CRYSTAL-ASSOCIATED COLITIS WITH ULCERATION LEADING TO HEMATOCHEZIA AND ABDOMINAL PAIN. CASE REP GASTROENTEROL.2016;10:332-37. DOI: 10.1159/000446575.",45.0,YR,A,F,Y,,,20161118.0,,OT,US,US,2016,Q4,Adult
129566611,12956661,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Colitis,,2016,Q4,1,I,,20161109.0,20161118,20161118,EXP,,US-SA-2016SA206897,AVENTIS,"DESAI M, REIPRICH A, KHOV N, YANG Z, MATHEW A, LEVENICK J. CRYSTAL-ASSOCIATED COLITIS WITH ULCERATION LEADING TO HEMATOCHEZIA AND ABDOMINAL PAIN. CASE REP GASTROENTEROL.2016;10:332-37. DOI: 10.1159/000446575.",45.0,YR,A,F,Y,,,20161118.0,,OT,US,US,2016,Q4,Adult
129566611,12956661,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Gastrointestinal oedema,,2016,Q4,1,I,,20161109.0,20161118,20161118,EXP,,US-SA-2016SA206897,AVENTIS,"DESAI M, REIPRICH A, KHOV N, YANG Z, MATHEW A, LEVENICK J. CRYSTAL-ASSOCIATED COLITIS WITH ULCERATION LEADING TO HEMATOCHEZIA AND ABDOMINAL PAIN. CASE REP GASTROENTEROL.2016;10:332-37. DOI: 10.1159/000446575.",45.0,YR,A,F,Y,,,20161118.0,,OT,US,US,2016,Q4,Adult
129566611,12956661,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Haematochezia,,2016,Q4,1,I,,20161109.0,20161118,20161118,EXP,,US-SA-2016SA206897,AVENTIS,"DESAI M, REIPRICH A, KHOV N, YANG Z, MATHEW A, LEVENICK J. CRYSTAL-ASSOCIATED COLITIS WITH ULCERATION LEADING TO HEMATOCHEZIA AND ABDOMINAL PAIN. CASE REP GASTROENTEROL.2016;10:332-37. DOI: 10.1159/000446575.",45.0,YR,A,F,Y,,,20161118.0,,OT,US,US,2016,Q4,Adult
129566611,12956661,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Haemoglobin decreased,,2016,Q4,1,I,,20161109.0,20161118,20161118,EXP,,US-SA-2016SA206897,AVENTIS,"DESAI M, REIPRICH A, KHOV N, YANG Z, MATHEW A, LEVENICK J. CRYSTAL-ASSOCIATED COLITIS WITH ULCERATION LEADING TO HEMATOCHEZIA AND ABDOMINAL PAIN. CASE REP GASTROENTEROL.2016;10:332-37. DOI: 10.1159/000446575.",45.0,YR,A,F,Y,,,20161118.0,,OT,US,US,2016,Q4,Adult
129566611,12956661,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Hypotension,,2016,Q4,1,I,,20161109.0,20161118,20161118,EXP,,US-SA-2016SA206897,AVENTIS,"DESAI M, REIPRICH A, KHOV N, YANG Z, MATHEW A, LEVENICK J. CRYSTAL-ASSOCIATED COLITIS WITH ULCERATION LEADING TO HEMATOCHEZIA AND ABDOMINAL PAIN. CASE REP GASTROENTEROL.2016;10:332-37. DOI: 10.1159/000446575.",45.0,YR,A,F,Y,,,20161118.0,,OT,US,US,2016,Q4,Adult
129566611,12956661,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Large intestinal ulcer,,2016,Q4,1,I,,20161109.0,20161118,20161118,EXP,,US-SA-2016SA206897,AVENTIS,"DESAI M, REIPRICH A, KHOV N, YANG Z, MATHEW A, LEVENICK J. CRYSTAL-ASSOCIATED COLITIS WITH ULCERATION LEADING TO HEMATOCHEZIA AND ABDOMINAL PAIN. CASE REP GASTROENTEROL.2016;10:332-37. DOI: 10.1159/000446575.",45.0,YR,A,F,Y,,,20161118.0,,OT,US,US,2016,Q4,Adult
129588311,12958831,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Chest pain,,2016,Q4,1,I,20160930.0,,20161117,20161117,DIR,,,FDA-CTU,,60.0,YR,,F,N,,,20161014.0,N,PH,US,US,2016,Q4,Adult
129588311,12958831,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Dysuria,,2016,Q4,1,I,20160930.0,,20161117,20161117,DIR,,,FDA-CTU,,60.0,YR,,F,N,,,20161014.0,N,PH,US,US,2016,Q4,Adult
129588311,12958831,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Hyponatraemia,,2016,Q4,1,I,20160930.0,,20161117,20161117,DIR,,,FDA-CTU,,60.0,YR,,F,N,,,20161014.0,N,PH,US,US,2016,Q4,Adult
129602161,12960216,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"22 IU, UNKNOWN FREQ. (BEFORE EACH MEAL, DOSE REDUCED BY 50%)",,,D,U,,,,22.0,IU,FORMULATION UNKNOWN,,2016,Q4,Chronic kidney disease,,2016,Q4,1,I,2012.0,20161114.0,20161121,20161121,EXP,,BH-ASTELLAS-2016US045273,ASTELLAS,,56.0,YR,,M,Y,,,20161121.0,,OT,GB,BH,2016,Q4,Adult
129602161,12960216,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"22 IU, UNKNOWN FREQ. (BEFORE EACH MEAL, DOSE REDUCED BY 50%)",,,D,U,,,,22.0,IU,FORMULATION UNKNOWN,,2016,Q4,Hyperglycaemia,,2016,Q4,1,I,2012.0,20161114.0,20161121,20161121,EXP,,BH-ASTELLAS-2016US045273,ASTELLAS,,56.0,YR,,M,Y,,,20161121.0,,OT,GB,BH,2016,Q4,Adult
129602161,12960216,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"22 IU, UNKNOWN FREQ. (BEFORE EACH MEAL, DOSE REDUCED BY 50%)",,,D,U,,,,22.0,IU,FORMULATION UNKNOWN,,2016,Q4,Hypertension,,2016,Q4,1,I,2012.0,20161114.0,20161121,20161121,EXP,,BH-ASTELLAS-2016US045273,ASTELLAS,,56.0,YR,,M,Y,,,20161121.0,,OT,GB,BH,2016,Q4,Adult
129602161,12960216,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"22 IU, UNKNOWN FREQ. (BEFORE EACH MEAL, DOSE REDUCED BY 50%)",,,D,U,,,,22.0,IU,FORMULATION UNKNOWN,,2016,Q4,Mouth ulceration,,2016,Q4,1,I,2012.0,20161114.0,20161121,20161121,EXP,,BH-ASTELLAS-2016US045273,ASTELLAS,,56.0,YR,,M,Y,,,20161121.0,,OT,GB,BH,2016,Q4,Adult
129602161,12960216,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"22 IU, UNKNOWN FREQ. (BEFORE EACH MEAL, DOSE REDUCED BY 50%)",,,D,U,,,,22.0,IU,FORMULATION UNKNOWN,,2016,Q4,Neuropathy peripheral,,2016,Q4,1,I,2012.0,20161114.0,20161121,20161121,EXP,,BH-ASTELLAS-2016US045273,ASTELLAS,,56.0,YR,,M,Y,,,20161121.0,,OT,GB,BH,2016,Q4,Adult
129602161,12960216,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"22 IU, UNKNOWN FREQ. (BEFORE EACH MEAL, DOSE REDUCED BY 50%)",,,D,U,,,,22.0,IU,FORMULATION UNKNOWN,,2016,Q4,Neutropenia,,2016,Q4,1,I,2012.0,20161114.0,20161121,20161121,EXP,,BH-ASTELLAS-2016US045273,ASTELLAS,,56.0,YR,,M,Y,,,20161121.0,,OT,GB,BH,2016,Q4,Adult
129602161,12960216,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"22 IU, UNKNOWN FREQ. (BEFORE EACH MEAL, DOSE REDUCED BY 50%)",,,D,U,,,,22.0,IU,FORMULATION UNKNOWN,,2016,Q4,Off label use,,2016,Q4,1,I,2012.0,20161114.0,20161121,20161121,EXP,,BH-ASTELLAS-2016US045273,ASTELLAS,,56.0,YR,,M,Y,,,20161121.0,,OT,GB,BH,2016,Q4,Adult
129602161,12960216,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"22 IU, UNKNOWN FREQ. (BEFORE EACH MEAL, DOSE REDUCED BY 50%)",,,D,U,,,,22.0,IU,FORMULATION UNKNOWN,,2016,Q4,Respiratory tract infection,,2016,Q4,1,I,2012.0,20161114.0,20161121,20161121,EXP,,BH-ASTELLAS-2016US045273,ASTELLAS,,56.0,YR,,M,Y,,,20161121.0,,OT,GB,BH,2016,Q4,Adult
129602161,12960216,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"22 IU, UNKNOWN FREQ. (BEFORE EACH MEAL, DOSE REDUCED BY 50%)",,,D,U,,,,22.0,IU,FORMULATION UNKNOWN,,2016,Q4,Toxicity to various agents,,2016,Q4,1,I,2012.0,20161114.0,20161121,20161121,EXP,,BH-ASTELLAS-2016US045273,ASTELLAS,,56.0,YR,,M,Y,,,20161121.0,,OT,GB,BH,2016,Q4,Adult
129615102,12961510,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 DF, AT MEALS AND AT NIGHT",,,,,,,,30.0,DF,,,2016,Q4,Blood bilirubin increased,,2016,Q4,2,F,20160629.0,20161129.0,20161121,20161205,EXP,,US-009507513-1611USA007128,MERCK,,66.0,YR,,M,Y,,,20161205.0,,CN,US,US,2016,Q4,Elderly
129615102,12961510,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 DF, AT MEALS AND AT NIGHT",,,,,,,,30.0,DF,,,2016,Q4,Death,,2016,Q4,2,F,20160629.0,20161129.0,20161121,20161205,EXP,,US-009507513-1611USA007128,MERCK,,66.0,YR,,M,Y,,,20161205.0,,CN,US,US,2016,Q4,Elderly
129615102,12961510,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 DF, AT MEALS AND AT NIGHT",,,,,,,,30.0,DF,,,2016,Q4,Hepatic pain,,2016,Q4,2,F,20160629.0,20161129.0,20161121,20161205,EXP,,US-009507513-1611USA007128,MERCK,,66.0,YR,,M,Y,,,20161205.0,,CN,US,US,2016,Q4,Elderly
129615102,12961510,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 DF, AT MEALS AND AT NIGHT",,,,,,,,30.0,DF,,,2016,Q4,Malignant neoplasm progression,,2016,Q4,2,F,20160629.0,20161129.0,20161121,20161205,EXP,,US-009507513-1611USA007128,MERCK,,66.0,YR,,M,Y,,,20161205.0,,CN,US,US,2016,Q4,Elderly
129615102,12961510,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 DF, AT MEALS AND AT NIGHT",,,,,,,,30.0,DF,,,2016,Q4,Yellow skin,,2016,Q4,2,F,20160629.0,20161129.0,20161121,20161205,EXP,,US-009507513-1611USA007128,MERCK,,66.0,YR,,M,Y,,,20161205.0,,CN,US,US,2016,Q4,Elderly
129639671,12963967,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q4,Vitamin B1 deficiency,,2016,Q4,1,I,201312.0,20161121.0,20161122,20161122,EXP,,JP-FRESENIUS KABI-FK201609049,FRESENIUS KABI,"KANEKO Y,TSURUTANI Y,SAGAWA N,KONDO M,SATA A,MIYAO M. A CASE OF AN ELDERLY DIABETIC PATIENT DEVELOPING WERNICKE ENCEPHALOPATHY WITHOUT ALCOHOL ABUSE OR AN UNBALANCED DIET. NIPPON-RON-IGAK_ZASSHI-JPN-J-GERIATR 2015;2:177-183.",70.0,YR,,M,Y,,,20161122.0,,OT,JP,JP,2016,Q4,Elderly
129639671,12963967,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q4,Wernicke's encephalopathy,,2016,Q4,1,I,201312.0,20161121.0,20161122,20161122,EXP,,JP-FRESENIUS KABI-FK201609049,FRESENIUS KABI,"KANEKO Y,TSURUTANI Y,SAGAWA N,KONDO M,SATA A,MIYAO M. A CASE OF AN ELDERLY DIABETIC PATIENT DEVELOPING WERNICKE ENCEPHALOPATHY WITHOUT ALCOHOL ABUSE OR AN UNBALANCED DIET. NIPPON-RON-IGAK_ZASSHI-JPN-J-GERIATR 2015;2:177-183.",70.0,YR,,M,Y,,,20161122.0,,OT,JP,JP,2016,Q4,Elderly
129763302,12976330,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Topical,"4 IU, QD",,,,,,,,4.0,IU,INJECTION,QD,2016,Q4,Blood triglycerides increased,,2016,Q4,2,F,20160813.0,20161115.0,20161126,20161128,EXP,,PHHY2016CN159127,NOVARTIS,,61.0,YR,,M,Y,,,20161128.0,,MD,CN,CN,2016,Q4,Adult
129763302,12976330,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Topical,"4 IU, QD",,,,,,,,4.0,IU,INJECTION,QD,2016,Q4,Blood urea increased,,2016,Q4,2,F,20160813.0,20161115.0,20161126,20161128,EXP,,PHHY2016CN159127,NOVARTIS,,61.0,YR,,M,Y,,,20161128.0,,MD,CN,CN,2016,Q4,Adult
129763302,12976330,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Topical,"4 IU, QD",,,,,,,,4.0,IU,INJECTION,QD,2016,Q4,C-reactive protein increased,,2016,Q4,2,F,20160813.0,20161115.0,20161126,20161128,EXP,,PHHY2016CN159127,NOVARTIS,,61.0,YR,,M,Y,,,20161128.0,,MD,CN,CN,2016,Q4,Adult
129763302,12976330,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Topical,"4 IU, QD",,,,,,,,4.0,IU,INJECTION,QD,2016,Q4,Haemoglobin decreased,,2016,Q4,2,F,20160813.0,20161115.0,20161126,20161128,EXP,,PHHY2016CN159127,NOVARTIS,,61.0,YR,,M,Y,,,20161128.0,,MD,CN,CN,2016,Q4,Adult
129763302,12976330,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Topical,"4 IU, QD",,,,,,,,4.0,IU,INJECTION,QD,2016,Q4,Incision site pain,,2016,Q4,2,F,20160813.0,20161115.0,20161126,20161128,EXP,,PHHY2016CN159127,NOVARTIS,,61.0,YR,,M,Y,,,20161128.0,,MD,CN,CN,2016,Q4,Adult
129763302,12976330,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Topical,"4 IU, QD",,,,,,,,4.0,IU,INJECTION,QD,2016,Q4,Low density lipoprotein increased,,2016,Q4,2,F,20160813.0,20161115.0,20161126,20161128,EXP,,PHHY2016CN159127,NOVARTIS,,61.0,YR,,M,Y,,,20161128.0,,MD,CN,CN,2016,Q4,Adult
129763302,12976330,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Topical,"4 IU, QD",,,,,,,,4.0,IU,INJECTION,QD,2016,Q4,Lymphocyte count decreased,,2016,Q4,2,F,20160813.0,20161115.0,20161126,20161128,EXP,,PHHY2016CN159127,NOVARTIS,,61.0,YR,,M,Y,,,20161128.0,,MD,CN,CN,2016,Q4,Adult
129763302,12976330,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Topical,"4 IU, QD",,,,,,,,4.0,IU,INJECTION,QD,2016,Q4,Neutrophil count increased,,2016,Q4,2,F,20160813.0,20161115.0,20161126,20161128,EXP,,PHHY2016CN159127,NOVARTIS,,61.0,YR,,M,Y,,,20161128.0,,MD,CN,CN,2016,Q4,Adult
129763302,12976330,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Topical,"4 IU, QD",,,,,,,,4.0,IU,INJECTION,QD,2016,Q4,Protein urine present,,2016,Q4,2,F,20160813.0,20161115.0,20161126,20161128,EXP,,PHHY2016CN159127,NOVARTIS,,61.0,YR,,M,Y,,,20161128.0,,MD,CN,CN,2016,Q4,Adult
129763302,12976330,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Topical,"4 IU, QD",,,,,,,,4.0,IU,INJECTION,QD,2016,Q4,Red blood cells urine positive,,2016,Q4,2,F,20160813.0,20161115.0,20161126,20161128,EXP,,PHHY2016CN159127,NOVARTIS,,61.0,YR,,M,Y,,,20161128.0,,MD,CN,CN,2016,Q4,Adult
129763302,12976330,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Topical,"4 IU, QD",,,,,,,,4.0,IU,INJECTION,QD,2016,Q4,White blood cell count increased,,2016,Q4,2,F,20160813.0,20161115.0,20161126,20161128,EXP,,PHHY2016CN159127,NOVARTIS,,61.0,YR,,M,Y,,,20161128.0,,MD,CN,CN,2016,Q4,Adult
129763302,12976330,42,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Topical,"10 IU, QD",,,,,,,,10.0,IU,INJECTION,QD,2016,Q4,Blood triglycerides increased,,2016,Q4,2,F,20160813.0,20161115.0,20161126,20161128,EXP,,PHHY2016CN159127,NOVARTIS,,61.0,YR,,M,Y,,,20161128.0,,MD,CN,CN,2016,Q4,Adult
129763302,12976330,42,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Topical,"10 IU, QD",,,,,,,,10.0,IU,INJECTION,QD,2016,Q4,Blood urea increased,,2016,Q4,2,F,20160813.0,20161115.0,20161126,20161128,EXP,,PHHY2016CN159127,NOVARTIS,,61.0,YR,,M,Y,,,20161128.0,,MD,CN,CN,2016,Q4,Adult
129763302,12976330,42,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Topical,"10 IU, QD",,,,,,,,10.0,IU,INJECTION,QD,2016,Q4,C-reactive protein increased,,2016,Q4,2,F,20160813.0,20161115.0,20161126,20161128,EXP,,PHHY2016CN159127,NOVARTIS,,61.0,YR,,M,Y,,,20161128.0,,MD,CN,CN,2016,Q4,Adult
129763302,12976330,42,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Topical,"10 IU, QD",,,,,,,,10.0,IU,INJECTION,QD,2016,Q4,Haemoglobin decreased,,2016,Q4,2,F,20160813.0,20161115.0,20161126,20161128,EXP,,PHHY2016CN159127,NOVARTIS,,61.0,YR,,M,Y,,,20161128.0,,MD,CN,CN,2016,Q4,Adult
129763302,12976330,42,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Topical,"10 IU, QD",,,,,,,,10.0,IU,INJECTION,QD,2016,Q4,Incision site pain,,2016,Q4,2,F,20160813.0,20161115.0,20161126,20161128,EXP,,PHHY2016CN159127,NOVARTIS,,61.0,YR,,M,Y,,,20161128.0,,MD,CN,CN,2016,Q4,Adult
129763302,12976330,42,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Topical,"10 IU, QD",,,,,,,,10.0,IU,INJECTION,QD,2016,Q4,Low density lipoprotein increased,,2016,Q4,2,F,20160813.0,20161115.0,20161126,20161128,EXP,,PHHY2016CN159127,NOVARTIS,,61.0,YR,,M,Y,,,20161128.0,,MD,CN,CN,2016,Q4,Adult
129763302,12976330,42,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Topical,"10 IU, QD",,,,,,,,10.0,IU,INJECTION,QD,2016,Q4,Lymphocyte count decreased,,2016,Q4,2,F,20160813.0,20161115.0,20161126,20161128,EXP,,PHHY2016CN159127,NOVARTIS,,61.0,YR,,M,Y,,,20161128.0,,MD,CN,CN,2016,Q4,Adult
129763302,12976330,42,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Topical,"10 IU, QD",,,,,,,,10.0,IU,INJECTION,QD,2016,Q4,Neutrophil count increased,,2016,Q4,2,F,20160813.0,20161115.0,20161126,20161128,EXP,,PHHY2016CN159127,NOVARTIS,,61.0,YR,,M,Y,,,20161128.0,,MD,CN,CN,2016,Q4,Adult
129763302,12976330,42,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Topical,"10 IU, QD",,,,,,,,10.0,IU,INJECTION,QD,2016,Q4,Protein urine present,,2016,Q4,2,F,20160813.0,20161115.0,20161126,20161128,EXP,,PHHY2016CN159127,NOVARTIS,,61.0,YR,,M,Y,,,20161128.0,,MD,CN,CN,2016,Q4,Adult
129763302,12976330,42,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Topical,"10 IU, QD",,,,,,,,10.0,IU,INJECTION,QD,2016,Q4,Red blood cells urine positive,,2016,Q4,2,F,20160813.0,20161115.0,20161126,20161128,EXP,,PHHY2016CN159127,NOVARTIS,,61.0,YR,,M,Y,,,20161128.0,,MD,CN,CN,2016,Q4,Adult
129763302,12976330,42,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Topical,"10 IU, QD",,,,,,,,10.0,IU,INJECTION,QD,2016,Q4,White blood cell count increased,,2016,Q4,2,F,20160813.0,20161115.0,20161126,20161128,EXP,,PHHY2016CN159127,NOVARTIS,,61.0,YR,,M,Y,,,20161128.0,,MD,CN,CN,2016,Q4,Adult
129763302,12976330,43,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Topical,"14 IU, QD",,,,,,,,14.0,IU,INJECTION,QD,2016,Q4,Blood triglycerides increased,,2016,Q4,2,F,20160813.0,20161115.0,20161126,20161128,EXP,,PHHY2016CN159127,NOVARTIS,,61.0,YR,,M,Y,,,20161128.0,,MD,CN,CN,2016,Q4,Adult
129763302,12976330,43,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Topical,"14 IU, QD",,,,,,,,14.0,IU,INJECTION,QD,2016,Q4,Blood urea increased,,2016,Q4,2,F,20160813.0,20161115.0,20161126,20161128,EXP,,PHHY2016CN159127,NOVARTIS,,61.0,YR,,M,Y,,,20161128.0,,MD,CN,CN,2016,Q4,Adult
129763302,12976330,43,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Topical,"14 IU, QD",,,,,,,,14.0,IU,INJECTION,QD,2016,Q4,C-reactive protein increased,,2016,Q4,2,F,20160813.0,20161115.0,20161126,20161128,EXP,,PHHY2016CN159127,NOVARTIS,,61.0,YR,,M,Y,,,20161128.0,,MD,CN,CN,2016,Q4,Adult
129763302,12976330,43,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Topical,"14 IU, QD",,,,,,,,14.0,IU,INJECTION,QD,2016,Q4,Haemoglobin decreased,,2016,Q4,2,F,20160813.0,20161115.0,20161126,20161128,EXP,,PHHY2016CN159127,NOVARTIS,,61.0,YR,,M,Y,,,20161128.0,,MD,CN,CN,2016,Q4,Adult
129763302,12976330,43,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Topical,"14 IU, QD",,,,,,,,14.0,IU,INJECTION,QD,2016,Q4,Incision site pain,,2016,Q4,2,F,20160813.0,20161115.0,20161126,20161128,EXP,,PHHY2016CN159127,NOVARTIS,,61.0,YR,,M,Y,,,20161128.0,,MD,CN,CN,2016,Q4,Adult
129763302,12976330,43,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Topical,"14 IU, QD",,,,,,,,14.0,IU,INJECTION,QD,2016,Q4,Low density lipoprotein increased,,2016,Q4,2,F,20160813.0,20161115.0,20161126,20161128,EXP,,PHHY2016CN159127,NOVARTIS,,61.0,YR,,M,Y,,,20161128.0,,MD,CN,CN,2016,Q4,Adult
129763302,12976330,43,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Topical,"14 IU, QD",,,,,,,,14.0,IU,INJECTION,QD,2016,Q4,Lymphocyte count decreased,,2016,Q4,2,F,20160813.0,20161115.0,20161126,20161128,EXP,,PHHY2016CN159127,NOVARTIS,,61.0,YR,,M,Y,,,20161128.0,,MD,CN,CN,2016,Q4,Adult
129763302,12976330,43,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Topical,"14 IU, QD",,,,,,,,14.0,IU,INJECTION,QD,2016,Q4,Neutrophil count increased,,2016,Q4,2,F,20160813.0,20161115.0,20161126,20161128,EXP,,PHHY2016CN159127,NOVARTIS,,61.0,YR,,M,Y,,,20161128.0,,MD,CN,CN,2016,Q4,Adult
129763302,12976330,43,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Topical,"14 IU, QD",,,,,,,,14.0,IU,INJECTION,QD,2016,Q4,Protein urine present,,2016,Q4,2,F,20160813.0,20161115.0,20161126,20161128,EXP,,PHHY2016CN159127,NOVARTIS,,61.0,YR,,M,Y,,,20161128.0,,MD,CN,CN,2016,Q4,Adult
129763302,12976330,43,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Topical,"14 IU, QD",,,,,,,,14.0,IU,INJECTION,QD,2016,Q4,Red blood cells urine positive,,2016,Q4,2,F,20160813.0,20161115.0,20161126,20161128,EXP,,PHHY2016CN159127,NOVARTIS,,61.0,YR,,M,Y,,,20161128.0,,MD,CN,CN,2016,Q4,Adult
129763302,12976330,43,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Topical,"14 IU, QD",,,,,,,,14.0,IU,INJECTION,QD,2016,Q4,White blood cell count increased,,2016,Q4,2,F,20160813.0,20161115.0,20161126,20161128,EXP,,PHHY2016CN159127,NOVARTIS,,61.0,YR,,M,Y,,,20161128.0,,MD,CN,CN,2016,Q4,Adult
129763302,12976330,44,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Topical,"16 IU, QD",,,,,,,,16.0,IU,INJECTION,QD,2016,Q4,Blood triglycerides increased,,2016,Q4,2,F,20160813.0,20161115.0,20161126,20161128,EXP,,PHHY2016CN159127,NOVARTIS,,61.0,YR,,M,Y,,,20161128.0,,MD,CN,CN,2016,Q4,Adult
129763302,12976330,44,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Topical,"16 IU, QD",,,,,,,,16.0,IU,INJECTION,QD,2016,Q4,Blood urea increased,,2016,Q4,2,F,20160813.0,20161115.0,20161126,20161128,EXP,,PHHY2016CN159127,NOVARTIS,,61.0,YR,,M,Y,,,20161128.0,,MD,CN,CN,2016,Q4,Adult
129763302,12976330,44,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Topical,"16 IU, QD",,,,,,,,16.0,IU,INJECTION,QD,2016,Q4,C-reactive protein increased,,2016,Q4,2,F,20160813.0,20161115.0,20161126,20161128,EXP,,PHHY2016CN159127,NOVARTIS,,61.0,YR,,M,Y,,,20161128.0,,MD,CN,CN,2016,Q4,Adult
129763302,12976330,44,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Topical,"16 IU, QD",,,,,,,,16.0,IU,INJECTION,QD,2016,Q4,Haemoglobin decreased,,2016,Q4,2,F,20160813.0,20161115.0,20161126,20161128,EXP,,PHHY2016CN159127,NOVARTIS,,61.0,YR,,M,Y,,,20161128.0,,MD,CN,CN,2016,Q4,Adult
129763302,12976330,44,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Topical,"16 IU, QD",,,,,,,,16.0,IU,INJECTION,QD,2016,Q4,Incision site pain,,2016,Q4,2,F,20160813.0,20161115.0,20161126,20161128,EXP,,PHHY2016CN159127,NOVARTIS,,61.0,YR,,M,Y,,,20161128.0,,MD,CN,CN,2016,Q4,Adult
129763302,12976330,44,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Topical,"16 IU, QD",,,,,,,,16.0,IU,INJECTION,QD,2016,Q4,Low density lipoprotein increased,,2016,Q4,2,F,20160813.0,20161115.0,20161126,20161128,EXP,,PHHY2016CN159127,NOVARTIS,,61.0,YR,,M,Y,,,20161128.0,,MD,CN,CN,2016,Q4,Adult
129763302,12976330,44,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Topical,"16 IU, QD",,,,,,,,16.0,IU,INJECTION,QD,2016,Q4,Lymphocyte count decreased,,2016,Q4,2,F,20160813.0,20161115.0,20161126,20161128,EXP,,PHHY2016CN159127,NOVARTIS,,61.0,YR,,M,Y,,,20161128.0,,MD,CN,CN,2016,Q4,Adult
129763302,12976330,44,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Topical,"16 IU, QD",,,,,,,,16.0,IU,INJECTION,QD,2016,Q4,Neutrophil count increased,,2016,Q4,2,F,20160813.0,20161115.0,20161126,20161128,EXP,,PHHY2016CN159127,NOVARTIS,,61.0,YR,,M,Y,,,20161128.0,,MD,CN,CN,2016,Q4,Adult
129763302,12976330,44,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Topical,"16 IU, QD",,,,,,,,16.0,IU,INJECTION,QD,2016,Q4,Protein urine present,,2016,Q4,2,F,20160813.0,20161115.0,20161126,20161128,EXP,,PHHY2016CN159127,NOVARTIS,,61.0,YR,,M,Y,,,20161128.0,,MD,CN,CN,2016,Q4,Adult
129763302,12976330,44,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Topical,"16 IU, QD",,,,,,,,16.0,IU,INJECTION,QD,2016,Q4,Red blood cells urine positive,,2016,Q4,2,F,20160813.0,20161115.0,20161126,20161128,EXP,,PHHY2016CN159127,NOVARTIS,,61.0,YR,,M,Y,,,20161128.0,,MD,CN,CN,2016,Q4,Adult
129763302,12976330,44,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Topical,"16 IU, QD",,,,,,,,16.0,IU,INJECTION,QD,2016,Q4,White blood cell count increased,,2016,Q4,2,F,20160813.0,20161115.0,20161126,20161128,EXP,,PHHY2016CN159127,NOVARTIS,,61.0,YR,,M,Y,,,20161128.0,,MD,CN,CN,2016,Q4,Adult
129772341,12977234,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,BEFORE EACH MEAL,,,,,,,,22.0,IU,,,2016,Q4,Chronic kidney disease,,2016,Q4,1,I,2012.0,20161114.0,20161128,20161128,EXP,,BH-ACCORD-045778,ACCORD,"ASHOOR MF, BINTOUQ AK, RUTTER MK, MALIK RA. PANCREATIC ISLET CELL TRANSPLANTATION AS A TREATMENT FOR BRITTLE TYPE 1 DIABETES: A CASE REPORT AND REVIEW OF THE LITERATURE. JOURNAL OF TAIBAH UNIVERSITY MEDICAL SCIENCES. 2016;11(4):395-400.",56.0,YR,,M,Y,,,20161128.0,,MD,BH,BH,2016,Q4,Adult
129772341,12977234,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,BEFORE EACH MEAL,,,,,,,,22.0,IU,,,2016,Q4,Hypertension,,2016,Q4,1,I,2012.0,20161114.0,20161128,20161128,EXP,,BH-ACCORD-045778,ACCORD,"ASHOOR MF, BINTOUQ AK, RUTTER MK, MALIK RA. PANCREATIC ISLET CELL TRANSPLANTATION AS A TREATMENT FOR BRITTLE TYPE 1 DIABETES: A CASE REPORT AND REVIEW OF THE LITERATURE. JOURNAL OF TAIBAH UNIVERSITY MEDICAL SCIENCES. 2016;11(4):395-400.",56.0,YR,,M,Y,,,20161128.0,,MD,BH,BH,2016,Q4,Adult
129772341,12977234,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,BEFORE EACH MEAL,,,,,,,,22.0,IU,,,2016,Q4,Mouth ulceration,,2016,Q4,1,I,2012.0,20161114.0,20161128,20161128,EXP,,BH-ACCORD-045778,ACCORD,"ASHOOR MF, BINTOUQ AK, RUTTER MK, MALIK RA. PANCREATIC ISLET CELL TRANSPLANTATION AS A TREATMENT FOR BRITTLE TYPE 1 DIABETES: A CASE REPORT AND REVIEW OF THE LITERATURE. JOURNAL OF TAIBAH UNIVERSITY MEDICAL SCIENCES. 2016;11(4):395-400.",56.0,YR,,M,Y,,,20161128.0,,MD,BH,BH,2016,Q4,Adult
129772341,12977234,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,BEFORE EACH MEAL,,,,,,,,22.0,IU,,,2016,Q4,Neutropenia,,2016,Q4,1,I,2012.0,20161114.0,20161128,20161128,EXP,,BH-ACCORD-045778,ACCORD,"ASHOOR MF, BINTOUQ AK, RUTTER MK, MALIK RA. PANCREATIC ISLET CELL TRANSPLANTATION AS A TREATMENT FOR BRITTLE TYPE 1 DIABETES: A CASE REPORT AND REVIEW OF THE LITERATURE. JOURNAL OF TAIBAH UNIVERSITY MEDICAL SCIENCES. 2016;11(4):395-400.",56.0,YR,,M,Y,,,20161128.0,,MD,BH,BH,2016,Q4,Adult
129772341,12977234,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,BEFORE EACH MEAL,,,,,,,,22.0,IU,,,2016,Q4,Respiratory tract infection,,2016,Q4,1,I,2012.0,20161114.0,20161128,20161128,EXP,,BH-ACCORD-045778,ACCORD,"ASHOOR MF, BINTOUQ AK, RUTTER MK, MALIK RA. PANCREATIC ISLET CELL TRANSPLANTATION AS A TREATMENT FOR BRITTLE TYPE 1 DIABETES: A CASE REPORT AND REVIEW OF THE LITERATURE. JOURNAL OF TAIBAH UNIVERSITY MEDICAL SCIENCES. 2016;11(4):395-400.",56.0,YR,,M,Y,,,20161128.0,,MD,BH,BH,2016,Q4,Adult
129781721,12978172,1,PS,Insulin glargine,INSULIN GLARGINE,1,Parenteral,VARIABLE,,,Y,U,,,205692.0,,,,,2016,Q4,Abnormal weight gain,,2016,Q4,1,I,20130404.0,20161121.0,20161128,20161128,EXP,GB-MHRA-EYC 00148629,GB-ELI_LILLY_AND_COMPANY-GB201611007567,ELI LILLY AND CO,,61.0,YR,,M,Y,86.0,KG,20161124.0,,CN,GB,GB,2016,Q4,Adult
129781721,12978172,1,PS,Insulin glargine,INSULIN GLARGINE,1,Parenteral,VARIABLE,,,Y,U,,,205692.0,,,,,2016,Q4,Aortic valve stenosis,,2016,Q4,1,I,20130404.0,20161121.0,20161128,20161128,EXP,GB-MHRA-EYC 00148629,GB-ELI_LILLY_AND_COMPANY-GB201611007567,ELI LILLY AND CO,,61.0,YR,,M,Y,86.0,KG,20161124.0,,CN,GB,GB,2016,Q4,Adult
129781721,12978172,1,PS,Insulin glargine,INSULIN GLARGINE,1,Parenteral,VARIABLE,,,Y,U,,,205692.0,,,,,2016,Q4,Arteriosclerosis,,2016,Q4,1,I,20130404.0,20161121.0,20161128,20161128,EXP,GB-MHRA-EYC 00148629,GB-ELI_LILLY_AND_COMPANY-GB201611007567,ELI LILLY AND CO,,61.0,YR,,M,Y,86.0,KG,20161124.0,,CN,GB,GB,2016,Q4,Adult
129781721,12978172,1,PS,Insulin glargine,INSULIN GLARGINE,1,Parenteral,VARIABLE,,,Y,U,,,205692.0,,,,,2016,Q4,Dyspnoea exertional,,2016,Q4,1,I,20130404.0,20161121.0,20161128,20161128,EXP,GB-MHRA-EYC 00148629,GB-ELI_LILLY_AND_COMPANY-GB201611007567,ELI LILLY AND CO,,61.0,YR,,M,Y,86.0,KG,20161124.0,,CN,GB,GB,2016,Q4,Adult
129800111,12980011,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,VARIABLE,,,Y,, UNK,,21081.0,,,,,2016,Q4,Abnormal weight gain,,2016,Q4,1,I,20130404.0,20161121.0,20161128,20161128,EXP,GB-MHRA-EYC 00148629,GB-SA-2016SA213355,AVENTIS,,61.0,YR,A,M,Y,86.0,KG,20161128.0,,CN,GB,GB,2016,Q4,Adult
129800111,12980011,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,VARIABLE,,,Y,, UNK,,21081.0,,,,,2016,Q4,Aortic valve stenosis,,2016,Q4,1,I,20130404.0,20161121.0,20161128,20161128,EXP,GB-MHRA-EYC 00148629,GB-SA-2016SA213355,AVENTIS,,61.0,YR,A,M,Y,86.0,KG,20161128.0,,CN,GB,GB,2016,Q4,Adult
129800111,12980011,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,VARIABLE,,,Y,, UNK,,21081.0,,,,,2016,Q4,Arteriosclerosis,,2016,Q4,1,I,20130404.0,20161121.0,20161128,20161128,EXP,GB-MHRA-EYC 00148629,GB-SA-2016SA213355,AVENTIS,,61.0,YR,A,M,Y,86.0,KG,20161128.0,,CN,GB,GB,2016,Q4,Adult
129800111,12980011,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,VARIABLE,,,Y,, UNK,,21081.0,,,,,2016,Q4,Dyspnoea exertional,,2016,Q4,1,I,20130404.0,20161121.0,20161128,20161128,EXP,GB-MHRA-EYC 00148629,GB-SA-2016SA213355,AVENTIS,,61.0,YR,A,M,Y,86.0,KG,20161128.0,,CN,GB,GB,2016,Q4,Adult
129806682,12980668,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2016,Q4,Cardiac failure,,2016,Q4,2,F,20161025.0,20161129.0,20161128,20161130,EXP,,IL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-098809,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,78.0,KG,20161130.0,,OT,IL,IL,2016,Q4,Elderly
129806682,12980668,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2016,Q4,Dyspnoea,,2016,Q4,2,F,20161025.0,20161129.0,20161128,20161130,EXP,,IL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-098809,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,78.0,KG,20161130.0,,OT,IL,IL,2016,Q4,Elderly
129822701,12982270,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Eye swelling,,2016,Q4,1,I,20160719.0,,20161128,20161128,DIR,US-FDA-356716,,FDA-CTU,,40.0,YR,,F,N,107.0,KG,20161128.0,N,PH,US,US,2016,Q4,Adult
129822701,12982270,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Nephrotic syndrome,,2016,Q4,1,I,20160719.0,,20161128,20161128,DIR,US-FDA-356716,,FDA-CTU,,40.0,YR,,F,N,107.0,KG,20161128.0,N,PH,US,US,2016,Q4,Adult
129859731,12985973,4,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,8 UNITS BEFORE SLEEPING,,,,, UNKNOWN,,,,,,,2016,Q4,Wernicke's encephalopathy,,2016,Q4,1,I,,20161116.0,20161130,20161130,EXP,,JP-LUPIN PHARMACEUTICALS INC.-2016-05294,LUPIN,"KANEKO Y, TSURUTANI Y, SAGAWA N, KONDO M, SATA A, MIYAO M, AZUMA R, ORIMO S, MIZUNO Y. A CASE OF AN ELDERLY DIABETIC PATIENT DEVELOPING WERNICKE ENCEPHALOPATHY WITHOUT ALCOHOL ABUSE OR AN UNBALANCED DIET. THE JAPANESE JOURNAL OF VETERINARY SCIENCE. 2015;52(2):177-183.",70.0,YR,,M,Y,,,20161130.0,,OT,JP,JP,2016,Q4,Elderly
129912941,12991294,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,VARIABLE,,,Y,U, UNKNOWN,,,,,,,2016,Q4,Abnormal weight gain,,2016,Q4,1,I,20130404.0,20161121.0,20161201,20161201,EXP,GB-MHRA-EYC 00148629,GB-NOVOPROD-520219,NOVO NORDISK,,61.0,YR,A,M,Y,86.0,KG,20161201.0,,CN,GB,GB,2016,Q4,Adult
129912941,12991294,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,VARIABLE,,,Y,U, UNKNOWN,,,,,,,2016,Q4,Aortic valve stenosis,,2016,Q4,1,I,20130404.0,20161121.0,20161201,20161201,EXP,GB-MHRA-EYC 00148629,GB-NOVOPROD-520219,NOVO NORDISK,,61.0,YR,A,M,Y,86.0,KG,20161201.0,,CN,GB,GB,2016,Q4,Adult
129912941,12991294,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,VARIABLE,,,Y,U, UNKNOWN,,,,,,,2016,Q4,Arteriosclerosis,,2016,Q4,1,I,20130404.0,20161121.0,20161201,20161201,EXP,GB-MHRA-EYC 00148629,GB-NOVOPROD-520219,NOVO NORDISK,,61.0,YR,A,M,Y,86.0,KG,20161201.0,,CN,GB,GB,2016,Q4,Adult
129912941,12991294,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,VARIABLE,,,Y,U, UNKNOWN,,,,,,,2016,Q4,Dyspnoea exertional,,2016,Q4,1,I,20130404.0,20161121.0,20161201,20161201,EXP,GB-MHRA-EYC 00148629,GB-NOVOPROD-520219,NOVO NORDISK,,61.0,YR,A,M,Y,86.0,KG,20161201.0,,CN,GB,GB,2016,Q4,Adult
129948882,12994888,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2016,Q4,Angioedema,,2016,Q4,2,F,20140919.0,20161125.0,20161202,20161206,EXP,,AU-PURDUE PHARMA-GBR-2016-0041990,PURDUE,,72.0,YR,,M,Y,80.0,KG,20161206.0,,OT,AU,AU,2016,Q4,Elderly
129948882,12994888,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2016,Q4,Dysphagia,,2016,Q4,2,F,20140919.0,20161125.0,20161202,20161206,EXP,,AU-PURDUE PHARMA-GBR-2016-0041990,PURDUE,,72.0,YR,,M,Y,80.0,KG,20161206.0,,OT,AU,AU,2016,Q4,Elderly
129948882,12994888,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2016,Q4,Dysphonia,,2016,Q4,2,F,20140919.0,20161125.0,20161202,20161206,EXP,,AU-PURDUE PHARMA-GBR-2016-0041990,PURDUE,,72.0,YR,,M,Y,80.0,KG,20161206.0,,OT,AU,AU,2016,Q4,Elderly
129948882,12994888,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2016,Q4,Rash maculo-papular,,2016,Q4,2,F,20140919.0,20161125.0,20161202,20161206,EXP,,AU-PURDUE PHARMA-GBR-2016-0041990,PURDUE,,72.0,YR,,M,Y,80.0,KG,20161206.0,,OT,AU,AU,2016,Q4,Elderly
129982221,12998222,17,C,GLARGINE INSULIN,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Asthma,,2016,Q4,1,I,20161001.0,,20161202,20161202,DIR,US-FDA-357206,,FDA-CTU,,68.0,YR,,F,N,130.5,KG,20161202.0,N,CN,US,US,2016,Q4,Elderly
129982221,12998222,17,C,GLARGINE INSULIN,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Lymphoedema,,2016,Q4,1,I,20161001.0,,20161202,20161202,DIR,US-FDA-357206,,FDA-CTU,,68.0,YR,,F,N,130.5,KG,20161202.0,N,CN,US,US,2016,Q4,Elderly
129993951,12999395,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,14 IU EVERY 24 HOURS IF THE PUMP BROKE DOWN,,,D,,,,,,,SOLUTION FOR INJECTION,,2016,Q4,Asthenia,,2016,Q4,1,I,2016.0,20161123.0,20161205,20161205,EXP,,FR-JNJFOC-20161200589,JANSSEN,,81.0,YR,E,F,Y,,,20161205.0,,OT,FR,FR,2016,Q4,Elderly
129993951,12999395,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,14 IU EVERY 24 HOURS IF THE PUMP BROKE DOWN,,,D,,,,,,,SOLUTION FOR INJECTION,,2016,Q4,Fall,,2016,Q4,1,I,2016.0,20161123.0,20161205,20161205,EXP,,FR-JNJFOC-20161200589,JANSSEN,,81.0,YR,E,F,Y,,,20161205.0,,OT,FR,FR,2016,Q4,Elderly
129993951,12999395,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,14 IU EVERY 24 HOURS IF THE PUMP BROKE DOWN,,,D,,,,,,,SOLUTION FOR INJECTION,,2016,Q4,Muscular weakness,,2016,Q4,1,I,2016.0,20161123.0,20161205,20161205,EXP,,FR-JNJFOC-20161200589,JANSSEN,,81.0,YR,E,F,Y,,,20161205.0,,OT,FR,FR,2016,Q4,Elderly
129993951,12999395,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,14 IU EVERY 24 HOURS IF THE PUMP BROKE DOWN,,,D,,,,,,,SOLUTION FOR INJECTION,,2016,Q4,Tremor,,2016,Q4,1,I,2016.0,20161123.0,20161205,20161205,EXP,,FR-JNJFOC-20161200589,JANSSEN,,81.0,YR,E,F,Y,,,20161205.0,,OT,FR,FR,2016,Q4,Elderly
129993951,12999395,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,14 IU EVERY 24 HOURS IF THE PUMP BROKE DOWN,,,D,,,,,,,SOLUTION FOR INJECTION,,2016,Q4,Vertigo,,2016,Q4,1,I,2016.0,20161123.0,20161205,20161205,EXP,,FR-JNJFOC-20161200589,JANSSEN,,81.0,YR,E,F,Y,,,20161205.0,,OT,FR,FR,2016,Q4,Elderly
130041682,13004168,19,C,GLARGINE,,2,Subcutaneous,,,,,,,,,40.0,IU,,QD,2016,Q4,Cardiac resynchronisation therapy,,2016,Q4,2,F,20150131.0,20161123.0,20161206,20161208,EXP,,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2015-BI-06195BI",BOEHRINGER INGELHEIM,,68.0,YR,,M,Y,117.2,KG,20161208.0,,MD,GB,GB,2016,Q4,Elderly
130041682,13004168,19,C,GLARGINE,,2,Subcutaneous,,,,,,,,,40.0,IU,,QD,2016,Q4,Contusion,,2016,Q4,2,F,20150131.0,20161123.0,20161206,20161208,EXP,,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2015-BI-06195BI",BOEHRINGER INGELHEIM,,68.0,YR,,M,Y,117.2,KG,20161208.0,,MD,GB,GB,2016,Q4,Elderly
130041682,13004168,19,C,GLARGINE,,2,Subcutaneous,,,,,,,,,40.0,IU,,QD,2016,Q4,Fall,,2016,Q4,2,F,20150131.0,20161123.0,20161206,20161208,EXP,,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2015-BI-06195BI",BOEHRINGER INGELHEIM,,68.0,YR,,M,Y,117.2,KG,20161208.0,,MD,GB,GB,2016,Q4,Elderly
130041682,13004168,19,C,GLARGINE,,2,Subcutaneous,,,,,,,,,40.0,IU,,QD,2016,Q4,Tenderness,,2016,Q4,2,F,20150131.0,20161123.0,20161206,20161208,EXP,,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2015-BI-06195BI",BOEHRINGER INGELHEIM,,68.0,YR,,M,Y,117.2,KG,20161208.0,,MD,GB,GB,2016,Q4,Elderly
130057612,13005761,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,Y,, UNK,,21081.0,,,,,2016,Q4,Alanine aminotransferase increased,,2016,Q4,2,F,,20161228.0,20161207,20161230,EXP,,JP-SA-2016SA221341,AVENTIS,"OYAMA M, KARASAWA S, SUZUKI S, MANAKA H. THE 54TH TOHOKU REGIONAL MEETING OF THE JAPAN DIABETES SOCIETY; 2016 NOV 12; SENDAI-SHI, MIYAGI PREFECTURE",39.0,YR,A,F,Y,,,20161231.0,,OT,JP,JP,2016,Q4,Adult
130057612,13005761,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,Y,, UNK,,21081.0,,,,,2016,Q4,Aspartate aminotransferase increased,,2016,Q4,2,F,,20161228.0,20161207,20161230,EXP,,JP-SA-2016SA221341,AVENTIS,"OYAMA M, KARASAWA S, SUZUKI S, MANAKA H. THE 54TH TOHOKU REGIONAL MEETING OF THE JAPAN DIABETES SOCIETY; 2016 NOV 12; SENDAI-SHI, MIYAGI PREFECTURE",39.0,YR,A,F,Y,,,20161231.0,,OT,JP,JP,2016,Q4,Adult
130057612,13005761,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,Y,, UNK,,21081.0,,,,,2016,Q4,Hepatic function abnormal,,2016,Q4,2,F,,20161228.0,20161207,20161230,EXP,,JP-SA-2016SA221341,AVENTIS,"OYAMA M, KARASAWA S, SUZUKI S, MANAKA H. THE 54TH TOHOKU REGIONAL MEETING OF THE JAPAN DIABETES SOCIETY; 2016 NOV 12; SENDAI-SHI, MIYAGI PREFECTURE",39.0,YR,A,F,Y,,,20161231.0,,OT,JP,JP,2016,Q4,Adult
130084501,13008450,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"8 DF, BEFORE SLEEP",,,U,U,,,,8.0,DF,,,2016,Q4,Wernicke's encephalopathy,,2016,Q4,1,I,201211.0,20161109.0,20161208,20161208,EXP,,JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-127885,RANBAXY,"KANEKO Y, TSURUTANI Y, SAGAWA N, KONDO M, SATA A, MIYAO M, ET AL. A CASE OF AN ELDERLY DIABETIC PATIENT DEVELOPING WERNICKE ENCEPHALOPATHY WITHOUT ALCOHOL ABUSE OR AN UNBALANCED DIET. NIPPON-RON-IGAK-ZASSHI-JPN-J-GERIATR. 2015;52 (2):177-83",70.0,YR,,M,Y,47.4,KG,20161208.0,,OT,JP,JP,2016,Q4,Elderly
130173721,13017372,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,,,,D,,,,,20.0,IU,UNSPECIFIED,QD,2016,Q4,Urine ketone body present,,2016,Q4,1,I,20160215.0,20161128.0,20161212,20161212,EXP,,JP-JNJFOC-20161209514,JANSSEN,,29.0,YR,A,M,Y,105.0,KG,20161212.0,,OT,JP,JP,2016,Q4,Young Adult
130253231,13025323,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,15.0,IU,,,2016,Q4,Acute kidney injury,,2016,Q4,1,I,20160331.0,20161205.0,20161214,20161214,EXP,ES-AGEMED-611911444,ES-GE HEALTHCARE MEDICAL DIAGNOSTICS-VISP-E2B_00000321,GE HEALTHCARE,,88.0,YR,,F,Y,,,20161214.0,,OT,ES,ES,2016,Q4,Elderly
130253231,13025323,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,15.0,IU,,,2016,Q4,Condition aggravated,,2016,Q4,1,I,20160331.0,20161205.0,20161214,20161214,EXP,ES-AGEMED-611911444,ES-GE HEALTHCARE MEDICAL DIAGNOSTICS-VISP-E2B_00000321,GE HEALTHCARE,,88.0,YR,,F,Y,,,20161214.0,,OT,ES,ES,2016,Q4,Elderly
130280052,13028005,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q4,Dyspnoea,,2016,Q4,2,F,20161125.0,20161215.0,20161214,20161227,EXP,,DE-BAYER-2016-232114,BAYER,,69.0,YR,E,F,Y,73.0,KG,20161227.0,,CN,DE,DE,2016,Q4,Elderly
130280052,13028005,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q4,Hypersensitivity,,2016,Q4,2,F,20161125.0,20161215.0,20161214,20161227,EXP,,DE-BAYER-2016-232114,BAYER,,69.0,YR,E,F,Y,73.0,KG,20161227.0,,CN,DE,DE,2016,Q4,Elderly
130280052,13028005,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q4,Hypertensive crisis,,2016,Q4,2,F,20161125.0,20161215.0,20161214,20161227,EXP,,DE-BAYER-2016-232114,BAYER,,69.0,YR,E,F,Y,73.0,KG,20161227.0,,CN,DE,DE,2016,Q4,Elderly
130280052,13028005,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q4,Loss of consciousness,,2016,Q4,2,F,20161125.0,20161215.0,20161214,20161227,EXP,,DE-BAYER-2016-232114,BAYER,,69.0,YR,E,F,Y,73.0,KG,20161227.0,,CN,DE,DE,2016,Q4,Elderly
130280052,13028005,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q4,Productive cough,,2016,Q4,2,F,20161125.0,20161215.0,20161214,20161227,EXP,,DE-BAYER-2016-232114,BAYER,,69.0,YR,E,F,Y,73.0,KG,20161227.0,,CN,DE,DE,2016,Q4,Elderly
130280052,13028005,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q4,Pulmonary oedema,,2016,Q4,2,F,20161125.0,20161215.0,20161214,20161227,EXP,,DE-BAYER-2016-232114,BAYER,,69.0,YR,E,F,Y,73.0,KG,20161227.0,,CN,DE,DE,2016,Q4,Elderly
130280052,13028005,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q4,Rash maculo-papular,,2016,Q4,2,F,20161125.0,20161215.0,20161214,20161227,EXP,,DE-BAYER-2016-232114,BAYER,,69.0,YR,E,F,Y,73.0,KG,20161227.0,,CN,DE,DE,2016,Q4,Elderly
130280052,13028005,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2016,Q4,Respiratory failure,,2016,Q4,2,F,20161125.0,20161215.0,20161214,20161227,EXP,,DE-BAYER-2016-232114,BAYER,,69.0,YR,E,F,Y,73.0,KG,20161227.0,,CN,DE,DE,2016,Q4,Elderly
130338061,13033806,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,Y,,,,,,,,,2016,Q4,Decreased appetite,,2016,Q4,1,I,,20161201.0,20161216,20161216,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-107401,BRISTOL MYERS SQUIBB,YASUDA.. A CASE OF PANNICULITIS WHICH DEVELOPED IN PATIENT RECEIVING TREATMENT FOR DIABETIC KETOACIDOSIS. PROGRAM AND ABSTRACTS OF THE PAPERS FOR THE 54TH KYUSHU LOCAL MEETING OF THE JAP. 2016;205,68.0,YR,,M,Y,,,20161216.0,,MD,JP,JP,2016,Q4,Elderly
130338061,13033806,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,Y,,,,,,,,,2016,Q4,Erythema,,2016,Q4,1,I,,20161201.0,20161216,20161216,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-107401,BRISTOL MYERS SQUIBB,YASUDA.. A CASE OF PANNICULITIS WHICH DEVELOPED IN PATIENT RECEIVING TREATMENT FOR DIABETIC KETOACIDOSIS. PROGRAM AND ABSTRACTS OF THE PAPERS FOR THE 54TH KYUSHU LOCAL MEETING OF THE JAP. 2016;205,68.0,YR,,M,Y,,,20161216.0,,MD,JP,JP,2016,Q4,Elderly
130338061,13033806,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,Y,,,,,,,,,2016,Q4,Feeling hot,,2016,Q4,1,I,,20161201.0,20161216,20161216,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-107401,BRISTOL MYERS SQUIBB,YASUDA.. A CASE OF PANNICULITIS WHICH DEVELOPED IN PATIENT RECEIVING TREATMENT FOR DIABETIC KETOACIDOSIS. PROGRAM AND ABSTRACTS OF THE PAPERS FOR THE 54TH KYUSHU LOCAL MEETING OF THE JAP. 2016;205,68.0,YR,,M,Y,,,20161216.0,,MD,JP,JP,2016,Q4,Elderly
130338061,13033806,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,Y,,,,,,,,,2016,Q4,Inflammation,,2016,Q4,1,I,,20161201.0,20161216,20161216,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-107401,BRISTOL MYERS SQUIBB,YASUDA.. A CASE OF PANNICULITIS WHICH DEVELOPED IN PATIENT RECEIVING TREATMENT FOR DIABETIC KETOACIDOSIS. PROGRAM AND ABSTRACTS OF THE PAPERS FOR THE 54TH KYUSHU LOCAL MEETING OF THE JAP. 2016;205,68.0,YR,,M,Y,,,20161216.0,,MD,JP,JP,2016,Q4,Elderly
130338061,13033806,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,Y,,,,,,,,,2016,Q4,Panniculitis,,2016,Q4,1,I,,20161201.0,20161216,20161216,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-107401,BRISTOL MYERS SQUIBB,YASUDA.. A CASE OF PANNICULITIS WHICH DEVELOPED IN PATIENT RECEIVING TREATMENT FOR DIABETIC KETOACIDOSIS. PROGRAM AND ABSTRACTS OF THE PAPERS FOR THE 54TH KYUSHU LOCAL MEETING OF THE JAP. 2016;205,68.0,YR,,M,Y,,,20161216.0,,MD,JP,JP,2016,Q4,Elderly
130338061,13033806,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,Y,,,,,,,,,2016,Q4,Pyrexia,,2016,Q4,1,I,,20161201.0,20161216,20161216,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-107401,BRISTOL MYERS SQUIBB,YASUDA.. A CASE OF PANNICULITIS WHICH DEVELOPED IN PATIENT RECEIVING TREATMENT FOR DIABETIC KETOACIDOSIS. PROGRAM AND ABSTRACTS OF THE PAPERS FOR THE 54TH KYUSHU LOCAL MEETING OF THE JAP. 2016;205,68.0,YR,,M,Y,,,20161216.0,,MD,JP,JP,2016,Q4,Elderly
130338061,13033806,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,Y,,,,,,,,,2016,Q4,Swelling,,2016,Q4,1,I,,20161201.0,20161216,20161216,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-107401,BRISTOL MYERS SQUIBB,YASUDA.. A CASE OF PANNICULITIS WHICH DEVELOPED IN PATIENT RECEIVING TREATMENT FOR DIABETIC KETOACIDOSIS. PROGRAM AND ABSTRACTS OF THE PAPERS FOR THE 54TH KYUSHU LOCAL MEETING OF THE JAP. 2016;205,68.0,YR,,M,Y,,,20161216.0,,MD,JP,JP,2016,Q4,Elderly
130369051,13036905,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,(23-0-0),,,U,,,,,,,,,2016,Q4,Acute pulmonary oedema,,2016,Q4,1,I,,20161206.0,20161216,20161216,EXP,,PHHY2016ES170337,SANDOZ,,80.0,YR,,M,Y,,,20161216.0,,OT,ES,ES,2016,Q4,Elderly
130369051,13036905,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,(23-0-0),,,U,,,,,,,,,2016,Q4,Hypersensitivity vasculitis,,2016,Q4,1,I,,20161206.0,20161216,20161216,EXP,,PHHY2016ES170337,SANDOZ,,80.0,YR,,M,Y,,,20161216.0,,OT,ES,ES,2016,Q4,Elderly
130369051,13036905,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,(23-0-0),,,U,,,,,,,,,2016,Q4,Renal impairment,,2016,Q4,1,I,,20161206.0,20161216,20161216,EXP,,PHHY2016ES170337,SANDOZ,,80.0,YR,,M,Y,,,20161216.0,,OT,ES,ES,2016,Q4,Elderly
130379311,13037931,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2016,Q4,Hyperglycaemia,,2016,Q4,1,I,20161205.0,20161208.0,20161218,20161218,EXP,,TW-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-105319,BRISTOL MYERS SQUIBB,,63.0,YR,,M,Y,64.6,KG,20161218.0,,OT,TW,TW,2016,Q4,Adult
130402771,13040277,2,SS,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,, UNKNOWN,,,,,SOLUTION FOR INJECTION,,2016,Q4,Liver disorder,,2016,Q4,1,I,201609.0,20161128.0,20161219,20161219,EXP,,JP-NOVOPROD-521393,NOVO NORDISK,HI ET AL.. A CASE OF A PATIENT WITH TYPE 1 DIABETES WITH A NEGATIVE ANTI-GAD ANTIBODY TEST AND A POSITIVE ANTI-IA-2 ANTIBODY TEST WHERE LIVER DISORDER DEVELOPED AFTER BASAL INSULIN WAS SWITCHED TO INSULIN DEGLUDEC. THE 54TH CHUGOKU-SHIKOKU REGIONAL MEETING OF THE JAPAN DIABETES SOCIETY,71.0,YR,E,M,Y,,,20161219.0,,MD,JP,JP,2016,Q4,Elderly
130457331,13045733,3,C,GLARGINE,,2,,,,,,,,,,,,,,2016,Q4,Abdominal pain,,2016,Q4,1,I,20161029.0,,20161220,20161220,DIR,,,FDA-CTU,,64.0,YR,,M,N,113.86,KG,20161130.0,N,PH,US,US,2016,Q4,Adult
130457331,13045733,3,C,GLARGINE,,2,,,,,,,,,,,,,,2016,Q4,Diarrhoea,,2016,Q4,1,I,20161029.0,,20161220,20161220,DIR,,,FDA-CTU,,64.0,YR,,M,N,113.86,KG,20161130.0,N,PH,US,US,2016,Q4,Adult
130457331,13045733,3,C,GLARGINE,,2,,,,,,,,,,,,,,2016,Q4,Dysgeusia,,2016,Q4,1,I,20161029.0,,20161220,20161220,DIR,,,FDA-CTU,,64.0,YR,,M,N,113.86,KG,20161130.0,N,PH,US,US,2016,Q4,Adult
130457331,13045733,3,C,GLARGINE,,2,,,,,,,,,,,,,,2016,Q4,Eructation,,2016,Q4,1,I,20161029.0,,20161220,20161220,DIR,,,FDA-CTU,,64.0,YR,,M,N,113.86,KG,20161130.0,N,PH,US,US,2016,Q4,Adult
130457331,13045733,3,C,GLARGINE,,2,,,,,,,,,,,,,,2016,Q4,Influenza,,2016,Q4,1,I,20161029.0,,20161220,20161220,DIR,,,FDA-CTU,,64.0,YR,,M,N,113.86,KG,20161130.0,N,PH,US,US,2016,Q4,Adult
130457331,13045733,3,C,GLARGINE,,2,,,,,,,,,,,,,,2016,Q4,Nausea,,2016,Q4,1,I,20161029.0,,20161220,20161220,DIR,,,FDA-CTU,,64.0,YR,,M,N,113.86,KG,20161130.0,N,PH,US,US,2016,Q4,Adult
130457331,13045733,3,C,GLARGINE,,2,,,,,,,,,,,,,,2016,Q4,Pancreatitis acute,,2016,Q4,1,I,20161029.0,,20161220,20161220,DIR,,,FDA-CTU,,64.0,YR,,M,N,113.86,KG,20161130.0,N,PH,US,US,2016,Q4,Adult
130457331,13045733,3,C,GLARGINE,,2,,,,,,,,,,,,,,2016,Q4,Vomiting,,2016,Q4,1,I,20161029.0,,20161220,20161220,DIR,,,FDA-CTU,,64.0,YR,,M,N,113.86,KG,20161130.0,N,PH,US,US,2016,Q4,Adult
130498931,13049893,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,(23-0-0),,,,,,,,,,,QD,2016,Q4,Hypersensitivity vasculitis,,2016,Q4,1,I,,20161207.0,20161221,20161221,EXP,,ES-LUPIN PHARMACEUTICALS INC.-2016-05561,LUPIN,"VENTURA-RIBES O, MACHANCOSES F, ROSEL REMIREZ J. VASCULITIS AFTER BLOOD PRESSURE MONITORING. REUMATOLOGIA CLINICA. 2016;12(4):216-218.",80.0,YR,,M,Y,,,20161221.0,,OT,ES,ES,2016,Q4,Elderly
130511671,13051167,4,C,INSULIN GLARGINE (TOUJEO SOLOSTAR),,2,,,,,,,,,,,,,,2016,Q4,Chronic inflammatory demyelinating polyradiculoneuropathy,,2016,Q4,1,I,20161202.0,,20161221,20161221,DIR,US-FDA-358503,,FDA-CTU,,53.0,YR,,F,N,109.0,KG,20161221.0,N,PH,US,US,2016,Q4,Adult
130511671,13051167,4,C,INSULIN GLARGINE (TOUJEO SOLOSTAR),,2,,,,,,,,,,,,,,2016,Q4,Fall,,2016,Q4,1,I,20161202.0,,20161221,20161221,DIR,US-FDA-358503,,FDA-CTU,,53.0,YR,,F,N,109.0,KG,20161221.0,N,PH,US,US,2016,Q4,Adult
130511671,13051167,4,C,INSULIN GLARGINE (TOUJEO SOLOSTAR),,2,,,,,,,,,,,,,,2016,Q4,Hyperreflexia,,2016,Q4,1,I,20161202.0,,20161221,20161221,DIR,US-FDA-358503,,FDA-CTU,,53.0,YR,,F,N,109.0,KG,20161221.0,N,PH,US,US,2016,Q4,Adult
130511671,13051167,4,C,INSULIN GLARGINE (TOUJEO SOLOSTAR),,2,,,,,,,,,,,,,,2016,Q4,Muscular weakness,,2016,Q4,1,I,20161202.0,,20161221,20161221,DIR,US-FDA-358503,,FDA-CTU,,53.0,YR,,F,N,109.0,KG,20161221.0,N,PH,US,US,2016,Q4,Adult
130564471,13056447,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8-30 UNITS, QD",,,,,,,,,,,,2016,Q4,Cerebral haemorrhage,,2016,Q4,1,I,20160205.0,20161118.0,20161222,20161222,EXP,,JP-ALLERGAN-1681874US,ALLERGAN,,81.0,YR,,F,Y,48.0,KG,20161222.0,,MD,JP,JP,2016,Q4,Elderly
130564471,13056447,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8-30 UNITS, QD",,,,,,,,,,,,2016,Q4,Hepatic function abnormal,,2016,Q4,1,I,20160205.0,20161118.0,20161222,20161222,EXP,,JP-ALLERGAN-1681874US,ALLERGAN,,81.0,YR,,F,Y,48.0,KG,20161222.0,,MD,JP,JP,2016,Q4,Elderly
130564471,13056447,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8-30 UNITS, QD",,,,,,,,,,,,2016,Q4,Off label use,,2016,Q4,1,I,20160205.0,20161118.0,20161222,20161222,EXP,,JP-ALLERGAN-1681874US,ALLERGAN,,81.0,YR,,F,Y,48.0,KG,20161222.0,,MD,JP,JP,2016,Q4,Elderly
130564471,13056447,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8-30 UNITS, QD",,,,,,,,,,,,2016,Q4,Seizure,,2016,Q4,1,I,20160205.0,20161118.0,20161222,20161222,EXP,,JP-ALLERGAN-1681874US,ALLERGAN,,81.0,YR,,F,Y,48.0,KG,20161222.0,,MD,JP,JP,2016,Q4,Elderly
130566231,13056623,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,U,,,,,,,,,2016,Q4,Blood glucose increased,,2016,Q4,1,I,2015.0,20161213.0,20161222,20161222,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201612006487,ELI LILLY AND CO,,56.0,YR,,M,Y,70.0,KG,20161222.0,,CN,CN,CN,2016,Q4,Adult
130566231,13056623,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,U,,,,,,,,,2016,Q4,Retinopathy,,2016,Q4,1,I,2015.0,20161213.0,20161222,20161222,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201612006487,ELI LILLY AND CO,,56.0,YR,,M,Y,70.0,KG,20161222.0,,CN,CN,CN,2016,Q4,Adult
130588621,13058862,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 U SQ DOSE:50 UNIT(S),,,U,, UNK,,21081.0,,,,BID,2016,Q4,Amyloidosis,,2016,Q4,1,I,,20161209.0,20161223,20161223,EXP,,US-SA-2016SA228336,AVENTIS,"GANDHI SM, NYLEN ES. LOCALIZED AMYLOIDOSIS: A CAUSE OF IMPAIRED GLYCEMIC CONTROL. 98TH ANNUAL MEETING AND EXPO OF THE ENDOCRINE SOCIETY; 2016 APR 01-04; BOSTON, MA, UNITED STATES. ENDOCR REV. 2016 JAN 01;37(2 SUPPL 1). DOI: 10.1210/ENDO-MEETINGS.2016.DGM.12.FRI-720",64.0,YR,A,M,Y,,,20161223.0,,OT,US,US,2016,Q4,Adult
130588621,13058862,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 U SQ DOSE:50 UNIT(S),,,U,, UNK,,21081.0,,,,BID,2016,Q4,Glycosylated haemoglobin increased,,2016,Q4,1,I,,20161209.0,20161223,20161223,EXP,,US-SA-2016SA228336,AVENTIS,"GANDHI SM, NYLEN ES. LOCALIZED AMYLOIDOSIS: A CAUSE OF IMPAIRED GLYCEMIC CONTROL. 98TH ANNUAL MEETING AND EXPO OF THE ENDOCRINE SOCIETY; 2016 APR 01-04; BOSTON, MA, UNITED STATES. ENDOCR REV. 2016 JAN 01;37(2 SUPPL 1). DOI: 10.1210/ENDO-MEETINGS.2016.DGM.12.FRI-720",64.0,YR,A,M,Y,,,20161223.0,,OT,US,US,2016,Q4,Adult
130588621,13058862,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 U SQ DOSE:50 UNIT(S),,,U,, UNK,,21081.0,,,,BID,2016,Q4,Hyperglycaemia,,2016,Q4,1,I,,20161209.0,20161223,20161223,EXP,,US-SA-2016SA228336,AVENTIS,"GANDHI SM, NYLEN ES. LOCALIZED AMYLOIDOSIS: A CAUSE OF IMPAIRED GLYCEMIC CONTROL. 98TH ANNUAL MEETING AND EXPO OF THE ENDOCRINE SOCIETY; 2016 APR 01-04; BOSTON, MA, UNITED STATES. ENDOCR REV. 2016 JAN 01;37(2 SUPPL 1). DOI: 10.1210/ENDO-MEETINGS.2016.DGM.12.FRI-720",64.0,YR,A,M,Y,,,20161223.0,,OT,US,US,2016,Q4,Adult
130588621,13058862,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 U SQ DOSE:50 UNIT(S),,,U,, UNK,,21081.0,,,,BID,2016,Q4,Off label use,,2016,Q4,1,I,,20161209.0,20161223,20161223,EXP,,US-SA-2016SA228336,AVENTIS,"GANDHI SM, NYLEN ES. LOCALIZED AMYLOIDOSIS: A CAUSE OF IMPAIRED GLYCEMIC CONTROL. 98TH ANNUAL MEETING AND EXPO OF THE ENDOCRINE SOCIETY; 2016 APR 01-04; BOSTON, MA, UNITED STATES. ENDOCR REV. 2016 JAN 01;37(2 SUPPL 1). DOI: 10.1210/ENDO-MEETINGS.2016.DGM.12.FRI-720",64.0,YR,A,M,Y,,,20161223.0,,OT,US,US,2016,Q4,Adult
130588621,13058862,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 U SQ DOSE:50 UNIT(S),,,U,, UNK,,21081.0,,,,BID,2016,Q4,Skin mass,,2016,Q4,1,I,,20161209.0,20161223,20161223,EXP,,US-SA-2016SA228336,AVENTIS,"GANDHI SM, NYLEN ES. LOCALIZED AMYLOIDOSIS: A CAUSE OF IMPAIRED GLYCEMIC CONTROL. 98TH ANNUAL MEETING AND EXPO OF THE ENDOCRINE SOCIETY; 2016 APR 01-04; BOSTON, MA, UNITED STATES. ENDOCR REV. 2016 JAN 01;37(2 SUPPL 1). DOI: 10.1210/ENDO-MEETINGS.2016.DGM.12.FRI-720",64.0,YR,A,M,Y,,,20161223.0,,OT,US,US,2016,Q4,Adult
130588621,13058862,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 U SQ DOSE:50 UNIT(S),,,U,, UNK,,21081.0,,,,BID,2016,Q4,Wrong technique in product usage process,,2016,Q4,1,I,,20161209.0,20161223,20161223,EXP,,US-SA-2016SA228336,AVENTIS,"GANDHI SM, NYLEN ES. LOCALIZED AMYLOIDOSIS: A CAUSE OF IMPAIRED GLYCEMIC CONTROL. 98TH ANNUAL MEETING AND EXPO OF THE ENDOCRINE SOCIETY; 2016 APR 01-04; BOSTON, MA, UNITED STATES. ENDOCR REV. 2016 JAN 01;37(2 SUPPL 1). DOI: 10.1210/ENDO-MEETINGS.2016.DGM.12.FRI-720",64.0,YR,A,M,Y,,,20161223.0,,OT,US,US,2016,Q4,Adult
130595801,13059580,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Hypersensitivity vasculitis,,2016,Q4,1,I,,20161212.0,20161223,20161223,EXP,,ES-GLAXOSMITHKLINE-ES2016GSK189344,GLAXOSMITHKLINE,"VENTURA-RIBES O, MACHANCOSES FH, ROSEL REMIREZ JF. VASCULITIS AFTER BLOOD PRESSURE MONITORING. REUMATOL-CLIN. 2016;12(4):216-218",80.0,YR,,M,Y,,,20161223.0,,OT,ES,ES,2016,Q4,Elderly
130618751,13061875,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2016,Q4,Abdominal distension,,2016,Q4,1,I,,20161212.0,20161226,20161226,EXP,,ES-AUROBINDO-AUR-APL-2016-15752,AUROBINDO,,80.0,YR,,M,Y,,,20161226.0,,OT,ES,ES,2016,Q4,Elderly
130618751,13061875,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2016,Q4,Acute pulmonary oedema,,2016,Q4,1,I,,20161212.0,20161226,20161226,EXP,,ES-AUROBINDO-AUR-APL-2016-15752,AUROBINDO,,80.0,YR,,M,Y,,,20161226.0,,OT,ES,ES,2016,Q4,Elderly
130618751,13061875,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2016,Q4,Anuria,,2016,Q4,1,I,,20161212.0,20161226,20161226,EXP,,ES-AUROBINDO-AUR-APL-2016-15752,AUROBINDO,,80.0,YR,,M,Y,,,20161226.0,,OT,ES,ES,2016,Q4,Elderly
130618751,13061875,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2016,Q4,Arrhythmia,,2016,Q4,1,I,,20161212.0,20161226,20161226,EXP,,ES-AUROBINDO-AUR-APL-2016-15752,AUROBINDO,,80.0,YR,,M,Y,,,20161226.0,,OT,ES,ES,2016,Q4,Elderly
130618751,13061875,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2016,Q4,Atrial fibrillation,,2016,Q4,1,I,,20161212.0,20161226,20161226,EXP,,ES-AUROBINDO-AUR-APL-2016-15752,AUROBINDO,,80.0,YR,,M,Y,,,20161226.0,,OT,ES,ES,2016,Q4,Elderly
130618751,13061875,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2016,Q4,Cyanosis,,2016,Q4,1,I,,20161212.0,20161226,20161226,EXP,,ES-AUROBINDO-AUR-APL-2016-15752,AUROBINDO,,80.0,YR,,M,Y,,,20161226.0,,OT,ES,ES,2016,Q4,Elderly
130618751,13061875,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2016,Q4,Dyspnoea,,2016,Q4,1,I,,20161212.0,20161226,20161226,EXP,,ES-AUROBINDO-AUR-APL-2016-15752,AUROBINDO,,80.0,YR,,M,Y,,,20161226.0,,OT,ES,ES,2016,Q4,Elderly
130618751,13061875,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2016,Q4,General physical condition abnormal,,2016,Q4,1,I,,20161212.0,20161226,20161226,EXP,,ES-AUROBINDO-AUR-APL-2016-15752,AUROBINDO,,80.0,YR,,M,Y,,,20161226.0,,OT,ES,ES,2016,Q4,Elderly
130618751,13061875,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2016,Q4,Hyperkalaemia,,2016,Q4,1,I,,20161212.0,20161226,20161226,EXP,,ES-AUROBINDO-AUR-APL-2016-15752,AUROBINDO,,80.0,YR,,M,Y,,,20161226.0,,OT,ES,ES,2016,Q4,Elderly
130618751,13061875,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2016,Q4,Hypersensitivity vasculitis,,2016,Q4,1,I,,20161212.0,20161226,20161226,EXP,,ES-AUROBINDO-AUR-APL-2016-15752,AUROBINDO,,80.0,YR,,M,Y,,,20161226.0,,OT,ES,ES,2016,Q4,Elderly
130618751,13061875,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2016,Q4,Hypopnoea,,2016,Q4,1,I,,20161212.0,20161226,20161226,EXP,,ES-AUROBINDO-AUR-APL-2016-15752,AUROBINDO,,80.0,YR,,M,Y,,,20161226.0,,OT,ES,ES,2016,Q4,Elderly
130618751,13061875,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2016,Q4,Oedema,,2016,Q4,1,I,,20161212.0,20161226,20161226,EXP,,ES-AUROBINDO-AUR-APL-2016-15752,AUROBINDO,,80.0,YR,,M,Y,,,20161226.0,,OT,ES,ES,2016,Q4,Elderly
130618751,13061875,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2016,Q4,Pallor,,2016,Q4,1,I,,20161212.0,20161226,20161226,EXP,,ES-AUROBINDO-AUR-APL-2016-15752,AUROBINDO,,80.0,YR,,M,Y,,,20161226.0,,OT,ES,ES,2016,Q4,Elderly
130618751,13061875,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2016,Q4,Renal impairment,,2016,Q4,1,I,,20161212.0,20161226,20161226,EXP,,ES-AUROBINDO-AUR-APL-2016-15752,AUROBINDO,,80.0,YR,,M,Y,,,20161226.0,,OT,ES,ES,2016,Q4,Elderly
130632091,13063209,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2016,Q4,Hypersensitivity vasculitis,,2016,Q4,1,I,,20161216.0,20161227,20161227,EXP,,ES-ORCHID HEALTHCARE-1061283,ORCHID,"VENTURA-RIBES O, MACHANCOSES FH, ROSEL REMIREZ JF. VASCULITIS AFTER BLOOD PRESSURE MONITORING. REUMATOL CLIN 2016; 12(4):216-218.",80.0,YR,,M,Y,,,20161227.0,,,ES,ES,2016,Q4,Elderly
130661052,13066105,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,8-30 UNITS/DAY,,,,,,,,,,,,2016,Q4,Hepatic function abnormal,,2016,Q4,2,F,20160220.0,20161118.0,20161227,20161227,EXP,,JP-TEVA-716479ISR,TEVA,,81.0,YR,,F,Y,48.0,KG,20161227.0,,OT,JP,JP,2016,Q4,Elderly
130676511,13067651,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2016,Q4,Acute kidney injury,,2016,Q4,1,I,,20150119.0,20161228,20161228,EXP,,US-AUROBINDO-AUR-APL-2015-00491,AUROBINDO,,76.0,YR,,F,Y,,,20161228.0,,OT,US,US,2016,Q4,Elderly
130676511,13067651,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2016,Q4,Crystal nephropathy,,2016,Q4,1,I,,20150119.0,20161228,20161228,EXP,,US-AUROBINDO-AUR-APL-2015-00491,AUROBINDO,,76.0,YR,,F,Y,,,20161228.0,,OT,US,US,2016,Q4,Elderly
130677031,13067703,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2016,Q4,Crystal nephropathy,,2016,Q4,1,I,201312.0,20161218.0,20161228,20161228,EXP,,US-INFO-000258,ACS DOBFAR,"BAIRD P, LEUNG S, HOANG H, BABALOLA O, DEVOE CE, WANCHOO R, JHAVERI KD. A CASE OF ACUTE KIDNEY INJURY FROM CRYSTAL NEPHROPATHY SECONDARY TO POMALIDOMIDE AND LEVOFLOXACIN USE. J ONCOL PHARM PRACT. 2016 APR;22(2):357-60.",76.0,YR,,F,Y,,,20161228.0,,MD,US,US,2016,Q4,Elderly
130713211,13071321,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,25.0,IU,UNSPECIFIED,,2016,Q4,Diabetic ketoacidosis,,2016,Q4,1,I,,20160403.0,20161229,20161229,EXP,,US-JNJFOC-20160403340,JANSSEN,"OHRI P, ACUNA MV, LUTHRA P. CANAGLIFLOZIN INDUCED DIABETIC KETOACIDOSIS, A CASE REPORT.. ENDOCRINE REVIEWS 2016;37 (2 SUPPLEMENT 1).",35.0,YR,A,F,Y,,,20161229.0,,OT,US,US,2016,Q4,Adult
130713211,13071321,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,25.0,IU,UNSPECIFIED,,2016,Q4,Diabetic ketoacidosis,,2016,Q4,1,I,,20160403.0,20161229,20161229,EXP,,US-JNJFOC-20160403340,JANSSEN,"OHRI P, ACUNA MV, LUTHRA P. CANAGLIFLOZIN INDUCED DIABETIC KETOACIDOSIS, A CASE REPORT.. ENDOCRINE REVIEWS 2016;37 (2 SUPPLEMENT 1).",35.0,YR,A,F,Y,,,20161229.0,,OT,US,US,2016,Q4,Adult
130757161,13075716,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2016,Q4,Blood glucose increased,,2016,Q4,1,I,20161101.0,20161228.0,20161230,20161230,PER,,US-ELI_LILLY_AND_COMPANY-US201612010288,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20161230.0,,CN,US,US,2016,Q4,Elderly
130758241,13075824,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Haemoglobin decreased,,2016,Q4,1,I,20160523.0,,20161230,20161230,DIR,US-FDA-359027,,FDA-CTU,,63.0,YR,,M,N,85.5,KG,20161229.0,N,CN,US,US,2016,Q4,Adult
130758241,13075824,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2016,Q4,Myocardial infarction,,2016,Q4,1,I,20160523.0,,20161230,20161230,DIR,US-FDA-359027,,FDA-CTU,,63.0,YR,,M,N,85.5,KG,20161229.0,N,CN,US,US,2016,Q4,Adult
130766071,13076607,37,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,UNKNOWN,,2016,Q4,Asthenia,,2016,Q4,1,I,20161119.0,20161221.0,20161230,20161230,PER,,US-CELGENEUS-USA-2016126364,CELGENE,,66.0,YR,,M,Y,74.3,KG,20161230.0,,OT,US,US,2016,Q4,Elderly
130766071,13076607,37,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,UNKNOWN,,2016,Q4,Dizziness,,2016,Q4,1,I,20161119.0,20161221.0,20161230,20161230,PER,,US-CELGENEUS-USA-2016126364,CELGENE,,66.0,YR,,M,Y,74.3,KG,20161230.0,,OT,US,US,2016,Q4,Elderly
79321703,7932170,2,C,GLARGINE,,2,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q4,Death,,2016,Q4,3,F,2010.0,20110425.0,20110505,20161003,EXP,,US-CELGENEUS-163-21880-11043204,CELGENE,,59.0,YR,,M,Y,,,20161003.0,,PH,US,US,2016,Q4,Adult
79321703,7932170,2,C,GLARGINE,,2,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q4,Plasma cell myeloma,,2016,Q4,3,F,2010.0,20110425.0,20110505,20161003,EXP,,US-CELGENEUS-163-21880-11043204,CELGENE,,59.0,YR,,M,Y,,,20161003.0,,PH,US,US,2016,Q4,Adult
933863016,9338630,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 IU, QD (BEFORE BED TIME 16 IU)",,,U,,,,,16.0,IU,,QD,2016,Q4,Condition aggravated,,2016,Q4,16,F,201301.0,20161017.0,20130610,20161025,EXP,,PHHY2013JP056227,NOVARTIS,"YAMATANI K, SOGA A, YOSHIKURA T, NAITO T, CHUMAN K, SACHIYO O ET AL.. A CASE OF CHRONIC MYELOID LEUKAEMIA DEVELOPED ULCER ON FINGERTIPS OF BOTH HANDS DURING ORAL ADMINISTRATION OF IMATINIB. THE 603RD KANTO REGINOAL MEETING THE JAPANESE SOCIETY OF INTERNAL MEDICINE. 2014",49.0,YR,,M,Y,90.6,KG,20161025.0,,OT,JP,JP,2016,Q4,Adult
933863016,9338630,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 IU, QD (BEFORE BED TIME 16 IU)",,,U,,,,,16.0,IU,,QD,2016,Q4,Diarrhoea,,2016,Q4,16,F,201301.0,20161017.0,20130610,20161025,EXP,,PHHY2013JP056227,NOVARTIS,"YAMATANI K, SOGA A, YOSHIKURA T, NAITO T, CHUMAN K, SACHIYO O ET AL.. A CASE OF CHRONIC MYELOID LEUKAEMIA DEVELOPED ULCER ON FINGERTIPS OF BOTH HANDS DURING ORAL ADMINISTRATION OF IMATINIB. THE 603RD KANTO REGINOAL MEETING THE JAPANESE SOCIETY OF INTERNAL MEDICINE. 2014",49.0,YR,,M,Y,90.6,KG,20161025.0,,OT,JP,JP,2016,Q4,Adult
933863016,9338630,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 IU, QD (BEFORE BED TIME 16 IU)",,,U,,,,,16.0,IU,,QD,2016,Q4,Infected skin ulcer,,2016,Q4,16,F,201301.0,20161017.0,20130610,20161025,EXP,,PHHY2013JP056227,NOVARTIS,"YAMATANI K, SOGA A, YOSHIKURA T, NAITO T, CHUMAN K, SACHIYO O ET AL.. A CASE OF CHRONIC MYELOID LEUKAEMIA DEVELOPED ULCER ON FINGERTIPS OF BOTH HANDS DURING ORAL ADMINISTRATION OF IMATINIB. THE 603RD KANTO REGINOAL MEETING THE JAPANESE SOCIETY OF INTERNAL MEDICINE. 2014",49.0,YR,,M,Y,90.6,KG,20161025.0,,OT,JP,JP,2016,Q4,Adult
933863016,9338630,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 IU, QD (BEFORE BED TIME 16 IU)",,,U,,,,,16.0,IU,,QD,2016,Q4,Osteomyelitis,,2016,Q4,16,F,201301.0,20161017.0,20130610,20161025,EXP,,PHHY2013JP056227,NOVARTIS,"YAMATANI K, SOGA A, YOSHIKURA T, NAITO T, CHUMAN K, SACHIYO O ET AL.. A CASE OF CHRONIC MYELOID LEUKAEMIA DEVELOPED ULCER ON FINGERTIPS OF BOTH HANDS DURING ORAL ADMINISTRATION OF IMATINIB. THE 603RD KANTO REGINOAL MEETING THE JAPANESE SOCIETY OF INTERNAL MEDICINE. 2014",49.0,YR,,M,Y,90.6,KG,20161025.0,,OT,JP,JP,2016,Q4,Adult
933863016,9338630,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 IU, QD (BEFORE BED TIME 16 IU)",,,U,,,,,16.0,IU,,QD,2016,Q4,Pain in extremity,,2016,Q4,16,F,201301.0,20161017.0,20130610,20161025,EXP,,PHHY2013JP056227,NOVARTIS,"YAMATANI K, SOGA A, YOSHIKURA T, NAITO T, CHUMAN K, SACHIYO O ET AL.. A CASE OF CHRONIC MYELOID LEUKAEMIA DEVELOPED ULCER ON FINGERTIPS OF BOTH HANDS DURING ORAL ADMINISTRATION OF IMATINIB. THE 603RD KANTO REGINOAL MEETING THE JAPANESE SOCIETY OF INTERNAL MEDICINE. 2014",49.0,YR,,M,Y,90.6,KG,20161025.0,,OT,JP,JP,2016,Q4,Adult
933863016,9338630,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 IU, QD (BEFORE BED TIME 16 IU)",,,U,,,,,16.0,IU,,QD,2016,Q4,Peripheral arterial occlusive disease,,2016,Q4,16,F,201301.0,20161017.0,20130610,20161025,EXP,,PHHY2013JP056227,NOVARTIS,"YAMATANI K, SOGA A, YOSHIKURA T, NAITO T, CHUMAN K, SACHIYO O ET AL.. A CASE OF CHRONIC MYELOID LEUKAEMIA DEVELOPED ULCER ON FINGERTIPS OF BOTH HANDS DURING ORAL ADMINISTRATION OF IMATINIB. THE 603RD KANTO REGINOAL MEETING THE JAPANESE SOCIETY OF INTERNAL MEDICINE. 2014",49.0,YR,,M,Y,90.6,KG,20161025.0,,OT,JP,JP,2016,Q4,Adult
933863016,9338630,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 IU, QD (BEFORE BED TIME 16 IU)",,,U,,,,,16.0,IU,,QD,2016,Q4,Pigmentation disorder,,2016,Q4,16,F,201301.0,20161017.0,20130610,20161025,EXP,,PHHY2013JP056227,NOVARTIS,"YAMATANI K, SOGA A, YOSHIKURA T, NAITO T, CHUMAN K, SACHIYO O ET AL.. A CASE OF CHRONIC MYELOID LEUKAEMIA DEVELOPED ULCER ON FINGERTIPS OF BOTH HANDS DURING ORAL ADMINISTRATION OF IMATINIB. THE 603RD KANTO REGINOAL MEETING THE JAPANESE SOCIETY OF INTERNAL MEDICINE. 2014",49.0,YR,,M,Y,90.6,KG,20161025.0,,OT,JP,JP,2016,Q4,Adult
933863016,9338630,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 IU, QD (BEFORE BED TIME 16 IU)",,,U,,,,,16.0,IU,,QD,2016,Q4,Skin necrosis,,2016,Q4,16,F,201301.0,20161017.0,20130610,20161025,EXP,,PHHY2013JP056227,NOVARTIS,"YAMATANI K, SOGA A, YOSHIKURA T, NAITO T, CHUMAN K, SACHIYO O ET AL.. A CASE OF CHRONIC MYELOID LEUKAEMIA DEVELOPED ULCER ON FINGERTIPS OF BOTH HANDS DURING ORAL ADMINISTRATION OF IMATINIB. THE 603RD KANTO REGINOAL MEETING THE JAPANESE SOCIETY OF INTERNAL MEDICINE. 2014",49.0,YR,,M,Y,90.6,KG,20161025.0,,OT,JP,JP,2016,Q4,Adult
933863016,9338630,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 IU, QD (BEFORE BED TIME 16 IU)",,,U,,,,,16.0,IU,,QD,2016,Q4,Skin ulcer,,2016,Q4,16,F,201301.0,20161017.0,20130610,20161025,EXP,,PHHY2013JP056227,NOVARTIS,"YAMATANI K, SOGA A, YOSHIKURA T, NAITO T, CHUMAN K, SACHIYO O ET AL.. A CASE OF CHRONIC MYELOID LEUKAEMIA DEVELOPED ULCER ON FINGERTIPS OF BOTH HANDS DURING ORAL ADMINISTRATION OF IMATINIB. THE 603RD KANTO REGINOAL MEETING THE JAPANESE SOCIETY OF INTERNAL MEDICINE. 2014",49.0,YR,,M,Y,90.6,KG,20161025.0,,OT,JP,JP,2016,Q4,Adult
933863016,9338630,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 IU, QD (BEFORE BED TIME 16 IU)",,,U,,,,,16.0,IU,,QD,2016,Q4,Vascular calcification,,2016,Q4,16,F,201301.0,20161017.0,20130610,20161025,EXP,,PHHY2013JP056227,NOVARTIS,"YAMATANI K, SOGA A, YOSHIKURA T, NAITO T, CHUMAN K, SACHIYO O ET AL.. A CASE OF CHRONIC MYELOID LEUKAEMIA DEVELOPED ULCER ON FINGERTIPS OF BOTH HANDS DURING ORAL ADMINISTRATION OF IMATINIB. THE 603RD KANTO REGINOAL MEETING THE JAPANESE SOCIETY OF INTERNAL MEDICINE. 2014",49.0,YR,,M,Y,90.6,KG,20161025.0,,OT,JP,JP,2016,Q4,Adult
98116682,9811668,42,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE:25 UNIT(S),,,,,,,,,,,QD,2016,Q4,Gastrointestinal haemorrhage,,2016,Q4,2,F,20111217.0,20151216.0,20140110,20161219,PER,,US-SANOFI-AVENTIS-2013SA049182,AVENTIS,,60.0,YR,A,M,Y,101.1,KG,20161219.0,,MD,US,US,2016,Q4,Adult
